Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.6920493437132277,-2.6449615102617328,0.0,0.0,0.0,68/91,18.74%,RPLP1;RPS14;RPL37A;RPL38;RPL30;RPL8;RPL21;RPL41;RPL14;RPL9;RPS24;RPL13;RPS27;RPLP2;RPS21;RPS23;RPS9;RPS29;RPS15;RPL22;RPS5;RPS16;RPL5;RPS4X;RPS2;RPS13;RPL34;RPL23;RPL17;RPS19;RPS8;RPS20;RPS27A;RPS17;RPL13A;RPS12;RPS7;RPS3;RPL27A;RPL3;RPL24;RPS18;SRP14;RPL18;RPL39;RPS11;RPL23A;RPL7A;RPL35A;SEC62;RPL26;RPL32;RPL18A;RPS25;RPL36;RPL12;RPS10;RPL27;RPL11;RPL31;RPL19;SSR2;TRAM1;RPLP0;RPS15A;RPS28;RPL37;RPL29
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.6972056714984246,-2.6435517651797844,0.0,0.0,0.0,65/87,18.74%,RPLP1;RPS14;RPL37A;RPL38;RPL30;RPL8;RPL21;RPL41;RPL14;RPL9;RPS24;RPL13;RPS27;RPLP2;RPS21;RPS23;RPS9;RPS29;RPS15;RPL22;RPS5;RPS16;RPL5;RPS4X;RPS2;RPS13;RPL34;RPL23;RPL17;RPS19;RPS8;RPS20;RPS27A;RPS17;RPL13A;RPS12;RPS7;RPS3;RPL27A;RPL3;RPL24;RPS18;SRP14;RPL18;RPL39;RPS11;RPL23A;RPL7A;RPL35A;RPL26;RPL32;RPL18A;RPS25;RPL36;RPL12;RPS10;RPL27;RPL11;RPL31;RPL19;RPLP0;RPS15A;RPS28;RPL37;RPL29
prerank,protein targeting to ER (GO:0045047),-0.6632385882333598,-2.596339175566253,0.0,0.0,0.0,70/99,19.89%,RPLP1;RPS14;RPL37A;RPL38;RPL30;RPL8;RPL21;RPL41;RPL14;RPL9;RPS24;RPL13;RPS27;RPLP2;RPS21;RPS23;RPS9;RPS29;RPS15;RPL22;RPS5;RPS16;RPL5;RPS4X;RPS2;RPS13;RPL34;RPL23;RPL17;RPS19;RPS8;RPS20;RPS27A;RPS17;RPL13A;RPS12;RPS7;RPS3;RPL27A;RPL3;RPL24;RPS18;SPCS3;SRP14;RPL18;RPL39;RPS11;RPL23A;RPL7A;RPL35A;SEC62;RPL26;RPL32;RPL18A;RPS25;RPL36;RPL12;SEC61G;RPS10;RPL27;RPL11;RPL31;RPL19;RPLP0;RPS15A;RPS28;RPL37;RPL29;SPCS1;RPL28
prerank,cytoplasmic translation (GO:0002181),-0.6696924416511632,-2.5872891785932133,0.0,0.0,0.0,65/91,18.74%,RPLP1;RPS14;RPL37A;RPL38;RPL30;RPL8;RPL21;RPL41;RPL14;RPL9;RPS24;RPL13;RPS27;RPS21;RPS23;RPS9;RPS29;RPS15;RPL22;RPS5;RPS16;RPL5;RPS4X;RPS2;RPS13;EIF3M;RPL34;RPL23;RPL17;RPS19;RPS8;RPS20;RPS27A;RPS17;RPL13A;RPS12;RPS7;RPS3;RPL27A;RPL3;RPL24;RPS18;RPL18;RPL39;RPS11;RPL23A;DRG2;RPL7A;RPL35A;RPL26;RPL32;RPL18A;RPS25;RPL36;RPL12;RPS10;RPL27;RPL11;RPL31;RPL19;RPLP0;RPS15A;RPS28;RPL37;RPL29
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.567100076302555,-2.2377142511093755,0.0,0.000586593856218047,0.003,66/110,18.74%,RPLP1;RPS14;RPL37A;RPL38;RPL30;RPL8;RPL21;RPL41;RPL14;RPL9;RPS24;RPL13;RPS27;RPLP2;RPS21;RPS23;RPS9;RPS29;RPS15;RPL22;RPS5;RPS16;RPL5;RPS4X;RPS2;RPS13;RPL34;RPL23;RPL17;RPS19;RPS8;RPS20;RPS27A;RPS17;RPL13A;RPS12;RPS7;RPS3;RPL27A;RPL3;RPL24;RNPS1;RPS18;RPL18;RPL39;RPS11;RPL23A;UPF1;RPL7A;RPL35A;RPL26;RPL32;RPL18A;RPS25;RPL36;RPL12;RPS10;RPL27;RPL11;RPL31;RPL19;RPLP0;RPS15A;RPS28;RPL37;RPL29
prerank,response to glucocorticoid (GO:0051384),0.8642861050602041,2.090661677561622,0.0,0.0050555412912330145,0.005,7/26,3.51%,SLIT3;SLIT2;ANXA1;ISL1;ADAM9;FAM107A;IL10
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.566035034025066,-2.0529087404374393,0.0,0.011894819862199287,0.061,41/69,27.07%,SDHA;COX4I1;COX7C;UQCR10;UQCRH;NDUFA8;COX8A;COX6B1;NDUFB3;NDUFS4;COX6A1;NDUFA6;COX5B;COX6C;NDUFS3;UQCR11;NDUFA12;NDUFC2;NDUFS2;NDUFB7;NDUFA1;NDUFB8;COX10;NDUFA3;NDUFB9;NDUFB4;NDUFS5;CYCS;NDUFC1;UQCRC2;COA6;UQCRB;NDUFA10;SDHAF2;NDUFB11;UQCRFS1;NDUFA9;NDUFA5;COX4I2;NDUFS6;NDUFA11
prerank,aerobic electron transport chain (GO:0019646),-0.5634494029929776,-2.029128359460715,0.0,0.014804511609312615,0.089,40/68,27.07%,SDHA;COX4I1;COX7C;UQCR10;UQCRH;NDUFA8;COX8A;COX6B1;NDUFB3;NDUFS4;COX6A1;NDUFA6;COX5B;COX6C;NDUFS3;UQCR11;NDUFA12;NDUFC2;NDUFS2;NDUFB7;NDUFA1;NDUFB8;COX10;NDUFA3;NDUFB9;NDUFB4;NDUFS5;CYCS;NDUFC1;UQCRC2;UQCRB;NDUFA10;SDHAF2;NDUFB11;UQCRFS1;NDUFA9;NDUFA5;COX4I2;NDUFS6;NDUFA11
prerank,bicarbonate transport (GO:0015701),0.837293588253029,2.0096139541787967,0.0,0.027299922972658278,0.049,3/25,0.04%,SLC4A10;SLC26A7;SLC4A4
prerank,regulation of BMP signaling pathway (GO:0030510),0.6873793224802538,1.9675046126362878,0.0,0.05830724289222077,0.145,16/73,5.45%,BMP4;BMPER;CRIM1;FSTL1;SMAD9;HTRA3;FOXD1;SULF1;VWC2;CCN1;SMAD6;SKIL;GDF5;BAMBI;BMPR1A;ZNF423
prerank,organic anion transport (GO:0015711),0.6753612797914609,1.937888550793089,0.0,0.09125252030675592,0.26,9/76,2.82%,SLC4A10;SLC26A7;SLC4A4;SLC23A1;SLCO3A1;LRRC8D;SLCO4A1;SLCO2A1;ABCG2
prerank,positive regulation of blood coagulation (GO:0030194),0.8508080753262768,1.9276391728716558,0.0,0.09585306288177796,0.309,7/17,9.56%,ST3GAL4;F3;THBS1;ANO6;THBD;HPSE;DMTN
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.562534619404632,-1.923689240274646,0.0,0.07662382246848239,0.425,15/46,8.91%,ATP1A2;SHANK3;CDH2;NRXN1;GRM3;DGKI;GRIK1;GRM5;GRM1;GRM7;MEF2C;OPHN1;GRM8;CACNG4;LRRK2
prerank,peptide biosynthetic process (GO:0043043),-0.4679436259308421,-1.919976670905458,0.0,0.07223794710833356,0.444,79/153,20.99%,RPLP1;RPS14;RPL37A;RPL38;RPL30;RPL8;RPL21;RPL41;RPL14;RPL9;RPS24;RPL13;EEF1A1;RPS27;RPLP2;RPS21;RPS23;RPS9;RPS29;RPS15;RPL22;RPS5;RPS16;GGT5;RPL5;RPS4X;RPS2;RPS13;RPL34;RPL23;RPL17;RPS19;RPS8;RPS20;RPS27A;RPS17;RPL13A;RPS12;RPS7;RPS3;RPL27A;RPL3;RPL24;RPS18;RPL18;RPL39;RPS11;MRPL3;RPL23A;RPL7A;RPL35A;RPL26;PCSK1;RPL32;RPL18A;RPS25;RPL36;RPL12;RPS10;RPL27;RPL11;MRPS11;RPL31;SARS1;RPL19;GGT7;RPLP0;RPS15A;RPS28;RPL37;MRPL51;RPL29;MRPL35;RPL28;HBS1L;MRPL34;EIF4EBP2;GGT1;SRBD1
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.8346848189539022,1.908869005700382,0.001584786053882726,0.12234409924783896,0.414,3/18,1.58%,EGFR;BMP4;DDX5
prerank,ion homeostasis (GO:0050801),0.7692613808329106,1.904026529784617,0.001447178002894356,0.11757744603039069,0.446,5/30,2.50%,SLC4A10;SLC4A4;FHL1;CAMK2D;WNK1
prerank,regulation of multicellular organism growth (GO:0040014),-0.7511108517449483,-1.9001438528543868,0.0,0.08935779743054917,0.554,7/15,11.27%,IGF1;PTCH1;GHR;STAT5B;MFSD2A;PPIB;APP
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),-0.5978868401740393,-1.8997000837156168,0.0,0.08176762844251564,0.556,15/35,8.85%,IRAG1;KSR1;APOE;RAPGEF3;PDE7B;ADCY1;RAPGEF2;AHR;RIMS2;ADCY2;GUCY1B1;CAP2;PDE4D;PDE9A;PDE2A
prerank,regulation of intracellular pH (GO:0051453),0.7516296761929394,1.8968488742878966,0.0,0.11766772355344841,0.494,12/34,13.01%,SLC4A10;SLC4A4;SLC9A2;SLC9B1;SLC9C1;SLC9A8;SLC4A8;SLC26A6;NOX1;SLC4A3;SLC9A1;SLC9A3
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.8996636957835762,1.8766750108153,0.0,0.16076621306120986,0.626,3/11,1.58%,EGFR;BMP4;DDX5
prerank,regulation of cellular pH (GO:0030641),0.7596633376877371,1.8630330810662077,0.001488095238095238,0.18857169016299147,0.719,12/29,13.01%,SLC4A10;SLC4A4;SLC9A2;SLC9B1;SLC9C1;SLC9A8;SLC4A8;SLC26A6;SLC4A3;ATP1A4;SLC9A1;SLC9A3
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.7875919675358355,-1.8620555027065335,0.0,0.12921359110580868,0.726,6/12,6.10%,IL34;LYN;CSF1;PTK2;BST2;MAPK3
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.791356543281096,1.859192755835617,0.0,0.18466513552885686,0.736,4/23,2.43%,SLC12A7;SLC12A2;SLC12A8;ATP6V0A4
prerank,cellular response to copper ion (GO:0071280),-0.7052720513389363,-1.858155476781734,0.0,0.12423757057336073,0.735,10/16,14.55%,SNCA;MT2A;MT1B;MT1E;MT1A;MT1F;MT1G;MT1M;MT1X;MT1H
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),-0.5560309222923373,-1.8572512720871461,0.0,0.11662044522430222,0.738,14/41,10.33%,IL34;TGFA;DOCK3;GRM5;ACE;NEDD9;EPHA4;ADRA2A;GPRC5B;LRP8;GAS6;NTRK2;SRC;HBEGF
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.7890677527220348,-1.8537569819626152,0.0022172949002217295,0.11503757291387255,0.756,3/10,2.25%,ERRFI1;ENG;ENPP1
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.692980025330038,-1.849892964106611,0.005555555555555556,0.11377476669562536,0.775,5/19,2.68%,TJP1;PRKCH;CLDN5;F11R;OCLN
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.6834273681809934,1.8420112285082357,0.0,0.23870580796771884,0.835,10/51,4.33%,BMPER;CRIM1;FSTL1;SMAD9;HTRA3;VWC2;SMAD6;SKIL;BAMBI;BMPR1A
prerank,response to ketone (GO:1901654),0.7751642941297489,1.8416735405234903,0.0031645569620253164,0.22174381878931268,0.836,4/24,1.44%,SLIT3;SLIT2;THBS1;TGFB3
prerank,response to copper ion (GO:0046688),-0.639758550631061,-1.838426497493101,0.005263157894736842,0.12456493064394997,0.825,11/20,14.55%,SNCA;MT2A;ATP5F1D;MT1B;MT1E;MT1A;MT1F;MT1G;MT1M;MT1X;MT1H
prerank,cation transport (GO:0006812),0.5902497763631461,1.828292769405738,0.0,0.2607937086091774,0.906,20/167,5.58%,SLC47A1;SLC4A4;PIEZO2;KCNB2;SLC9B2;SLC23A1;KCNK5;KCNJ2;SLC12A2;KCNMB3;KCNMB2;SLC5A6;ATP1B1;TRPM6;ANO6;KCNS3;TRPM4;KCNK7;SCN11A;SLC38A7
prerank,keratinocyte differentiation (GO:0030216),0.7317886047168463,1.8212991103178546,0.001584786053882726,0.2746844101569938,0.926,12/29,7.78%,CLIC4;ANXA1;DSP;ADAM9;TGM3;BCR;SPRR1A;WNT16;PIP5K1A;TGM1;JAG1;EXPH5
prerank,peptide cross-linking (GO:0018149),0.7574501318891035,1.8207872823885003,0.0015552099533437014,0.26036037649850025,0.929,8/25,6.47%,THBS1;FN1;ANXA1;DSP;COL3A1;TGM3;SPRR1A;TGM1
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.6338221916132655,1.8187910338406768,0.0,0.25396660368899965,0.932,21/79,11.02%,SLIT2;BMPER;CRIM1;THBS1;SMAD9;HTRA3;SULF1;VWC2;NEDD4;SMAD6;SKIL;BAMBI;BMPR1A;ATP2B4;FGF2;UBE2D3;AGTR2;SKI;SULF2;NIBAN2;NOG
prerank,monosaccharide transmembrane transport (GO:0015749),0.8002711964186116,1.814727795094578,0.00338409475465313,0.25788877853389747,0.942,2/16,0.26%,SLC23A1;SLC23A2
prerank,neuron cell-cell adhesion (GO:0007158),-0.7311441335807981,-1.8134952309525683,0.0024330900243309003,0.16212802414915467,0.913,10/14,21.55%,NRXN1;NCAM2;NRXN3;ASTN2;CNTN4;ASTN1;NLGN1;CDK5R1;NLGN2;NINJ2
prerank,endodermal cell differentiation (GO:0035987),0.7083321940703665,1.7908755844489135,0.0015384615384615385,0.3520785387662908,0.981,13/31,12.62%,COL8A1;COL12A1;FN1;COL6A1;INHBA;ITGA5;ITGAV;MMP14;ITGB5;CTR9;SETD2;PAF1;RTF1
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),-0.7356996770814191,-1.787070530721414,0.004672897196261682,0.21199707786125907,0.961,8/12,21.66%,PCGF5;SMCHD1;YTHDC1;CDYL;METTL3;BRCA1;HNRNPU;RBM15B
prerank,negative regulation of calcium ion transport (GO:0051926),-0.6839287074187581,-1.780548144886748,0.0049261083743842365,0.21777296912094993,0.966,7/15,16.64%,ATP1A2;ADRA2A;TMBIM6;SLC30A1;TRIM27;CBARP;NOS1
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.8329651727723248,1.7782056805446096,0.0035842293906810036,0.4081844038541536,0.994,8/11,11.71%,BMP4;ZFPM2;ISL1;BMPR1A;JAG1;GATA4;GATA3;TGFB2
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.6032844783033681,-1.777422153089269,0.002849002849002849,0.2149447487427558,0.969,12/26,18.17%,LYN;PICALM;MBP;EPHA4;GRIN2B;AIM2;GRIN1;PSME2;TTBK1;APH1B;PSENEN;VSIR
prerank,cellular response to drug (GO:0035690),-0.6183080257301858,-1.772001685016239,0.0,0.21801738322770747,0.972,11/25,15.66%,PPM1E;PDE4B;ACER2;RAP2A;TFRC;MEF2C;AIM2;GAS6;KCNQ1;CERS1;PPM1F
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.6501204471758469,-1.772001679254894,0.009925558312655087,0.20853836656563324,0.972,5/18,9.17%,IGF1;IGFBP2;IGF2;RPS3;IL18
prerank,collagen fibril organization (GO:0030199),0.6054484418828757,1.7708390617137417,0.0012330456226880395,0.4305876739761605,0.996,21/88,5.74%,COL25A1;COL8A1;COL12A1;TLL1;ADAMTS2;COL6A2;COL6A1;COL5A2;CYP1B1;COL23A1;COL8A2;P3H2;BMP1;DDR2;COL3A1;P4HA2;PLOD2;P4HA1;COL6A3;TGFBR1;P3H4
prerank,cAMP-mediated signaling (GO:0019933),-0.6171477332921169,-1.7600646987877668,0.002793296089385475,0.22893454666287666,0.982,11/24,8.85%,KSR1;RAPGEF3;PDE7B;ADCY1;RAPGEF2;AHR;RIMS2;ADCY2;CAP2;PDE4D;PDE2A
prerank,endoderm formation (GO:0001706),0.6815684512786105,1.7596134485043693,0.0015082956259426848,0.48170116612193836,0.999,9/35,8.23%,COL8A1;COL12A1;FN1;COL6A1;INHBA;ITGA5;ITGAV;MMP14;ITGB5
prerank,ganglioside biosynthetic process (GO:0001574),-0.6661371397674979,-1.755102988715056,0.012195121951219513,0.23123529812115415,0.987,8/15,17.88%,ST6GALNAC3;ST3GAL1;ST8SIA4;ST8SIA6;ST3GAL5;ST6GALNAC4;B4GALT5;ST6GALNAC6
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.7947122081936185,1.7543335714291866,0.0049833887043189366,0.4939483647677752,0.999,6/15,11.02%,BMP4;SMO;SIX1;GDNF;SIX4;NOG
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.667130652822515,1.7536242549500245,0.00291970802919708,0.4784227241936843,0.999,7/39,3.35%,STK39;FHL1;PTPN3;ANK2;NEDD4;WWP2;FXYD5
prerank,positive regulation of hemostasis (GO:1900048),0.85715001750977,1.7526212201891664,0.005454545454545455,0.4476098481699385,0.999,4/10,9.56%,ST3GAL4;THBS1;HPSE;DMTN
prerank,positive regulation of coagulation (GO:0050820),0.85715001750977,1.7526212201891664,0.005454545454545455,0.4476098481699385,0.999,4/10,9.56%,ST3GAL4;THBS1;HPSE;DMTN
prerank,mesonephric tubule development (GO:0072164),0.798915633875777,1.751479506585824,0.0033277870216306157,0.4373230459186604,0.999,5/15,2.36%,SLIT2;BMP4;SIX1;PKD1;WNT11
prerank,chloride transport (GO:0006821),0.6036256755296253,1.7441783963277184,0.0,0.4646403556735371,0.999,8/74,4.47%,SLC4A10;SLC26A7;SLC12A7;SLC12A2;CLIC4;SLC12A8;ANO6;GLRB
prerank,ion transport (GO:0006811),0.5788511642389004,1.7408600734872797,0.0011547344110854503,0.4693982924404833,0.999,9/111,2.80%,SLC26A7;PIEZO2;SLC9A2;SLC12A7;SLC26A2;SLC12A2;SLC24A3;WNK1;ANO6
prerank,digestive tract development (GO:0048565),0.6741102187253747,1.7383823054379013,0.007072135785007072,0.468884602957558,0.999,13/33,11.91%,RARB;PCSK5;SMO;COBL;PKD1;GLI3;STRA6;CCDC40;CLMP;GATA4;AGR2;TGFB2;MEGF8
prerank,aorta development (GO:0035904),-0.6926217335538098,-1.7361054453050602,0.01240694789081886,0.2716380780332803,0.995,7/14,10.16%,ROBO1;PDGFRB;ADAMTS9;TBX1;PDE2A;ROBO2;EFEMP2
prerank,epidermal cell differentiation (GO:0009913),0.6589531216409512,1.7314007680299264,0.007204610951008645,0.4940731579328885,0.999,11/41,6.86%,CLIC4;ANXA1;DSP;ADAM9;TGM3;BCR;SPRR1A;WNT16;PIP5K1A;TGM1;JAG1
prerank,positive regulation of nuclear division (GO:0051785),-0.5986265181172535,-1.7264847428765098,0.0,0.2890242074279291,0.999,8/25,11.16%,IGF1;TGFA;PDGFRB;INSR;IGF2;RGCC;EDN1;EDN3
prerank,central nervous system neuron development (GO:0021954),-0.6583896694633647,-1.7205007841130326,0.007352941176470588,0.297032972312317,0.999,8/15,17.55%,RAPGEF2;MAP2;LHX6;NTRK2;MAPT;HSP90AB1;ATP7A;B4GALT5
prerank,positive regulation of RNA metabolic process (GO:0051254),0.6450968977863206,1.7201321459425059,0.002758620689655172,0.5522862889341367,1.0,6/45,5.36%,SLC38A2;EGFR;BMP4;DDX5;DXO;NFKB1
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.8198138072243495,1.7196042008544816,0.012367491166077738,0.538246629473275,1.0,2/11,0.45%,SLIT2;CCN3
prerank,negative regulation of leukocyte migration (GO:0002686),0.8420002342387067,1.7163437484229729,0.012280701754385965,0.5442438892403259,1.0,2/10,1.04%,SLIT2;BMP5
prerank,extracellular matrix organization (GO:0030198),0.5284205024357542,1.709494820488985,0.0,0.5745694899504767,1.0,51/276,6.42%,COL25A1;COL8A1;ADAMTSL3;COL12A1;CDH1;SH3PXD2A;SMOC2;VIT;THBS1;ADAMTSL1;THSD4;TLL1;ADAMTS17;ITGB8;FN1;MMP28;ADAMTS2;COL6A2;COL6A1;CD44;COL5A2;CYP1B1;COL23A1;COL8A2;DSPP;ITGB1;MFAP5;P3H2;ITGA10;ADAMTSL5;BMP1;DDR2;COL3A1;P4HA2;GSN;CAPN2;ITGA5;PLOD2;P4HA1;PDGFA;COL6A3;TGFBR1;ADAM12;HTRA1;FLRT2;P3H4;ADAMTS5;MATN1;MMP16;ITGAV;MMP14
prerank,cellular response to chemokine (GO:1990869),0.6467313446931657,1.7094725039025092,0.008086253369272238,0.5587496580432756,1.0,4/46,2.50%,STK39;SLC12A2;PTK2B;WNK1
prerank,sodium ion import across plasma membrane (GO:0098719),0.753408217083944,1.7092229683473372,0.019448946515397084,0.545451914448708,1.0,4/17,5.11%,SLC9A2;SLC12A2;SLC9C1;TRPM4
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.700776131882756,1.7075233036745967,0.004405286343612335,0.5422201075407703,1.0,4/27,3.20%,EGFR;BMP4;DDX5;EIF4G1
prerank,rRNA processing (GO:0006364),-0.3914079651469285,-1.7071260720512313,0.0,0.3305827214985155,0.999,62/172,18.74%,NSA2;RPLP1;RPS14;RPL37A;RPL38;RPL30;RPL8;RPL21;RPL41;RPL14;RPL9;RPS24;RPL13;RPS27;RPLP2;RPS9;RPS15;RPL22;RPS16;RPL5;RPS2;RPL34;RPL23;RPL17;RPS19;RPS17;RPL13A;RPS7;RPL27A;RPL3;RPL24;EXOSC8;IMP3;RPL18;RPL39;EMG1;RPL23A;SNU13;RPL7A;RPL35A;POP5;RPL26;RPL32;RPL18A;RPS25;RPL36;RPL12;RIOK1;RPL27;LAS1L;RPL11;TSR3;DDX54;PIH1D1;RPL31;RPL19;RPLP0;THUMPD1;RPS28;RPL37;NOB1;RPL29
prerank,transepithelial transport (GO:0070633),0.778355191254492,1.704925829689257,0.011419249592169658,0.5455317941032056,1.0,5/15,2.82%,SLC23A1;SLC23A2;SLC12A2;CXADR;ABCG2
prerank,B cell receptor signaling pathway (GO:0050853),-0.5507624056628571,-1.7042789965516003,0.0060790273556231,0.3280037312685913,0.999,21/32,39.24%,BCL2;RFTN1;TEC;MEF2C;VAV3;CD38;BMX;BLNK;NCKAP1L;LAT2;SYK;PIK3CD;BTK;PTPRC;PLEKHA1;PRKCB;ITK;LCK;CD79A;CTLA4;BLK
prerank,ureteric bud development (GO:0001657),0.7628634723344027,1.7041048436410327,0.00825082508250825,0.5369995959547709,1.0,5/17,2.57%,SLIT2;BMP4;SIX1;WNT11;GPC3
prerank,negative regulation of signaling receptor activity (GO:2000272),-0.5861701076609671,-1.7024623171636826,0.0029498525073746312,0.3228473820486101,0.999,8/25,13.14%,ERRFI1;PPARA;SLC6A9;CBLB;SOCS5;CNRIP1;ACE2;ZFYVE28
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.40407010203342447,-1.7005246049099183,0.0,0.3189909610819077,0.999,74/168,17.78%,RPLP1;RPS14;CNOT6L;RPL37A;RPL38;RPL30;RPL8;RPL21;RPL41;RPL14;RPL9;RPS24;RPL13;RPS27;RPLP2;RPS21;RPS23;RPS9;RPS29;RPS15;RPL22;RPS5;RPS16;AGO1;RPL5;RPS4X;RPS2;RPS13;NBDY;RPL34;RPL23;RPL17;RPS19;RPS8;CNOT8;RPS20;RPS27A;RPS17;RPL13A;RPS12;RPS7;RPS3;RPL27A;RPL3;RPL24;EXOSC8;RNPS1;LSM1;RPS18;RPL18;RPL39;RPS11;RPL23A;UPF1;RPL7A;RPL35A;RPL26;RPL32;RPL18A;TENT4B;RPS25;RPL36;RPL12;RPS10;RPL27;RPL11;DCP1B;CNOT9;RPL31;DCP2;RPL19;RPLP0;RPS15A;RPS28
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.6253695342339773,-1.6987585319046052,0.002544529262086514,0.31495349926535643,0.999,9/17,19.26%,COX4I1;COX7C;COX8A;COX6B1;COX6A1;COX5B;COX6C;COX10;CYCS
prerank,positive regulation of potassium ion transport (GO:0043268),0.6503513216502549,1.698504313497788,0.008547008547008548,0.558871593863037,1.0,5/38,1.46%,KCNJ2;FHL1;KCNMB3;KCNMB2;ANK2
prerank,carbohydrate transport (GO:0008643),0.8146109731451567,1.6976184559075627,0.012345679012345678,0.5512706667997371,1.0,2/11,0.26%,SLC23A1;SLC23A2
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.6344326911237802,1.6975521630205002,0.004207573632538569,0.5388971874998988,1.0,17/43,12.38%,BMP4;KLF5;NFIB;FOXO3;DDX5;KLF4;IL10;JUN;FGF2;NFATC4;TEAD1;SMARCA4;ATOH8;GATA3;TGFB2;REST;STAT3
prerank,steroid hormone mediated signaling pathway (GO:0043401),0.7800595089287092,1.6948475526069675,0.010638297872340425,0.5439073037372465,1.0,3/13,1.76%,BMP4;NR3C2;ESR2
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.7428712805952224,1.6946516694666842,0.0031397174254317113,0.5329214593131762,1.0,9/21,8.00%,BMP4;CCN3;TGFB3;BMP6;GDF5;NUP93;BMPR1A;TGFBR1;WWTR1
prerank,sprouting angiogenesis (GO:0002040),0.6169605913614815,1.692590574381765,0.011049723756906077,0.5330958388533665,1.0,9/51,2.85%,RSPO3;SLIT2;BMP4;BMPER;THBS1;PTK2B;PARVA;PGF;SEMA3E
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.5925166818366729,-1.6923671074473725,0.006042296072507553,0.3261634368177111,0.999,4/23,2.27%,ENG;TGFBR3;NREP;ITGA3
prerank,regulation of smooth muscle contraction (GO:0006940),0.7135342474632785,1.6919481820882045,0.013008130081300813,0.5257762942882336,1.0,3/20,3.11%,KCNB2;PLCE1;ADRB2
prerank,positive regulation of CREB transcription factor activity (GO:0032793),-0.6234372708855295,-1.691494049713421,0.010416666666666666,0.31958191947574643,0.999,9/18,22.10%,CAMK1D;RPS6KA5;PRKD1;ADCY1;LRP8;CRTC2;ADCY8;VEGFA;CD200
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.6967188618799947,1.6899934042626739,0.00946372239747634,0.5271876328987027,1.0,7/26,8.85%,FOXP1;ISL1;CRY2;KANK2;PIAS2;STRN3;SMARCA4
prerank,cellular component maintenance (GO:0043954),-0.7013278476324047,-1.6897844583352182,0.013953488372093023,0.31610891140639197,0.999,4/12,8.76%,IGF1R;ITGA3;INSR;CLDN1
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.7334024527874632,-1.6882844448670784,0.007125890736342043,0.31250655574283076,0.999,5/11,6.65%,PLCB1;IGF1;IGF1R;PIK3R1;GHR
prerank,cellular zinc ion homeostasis (GO:0006882),-0.5687721953358111,-1.687814731926674,0.01092896174863388,0.30564627245045606,0.999,14/26,14.55%,SLC30A10;SLC39A10;SLC39A8;SLC39A7;MT2A;SLC30A1;MT1B;MT1E;MT1A;MT1F;MT1G;MT1M;MT1X;MT1H
prerank,translation (GO:0006412),-0.3977487382984651,-1.6873584248512652,0.0,0.2990876623306632,0.999,84/208,20.59%,RPLP1;RPS14;RPL37A;RPL38;RPL30;RPL8;RPL21;RPL41;RPL14;RPL9;RPS24;RPL13;EEF1A1;RPS27;RPLP2;RPS21;RPS23;RPS9;RPS29;EEF1B2;RPS15;RPL22;RPS5;LARS2;RPS16;RPL5;RPS4X;RPS2;RPS13;RPL34;RPL23;RPL17;RPS19;RPS8;RPS20;RPS27A;RPS17;RPL13A;RPS12;RPS7;RPS3;RPL27A;RPL3;RPL24;FASTKD2;RPS18;RPL18;RPL39;RPS11;MRPL3;RPL23A;IARS1;DRG2;RPL7A;PPA1;RPL35A;RPL26;RPL32;RPL18A;RPS25;RPL36;RPL12;RPS10;RPL27;RPL11;MRPS11;RPL31;SARS1;RPL19;GARS1;RPLP0;MRPL2;RPS15A;RPS28;RPL37;MRPL51;RPL29;MRPL35;APEH;RPL28;RARS2;HBS1L;MRPL34;EIF4EBP2
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.7005959857714152,1.686619294297413,0.01195814648729447,0.5367540410920538,1.0,7/26,2.62%,STK39;FHL1;ANK2;ATP1B1;NEDD4;ITGB1;WWP2
prerank,regulation of interleukin-1 production (GO:0032652),0.7534528242569382,1.6865159966704975,0.016304347826086956,0.5267065138858205,1.0,3/15,3.51%,FOXP1;ANXA1;IL10
prerank,regulation of phagocytosis (GO:0050764),-0.49931285032230693,-1.686038301764552,0.003937007874015748,0.29552109648051694,1.0,15/53,9.28%,CAMK1D;MERTK;TGM2;CD47;IL15RA;DYSF;SYT7;CYBA;SCARB1;SIRPA;SYT11;GAS6;GATA2;CALR;SPHK1
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.730510647706359,1.6841703695912453,0.011437908496732025,0.530435322537017,1.0,6/20,11.02%,SMOC2;THBS1;SULF1;FGF2;SULF2;NOG
prerank,regulation of acrosome reaction (GO:0060046),-0.7253815948480931,-1.682069899218578,0.016203703703703703,0.2987574969331671,1.0,2/10,9.15%,PLCB1;GLRA1
prerank,cellular response to glucagon stimulus (GO:0071377),-0.6350455522086165,-1.6815215648110475,0.014962593516209476,0.29343659331288496,1.0,12/17,15.58%,ADCY5;ADCY1;PRKAR2B;ADCY7;ADCY2;PRKACB;PRKAR1B;PRKAR1A;CYSLTR2;ADCY4;ADCY3;ADCY8
prerank,heterochromatin organization (GO:0070828),-0.6696435848250873,-1.680306244183892,0.015424164524421594,0.2903639588279333,1.0,4/14,10.26%,MECOM;PRDM16;SMCHD1;HP1BP3
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.5918959641027622,-1.6788284728982412,0.010958904109589041,0.2876309647250992,1.0,6/21,9.74%,PLTP;APOE;PTCH1;NR1H3;GPS2;EEPD1
prerank,rRNA metabolic process (GO:0016072),-0.40052838142377695,-1.676985473544471,0.0,0.286648864405219,1.0,60/160,18.74%,RPLP1;RPS14;RPL37A;RPL38;RPL30;RPL8;RPL21;RPL41;RPL14;RPL9;RPS24;RPL13;RPS27;RPLP2;RPS9;RPS15;RPL22;RPS16;RPL5;RPS2;RPL34;RPL23;RPL17;RPS19;RPS17;RPL13A;RPS7;MAPT;RPL27A;RPL3;RPL24;EXOSC8;IMP3;RPL18;RPL39;EMG1;RPL23A;SNU13;RPL7A;RPL35A;POP5;RPL26;RPL32;RPL18A;RPS25;RPL36;RPL12;NIFK;RPL27;LAS1L;RPL11;DDX54;PIH1D1;RPL31;RPL19;RPLP0;RPS28;RPL37;NOB1;RPL29
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.7886697571889567,1.6748018238431543,0.018214936247723135,0.576953927667177,1.0,1/13,0.01%,SLC4A10
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.7794537465298611,1.6733083740672734,0.010135135135135136,0.5753396764566236,1.0,3/14,2.50%,STK39;PTK2B;WNK1
prerank,embryonic digestive tract development (GO:0048566),0.7279963383625078,1.6716316698157738,0.007861635220125786,0.574459284500107,1.0,4/18,2.70%,RARB;PCSK5;GLI3;STRA6
prerank,heart development (GO:0007507),0.5424163420426198,1.6713662296798373,0.003389830508474576,0.5655588083036089,1.0,28/150,6.07%,MICAL2;BMP4;PLCE1;SGCD;ZFPM2;BMP5;NTRK3;PCSK5;FN1;CXADR;PKD1;AKAP13;CSRP3;PDLIM7;GPC3;HDAC9;ISL1;STRA6;CACNA1C;COL3A1;MEF2A;TCF25;FOXC2;PDLIM5;TGFBR1;FLRT2;TNNI3;TGFBR2
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.49024365898695216,-1.6708950020463567,0.0,0.29629365759187654,1.0,12/49,10.04%,IGF1;LYN;IL31RA;KIT;PARP14;IL6ST;IL6R;ARL2BP;GHR;ERBB4;IL18;TNFRSF1A
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.6851491770808318,1.6705493799653797,0.010401188707280832,0.5610386947945838,1.0,11/25,7.87%,CXADR;ANK2;DSP;CAMK2D;CACNA1C;DSG2;DSC2;TRPM4;DLG1;FGF13;JUP
prerank,positive regulation of cell junction assembly (GO:1901890),-0.48013236481846605,-1.670543359242453,0.0,0.2909047900428861,1.0,22/56,21.02%,TEK;CLDN5;NRXN1;CNTNAP2;IL1RAPL1;KDR;EPHB1;MAP4K4;GRID2;FLOT1;SRPX2;RAC1;MYOC;LRRC4B;ACE2;AGT;PPM1F;CLSTN3;CLSTN1;NLGN1;VEGFA;NLGN2
prerank,cGMP-mediated signaling (GO:0019934),-0.6885032906228769,-1.669985738215051,0.017326732673267328,0.28677921859548966,1.0,7/13,12.07%,IRAG1;APOE;GUCY1B1;KCNC2;PDE9A;PDE2A;PDE3A
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.5593444270244963,1.6699363230976259,0.006075334143377886,0.5555773797944492,1.0,24/104,11.34%,BMPER;CRIM1;CCN3;SMAD9;CD109;HTRA3;VWC2;SMAD6;SKIL;IGSF1;BAMBI;BMPR1A;SPRED2;TGFBR1;TGFBR2;TGFB1I1;UBE2D3;IL17RD;PPM1A;SKI;NKX2-1;BCL9L;NOG;ACVR1
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.5988148719822202,1.6695130136675276,0.01078167115902965,0.5484041997917524,1.0,12/56,5.77%,BMP4;BMPER;BMP5;TGFB3;INHBA;BMP6;SMAD6;GDF6;GDF5;BMPR1A;TGFBR1;BMP15
prerank,transition metal ion transport (GO:0000041),-0.5161878088333378,-1.6692118655435473,0.009287925696594427,0.2828419899913957,1.0,15/35,14.74%,CP;SLC30A10;FTH1;TRPC3;TFRC;SLC39A8;ATOX1;ATP2C1;COX17;TTYH1;SLC31A1;SLC30A1;TRPC4;TRPC6;SLC11A2
prerank,cartilage development (GO:0051216),0.617986600355749,1.6691447402107527,0.0055248618784530384,0.5413542164364736,1.0,17/49,11.54%,BMP4;CCN3;ITGB8;NFIB;PKD1;CD44;ZBTB16;SULF1;GDF5;DDRGK1;SNX19;FGF2;SLC39A14;SULF2;HYAL3;WNT2B;TRIP11
prerank,embryonic skeletal system development (GO:0048706),0.6464637681664277,1.6683078341719202,0.014903129657228018,0.5363760791955188,1.0,7/35,2.74%,KIAA1217;PCSK5;WNT9A;SIX1;SULF1;WNT11;HOXA3
prerank,regulation of fibrinolysis (GO:0051917),0.7621128456574079,1.6680956745094937,0.01870748299319728,0.5286604391560189,1.0,2/13,4.12%,THBS1;THBD
prerank,inorganic anion transport (GO:0015698),0.610284259311056,1.6675696530651192,0.006666666666666667,0.5225961957340708,1.0,4/53,2.80%,SLC4A10;SLC26A7;CLIC4;ANO6
prerank,carboxylic acid transmembrane transport (GO:1905039),0.6522457269879313,1.6671187517835013,0.010144927536231883,0.5165639746019867,1.0,8/40,5.58%,SLC38A2;SLC23A1;SLC23A2;SLC38A1;SLC5A6;SLC16A1;SLC38A6;SLC38A7
prerank,response to glucagon (GO:0033762),-0.6183982563663963,-1.6641389349220448,0.015873015873015872,0.2910287651983137,1.0,12/19,15.58%,ADCY5;ADCY1;PRKAR2B;ADCY7;ADCY2;PRKACB;PRKAR1B;PRKAR1A;CYSLTR2;ADCY4;ADCY3;ADCY8
prerank,circulatory system development (GO:0072359),0.5489677427285828,1.6626825412780448,0.002331002331002331,0.533975750319952,1.0,23/118,6.07%,MICAL2;PLCE1;NXN;ZFPM2;NTRK3;PCSK5;FN1;CXADR;PKD1;AKAP13;PDLIM7;HDAC9;ISL1;STRA6;CACNA1C;COL3A1;MEF2A;TCF25;FOXC2;PDLIM5;TGFBR1;TNNI3;TGFBR2
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.6774373281350918,1.6577530346794707,0.017804154302670624,0.5535428826108517,1.0,7/25,5.45%,BMP4;FOXD1;SULF1;CCN1;GDF5;BMPR1A;ZNF423
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.7059108117116984,-1.6564461734571656,0.022727272727272728,0.3059297827249612,1.0,2/10,6.13%,ATP1A2;ADRA2A
prerank,positive regulation of cholesterol transport (GO:0032376),-0.5433537269656792,-1.6563637421105484,0.027190332326283987,0.3003661361198564,1.0,9/27,16.31%,PLTP;APOE;PTCH1;NR1H3;GPS2;ABCA5;EEPD1;ABCB4;SCP2
prerank,negative regulation of leukocyte activation (GO:0002695),-0.6332558708370218,-1.6561683419510322,0.018912529550827423,0.295123116529325,1.0,9/15,25.14%,IL31RA;NR1H3;GRN;CD300A;HAVCR2;CD84;LRFN5;CD200;GPER1
prerank,zinc ion homeostasis (GO:0055069),-0.5500157529687293,-1.6516101373523042,0.008547008547008548,0.3010095510333719,1.0,14/28,14.55%,SLC30A10;SLC39A10;SLC39A8;SLC39A7;MT2A;SLC30A1;MT1B;MT1E;MT1A;MT1F;MT1G;MT1M;MT1X;MT1H
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.5914864930815873,1.6507090185958655,0.007989347536617843,0.585523600457351,1.0,29/59,19.21%,STK39;CAMK2D;WNK1;CIT;PRKCD;HIPK1;GSK3B;TGFBR1;TGFBR2;MARK2;DYRK2;CDC42BPG;DYRK3;CAD;TAF1;CHEK1;ACVR1;CSNK2A2;CSNK2A1;NLK;MAPK1;PRKCA;WNK3;MAP3K12;PRKDC;MAPK8;CDC42BPA;PRKD2;ULK1
prerank,acute inflammatory response (GO:0002526),0.7120078235344492,1.6503744605658932,0.0124804992199688,0.5784746530613252,1.0,5/23,5.80%,F3;LBP;ANO6;VNN1;PLSCR1
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.6271452153835146,-1.6503701186603805,0.017994858611825194,0.2991984178140051,1.0,4/15,9.54%,PLTP;APOE;SCARB1;ABCA5
prerank,peptidyl-threonine modification (GO:0018210),0.5810195822044925,1.6498512857479115,0.0038560411311053984,0.5735511594903855,1.0,31/66,19.21%,STK39;CAMK2D;WNK1;CIT;PRKCD;HIPK1;GSK3B;GALNT13;TGFBR1;TGFBR2;MARK2;DYRK2;CDC42BPG;DYRK3;CAD;TAF1;CHEK1;ACVR1;CSNK2A2;CSNK2A1;NLK;MAPK1;GALNT11;PRKCA;WNK3;MAP3K12;PRKDC;MAPK8;CDC42BPA;PRKD2;ULK1
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.7095285506625288,-1.646715241593409,0.002347417840375587,0.30364961134525276,1.0,4/10,8.08%,LYN;RAPGEF2;CXCL12;GAS6
prerank,sodium ion transport (GO:0006814),0.5639019792725702,1.6462862980613835,0.007575757575757576,0.5851679141530667,1.0,17/85,8.73%,SLC4A4;SLC9B2;SLC23A1;SLC12A2;SLC24A3;SLC5A6;ATP1B1;SLC6A7;ANO6;SLC6A19;NALCN;SCN11A;SLC38A7;SLC4A8;FGF13;PKD2L1;SLC6A16
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.5618654381309828,1.644317979456993,0.0012468827930174563,0.5882050070331166,1.0,20/86,7.81%,BMP4;THBS1;BMP5;TGFB3;FOXD1;SULF1;CCN1;INHBA;BMP6;GDF6;GDF5;NUP93;GIPC1;BMPR1A;TGFBR1;ZNF423;BMP15;EP300;TGFB1I1;CREBBP
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.7879719186868109,1.6417918637159055,0.012131715771230503,0.5947025473856076,1.0,1/12,0.11%,FZR1
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.729381314542781,1.6382980513086811,0.02975206611570248,0.6076058473549413,1.0,3/17,1.69%,SLIT2;FSTL1;SULF1
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.596439899798361,1.6374365544611973,0.01476510067114094,0.6040748557110835,1.0,7/54,2.62%,STK39;KCNJ2;FHL1;KCNMB3;KCNMB2;NEDD4;WWP2
prerank,metal ion homeostasis (GO:0055065),0.619446291522776,1.6361890527907823,0.025069637883008356,0.6034813302969961,1.0,6/40,3.44%,SLC12A7;SLC12A2;SLC12A8;CNNM2;CNNM4;CLDN16
prerank,ureteric bud morphogenesis (GO:0060675),0.7228001200510751,1.635027950327113,0.03166666666666667,0.6021486713944603,1.0,6/16,10.39%,BMP4;SIX1;WNT11;GDNF;FGF2;GATA3
prerank,sulfate transport (GO:0008272),0.746024927555623,1.6343918326652522,0.029565217391304348,0.5977911495762449,1.0,2/14,0.36%,SLC26A7;SLC26A2
prerank,pharyngeal system development (GO:0060037),0.7283528885216608,1.633755818401667,0.021630615640599003,0.5941771113948122,1.0,10/15,11.71%,BMP4;BMP5;ISL1;BMPR1A;TGFBR1;HES1;SIX4;GATA3;NOG;TGFB2
prerank,postsynaptic membrane organization (GO:0001941),-0.6191106263234798,-1.632957464085857,0.0196078431372549,0.335319002604176,1.0,6/17,11.54%,SHANK3;APOE;NRXN1;GPHN;LRRC4;MUSK
prerank,spinal cord development (GO:0021510),0.7810709962777802,1.632687354761444,0.027257240204429302,0.5929372159033061,1.0,2/12,1.37%,VIT;PKD1
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.7301915092632435,1.6320944647799578,0.02847571189279732,0.5885929946866427,1.0,5/16,7.51%,BMP4;SIX1;FOXD1;GDNF;FGF2
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.5184215822463724,-1.6311719903192587,0.009375,0.3339876628478271,1.0,24/38,30.59%,NDUFA8;NDUFB3;NDUFS4;NDUFA6;NDUFS3;NDUFA12;NDUFC2;NDUFS2;NDUFB7;NDUFA1;NDUFB8;NDUFA3;NDUFB9;NDUFB4;NDUFS5;NDUFC1;NDUFA10;NDUFB11;NDUFA9;NDUFA5;NDUFS6;NDUFA11;NDUFS1;NDUFA2
prerank,regulation of membrane depolarization (GO:0003254),0.7163865655487591,1.6309909037183288,0.02922077922077922,0.5874033426283639,1.0,3/18,2.01%,FHL1;PTPN3;CAMK2D
prerank,gland development (GO:0048732),0.5885647472580304,1.6306361314424556,0.014138817480719794,0.5819364924839306,1.0,14/59,7.89%,MET;IGSF3;COBL;ANXA1;SIX1;TGFB3;EZR;WNT11;STRA6;RIPK3;TGFBR1;PRKCSH;FOXE1;HES1
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.7169115741002929,-1.6291008027127365,0.007058823529411765,0.33396080729430844,1.0,6/10,11.07%,DCN;BCL2;KDR;LRRK2;SRC;MYOC
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.6114202561348943,-1.6272871442979133,0.023195876288659795,0.3339185526521233,1.0,9/16,17.68%,APOE;NOS3;GUCY1B1;NDNF;KCNC2;GUCY1A1;AGT;NOS1;DDAH2
prerank,response to chemokine (GO:1990868),0.7572005959868697,1.6261791189186956,0.02040816326530612,0.5995132136091443,1.0,3/13,2.50%,STK39;SLC12A2;WNK1
prerank,response to UV-A (GO:0070141),0.7452690531515666,1.6249683720354806,0.032758620689655175,0.5988440934805603,1.0,1/14,0.19%,EGFR
prerank,organic acid transport (GO:0015849),0.5499606109893758,1.6234580553312532,0.009615384615384616,0.5999844182416896,1.0,11/94,3.41%,SLC26A7;SLC38A2;SLC23A1;SLC23A2;SLC38A1;SLC5A6;LRRC8D;SLC16A1;ABCG2;SLC7A2;SLC6A19
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.545696555941211,-1.6230282290243012,0.020958083832335328,0.3405930611609213,1.0,4/26,8.48%,ATP1A2;CALM1;ADRA2A;CALM3
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.7640275429974245,1.6225423930435072,0.030035335689045935,0.5980407962746819,1.0,3/12,1.04%,SLIT2;CCN3;BMP5
prerank,AMP metabolic process (GO:0046033),0.754349224092776,1.621454384324687,0.03934426229508197,0.5969771269852269,1.0,2/13,1.81%,NT5E;NT5C1A
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.7021852625391518,-1.6214057243686721,0.02040816326530612,0.33973560839295225,1.0,6/10,21.35%,SNCA;SET;KLF15;NOC2L;BRCA1;CTBP1
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.6263230875232085,1.620936123087666,0.02145922746781116,0.5929626947586198,1.0,11/39,7.71%,SLIT2;BMP4;MET;SIX1;PKD1;SEMA3E;LRP6;GDNF;TGFBR2;FGF2;NRP1
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.5861362643409345,-1.618420836634248,0.02284263959390863,0.3423814880883273,1.0,11/19,22.79%,CAMK1D;RIPOR2;DAPK2;MDK;RAC1;NCKAP1L;TIRAP;CCL19;CD74;DNM1L;THBS4
prerank,epiboly involved in wound healing (GO:0090505),0.733190554957236,1.6179676484710601,0.029513888888888888,0.6025400928489785,1.0,3/16,1.94%,TMEFF2;CD44;CCN1
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.7281443586062931,1.6173757952079153,0.035,0.5992463741318378,1.0,4/16,6.68%,NT5E;DPYSL3;NT5C1A;UPP2
prerank,carnitine shuttle (GO:0006853),-0.6731057781838913,-1.6166203838703364,0.02564102564102564,0.342026990643804,1.0,5/11,11.01%,PRKAG2;CPT1A;ACACA;ACACB;PRKAA2
prerank,chemokine-mediated signaling pathway (GO:0070098),0.6223308519624046,1.6162446023167103,0.027932960893854747,0.5986884342440163,1.0,3/42,2.50%,STK39;PTK2B;WNK1
prerank,positive regulation of chemotaxis (GO:0050921),0.6191084902665975,1.616107940326218,0.019390581717451522,0.5926761055289236,1.0,5/43,1.07%,SMOC2;F3;THBS1;MET;NTRK3
prerank,negative regulation of endocytosis (GO:0045806),-0.5629813488843471,-1.6157881930084799,0.01729106628242075,0.33939718886051873,1.0,7/24,9.48%,PRKD1;PICALM;MCTP1;NR1H3;SYT11;RAC1;CD300A
prerank,regulation of monocyte chemotaxis (GO:0090025),0.6783951398299463,1.6152661268131205,0.03129890453834116,0.5908389126449715,1.0,3/24,2.80%,SLIT2;CCN3;ANO6
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.6030969970925631,-1.6146004712369748,0.017456359102244388,0.33730628030154414,1.0,11/17,22.79%,CAMK1D;RIPOR2;DAPK2;MDK;RAC1;NCKAP1L;TIRAP;CCL19;CD74;DNM1L;THBS4
prerank,vesicle transport along actin filament (GO:0030050),-0.5972662190947999,-1.6127252419333167,0.021505376344086023,0.3371017727947593,1.0,7/19,18.00%,MYO1B;MYO6;FNBP1L;MYO5A;MYO5C;WASL;MYO1F
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.7494088992339135,1.6125476897492683,0.031746031746031744,0.5987174265955072,1.0,6/14,10.39%,THBS1;SULF1;FGF2;FUZ;SULF2;GATA3
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.6315400555245326,1.6115803041550445,0.014285714285714285,0.5977263276862285,1.0,11/38,9.48%,KCNJ2;ANK2;DSP;CAMK2D;ISL1;CACNA1C;DSG2;DSC2;TRPM4;JUP;CACNB2
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.6077537902824255,1.6114523654908408,0.025245441795231416,0.5919240608672086,1.0,7/44,2.80%,KCNJ2;KCNMB3;KCNMB2;ANK2;ATP1B1;WNK1;ANO6
prerank,response to interferon-alpha (GO:0035455),-0.6295626126386913,-1.6112384314489276,0.021897810218978103,0.3362419243963594,1.0,6/16,10.24%,IFNAR1;BST2;IFITM1;GAS6;IFNAR2;IFITM3
prerank,basement membrane organization (GO:0071711),-0.637262291433819,-1.6078914960747241,0.0367816091954023,0.3403236191425427,1.0,6/14,8.45%,NID1;NID2;COL4A1;RAMP2;LAMB1;CTSS
prerank,regulation of histone acetylation (GO:0035065),-0.5193556812523739,-1.6057049005730388,0.01875,0.3412579591150419,1.0,14/33,18.30%,RPS6KA5;RAPGEF3;SNCA;MAPK3;PPARGC1A;ARRB1;SET;MYOCD;NOC2L;RUVBL2;NOS1;FLCN;PARK7;BRCA1
prerank,positive regulation of phosphatase activity (GO:0010922),-0.5684812055687857,-1.604154526951366,0.03823529411764706,0.34078899876855506,1.0,9/21,9.60%,ITGA1;PDGFRB;CALM1;MEF2C;BMP2;CALM3;PLEK;CD300A;HSP90AB1
prerank,axon extension (GO:0048675),0.6711052335151054,1.6034680567025104,0.03542673107890499,0.6293306317369898,1.0,6/23,9.27%,SLIT3;SLIT2;ALCAM;ULK2;NRP1;SPG11
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.7012775852080317,-1.6031497008663531,0.040865384615384616,0.33883942333484135,1.0,3/10,5.83%,SEMA6A;DCN;DAB2IP
prerank,external encapsulating structure organization (GO:0045229),0.5047287292469357,1.6030120098336138,0.0,0.6253339744378552,1.0,41/205,7.51%,COL8A1;ADAMTSL3;CDH1;SH3PXD2A;SMOC2;VIT;THBS1;ADAMTSL1;THSD4;ADAMTS17;ITGB8;FN1;MMP28;ADAMTS2;COL6A2;COL6A1;CD44;COL5A2;COL23A1;COL8A2;DSPP;ITGB1;MFAP5;ITGA10;ADAMTSL5;DDR2;COL3A1;TGM3;ITGA5;PDGFA;COL6A3;ADAM12;ADAMTS5;MATN1;MMP16;ITGAV;MMP14;TGM1;SMOC1;LOXL1;FGF2
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.7600358961233538,1.6013007330969637,0.046263345195729534,0.6284863219499165,1.0,2/12,1.90%,BMP4;NEDD4
prerank,mesenchyme development (GO:0060485),0.7150104367045571,1.6000650462717398,0.039538714991762765,0.6288889101999274,1.0,5/15,8.03%,BMP4;WNT11;ISL1;TGFBR1;GATA4
prerank,glycine transport (GO:0015816),-0.6880513232989336,-1.5993032031705956,0.02517162471395881,0.3447243346815646,1.0,6/10,23.33%,SLC6A9;SLC38A5;SLC6A17;SLC25A38;SLC7A8;SLC36A2
prerank,positive regulation of wound healing (GO:0090303),0.6245260178157371,1.5992172507489955,0.028189910979228485,0.6272915634161924,1.0,7/36,4.99%,SMOC2;ST3GAL4;THBS1;ANXA1;ITGB1;PLPP3;FOXC2
prerank,renal water homeostasis (GO:0003091),-0.5672179204076512,-1.5980703434419894,0.03197674418604651,0.3432498869009252,1.0,12/23,15.58%,ADCY5;ADCY1;PRKAR2B;ADCY7;ADCY2;PRKACB;AQP4;PRKAR1B;PRKAR1A;ADCY4;ADCY3;ADCY8
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.5594756103483842,1.598017729603819,0.00784313725490196,0.6277180308597696,1.0,13/76,7.28%,EGFR;NR3C2;CCN3;RASSF2;EZR;TCIM;NFAT5;PDCD4;EP300;TRIP6;DLG1;TRIM44;IFI35
prerank,positive regulation of phagocytosis (GO:0050766),-0.47659708926633354,-1.5974181852935758,0.00392156862745098,0.3404981804060357,1.0,25/47,28.50%,CAMK1D;MERTK;CD47;IL15RA;MYO18A;CYBA;SIRPA;GAS6;C4B;GATA2;CALR;APPL2;RAB27A;NCKAP1L;LMAN2;LYAR;C3;CCL2;TREM2;PTPRC;DOCK2;IL2RG;AHSG;C2;PLA2G5
prerank,lymphocyte mediated immunity (GO:0002449),0.7568472764505266,1.5954792452372368,0.03852889667250438,0.635362586395255,1.0,5/12,10.17%,CD55;GNL1;KLRC2;JAG1;CD46
prerank,regulation of protein import into nucleus (GO:0042306),0.6258611242423332,1.5954749423571681,0.019637462235649546,0.6292234673503956,1.0,8/36,7.87%,CDH1;BMP4;PRKCD;ZIC1;MDFIC;HCLS1;MAVS;JUP
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.6651042006061357,-1.5931661151968106,0.026634382566585957,0.34742822080563623,1.0,6/11,18.14%,PARP14;PARP8;PARP11;TIPARP;PARP12;PARP16
prerank,potassium ion transmembrane transport (GO:0071805),0.5205561396349302,1.5928114398132842,0.0023094688221709007,0.6373773682922023,1.0,14/135,4.00%,SLC9A2;KCNB2;KCNK5;SLC12A7;KCNJ2;SLC12A2;SLC24A3;KCNQ5;ATP1B1;SLC12A8;KCNS3;SLC9C1;NALCN;KCNB1
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.7431874065685198,1.5923318891038933,0.0285204991087344,0.6336759898468353,1.0,3/12,8.85%,FOXP1;PIAS2;SMARCA4
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.7552681328578102,1.5918493496113864,0.046632124352331605,0.6302543013879981,1.0,7/12,7.87%,DSP;CACNA1C;DSG2;DSC2;TRPM4;DLG1;JUP
prerank,extracellular structure organization (GO:0043062),0.5015847988464176,1.5912582512561013,0.0,0.6273690502172917,1.0,40/204,7.51%,COL8A1;ADAMTSL3;CDH1;SH3PXD2A;SMOC2;VIT;THBS1;ADAMTSL1;THSD4;ADAMTS17;ITGB8;FN1;MMP28;ADAMTS2;COL6A2;COL6A1;CD44;COL5A2;COL23A1;COL8A2;DSPP;ITGB1;MFAP5;ITGA10;ADAMTSL5;DDR2;COL3A1;ITGA5;PDGFA;COL6A3;TGFBR1;ADAM12;ADAMTS5;MATN1;MMP16;ITGAV;MMP14;SMOC1;LOXL1;FGF2
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.7411097364837806,1.5909897334711711,0.031825795644891124,0.6228146007394005,1.0,2/14,2.42%,ME1;NMNAT2
prerank,positive regulation of organelle organization (GO:0010638),0.6413635005598867,1.5908349865440816,0.02654867256637168,0.6177036597856999,1.0,12/32,15.88%,SORBS3;ANXA1;ATL3;ANXA2;ADRB2;GSK3B;RAB3GAP2;SMCR8;C2CD5;KATNBL1;SYNJ1;FYCO1
prerank,metanephros development (GO:0001656),0.6474498591470064,1.5900625083218762,0.031201248049921998,0.6162245239350206,1.0,6/26,5.16%,BMP4;SIX1;PKD1;FOXD1;GDF6;GDNF
prerank,negative regulation of potassium ion transport (GO:0043267),0.7582182199394303,1.5895693895999812,0.0274442538593482,0.613278149501899,1.0,2/13,1.56%,STK39;PTK2B
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.7750894113597627,1.587832078915777,0.03356890459363958,0.6173538136779972,1.0,1/11,0.08%,STK39
prerank,carboxylic acid transport (GO:0046942),0.5785543325698922,1.587326943603884,0.018641810918774968,0.614521176635931,1.0,7/55,2.02%,SLC38A2;SLC23A1;SLC23A2;SLC38A1;SLC16A9;SLC6A7;SLC16A1
prerank,detection of mechanical stimulus (GO:0050982),0.6870605061665306,1.5861482146461596,0.025889967637540454,0.6151795508068805,1.0,7/19,11.00%,PIEZO2;PKD1;CSRP3;PKD2L2;JUP;PKD2L1;PKD1L2
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.6901536982038707,1.5859307676625334,0.034482758620689655,0.6108236871753586,1.0,5/18,12.11%,ANXA1;ISL1;FAM107A;KLF9;REST
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.6658191207830535,-1.584788544663507,0.04600484261501211,0.36651958544256197,1.0,4/12,5.83%,SEMA6A;ADAMTS12;DCN;DAB2IP
prerank,ncRNA processing (GO:0034470),-0.36214326232694927,-1.5841847402453642,0.0,0.3636004524578916,1.0,69/200,19.94%,RPLP1;RPS14;RPL37A;RPL38;RPL30;RPL8;RPL21;RPL41;RPL14;RPL9;RPS24;RPL13;RPS27;RPLP2;RPS9;RPS15;RPL22;RPS16;AGO1;RPL5;RPS2;RPL34;RPL23;RPL17;RPS19;RPS17;RPL13A;RPS7;LIN28B;RPL27A;RPL3;RPL24;EXOSC8;IMP3;AGO4;RPL18;RPL39;EMG1;RPL23A;SNU13;RPL7A;RPL35A;POP5;RPL26;SMAD1;RPL32;RPL18A;RPS25;RPL36;SMAD3;RPL12;RPL27;LAS1L;RPL11;METTL3;DDX54;PIH1D1;RPL31;TARBP2;SARS1;RPL19;RPLP0;RPS28;RPL37;NOB1;RPL29;EXOSC3;RPL28;INTS4
prerank,skin development (GO:0043588),0.5579422833217598,1.5839910061022442,0.01783264746227709,0.6154772864056111,1.0,16/65,6.86%,CLIC4;MET;ANXA1;PKD1;COL5A2;DSP;COL3A1;ADAM9;TGM3;BCR;SPRR1A;WNT16;PDGFA;PIP5K1A;TGM1;JAG1
prerank,entry into host (GO:0044409),0.7367959178018768,1.5839662454233885,0.03773584905660377,0.6103809938457911,1.0,5/13,9.97%,CDH1;MET;ITGAV;CTNND1;CXCR4
prerank,response to zinc ion (GO:0010043),-0.5369884264753116,-1.5833876795409485,0.017948717948717947,0.3613368652711928,1.0,13/25,14.55%,PAM;CRIP1;GLRA1;MT2A;SLC30A4;MT1B;MT1E;MT1A;MT1F;MT1G;MT1M;MT1X;MT1H
prerank,negative regulation of interleukin-12 production (GO:0032695),0.7322465235972104,1.5811281402057225,0.035897435897435895,0.6192866707479384,1.0,4/14,12.58%,THBS1;IL10;CMKLR1;PIBF1
prerank,negative regulation of viral transcription (GO:0032897),-0.6326004480988321,-1.5808992761246994,0.02284263959390863,0.3637126322658649,1.0,7/13,21.39%,TRIM14;TRIM62;IFITM3;TRIM21;TRIM27;LARP7;TRIM32
prerank,regulation of T cell chemotaxis (GO:0010819),0.7696604770442327,1.580380920629969,0.028268551236749116,0.6180845305705116,1.0,2/11,2.50%,STK39;WNK1
prerank,tricarboxylic acid metabolic process (GO:0072350),-0.6213717939575695,-1.5790604513347803,0.0425531914893617,0.3648227551038414,1.0,9/12,31.48%,ACLY;IDH3A;ACO2;ASS1;IDH2;ACO1;GLUD1;IDH3B;IDH1
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.7225261936669811,1.5790332978734596,0.03826086956521739,0.6196408442621265,1.0,3/15,3.21%,ANXA1;ISL1;FAM107A
prerank,negative regulation of myotube differentiation (GO:0010832),0.756135731880021,1.5788220631597356,0.03185840707964602,0.6155894476736424,1.0,2/12,1.50%,CCN3;HDAC4
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.5566025413038436,-1.5773450275006538,0.020710059171597635,0.3649877585447779,1.0,10/22,14.88%,SLC16A2;KDM2B;MDK;NES;GATA2;LRRK2;TOX;TAFA1;PROX1;APPL2
prerank,regulation of response to stress (GO:0080134),0.7726606309492804,1.577095955437037,0.0497335701598579,0.6192126426773499,1.0,3/10,3.51%,SLC38A2;EIF4G1;IL10
prerank,membrane repolarization during action potential (GO:0086011),0.7448030605745662,1.5743035051834033,0.04085257548845471,0.6280955177873836,1.0,2/13,1.46%,KCNJ2;ATP1B1
prerank,negative regulation of histone acetylation (GO:0035067),-0.6593956699199436,-1.5732182326445392,0.037296037296037296,0.37281691050516885,1.0,6/11,24.23%,SNCA;SET;NOC2L;BRCA1;CTBP1;SPI1
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.6649052074920101,-1.5728421053457449,0.026905829596412557,0.36943774174748506,1.0,7/11,24.96%,UQCR10;UQCRH;UQCR11;CYCS;UQCRC2;UQCRB;UQCRFS1
prerank,purine-containing compound catabolic process (GO:0072523),0.7363867095152188,1.5724953210650392,0.04280821917808219,0.6320975892824066,1.0,2/13,1.81%,NT5E;NT5C1A
prerank,peptidyl-proline hydroxylation (GO:0019511),0.7515382892379429,1.572019466900801,0.04639175257731959,0.6294755572540051,1.0,4/11,4.41%,EGLN3;P3H2;P4HA2;P4HA1
prerank,amino acid transmembrane transport (GO:0003333),0.5959283715579157,1.5717917398445056,0.027972027972027972,0.6254667537501188,1.0,8/45,5.71%,SLC47A1;SLC38A2;SLC38A1;LRRC8D;SLC38A6;SFXN1;SLC38A7;SFXN2
prerank,chemical homeostasis (GO:0048878),0.5606083860559031,1.5713941734252488,0.0234375,0.6223411136919582,1.0,7/61,6.88%,SLC4A10;SLC4A4;WNK1;PNPLA3;RBP1;HNF4A;SLC4A8
prerank,organic cation transport (GO:0015695),0.6797291107132815,1.5689943539924536,0.0420032310177706,0.6295570778573262,1.0,1/20,0.02%,SLC47A1
prerank,regulation of sensory perception of pain (GO:0051930),0.7562224761842381,1.567776939984189,0.06108202443280977,0.6308531726607448,1.0,4/11,8.56%,CCN3;MGLL;SCN11A;ACP3
prerank,BMP signaling pathway (GO:0030509),0.5555223244321382,1.5658988830633789,0.018469656992084433,0.635271540900508,1.0,20/62,14.79%,BMP4;SMAD9;BMP5;TGFB3;DDX5;BMP6;SMAD6;GDF6;GDF5;PDCD4;BMPR1A;BMP15;NOG;RGMB;ACVR1;TGFB2;MEGF8;CHRD;SMURF1;AMHR2
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.6871984336841925,-1.5654087331848285,0.03881278538812785,0.387036926700731,1.0,2/10,2.57%,LYN;KIT
prerank,nucleotide biosynthetic process (GO:0009165),0.6929596490708553,1.5648306030510697,0.0438871473354232,0.6358944738333044,1.0,5/18,11.64%,ME1;NMNAT2;RRM2;PRPS2;NMNAT1
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),-0.5810278738256944,-1.5645742464327788,0.04060913705583756,0.38511705556392983,1.0,7/18,7.31%,FLT1;COL4A3;AKT3;ITGA4;IGF2;MEF2C;MDK
prerank,ventricular septum morphogenesis (GO:0060412),0.6400780709603565,1.5640222434148714,0.0296875,0.6350832249335291,1.0,11/27,11.71%,SLIT3;SLIT2;BMP4;ZFPM2;BMPR1A;TGFBR1;TGFBR2;HES1;NOG;ACVR1;TGFB2
prerank,aorta morphogenesis (GO:0035909),-0.5879520287032445,-1.5628343294113127,0.040100250626566414,0.3857472663294425,1.0,10/17,15.98%,ENG;MYLK;PDGFRB;ADAMTS9;TBX1;RBPJ;HEY2;EFEMP2;PROX1;HEY1
prerank,regulation of viral life cycle (GO:1903900),-0.5693192640311295,-1.5627442630174448,0.04896907216494845,0.3816304082376161,1.0,10/21,18.10%,PPIA;TRIM14;TRIM62;HS3ST5;NECTIN2;TRIM21;TRIM27;KPNA2;TYRO3;TRIM6
prerank,potassium ion transport (GO:0006813),0.5122587410428039,1.5612839469789241,0.005847953216374269,0.6440303465966989,1.0,12/120,4.00%,SLC9A2;KCNB2;KCNK5;KCNJ2;KCNMB3;KCNMB2;SLC24A3;KCNQ5;KCNS3;SLC9C1;NALCN;KCNB1
prerank,modulation by symbiont of entry into host (GO:0052372),-0.5946333581487173,-1.5594375268249352,0.029612756264236904,0.3869871715487936,1.0,8/16,18.10%,TRIM14;TRIM62;HS3ST5;NECTIN2;TRIM21;TRIM27;FUCA2;TRIM6
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.7201145834033675,1.558756706929634,0.04201680672268908,0.6520139148887236,1.0,5/15,7.51%,SMOC2;THBS1;MET;P2RX4;FGF2
prerank,maintenance of protein localization in organelle (GO:0072595),-0.5635465817009341,-1.5579846309991523,0.029649595687331536,0.3872279850482356,1.0,9/19,16.12%,TAPT1;ARL2BP;TAF3;BCL3;HK2;CHCHD10;AKT1;TOPORS;HK1
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.7402460126699654,1.557811588471114,0.05749128919860627,0.6519401358450041,1.0,5/12,11.02%,SMO;SIX1;GDNF;SIX4;NOG
prerank,peptidyl-lysine acetylation (GO:0018394),0.7525489221690631,1.5572729607689832,0.059964726631393295,0.6497337059775395,1.0,5/10,12.88%,EP300;KAT2A;CREBBP;KAT5;KAT2B
prerank,maintenance of blood-brain barrier (GO:0035633),-0.5028454244610945,-1.556186406507275,0.030395136778115502,0.38843041889310415,1.0,15/30,9.04%,TJP1;GJB6;PECAM1;CLDN5;ESAM;MBP;F11R;OCLN;LAMA2;ACTB;SLC1A1;JAM3;GJA1;CLDN1;MFSD2A
prerank,melanocyte differentiation (GO:0030318),-0.6593682261934553,-1.5556405790039638,0.04956896551724138,0.3861955420774686,1.0,6/11,10.91%,LRMDA;ENPP1;KIT;MEF2C;SLC24A5;MITF
prerank,nucleotide metabolic process (GO:0009117),0.6492726391444154,1.5555091527022928,0.04732824427480916,0.6542829876648018,1.0,6/23,12.72%,ME1;FHIT;NMNAT2;CTPS2;NMNAT1;REXO2
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.7641326981579744,1.5550336132095326,0.05137614678899083,0.6518570979687229,1.0,2/11,1.46%,KCNJ2;ATP1B1
prerank,response to estrogen (GO:0043627),0.6216472792186303,1.5544102761766079,0.03988183161004431,0.649909836928365,1.0,12/31,17.97%,KRT19;SERPINB9;EP300;CYP27B1;BCAS3;GATA3;TRIM25;KMT2D;CITED2;ASH2L;NCOA4;AR
prerank,sodium ion transmembrane transport (GO:0035725),0.5249695474381727,1.5535523421694921,0.01968019680196802,0.6494131676662591,1.0,12/84,5.51%,SLC4A4;SLC9A2;SLC12A2;SLC24A3;ATP1B1;SLC6A7;ANO6;SLC6A19;SLC9C1;NALCN;TRPM4;SCN11A
prerank,negative regulation of T cell differentiation (GO:0045581),0.7695561748710823,1.5530537279096601,0.04869565217391304,0.6473961245000234,1.0,2/10,1.61%,BMP4;GLI3
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.5783184523737808,1.5525247980576244,0.0226628895184136,0.6454359723152346,1.0,10/45,5.77%,BMP4;BMP5;TGFB3;INHBA;BMP6;GDF6;GDF5;BMPR1A;TGFBR1;BMP15
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.7710519167677619,1.5520613123097309,0.03496503496503497,0.6432840435455782,1.0,2/10,2.50%,STK39;WNK1
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.636366596122976,1.5508159551008158,0.042335766423357665,0.6443427807379012,1.0,10/27,7.87%,ANK2;DSP;CAMK2D;CACNA1C;DSG2;DSC2;TRPM4;DLG1;FGF13;JUP
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.6099307021082828,1.550756829365201,0.038922155688622756,0.6402616417633558,1.0,6/30,8.85%,FOXP1;DDX5;EP300;PIAS2;KDM1A;SMARCA4
prerank,positive regulation of histone acetylation (GO:0035066),-0.5354848885809034,-1.5507409400206602,0.03856749311294766,0.3965290368556404,1.0,11/23,25.64%,RPS6KA5;MAPK3;PPARGC1A;ARRB1;RUVBL2;PIH1D1;NOS1;BRCA1;SPHK2;TADA2B;SMARCB1
prerank,response to nitric oxide (GO:0071731),-0.6363441119609902,-1.5492415341415071,0.03132530120481928,0.39687650637277405,1.0,9/13,29.99%,FOXO1;GUCY1B1;KCNC2;EGLN1;CCL19;TXN;MMP3;MT3;AQP1
prerank,response to estradiol (GO:0032355),0.624739744499499,1.5492363956568722,0.03715170278637771,0.6437227651526026,1.0,11/31,15.33%,EGFR;ANXA1;MYOG;SOCS2;STRN3;KAT5;FOXA1;CYP19A1;STAT3;LCOR;NRIP1
prerank,regulation of cell junction assembly (GO:1901888),-0.5280591128410572,-1.548991202864887,0.03188405797101449,0.39330603503405825,1.0,9/27,8.81%,TJP1;PRKCH;CLDN5;RAPGEF2;F11R;OCLN;MEF2C;RAPGEF1;FLOT1
prerank,regulation of DNA repair (GO:0006282),0.5809743758285022,1.548147078127459,0.03443328550932568,0.6449426247244403,1.0,13/44,16.77%,EGFR;EYA2;EYA4;EYA3;TRIP12;RNF168;RAD52;UBR5;ERCC8;DHX9;PML;USP1;UBE2N
prerank,cellular response to hydrogen peroxide (GO:0070301),0.605680430475935,1.547387464954325,0.028528528528528527,0.6443150739425363,1.0,8/33,6.81%,MAP3K5;ANXA1;CYP1B1;PRKCD;ABL1;RIPK3;NFE2L2;ANKZF1
prerank,activation of protein kinase A activity (GO:0034199),-0.5860635958784481,-1.5470882369478725,0.034739454094292806,0.39474915025562396,1.0,11/16,15.58%,ADCY5;ADCY1;PRKAR2B;ADCY7;ADCY2;PRKACB;PRKAR1B;PRKAR1A;ADCY4;ADCY3;ADCY8
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.49586273424829663,1.5462212758688794,0.009111617312072893,0.6458335245224543,1.0,40/128,14.79%,BMP4;SMAD9;BMP5;TGFB3;DDX5;ITGB1;INHBA;BMP6;SMAD6;COL3A1;ADAM9;GDF6;GDF5;GCNT2;BAMBI;PDCD4;BMPR1A;LTBP2;TGFBR1;BMP15;TGFBR2;ID1;JUN;TGFB1I1;ITGB5;SKI;PARD3;RGMB;ACVR1;TGFB2;RHOA;ZMIZ1;MEGF8;NLK;RNF111;INHBB;TGFBRAP1;SMURF1;ARHGEF18;AMHR2
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.586751430689121,1.5461380292171212,0.025,0.6419593738824898,1.0,10/39,7.87%,STK39;PTPN3;SLMAP;NEDD4;CAMK2D;WNK1;FXYD5;DMD;FGF13;FXYD7
prerank,cellular response to reactive oxygen species (GO:0034614),0.5554702894454117,1.5449507506979006,0.016150740242261104,0.6438215094182294,1.0,11/59,7.13%,EGFR;MAP3K5;ANXA1;CYP1B1;PRKCD;ABL1;RIPK3;NFE2L2;ANKZF1;CHUK;JUN
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.7595941748448457,1.5446632448389932,0.06514084507042253,0.6410625918123907,1.0,3/10,6.68%,NT5E;NT5C1A;UPP2
prerank,response to alcohol (GO:0097305),0.6338416210141317,1.5426565282106788,0.05271084337349398,0.6466599038297163,1.0,5/27,6.07%,SLIT3;SLIT2;ADH7;TGFBR1;TGFBR2
prerank,positive regulation of DNA metabolic process (GO:0051054),0.5488070702361374,1.5423695999561915,0.015894039735099338,0.6439840415705183,1.0,20/61,19.95%,EGFR;SMOC2;EYA2;EYA4;EYA3;FGF2;USP7;APLF;RNF168;ERCC8;DHX9;PML;STPG4;ATRX;UBE2N;WRN;NBN;PRKD2;USP9X;MRE11
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.6018398493323652,1.5422128795799983,0.029154518950437316,0.6406642855413894,1.0,11/35,13.71%,NR3C2;DDX5;ESR2;NEDD4;RBFOX2;TADA3;CALCOCO1;UBR5;ZMIZ1;PLPP1;DDX17
prerank,skeletal system development (GO:0001501),0.4935615233721341,1.5416588609284172,0.009070294784580499,0.6389037528743631,1.0,36/148,11.71%,KIAA1217;TNFRSF11B;CDH11;EXT1;TLL1;BMP5;ITGB8;PCSK5;PKD1;CD44;ZBTB16;SULF1;AKAP13;DSPP;WNT11;FGFR1;HHIP;BMP6;BMP1;DDRGK1;PAPSS2;TGFBR1;PHEX;MMP16;MMP14;SLC10A7;UFD1;P3H1;SULF2;HYAL3;NOG;EIF2AK3;EBP;TRIP11;NPR3;TGFB2
prerank,chordate embryonic development (GO:0043009),0.5598707649265975,1.5416074598953489,0.0326530612244898,0.6351047897786433,1.0,18/55,11.02%,KIAA1217;MBNL1;BMP5;PCSK5;PKD1;TGFB3;FUT8;SULF1;WNT11;FGFR1;ISL1;TGFBR1;STIL;ADAM10;SIX4;SULF2;GATA3;NOG
prerank,modulation by symbiont of host process (GO:0044003),-0.6707628654437666,-1.541105804974222,0.04408352668213457,0.4077432036649672,1.0,5/10,13.95%,B2M;RPS27A;UBC;UBB;MRC1
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.5691240629789661,1.5404653484878585,0.02592087312414734,0.6363582607597608,1.0,10/53,9.20%,EGFR;EYA2;DDX5;PRKCD;SPRED2;BCLAF1;EYA4;EYA3;ATM;RNF168
prerank,protein hydroxylation (GO:0018126),0.7058677182072189,1.540027920543665,0.05536912751677853,0.6344290974354124,1.0,7/15,16.92%,EGLN3;P3H2;PLOD2;P3H4;P3H1;VIPAS39;JMJD4
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.740504927977203,1.5396846002662339,0.043993231810490696,0.6320690499364077,1.0,6/13,5.26%,BMP4;TGFB3;BMP6;NUP93;BMPR1A;TGFBR1
prerank,blood vessel morphogenesis (GO:0048514),-0.44549830470389196,-1.5395973412834567,0.022727272727272728,0.40855064955268167,1.0,20/54,11.66%,FLT1;EFNB2;ENG;TGFBR3;LAMA1;CCBE1;CDH2;KDR;RASIP1;COL4A1;TBX1;RAMP2;SOX17;SLC1A1;RBPJ;HEY2;FLT4;AGGF1;ADM;SOX18
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.5715154881808092,-1.5394689364136873,0.0425531914893617,0.4049077658695684,1.0,6/17,9.60%,ITGA1;PDGFRB;CALM1;CALM3;CD300A;HSP90AB1
prerank,neutral amino acid transport (GO:0015804),0.6286882778745306,1.538223278121167,0.04380664652567976,0.6348817835461108,1.0,4/28,4.52%,SLC38A2;SLC38A1;SLC6A7;SLC38A6
prerank,regulation of integrin activation (GO:0033623),-0.5893651980005689,-1.537091419563664,0.04390243902439024,0.4074187628362446,1.0,5/15,9.09%,PIEZO1;RASIP1;JAM3;PLEK;SRC
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.4359066717597467,-1.5366340591901435,0.026923076923076925,0.4047594405570567,1.0,13/57,10.04%,IGF1;LYN;IL31RA;KIT;PARP14;IL6ST;INPP5F;IL6R;ARL2BP;GHR;ERBB4;IL18;TNFRSF1A
prerank,response to hydrogen peroxide (GO:0042542),0.5701605458482468,1.5351515992792426,0.037089871611982884,0.6452243797593661,1.0,9/45,6.81%,MAP3K5;ANXA1;CYP1B1;PRKCD;ADAM9;ABL1;RIPK3;NFE2L2;ANKZF1
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.7346262161292734,1.5348768258375,0.057971014492753624,0.642500368493303,1.0,4/11,11.97%,RNF185;VCP;UFD1;UGGT2
prerank,regulation of activated T cell proliferation (GO:0046006),-0.5071006270995296,-1.5343418213707436,0.03048780487804878,0.40709805318871095,1.0,6/30,9.17%,IGF1;IGFBP2;IGF2;RPS3;PRKAR1A;IL18
prerank,pancreas development (GO:0031016),0.7376015285481685,1.5340625960240046,0.03880070546737213,0.642546967527201,1.0,4/12,4.70%,MET;TCF7L2;ISL1;CCDC40
prerank,epithelial to mesenchymal transition (GO:0001837),-0.45292435877612813,-1.5339837312828193,0.010101010101010102,0.4041233013323555,1.0,14/47,8.28%,LEF1;WNT4;ENG;TGFBR3;TBX3;WNT5A;HIF1A;NOTCH1;BMP7;LOXL3;NOTCH4;RBPJ;BMP2;HEY2
prerank,regulation of cell growth (GO:0001558),0.48406506492680806,1.5333964778494986,0.003289473684210526,0.6417963709754029,1.0,39/204,12.86%,SLIT3;SLIT2;EGFR;PLCE1;CCN3;FHL1;NDRG3;OSGIN2;ESR2;CAMK2D;AGTR1;WNT11;INHBA;EIF4G1;FAM107A;IP6K2;SGK3;SOCS2;TGFBR1;KLHL22;HNF4A;MMP14;BAP1;ADAM10;CYP27B1;SMARCA4;CDKN1B;BCL6;AGTR2;MTOR;PAK4;CDC42;LTBP4;RB1;CSNK2A1;TGFB2;USP47;ST7L;WFDC1
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.6263009211362225,-1.532891427592585,0.057971014492753624,0.40341488374585366,1.0,2/12,2.13%,SERINC3;SERINC5
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.7300128807522385,1.5324651390407054,0.059033989266547404,0.6422852025035408,1.0,3/11,4.73%,RSPO3;MLLT3;PLEKHA4
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.4889249750772491,-1.5320188591022719,0.02976190476190476,0.402217165093765,1.0,12/32,25.56%,CEMIP;CALM1;SNCA;CALM3;JPH2;PLCG1;APLNR;HTT;HAP1;CASQ1;GPER1;AKAP6
prerank,L-serine metabolic process (GO:0006563),-0.6596298795770867,-1.531348602482418,0.04576659038901602,0.4004702081287359,1.0,2/10,2.13%,SERINC3;SERINC5
prerank,positive regulation of DNA replication (GO:0045740),0.6923635834529951,1.530845560367268,0.054009819967266774,0.6457954499961521,1.0,8/16,21.13%,EGFR;BCAR3;STN1;DHX9;FAF1;ATAD5;GLI2;EGF
prerank,cellular response to BMP stimulus (GO:0071773),0.5361395771205599,1.530237458238854,0.026041666666666668,0.6447199401675645,1.0,12/66,5.77%,BMP4;SMAD9;BMP5;TGFB3;DDX5;BMP6;SMAD6;GDF6;GDF5;PDCD4;BMPR1A;BMP15
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.6310854202357952,1.5300822273563535,0.038109756097560975,0.6417187021968781,1.0,6/25,5.06%,STK39;ANK2;ATP1B1;WNK1;DMD;COA8
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.6888505003516294,1.5297149460597896,0.06208053691275168,0.6395735549060703,1.0,3/15,2.90%,PIEZO2;TMEM120A;TMC1
prerank,embryonic organ development (GO:0048568),0.5429263503881744,1.5275790657805268,0.030666666666666665,0.646257825691934,1.0,18/61,11.71%,PBX3;RARB;PCSK5;COBL;GLI3;PBX1;STRA6;BMPR1A;PDGFA;GDNF;TGFBR2;STIL;FOXE1;TEAD1;ERCC3;GATA3;IFT122;TGFB2
prerank,dopaminergic neuron differentiation (GO:0071542),0.6604590251587623,1.5261307993119586,0.065,0.6492902222767183,1.0,6/19,10.12%,LRP6;PITX3;PHOX2A;NR4A2;CDNF;FOXA1
prerank,xenobiotic transport (GO:0042908),0.679259563122872,1.525738262135445,0.05324459234608985,0.6475359378954676,1.0,2/17,2.82%,SLC47A1;ABCG2
prerank,vitamin transport (GO:0051180),0.6140707846152091,1.5255046803544323,0.04012841091492777,0.6449301726522944,1.0,3/29,2.82%,SLC23A1;SLC5A6;ABCG2
prerank,potassium ion homeostasis (GO:0055075),0.6360844702492889,1.5254803248367577,0.05271317829457364,0.6413661903709852,1.0,5/23,1.55%,SLC12A7;KCNJ2;SLC12A2;ATP1B1;SLC12A8
prerank,response to hexose (GO:0009746),0.6324030644466958,1.5253430596732067,0.05206738131699847,0.638376986683878,1.0,7/25,16.64%,THBS1;TCF7L2;HNF4A;EIF2B2;SELENOT;EIF2B3;IRS2
prerank,negative chemotaxis (GO:0050919),0.5992074797520898,1.5251641635842978,0.05185185185185185,0.6356272084468899,1.0,9/33,6.37%,SLIT3;SLIT2;NTN1;SEMA3D;SEMA3C;UNC5C;SEMA3E;PDGFA;ITGAV
prerank,positive regulation of heart contraction (GO:0045823),-0.5636207482356915,-1.5249484865504734,0.022900763358778626,0.41548570753587616,1.0,10/19,22.16%,ATP1A2;KCNQ1;EDN1;RYR2;ADM;EDN3;GSK3A;ATP2A2;SCN3B;CHGA
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.6868128330412964,1.5243120011599784,0.042993630573248405,0.6358791671511206,1.0,2/17,1.37%,EGFR;PKD1
prerank,positive regulation of neuron migration (GO:2001224),-0.6404083901663659,-1.5237770298548101,0.05463182897862233,0.415214305509404,1.0,4/11,7.31%,SEMA6A;RAPGEF2;DAB2IP;MDK
prerank,lung epithelium development (GO:0060428),0.7478147483455133,1.523138513678401,0.0650994575045208,0.6376703919843618,1.0,3/10,2.70%,BMP4;PKD1;STRA6
prerank,kidney development (GO:0001822),0.5459677889912623,1.521906644375888,0.023287671232876714,0.6400596138106065,1.0,14/65,6.52%,BMP4;PCSK5;SIX1;PKD1;ZBTB16;SULF1;AGTR1;STRA6;GDF6;GDNF;TGFBR1;KANK2;TFAP2A;ARL3
prerank,activation of phospholipase C activity (GO:0007202),0.6233210529501335,1.5211384271241417,0.038980509745127435,0.6401264934391063,1.0,2/29,0.48%,EGFR;EDNRA
prerank,substantia nigra development (GO:0021762),-0.4814276809036193,-1.5202508272759145,0.013114754098360656,0.421746631700746,1.0,15/37,16.88%,MBP;CALM1;PLP1;MAOB;GNB4;ACTB;ATP5PF;CALM3;COX6B1;DYNLL1;BASP1;PADI2;NDUFS3;TTBK1;CNP
prerank,secretion (GO:0046903),-0.6104382114059259,-1.520147119766835,0.045112781954887216,0.4182947461976692,1.0,5/14,3.88%,FBLN5;RIMS1;NPR1;SLC22A6;SLC22A4
prerank,mesonephros development (GO:0001823),0.7233573502726656,1.5201425324446993,0.06678700361010831,0.641192635305119,1.0,2/11,1.61%,BMP4;ZBTB16
prerank,cellular response to zinc ion (GO:0071294),-0.5900619666196528,-1.5199743734204578,0.04449648711943794,0.4151516728654301,1.0,10/15,14.55%,GLRA1;MT2A;MT1B;MT1E;MT1A;MT1F;MT1G;MT1M;MT1X;MT1H
prerank,cGMP biosynthetic process (GO:0006182),0.7436863176898254,1.5195375441904637,0.07705479452054795,0.6402359591944445,1.0,1/10,0.09%,GUCY2C
prerank,base conversion or substitution editing (GO:0016553),-0.628630976927,-1.5175328689166399,0.04821802935010482,0.4188995917566645,1.0,4/11,16.22%,APOBEC1;ADARB2;ADARB1;METTL3
prerank,glutamate receptor signaling pathway (GO:0007215),-0.48068801383315607,-1.5159329479741042,0.030927835051546393,0.41999427959069136,1.0,15/37,8.98%,PLCB1;GRM3;GRIK1;GRIN2A;GRM5;GRM1;GRM7;GRIA4;GRIA2;GRIA3;GRIN2B;GRID2;GRM8;GRIN3A;GRIK2
prerank,regulation of cAMP-mediated signaling (GO:0043949),-0.5211668658536545,-1.5158941484541624,0.03757225433526012,0.41647306198124295,1.0,12/24,16.95%,RAPGEF2;PRKAR2B;PEX5L;PRKAR1B;PDE4D;PDE2A;PRKAR1A;PDE11A;PDE3A;CGAS;PDE3B;RNF157
prerank,limb morphogenesis (GO:0035108),0.641360625548314,1.5154535731790082,0.07855973813420622,0.655885045540977,1.0,8/20,12.08%,MBNL1;PCSK5;GLI3;LRP6;SKI;TGFB2;MEGF8;IQCE
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.5700463409474275,1.5152454194172125,0.04888268156424581,0.6532305893277512,1.0,4/41,1.46%,KCNJ2;KCNMB3;KCNMB2;ANK2
prerank,nucleoside catabolic process (GO:0009164),0.7329099924926423,1.5150331106342967,0.07491289198606271,0.6506916527089254,1.0,4/11,10.50%,NT5E;NT5C1A;UPP2;DERA
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.6295730904324381,1.514770307388205,0.0654490106544901,0.648423185313943,1.0,7/26,6.74%,EYA2;FGFR1;INHBA;GATA1;GDNF;EYA4;EYA3
prerank,muscle tissue development (GO:0060537),0.7019055906698867,1.514438787770819,0.06324786324786325,0.6463186846716437,1.0,5/13,4.15%,BMP4;SMO;CSRP3;STRA6;CSRP2
prerank,regulation of cell communication (GO:0010646),0.5991801370297399,1.5141049975083452,0.04035874439461883,0.6444397454848891,1.0,7/35,4.79%,GRK5;CXADR;ANXA1;ANK2;CAMK2D;MGLL;SOCS2
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.5684057719368347,1.5136337432117164,0.03824362606232295,0.6431606414482522,1.0,11/43,10.61%,BMP4;FOXP1;THBS1;IL10;BMPR1A;IGFBP5;NR4A3;JUN;FGF2;NOX1;HTR1B
prerank,positive regulation of protein catabolic process (GO:0045732),0.5207533516814293,1.513575214043493,0.024721878862793572,0.6400685837937004,1.0,25/84,14.53%,FZR1;WWP1;EZR;NEDD4;GPC3;WWP2;ADAM9;ASB9;GSK3B;STX5;VCP;ASB11;PLK3;IDE;TNFRSF1B;NSF;CDKN1B;RDX;SEC22B;CSNK2A1;SH3D19;ADAM8;AMER1;SMURF1;VIP
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.6236906523770912,1.5133353862262646,0.07836990595611286,0.6377249367559746,1.0,7/23,11.02%,BMP4;SMO;SIX1;GDNF;FGF2;SIX4;NOG
prerank,smoothened signaling pathway (GO:0007224),0.5897822281004571,1.5125653337111005,0.050684931506849315,0.6379464441188969,1.0,8/32,9.50%,SMO;GLI3;HIPK1;STIL;DYRK2;PKD2L1;TMEM231;EVC2
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.5750995547100942,1.5124743585176177,0.027065527065527065,0.6351010717365879,1.0,11/46,11.25%,CDH1;TCF7L2;NEDD4;PRKCD;ZIC1;GSK3B;HCLS1;MAVS;JUP;NRDE2;UBR5
prerank,atrioventricular valve morphogenesis (GO:0003181),0.6475251042649947,1.5124353987265713,0.08333333333333333,0.6320308093035637,1.0,8/19,11.71%,SLIT3;SMAD6;BMPR1A;TGFBR2;GATA4;MDM4;ACVR1;TGFB2
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.6112724509108864,1.5119156225687762,0.05697151424287856,0.6311069494763925,1.0,12/27,13.50%,KAT6B;SGF29;CPA4;TRRAP;ATAT1;EP300;KAT2A;CREBBP;TAF6L;KAT5;KAT2B;BRD8
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.6883657303409886,1.5116050644061831,0.0676818950930626,0.6292172883831677,1.0,2/15,1.46%,KCNJ2;ATP1B1
prerank,regulation of cell killing (GO:0031341),0.6762014633047699,1.5107513843698173,0.07094594594594594,0.6297212872004032,1.0,7/16,11.71%,CFH;CD55;IL10;FZD7;CR1L;NOX1;TGFB2
prerank,ventricular septum development (GO:0003281),0.5781957147460591,1.508207580247815,0.038461538461538464,0.6376638066241553,1.0,14/37,11.71%,SLIT3;SLIT2;ZFPM2;STRA6;BMPR1A;TGFBR1;TGFBR2;HES1;GATA4;MDM4;GATA3;NOG;ACVR1;TGFB2
prerank,cellular response to osmotic stress (GO:0071470),0.645318879272235,1.5074683752327545,0.06220095693779904,0.63769586739355,1.0,3/21,3.71%,STK39;LRRC8D;YBX3
prerank,protein K11-linked ubiquitination (GO:0070979),0.6111857952060058,1.5061542300562294,0.05222734254992319,0.640418867449627,1.0,5/27,8.72%,FZR1;UBE2B;ANAPC5;UBE2D3;CDC16
prerank,regulation of ERBB signaling pathway (GO:1901184),0.6701472291731804,1.5059418919081176,0.07903225806451612,0.638209530410685,1.0,1/15,0.19%,EGFR
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.5556275813474376,-1.5056348130763761,0.06565656565656566,0.443362938978023,1.0,6/18,8.98%,UNC13C;CDH8;GRIK1;GRIA2;GRID2;GRIK2
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.5847726497088226,-1.5056304920043793,0.03855421686746988,0.43955770082178197,1.0,7/15,22.29%,ABHD12;GGT5;ALDH4A1;SARDH;GGT7;GGT1;HOGA1
prerank,cAMP metabolic process (GO:0046058),-0.6069652121782203,-1.5050241835941314,0.07459207459207459,0.43752214119055466,1.0,8/13,15.58%,ADCY5;ADCY1;ADCY7;ADCY2;PDE4D;ADCY4;ADCY3;ADCY8
prerank,regulation of protein catabolic process (GO:0042176),0.49981661222625917,1.5044068108394626,0.01907032181168057,0.6418096833725333,1.0,16/99,8.98%,FZR1;EGFR;WWP1;NEDD4;GPC3;WWP2;ASB9;GSK3B;STX5;VCP;ASB11;IDE;NSF;MDM4;CHEK2;CDKN1B
prerank,positive regulation of neutrophil migration (GO:1902624),-0.5514272576337067,-1.5034264706504141,0.050505050505050504,0.4384789075229902,1.0,11/18,22.79%,CAMK1D;RIPOR2;DAPK2;MDK;RAC1;NCKAP1L;TIRAP;CCL19;CD74;DNM1L;THBS4
prerank,regulation of cholesterol efflux (GO:0010874),-0.4849017255674374,-1.502119005415434,0.036036036036036036,0.43875413013059944,1.0,7/30,9.74%,PLTP;APOE;PTCH1;NR1H3;GPS2;ABCA5;EEPD1
prerank,regulation of cellular senescence (GO:2000772),-0.5009694309016129,-1.5020733015147185,0.039634146341463415,0.4352933769982505,1.0,13/28,22.31%,SLC30A10;B2M;AKT3;NUAK1;CDK6;YPEL3;YBX1;ABI3;CGAS;VASH1;ING2;RBL1;NEK4
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.7038371082136277,1.500164768207284,0.07001795332136446,0.6571856729690776,1.0,5/12,6.10%,SORBS1;ZBTB7B;C1QTNF12;ERFE;IRS1
prerank,cellular response to estradiol stimulus (GO:0071392),0.6664561218951722,1.4999859419362638,0.05695142378559464,0.6548824882778095,1.0,5/18,15.33%,EGFR;MYOG;KAT5;LCOR;NRIP1
prerank,androgen receptor signaling pathway (GO:0030521),0.7198591173694702,1.4996889030461789,0.08617594254937164,0.6529550616640962,1.0,8/11,21.00%,DDX5;ZMIZ1;PLPP1;DDX17;AR;ARID1A;PMEPA1;RNF14
prerank,cAMP biosynthetic process (GO:0006171),-0.6535492288846878,-1.497677371977777,0.06387665198237885,0.444995270402327,1.0,7/10,15.58%,ADCY5;ADCY1;ADCY7;ADCY2;ADCY4;ADCY3;ADCY8
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.6376357970043895,-1.4974075088688024,0.058695652173913045,0.4421250851811761,1.0,6/11,10.71%,EFNB2;SOX6;MEF2C;BMP2;FRS2;MYOCD
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.6889523680242013,1.4964227962340246,0.0673758865248227,0.6645863159445232,1.0,2/15,1.74%,GLI3;CD55
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.5524852788196702,1.4958594431632148,0.028925619834710745,0.6638752101946169,1.0,9/50,7.28%,EGFR;NR3C2;TCIM;NFAT5;PDCD4;EP300;TRIP6;TRIM44;IFI35
prerank,positive regulation of positive chemotaxis (GO:0050927),0.6899058934009451,1.4950509068814033,0.06907894736842106,0.6642690986366809,1.0,3/15,2.60%,F3;NTRK3;PGF
prerank,establishment of endothelial barrier (GO:0061028),-0.4897548797823492,-1.4948219341578055,0.04833836858006042,0.4462643910211687,1.0,13/29,11.66%,TJP1;PECAM1;RAPGEF3;RAPGEF2;F11R;PPP1R16B;RAPGEF1;ROBO4;PDE4D;PDE2A;MYADM;RAB1B;SOX18
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.5230520924255193,1.491987784292387,0.02631578947368421,0.6745969854984443,1.0,13/74,6.74%,BMP4;THBS1;EYA2;TCF7L2;BMP5;GSK3B;GATA1;BIRC6;GDNF;TGFBR1;ITGAV;EYA4;EYA3
prerank,detection of calcium ion (GO:0005513),0.6922310011029961,1.4915735728313213,0.06666666666666667,0.6730866211449104,1.0,2/13,0.60%,KCNMB3;KCNMB2
prerank,heterotypic cell-cell adhesion (GO:0034113),0.6101840540691731,1.4911010610758153,0.0748829953198128,0.672243910376692,1.0,9/25,7.87%,CXADR;PARVA;DSP;ITGB1;DSG2;ITGA5;DSC2;ITGAV;JUP
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.6543514080102439,1.4902762770267632,0.08090614886731391,0.6728142205755037,1.0,3/20,2.01%,STK39;NEDD4;CAMK2D
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.626579671968347,-1.4900827195428181,0.06436781609195402,0.45666804766136426,1.0,5/11,22.15%,NOS3;CALM1;QDPR;AKT1;PTS
prerank,primary neural tube formation (GO:0014020),0.5959362664259433,1.4897038429774034,0.06518518518518518,0.6722546971955287,1.0,10/30,11.71%,COBL;LMO4;LRP6;PRICKLE1;STIL;BCL10;FUZ;SKI;IFT122;TGFB2
prerank,positive regulation of synapse assembly (GO:0051965),-0.5046764063305966,-1.488861738738708,0.02786377708978328,0.45672197645137136,1.0,19/27,36.74%,NRXN1;IL1RAPL1;EPHB1;GRID2;SRPX2;LRRC4B;CLSTN3;SEMA4A;CLSTN1;NLGN1;NLGN2;AGRN;VSTM5;CUX2;WNT7A;NLGN3;EPHB2;CLSTN2;BDNF
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.6868688673644936,1.4888426692982064,0.07801418439716312,0.6728572746448033,1.0,5/14,12.08%,NT5E;NT5C1A;UPP2;CAD;ERH
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.5355017675267844,-1.4886202089532221,0.06282722513089005,0.4539351900836562,1.0,10/20,25.42%,RPS6KA5;MAPK3;PPARGC1A;ARRB1;PRKAA2;RUVBL2;NOS1;BRCA1;TADA2B;DIP2A
prerank,sulfur compound transport (GO:0072348),0.6128090170468445,1.4883548846181904,0.050955414012738856,0.671858032321112,1.0,4/27,2.82%,SLC26A7;SLC5A6;LRRC8D;ABCG2
prerank,regulation of muscle cell differentiation (GO:0051147),0.5834314220636336,1.488214385429889,0.06841339155749636,0.6693583264443123,1.0,10/31,10.90%,CDON;BOC;CTNNA1;HDAC9;MYOG;MEF2A;ABL1;TCF3;TCF23;CDC42
prerank,positive regulation of catabolic process (GO:0009896),0.5285745110324747,1.4877591900785017,0.035479632063074903,0.6682173296965428,1.0,15/65,11.42%,FZR1;WWP1;NEDD4;GPC3;WWP2;ASB9;GSK3B;STX5;VCP;ASB11;IDE;NSF;CDKN1B;SEC22B;CSNK2A1
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.5729658756754479,1.486949939492524,0.05499276410998553,0.6688088689022963,1.0,12/33,12.38%,KLF5;FOXO3;KLF4;IL10;JUN;FGF2;TEAD1;SMARCA4;ATOH8;GATA3;TGFB2;STAT3
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.5496791931130698,-1.486798672984228,0.04773869346733668,0.45618834540001924,1.0,9/17,16.02%,ATP5F1B;ATP5PF;ATP5F1E;ATP5ME;ATP5MC1;ATP5F1D;VPS9D1;ATP5MC2;ATP5F1A
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.7116459099534695,1.4865113718997487,0.07381370826010544,0.6679105397179356,1.0,4/11,5.32%,MAP3K5;CYP1B1;PRKCD;DIABLO
prerank,positive regulation of transporter activity (GO:0032411),0.6907830698519938,1.4862311953980802,0.06607142857142857,0.6661647870678581,1.0,1/13,0.08%,STK39
prerank,alcohol catabolic process (GO:0046164),-0.6485345175649684,-1.4861462903246028,0.06004618937644342,0.4545262212197885,1.0,2/10,2.17%,APOE;CYP27A1
prerank,tube closure (GO:0060606),0.5900674289672555,1.48588687479093,0.06379821958456973,0.6647717980052147,1.0,10/31,11.71%,COBL;LMO4;LRP6;PRICKLE1;STIL;BCL10;FUZ;SKI;IFT122;TGFB2
prerank,regulation of sequestering of calcium ion (GO:0051282),0.7036581307553259,1.4856675449864036,0.08561643835616438,0.6626930479845234,1.0,3/12,3.95%,ANK2;PTK2B;DIAPH1
prerank,sulfation (GO:0051923),0.710104090945987,1.4852433690938798,0.07342657342657342,0.6615356334624515,1.0,3/11,4.37%,UST;SULT1A1;CHST5
prerank,vasculogenesis (GO:0001570),-0.468746404429292,-1.4849851496870927,0.061764705882352944,0.45445108519714433,1.0,13/32,11.66%,ENG;TGFBR3;PDGFRB;KDR;RASIP1;NOTCH1;RAMP2;SOX17;HEY2;AGGF1;ADM;SPRED1;SOX18
prerank,positive regulation of protein import into nucleus (GO:0042307),0.607685721507659,1.484027782593635,0.07956318252730109,0.6638082998895787,1.0,10/28,16.59%,CDH1;PRKCD;ZIC1;HCLS1;MAVS;JUP;UBR5;RAN;DMAP1;FLNA
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.6797668131186076,1.483882727557923,0.06622516556291391,0.6614706016892046,1.0,5/15,7.51%,SMOC2;MET;FGFR1;P2RX4;FGF2
prerank,negative regulation of cartilage development (GO:0061037),0.6823997598016961,1.4837782095604153,0.08188153310104529,0.6589575142070592,1.0,5/13,5.26%,WNT9A;WNT11;EFEMP1;GDF5;TGFBR1
prerank,integrin-mediated signaling pathway (GO:0007229),0.5127857364870422,1.483356927644345,0.03201024327784891,0.6580895661875565,1.0,20/73,11.05%,ITGBL1;ITGB8;FN1;PTK2B;ITGB1;ITGA10;PLPP3;COL3A1;ADAM9;ITGA5;ABL1;ITGAV;PRAM1;NRP1;ITGB5;ADAM10;PTPRA;CDH17;CDC42;ITGB4
prerank,positive regulation of nervous system development (GO:0051962),-0.4482867228841671,-1.483178006469248,0.02181818181818182,0.456512908384668,1.0,15/42,21.39%,TGM2;NRXN1;IL1RAPL1;EPHB1;GRID2;SRPX2;FAIM;LRRC4B;CX3CR1;NUMBL;CLSTN3;CLSTN1;NLGN1;NLGN2;TRIM32
prerank,purine nucleotide catabolic process (GO:0006195),0.7005194424078813,1.4830447177831247,0.08596491228070176,0.6566772835119761,1.0,2/13,1.81%,NT5E;NT5C1A
prerank,inorganic cation import across plasma membrane (GO:0098659),0.5166303881905441,1.482690644902393,0.037783375314861464,0.6553036582924853,1.0,17/75,13.16%,SLC9A2;SLC12A7;KCNJ2;SLC12A2;ATP1B1;SLC12A8;SLC9C1;TRPM4;ATP2B4;SLC39A14;KCNJ15;ATP1A3;ATP1A4;ATP1A1;SLC9A1;SLC9A3;KCNJ9
prerank,mesenchymal to epithelial transition (GO:0060231),0.7159201442323324,1.4826641086133694,0.07495429616087751,0.6525675190355467,1.0,2/10,4.03%,BMP4;FZD7
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.38579799264721626,-1.4823550909023184,0.00510204081632653,0.455483412629769,1.0,31/91,16.90%,CP;SLC30A10;FTH1;SLC39A10;TFRC;SLC40A1;SLC39A8;SLC39A7;ATOX1;FTL;MT2A;ATP6AP1;CAND1;APP;SLC22A17;SLC31A1;SLC30A1;ATP6V1A;MT1B;MT1E;MT1A;MT1F;MT1G;MT1M;MT1X;MT1H;SLC11A2;BOLA2;NUBP1;GLRX3;ATP7A
prerank,regulation of microtubule-based movement (GO:0060632),-0.6290519155214658,-1.4811596235143583,0.0651685393258427,0.455647146900685,1.0,7/11,23.67%,MAP2;LAMP1;NEFH;DYNLT2B;IGBP1;DRC1;HAP1
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.5871090699921958,1.4808843294194516,0.06101190476190476,0.6573990550955855,1.0,5/32,11.29%,FZR1;FOXN3;ATM;MRNIP;CHEK1
prerank,integrated stress response signaling (GO:0140467),0.6830360722509893,1.4808483142400046,0.0812603648424544,0.6547598597812111,1.0,6/14,11.64%,DDIT3;NFE2L2;EIF2AK4;QRICH1;EIF2AK3;OMA1
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.6605472798331917,1.4787962860086923,0.0859106529209622,0.6606382594512024,1.0,5/16,12.88%,NAA40;EP300;CREBBP;NAA35;KAT2B
prerank,regulation of cell death (GO:0010941),0.5034046354097943,1.478413799410415,0.03383458646616541,0.6593415439084432,1.0,23/94,12.74%,BMP4;CCN3;ACER3;LRPAP1;CCN1;WNT11;EIF4G1;WNT16;CCN5;BECN1;CLU;CELF1;RIPK2;FGF2;TNFRSF1B;SPEF1;SRGAP2;CDKN1B;AGR2;SRSF6;CD36;BNIP3;HTR2B
prerank,catecholamine biosynthetic process (GO:0042423),-0.6083711838557533,-1.477459918206425,0.06542056074766354,0.4635047068148992,1.0,3/11,6.97%,MOXD1;SNCA;DDC
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.5447428917647946,1.4772730386609814,0.04576043068640646,0.6614704500305488,1.0,2/55,0.56%,FBXL7;FHL1
prerank,histone modification (GO:0016570),0.49706829853766976,1.4767899803440976,0.030048076923076924,0.6606077938393966,1.0,37/109,17.92%,EYA2;HDAC4;CCNA2;HDAC9;PRKCD;RCOR3;KAT6B;UBE2B;CTCFL;SGF29;CPA4;TRRAP;EYA4;EP300;EYA3;TBL1X;HDAC10;KAT2A;CREBBP;TAF6L;KAT5;USP22;USP3;USP21;BAZ2A;EHMT2;EHMT1;BRD8;CARM1;UFL1;PRMT6;PRMT2;MAP3K12;UBE2N;MORF4L2;HUWE1;BRMS1L
prerank,regulation of synapse maturation (GO:0090128),-0.6411734356738665,-1.4765419267201352,0.054466230936819175,0.46280358310297726,1.0,5/10,15.19%,NRXN1;ARHGEF15;DAB2IP;CAMK2B;ADGRL1
prerank,epithelial tube morphogenesis (GO:0060562),0.5804334591143221,1.4760619432511468,0.0734632683658171,0.6609461743413098,1.0,4/32,1.37%,SLIT2;BMP4;MET;PKD1
prerank,eye development (GO:0001654),0.5326540437272836,1.4747284367789246,0.054945054945054944,0.6637481504647877,1.0,16/54,14.54%,PBX3;COL5A2;PBX1;STRA6;HIPK1;EFEMP1;CACNA1C;RAB18;SMOC1;TSKU;SKI;TGFB2;FOXC1;SCO2;CPAMD8;ADAMTS18
prerank,purine nucleotide metabolic process (GO:0006163),0.6144230973211178,1.4745312712840226,0.07550077041602465,0.6618419751906942,1.0,3/24,2.13%,NT5E;NT5C1A;FHIT
prerank,positive regulation of embryonic development (GO:0040019),-0.5383755740539269,-1.473524328574031,0.061170212765957445,0.4683336380447049,1.0,8/19,17.55%,PLCB1;WNT4;TENM4;OSR1;NR2C2;CFL1;RBM19;B4GALT5
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.7377542379900789,1.473424804544139,0.08851224105461393,0.6637401281645045,1.0,3/10,2.01%,STK39;NEDD4;CAMK2D
prerank,positive regulation of T cell migration (GO:2000406),0.6279860283725466,1.473106238084824,0.09657320872274143,0.6623761843506898,1.0,5/20,12.15%,STK39;WNK1;ADAM10;RHOA;TNFRSF14
prerank,regulation of smoothened signaling pathway (GO:0008589),0.5403969655685358,1.4705375310793956,0.05446927374301676,0.6705853050022182,1.0,15/50,12.25%,SMO;GLI3;HHIP;GPC3;ZIC1;VCP;CREBBP;GLIS2;FUZ;ARMC9;IFT122;HERC4;MEGF8;TTC23;KIF7
prerank,positive regulation of protein import (GO:1904591),0.596645197799286,1.47048091727639,0.0715372907153729,0.6680566305460085,1.0,7/30,7.87%,CDH1;PRKCD;ZIC1;ARHGEF5;HCLS1;MAVS;JUP
prerank,T cell migration (GO:0072678),0.6981098592693572,1.4693864063647506,0.10101010101010101,0.6700882680611611,1.0,1/13,0.48%,SLC12A2
prerank,endothelial cell proliferation (GO:0001935),0.6313456032763294,1.4672636364414064,0.0945945945945946,0.6760409561306626,1.0,2/17,0.36%,BMP4;BMPER
prerank,mesenchymal cell differentiation (GO:0048762),-0.42797301709959046,-1.4667580199679344,0.02181818181818182,0.48651346815104146,1.0,15/51,8.28%,RANBP3L;LEF1;WNT4;ENG;TGFBR3;WNT5A;HIF1A;NOTCH1;BMP7;LOXL3;NOTCH4;RBPJ;MEF2C;BMP2;HEY2
prerank,PERK-mediated unfolded protein response (GO:0036499),0.7144098709923248,1.4663600849708818,0.08614864864864864,0.6771232356805145,1.0,4/10,11.12%,DDIT3;NFE2L2;QRICH1;EIF2AK3
prerank,thymus development (GO:0048538),0.6865983023925595,1.4656810559531528,0.09780775716694773,0.677275373998659,1.0,5/13,7.89%,SIX1;RIPK3;TGFBR1;FOXE1;HES1
prerank,protein localization to centrosome (GO:0071539),0.6657088832869283,1.4649565557035051,0.0888529886914378,0.6777836297870421,1.0,11/17,24.51%,GOLGB1;CEP131;STIL;PCM1;PIBF1;CSNK1D;NUDCD3;CEP192;C2CD3;CCDC14;CEP83
prerank,L-glutamate transmembrane transport (GO:0015813),-0.6287593534498964,-1.464752451777738,0.08163265306122448,0.48942765249219633,1.0,4/10,13.40%,SLC1A3;SLC1A1;SLC1A2;SLC25A18
prerank,glycerophospholipid catabolic process (GO:0046475),-0.4915228741525931,-1.4645095372301677,0.05214723926380368,0.4867595491911784,1.0,6/27,8.17%,GPCPD1;ENPP2;ENPP6;ABHD12;INPP5F;PNPLA8
prerank,gene expression (GO:0010467),-0.32894524613031795,-1.4644856665687613,0.0,0.4833280169255606,1.0,129/348,23.94%,RBPMS;RBMS1;ATXN1;RPLP1;NOVA1;RPS14;PTMA;RPL37A;RPL38;RPL30;SETX;RPL8;RPL21;RPL41;RPL14;RPL9;RPS24;RPL13;EEF1A1;RPS27;TSPAN5;RPLP2;RPS21;APOBEC1;RPS23;ANGPT2;RPS9;RPS29;RPS15;RPL22;RPS5;RPS16;RPL5;RPS4X;RPS2;RPS13;ADARB2;RPL34;RPL23;RPL17;CELF2;RPS19;RPS8;RPS20;RPS27A;RPS17;ADARB1;ELAVL4;RPL13A;RPS12;BCL3;RPS7;RPS3;RPL27A;RPL3;RPL24;FASTKD2;RNPS1;RPS18;HNRNPH3;RPL18;DTX1;RPL39;RPS11;NUP160;EIF4E;PABPN1;MRPL3;SRSF9;RPL23A;UPF1;RPL7A;RPL35A;YTHDC1;RPL26;PWP1;RPL32;RPL18A;RPS25;RPL36;RPL12;RPS10;XAB2;SLBP;RPL27;WDR33;RPL11;POLR2K;NUP210;TOPORS;MRPS11;DDX54;HHEX;RPL31;SARS1;RPL19;RPLP0;RPS15A;RPS28;POM121;RPL37;NUP205;MRPL51;RPL29;RNASEL;MRPL35;POLR2C;RPL28;HBS1L;TSPAN33;MRPL34;THOC7;EIF4EBP2;SRBD1;POLR2G;TESC;HNRNPU;RBM15B;SRSF1;NUP62;MRPL44;POLR2L;NUFIP1;TFIP11;GSPT2;NOX4;MRPL11;HARS2;RPL7
prerank,negative regulation of coagulation (GO:0050819),-0.5833557289249349,-1.4644413337985094,0.07560975609756097,0.47995248980964467,1.0,6/14,10.01%,VTN;APOE;TFPI;CD34;HS3ST5;EDN1
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.5421558269193264,1.4639780551123507,0.0644718792866941,0.6794323940774533,1.0,12/43,19.95%,FZR1;FOXN3;ATM;RAD17;MRNIP;CHEK1;INTS3;TAOK3;CLSPN;NBN;CHFR;MRE11
prerank,regulation of myotube differentiation (GO:0010830),0.6177170872004677,1.46317367200194,0.08293460925039872,0.6801213656616144,1.0,5/24,6.42%,CCN3;HDAC4;HDAC9;MYOG;MMP14
prerank,negative regulation of cell growth (GO:0030308),0.4835511094600789,1.462273706326945,0.02715466351829988,0.6811860409813513,1.0,18/121,9.66%,SLIT3;SLIT2;CCN3;FHL1;NDRG3;OSGIN2;ESR2;WNT11;INHBA;IP6K2;ULK2;HNF4A;FGF13;CYP27B1;SMARCA4;CDKN1B;BCL6;AGTR2
prerank,outflow tract septum morphogenesis (GO:0003148),0.6066255963325222,1.462101626910942,0.0754414125200642,0.6792569328246073,1.0,9/24,7.71%,BMP4;ZFPM2;PARVA;SEMA3C;ISL1;SMAD6;BMPR1A;TGFBR2;NRP1
prerank,motor neuron axon guidance (GO:0008045),0.65683277452375,1.4619266743021646,0.09693877551020408,0.6773828219076109,1.0,5/15,8.92%,SLIT2;NTN1;NTN5;NTN3;TMEFF1
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.6807366833930347,1.4617527552323946,0.0893169877408056,0.6753885954653348,1.0,4/13,8.83%,GLI3;ZBTB7B;TGFBR2;CBFB
prerank,aortic valve morphogenesis (GO:0003180),0.5943904884264385,1.4605310660247512,0.07598784194528875,0.6776676625983492,1.0,4/30,3.01%,SLIT3;SLIT2;BMP4;SMAD6
prerank,amino sugar metabolic process (GO:0006040),-0.6275263721073098,-1.4599967822590088,0.07657657657657657,0.4899029422114198,1.0,3/10,6.31%,ST3GAL1;ST6GAL1;CSGALNACT1
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.5980330390806002,1.4595591015013305,0.07228915662650602,0.6790555851103646,1.0,14/27,24.24%,CRY2;USP2;BHLHE40;FBXL6;PER2;PER3;PML;RBM4B;FBXL17;FBXL8;MTA1;CRTC1;FBXL3;RBM4
prerank,positive regulation of DNA repair (GO:0045739),0.5372190512906908,1.4593189842389465,0.05548037889039242,0.6774229379039401,1.0,11/46,16.77%,EGFR;EYA2;EYA4;EYA3;HDAC10;RNF168;ERCC8;DDX11;FOXM1;DHX9;UBE2N
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.5494610765205773,1.4588814853280831,0.054016620498614956,0.6766539466616494,1.0,7/45,3.14%,EGFR;PLCE1;REPS2;PTK2B;SHC1;EFEMP1;GAREM1
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.4249222191583947,-1.456341798445929,0.015151515151515152,0.4944206817479805,1.0,30/56,30.79%,NDUFA8;NDUFB3;NDUFS4;NDUFA6;NDUFS3;NDUFA12;NDUFC2;NDUFS2;NDUFAF4;NDUFB7;NDUFA1;NDUFB8;NDUFA3;NDUFB9;NDUFB4;TIMMDC1;NDUFAF8;NDUFS5;NDUFC1;NDUFA10;NDUFB11;NDUFA9;NDUFA5;NDUFS6;NDUFA11;DMAC1;NDUFS1;TMEM126A;NDUFA2;BCS1L
prerank,NADH dehydrogenase complex assembly (GO:0010257),-0.4249222191583947,-1.456341798445929,0.015151515151515152,0.4944206817479805,1.0,30/56,30.79%,NDUFA8;NDUFB3;NDUFS4;NDUFA6;NDUFS3;NDUFA12;NDUFC2;NDUFS2;NDUFAF4;NDUFB7;NDUFA1;NDUFB8;NDUFA3;NDUFB9;NDUFB4;TIMMDC1;NDUFAF8;NDUFS5;NDUFC1;NDUFA10;NDUFB11;NDUFA9;NDUFA5;NDUFS6;NDUFA11;DMAC1;NDUFS1;TMEM126A;NDUFA2;BCS1L
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.6421090984723994,-1.456282915781165,0.07900677200902935,0.49118409393295187,1.0,8/10,26.40%,APOD;LRCH1;RIPOR2;PADI2;AKT1;WASL;CD200;MIA3
prerank,neurotransmitter secretion (GO:0007269),-0.43432668767186206,-1.4561580161323464,0.022388059701492536,0.488194422451999,1.0,20/44,27.22%,NRXN1;LIN7A;HSPA8;RIMS1;RIMS2;SNCA;PIP5K1C;SYN1;CPLX1;SNAP25;UNC13A;LIN7C;PPFIA3;SYT1;SNAPIN;SLC32A1;CDK5;STXBP3;SYN2;RAB3A
prerank,atrial septum development (GO:0003283),0.6622145637840787,1.454633427382991,0.08605851979345955,0.692352490956445,1.0,6/13,11.71%,ANK2;ISL1;NOTCH2;GATA4;MDM4;TGFB2
prerank,negative regulation of heart contraction (GO:0045822),-0.6106226584545851,-1.4546011783708874,0.09903381642512077,0.4894710560971959,1.0,1/11,0.02%,ATP1A2
prerank,negative regulation of growth (GO:0045926),0.4782247349303819,1.4545445323219246,0.0246189917936694,0.6900988191543107,1.0,17/121,9.66%,SLIT3;SLIT2;CCN3;FHL1;NDRG3;OSGIN2;ESR2;WNT11;INHBA;IP6K2;NOTCH2;HNF4A;CYP27B1;SMARCA4;CDKN1B;BCL6;AGTR2
prerank,positive regulation of epithelial cell migration (GO:0010634),0.4905723662939757,1.4525465816634022,0.040194884287454324,0.6961904869128651,1.0,11/92,4.99%,SMOC2;BMP4;FOXP1;DOCK5;THBS1;MAPRE2;ANXA3;PTK2B;ADAM9;ABL1;FOXC2
prerank,positive regulation of cell cycle (GO:0045787),0.5160613438180128,1.4511345589609728,0.0535031847133758,0.6996907592247414,1.0,13/62,11.71%,EGFR;SMOC2;PKD1;LRP6;CDC25B;TGM1;USP2;CDKN1B;FOXA1;PKN2;CHEK1;USP22;TGFB2
prerank,regulation of neutrophil migration (GO:1902622),-0.6332460510097877,-1.4508927975329948,0.06293706293706294,0.49748080543045503,1.0,5/10,16.06%,JAM3;RHOH;RHOG;RAC1;NCKAP1L
prerank,positive regulation of dendrite extension (GO:1903861),-0.5334432233349118,-1.4503874844631068,0.07532467532467532,0.4955595101308746,1.0,11/17,27.33%,NEDD4L;RIMS1;RIMS2;RNF157;UNC13A;CPNE5;SYT1;CPNE9;ITSN2;SYT17;SYT2
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.6257331772753165,-1.4502870088283746,0.08314606741573034,0.49251574983712576,1.0,6/10,16.64%,PDE4B;CALM1;CALM3;CACNA2D1;NOS1AP;NIPSNAP2
prerank,photoperiodism (GO:0009648),0.5902593906021432,1.4497494980583578,0.0783132530120482,0.7029308870351905,1.0,14/28,24.24%,CRY2;USP2;BHLHE40;FBXL6;PER2;PER3;PML;RBM4B;FBXL17;FBXL8;MTA1;CRTC1;FBXL3;RBM4
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.6067408175906042,1.4492144765997086,0.07898894154818326,0.7027126084756665,1.0,5/22,3.75%,CD44;WNK1;KLF4;IL10;GCNT2
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.5944273429106001,1.448683351892823,0.05588235294117647,0.7023705328657549,1.0,3/27,3.14%,SLC47A1;SLC38A1;SLC7A2
prerank,calcium-ion regulated exocytosis (GO:0017156),-0.48809802341217184,-1.4483727897567158,0.06017191977077364,0.49487664794359854,1.0,16/27,27.33%,RIMS1;RIMS2;SYT7;SYT11;SYT12;SYT9;ARL8B;SDF4;PPP3CB;SYT13;SYT15;SYT1;SYT5;DOC2B;SYT17;SYT2
prerank,regulation of dendrite extension (GO:1903859),-0.524163814601629,-1.4478734954066343,0.08333333333333333,0.4931402610673705,1.0,11/18,27.33%,NEDD4L;RIMS1;RIMS2;RNF157;UNC13A;CPNE5;SYT1;CPNE9;ITSN2;SYT17;SYT2
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.6732055803182111,1.4476922415074782,0.09874326750448834,0.7039320546223587,1.0,5/13,6.10%,SORBS1;ZBTB7B;C1QTNF12;ERFE;IRS1
prerank,atrioventricular valve development (GO:0003171),0.6579017174784935,1.4467125525728048,0.1079136690647482,0.7054819232315253,1.0,6/14,11.71%,SLIT3;BMPR1A;TGFBR2;MDM4;ACVR1;TGFB2
prerank,response to amyloid-beta (GO:1904645),-0.4347484424589066,-1.4458746595070944,0.02909090909090909,0.49592908651136286,1.0,16/44,14.71%,IGF1;IGF1R;VCAM1;GRIN2A;GRM5;CASP4;ITGA4;EPHA4;GJA1;MMP2;APP;CACNA1B;CACNA2D1;GRIN1;CHRNA7;CACNB1
prerank,negative regulation of complement activation (GO:0045916),0.7289377060336791,1.4453702936973352,0.10825688073394496,0.7085801568591082,1.0,4/10,11.05%,CD55;CR1L;CD46;SERPING1
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.5028428445347213,1.4444891998321223,0.04204993429697766,0.7096257344006732,1.0,9/66,6.47%,EGFR;FHL1;ANXA1;PKD1;KLF4;EIF4G1;FAM107A;KANK2;DLG1
prerank,odontogenesis (GO:0042476),0.5669212620939267,1.4434108643466332,0.09090909090909091,0.7117306691628117,1.0,6/35,4.60%,BMP4;EDA;TGFB3;INHBA;LRP6;AQP6
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.6319270362468672,1.441384518134922,0.08201892744479496,0.7178236690889477,1.0,2/20,1.37%,EGFR;PKD1
prerank,inorganic anion transmembrane transport (GO:0098661),0.5131263753399179,1.441107066741628,0.04569190600522193,0.7164090897468816,1.0,11/63,9.37%,SLC12A7;SLC26A2;SLC12A2;SLC5A6;SLC12A8;ANO6;GLRB;SLC4A8;GABRA3;SLC25A14;ANO9
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.416014592591025,-1.4408303117746717,0.02390438247011952,0.5085346999265474,1.0,19/57,17.07%,ADCY5;ADCY1;ADCY7;ADCY2;GRM7;ADRA2A;GPR37;GRM8;LPAR1;PDE2A;CHRM3;PSAP;ADCY4;CHRM2;P2RY12;GPR37L1;ADCY3;ADCY8;NPY1R
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.5366871187101526,-1.4402005069726098,0.07397959183673469,0.5071116583841732,1.0,11/19,23.67%,IGF1;APOE;PICALM;RTN1;NTRK2;CHRNA7;GGA3;BIN1;RTN4;PIN1;HAP1
prerank,regulation of endothelial cell migration (GO:0010594),0.4961659586577397,1.4397827461949113,0.04234122042341221,0.7194219766230829,1.0,9/85,2.10%,SLIT2;SMOC2;BMP4;FOXP1;BMPER;THBS1;ANXA3;PTK2B;RHOJ
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.6018161726402312,1.4384979800145676,0.09508716323296355,0.7224313353812437,1.0,6/24,4.13%,CDON;BOC;CTNNA1;MYOG;MEF2A;ABL1
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.6663894699607726,1.437772792848391,0.12027491408934708,0.7227848769104349,1.0,4/13,10.66%,CYFIP2;PERP;RIPK2;TBC1D10A
prerank,cellular response to alkaloid (GO:0071312),-0.5395063023705813,-1.4377537669293916,0.07179487179487179,0.5116296843777084,1.0,7/17,15.89%,TGM2;SLC8A1;RYR2;CASP3;BLM;RYR3;CASQ2
prerank,negative regulation of histone modification (GO:0031057),-0.5735822390156123,-1.436894388191259,0.06467661691542288,0.5110385620880815,1.0,9/14,27.60%,JARID2;SNCA;SET;NOC2L;BRCA1;CTBP1;SPHK2;TWIST1;AASS
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.539454952974641,1.4364918009703613,0.07452574525745258,0.7257275151193976,1.0,10/43,7.07%,SORBS1;GRB10;PRKCD;PID1;ZBTB7B;C1QTNF12;ERFE;SIK2;IRS1;PTPN2
prerank,muscle cell migration (GO:0014812),0.7062225308629373,1.436171198894783,0.11151079136690648,0.7244808895140847,1.0,2/10,1.37%,CCN3;SIX1
prerank,positive regulation of cellular senescence (GO:2000774),-0.631817773973654,-1.4359868650056167,0.08944954128440367,0.5107227357917128,1.0,4/10,13.66%,B2M;YPEL3;ABI3;CGAS
prerank,negative regulation of insulin secretion (GO:0046676),0.6367074658007125,1.4353009773474865,0.08756567425569177,0.7253632659958147,1.0,6/17,12.79%,CCN3;KCNB1;KLF7;IRS1;REST;INHBB
prerank,retina homeostasis (GO:0001895),-0.5031340812702596,-1.4351106267124567,0.06424581005586592,0.5103428426086062,1.0,8/23,18.77%,B2M;ATP1B2;ACTB;POTEF;CDH3;WHRN;PRDX1;ACTG1
prerank,positive regulation of vasoconstriction (GO:0045907),0.6690594383803055,1.4347407682468982,0.11222780569514237,0.7250621208877167,1.0,2/13,5.11%,ADRA1B;TRPM4
prerank,response to interferon-gamma (GO:0034341),-0.39113337004787113,-1.4330464646160945,0.02830188679245283,0.5136139560141477,1.0,26/67,24.48%,WNT5A;CD47;GBP7;SNCA;GBP4;BST2;AQP4;IFITM1;GAPDH;SIRPA;DAPK1;RPL13A;IFITM3;TRIM21;SP100;GBP5;GBP2;CCL19;CD74;CD40;CASP1;STAT1;KYNU;AIF1;GBP3;CCL2
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.6240618859017983,1.432471217276176,0.08176100628930817,0.7322654704723601,1.0,1/21,0.11%,FZR1
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.5814224153486351,-1.4319726723700574,0.09046454767726161,0.5135995832349137,1.0,3/13,4.76%,ERRFI1;CBLB;SOCS5
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.5530366437937209,1.4308578949008777,0.0746054519368723,0.7368003245687434,1.0,7/37,7.57%,MAPRE2;EFNA5;PHLDB2;FAM107A;GAS2L2;GSK3B;MARK2
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.6083517735106594,-1.4296806842092151,0.07936507936507936,0.5175749559098242,1.0,4/11,4.54%,MECOM;WNT5A;ETV6;CD34
prerank,histone H4 deacetylation (GO:0070933),0.6918964317848115,1.428612166766469,0.11538461538461539,0.7441685324280988,1.0,4/10,12.11%,HDAC4;HDAC9;HDAC8;REST
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.5938542256211957,1.428310386962901,0.08653846153846154,0.7428121060170052,1.0,4/25,2.88%,SLIT2;LIMK2;PRKCD;ARHGAP44
prerank,nucleotide catabolic process (GO:0009166),0.6412035326921139,1.428237328019962,0.11480865224625623,0.7405640703260084,1.0,4/16,10.50%,NT5E;NT5C1A;VCP;DERA
prerank,potassium ion import across plasma membrane (GO:1990573),0.5494236646559547,1.42816890866528,0.08860759493670886,0.7382681189802337,1.0,5/41,1.55%,SLC12A7;KCNJ2;SLC12A2;ATP1B1;SLC12A8
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.48432335438227336,1.4277488792939146,0.04791154791154791,0.7374854530436799,1.0,15/93,10.42%,EGFR;RASSF2;NGF;NTRK3;CD44;DOCK7;EIF4G1;DMD;NCK2;HCLS1;RIPK2;ATP2B4;BCAR3;DMTN;CNKSR3
prerank,mammary gland epithelium development (GO:0061180),-0.5579891628094877,-1.4263551016569322,0.07416267942583732,0.5251101298070444,1.0,7/14,30.99%,WNT4;ERBB4;AKT1;CSF1R;WNT2;WNT3;EPHA2
prerank,positive regulation of integrin activation (GO:0033625),-0.5959360613227646,-1.425425816931932,0.07322654462242563,0.5245576572930648,1.0,5/11,13.38%,PIEZO1;RASIP1;PLEK;SRC;P2RY12
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.6313018688733799,1.4248526241357826,0.11018363939899833,0.7474477367385478,1.0,2/16,2.50%,ST3GAL4;NFAT5
prerank,regulation of mononuclear cell migration (GO:0071675),0.5948956009590445,1.4245414208568778,0.10638297872340426,0.7462538728978683,1.0,3/23,1.04%,SLIT2;THBS1;BMP5
prerank,phosphatidylserine metabolic process (GO:0006658),-0.45537353392404356,-1.4243887117697152,0.07540983606557378,0.5245842089377611,1.0,6/32,6.30%,OSBPL8;SERINC5;PLA1A;ABHD12;OSBPL10;SERINC1
prerank,positive regulation of protein metabolic process (GO:0051247),0.4758895675831251,1.424325850228697,0.04004854368932039,0.744681232198623,1.0,21/110,8.98%,FZR1;WWP1;NEDD4;AGTR1;INHBA;GPC3;WWP2;ISL1;KLF4;EIF4G1;ASB9;GSK3B;STX5;VCP;ASB11;CD80;CLU;IDE;NSF;BCL10;CDKN1B
prerank,action potential (GO:0001508),0.5429852979998958,1.4241983437912886,0.08519553072625698,0.742657278382717,1.0,6/44,5.51%,KCNJ2;KCNMB3;KCNMB2;KCNB1;DMD;SCN11A
prerank,regulation of DNA replication (GO:0006275),0.5265358396263665,1.423943013170544,0.06729475100942127,0.7412670104772835,1.0,17/49,21.73%,EGFR;CCNA2;BCAR3;RAD17;WAPL;STN1;GTPBP4;EHMT2;ORC5;DHX9;FAF1;ATAD5;GLI2;ZBTB38;USP37;EGF;ATR
prerank,histone H3 deacetylation (GO:0070932),0.6443400702920629,1.4239245538814254,0.1035653650254669,0.7388302627383599,1.0,4/15,10.68%,HDAC4;HDAC9;PER2;HDAC8
prerank,negative regulation of transmembrane transport (GO:0034763),0.7133418028428092,1.4228685283331304,0.11016949152542373,0.7408569043647106,1.0,1/10,0.45%,THBS1
prerank,aortic valve development (GO:0003176),0.5652798045543614,1.4227042127044631,0.08902077151335312,0.7390687244939491,1.0,9/34,11.30%,SLIT3;SLIT2;BMP4;SMAD6;JAG1;GATA4;TNFRSF1B;GATA3;RB1
prerank,secretory granule organization (GO:0033363),-0.6109580776722634,-1.4221921938758395,0.09312638580931264,0.5282840568337863,1.0,2/10,4.30%,ABCA1;SRGN
prerank,regulation of cholesterol storage (GO:0010885),-0.5662154746502585,-1.4194852164473484,0.09767441860465116,0.5334823763448107,1.0,8/15,20.74%,PPARA;ABCA1;PPARD;NR1H3;SCARB1;MSR1;ABCG1;LPL
prerank,heart morphogenesis (GO:0003007),-0.4107008134428968,-1.4187573983208475,0.043010752688172046,0.5324656446951721,1.0,13/50,8.28%,ENG;TGFBR3;CHD7;NOS3;TBX3;EPHB4;PTK2;NOTCH1;TBX1;INSR;SOX17;BMP2;HEY2
prerank,ribosome biogenesis (GO:0042254),-0.3366410514795699,-1.4175644904477067,0.0,0.5330729862216445,1.0,61/187,18.74%,RPLP1;RPS14;RPL37A;RPL38;RPL30;RPL8;RPL21;RPL41;RPL14;RPL9;RPS24;RPL13;RPS27;RPLP2;RPS9;RPS15;RPL22;RPS16;RPL5;RPS2;RPL34;RPL23;RPL17;RPS19;RPS17;RPL13A;RPS7;RPL27A;RPL3;RPL24;EXOSC8;IMP3;RPL18;RPL39;NOC2L;EMG1;RPL23A;SNU13;RPL7A;RPL35A;POP5;RPL26;RPL32;RPL18A;RPS25;RPL36;RPL12;RIOK1;RPL27;LAS1L;RPL11;DDX54;PIH1D1;RPL31;RPL19;DDX31;RPLP0;RPS28;RPL37;NOB1;RPL29
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.44311007339777353,-1.4160913724234983,0.038461538461538464,0.5342805599480293,1.0,10/34,7.73%,FLT1;PIK3R1;TEK;PDGFRB;PRKD1;KIT;PTK2;DAB2IP;PDGFRA;EPHA8
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.5306910051261851,-1.4160171622214166,0.08020050125313283,0.5314080263722786,1.0,11/16,28.36%,ATP5F1B;ATP5PF;ATP5F1E;ATP5ME;ATP5MC1;ATP5F1D;ATP5MC2;ATP5F1A;ATP5MF;ATP5MG;ATP5MC3
prerank,inositol phosphate-mediated signaling (GO:0048016),0.6067345020110069,1.4155875668635896,0.09836065573770492,0.7669631888491049,1.0,3/19,2.50%,PLCE1;PPP3CA;NFAT5
prerank,positive regulation of endothelial cell migration (GO:0010595),0.48688397358056007,1.4149293389301734,0.04881101376720901,0.7672881830029549,1.0,14/84,7.71%,SMOC2;BMP4;FOXP1;THBS1;MET;ANXA3;PTK2B;FGFR1;PLPP3;ABL1;FOXC2;P2RX4;FGF2;NRP1
prerank,water-soluble vitamin metabolic process (GO:0006767),0.5011448002579412,1.4146124150118395,0.06275579809004093,0.7662063019647856,1.0,9/68,9.02%,SLC23A1;SLC23A2;AOX1;SLC5A6;VNN1;RFK;MMACHC;FPGS;CD320
prerank,negative regulation of cell motility (GO:2000146),0.4746431236769573,1.414480213607663,0.03803680981595092,0.7641645105594518,1.0,24/108,11.61%,CDH1;SLIT2;TMEFF2;CLIC4;DPYSL3;FOXO3;CYP1B1;SULF1;PTPRU;WNT11;CCDC125;IGFBP5;ZMYND8;VCL;JAG1;RAP2C;DUSP10;SRGAP2;SRGAP3;FUZ;GATA3;NKX2-1;NOG;GTPBP4
prerank,positive regulation of protein maturation (GO:1903319),-0.610735724291066,-1.4143538024865807,0.09049773755656108,0.5336460423541548,1.0,2/11,5.41%,CCBE1;NKD2
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.6213654402156898,1.4141890236325831,0.10961214165261383,0.7629081437339486,1.0,7/17,12.38%,CD55;GNL1;IL18BP;JAG1;CD46;TLR4;STAT3
prerank,negative regulation of cell death (GO:0060548),0.48014640825996147,1.4140137250177764,0.04438964241676942,0.7611192995133399,1.0,19/88,10.36%,BMP4;CCN3;LRPAP1;CCN1;WNT11;EIF4G1;GSK3B;WNT16;CCN5;KANK2;BECN1;CLU;FGF2;GATA4;TNFRSF1B;SPEF1;SRGAP2;AGR2;SRSF6
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.5704464246190247,1.4137231108777344,0.10030395136778116,0.7598110276258296,1.0,1/29,0.01%,SLC4A10
prerank,negative regulation of nuclear division (GO:0051784),0.678885606439699,1.4137012664822732,0.12788632326820604,0.7573567923271699,1.0,3/11,11.40%,BMP4;CHEK1;NANOS2
prerank,regulation of cellular biosynthetic process (GO:0031326),-0.4708333726662335,-1.4130821524889519,0.0830945558739255,0.5345052312337235,1.0,19/28,34.41%,PRKAG2;CD47;SIRPA;RAC1;MITF;PRKAA2;NOS1AP;CX3CR1;NR1H4;SIRT5;FGFR4;MED1;C3;ADIPOR2;MFSD12;PRKAB2;CCL5;PDK4;STC2
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.6059459724834961,1.4122505400423135,0.11201298701298701,0.761031917058953,1.0,5/21,10.42%,RASSF2;DMD;NCK2;DMTN;CNKSR3
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.6228249077179708,1.4122503138657767,0.11754966887417219,0.758536730445645,1.0,4/17,11.56%,UBASH3A;EZR;PTPN2;PHPT1
prerank,import into cell (GO:0098657),0.5421510752663239,1.4118924452176005,0.07876230661040788,0.7575216462232841,1.0,5/41,1.62%,SLC47A1;SLC12A7;SLC38A1;SLC5A6;LRRC8D
prerank,vesicle transport along microtubule (GO:0047496),0.5996598334977129,1.4113730385458334,0.08948194662480377,0.7571521163023716,1.0,6/23,7.44%,KIF13A;NDEL1;DYNC1I1;PAFAH1B1;FBXW11;KIF1C
prerank,lipid catabolic process (GO:0016042),-0.5268380393112331,-1.4108497091406813,0.0845771144278607,0.5385135043037584,1.0,7/18,29.66%,PLA1A;ACADL;LIPE;HSD11B1;LPL;HSD17B14;MT3
prerank,embryonic eye morphogenesis (GO:0048048),0.6668930655628843,1.410551750998364,0.13285457809694792,0.7581670527339381,1.0,4/11,6.12%,MFAP5;EFEMP1;LRP6;RARG
prerank,"wound healing, spreading of cells (GO:0044319)",0.5851804130560622,1.4104186509494403,0.10301109350237718,0.7562664386333224,1.0,4/24,3.99%,TMEFF2;CD44;CCN1;ITGA5
prerank,ganglioside metabolic process (GO:0001573),-0.4969389816454212,-1.4097467794869538,0.07650273224043716,0.5388909650370965,1.0,8/20,18.16%,ST6GALNAC3;ST8SIA4;ST8SIA6;GM2A;ST3GAL5;ST6GALNAC4;ST6GALNAC6;HEXB
prerank,positive regulation of macrophage differentiation (GO:0045651),-0.6095413790574526,-1.4094092949376718,0.09382716049382717,0.5368395239944478,1.0,2/11,3.93%,IL34;CSF1
prerank,cGMP metabolic process (GO:0046068),0.6770361400276851,1.407987091666518,0.12714776632302405,0.7642934707690644,1.0,1/12,0.09%,GUCY2C
prerank,neural tube closure (GO:0001843),0.5513775051994106,1.407981539450688,0.08529411764705883,0.7618489401011027,1.0,10/34,11.71%,COBL;LMO4;LRP6;PRICKLE1;STIL;BCL10;FUZ;SKI;IFT122;TGFB2
prerank,response to progesterone (GO:0032570),0.6186687554416167,1.4077173493133452,0.11594202898550725,0.760551094828859,1.0,2/18,1.44%,THBS1;TGFB3
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.6620589770708051,1.4077044591568084,0.13989637305699482,0.7581858266829679,1.0,5/13,7.26%,MET;IL10;NFE2L2;NR4A3;PYCR1
prerank,nucleotide-sugar metabolic process (GO:0009225),0.6667427516230083,1.4064060026375735,0.1276595744680851,0.7612260545899321,1.0,2/12,2.18%,FUT8;GMDS
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.4994854599353689,1.4058470061059303,0.06282722513089005,0.7612939013749891,1.0,18/67,15.10%,VIT;DOCK5;FN1;PTK2B;GSK3B;ABL1;NRP1;JUP;LIMS2;DMTN;AGR2;CDC42;TRIOBP;CD36;RSU1;S100A10;ILK;EMP2
prerank,positive regulation of cytokinesis (GO:0032467),0.5555182968986261,1.405821932346352,0.09829059829059829,0.7590191312657213,1.0,9/32,12.45%,CIT;GIPC1;CDC25B;PKP4;PKN2;CDC42;DRD3;RHOA;PRKCE
prerank,regulation of MAPK cascade (GO:0043408),-0.3355602995587368,-1.405560050912789,0.00847457627118644,0.5457544809252906,1.0,36/157,9.06%,FLT1;IGF1;KSR1;LYN;IGF1R;PHLPP1;TGFBR3;TEK;EPHA7;KIT;JCAD;KDR;PAK1;TNIK;NRK;ROR2;TBX1;INSR;EPHB1;PAK5;PELI2;FAS;DAB2IP;IGF2;MAPK3;ADRA2A;MAP4K4;GPR37;LBH;BMP2;EPHA8;RIT2;LPAR1;FLT4;DUSP3;NTRK2
prerank,activation of protein kinase B activity (GO:0032148),-0.45762438436794994,-1.4055076361064074,0.07692307692307693,0.5428920615815386,1.0,15/29,18.39%,IGF1;OSBPL8;WNT5A;PPIA;CCDC88A;INSR;RICTOR;ADRA2A;GAS6;IL18;FGF1;AKT1;NTF3;PARK7;TXN
prerank,myoblast differentiation (GO:0045445),0.640645621308614,1.4045970314893885,0.1206896551724138,0.7617058073670497,1.0,8/14,13.71%,TCF7L2;MBNL1;DDX5;PLEKHM3;JAG1;RB1;REST;DDX17
prerank,epithelial cell-cell adhesion (GO:0090136),0.6763293729075542,1.4043911379125404,0.13253012048192772,0.7601912513298399,1.0,5/11,8.23%,CCN3;DSP;VCL;JUP;ITGB5
prerank,sarcomere organization (GO:0045214),0.5814698712175236,1.4037247704971865,0.08866279069767442,0.7605974708155051,1.0,9/27,19.67%,KRT19;CSRP3;CSRP2;FHOD3;SIX4;WDR1;TPM1;MYLK3;MYOM2
prerank,cellular response to unfolded protein (GO:0034620),-0.4766179525686867,-1.4027753534063874,0.08875739644970414,0.548245557490384,1.0,7/26,14.06%,HSPA8;ERN1;DAB2IP;TMBIM6;HSPA9;OPTN;PACRG
prerank,negative regulation of protein localization to cell surface (GO:2000009),-0.5824633265070747,-1.402601310632054,0.11082474226804123,0.5457343716894884,1.0,3/11,5.11%,PICALM;NEDD4L;GPM6B
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.6125469226605872,1.4023781765274208,0.11844331641285956,0.7640249970642035,1.0,5/18,12.79%,CCN3;KCNB1;IRS1;REST;INHBB
prerank,organelle disassembly (GO:1903008),0.5477843374631982,1.4017423857582758,0.10130246020260492,0.7643820938846149,1.0,19/33,22.13%,ULK2;STX5;VCP;DDRGK1;PLK3;MRRF;EIF2D;KLC1;DYRK3;GFM2;KIF9;RB1CC1;UFL1;ATG2A;GBF1;MTIF2;ULK1;UBA5;CDK1
prerank,regulation of ion transmembrane transport (GO:0034765),0.5607402726488006,1.4015369162082385,0.10147058823529412,0.7629188619001643,1.0,5/33,2.80%,KCNJ2;NEDD4;WNK1;WWP2;ANO6
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.5243300308979226,1.4007106626638677,0.07994389901823282,0.7638969846544954,1.0,6/46,5.36%,BMP4;FOXP1;THBS1;TCF7L2;IGFBP5;NR4A3
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.5216435217262677,-1.4003977703884336,0.09429280397022333,0.54970905179604,1.0,8/16,16.10%,ACE;ADM;KLK2;BMPR2;GPR37L1;GSK3A;PRCP;KLK1
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.619573279522353,1.398924232428412,0.13228346456692913,0.7691444347800894,1.0,4/17,5.09%,ADRA1B;AKAP13;ADRB2;ADCY9
prerank,negative regulation of interleukin-8 production (GO:0032717),0.6183173799589329,1.3987858473039534,0.11942675159235669,0.7673969458835079,1.0,6/17,7.33%,ANXA1;KLF4;IL10;ANXA4;OTUD7B;TLR6
prerank,pulmonary valve morphogenesis (GO:0003184),0.6153317443777876,1.39825709249597,0.1273031825795645,0.7673257150006427,1.0,6/17,6.86%,SLIT2;BMP4;STRA6;SMAD6;NOTCH2;JAG1
prerank,regulation of transport (GO:0051049),-0.4446263549553935,-1.3969904164229765,0.041379310344827586,0.5575720441604083,1.0,11/36,18.77%,LEPR;EPB41;MYO6;SNCA;ACTB;ICA1;LRRK2;FES;SCFD1;CLDN10;ACTG1
prerank,negative regulation of gluconeogenesis (GO:0045721),0.6867496819639523,1.3968891766473437,0.13863216266173753,0.7708664624278627,1.0,4/11,8.90%,C1QTNF12;ERFE;EP300;CLK2
prerank,positive regulation of angiogenesis (GO:0045766),0.46193083511701655,1.3962659135970075,0.054282267792521106,0.7711550057407628,1.0,16/108,5.37%,SMOC2;F3;BMPER;THBS1;ITGB8;ANXA3;CYP1B1;PTGIS;ITGB1;PGF;ISL1;KLF4;HIPK1;ITGA5;FOXC2;ADAM12
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.6549658036421732,1.3960969169447448,0.1330998248686515,0.7695363630149434,1.0,3/11,10.17%,THBS1;BMPR1A;CD46
prerank,non-motile cilium assembly (GO:1905515),0.5693092640907975,1.3954452640357053,0.10534124629080119,0.77001102604991,1.0,22/30,31.16%,ARL13A;RPGRIP1;FUZ;PCM1;DISC1;IFT122;TOGARAM1;PIBF1;IFT88;CSNK1D;GORAB;CEP89;DCTN1;C2CD3;TMEM80;TMEM17;BBS10;VANGL2;BBS1;BBS4;TMEM107;TMEM216
prerank,purine ribonucleotide catabolic process (GO:0009154),0.5912345615086434,1.3952611316580315,0.128,0.7684300574365028,1.0,3/21,4.89%,NT5E;NT5C1A;NUDT4
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.6107484709040552,1.3942419447084258,0.14123376623376624,0.7703487635254374,1.0,2/16,1.44%,BMP4;TGFB3
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.6676456405590034,1.3941296251222925,0.13214285714285715,0.7684665671565053,1.0,3/12,3.75%,CD44;IL10;GCNT2
prerank,positive regulation of macrophage activation (GO:0043032),0.6224178749102626,1.3926477200143033,0.11308562197092084,0.7721809550067432,1.0,4/17,11.44%,THBS1;LBP;TLR6;TLR4
prerank,vascular transport (GO:0010232),0.47527919971006194,1.3923226921995855,0.06756756756756757,0.7711918870831277,1.0,11/81,3.14%,SLC4A4;SLC38A2;SLC12A2;SLCO3A1;SLC38A1;SLC24A3;SLC5A6;SLC2A13;SLC16A1;ABCG2;SLC7A2
prerank,positive regulation of phospholipid transport (GO:2001140),-0.5953544906887551,-1.392265733651013,0.09234234234234234,0.5693774339728195,1.0,3/10,14.05%,APOE;DBI;ABCB4
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.444128588330665,-1.392169218910294,0.056105610561056105,0.5665278587321182,1.0,8/35,6.83%,FLT1;PTPRM;NR2F2;COL4A3;APOE;SPARC;MEF2C;RGCC
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.5835233042730334,-1.3921138053431719,0.102803738317757,0.5636773770344562,1.0,7/12,26.17%,APOE;PICALM;CHRNA7;RANBP9;TMED10;FKBP1A;ABCA2
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.6450358941173897,1.3915592123604354,0.13556338028169015,0.7721887934743141,1.0,7/14,15.61%,THBS1;KLF4;MEOX2;RHOA;MAP2K5;STARD13;ITGB1BP1
prerank,regulation of tissue remodeling (GO:0034103),-0.5212790274412843,-1.3915428504259644,0.08439897698209718,0.5622422842409951,1.0,6/18,9.17%,LEPR;CST3;SYT7;MDK;FLT4;IL18
prerank,positive regulation of mitotic nuclear division (GO:0045840),-0.43501563154833245,-1.3912430835344536,0.047021943573667714,0.5601918764708852,1.0,8/34,11.16%,IGF1;TGFA;PDGFRB;INSR;IGF2;RGCC;EDN1;EDN3
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.6699214039377797,1.390922563616472,0.1486725663716814,0.772603721828807,1.0,3/12,7.36%,TMEFF2;IL10;AP2A1
prerank,regulation of neuron projection development (GO:0010975),-0.33781572264311016,-1.3908883504204435,0.02830188679245283,0.5582784165988229,1.0,51/163,13.88%,EFNB2;CAMK1D;LYN;SHANK3;CDH2;APOE;ITGA6;PRKD1;IL1RAPL1;CTNNA2;RAPGEF2;PPFIA2;CHN1;LRRC4C;WNT5A;PTK7;FUT9;SERPINI1;PAK1;SETX;ATP1B2;DCC;CCDC88A;CSMD3;ROR2;TENM3;NDNF;DAB2IP;EPHA4;RAPGEF1;DENND5A;MDK;RIT2;LPAR1;CDKL5;LRRK2;MFSD2A;NTRK2;SPOCK1;PLK5;TOX;ABI3;CRMP1;LRRC7;MAG;CIB1;BRSK2;MINAR1;CAMK2B;ABL2;FES
prerank,sulfur compound catabolic process (GO:0044273),-0.4265850011857915,-1.3896481020423759,0.04482758620689655,0.5592090756609173,1.0,18/38,23.59%,FMOD;OGN;DCN;LUM;GGT5;IDS;OMD;PRELP;NCAN;CSPG5;CSPG4;GGT7;HEXB;GGT1;VCAN;TXN2;BGN;GALNS
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.6445647820413707,1.38916832177671,0.13356164383561644,0.777814472045781,1.0,2/13,1.27%,BMP4;NFIB
prerank,vasculature development (GO:0001944),-0.5297766818929098,-1.3889527354863702,0.10899182561307902,0.5582521654048311,1.0,11/16,22.78%,ERRFI1;PDGFRB;ACVR2B;NOTCH4;PDGFRA;FLT4;SOX18;BMPR2;ACVRL1;APLNR;FOXF1
prerank,signal release from synapse (GO:0099643),-0.416900584657659,-1.3885046269105537,0.043795620437956206,0.5568525185957636,1.0,19/43,27.22%,NRXN1;LIN7A;HSPA8;RIMS1;SNCA;PIP5K1C;SYN1;CPLX1;SNAP25;UNC13A;LIN7C;PPFIA3;SYT1;SNAPIN;SLC32A1;CDK5;STXBP3;SYN2;RAB3A
prerank,regulation of interleukin-12 production (GO:0032655),0.5182729741555901,1.3882315545745938,0.10320781032078104,0.7793437532110504,1.0,9/47,12.58%,FOXP1;THBS1;ISL1;IL10;RIPK2;TLR4;IL16;CMKLR1;PIBF1
prerank,regulation of blood coagulation (GO:0030193),0.5662965646116923,1.3869030088256278,0.13608562691131498,0.7825829226437788,1.0,6/27,9.56%,ST3GAL4;THBS1;THBD;SERPINE2;HPSE;DMTN
prerank,inorganic cation transmembrane transport (GO:0098662),0.42862282786735,1.3859502227765836,0.015739769150052464,0.7843027398256619,1.0,35/268,8.98%,SLC4A4;SLC9A2;KCNB2;KCNK5;KCNJ2;SLC12A2;SLC24A3;PKD1;KCNQ5;ATP1B1;SLC6A7;ATP2C2;ATP6V0A4;TRPM6;ANO6;KCNS3;CACNA1C;SLC39A11;SLC6A19;SLC9C1;NALCN;KCNB1;MCOLN3;TRPM4;KCNK7;SCN11A;ITGAV;SLC9A8;SLC4A8;P2RX4;ATP2B4;SLC39A14;PKD2L1;SLC6A16;SLC25A14
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.6415188101637866,1.385565677444045,0.13798977853492334,0.7835645532876854,1.0,3/14,4.05%,THBS1;ANO6;PDCD4
prerank,positive regulation of ERAD pathway (GO:1904294),0.6445482141376407,1.3847504738176013,0.14616755793226383,0.784664225961678,1.0,3/13,4.68%,USP13;NFE2L2;RNF185
prerank,autonomic nervous system development (GO:0048483),0.6194369620786743,1.3845461651490132,0.11090909090909092,0.7832591272262006,1.0,5/17,10.39%,FN1;PHOX2A;GDNF;NRP1;GATA3
prerank,skeletal muscle organ development (GO:0060538),0.5719625767126421,1.3845290063510236,0.10725075528700906,0.7810738026240641,1.0,6/26,3.48%,SIX1;DISP1;CSRP3;STRA6;LARGE1;MYOG
prerank,regulation of mRNA metabolic process (GO:1903311),0.6767685770474208,1.3840096038464476,0.15384615384615385,0.7810285284878463,1.0,1/11,0.67%,SLTM
prerank,renal system development (GO:0072001),0.5115432552855239,1.3832734909291249,0.0921409214092141,0.7818343614400447,1.0,10/52,6.52%,BMP4;PCSK5;SIX1;PKD1;SULF1;AGTR1;STRA6;TGFBR1;TFAP2A;ARL3
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.6591701279700188,1.382806190264941,0.13776337115072934,0.7814704642845957,1.0,4/13,14.48%,BMP4;VNN1;ADAM8;CAMK4
prerank,stem cell development (GO:0048864),-0.5223500015006265,-1.382428696387928,0.105,0.5723180249353932,1.0,10/16,35.50%,CDH2;TAPT1;NOLC1;NRG1;PTPRC;SHH;WNT7A;KBTBD8;SNAI2;CYP26C1
prerank,peripheral nervous system development (GO:0007422),0.5799257886268128,1.382279203137524,0.1281645569620253,0.7813722939079758,1.0,5/23,5.16%,NGF;PMP22;EGR2;ADGRG6;GDNF
prerank,protein localization to mitochondrion (GO:0070585),-0.6010783711228466,-1.3821236998557704,0.12440191387559808,0.5702995824342124,1.0,6/11,18.86%,LRRK2;HK2;AKT1;HK1;COX18;RALA
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.6110079904252512,1.3814782049769851,0.13793103448275862,0.782551569791065,1.0,4/17,12.71%,BMP4;FGF2;ATOH8;SFN
prerank,negative regulation of macrophage activation (GO:0043031),-0.5380021839249028,-1.3805469105472155,0.1201923076923077,0.572258272339834,1.0,4/16,7.47%,IL31RA;NR1H3;GRN;SYT11
prerank,regulation of muscle contraction (GO:0006937),0.5562842822706835,1.380409101853862,0.12996941896024464,0.7846920246570738,1.0,2/26,0.44%,KCNB2;PLCE1
prerank,transport across blood-brain barrier (GO:0150104),0.47020616995130204,1.377321869566033,0.06674907292954264,0.7949178013136083,1.0,11/83,3.14%,SLC4A4;SLC38A2;SLC12A2;SLCO3A1;SLC38A1;SLC24A3;SLC5A6;SLC2A13;SLC16A1;ABCG2;SLC7A2
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.5879077635878844,1.377116757378371,0.13777089783281735,0.7912664742664256,1.0,5/21,6.74%,EYA2;GATA1;GDNF;EYA4;EYA3
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.5879077635878844,1.377116757378371,0.13777089783281735,0.7912664742664256,1.0,5/21,6.74%,EYA2;GATA1;GDNF;EYA4;EYA3
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.6415139305235904,1.3769756392270975,0.1371841155234657,0.7895958003068478,1.0,2/12,2.78%,FOXP1;KLF4
prerank,sensory perception of sound (GO:0007605),-0.3712404467309932,-1.376538697122466,0.022099447513812154,0.5820633761773251,1.0,19/88,10.36%,COL4A3;CEMIP;CACNA1D;DCDC2;ADGRV1;KIT;USP53;ALDH7A1;COL1A1;GRM7;TBX1;RIPOR2;EPS8L2;PCDH15;CLIC5;KCNQ1;CCDC50;GRAP;GSDME
prerank,ceramide transport (GO:0035627),-0.571657052184219,-1.3754036949191895,0.11358574610244988,0.5827885165866838,1.0,4/12,14.05%,PLTP;CERT1;PSAP;ABCB4
prerank,pulmonary valve development (GO:0003177),0.5985500348540965,1.3743225278184008,0.1388888888888889,0.7985625096345677,1.0,7/18,8.32%,SLIT2;BMP4;STRA6;SMAD6;NOTCH2;JAG1;TNFRSF1B
prerank,regulation of T cell mediated immunity (GO:0002709),0.684000483513703,1.3737790444206524,0.14732965009208104,0.7985546096054515,1.0,3/10,8.32%,RIPK3;TRPM4;TNFRSF1B
prerank,cardiac muscle tissue development (GO:0048738),0.5077230844085505,1.3733721395017429,0.11035422343324251,0.7981005104010707,1.0,7/50,4.33%,BMP4;SGCD;BMP5;AKAP13;CSRP3;NOTCH2;BMPR1A
prerank,cellular response to amyloid-beta (GO:1904646),-0.43135416990505726,-1.3729050252300805,0.08881578947368421,0.5878059506658445,1.0,13/35,14.71%,IGF1;IGF1R;VCAM1;GRIN2A;GRM5;CASP4;ITGA4;EPHA4;GJA1;APP;CACNA2D1;GRIN1;CACNB1
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.60150966551003,1.3727397102239294,0.14521452145214522,0.7986009036470969,1.0,3/15,4.13%,EGFR;PTK2B;ABL1
prerank,regulation of interleukin-8 production (GO:0032677),0.48911488840025746,1.3715631853246613,0.07445442875481387,0.8012443133453685,1.0,11/69,8.66%,F3;ANXA1;LBP;KLF4;IL10;ANXA4;DDIT3;OTUD7B;MAVS;TLR6;BCL10
prerank,regulation of intracellular protein transport (GO:0033157),0.5379413984735218,1.3697223216562318,0.12589413447782546,0.8067523559247507,1.0,7/32,12.48%,BMP4;NDEL1;PLK3;CEP131;PCM1;BCAS3;PTPN14
prerank,cellular response to purine-containing compound (GO:0071415),-0.584512567352369,-1.369603688887699,0.13151927437641722,0.5953629877234385,1.0,5/10,15.89%,P2RY1;SLC8A1;RYR2;RYR3;CASQ2
prerank,potassium ion export across plasma membrane (GO:0097623),0.6507934815598619,1.3690199127168123,0.159369527145359,0.8076660145838742,1.0,1/13,0.26%,KCNK5
prerank,histone deubiquitination (GO:0016578),0.6063900552339616,1.3688707885647704,0.13495934959349593,0.8060315488432802,1.0,7/18,11.86%,TRRAP;USP49;KAT2A;USP7;USP22;USP3;USP21
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.558322107862422,1.368868572019135,0.1336405529953917,0.8038171764563481,1.0,8/27,10.56%,PTPN3;SLMAP;CAMK2D;FXYD5;DLG1;ATP2B4;FXYD7;COMMD1
prerank,neuromuscular junction development (GO:0007528),-0.47053566955600656,-1.3686720743507454,0.08806818181818182,0.5953532627915387,1.0,11/24,14.71%,UNC13C;PDZRN3;PPFIBP2;GPHN;ANK3;ZC4H2;PPFIBP1;LRRK2;MUSK;CACNB4;CACNB1
prerank,retinol metabolic process (GO:0042572),0.6222874315640916,1.3681788089008162,0.14358108108108109,0.8044654318571136,1.0,2/14,2.44%,CYP1B1;ADH7
prerank,dendritic spine organization (GO:0097061),-0.457924896598997,-1.3676949068831883,0.09253731343283582,0.5955057595277584,1.0,6/26,5.10%,DOCK10;IGF1R;SHANK3;ITGA3;INSR;EPHB1
prerank,organophosphate catabolic process (GO:0046434),-0.5717631155210057,-1.367456687766719,0.12179487179487179,0.5932125902290406,1.0,2/11,4.59%,ENPP2;ABHD12
prerank,eye photoreceptor cell development (GO:0042462),0.6131970649531219,1.3659333083226401,0.12095400340715502,0.8115773701042008,1.0,2/15,5.71%,RP1;RPGRIP1
prerank,ERBB signaling pathway (GO:0038127),0.48785881275503923,1.3654284250177284,0.10076530612244898,0.8115479978165364,1.0,7/64,3.14%,EGFR;PLCE1;REPS2;PTK2B;SHC1;EFEMP1;GAREM1
prerank,early endosome to Golgi transport (GO:0034498),0.6805176446911042,1.3649519121133926,0.1282051282051282,0.8112247944444777,1.0,5/11,16.76%,EHD3;STX5;RAB6A;RBSN;SNX2
prerank,negative regulation of epithelial cell proliferation (GO:0050680),-0.3830509627864461,-1.363980529234298,0.05263157894736842,0.6013754377192629,1.0,13/66,6.83%,ROBO1;MCC;PTPRM;MTSS1;NR2F2;TGFBR3;APOE;B2M;SPARC;CDK6;DAB2IP;AQP11;RGCC
prerank,cell-cell junction assembly (GO:0007043),-0.3769945733774821,-1.3635899228501642,0.051643192488262914,0.5997002602002126,1.0,18/63,7.25%,TJP1;TLN2;GJB6;CDH2;CLDN5;EPB41L3;CDH8;GJB2;GJC1;GJD3;CDH10;ARVCF;TLN1;ACTB;RAMP2;PIP5K1C;JAM3;GJA1
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.6559539958052015,1.3626661985066857,0.1486013986013986,0.8183893801463317,1.0,5/12,7.65%,NFIB;EPHB6;PAFAH1B1;MYCBP2;TSKU
prerank,acidic amino acid transport (GO:0015800),-0.5170411759094253,-1.3619680769572728,0.12096774193548387,0.6020533494730547,1.0,7/17,7.25%,SLC1A3;SLC6A13;SLC6A1;SLC1A1;SLC1A2;SLC6A6;GJA1
prerank,metal ion export (GO:0070839),0.5438654771640428,1.3614868153890367,0.12005856515373353,0.8211100856219771,1.0,3/31,1.46%,SLC4A4;KCNK5;ATP1B1
prerank,actin polymerization or depolymerization (GO:0008154),0.5107807258777428,1.361051661651975,0.08928571428571429,0.82077734872863,1.0,11/50,10.81%,MICAL2;COBL;VILL;ABI1;FAM107A;GSN;DIAPH1;MSRB2;TTC17;WDR1;WASHC5
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.6043663385747212,1.360968074437272,0.16974789915966387,0.8189378924547982,1.0,2/15,2.57%,RSPO3;GPC3
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.560162877742269,1.360950499179815,0.14,0.8168074064112142,1.0,6/27,7.72%,DDX5;CD44;SMYD2;SPRED2;ATM;KDM1A
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.5983690058286254,1.3606428606632184,0.13957307060755336,0.8159319224288081,1.0,7/17,14.03%,BMP4;NOTCH2;BMPR1A;JAG1;NOG;ACVR1;GALNT11
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.5925188739817693,1.3604153003686685,0.11764705882352941,0.8146863235665849,1.0,8/21,10.19%,EXT1;HS3ST4;SULF1;GLCE;HS6ST2;SGSH;HPSE;SULF2
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.6012412733769282,1.3603147456383888,0.139937106918239,0.8129471743365173,1.0,9/20,16.09%,MCUB;MICU1;PARL;PMPCB;SPG7;MCU;STOML2;SLC8B1;YME1L1
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.46353670873471275,-1.35943568187058,0.10455764075067024,0.6073930174597654,1.0,5/22,13.96%,APOD;ADRA2A;PPP2R5A;ASXL3;PDE3B
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.48407803422257917,1.3592017466404938,0.11082138200782268,0.8154628332530401,1.0,12/57,18.02%,FZR1;FOXN3;ATM;CHEK2;RAD17;MRNIP;CHEK1;PRKDC;TAOK3;ATF2;CLSPN;NBN
prerank,regulation of autophagosome maturation (GO:1901096),0.6373838740381063,1.3587691853952262,0.15051903114186851,0.8150468772817848,1.0,8/13,23.78%,ADRB2;TBC1D25;SMCR8;CLEC16A;FYCO1;CLN3;TMEM39A;PHF23
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.4862895525436264,1.3585510266121825,0.10217113665389528,0.8138300989522453,1.0,2/65,0.56%,FBXL7;FHL1
prerank,carboxylic acid metabolic process (GO:0019752),0.5465511235486815,1.358497872225685,0.1268882175226586,0.8119252529944339,1.0,9/33,10.98%,SLC23A1;SLC23A2;PTGIS;PON3;LIPT2;CARNMT1;CYP2S1;GNE;GNMT
prerank,regulation of microtubule-based process (GO:0032886),0.5266041769689991,1.3580959586250678,0.11781206171107994,0.8113971273644773,1.0,7/36,7.57%,EFNA5;PHLDB2;FAM107A;GSK3B;DIAPH1;MEMO1;MARK2
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.5284044389608713,-1.357684567609249,0.11466666666666667,0.6098763863485877,1.0,5/15,7.12%,GRM3;GRM5;GRM1;GRM7;GRM8
prerank,positive regulation of collagen metabolic process (GO:0010714),0.595414831390331,1.357037318137768,0.16150081566068517,0.813658931700996,1.0,2/17,1.44%,BMP4;TGFB3
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.4341928744355655,-1.357032891005061,0.08484848484848485,0.6088663883153875,1.0,10/34,9.28%,FLT1;SEMA6A;PRKD1;KDR;NOTCH1;ERN1;RAMP2;DAB2IP;FLT4;SPHK1
prerank,muscle organ development (GO:0007517),0.48743588350023204,1.3561324004498865,0.12158469945355191,0.8153202118853946,1.0,8/54,5.23%,MKX;SGCD;FHL1;MRAS;LARGE1;MEF2A;DMD;COL6A3
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.522346420811696,1.3546889333338201,0.13043478260869565,0.8190740489180014,1.0,9/31,15.93%,FHL1;KLF4;FAM107A;KANK2;DLG1;RB1;RBL2;CDKN2D;PRMT2
prerank,regulation of RNA metabolic process (GO:0051252),0.49055392978897266,1.3546380498427477,0.09668874172185431,0.8172013306118505,1.0,21/59,19.42%,AHNAK2;MBNL1;AHNAK;CLK1;MBNL2;SON;HNRNPH1;CELF1;FUS;TNFRSF1B;CLK2;PCBP4;METTL4;HNRNPL;SNRNP70;FAM50A;TRA2B;YTHDF2;RC3H2;ZNF326;GRSF1
prerank,regulation of response to biotic stimulus (GO:0002831),0.555020798548474,1.3540514023825068,0.13622291021671826,0.8174836462438247,1.0,7/28,12.39%,FOXP1;CD55;RNF135;ERAP1;IRF1;CD36;BIRC3
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.5884959249649614,1.3539943759770285,0.14308681672025725,0.8156221029532507,1.0,4/20,4.05%,THBS1;ANO6;GSN;PDCD4
prerank,protein localization to microtubule organizing center (GO:1905508),0.6305173378082811,1.3532829785063212,0.17077175697865354,0.8164516768902974,1.0,9/15,24.51%,CEP131;STIL;PCM1;PIBF1;CSNK1D;CEP192;C2CD3;CCDC14;CEP83
prerank,protein kinase B signaling (GO:0043491),-0.4610143737064934,-1.3530078362433315,0.09895833333333333,0.6190548833821906,1.0,7/23,17.50%,IGF1;KDR;SETX;GAS6;AKT1;TYRO3;THEM4
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.4757970443867856,1.3527737376500748,0.09230769230769231,0.8164920121593121,1.0,10/73,8.42%,EGFR;NGF;NTRK3;CD44;DOCK7;EIF4G1;HCLS1;RIPK2;ATP2B4;BCAR3
prerank,cellular response to peptide (GO:1901653),-0.38450873423659904,-1.3525490830680458,0.050980392156862744,0.6176767502178062,1.0,17/56,14.71%,IGF1;IGF1R;VCAM1;GRIN2A;GRM5;CASP4;VIM;NOD1;ITGA4;EPHA4;RPL23;GJA1;SRC;APP;CACNA2D1;GRIN1;CACNB1
prerank,visual system development (GO:0150063),0.5230683421226521,1.3524382530864782,0.12684365781710916,0.8157258465594734,1.0,11/37,16.20%,PBX3;PBX1;HIPK1;RAB18;SMOC1;TGFB2;FOXC1;SCO2;CPAMD8;ADAMTS18;PAX6
prerank,regulation of axon regeneration (GO:0048679),-0.5501003039229879,-1.352382744195461,0.11981566820276497,0.6152826929021402,1.0,9/12,37.43%,INPP5F;EPHA4;GRN;CERS2;PTN;RTN4R;RTN4RL1;KLK8;CNTF
prerank,protein localization to cell surface (GO:0034394),0.550130522479058,1.3521111753608777,0.14674735249621784,0.8149532561467621,1.0,11/26,16.59%,ANK2;PTPRU;WNT11;VCL;PIGU;RIC3;GGA2;SMURF1;USP4;EMP2;FLNA
prerank,negative regulation of hemostasis (GO:1900047),-0.5646623447280223,-1.3520180659079495,0.12558139534883722,0.6136144176584403,1.0,5/12,10.01%,VTN;APOE;TFPI;CD34;EDN1
prerank,aminoglycan biosynthetic process (GO:0006023),0.4958345601029621,1.351949334696142,0.10714285714285714,0.8135578235760696,1.0,13/49,10.77%,GPC6;EXT1;HS3ST1;GPC3;B3GNT2;GCNT2;HS6ST2;HEXA;GPC4;B4GAT1;B3GNT6;NDST1;B4GALT7
prerank,atrial septum morphogenesis (GO:0060413),0.6533215212638137,1.350942244681401,0.1787709497206704,0.8156813570044814,1.0,5/10,11.71%,ISL1;NOTCH2;GATA4;ACVR1;TGFB2
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.6545912381732423,1.3503026221972887,0.1582608695652174,0.8161363041342029,1.0,2/12,5.14%,SOAT1;ACSL3
prerank,embryonic limb morphogenesis (GO:0030326),0.5320490299956416,1.3502474101254227,0.10930576070901034,0.8142697981595421,1.0,12/34,11.91%,MBNL1;GLI3;LRP6;CACNA1C;AFF3;RARG;TFAP2A;CREBBP;SKI;NOG;TGFB2;MEGF8
prerank,actin filament-based transport (GO:0099515),-0.4892216199047563,-1.350113252779761,0.10054347826086957,0.6167946362719904,1.0,7/21,18.00%,MYO1B;MYO6;FNBP1L;MYO5A;MYO5C;WASL;MYO1F
prerank,regulation of RNA splicing (GO:0043484),0.48128143676378377,1.3499721191119876,0.09765625,0.8133778677746958,1.0,11/69,8.90%,SLC38A2;AHNAK2;MBNL1;AHNAK;CLK1;MBNL2;SON;HNRNPH1;CELF1;FUS;CLK2
prerank,establishment of epithelial cell polarity (GO:0090162),0.597240161581901,1.3499026271326715,0.1486697965571205,0.8115761036267747,1.0,7/19,12.11%,CYTH3;EZR;GOLPH3;PARD3;CDC42;RHOA;MYO9A
prerank,adrenergic receptor signaling pathway (GO:0071875),0.5732850714155175,1.3495855932576335,0.16257668711656442,0.8108122851393701,1.0,4/20,5.09%,ADRA1B;AKAP13;ADRB2;ADCY9
prerank,cellular protein metabolic process (GO:0044267),-0.29442662247956897,-1.3490050495761725,0.0,0.6176252246024121,1.0,131/396,18.78%,CP;IGF1;LTBP1;IGFBP2;CDH2;ST3GAL1;APOE;ST3GAL6;IGFBP7;SPARCL1;ST8SIA4;RPLP1;RPS14;MSRA;IGFBP3;CTSH;RPL37A;ITIH2;RPL38;RPL30;CST3;IGFBP4;RPL8;CSF1;RPL21;RPL41;RPL14;RPL9;RPS24;RPL13;EEF1A1;RPS27;RPLP2;VWA1;RPS21;PAPPA;RPS23;RPS9;RPS29;TNC;RPS15;RPL22;RPS5;DAB2IP;RPS16;IGF2;RPL5;RPS4X;RPS2;UBE2I;RPS13;LGALS1;RPL34;NOTUM;RPL23;RPL17;PLAT;RPS19;LAMB1;RPS8;RPS20;RPS27A;RPS17;GAS6;RPL13A;SCG3;RPS12;SERPIND1;SPP1;RPS7;RPS3;GATA6;MMP2;RPN2;RPL27A;LCMT1;RPL3;RPL24;F5;CHRM3;ADORA2A;RPS18;SPCS3;RPL18;RPL39;RPS11;SFTPA2;SFTPA1;APP;HSP90B1;MRPL3;PDIA6;CSF2RA;RPL23A;SDC2;ABL2;RPL7A;RPL35A;RPL26;RPL32;ERO1A;PENK;RPL18A;ICMT;RPS25;RPL36;MSRB1;APLP2;RPL12;UBL5;RPS10;VGF;RPL27;RPL11;MRPS11;RPL31;QSOX1;SARS1;FUCA2;RPL19;RPLP0;APH1B;RPS15A;PNPLA2;RPS28;PSENEN;MATN3;RPL37;MRPL51;RPL29;MRPL35
prerank,positive regulation of RNA splicing (GO:0033120),0.5448409794667135,1.3489177291655998,0.12652439024390244,0.8115904976036712,1.0,1/29,0.04%,SLC38A2
prerank,protein import into peroxisome membrane (GO:0045046),0.5763557484241342,1.3479125283582385,0.1370309951060359,0.8137778427965503,1.0,8/22,19.53%,ABCD3;PXMP2;SLC25A17;PEX2;ACBD5;PEX12;FIS1;PEX16
prerank,phospholipid catabolic process (GO:0009395),-0.4609425743913145,-1.3468128827278845,0.11046511627906977,0.6219455454245525,1.0,4/24,4.59%,GPCPD1;ENPP2;ENPP6;ABHD12
prerank,regulation of establishment of cell polarity (GO:2000114),0.5920708402408958,1.3465884017505134,0.14959349593495935,0.8170939816112291,1.0,5/16,14.16%,PTK2B;GSN;SHTN1;BCAS3;CYRIB
prerank,actin filament depolymerization (GO:0030042),0.6455654181118856,1.3464166716906996,0.1625207296849088,0.8157606336365559,1.0,2/11,3.64%,MICAL2;GSN
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.5456133057874899,1.346203156532071,0.13509544787077826,0.8145041534712628,1.0,1/31,0.11%,FZR1
prerank,endothelial cell migration (GO:0043542),0.5311303089231624,1.3461104083013626,0.12927191679049035,0.8128834875092126,1.0,13/37,16.82%,CCN3;FSTL1;CYP1B1;GIPC1;ABL1;ID1;NRP1;RHOA;S100A2;EMP2;STARD13;LGALS8;NR4A1
prerank,glycolipid biosynthetic process (GO:0009247),0.5096794549643784,1.3457559796897685,0.1361031518624642,0.8122394915129001,1.0,9/38,12.99%,ST3GAL4;LARGE1;A4GALT;PIGB;PIGL;PIGU;PIGN;DPM1;ST3GAL2
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.5838114407560715,1.345717163155021,0.14401294498381878,0.8103957977413647,1.0,3/18,4.03%,CCN3;HDAC4;FZD7
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.4600994724968726,1.3455697312368093,0.07272727272727272,0.8089611354615266,1.0,17/101,11.21%,THBS1;CYFIP2;SAMD4A;PERP;EZR;AGTR1;INHBA;KLF4;EIF4G1;NIBAN1;LARP4B;FBXW11;PLD1;RDX;MTOR;TBC1D10A;IST1
prerank,cellular response to organic substance (GO:0071310),0.4480805973478053,1.3454837855682644,0.07810650887573964,0.8072732941558154,1.0,17/116,7.07%,SLIT3;SLIT2;DPYSL3;CYP1B1;RAMP1;SHC1;NFAT5;KLF4;PID1;BMPR1A;IGFBP5;SOCS2;TGFBR1;TGFBR2;HCLS1;IL18BP;PTPN2
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.6437488863961452,1.3451490729031417,0.17043478260869566,0.806567732401108,1.0,2/12,4.46%,BDH2;GCLC
prerank,plasma membrane bounded cell projection organization (GO:0120036),-0.3380833012199509,-1.3450016946047236,0.02040816326530612,0.6251199153261996,1.0,27/124,11.27%,PTPRM;LYN;FRYL;APOE;CNTNAP2;RAPGEF2;GPM6A;MAP2;ATP1B2;PLP1;GPM6B;CNTN4;STMN4;STMN3;OPHN1;SH3GL2;LAMB1;MICALL1;EPHA8;ARMC2;PLEK;RASGRF1;MAPT;RAC1;UHMK1;MYOC;APP
prerank,cardiac muscle cell contraction (GO:0086003),0.5931464670003813,1.3448042524473074,0.15654952076677317,0.8059913844139128,1.0,4/19,3.64%,KCNJ2;CAMK2D;CACNA1C;GSN
prerank,skeletal system morphogenesis (GO:0048705),0.5095331428331814,1.3441496053634068,0.12571428571428572,0.8065224337598736,1.0,13/42,15.28%,SIX1;FGFR1;HHIP;HOXA3;LRP6;TGFBR1;TFAP2A;FUZ;SKI;MEGF8;LRP5;HOXB3;ANKRD11
prerank,autophagy of peroxisome (GO:0030242),0.6473196956362613,1.343254973310144,0.156140350877193,0.8082706158865545,1.0,4/12,13.47%,ATM;SQSTM1;RB1CC1;ACBD5
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.5512162153704103,1.3428378993958223,0.16383307573415765,0.8080199423759282,1.0,5/25,8.66%,EGFR;THBS1;FZD7;NRP1;BCL10
prerank,regulation of glycogen metabolic process (GO:0070873),0.6390467718578179,1.3427439844549092,0.16089965397923875,0.806458969861299,1.0,2/12,2.77%,PPP1R3B;PPP1R3C
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.4360375683112615,-1.3426682649810524,0.0856269113149847,0.6297880813359945,1.0,11/33,16.70%,IGF1;IGF1R;PIK3R1;NYAP2;EDN1;HTR2A;PIK3C2A;MYO16;AKT1;PIK3R5;TYRO3
prerank,metal ion transport (GO:0030001),-0.35314904168197,-1.3426195218958836,0.05339805825242718,0.6270624956350652,1.0,25/86,14.09%,ITPR1;CACNA1D;TRPC3;CACNA1E;CALCRL;SLC41A1;TPT1;RAMP2;SLC39A8;NDFIP2;GRIN3A;ATP2C1;SELENOK;MMGT1;CAMK2A;SLC8A1;RYR2;CACNG7;CACNA1B;SLC3A2;CACNA2D1;SLC30A1;TRPC4;CHRNA7;RYR3
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.41552069472963954,-1.3424671769249625,0.06713780918727916,0.6246278449599268,1.0,17/39,18.62%,RPS14;RPS24;RPS27;RPS15;RPS5;RPS16;RPS19;RPS17;RPS7;EMG1;SNU13;RPS25;RIOK1;TSR3;MRPS11;RPS28;NOB1
prerank,blood vessel diameter maintenance (GO:0097746),0.5226162675991178,1.342391340447086,0.12917271407837447,0.8059458652293219,1.0,7/34,9.73%,EDNRA;KCNMB2;AGTR1;GCLC;SCPEP1;AGTR2;PER2
prerank,chondrocyte differentiation (GO:0002062),0.5290650261053244,1.342386715228141,0.14688427299703263,0.804025509201866,1.0,9/32,11.12%,BMP4;CCN3;NFIB;SULF1;SNX19;SLC39A14;SULF2;WNT2B;EIF2AK3
prerank,endothelial tube morphogenesis (GO:0061154),0.6578383262792361,1.3419814115198914,0.1658119658119658,0.8036807326633364,1.0,1/10,0.27%,BMP4
prerank,regulation of interleukin-13 production (GO:0032656),-0.5443241382508367,-1.3418339536649453,0.12289156626506025,0.6239017636330159,1.0,3/13,9.17%,LEF1;TNFRSF21;IL18
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.539639736554628,1.3418108199339362,0.12577639751552794,0.8023821326584663,1.0,9/32,7.56%,THBS1;ANXA1;RHOJ;HDAC9;KLF4;MEOX2;FOXC2;FGF2;MAP3K3
prerank,positive regulation of protein processing (GO:0010954),-0.4927033936412943,-1.3414743685420663,0.11959287531806616,0.6222180493125676,1.0,4/19,5.87%,CCBE1;CLEC3B;NKD2;MYH9
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.552713324351082,-1.340619326482852,0.14666666666666667,0.6219316921623342,1.0,2/12,9.17%,IL1R1;IL18
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.483541773618878,1.3401429530981226,0.11037234042553191,0.8069874605370434,1.0,8/55,6.43%,THBS1;CYP1B1;AGTR1;PID1;COQ7;ARF4;TGFBR2;TFAP2A
prerank,neuron differentiation (GO:0030182),0.4304306461389956,1.3400360464561605,0.056433408577878104,0.8054608755223183,1.0,26/165,11.87%,VSX1;PBX3;MET;WNT9A;PBX1;WNT11;WNK1;INHBA;LRP6;PITX3;LHX2;PHOX2A;WNT16;FZD7;NR4A2;ACSL3;TGFBR1;CDNF;ITM2C;FZD2;ERCC3;ATOH8;FOXA1;WNT2B;TGFB2;THOC2
prerank,positive regulation of lipid kinase activity (GO:0090218),-0.44560617612006725,-1.3395312537573416,0.1144578313253012,0.6224442077323084,1.0,9/29,7.73%,FLT1;TEK;PDGFRB;PRKD1;KIT;PTK2;CD81;PDGFRA;EPHA8
prerank,cell-matrix adhesion (GO:0007160),0.45347992899022516,1.3393414827615593,0.09328358208955224,0.806415275486271,1.0,19/95,8.36%,MSLN;ITGBL1;ITGB8;FN1;PKD1;SORBS1;CD44;ITGB1;ITGA10;COL3A1;ADAM9;BCR;PIP5K1A;VCL;ITGAV;TRIP6;ITGB5;MKLN1;PPFIA1
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.5161543435171598,-1.338970565448924,0.11082474226804123,0.6214239673954384,1.0,10/17,23.67%,IGF1;APOE;RTN1;NTRK2;CHRNA7;GGA3;BIN1;RTN4;PIN1;HAP1
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.3338095126781641,-1.338908050934413,0.046875,0.618847750090963,1.0,29/121,10.14%,IGF1;IL34;VTN;LYN;IL31RA;PECAM1;ENPP2;KIT;PARP14;TNK2;GRM5;ACE;IL6ST;TEC;IL6R;NEDD9;ARL2BP;CD81;EPHA4;IGF2;GHR;GPRC5B;LRP8;GAS6;ERBB4;SRC;IL18;TNFRSF1A;FGF7
prerank,positive regulation of cartilage development (GO:0061036),0.5909733710617522,1.3387292438282214,0.15551839464882944,0.8069554377438539,1.0,5/17,3.54%,BMP4;ZBTB16;BMP1;GDF6;GDF5
prerank,positive regulation of fatty acid metabolic process (GO:0045923),-0.5333457745292598,-1.3363907757934965,0.1306532663316583,0.6245085945288072,1.0,5/15,6.57%,PPARA;LPGAT1;PPARD;NR1H3;PPARGC1A
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.5504401706937917,-1.3354866062351631,0.16784869976359337,0.6245616867042195,1.0,5/12,13.99%,PIK3R1;ERN1;DAB2IP;TMEM33;BOK
prerank,negative regulation of cell migration (GO:0030336),0.4352838554664811,1.3348005078242573,0.06810035842293907,0.8209338539295824,1.0,24/137,8.97%,CDH1;SLIT2;TMEFF2;CLIC4;DPYSL3;FOXO3;CYP1B1;SULF1;ARHGDIB;PHLDB2;PTPRU;WNT11;COL3A1;BMPR1A;IGFBP5;ZMYND8;VCL;JAG1;RAP2C;FGF2;DUSP10;SRGAP2;SRGAP3;FUZ
prerank,mesenchymal cell development (GO:0014031),-0.4814838611946416,-1.3344370713224183,0.12468193384223919,0.6251247668178563,1.0,4/18,8.28%,CDH2;NOTCH1;TAPT1;HEY2
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.6074452045172251,1.334393391177775,0.17224080267558528,0.820542967838578,1.0,4/15,6.43%,SIX1;TGFBR1;TGFBR2;TFAP2A
prerank,SNARE complex assembly (GO:0035493),0.6660923336611955,1.333744371624728,0.18661971830985916,0.8211721667045423,1.0,1/10,0.71%,STXBP6
prerank,negative regulation of peptidase activity (GO:0010466),-0.4029781199531382,-1.3332598243262803,0.09154929577464789,0.6262643115016331,1.0,9/47,9.45%,VTN;TIMP3;SPOCK2;SERPINI1;CST3;GAPDH;SPOCK3;SERPIND1;SPOCK1
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.5376524718588997,1.3327496256461508,0.1606060606060606,0.823039748719171,1.0,11/29,11.39%,TCF7L1;TCF7L2;TRRAP;EP300;CREBBP;SMARCA4;KAT5;TLE4;BCL9L;TLE3;TLE2
prerank,osteoclast differentiation (GO:0030316),0.5674200945969212,1.3325263989587133,0.16031746031746033,0.8219623438385886,1.0,4/22,7.52%,FOXP1;ANXA2;TNFSF11;GAB2
prerank,fatty acid oxidation (GO:0019395),0.4787047136257803,1.3319557952187415,0.12137203166226913,0.8222578045918518,1.0,10/57,7.54%,ABCD3;BDH2;EHHADH;ADH7;ACADM;AUH;HACL1;ECHDC1;PECR;DECR1
prerank,positive regulation of leukocyte activation (GO:0002696),0.5890577005777514,1.3297198647649213,0.16666666666666666,0.8292171889647303,1.0,4/18,11.44%,THBS1;LBP;TLR6;TLR4
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.4457043136481013,1.3294636292069761,0.08244994110718493,0.8284456728579689,1.0,15/113,7.71%,EGFR;BMP4;F3;TCF7L2;BMP5;NRAS;BMP6;PGF;NOTCH2;FZD7;TGFBR1;NR4A3;TGM1;FGF2;NRP1
prerank,positive regulation of calcium ion import (GO:0090280),-0.5442084744133097,-1.3292562470538956,0.1607565011820331,0.6367716435386873,1.0,7/12,32.74%,PDGFRB;CXCL12;SPHK2;STC1;CCL2;ATP2A1;RAMP3
prerank,regulation of protein localization to membrane (GO:1905475),0.5529250654240913,1.3290275901746336,0.14285714285714285,0.8282196533634316,1.0,6/28,7.41%,GPC6;GPC3;GSN;MMP14;STX8;GPC4
prerank,angiogenesis involved in wound healing (GO:0060055),-0.5632330663746613,-1.3290069731022995,0.12808988764044943,0.6348021373273205,1.0,9/11,25.21%,KDR;CD34;NDNF;MCAM;GATA2;PRCP;SRF;VEGFA;ADIPOR2
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.6019271213134457,1.3288798998466536,0.15371621621621623,0.826864205050042,1.0,7/17,10.90%,BAIAP2L1;NTRK3;ABL1;HCLS1;NRP1;BCAS3;CDC42
prerank,axonal transport of mitochondrion (GO:0019896),-0.5703072013644965,-1.3288718884718778,0.14351851851851852,0.6325012014872855,1.0,6/11,23.67%,HIF1A;MAPT;SYBU;TRAK2;NEFL;HAP1
prerank,regulation of collagen biosynthetic process (GO:0032965),0.5716544659730108,1.3286572012617266,0.16588419405320814,0.825872291286626,1.0,2/19,1.44%,BMP4;TGFB3
prerank,regulation of vasoconstriction (GO:0019229),0.5378888567766287,1.3268920863211349,0.1634756995581738,0.8308118135520262,1.0,4/27,5.11%,KCNMB2;ADRA1B;AGTR1;TRPM4
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.500973780129668,1.3266212074056885,0.13389121338912133,0.8299246315292134,1.0,11/44,14.68%,THBS1;NGF;CD44;KLF4;CAST;CSNK2A1;USP47;DNAJB6;SFN;MAP2K5;CDKN2D
prerank,in utero embryonic development (GO:0001701),0.550250321305664,1.3246306701762618,0.15730337078651685,0.8360149194527153,1.0,7/25,8.30%,MBNL1;PKD1;TGFB3;FUT8;TGFBR1;STIL;ADAM10
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.5025762964468058,1.324155660604362,0.14076246334310852,0.8359667234268435,1.0,10/33,15.93%,FHL1;KLF4;FAM107A;KANK2;DLG1;PLK3;RB1;RBL2;CDKN2D;PRMT2
prerank,calcium-mediated signaling (GO:0019722),0.44545202475732876,1.3240014112258902,0.10963855421686747,0.8347114195767451,1.0,23/93,15.73%,EGFR;PLCE1;ANK2;ATP1B1;PPP3CA;AGTR1;CACNA1C;NUDT4;TRPM4;TNNI3;TNFSF11;P2RX4;DMTN;RCAN1;CXCR4;EIF2AK3;SLC9A1;HTR2B;PPP3CC;MCU;PRKAA1;PRKACA;TRPM2
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.5326690448754552,-1.323989898512934,0.13958810068649885,0.6453336551390446,1.0,6/12,18.14%,PARP8;PARP11;PARP1;TIPARP;PARP12;PARP16
prerank,regulation of plasminogen activation (GO:0010755),0.6156198877500585,1.323881156819765,0.1737649063032368,0.8332913972678542,1.0,2/12,6.41%,THBS1;SERPINE2
prerank,artery development (GO:0060840),-0.4516972921488679,-1.3232551926373208,0.12827225130890052,0.644726487299426,1.0,7/23,10.16%,ROBO1;ENG;TBX1;ACVR2B;PDE2A;ROBO2;EFEMP2
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.569640630445822,1.3231887128853002,0.1590909090909091,0.8340632022276226,1.0,5/21,13.70%,LRP6;GSK3B;FZD2;CSNK1A1;AMER1
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.6139963575735065,1.3231821111920978,0.17398648648648649,0.8303211866420125,1.0,6/15,19.11%,TNRC6C;CNOT7;TOB1;NANOS2;ZFP36L1;PABPC1
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.6139963575735065,1.3231821111920978,0.17398648648648649,0.8303211866420125,1.0,6/15,19.11%,TNRC6C;CNOT7;TOB1;NANOS2;ZFP36L1;PABPC1
prerank,cortical actin cytoskeleton organization (GO:0030866),0.575876360823754,1.3227636574136743,0.14653784219001612,0.8301449865460608,1.0,6/20,8.89%,FMNL2;DLG1;NCKAP1;RHOQ;FMNL3;FHOD3
prerank,regulation of ruffle assembly (GO:1900027),-0.46490588508227465,-1.3223553056280097,0.13010204081632654,0.6449343496147261,1.0,8/23,15.78%,EPS8;ARHGAP24;EVL;EPS8L2;ABI3;P2RY12;PFN1;PLEKHM1
prerank,regulation of developmental growth (GO:0048638),-0.423916800204569,-1.3216657894685335,0.09183673469387756,0.6443257216398488,1.0,11/29,12.84%,PLCB1;IGF1;APOE;INSR;GHR;STAT5B;SPAAR;MFSD2A;APP;MUSK;OLFM1
prerank,protein localization to plasma membrane (GO:0072659),0.43295157429312325,1.321109180786102,0.07807118254879448,0.8346903626202378,1.0,21/129,7.87%,CDH1;KCNB2;ANK2;ATP1B1;SLMAP;EZR;MRAP;RAMP1;NECTIN3;LRP6;TTC7A;RAP1A;RAPGEF6;EHD3;KCNB1;PIP5K1A;GAK;DLG1;PRAM1;FGF13;JUP
prerank,anterior/posterior pattern specification (GO:0009952),0.47184828419462077,1.3204994986574752,0.11946308724832215,0.8352685796006561,1.0,21/53,20.19%,PCSK5;HOXA5;HOXA3;HOXB6;DDIT3;HOXA6;TGFBR1;HOXB5;BHLHE40;HES1;GATA4;SKI;TIFAB;HES7;LRP5;HOXB3;HOXC5;HOXC6;HEYL;CELSR2;HOXD3
prerank,lipoprotein catabolic process (GO:0042159),-0.5595321328968703,-1.320174377713484,0.14761904761904762,0.6464472307528629,1.0,4/11,12.64%,APOE;NOTUM;ABHD17C;CTSD
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.3595593291805512,-1.3196045516068478,0.07142857142857142,0.6454686576627566,1.0,18/72,9.17%,FLT1;IGF1;LYN;IGF1R;PIK3R1;TEK;PDGFRB;PDGFD;DCN;KIT;KDR;PTK2;ROR2;INSR;PDGFRA;NTRK2;SRC;IL18
prerank,regulation of heart contraction (GO:0008016),-0.34446277328098945,-1.3193531905280798,0.05813953488372093,0.6435866882680368,1.0,28/90,17.33%,ATP1A2;ITPR1;ATP1B3;CALM1;NPR1;ATP1B2;DMPK;ABCC9;ATP2B1;CELF2;PDE4D;CALM3;DES;FXYD6;KCNQ1;SLC8A1;RYR2;ACE2;AGT;RYR3;KCNJ12;STIM1;GSK3A;CASQ2;NOS1;FXYD1;CORIN;ATP2A2
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.5836930425119576,1.318507739760514,0.18197278911564627,0.8411967296836738,1.0,4/15,7.51%,BMPER;KLF4;ITGA5;FGF2
prerank,positive regulation of vasculature development (GO:1904018),0.4444838348755406,1.318267215662343,0.11246943765281174,0.8402807263203352,1.0,11/94,2.79%,SMOC2;F3;THBS1;ITGB8;ANXA3;CYP1B1;PTGIS;ITGB1;PGF;ISL1;HIPK1
prerank,triglyceride homeostasis (GO:0070328),-0.44256069630722933,-1.317703410453784,0.13725490196078433,0.6460008614605218,1.0,8/26,15.24%,APOE;NR1H3;C1QTNF3;SCARB1;PNPLA8;IL18;NR1H4;MTLN
prerank,regulation of transferase activity (GO:0051338),0.5837550151850992,1.316436965926093,0.18612521150592218,0.8457920580232834,1.0,10/17,18.57%,SPTSSB;SMG6;ATM;PPP1R3F;EMP2;FEM1B;LDB2;LDB1;FEM1A;PINX1
prerank,cell-cell junction maintenance (GO:0045217),-0.5629793485448589,-1.3155524339444564,0.13513513513513514,0.6501087990736789,1.0,5/11,24.62%,TJP1;MYADM;CSF1R;NLGN2;PRTN3
prerank,protein localization to cell periphery (GO:1990778),0.42877472384854337,1.3155320075175956,0.08304891922639362,0.8474956290641821,1.0,22/133,7.87%,CDH1;KCNB2;ANK2;ATP1B1;SLMAP;EZR;MRAP;RAMP1;LRP6;TTC7A;RAP1A;RAPGEF6;EHD3;KCNB1;RABEP1;PIP5K1A;GAK;DLG1;ARL3;PRAM1;FGF13;JUP
prerank,negative regulation of wound healing (GO:0061045),0.5317583634299153,1.315515380112743,0.1633281972265023,0.8456729719395344,1.0,6/28,7.51%,SLC12A2;CD109;PHLDB2;THBD;SERPINE2;FGF2
prerank,linoleic acid metabolic process (GO:0043651),-0.49695165933628843,-1.3154592151307247,0.13636363636363635,0.6477584864341164,1.0,4/17,12.75%,ACSL1;PNPLA8;FADS2;ALOX12
prerank,lipid phosphorylation (GO:0046834),-0.5743984741294444,-1.3149239126825998,0.15676959619952494,0.6468637381117643,1.0,5/10,15.24%,DGKB;DGKI;DGKD;DGKG;DGKE
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),-0.3345534907723624,-1.3148913687897228,0.026845637583892617,0.6442634657050486,1.0,32/110,15.58%,ADGRL3;ADGRL4;ADCY5;ADCY1;RAPGEF2;ABCA1;GNG2;ADGRE5;GNAS;LGR4;ADCY7;CALCRL;ADCY2;RAMP2;S1PR1;ADRA2A;PTGFR;PTH1R;LPAR1;S1PR3;ADORA2A;ADGRG1;ADM;ADCY4;LPAR2;IAPP;ADGRB1;TBXA2R;ADGRL1;ADGRE1;ADCY3;ADCY8
prerank,epithelial cell differentiation (GO:0030855),0.4498642806623561,1.3148738232106605,0.10664993726474278,0.8463088217783296,1.0,7/88,4.03%,BMP4;FSTL1;ANXA1;SIX1;BDH2;ANXA4;FZD7
prerank,regulation of amyloid-beta formation (GO:1902003),-0.41701785757641613,-1.3141273132933478,0.13256484149855907,0.6439698163245323,1.0,17/34,20.49%,IGF1;APOE;PICALM;RTN1;EPHA4;NTRK2;LRRTM3;CASP3;CHRNA7;GSAP;GSK3A;GGA3;ABCG1;RELA;BIN1;RTN4;TMED10
prerank,regulation of cardiac conduction (GO:1903779),-0.3806019260229508,-1.313978040677797,0.08270676691729323,0.6418234307679758,1.0,20/54,17.33%,ATP1A2;ITPR1;ATP1B3;NPR1;ATP1B2;DMPK;ABCC9;ATP2B1;FXYD6;SLC8A1;RYR2;ACE2;AGT;RYR3;STIM1;CASQ2;NOS1;FXYD1;CORIN;ATP2A2
prerank,cytosolic transport (GO:0016482),0.4375998053894491,1.3138635303558637,0.09976525821596244,0.8483466722509773,1.0,48/108,23.38%,VPS13A;VPS13C;EHD3;EEA1;STX5;VPS54;RAB6A;ANKRD27;BECN1;GAK;ERC1;STX8;DOP1B;AP2A1;VPS53;TMEM87B;RBSN;RGP1;VTI1A;TBC1D10A;WASHC1;STX16;RAB5A;SNX32;EMP2;HOOK2;TMEM87A;SNX2;GBF1;SPAG9;TBC1D5;ARL1;VPS51;AP4M1;CORO7;MON2;RAB7A;CLN3;VPS50;DCTN1;VPS29;BET1L;VPS26A;ARFRP1;RILP;TBC1D17;PIKFYVE;WDR81
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.4039131900419983,-1.3133260937371505,0.11437908496732026,0.641310692656563,1.0,13/39,9.70%,ROBO1;EPN2;NOS3;MAML2;MAML3;NOTCH1;TSPAN5;IL6ST;NOTCH4;RBPJ;JAG2;SRC;ROBO2
prerank,epithelial structure maintenance (GO:0010669),0.6438762041546867,1.31296130282488,0.19182948490230906,0.8499268881522057,1.0,2/11,3.06%,CXADR;MUC6
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.44297942454447004,-1.3122523788432119,0.1452991452991453,0.6419268254600786,1.0,14/27,22.60%,DCN;UGDH;CSGALNACT1;CHST3;CHSY3;PXYLP1;XYLT2;NCAN;CSPG5;B3GAT2;CSPG4;CHSY1;VCAN;BGN
prerank,calcium ion transmembrane transport (GO:0070588),0.457983943210174,1.3120498724184397,0.11547911547911548,0.8516760844952823,1.0,27/86,16.09%,SLC35G1;SLC24A3;PKD1;ATP2C2;TRPM6;ANO6;CACNA1C;NALCN;MCOLN3;TRPM4;GRIN2C;ITGAV;P2RX4;ATP2B4;MCUB;MICU1;PARL;PMPCB;TRPC5;SPG7;MCU;TRPM7;STOML2;SLC8B1;TRPC7;TRPM2;YME1L1
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.5850540118974052,1.3112931352244102,0.17412140575079874,0.8526953718787627,1.0,3/18,3.12%,SLIT2;PTK2B;MTUS1
prerank,reverse cholesterol transport (GO:0043691),-0.5289315156513396,-1.311261352253478,0.1670886075949367,0.6424350581311659,1.0,4/13,9.54%,APOE;ABCA1;SCARB1;ABCA5
prerank,regulation of B cell differentiation (GO:0045577),0.5737001944769602,1.3111997159955937,0.18451400329489293,0.8512223302260157,1.0,3/17,6.42%,PPP2R3C;INHBA;MMP14
prerank,positive regulation of protein sumoylation (GO:0033235),0.6329188722866955,1.3110448403781327,0.18683274021352314,0.8499437968561055,1.0,2/10,5.60%,HDAC4;PIAS3
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.43294077194722735,1.3101462922229559,0.1,0.8517174173358029,1.0,31/122,18.20%,EGFR;SMOC2;THBS1;SAMD4A;SORBS1;KLF4;NIBAN1;NFKB1;LARP4B;IRS1;FGF2;DYRK2;BCAR3;PLD1;NOX1;MTOR;STN1;TLR4;TGFB2;CIITA;FXR2;NAMPT;DHX9;PRKDC;IRS2;LDB1;FAF1;ATAD5;YTHDF3;AR;ZCCHC4
prerank,regulation of gene expression (GO:0010468),0.38901792696478676,1.3089174639072239,0.002002002002002002,0.8545186492325294,1.0,157/903,13.00%,SLC38A2;BNC2;CDH1;BMP4;F3;FOXP1;VSX1;AHNAK2;SLC24A3;TCF7L1;ZFHX3;MBNL1;PRRX2;NGF;ITGB8;NTRK3;FN1;PRDM6;SMO;FOXN3;SIX1;HOXA5;ANK2;ATP1B1;FOXD1;HDAC4;EZR;AHNAK;ESR2;NFIA;USP13;WNT11;KRAS;INHBA;BMP6;WWP2;KLF4;EFEMP1;PID1;COQ7;CLK1;IL10;PITX3;GSN;IGSF1;KAT6B;YBX3;GCNT2;ZBTB7B;GSK3B;WNT16;NOTCH2;FZD7;ZNF148;ABL1;ZFP64;BMPR1A;DDIT3;NFE2L2;CTCFL;TNRC6C;AFF3;DDRGK1;CRABP2;GDNF;TGFBR1;JMJD1C;NFKB1;ZNF423;TRRAP;SERPINB9;TOB2;PLSCR1;MBNL2;MOV10;CLU;EP300;TFAP2A;ERC1;SON;HCLS1;FGF22;TRIM44;HNRNPH1;TRIM26;CNOT7;CELF1;ATM;TLR6;ATP2B4;HDAC10;FGF2;TADA3;TSKU;NELL1;CREBBP;BHLHE40;FUS;SMCR8;WWTR1;GATA4;ADAM10;TOB1;TAF6L;CALCOCO1;CAVIN4;ZNF462;CLK2;CHEK2;PCBP4;NFYA;CTR9;HMG20A;RDX;BCL6;TCF3;NFKB2;ATOH8;GON4L;BRCA2;AGR2;CD46;FOXK2;GPBP1L1;GCFC2;GATA3;TCF23;ZNHIT3;MTOR;PHF12;NKX2-1;ZC3H7A;NOG;TAF1;EIF2AK3;GNB3;UBR5;RB1;RBL2;TLR4;ZBTB11;ZNF507;TGFB2;MEGF8;REST;NLK;CD36;NFIL3;STAT3;FOXC1;METTL4;SNX12;BAZ2A;RBMS3;ASCC1;MAPK1;ZBTB4
prerank,actin crosslink formation (GO:0051764),0.622673092687645,1.308012627207888,0.20863309352517986,0.8561888885917756,1.0,3/12,3.52%,DPYSL3;BAIAP2L1;GAS2L2
prerank,nuclear migration (GO:0007097),0.6127301253904981,1.3078661591871317,0.17537942664418213,0.8548953222876055,1.0,6/13,11.89%,DOCK7;SYNE2;PAFAH1B1;FBXW11;PCM1;TMEM201
prerank,protein targeting to peroxisome (GO:0006625),0.529337364785305,1.3072431592161196,0.13978494623655913,0.8554676199490587,1.0,13/29,24.26%,ABCD3;PXMP2;HACL1;SLC25A17;PEX2;ACBD5;PEX12;FIS1;PEX16;LONP2;PEX7;PXMP4;PEX13
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.5148456837952446,-1.3068441363505268,0.1485148514851485,0.6538905209996215,1.0,7/15,25.29%,OSBPL8;PPARA;PLIN2;PNPLA2;LPL;PLIN3;TREM2
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.5247557332277666,-1.3055816412633994,0.15853658536585366,0.6553596179168615,1.0,4/14,11.59%,ZEB1;OSR1;NOTCH4;SPRED1
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.6131336527749528,1.3052658493579612,0.16062176165803108,0.8614205596434601,1.0,6/13,21.44%,TNRC6C;CNOT7;TOB1;TNRC6A;PABPC1;EIF4ENIF1
prerank,Wnt signaling pathway (GO:0016055),0.4382493671257271,1.305096856479735,0.11138613861386139,0.8601894551401699,1.0,23/92,13.70%,TCF7L1;NXN;TCF7L2;WNT9A;WNT11;PLPP3;LRP6;STRN;GSK3B;WNT16;FZD7;NR4A2;RARG;GPC4;FZD2;CSNK1G3;CSNK1E;BCL9L;WNT2B;USP34;CSNK1A1;LRP5;AMER1
prerank,protein K63-linked ubiquitination (GO:0070534),0.49393213726850005,1.3048300992003465,0.15080527086383602,0.8593985309823761,1.0,13/41,17.17%,TRAF3IP2;NEDD4;WWP2;RNF115;UBE2B;RNF135;RNF168;ARIH2;BFAR;TRAF5;UBE2S;UBE2N;UBE2G1
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.5367597198843477,1.3046012631821609,0.1656441717791411,0.8584786459760042,1.0,7/26,11.63%,SMOC2;CDC25B;USP2;HES1;FOXA1;PKN2;USP22
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.5161634771591099,1.3045335180953526,0.15565345080763582,0.8568763593682373,1.0,7/33,12.06%,PKD1;TCIM;DDRGK1;ATP2B4;CDKN1B;TAF1;PAF1
prerank,response to calcium ion (GO:0051592),0.4372507687251016,1.303043242755328,0.10206561360874848,0.8611012740872479,1.0,10/102,4.30%,THBS1;CLIC4;KCNMB3;KCNMB2;NEDD4;PPP3CA;CAMK2D;ADAM9;MEF2A;SYT8
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.6257133615365716,1.3025869781173811,0.18609022556390978,0.8610546186080528,1.0,9/11,31.40%,UBN1;CABIN1;HIRA;ATRX;RBBP4;ASF1B;NASP;HAT1;IPO4
prerank,negative regulation of cell division (GO:0051782),-0.5516255330519783,-1.3024254265166826,0.18457943925233644,0.6627298281294414,1.0,7/11,30.60%,TXNIP;BLM;CHMP4C;ORC6;E2F7;VPS4A;E2F8
prerank,negative regulation of cation channel activity (GO:2001258),-0.4336040378056646,-1.302380697984399,0.13450292397660818,0.6602374819784362,1.0,10/26,27.29%,KCNAB1;SLC6A9;CALM1;CALM3;CBARP;CASQ2;GPR35;FKBP1A;SRI;CRHR1
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.42162956853517675,-1.302014325700899,0.08970099667774087,0.6588628400383498,1.0,13/32,19.51%,ITGA1;PDGFRB;PPIA;CALM1;PPP1R16B;CALM3;CD300A;HSP90AB1;PPP2R5A;DUSP26;PPP1R7;PPP1R15B;CDCA2
prerank,anion transport (GO:0006820),0.5117648584052004,1.3009161450814735,0.16909620991253643,0.8657754295357359,1.0,3/33,2.82%,SLC26A7;LRRC8D;ABCG2
prerank,regulation of peptide hormone secretion (GO:0090276),-0.36199731948398106,-1.3007649882795036,0.07981220657276995,0.6602001788349203,1.0,10/67,6.13%,ITPR1;CHD7;RAPGEF4;CACNA1D;SLC2A1;RAPGEF3;CACNA1E;KCNC2;SYT7;ADRA2A
prerank,negative regulation of chemotaxis (GO:0050922),0.5140152042060062,1.300464907298485,0.1676470588235294,0.8656546464721723,1.0,5/31,2.85%,SLIT2;THBS1;SEMA3D;SEMA3C;SEMA3E
prerank,neuron migration (GO:0001764),-0.3789965758307485,-1.3001970299914147,0.10622710622710622,0.6595177879759678,1.0,18/48,12.49%,ADGRL3;AUTS2;DCDC2;SH3RF1;RAPGEF2;GPM6A;NAV1;ASTN2;NDNF;MEF2C;ASTN1;CDKL5;DCX;NTRK2;RAC1;SPOCK1;MDGA1;TUBB2A
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.4798202068951211,-1.2998068331842965,0.13730569948186527,0.6581353029960127,1.0,7/19,5.83%,ROBO1;SEMA6A;CCBE1;DCN;JCAD;TSPAN12;DAB2IP
prerank,negative regulation of phosphorylation (GO:0042326),0.4415586304817023,1.2992869770014401,0.12656641604010024,0.8684563066933025,1.0,9/85,4.57%,SLIT2;BMP4;NTRK3;HDAC4;PLPP3;INHBA;PID1;LRP6;NIBAN1
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.43666504546828827,-1.2992457750372977,0.1196319018404908,0.6573746539468575,1.0,8/27,7.73%,FLT1;TEK;PDGFRB;PRKD1;KIT;PTK2;PDGFRA;EPHA8
prerank,connective tissue development (GO:0061448),0.49986118913684535,1.298038940438159,0.15781710914454278,0.8716073833524908,1.0,9/35,11.54%,ITGB8;PKD1;CD44;ZBTB16;SULF1;DDRGK1;SULF2;HYAL3;TRIP11
prerank,negative regulation of vascular permeability (GO:0043116),0.6054029002625566,1.2976443373009832,0.1917562724014337,0.8712980104364788,1.0,1/12,0.15%,SLIT2
prerank,cellular biogenic amine metabolic process (GO:0006576),-0.5427133720013051,-1.2974651633323464,0.16009280742459397,0.6606598898144502,1.0,10/12,41.63%,MAOA;DDC;ATP7A;SMS;SRM;SLC22A3;SLC29A4;AMD1;ODC1;TRH
prerank,positive regulation of protein export from nucleus (GO:0046827),0.6051874083892851,1.2973016675897593,0.2098976109215017,0.8708345487688457,1.0,2/15,3.92%,TCF7L2;GSK3B
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.5216952147533045,1.2967002916229449,0.18562874251497005,0.8714117569785611,1.0,4/28,6.42%,EGFR;TCIM;WWP2;MMP14
prerank,fat cell differentiation (GO:0045444),0.46786613454793946,1.2962550510002904,0.14209827357237717,0.8713993815321892,1.0,13/57,9.73%,TCF7L2;BBS9;TMEM120A;KLF4;PID1;SMAD6;GDF6;EGR2;NR4A2;NR4A3;EP300;ERAP1;PER2
prerank,regulation of myeloid cell differentiation (GO:0045637),0.4695283885027442,1.2962528561681677,0.14359637774902975,0.8695869467199697,1.0,17/62,14.91%,THBS1;HOXA5;PTK2B;ZBTB16;GATA1;TNRC6C;NR4A3;MOV10;EP300;CREBBP;CBFB;CTR9;PAF1;KAT2B;KMT2C;KMT2D;PRMT6
prerank,regulation of Wnt signaling pathway (GO:0030111),0.4317818915701343,1.2962376891412541,0.11890606420927467,0.867841183934588,1.0,17/108,10.19%,RSPO3;TRABD2B;TCF7L1;NXN;CTNND2;SULF1;GRB10;GPC3;MDFIC;FZD7;TSKU;TMEM237;CBFB;SMARCA4;SKI;DISC1;SULF2
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.551641116450523,-1.2959577743721213,0.16777041942604856,0.6629571597742878,1.0,7/10,28.36%,ATP5MC1;ATP5F1D;VPS9D1;ATP5MC2;ATP5F1A;ATP5MG;ATP5MC3
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.5983153195581223,1.2959203447388405,0.19655172413793104,0.8673181315462459,1.0,3/14,4.77%,SLIT2;BMPR1A;IGFBP5
prerank,embryonic appendage morphogenesis (GO:0035113),0.6027473890203376,1.2958442268748191,0.2003338898163606,0.8657924520421758,1.0,5/12,11.91%,MBNL1;LRP6;SKI;TGFB2;MEGF8
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.5156000440020931,-1.2958144713068251,0.15384615384615385,0.660812700497064,1.0,5/14,7.40%,LYN;PIK3R1;PTK2;GHR;STAT5B
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.48527397895847635,-1.2957660786395555,0.16879795396419436,0.6584102412174603,1.0,6/18,7.31%,IL34;DAAM2;TENM4;NOTCH1;TNFRSF21;MDK
prerank,regulation of cell morphogenesis (GO:0022604),0.5204433659643153,1.2954548405204878,0.16972477064220184,0.8655653079034339,1.0,7/30,12.11%,FMNL2;CD44;EFNA5;MOV10;BCL9L;SH3D19;MYO9A
prerank,peptidyl-serine phosphorylation (GO:0018105),0.41279020972655545,1.295375657212304,0.09100998890122086,0.8640830692167195,1.0,52/153,17.86%,STK39;PKD1;MARK1;CAMK2D;WNK1;PRKCD;HIPK1;MKNK2;GSK3B;SGK3;ULK2;TLK1;TGFBR1;TGFBR2;CHUK;ATM;MARK2;DYRK2;SMG1;DYRK3;CSNK1G3;MARK3;MTOR;CSNK1E;PKN2;PAK2;TAF1;EIF2AK3;CSNK2A2;CSNK2A1;IKBKE;NLK;PRKCE;CSNK1A1;MAPK1;MORC3;CAB39;VRK3;CAMK4;PRKCA;PRKACA;MAP2K2;CSNK1D;MAP3K12;PRKDC;MAP4K1;TOP1;MAPK8;VRK2;MAPKAPK2;TLK2;CLSPN
prerank,regulation of hippo signaling (GO:0035330),0.5665659662695978,1.295166928392105,0.19508196721311474,0.8630874408125884,1.0,4/17,12.34%,MOB3B;CIT;MARK3;NEK8
prerank,ERK1 and ERK2 cascade (GO:0070371),-0.4584205743312163,-1.2950135580269138,0.1586021505376344,0.6583186273474415,1.0,4/21,6.10%,IGF1;CTSH;KDR;MAPK3
prerank,polyol biosynthetic process (GO:0046173),0.5786013744344746,1.294980063891336,0.18543046357615894,0.8620125277207838,1.0,6/16,8.58%,ACER3;IP6K2;FGF2;IP6K3;PPIP5K2;CYP27B1
prerank,oligosaccharide biosynthetic process (GO:0009312),0.5665669250400689,1.2947866785862623,0.1777408637873754,0.8610106936386617,1.0,2/20,1.51%,ST3GAL4;FUT8
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.5553024933696812,-1.2946209366737151,0.16511627906976745,0.6570410916604167,1.0,3/11,2.59%,TJP1;RAPGEF2;F11R
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.6144132581915182,1.2945186242122797,0.20552677029360966,0.8602662699788608,1.0,4/12,5.36%,DOCK5;DOCK7;IGFBP5;NR4A3
prerank,regulation of NMDA receptor activity (GO:2000310),-0.4064941073944767,-1.2942463312854466,0.10443037974683544,0.6558401829203904,1.0,13/32,13.36%,SLC6A9;GRIN2A;GRIA4;GRIA2;GRIA3;GRIN2B;MEF2C;DAPK1;CAMK2A;APP;LRRC7;GRIN1;CAMK2B
prerank,Rac protein signal transduction (GO:0016601),-0.4846561182607111,-1.2940073711586606,0.16624040920716113,0.6541299178079998,1.0,9/18,20.93%,EPS8;ELMO1;RHOH;RHOG;RAC1;CDH13;HACE1;ABI2;HACD3
prerank,mitochondrial transcription (GO:0006390),0.6416538726921954,1.2937300846574633,0.22857142857142856,0.861638279250886,1.0,1/10,1.54%,FOXO3
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.38783843987016603,1.2931908250874842,0.015120967741935484,0.8619584177719563,1.0,106/572,12.62%,FOXP2;BMP4;FOXP1;KLF12;RARB;ZFHX3;ZFPM2;TCF7L2;PRDM6;NFIB;HDAC4;FOXO3;DDX5;GLI3;ZBTB16;EZR;ESR2;NEDD4;NR2F1;BMP6;WWP2;HDAC9;ISL1;CRY2;KLF4;CUX1;SMYD2;FOXP4;SKIL;ZBTB7B;MEF2A;ZNF148;DDIT3;TLE6;GATA1;KLF7;NR4A2;TCF25;FOXC2;NR4A3;NFKB1;ZNF8;ID4;KANK2;BPTF;GLIS1;ID1;RARG;EP300;TFAP2A;DLG1;PLK3;USP2;OTUD7B;TBL1X;E2F6;JUN;FOXE1;NR6A1;KLF10;HDAC10;ZMYM5;KDM1A;RNF2;CREBBP;GLIS2;BHLHE40;HES1;NFATC4;ETV5;JDP2;UBE2D3;MDM4;CBFB;SMARCA4;TCERG1;KAT5;CTR9;DCAF1;BCL6;TCF3;MXD1;PHF21A;PER2;FRK;PPM1A;SKI;GATA3;TCF23;PHF12;NKX2-1;HDAC8;NOG;TAF1;RB1;PEX2;PAF1;REST;MTDH;CBX2;NFIL3;RXRA;STAT3;FOXC1;GATAD2B;RTF1
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.5845782050886781,1.2928995002988082,0.21739130434782608,0.8612909031818349,1.0,4/14,5.26%,WNT9A;EFEMP1;GDF5;TGFBR1
prerank,negative regulation of cellular process (GO:0048523),0.39040395333991845,1.2927621553905304,0.01917255297679112,0.8600845159995778,1.0,96/521,12.88%,SLIT3;SLIT2;ZBTB7C;BMP4;CCN3;FHL1;TES;NDRG3;NGF;BMP5;WNT9A;OSGIN2;TGFB3;PTK2B;CYP1B1;ESR2;ARHGDIB;LRPAP1;ABI1;CCN1;PTPRU;WNT11;P3H2;INHBA;CD9;KLF4;SMAD6;SMYD2;VPS13C;MYOG;IL10;STRN;IP6K2;LMNA;WNT16;PDCD4;CCN5;KANK2;NCK2;PLSCR1;BECN1;HNF4A;RARG;CLU;TDRD9;TFAP2A;PLXNA2;SSTR3;CNOT7;CELF1;PTPN2;IFI35;KLF10;FGF2;TGFB1I1;BAP1;ADAM10;TOB1;TNFRSF1B;SPEF1;SRGAP2;CYP27B1;MDM4;SMARCA4;FUZ;CDKN1B;BCL6;CGREF1;FABP3;AGTR2;P3H1;FRK;SKI;AGR2;DIS3L2;SRSF6;GATA3;NIBAN2;PIM2;EIF2AK3;IRF1;RB1;GTPBP4;TGFB2;ZBTB49;REST;IGFBP6;BNIP3;CASK;PTPN14;PLPP1;ST7L;SLURP1;HTR2B;WFDC1;KAT2B
prerank,protein localization to cilium (GO:0061512),0.513828863440089,1.2921068830502378,0.17321688500727803,0.8608107148348,1.0,10/32,15.75%,BBS9;RABEP1;ZNF423;ARL3;IFT122;EHD1;TTC21A;INVS;MAPK15;CSNK1D
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.5873173028243174,1.292096769887514,0.18803418803418803,0.859103616137177,1.0,9/14,25.54%,TNKS2;BRCA2;XRCC5;ATRX;ACD;TPP1;PINX1;ATR;TERT
prerank,positive regulation of phospholipase C activity (GO:0010863),0.49680961444470956,1.2918937594933855,0.16596931659693165,0.8581443623522677,1.0,4/40,2.39%,EGFR;EDNRA;NTRK3;FGFR1
prerank,supramolecular fiber organization (GO:0097435),0.39766893443091994,1.2915410152110742,0.04933196300102775,0.8577731802227692,1.0,40/334,6.56%,COL25A1;COL8A1;COL12A1;TLL1;SNCAIP;ADAMTS2;COL6A2;CLIP4;COL6A1;COL5A2;CYP1B1;COL23A1;COL8A2;DSP;SHROOM3;P3H2;TMOD3;BMP1;DDR2;COL3A1;P4HA2;GSN;RIPK3;HDGFL3;TNXB;PLOD2;P4HA1;TLE6;LTBP2;LTBP3;FAT1;COL6A3;TGFBR1;MAP7D3;P3H4;CLIP1;MPRIP;DLG1;PLK3;SLAIN2
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.5649323565941184,-1.291436000349699,0.17233560090702948,0.6600398341399897,1.0,5/10,13.96%,SHANK3;APP;SYP;CAMK2B;NETO1
prerank,positive regulation of dendrite development (GO:1900006),0.6290951087998333,1.2913840837681572,0.2126865671641791,0.8565758537614377,1.0,2/10,1.30%,BMP5;COBL
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.5220451742208284,1.2906810115893068,0.17364341085271318,0.8576252797216563,1.0,3/26,3.20%,EGFR;ANXA1;EIF4G1
prerank,regulation of T cell migration (GO:2000404),-0.4766688925256146,-1.290622032302233,0.17585301837270342,0.6599548422463191,1.0,5/18,11.27%,APOD;CXCL12;LRCH1;RIPOR2;APP
prerank,regulation of bone mineralization (GO:0030500),0.46839457656829303,1.2905323521629144,0.15033557046979865,0.8564858475738554,1.0,14/55,8.58%,BMP4;TGFB3;PTK2B;CCN1;BMP6;DDR2;ANO6;SGMS2;BMPR1A;TRPM4;TFAP2A;TXLNG;NELL1;CYP27B1
prerank,neuron projection fasciculation (GO:0106030),-0.5520964690927577,-1.2901897235566058,0.16554809843400448,0.658790304801388,1.0,6/10,20.66%,CNTN4;EPHA4;NRCAM;RTN4;CDK5R1;AMIGO1
prerank,fatty acid beta-oxidation (GO:0006635),0.47425435788861714,1.2898233966102548,0.15217391304347827,0.8576244561676342,1.0,11/51,13.35%,ABCD3;BDH2;EHHADH;ACADM;AUH;ECHDC1;ACOT8;DECR1;SLC25A17;PEX2;ACOX3
prerank,respiratory tube development (GO:0030323),0.5206766690077869,1.2896749089121056,0.18433179723502305,0.8564976722615983,1.0,5/28,7.51%,BMP4;PCSK5;STRA6;CCDC40;FGF2
prerank,regulation of Ras protein signal transduction (GO:0046578),0.4356411897565722,1.2896029301576966,0.12150668286755771,0.8550706412913248,1.0,12/86,6.29%,PLCE1;ARHGEF28;NGF;STK19;ARHGDIB;AKAP13;SHC1;ARHGAP44;BCR;NOTCH2;KANK2;SHOC2
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.49687077634003074,1.289561442091533,0.16714697406340057,0.8535808142675854,1.0,3/35,3.05%,PCDHB16;CDH11;PCDHB13
prerank,positive regulation of vacuole organization (GO:0044090),0.6210134080704917,1.2890747949861603,0.20104895104895104,0.8535844261407644,1.0,3/10,7.20%,ANXA2;RAB3GAP2;LRSAM1
prerank,actin filament bundle assembly (GO:0051017),0.5105731082745029,1.2890549001369396,0.17602427921092564,0.8519550035973579,1.0,7/33,5.31%,DPYSL3;BAIAP2L1;CALD1;EZR;PAWR;FAM107A;ESPN
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.5520625425489352,-1.2889351694583402,0.19213973799126638,0.6604251563175312,1.0,2/10,6.10%,KCNAB1;ANK3
prerank,cellular response to superoxide (GO:0071451),-0.5536052952980248,-1.288731860387591,0.19004524886877827,0.658627872514464,1.0,5/10,19.30%,NOS3;SOD3;ATP7A;PRDX1;SOD2
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.6214323060285196,1.288269938019406,0.20677361853832443,0.853141113195351,1.0,3/10,6.07%,CD55;ZBTB7B;TGFBR2
prerank,actin filament bundle organization (GO:0061572),0.5105037671571929,1.2878964264781068,0.18816388467374812,0.8529017876336419,1.0,7/33,5.31%,DPYSL3;BAIAP2L1;CALD1;EZR;PAWR;FAM107A;ESPN
prerank,mitochondrial protein processing (GO:0034982),0.6304649512256378,1.2876512436453376,0.19859402460456943,0.8520631229504163,1.0,6/11,16.09%,PMPCB;OMA1;IMMP1L;SPG7;STOML2;YME1L1
prerank,peptidyl-lysine modification (GO:0018205),0.4317799785780415,1.2874007134070526,0.1073170731707317,0.8512934423260267,1.0,34/99,21.10%,HDAC4;HDAC9;NUP93;EGR2;PLOD2;TRPM4;PIAS3;P3H4;EP300;PIAS2;LIPT2;LOXL1;HDAC10;KAT5;NUP188;RANBP2;METTL21C;KAT2B;VIPAS39;NSMCE2;LOXL4;SAE1;EEF1AKMT1;NUP107;AAAS;RNF212B;SENP3;RAE1;LIPT1;NUP54;PIAS1;METTL21A;SUMO1;NUP98
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.5857576784899214,1.2869850960766842,0.21869782971619364,0.8512677356536503,1.0,8/16,18.23%,DDX5;ESR2;RBFOX2;TADA3;DDX17;NCOA4;AR;ARID1A
prerank,cellular component disassembly (GO:0022411),0.4753398462309684,1.2867436476295375,0.14555256064690028,0.8504986678371607,1.0,15/53,12.46%,TLL1;CD44;BMP1;GSN;CAPN2;HTRA1;ADAMTS5;MMP16;MMP14;TIMP2;ADAM10;DYRK3;WASHC1;ADAM8;KIF9
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.409862121556938,1.2866125581094894,0.09152542372881356,0.8493625958941367,1.0,19/159,6.07%,CDH1;PCDHB16;GPC6;HMCN1;CDH11;CXADR;PKD1;ALCAM;NECTIN3;FAT2;MPZL2;ITGB1;PCDHB13;CLDN16;DSG2;CLDN11;PVR;SDK1;TGFBR2
prerank,smooth muscle tissue development (GO:0048745),0.6303907582339607,1.2863535280367746,0.20614828209764918,0.8485963035832641,1.0,3/10,2.70%,BMP4;SMO;STRA6
prerank,positive regulation of chemokine production (GO:0032722),-0.3917947362965433,-1.2860651592580494,0.1326530612244898,0.6648751684253184,1.0,14/44,20.74%,MBP;WNT5A;HIF1A;IL6R;IL18;TLR3;EGR1;APP;TLR7;SYK;TIRAP;CD74;CSF1R;LPL
prerank,positive regulation of leukocyte migration (GO:0002687),-0.42513760552043,-1.2858689858819434,0.14647887323943662,0.6630675128238906,1.0,10/27,26.40%,CSF1;IL6R;JAM3;MDK;EDN3;NCKAP1L;VEGFA;PTN;AIF1;MIA3
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.4797096684293297,1.2857488158608195,0.16361071932299012,0.8492264754501736,1.0,16/45,21.05%,BMP4;PTPN3;IL10;CDKN1B;BCL6;CHEK1;FOXC1;HECA;BTG3;PRCC;FZD3;ZFP36L1;CHFR;NME6;GAS1;TGFB1
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.4490671748450003,-1.2857469424820933,0.13736263736263737,0.6611114041782955,1.0,7/23,11.27%,CEMIP;PRKAG2;CALM1;BMP7;CALM3;SPHK1;APP
prerank,negative regulation of cell differentiation (GO:0045596),0.4079095753396336,1.2852349923768658,0.07311586051743532,0.8494824064522146,1.0,40/181,13.60%,EGFR;BMP4;CRIM1;ZFPM2;BMP5;WNT9A;PTK2B;ZBTB16;COL5A2;EFEMP1;SMAD6;GDF5;BAMBI;PDCD4;SPRED2;TRPM4;TGFBR1;TRIO;TWIST2;ITGAV;JAG1;TSKU;HES1;WWTR1;EIF2AK4;IL17RD;CTR9;SKI;FOXA1;GATA3;TCF23;NKX2-1;NOG;RB1;PAF1;REST;ITGB3;CHRD;LRP5;LDLRAD4
prerank,cellular response to catecholamine stimulus (GO:0071870),-0.44622963565990137,-1.285055957362628,0.15512465373961218,0.6608921635132596,1.0,9/23,10.95%,PDE4B;TGM2;GNG2;SNCA;MAPK3;APLP1;LRRK2;KCNQ1;RYR2
prerank,regulation of chromatin binding (GO:0035561),0.6184531290149321,1.2850067424458076,0.22456140350877193,0.8487301619232174,1.0,4/10,13.66%,BTAF1;WAPL;KDM4D;DDX11
prerank,negative regulation of myoblast differentiation (GO:0045662),0.6054265346303114,1.2847333138962187,0.20379965457685664,0.8481082013590343,1.0,2/13,6.17%,BMP4;PRICKLE1
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.43752585164246044,1.2841749247879033,0.12075471698113208,0.848501710812066,1.0,21/87,20.59%,FBXL7;FHL1;KLF4;FAM107A;KANK2;DLG1;RB1;RBL2;USP47;PSMC6;CDKN2D;PRMT2;PSMD8;ZFP36L1;PINX1;PSMB1;PSMD13;PSMD1;AURKA;PSMD7;PSMA8
prerank,positive regulation of defense response to virus by host (GO:0002230),0.5359727973333569,1.2839931297316731,0.21829855537720708,0.847581992912882,1.0,5/24,8.41%,TRAF3IP2;ZDHHC11;TRIM44;MAVS;EIF2AK4
prerank,cell-cell junction organization (GO:0045216),0.4395778723934009,1.2834796427462767,0.1397984886649874,0.8478873314948522,1.0,18/79,11.79%,CDH1;CDH11;CXADR;TGFB3;CTNND2;NECTIN3;DSP;CTNNA1;DSG2;PVR;SDK1;PKP4;JUP;LIMS2;CTNND1;CDH17;TGFB2;CSK
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.41904530057642714,1.2829411424536072,0.11010215664018161,0.848331495302649,1.0,22/140,12.51%,PLCE1;EDNRA;PTGDR;GPR4;ADRA1B;CD55;AGTR1;CACNA1C;LPAR4;P2RX2;ABL1;TRPM4;P2RX4;PTGER1;BDKRB1;PTGER2;CXCR4;FPR3;SELENOT;DRD3;CD36;CMKLR1
prerank,positive regulation of cell division (GO:0051781),0.49334432350431495,1.2828248694469808,0.16973125884016974,0.8471515231574518,1.0,10/38,12.74%,CIT;GIPC1;CDC25B;PKP4;PKN2;CDC42;DRD3;RHOA;PRKCE;HTR2B
prerank,striated muscle tissue development (GO:0014706),0.5146234024831834,1.2818448045053221,0.187039764359352,0.8490733173900837,1.0,5/29,3.48%,SGCD;BMP5;SIX1;CSRP3;MYOG
prerank,modulation of chemical synaptic transmission (GO:0050804),-0.32455967106825,-1.281209752384924,0.05333333333333334,0.6706366280511363,1.0,35/107,15.92%,ATP1A2;CDH2;GRM3;MCTP1;LRRC4C;NRG3;DGKI;RIMS1;RIMS2;GRIK1;GRM5;GRM1;GRM7;MEF2C;OPHN1;GRID2;GRM8;LRP8;SYN1;LRRK2;GRIK2;LRRC4;CAMK2A;MCTP2;APP;CACNA1B;CPLX1;DLGAP2;NPTXR;CX3CR1;CHRNA7;TMEM108;ABR;KCNMB4;CLSTN3
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.5673645728308276,1.2808611377384362,0.19800332778702162,0.849400402380003,1.0,5/16,10.01%,THBS1;PHLDB2;FAM107A;DMTN;BCAS3
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.5673645728308276,1.2808611377384362,0.19800332778702162,0.849400402380003,1.0,5/16,10.01%,THBS1;PHLDB2;FAM107A;DMTN;BCAS3
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.4528547158682801,-1.2808598373374291,0.16193181818181818,0.6693107001733519,1.0,6/23,11.48%,ACSL1;ELOVL7;ELOVL6;FAR2;ACOT7;HSD17B12
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.6236614956382461,1.2804248483749578,0.20695970695970695,0.8477296951417483,1.0,3/10,3.51%,WNK1;KLF4;IL10
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.6236614956382461,1.2804248483749578,0.20695970695970695,0.8477296951417483,1.0,3/10,3.51%,WNK1;KLF4;IL10
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.5308099253931903,1.2785217879599604,0.18025078369905956,0.8533427535647056,1.0,2/22,2.56%,BMP4;INHBA
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.2856000859078467,-1.2784597747280717,0.0,0.6747104550542796,1.0,95/306,18.78%,RBMS1;APOE;RPLP1;RPS14;FUT9;PTMA;RPL37A;RPL38;RPL30;RPL8;RPL21;RPL41;RPL14;RPL9;RPS24;RPL13;EEF1A1;RPS27;RPLP2;RPS21;RPS23;RPS9;RPS29;EEF1B2;RPS15;RPL22;RPS5;RPS16;RPL5;RPS4X;RPS2;RPS13;RPL34;RPL23;RPL17;RPS19;SET;RPS8;RPS20;RPS27A;RPS17;RPL13A;RPS12;BCL3;RPS7;RPS3;RPL27A;RPL3;RPL24;RNPS1;RPS18;RPL18;DTX1;ALAS1;RPL39;RPS11;MRPL3;ORC4;POLA2;RPL23A;GAL3ST2;UPF1;RPL7A;BLM;RPL35A;RPL26;PWP1;RPL32;RPL18A;RPS25;RPL36;RPL12;RPS10;XAB2;RPL27;RPL11;POLR2K;TOPORS;MRPS11;RPL31;SARS1;RPL19;ORC6;CDC7;RPLP0;RPS15A;B4GALT5;RPS28;DONSON;BRCA1;PCLAF;RPL37;MRPL51;RPL29;MRPL35
prerank,regulation of protein localization to nucleus (GO:1900180),0.4856360846612419,1.278359441481482,0.1765536723163842,0.8523987313015993,1.0,6/43,8.00%,BMP4;LIMK2;CTNNA1;GSK3B;OTUD7B;WWTR1
prerank,endocardial cushion morphogenesis (GO:0003203),0.5611794220992963,1.2781279629329414,0.19185059422750425,0.8516245662464204,1.0,8/18,11.71%,BMP4;ISL1;BMPR1A;TGFBR2;MDM4;NOG;ACVR1;TGFB2
prerank,amino acid transport (GO:0006865),0.4725403515121243,1.277690591798069,0.1711229946524064,0.8516240541467927,1.0,6/49,5.58%,SLC38A2;SLC38A1;SLC7A2;SLC6A19;SLC38A6;SLC38A7
prerank,negative regulation of protein catabolic process (GO:0042177),0.48272878054317414,1.2774328838387372,0.18156028368794327,0.8508809220913889,1.0,12/40,17.79%,EGFR;PTPN3;IL10;NELL1;TIMP2;MDM4;RGP1;SNX12;SNRNP70;FLNA;HMGCR;AZIN1
prerank,positive regulation of metabolic process (GO:0009893),-0.32901593301093074,-1.2773447322883873,0.059602649006622516,0.6758252994966552,1.0,22/103,9.98%,LEPR;CAMK1D;IGF1R;ACSL1;PPARGC1B;ESRRG;GATM;GNAS;PRDM16;ELOVL6;INSR;EBF2;PPARGC1A;ACLY;GJA1;ACACA;ACACB;MFN2;ACADL;IL18;LPIN1;IL4R
prerank,oligodendrocyte differentiation (GO:0048709),-0.4725968536443701,-1.2772701758374174,0.16886543535620052,0.673598244724249,1.0,7/19,21.01%,SOX13;SOX6;MYRF;EIF2B5;TPPP;SOX10;PTPRZ1
prerank,T cell differentiation in thymus (GO:0033077),0.5901367068759167,1.2769666647728746,0.20729684908789386,0.8510984757996451,1.0,2/14,4.21%,GLI3;RIPK3
prerank,hexose transmembrane transport (GO:0008645),-0.4620296717322641,-1.276210487104437,0.17914438502673796,0.6744497771445636,1.0,7/21,20.34%,SLC2A1;PPARD;SLC5A3;SLC2A12;SLC50A1;SLC45A1;SLC2A8
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.4276396244034515,-1.2758615566489284,0.15028901734104047,0.6731164500102089,1.0,15/26,24.16%,SHANK3;NRXN1;RIMS1;RIMS2;LRRK2;APP;GRIN1;CHRNA7;TMEM108;PRKCZ;NLGN1;NLGN2;MTMR2;STX1B;CBLN1
prerank,DNA geometric change (GO:0032392),0.5340770770266128,1.2755249824120982,0.16478190630048464,0.8550219777803169,1.0,10/24,24.03%,ANXA1;DDX11;DDX1;DHX9;WRN;MCM9;NBN;MRE11;RECQL5;HMGB2
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.5416251858680515,1.2754710278887182,0.19585987261146498,0.8536328806775889,1.0,9/23,12.25%,GLI3;HHIP;GPC3;VCP;GLIS2;IFT122;HERC4;MEGF8;KIF7
prerank,clathrin coat assembly (GO:0048268),-0.4915023149696196,-1.2753147145104937,0.17277486910994763,0.6725928297530274,1.0,9/15,22.20%,SGIP1;PICALM;NSG1;HIP1;PIK3C2A;HIP1R;EPS15;AP2S1;NSG2
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),-0.3875067072255215,-1.2750816757277947,0.12627986348122866,0.6709461914168727,1.0,14/40,20.96%,VTN;SGIP1;B2M;INSR;ARRB1;DGKD;CD63;HIP1;WASL;CCL19;NTF3;ARRB2;GREM1;VEGFA
prerank,endothelial cell development (GO:0001885),-0.44200149236805525,-1.2748549295760687,0.16822429906542055,0.669328463182511,1.0,12/25,9.47%,COL22A1;PECAM1;RAPGEF3;COL18A1;COL15A1;RAPGEF2;PPP1R16B;RAPGEF1;ROBO4;PDE4D;PDE2A;MYADM
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),-0.3284745891483888,-1.2744188121010676,0.08823529411764706,0.6683176716324627,1.0,25/100,9.17%,FLT1;IGF1;LYN;IGF1R;PIK3R1;TEK;PDGFRB;PDGFD;PIP5K1B;DCN;KIT;KDR;PPP1R16B;PTK2;ROR2;INSR;PIP5K1C;DAB2IP;MAPK3;PDGFRA;IER3;ENTPD5;NTRK2;SRC;IL18
prerank,liver development (GO:0001889),0.5015723468735518,1.2743868995813734,0.18906942392909898,0.8561762343315749,1.0,5/32,5.75%,MET;COBL;ANXA1;CCDC40;PRKCSH
prerank,negative regulation of protein processing (GO:0010955),0.604813317066342,1.273767207439286,0.2134251290877797,0.856953863180084,1.0,2/12,6.41%,THBS1;SERPINE2
prerank,sensory organ development (GO:0007423),0.4741950080833397,1.2736770778286257,0.16620498614958448,0.8556461270540722,1.0,13/51,14.54%,PBX3;PBX1;STRA6;HIPK1;RAB18;SMOC1;SIX4;GATA3;TGFB2;FOXC1;SCO2;CPAMD8;ADAMTS18
prerank,DNA double-strand break processing (GO:0000729),0.5638521273430894,1.2736213528487348,0.20812182741116753,0.854284991515879,1.0,9/18,19.95%,RNF138;ATM;KAT5;RAD52;EXD2;RBBP8;UBE2N;NBN;MRE11
prerank,sensory perception (GO:0007600),-0.37777321926731283,-1.2727930498056754,0.1524163568773234,0.6711697130897193,1.0,12/45,17.99%,RETREG1;ADGRV1;GNAS;PCDH15;TTC8;ADORA2A;CHRNA7;PENK;KCNA2;P2RX7;NTSR2;WHRN
prerank,L-amino acid transport (GO:0015807),0.5200977180971738,1.2727576796491396,0.16816816816816818,0.856014756452439,1.0,3/28,5.39%,SLC38A2;SLC7A2;SFXN1
prerank,cellular response to heat (GO:0034605),0.49660183712031486,1.2720875060206367,0.1836441893830703,0.8569011419050928,1.0,3/35,4.82%,THBS1;TCIM;VCP
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.41053055920561965,-1.2719304373416762,0.14860681114551083,0.6714961383094669,1.0,16/34,18.66%,GRIN2A;GABRG3;GRIN2B;MEF2C;GRID2;GABRA1;GABRA2;LRRK2;GLRA1;GRIN1;GABRA4;AKT1;GSK3A;GABRG1;INSYN2A;ARRB2
prerank,myeloid cell development (GO:0061515),0.5658901084180012,1.2718660754861144,0.22203672787979967,0.8560778885209916,1.0,3/18,4.55%,FOXP1;ANXA2;GATA1
prerank,ATP transport (GO:0015867),-0.5550215513756384,-1.2717427329285953,0.1956989247311828,0.6696537748949614,1.0,6/10,26.03%,CD47;ABCC6;SLC25A4;SLC25A24;SLC25A42;SLC17A9
prerank,cognition (GO:0050890),0.48321461127159365,1.2716950897413493,0.17458100558659218,0.8550916422804038,1.0,5/42,3.21%,ST3GAL4;SOBP;STRA6;MGAT3;FAM107A
prerank,microvillus assembly (GO:0030033),0.5922154399390132,1.2715182568738237,0.20930232558139536,0.8541537184904222,1.0,6/14,7.01%,EZR;RAP1A;FXYD5;RAPGEF6;ESPN;RAP2C
prerank,regulation of endopeptidase activity (GO:0052548),-0.3657979738626041,-1.2714991569063097,0.10077519379844961,0.6680889876198216,1.0,16/59,19.63%,VTN;TIMP3;SPOCK2;PICALM;SERPINI1;GAPDH;SPOCK3;SERPIND1;SPOCK1;AGT;PSME2;AKT1;APH1B;PSENEN;VSIR;PSMB8
prerank,positive regulation of gene expression (GO:0010628),0.38544849559396527,1.2699048491794154,0.034623217922606926,0.8583863035340903,1.0,51/442,7.74%,SLC38A2;EGFR;BMP4;F3;THBS1;SLC24A3;SAMD4A;NGF;ITGB8;NTRK3;FN1;SMO;HOXA5;ANK2;FOXD1;DDX5;EZR;WNT11;KRAS;INHBA;BMP6;KLF4;PID1;IL10;GSN;ZBTB7B;GSK3B;WNT16;POLR1G;NFE2L2;CTCFL;NIBAN1;TNRC6C;DDRGK1;TGFBR1;SERPINB9;PLSCR1;LARP4B;MOV10;CLU;HILPDA;EP300;TFAP2A;FGF22;CELF1;TAF1C;ATM;TLR6;FGF2;TADA3;KAT2A
prerank,canonical Wnt signaling pathway (GO:0060070),0.45315395859603724,1.2698726498356898,0.16334661354581673,0.8569263079533146,1.0,23/68,16.85%,TCF7L1;TCF7L2;WNT9A;WNT11;PLPP3;LRP6;GSK3B;WNT16;FZD7;NR4A2;RARG;FZD2;GATA3;CSNK1E;BCL9L;WNT2B;CSNK1A1;LRP5;AMER1;RAB5A;FRZB;FZD9;FZD3
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.47559357818362763,-1.268079591196188,0.1715686274509804,0.6763183593810879,1.0,8/16,18.96%,ST6GALNAC3;ST8SIA4;ST8SIA6;ST3GAL5;ST6GALNAC4;ST8SIA1;ST6GALNAC6;ST8SIA5
prerank,nucleosome assembly (GO:0006334),0.5109041912294557,1.2680544251393537,0.17352941176470588,0.8619716420018558,1.0,5/31,6.93%,CHAF1B;UBN1;KAT6B;CABIN1;NAP1L2
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.5291850743461837,-1.267963354127181,0.18377088305489261,0.6743031226388799,1.0,6/11,22.48%,PTPRT;BCL3;NF2;LEPROT;SH2B3;SOCS1
prerank,transport along microtubule (GO:0010970),0.5973701245119036,1.2677904116173646,0.21273031825795644,0.8613792068124323,1.0,4/13,10.90%,ARHGAP21;DYNC1I1;SPG11;CDC42
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.5003392020539787,-1.2677571585485548,0.1890547263681592,0.6725839464236651,1.0,4/16,7.45%,APOD;PPARA;ADCY7;SIRPA
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.5019373889757218,1.267733481140219,0.19054441260744986,0.8600398280418604,1.0,11/30,17.63%,ABLIM3;NPEPPS;BAP1;UBE2D3;HPS4;ARIH2;CSNK2A2;RNF31;HSPA1L;SAE1;HUWE1
prerank,peptidyl-serine modification (GO:0018209),0.4028046549292175,1.2675171464020896,0.10757409440175632,0.8592596885122238,1.0,54/166,18.28%,STK39;PKD1;MARK1;CAMK2D;WNK1;PRKCD;HIPK1;MKNK2;GSK3B;GALNT13;SGK3;ULK2;TLK1;TGFBR1;TGFBR2;CHUK;ATM;MARK2;DYRK2;SMG1;POGLUT3;DYRK3;CSNK1G3;MARK3;MTOR;CSNK1E;PKN2;PAK2;TAF1;EIF2AK3;CSNK2A2;CSNK2A1;IKBKE;PRKCE;CSNK1A1;MAPK1;MORC3;CAB39;VRK3;CAMK4;PRKCA;PRKACA;CSNK1D;MAP3K12;PRKDC;MAP4K1;TOP1;MAPK8;VRK2;MAPKAPK2;TLK2;CLSPN;POGLUT2;CSNK1G1
prerank,organelle transport along microtubule (GO:0072384),0.5060641560363297,1.2672752108500391,0.18851251840942562,0.8585301836985393,1.0,15/31,23.90%,ARHGAP21;NDEL1;DYNC1I1;RAB6A;PAFAH1B1;FBXW11;CDC42;TMEM201;BORCS5;CLN3;LRPPRC;UXT;RHOT2;TRAK1;RHOT1
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.48135423669016414,1.2672527722168794,0.16569767441860464,0.8570546295931356,1.0,6/39,3.51%,CDH1;WNK1;BMP6;KLF4;FXYD5;IL10
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.4983258356111478,1.2669178929981628,0.1924198250728863,0.8567365722316592,1.0,9/32,15.85%,DDX5;FHIT;HIPK1;EP300;DYRK2;CDIP1;STK11;SNW1;PML
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.48354043935418356,1.2666721339155174,0.18028169014084508,0.8561088362279062,1.0,12/38,17.63%,ABLIM3;NPEPPS;BAP1;UBE2D3;HPS4;ARIH2;PARL;CSNK2A2;RNF31;HSPA1L;SAE1;HUWE1
prerank,visual perception (GO:0007601),0.43721140984663714,1.2663249343407954,0.13027295285359802,0.8557297556156168,1.0,17/84,19.44%,SLC4A10;PITPNA;EFEMP1;EYA4;EYA3;CRYBG3;MYO9A;DNAJC19;IMPG2;PAX6;POU6F2;ATF6;ARR3;WFS1;TULP2;COL11A1;OAT
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.4793392979856852,-1.2662600296063067,0.15671641791044777,0.6750282370644355,1.0,7/17,10.95%,ATP1A2;GJC1;GJD3;ATP1B2;GJA1;SLC8A1;RYR2
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.4457532010917924,-1.2661646166811904,0.16756756756756758,0.6730747411182709,1.0,3/21,4.94%,OSBPL8;PLA1A;OSBPL10
prerank,nerve growth factor signaling pathway (GO:0038180),0.6150502372822295,1.265564805539376,0.22395833333333334,0.8569934978896424,1.0,3/10,7.53%,NGF;RAP1A;KIDINS220
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.42472013153657917,-1.2655359370014654,0.13450292397660818,0.6728005406205224,1.0,8/26,13.14%,ERRFI1;TGFA;CBLB;SOCS5;ADRA2A;HBEGF;APP;ZFYVE28
prerank,endochondral bone morphogenesis (GO:0060350),0.6150529649628633,1.2651765157099613,0.23356401384083045,0.8568396887226504,1.0,1/11,0.27%,BMP4
prerank,negative regulation of phagocytosis (GO:0050765),-0.47528160141322773,-1.2647515626545593,0.1724137931034483,0.6729954857404239,1.0,5/17,9.48%,CD47;DYSF;SIRPA;SYT11;CD300A
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.5114241641677213,-1.2633212792691617,0.1909307875894988,0.6752930567176847,1.0,4/13,15.27%,NOS3;CALM1;QDPR;AKT1
prerank,endocardial cushion development (GO:0003197),0.5318085602720348,1.263046598843597,0.20833333333333334,0.863096168385466,1.0,8/21,11.71%,BMP4;ISL1;BMPR1A;GATA4;MDM4;NOG;ACVR1;TGFB2
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.4903319148332054,1.2627364047950584,0.18906942392909898,0.8627018470303752,1.0,4/33,4.86%,EGFR;ANXA1;EIF4G1;DDRGK1
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.41431984135698974,-1.2623830590983058,0.15457413249211358,0.6759588955480557,1.0,8/31,14.06%,HSPA8;ERN1;DAB2IP;ATXN3;TMBIM6;HSPA9;OPTN;PACRG
prerank,mitochondrial RNA metabolic process (GO:0000959),0.5812346462908788,1.2615213933036646,0.2286634460547504,0.865669650517024,1.0,2/14,6.39%,FOXO3;EARS2
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.566137009683993,1.2614450270962279,0.2233169129720854,0.8643928388740986,1.0,8/15,21.20%,BMP4;CYP27B1;FOXC1;SFN;TRIM16;SULT2B1;SFRP4;NCOA3
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.5703627720802957,1.2613548669696806,0.22483221476510068,0.8631764514366838,1.0,3/15,11.71%,TGFB3;IL10;TGFB2
prerank,regulation of lipid storage (GO:0010883),0.5361535713531773,1.260864671658632,0.19334389857369255,0.8634486709172908,1.0,8/22,16.86%,FTO;NFKB1;HILPDA;ITGAV;PTPN2;IKBKE;ITGB3;ALKBH7
prerank,response to laminar fluid shear stress (GO:0034616),0.6217867786695982,1.2601304948507188,0.23992673992673993,0.8645334793890603,1.0,3/10,4.43%,KLF4;SMAD6;NFE2L2
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.40678883037866714,1.2597506228637683,0.1217877094972067,0.8643326282480819,1.0,20/150,7.52%,EGFR;F3;THBS1;MET;TCF7L2;TNFAIP8L3;ITGB1;FGFR1;STRN;GCNT2;PDGFA;TGFBR1;CD80;IRS1;HCLS1;FGF22;P2RX4;PIK3AP1;FGF2;GAB2
prerank,cellular response to type I interferon (GO:0071357),-0.3871176500423388,-1.2596623111016305,0.13405797101449277,0.6797229878390193,1.0,17/41,22.60%,IFNAR1;IRF2;SAMHD1;BST2;IFITM1;IFIT2;IFNAR2;IFITM3;EGR1;OAS2;IFIT3;SP100;GBP2;RNASEL;PSMB8;STAT1;IRF7
prerank,type I interferon signaling pathway (GO:0060337),-0.3871176500423388,-1.2596623111016305,0.13405797101449277,0.6797229878390193,1.0,17/41,22.60%,IFNAR1;IRF2;SAMHD1;BST2;IFITM1;IFIT2;IFNAR2;IFITM3;EGR1;OAS2;IFIT3;SP100;GBP2;RNASEL;PSMB8;STAT1;IRF7
prerank,nitrogen compound transport (GO:0071705),0.4094464228897118,1.2596579954018587,0.13860252004581902,0.8631500129805629,1.0,9/141,3.41%,SLC38A2;SLC23A1;SLC12A2;SLC38A1;LRRC8D;RAMP1;ABCG2;SLC7A2;SLC6A19
prerank,regulation of osteoblast proliferation (GO:0033688),0.5491559071425394,1.2588309296189326,0.21694915254237288,0.8646708426048206,1.0,5/17,11.89%,CCN1;NELL1;HPSE;NPR3;RHOA
prerank,regulation of ossification (GO:0030278),0.4875659076334198,1.2587921264372466,0.1891891891891892,0.8632849441948356,1.0,10/36,11.71%,BMP4;ZBTB16;DDR2;SGMS2;LRP6;SMAD6;TXLNG;CYP27B1;ACVR1;TGFB2
prerank,intestinal absorption (GO:0050892),-0.5106203571982096,-1.2583135174990094,0.20286396181384247,0.6816090255063435,1.0,4/13,9.07%,F11R;UGCG;ADRA2A;KCNQ1
prerank,regulation of lamellipodium assembly (GO:0010591),0.49041294833603044,1.2580674397628944,0.20202020202020202,0.8643462505861431,1.0,2/34,0.44%,SLIT2;PLCE1
prerank,neuronal action potential (GO:0019228),0.5365767119512695,1.2580477549691704,0.20347003154574134,0.8628893833426502,1.0,3/22,5.51%,KCNMB3;KCNMB2;SCN11A
prerank,glycosaminoglycan metabolic process (GO:0030203),0.46066281593457276,1.2568471417071816,0.1703225806451613,0.8659397204744499,1.0,14/54,11.45%,GPC6;EXT1;HS3ST1;GPC3;GCNT2;HS6ST2;HEXA;NAGLU;GPC4;SGSH;HPSE;NDST1;B4GALT7;GLB1
prerank,gliogenesis (GO:0042063),0.5688846622180523,1.256427972596051,0.21818181818181817,0.8659743809188449,1.0,3/15,2.75%,NFIB;ANXA1;CD9
prerank,positive regulation of ossification (GO:0045778),0.4846255131610937,1.256203707371323,0.19174041297935104,0.8652771040558923,1.0,9/39,7.70%,BMP4;TGFB3;ZBTB16;CCN1;BMP6;ANO6;BMPR1A;TFAP2A;NELL1
prerank,extracellular matrix disassembly (GO:0022617),0.4610684470991032,1.2558044767199628,0.1753681392235609,0.86519986636242,1.0,14/53,12.46%,TLL1;CD44;BMP1;GSN;CAPN2;HTRA1;ADAMTS5;MMP16;MMP14;TIMP2;ADAM10;WASHC1;ADAM8;KIF9
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.5199015188828188,1.2554932560375585,0.1997041420118343,0.8648833320701068,1.0,5/26,8.63%,ST3GAL4;LARGE1;GOLPH3;RRM2;B3GNT6
prerank,regulation of platelet activation (GO:0010543),-0.4496792147848234,-1.255449888449383,0.17563739376770537,0.6884260299730205,1.0,7/21,8.53%,LYN;APOE;NOS3;TEC;PRKCQ;PDGFRA;PLEK
prerank,regulation of fibroblast migration (GO:0010762),0.5429291977508833,1.2554089495261702,0.20706260032102727,0.8636394376181946,1.0,6/20,12.45%,THBS1;ITGB1;DDR2;FGF2;DMTN;PRKCE
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.3811405965865731,1.2548212632435403,0.05761316872427984,0.8642430283400021,1.0,52/348,11.44%,SLC38A2;BMP4;F3;SLC24A3;NGF;ITGB8;NTRK3;FN1;SMO;HOXA5;ANK2;FOXD1;EZR;WNT11;KRAS;INHBA;BMP6;ANXA2;KLF4;PID1;GSN;ZBTB7B;GSK3B;WNT16;NFE2L2;CTCFL;TNRC6C;DDRGK1;TGFBR1;SERPINB9;PLSCR1;MOV10;CLU;TFAP2A;FGF22;CELF1;ATM;TLR6;FGF2;TADA3;NSF;CALCOCO1;RDX;AGR2;CD46;TCF23;MTOR;NKX2-1;NOG;EIF2AK3;UBR5;TLR4
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.4956569832899543,1.2540775630995242,0.19907407407407407,0.8653649760310571,1.0,8/29,13.60%,BMP5;SPRED2;IL17RD;FUZ;FOXA1;GATA3;NKX2-1;LDLRAD4
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.5963708163652144,1.2532201555849645,0.24444444444444444,0.8655645506899451,1.0,4/10,13.75%,PPP3CA;NFAT5;NFATC4;PPP3CC
prerank,calcineurin-mediated signaling (GO:0097720),0.5963708163652144,1.2532201555849645,0.24444444444444444,0.8655645506899451,1.0,4/10,13.75%,PPP3CA;NFAT5;NFATC4;PPP3CC
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),-0.4297002062027675,-1.2530770291949078,0.17027027027027028,0.6937573022577049,1.0,3/23,4.76%,ERRFI1;CBLB;SOCS5
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.5631997138740532,1.252978383731051,0.2267536704730832,0.86492641016555,1.0,3/16,7.51%,THBS1;AGTR1;FGF2
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.5572513774498316,-1.2529693442670762,0.22869955156950672,0.6918161457952018,1.0,3/10,6.10%,LYN;FAS;MAPK3
prerank,organic substance transport (GO:0071702),0.41156712918333005,1.2528236498330563,0.13773148148148148,0.8640398646357529,1.0,7/121,2.82%,SLC47A1;SLC23A1;ABCD3;DISP1;RAMP1;SLCO2A1;ABCG2
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.5002300168969956,-1.2527404136902098,0.1926605504587156,0.6903154847857249,1.0,8/13,39.07%,LCMT1;CDK5RAP2;ANAPC15;XRCC3;GEN1;NDC80;CCNB1;PCID2
prerank,regulation of dendritic spine development (GO:0060998),-0.44753496273287174,-1.2514826839104525,0.18087855297157623,0.6922640915409112,1.0,6/19,13.36%,SHANK3;APOE;PPFIA2;MEF2C;GRIN3A;CAMK2B
prerank,neuron remodeling (GO:0016322),-0.5417314960698459,-1.2514678178298375,0.18048780487804877,0.6900401300558897,1.0,6/10,36.31%,EPHA8;C1QA;APP;C3;RND1;CX3CL1
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),-0.5646890117139632,-1.2513876514477031,0.20551378446115287,0.6880153607393953,1.0,3/10,10.33%,TGFA;ADRA2A;HBEGF
prerank,negative regulation of cellular catabolic process (GO:0031330),0.44809454597534687,1.2510702113287426,0.1822721598002497,0.868964157591141,1.0,18/63,12.74%,MET;PTPN3;EIF4G3;DAPL1;EIF4G1;FOXK1;IL10;KLHL22;TAB3;NELL1;TIMP2;RGP1;FOXK2;MTOR;WASHC1;NRDE2;STAT3;HTR2B
prerank,lung development (GO:0030324),0.49290103715321,1.2510614629230157,0.17522658610271905,0.8675187453392085,1.0,6/33,7.51%,BMP4;PKD1;WNT11;STRA6;CCDC40;FGF2
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.4733149483053601,-1.2510424803917657,0.2052505966587112,0.6868544273354888,1.0,4/17,11.01%,PPARA;PRKAG2;PPARD;PRKAA2
prerank,regulation of membrane repolarization (GO:0060306),0.5860408222776423,1.2503533721670024,0.23769100169779286,0.8685887402772783,1.0,1/13,0.42%,KCNJ2
prerank,sodium-independent organic anion transport (GO:0043252),0.6068373181724064,1.2502805577821248,0.2396551724137931,0.8673822440196721,1.0,3/10,2.33%,SLCO3A1;SLCO4A1;SLCO2A1
prerank,extracellular matrix assembly (GO:0085029),-0.442175322125208,-1.2501536926425596,0.19230769230769232,0.6873873863018567,1.0,14/23,25.17%,FBLN5;GPM6B;RAMP2;MYH11;LAMB1;MFAP4;GAS6;EFEMP2;QSOX1;ATP7A;HAS2;EMILIN1;HAS3;LAMB2
prerank,mitochondrion disassembly (GO:0061726),0.4929061745570481,1.2500831562566816,0.203240058910162,0.8666129511158802,1.0,13/34,19.48%,WIPI2;ULK2;BECN1;ATG3;MARK2;SQSTM1;BNIP3;RB1CC1;AMBRA1;ATG2A;ATG7;ULK1;FIS1
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.391649470178541,-1.250079451440567,0.15605095541401273,0.6854191523387391,1.0,11/35,16.62%,VTN;SGIP1;B2M;PICALM;TNK2;FLOT1;RAC1;HIP1;HIP1R;SNAP91;CCL19
prerank,anterograde trans-synaptic signaling (GO:0098916),-0.29010512408721667,-1.2495245386950955,0.01282051282051282,0.6849567809825845,1.0,62/224,15.46%,SLC1A3;UNC13C;DTNA;PDE7B;NRXN1;GRM3;NOVA1;MBP;CACNA1E;PRKAR2B;SLC6A1;CALM1;GRIK1;GRIN2A;GRM5;PLP1;GABRG3;GRM1;SNCA;PRKACB;GRM7;GRIA4;GRIA2;SLC1A1;SLC1A2;GRIA3;GRIN2B;PRKAR1B;SDCBP;SYN1;GABRA1;GABRA2;ATXN3;APBA2;RIT2;GRIK2;PRKAR1A;GLRA1;GABRB2;GABARAP;GABRB1;CHRM3;APBA1;KCND2;SLC12A5;HTR2A;RPS6KA1;CACNA1B;KCNQ3;CPLX1;CHRM2;SST;GRIN1;CHRFAM7A;CHRNA7;HRH1;CACNB4;PENK;GABRA4;CACNB1;KCNMB4;SNAP25
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.5475446224498532,-1.2493231742183797,0.19383259911894274,0.6833943765507816,1.0,6/10,17.14%,GABRG3;GABRA1;GABRA2;GABRB2;GABRA4;GABRG1
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.3712181404964379,1.2489035174567606,0.0,0.8692619993737759,1.0,381/1645,18.41%,BNC2;CDH1;FOXP2;EGFR;ZBTB7C;BMP4;FOXP1;MKX;KLF12;NR3C2;WWP1;VSX1;PBX3;KLF5;SLTM;TFCP2L1;SMAD9;TCF7L1;MAP3K5;ZFHX3;ZFPM2;TCF7L2;PRRX2;TBX15;PLAGL1;NFIB;FOXN3;ZIC4;ZFHX4;SIX1;HOXA5;TGFB3;MLLT3;FOXD1;HDAC4;FOXO3;DDX5;GLI3;ZBTB16;PBX1;ESR2;RBFOX2;CAMK2D;TCIM;GRHL1;NFIA;USP13;WNT11;KLF3;SHC1;NFAT5;NR2F1;INHBA;WWP2;HDAC9;ISL1;CRY2;HOXA3;KLF4;EFEMP1;CUX1;LRP6;SMAD6;PURG;FOXK1;FOXP4;SP140;GDF6;MYOG;NOBOX;IL10;PITX3;BARHL2;LHX2;PHOX2A;RCOR3;IGSF1;KAT6B;HOXB6;L3MBTL3;ELF1;ZBTB7B;ZIC1;BTAF1;ANXA4;BAMBI;MDFIC;MEF2A;FZD7;PDCD4;ZNF148;ABL1;MEOX2;EGR2;HDGFL3;DDIT3;NFE2L2;ARID4A;GCLC;GATA1;KLF7;CTCFL;NR4A2;E2F5;ATP8B1;TCF20;FOXC2;HOXA6;CRABP2;ATF1;TGFBR1;JMJD1C;NR4A3;NFKB1;ZNF8;ZNF423;TRRAP;ID4;CD80;PIAS3;BPTF;SCMH1;FOXO6;GLIS1;TWIST2;HNF4A;HNF1A;ID1;BCLAF1;BAZ2B;FOXD2;PRICKLE1;PRRX1;EP300;TFAP2A;HOXB5;ERC1;PIAS2;MBTD1;FBXW11;HCLS1;LBX1;TRIM44;CAMTA2;CNOT7;TBL1X;CHUK;E2F6;JUN;TASP1;FOXE1;HIVEP3;RRM2;NR6A1;KLF10;ATP2B4;HDAC10;FGF2;TRIM45;TADA3;TGFB1I1;KDM1A;KAT2A;BAP1;CREBBP;KLF9;GLIS2;BHLHE40;HES1;NFATC4;FUS;CREB3L3;PHC2;WWTR1;ETV5;GATA4;HIF3A;JDP2;TNFRSF4;TEAD1;TAF6L;CALCOCO1;CCNL2;BCL10;MDM4;CBFB;SMARCA4;CHEK2;CDKN1B;MNAT1;CARF;NFYA;KAT5;FZD2;CTR9;HMG20A;BCL6;TOX4;TCF3;MXD1;NFKB2;SIX4;E2F3;PER2;BCL11B;ZNF585B;ZNF585A;PPM1A;ZKSCAN1;ATOH8;MBD1;ARID4B;MED14;GON4L;BRCA2;FOXA1;FOXK2;GPBP1L1;GCFC2;PRDM15;GATA3;TCF23;ZNHIT3;QRICH1;PHF12;NKX2-1;SETD5;BRD9;MYRFL;EBF4;NIBAN2;PIM2;ZNF383;ZFP62;RNF10;IRF1;RB1;RGMB;ACVR1;TLE2;HSF5;ZBTB11;USP22;ZBTB49;BAZ1A;USP21;ZBTB37;ZMIZ1;USP47;REST;NLK;MTDH;KLF16;NFIL3;SPINDOC;RXRA;STAT3;WIZ;FOXC1;METTL4;EHF;RNF111;KDM3B;PGBD1;BAZ2A;RFX5;HIVEP2;STAT5A;ASCC1;ZBTB4;CIITA;XRCC5;CIPC;HES7;EHMT1;LRP5;REL;DDX17;ZXDC;FOXM1;MGA;CEBPB;TGFBRAP1;SOX21;ZNF76;TFE3;THAP1;KMT2D;TRIM16;BRD3;GTF2IRD1;LCOR;CARM1;LBHD1;TFEB;CAMK4;ZBTB32;MYNN;ILK;HOXB3;HTATIP2;FOXL1;ATF7;ZXDB;PRMT6;BRWD1;TAF15;FBXL19;RBBP8;ERN2;CDK18;AATF;HCFC1;ZFX;SBNO2;ELF4;XPC;ELP4;ZNF25;SNW1;MAP2K2;JMJD6;DHX9;PML;SRCAP;HOXC5;PCGF1;PRMT2;ZNF711;MAP3K12;ZBTB18;CREBRF;PAX6;MED27;ZNF496;NFIX;ZIC5;ELOA;HIRA;ATRX;MED17;DMAP1;CSRNP2;SERTAD3;SAP30;MAEL;RORA;NR4A1;CITED2;LDB1;SAMD13;ACTR8;SCML4;STAT6;EPC1;KDM2A;ATF2;TSC22D4;ZBTB40;ZBTB7A;YY1;CREBL2;POLA1;ZNF182;YEATS2;AR;E2F2;POU6F2;ATF6;CBX5;ZMIZ2;ELF3;CSRNP1;HOXC6;ARID1A;DMRTA1;SRRT;ATAD2;FOXD3;IKZF3;REXO4
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.5075945023765093,-1.2486299927158324,0.21026894865525672,0.683325619440713,1.0,6/12,28.48%,MAP2;SNCA;TUBB4A;STMN2;STMN1;ARHGEF7
prerank,ceramide catabolic process (GO:0046514),0.588866261939988,1.2483345197975761,0.23278688524590163,0.8697818051504914,1.0,3/14,5.93%,ACER3;NAGA;HEXA
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.5811443853252858,1.2479988248664922,0.24715447154471545,0.8695599687016422,1.0,2/14,1.46%,ANK2;ATP1B1
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.42768808646882167,1.2476464389604802,0.15676359039190899,0.8693800140682092,1.0,27/87,14.79%,SMAD9;TGFB3;ITGB1;SMAD6;COL3A1;ADAM9;GDF5;GCNT2;BAMBI;BMPR1A;LTBP2;TGFBR1;TGFBR2;ID1;JUN;ITGB5;SKI;PARD3;ACVR1;TGFB2;RHOA;ZMIZ1;NLK;TGFBRAP1;SMURF1;ARHGEF18;AMHR2
prerank,positive regulation of intracellular protein transport (GO:0090316),0.4013884549866352,1.2472521456013765,0.11657142857142858,0.8693529334521211,1.0,45/144,21.35%,CDH1;TCF7L2;ABLIM3;NPEPPS;PRKCD;ZIC1;GSK3B;KCNB1;PLK3;CEP131;HCLS1;MAVS;BAP1;JUP;UBE2D3;PCM1;BCAS3;HPS4;SAR1B;ARIH2;UBR5;CSNK2A2;SFN;C2CD5;PPP3CC;RNF31;HSPA1L;RAN;SAE1;ITGB1BP1;DMAP1;FLNA;TCAF2;MAPK8;HUWE1;NMT1;CHP1;MIEF1;FIS1;BBC3;PIK3R2;EFCAB7;TGFB1;SH3GLB1;PRNP
prerank,heart looping (GO:0001947),0.4743505380763969,1.2468682702675846,0.19710144927536233,0.8692764136835719,1.0,6/40,8.03%,MICAL2;SMO;CCDC40;TGFBR2;STIL;GATA4
prerank,respiratory electron transport chain (GO:0022904),-0.5046142875733227,-1.2467425155371032,0.19548872180451127,0.6872551055361439,1.0,7/14,28.33%,SDHA;GPD2;PPARGC1A;SLC25A18;UQCRFS1;NDUFA5;ETFRF1
prerank,polyamine metabolic process (GO:0006595),0.5841133141887856,1.2465233125664914,0.24645390070921985,0.8690671563018588,1.0,2/13,7.47%,SMOX;HDAC10
prerank,axoneme assembly (GO:0035082),0.49379100164062173,1.246271229254588,0.20356612184249628,0.8685556114534716,1.0,7/31,11.55%,RP1;DNAAF3;CCDC40;SPEF1;SPAG17;RSPH6A;TOGARAM1
prerank,ceramide biosynthetic process (GO:0046513),-0.3875175929288356,-1.2452489647256728,0.15087719298245614,0.6895146967791403,1.0,7/40,5.20%,ST6GALNAC3;CERS4;ST8SIA4;SGMS1;DEGS2;ST8SIA6;SPTSSA
prerank,carbohydrate biosynthetic process (GO:0016051),0.5389448630289242,1.2449995709778088,0.2138157894736842,0.8716076060991712,1.0,2/21,1.51%,ST3GAL4;FUT8
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.4221713785599152,1.2447323203792753,0.1528117359413203,0.8711478030362929,1.0,21/95,10.77%,ST3GAL4;GPC6;EXT1;UST;DSE;HS3ST1;GLCE;GPC3;B3GNT2;GCNT2;CHST13;CHST5;HS6ST2;HEXA;GPC4;SLC10A7;B4GAT1;B4GALT1;NDST1;ABCC5;B4GALT7
prerank,regulation of signal transduction (GO:0009966),0.39381360505116425,1.2443423717304887,0.10831509846827134,0.8711383572507365,1.0,36/190,12.33%,RSPO3;PLCE1;TCF7L1;GRK5;SULF1;CD55;HHIP;GDF5;ELF1;ZIC1;MDFIC;MGLL;IGFBP5;SOCS2;GDNF;FRMPD1;CD80;NCK2;PLSCR1;SIK2;CLU;PTPN2;CREBBP;WWTR1;CASTOR2;TMEM237;CBFB;FUZ;USP33;CD46;GATA3;KCTD8;ACVR1;CSK;CD36;IGFBP6
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.41490941820516186,1.2441564632031055,0.1395617070357555,0.8703528582896549,1.0,18/114,15.37%,TNFRSF11B;CARD14;EDA;FOXO3;PTK2B;TNFRSF13B;TNFSF11;CHUK;TNFRSF4;TNFRSF1B;CDIP1;TNFRSF14;BIRC3;TRADD;TRAF5;PSMC6;ILK;TNFRSF13C
prerank,bile acid and bile salt transport (GO:0015721),-0.43137099437753074,-1.243123039817335,0.17478510028653296,0.6940277784605137,1.0,3/24,1.56%,SLCO2B1;NCOA1;SLCO1C1
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.5260210269605436,1.2428209950798161,0.215625,0.8736346709876383,1.0,10/25,19.74%,RNF185;VCP;UFD1;OMA1;UGGT2;UBE2W;YME1L1;LONP1;FBXL17;CLPP
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.5816708319413312,1.2425257801138774,0.23392857142857143,0.8732251102499441,1.0,3/12,8.63%,B3GNT2;B4GAT1;B3GNT6
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.47185776633157384,-1.2418457354077335,0.18796992481203006,0.6958909102165295,1.0,2/16,1.14%,SOX5;SOX6
prerank,mitochondrion localization (GO:0051646),0.5290055006066865,1.24157007057182,0.2266881028938907,0.8751739218771066,1.0,4/19,7.57%,MARK1;MEF2A;TLE6;MARK2
prerank,cell differentiation in hindbrain (GO:0021533),-0.5288343066004295,-1.2413974511246764,0.22602739726027396,0.6951598354875852,1.0,9/11,26.47%,OPHN1;GRID2;FAIM2;PROX1;ATP7A;KNDC1;LHX1;CBLN1;CEND1
prerank,cellular response to peptide hormone stimulus (GO:0071375),-0.30853838798913724,-1.2405975924779562,0.0949367088607595,0.6953987417115325,1.0,29/102,15.73%,TBC1D4;PIK3R1;ADCY5;SLC30A10;FOXO1;ADCY1;ENPP1;CPEB2;PRKAR2B;ADCY7;ADCY2;PRKACB;INSR;PRKAR1B;LPIN3;PARP1;MYO5A;PRKAR1A;SRC;INSIG2;LPIN1;CYSLTR2;ADCY4;RPS6KB1;PDE3B;AKT1;ADCY3;ADCY8;GSK3A
prerank,regulation of biomineral tissue development (GO:0070167),-0.41732451073677174,-1.2404272958064386,0.19020172910662825,0.6937358350915402,1.0,8/26,8.28%,ANKH;NOS3;ENPP1;NOTCH1;S1PR1;NOTUM;GAS6;HEY2
prerank,maintenance of protein location in nucleus (GO:0051457),-0.4414933958323408,-1.240327977970254,0.19337016574585636,0.6919035954000378,1.0,9/20,21.42%,ARL2BP;TAF3;BCL3;CHCHD10;SP100;TOPORS;SUN1;PARK7;HNRNPU
prerank,regulation of establishment of protein localization (GO:0070201),-0.4871079719735721,-1.240210484680875,0.19095477386934673,0.6900918446795418,1.0,9/14,33.72%,CORO2B;CEP120;CTSD;SCFD1;TREM2;DNAJA1;CEP135;CENPJ;PTP4A3
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.4436003249260696,1.2401270732767868,0.17205692108667528,0.8788898974535285,1.0,11/63,11.34%,BMP4;THBS1;TCF7L2;FGFR1;BIRC6;TGFBR1;ITGAV;BCL10;AGTR2;PAK2;ACVR1
prerank,T-helper cell differentiation (GO:0042093),0.5731100971738063,1.2401066208801068,0.22661870503597123,0.8775027940528533,1.0,1/14,0.32%,FOXP1
prerank,regulation of protein phosphorylation (GO:0001932),0.3862760401489841,1.2400710764156102,0.09528907922912205,0.876195614623076,1.0,20/256,5.02%,SLIT2;EGFR;BMP4;BMPER;PLCE1;SLCO3A1;CARD14;NTRK3;FN1;EFNA5;CCN1;LIMK2;KRAS;PLPP3;PGF;PID1;LRP6;ABL1;NIBAN1;PDGFA
prerank,ether lipid metabolic process (GO:0046485),0.5673780108910481,1.239378601536777,0.24196277495769883,0.8772141273082809,1.0,6/14,13.64%,NCEH1;PAFAH1B1;PEDS1;GNPAT;DHRS7B;AGPS
prerank,positive chemotaxis (GO:0050918),0.552865869245743,1.2393703446282356,0.21440536013400335,0.8757899381800749,1.0,2/17,7.71%,MET;NRP1
prerank,neuron maturation (GO:0042551),-0.4601996624010548,-1.2392779336204776,0.1813031161473088,0.690746047097629,1.0,9/18,36.31%,EPHA8;C1QA;APP;B4GALT5;ACTL6B;C3;RND1;SRRM4;CX3CL1
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.3738566961771456,1.2391123639021018,0.0525783619817998,0.8752632818437579,1.0,118/476,16.34%,CDH1;EGFR;BMP4;MAP3K5;ZFHX3;NFIB;SIX1;TGFB3;MLLT3;HDAC4;FOXO3;GLI3;ZBTB16;ESR2;WNT11;SHC1;INHBA;KLF4;LRP6;FOXK1;GDF6;IL10;PITX3;LHX2;KAT6B;ELF1;ZIC1;BAMBI;MDFIC;FZD7;EGR2;DDIT3;GATA1;CTCFL;FOXC2;TGFBR1;NFKB1;ZNF423;CD80;HNF4A;HNF1A;EP300;TFAP2A;FBXW11;TRIM44;TBL1X;CHUK;JUN;TASP1;FOXE1;HIVEP3;FGF2;TRIM45;TADA3;TGFB1I1;KAT2A;CREBBP;GLIS2;HES1;GATA4;TEAD1;CALCOCO1;BCL10;SMARCA4;CHEK2;NFYA;KAT5;FZD2;TCF3;SIX4;PPM1A;ATOH8;MED14;BRCA2;FOXK2;GATA3;QRICH1;NKX2-1;MYRFL;NIBAN2;PIM2;RNF10;IRF1;RGMB;ACVR1;USP22;USP21;ZMIZ1;REST;NFIL3;RXRA;STAT3;FOXC1;EHF;RNF111;CIITA;LRP5;ZXDC;FOXM1;CEBPB;TFE3;TRIM16;LBHD1;TFEB;CAMK4;ILK;TAF15;HCFC1;ELF4;XPC;MAP2K2;JMJD6;PML;PRMT2;ZNF711;MAP3K12;PAX6;ZNF496
prerank,negative regulation of cellular senescence (GO:2000773),-0.506679035562821,-1.2390547312425313,0.20466321243523317,0.6893443397156651,1.0,4/13,9.25%,SLC30A10;AKT3;CDK6;YBX1
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.46329391526414554,1.2389893972166626,0.20352781546811397,0.8742876830315984,1.0,4/48,5.09%,GUCY2C;SLC26A2;PAPSS2;ADCY9
prerank,keratan sulfate catabolic process (GO:0042340),-0.5216393345952599,-1.2389381764007865,0.22018348623853212,0.6875692201753352,1.0,6/11,18.16%,FMOD;OGN;LUM;OMD;PRELP;HEXB
prerank,glucose transmembrane transport (GO:1904659),-0.4623644668248691,-1.2385530552823474,0.2400990099009901,0.6865277369478732,1.0,6/18,20.34%,SLC2A1;SORT1;PPARD;SLC5A3;SLC45A1;SLC2A8
prerank,heart process (GO:0003015),0.5671670645218782,1.2384730000662398,0.25125628140703515,0.8746352078038894,1.0,2/14,5.96%,SGCD;TNNI3
prerank,protein ADP-ribosylation (GO:0006471),-0.40858079676989795,-1.2383889444204488,0.15363128491620112,0.6849454948222716,1.0,10/28,18.91%,PARP14;ART3;PARP8;PARP11;PARP1;TIPARP;PARP12;SIRT5;PARP16;HPF1
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.576295554669424,1.2378671187215822,0.2424778761061947,0.8754357630896478,1.0,3/13,4.37%,MGAT3;LARGE1;CHST5
prerank,glial cell development (GO:0021782),-0.42645492679494235,-1.2375962727534306,0.19832402234636873,0.6853401360079234,1.0,10/25,21.00%,CDK6;MDK;APP;MYRF;EIF2B5;NRROS;CSPG5;TPPP;SOX10;DLL1
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.42216843424860834,1.2374426935179048,0.1809169764560099,0.8755188062999001,1.0,17/86,7.71%,EGFR;PTK2B;CD44;EFNA5;BMP6;PRKCD;ITGA5;ABL1;GATA1;PDGFA;CD80;IL5;HCLS1;CNOT7;RAP2C;RIPK2;NRP1
prerank,regulation of cartilage development (GO:0061035),0.5336519897191294,1.2372288271964575,0.22741433021806853,0.8748316819696895,1.0,4/18,2.72%,BMP4;ZBTB16;WNT11;BMP1
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.5221243406678291,-1.2371053277294788,0.22823529411764706,0.6826263807095014,1.0,5/11,25.82%,CALM1;CALM3;CASQ2;FKBP1A;SRI
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.5221243406678291,-1.2371053277294788,0.22823529411764706,0.6826263807095014,1.0,5/11,25.82%,CALM1;CALM3;CASQ2;FKBP1A;SRI
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.5479771241731812,1.2368680008224244,0.232,0.8747356504565333,1.0,3/19,4.97%,SLC26A2;SULT1A1;PAPSS2
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.4928974717118806,1.2366879536133113,0.2147147147147147,0.8739235928370077,1.0,10/34,16.59%,DOCK5;ABL1;NRP1;LIMS2;DMTN;CDC42;TRIOBP;S100A10;ILK;FLNA
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.45104401669635497,1.2365776179652874,0.2070365358592693,0.8728708524419024,1.0,9/56,11.30%,EGFR;ANXA1;EIF4G1;CDC25B;ANAPC5;CDC16;RDX;RAD51C;RB1
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.49908526275468706,-1.235645650447066,0.21897810218978103,0.6848202675090206,1.0,6/13,24.10%,ELOVL7;ELOVL6;ELOVL4;TECRL;HACD3;HACD2
prerank,positive regulation of lipid transport (GO:0032370),-0.4980522835072457,-1.2354725741879256,0.21232876712328766,0.6833111685354443,1.0,4/12,14.05%,APOE;SPP1;DBI;ABCB4
prerank,negative regulation of actin filament polymerization (GO:0030837),0.5256823833178103,1.2352238733446628,0.21794871794871795,0.8763157092738577,1.0,3/22,3.64%,SLIT2;PRKCD;GSN
prerank,lipoprotein biosynthetic process (GO:0042158),-0.5181438514438945,-1.2351292388385984,0.23820754716981132,0.6822397753765632,1.0,4/11,10.02%,APOE;UGCG;WIPI1;PORCN
prerank,positive regulation of bone mineralization (GO:0030501),0.4837128937886121,1.235008427660507,0.20266272189349113,0.875647610378009,1.0,8/35,7.70%,BMP4;TGFB3;CCN1;BMP6;ANO6;BMPR1A;TFAP2A;NELL1
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.3955768821855409,-1.2349686514717495,0.1702127659574468,0.6806742610718606,1.0,9/33,5.83%,MCC;PTPRG;PTPRM;NR2F2;APOE;DCN;ADAMTS9;EVL;DAB2IP
prerank,cellular response to ketone (GO:1901655),-0.3921561038363659,-1.2349249848260864,0.18092105263157895,0.6787678878339216,1.0,8/35,9.09%,ADCY5;ADCY1;GNG2;AHR;ADCY2;PTGFR;SPP1;SRC
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.511069294720236,-1.2347143392924371,0.20048899755501223,0.6774286131794309,1.0,4/12,5.83%,UNC13C;RIMS1;RIMS2;SYT7
prerank,stress fiber assembly (GO:0043149),0.5665846787032552,1.2341945659329892,0.25084175084175087,0.8755919829171799,1.0,5/15,11.89%,PHACTR1;SORBS1;ITGB1;ITGB5;RHOA
prerank,contractile actin filament bundle assembly (GO:0030038),0.5665846787032552,1.2341945659329892,0.25084175084175087,0.8755919829171799,1.0,5/15,11.89%,PHACTR1;SORBS1;ITGB1;ITGB5;RHOA
prerank,regulation of mast cell degranulation (GO:0043304),-0.4840313751595394,-1.2341549148706061,0.20833333333333334,0.6771938865330303,1.0,5/14,16.35%,LYN;CD300A;CD84;FES;SYK
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.5468029229045257,1.2338818857758096,0.23275862068965517,0.8752740178500287,1.0,5/15,12.58%,VCP;NPLOC4;OS9;UFD1;FAF2
prerank,central nervous system development (GO:0007417),0.3806260425847378,1.2330307626409656,0.11332633788037776,0.8769727805668447,1.0,25/250,7.85%,SLC23A1;VIT;WWP1;PBX3;DCLK1;ZFHX3;PDGFC;SMO;NFIB;ZIC4;PKD1;ZBTB16;PBX1;ADGRL2;GSN;ZIC1;EGR2;NR4A2;BPTF;GRIN2C;TGFBR2;RAB18;ECRG4;NCKAP1;GLIS2
prerank,electron transport chain (GO:0022900),-0.4839347293693639,-1.2330193568243246,0.20147420147420148,0.678534055003781,1.0,8/15,28.33%,SDHA;PDIA5;PPARGC1A;CYB561;POR;UQCRFS1;NDUFA5;ETFRF1
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.5164186078046744,-1.23270338615395,0.2438423645320197,0.6774668769133796,1.0,4/10,10.88%,CST3;NOTCH1;TNFRSF1A;DPP4
prerank,regulation of regulated secretory pathway (GO:1903305),-0.39409796322294777,-1.2324534872980664,0.16510903426791276,0.6761989432154332,1.0,18/34,27.33%,RIMS1;RIMS2;SYT7;SYN1;SYT11;SYT12;SYT9;LRRK2;SYT13;RAB27A;RAB15;SYT15;SYT1;SNAPIN;SYT5;SYT17;RAB3A;SYT2
prerank,cellular response to organonitrogen compound (GO:0071417),0.4214934176501273,1.2318507398668717,0.18170731707317073,0.8796576823706329,1.0,16/99,11.08%,CDH1;SLIT2;EZR;CTNNA1;RAP1A;CAPN2;DIAPH1;IGFBP5;GOLPH3;P2RX4;JUP;DMTN;SLC26A6;MTOR;HTR1B;TAF1
prerank,regulation of DNA biosynthetic process (GO:2000278),0.4914521358915014,1.2311147855629212,0.219435736677116,0.8808310977366302,1.0,5/27,7.51%,SMOC2;PDGFA;SMG6;ATM;FGF2
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.477337392313687,-1.2305732129837976,0.20558375634517767,0.6798869357944657,1.0,5/14,20.06%,MOXD1;ALDH9A1;SLC22A2;NOS1;DAGLA
prerank,response to acidic pH (GO:0010447),0.5758454768552597,1.2302686354072716,0.24424778761061947,0.8824139454345518,1.0,3/13,12.17%,GPR4;PKD2L1;SLC9A1
prerank,neuron projection development (GO:0031175),-0.30287201242354056,-1.2300400112013326,0.06930693069306931,0.6796770391915951,1.0,56/168,17.99%,PTPRM;DOCK10;LYN;FRYL;SHANK3;APOE;ADGRV1;CNTNAP2;RAPGEF2;EPB41L3;GPM6A;PAK1;MAP2;TNIK;PLP1;NRK;BMP7;GRM7;EPHB1;GPM6B;CNTN4;STMN4;SGK1;DAB2IP;EPHA4;NYAP2;STMN3;MAP4K4;OPHN1;SH3GL2;LAMB1;MICALL1;EPHA8;LRRK2;RASGRF1;MAPT;UHMK1;MYOC;APP;CNTNAP1;UBB;SLC9A6;MYO16;TMEM108;ALS2;BLOC1S6;ATXN10;NCKAP1L;WASL;BLOC1S5;ATP7A;OMG;PRMT1;NTF3;STX3;WHRN
prerank,relaxation of muscle (GO:0090075),0.5751660447861179,1.2299815500492606,0.2813008130081301,0.8820617245764989,1.0,5/13,7.14%,KCNJ2;ATP1B1;CAMK2D;GSN;P2RX4
prerank,Golgi to endosome transport (GO:0006895),0.549792354546662,1.2293682903292322,0.24880382775119617,0.8828654890960218,1.0,8/16,18.73%,VPS13A;VPS13C;DOP1B;AP2A1;GBF1;AP4M1;CORO7;MON2
prerank,regulation of actin filament depolymerization (GO:0030834),-0.5058845312021751,-1.229086599493715,0.23569794050343248,0.680688299276697,1.0,2/12,8.53%,PLEKHH2;PLEK
prerank,histone acetylation (GO:0016573),0.4291523393094909,1.2289781917600144,0.18758085381630013,0.8828652211858995,1.0,26/69,18.84%,KAT6B;NAA40;SGF29;CPA4;TRRAP;EP300;TADA3;KAT2A;CREBBP;TAF6L;BRD1;KAT5;BRCA2;ZZZ3;TAF9;KAT2B;BRD8;TRIM16;TAF12;DMAP1;KAT14;EPC1;MORF4L2;ATF2;YEATS2;TADA1
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.39448211212247764,-1.2287317241968743,0.16025641025641027,0.6798349959215435,1.0,3/33,3.93%,IL34;LEF1;CSF1
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.48364997977282387,-1.2283689598771026,0.21481481481481482,0.6788421161285112,1.0,7/14,17.03%,NOS3;ACE;ENPEP;EDN1;EDN3;ACE2;CORIN
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.4368776766892969,-1.228228387152558,0.17223650385604114,0.6773294145555899,1.0,11/21,22.60%,DCN;UGDH;CSGALNACT1;CHST3;CHSY3;NCAN;CSPG5;CSPG4;CHSY1;VCAN;BGN
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.48976587363311525,1.2280546026461634,0.2323529411764706,0.8847487067757273,1.0,9/31,14.75%,SIX1;HOXA3;TGFBR1;TGFBR2;TFAP2A;FUZ;NOG;MEGF8;HOXB3
prerank,activin receptor signaling pathway (GO:0032924),0.5510563065696302,1.228028364537718,0.2425249169435216,0.8834385601759166,1.0,6/15,14.79%,INHBA;GDF6;TGFBR1;ACVR1;INHBB;AMHR2
prerank,response to cholesterol (GO:0070723),0.5456543847260832,1.227277360201145,0.2468354430379747,0.8847919479842237,1.0,5/17,9.05%,SMO;LRP6;TGFBR1;TGFBR2;GRAMD1C
prerank,regulation of keratinocyte migration (GO:0051547),0.5896310409528239,1.2269310797320192,0.25215889464594127,0.8846684494772453,1.0,3/12,10.44%,MAPRE2;ADAM9;MTOR
prerank,chloride transmembrane transport (GO:1902476),0.4494521786031509,1.2267145326671922,0.22251655629139072,0.8840573860624326,1.0,8/48,9.37%,SLC12A7;SLC12A2;SLC12A8;ANO6;GLRB;SLC4A8;GABRA3;ANO9
prerank,muscle cell differentiation (GO:0042692),-0.3941546377550679,-1.2264602228078558,0.1348973607038123,0.6805559364527821,1.0,13/32,10.71%,WNT5B;MRTFB;SGCZ;TMEM204;SPEG;TBX1;TBX18;MEF2C;HEY2;GATA6;MEGF10;NINJ1;MYOCD
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.47067232963914035,-1.225844870560818,0.19618528610354224,0.6803280708383302,1.0,10/16,24.93%,ARHGAP24;AUTS2;STMN3;RASGRF1;GABARAP;ALS2;KBTBD7;ARF6;PIK3CG;PIK3CB
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.5354430679574163,1.2255852269945624,0.2492063492063492,0.8865933910320071,1.0,3/20,1.61%,HOXA5;PTK2B;ZBTB16
prerank,negative regulation of interleukin-1 beta production (GO:0032691),-0.45208279384067707,-1.2247432474487785,0.20765027322404372,0.6816786473432103,1.0,4/19,19.13%,IGF1;CX3CR1;TNFAIP3;GIT1
prerank,response to prostaglandin E (GO:0034695),-0.532628747337385,-1.2246474893006773,0.2460136674259681,0.680001944560578,1.0,2/10,2.79%,TGFBR3;GNG2
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.3956824788271914,-1.224458282494147,0.18122977346278318,0.6786773931913074,1.0,12/34,18.93%,LYN;MFHAS1;LGR4;DAB2IP;GPS2;TLR3;CD300A;LRRC14;TNFAIP3;TYRO3;GRAMD4;SMPDL3B
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.45710111290477307,-1.223867511878349,0.23421052631578948,0.6784296793991537,1.0,7/17,6.53%,NOTCH3;MAML2;MAML3;NOTCH1;PLXND1;NOTCH4;RBPJ
prerank,positive regulation of actin filament polymerization (GO:0030838),0.46777907888560044,1.222617572799354,0.22298221614227087,0.8960540262676051,1.0,10/44,13.61%,BAIAP2L1;PTK2B;CDC42EP5;GSN;NCK2;FCHSD1;NCKAP1;PRKCE;CTTN;FCHSD2
prerank,positive regulation of locomotion (GO:0040017),0.4952319857058414,1.22239442080301,0.24279210925644917,0.8954326966137826,1.0,2/27,0.98%,THBS1;NTN1
prerank,response to fatty acid (GO:0070542),0.5488469612185175,1.2221940423946482,0.2613065326633166,0.8947624474553119,1.0,6/17,13.00%,FOXO3;PID1;IRS1;SCD;CD36;PPP5C
prerank,negative regulation of autophagy (GO:0010507),0.45123855741792523,1.222116145888016,0.20794701986754968,0.8936038278832128,1.0,15/54,12.74%,MET;EIF4G3;DAPL1;EIF4G1;FOXK1;IL10;KLHL22;TAB3;SMG1;SMCR8;FOXK2;MTOR;WASHC1;STAT3;HTR2B
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.5261230142038408,-1.221834545731817,0.23708920187793428,0.6822518599947945,1.0,5/11,16.54%,LYN;MFHAS1;CYBA;TNFAIP3;TIRAP
prerank,regulation of cellular component movement (GO:0051270),0.4501537431117011,1.2210180448229067,0.21837549933422104,0.8961937444449397,1.0,8/49,6.13%,EGFR;ARAP1;CD9;DIAPH1;ABL1;TGFBR1;MYCBP2;MEMO1
prerank,regulation of JNK cascade (GO:0046328),-0.31260173021303966,-1.2208804472626542,0.0963855421686747,0.6830752892075831,1.0,24/101,11.27%,PLCB1;MECOM;IGF1R;PHLPP1;TGFBR3;TNFRSF19;MFHAS1;SH3RF1;TPD52L1;RAP2A;CCN2;MTURN;EPHB1;DAB2IP;MAP4K4;SDCBP;GPS2;SIRPA;SH3RF3;FLT4;DUSP3;ANKRD6;MAP3K10;APP
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.4320291248423776,1.220528556146962,0.19382716049382717,0.8964669367783328,1.0,18/76,13.68%,BAIAP2L1;NTRK3;SORBS3;PTK2B;CDC42EP5;ABL1;NCK2;FCHSD1;HCLS1;NRP1;NCKAP1;WDR1;BCAS3;CDC42;PRKCE;CTTN;FCHSD2;KATNBL1
prerank,regulation of cytoskeleton organization (GO:0051493),0.4069719410698923,1.220231112962976,0.1773220747889023,0.8961610478504993,1.0,31/108,15.22%,CLIC4;SORBS3;EFNA5;EZR;PHLDB2;PRKCD;ARHGAP44;FAM107A;CAPN2;GSK3B;DIAPH1;ABL1;CAPN6;PDGFA;ARHGEF5;MARK2;IQGAP1;SPEF1;RHOQ;MLST8;DMTN;MTOR;RHOBTB1;PAK2;RHOA;MAPK1;KATNBL1;LRP1;ARHGAP17;RND3;PRKAA1
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.6030670684798608,1.2196013484498347,0.26480836236933797,0.8969587103272992,1.0,4/10,15.67%,RARB;RARG;RXRA;SNW1
prerank,ganglion development (GO:0061548),0.6077912124754024,1.21902193530795,0.26545454545454544,0.8976515171004549,1.0,3/11,16.85%,UNC5C;NRP1;FZD3
prerank,negative regulation of endopeptidase activity (GO:0010951),-0.36998938273483495,-1.2187145702669362,0.17518248175182483,0.6874274123286929,1.0,8/47,9.45%,VTN;TIMP3;SPOCK2;SERPINI1;GAPDH;SPOCK3;SERPIND1;SPOCK1
prerank,embryonic organ morphogenesis (GO:0048562),0.4533241720256488,1.2186620222410853,0.21540656205420827,0.8975716509963365,1.0,10/42,11.91%,SIX1;MFAP5;HOXA3;EFEMP1;RARG;FOXE1;HES1;FUZ;ACVR1;MEGF8
prerank,regulation of viral entry into host cell (GO:0046596),-0.39691654347640715,-1.2186234294086336,0.17403314917127072,0.6857545816877156,1.0,12/30,18.10%,LY6E;TRIM14;TRIM62;IFITM1;LGALS1;HS3ST5;NECTIN2;IFITM3;TRIM21;TRIM27;CD74;TRIM6
prerank,positive regulation of keratinocyte migration (GO:0051549),0.6084883329115823,1.2181185004675867,0.24347826086956523,0.8980713791150464,1.0,3/10,10.44%,MAPRE2;ADAM9;MTOR
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.5461837810315443,1.217205895989477,0.2747826086956522,0.8998644033036387,1.0,3/15,4.37%,MGAT3;LARGE1;CHST5
prerank,peroxisomal membrane transport (GO:0015919),0.5034569310966591,1.2169709002781173,0.24648985959438377,0.899280623994366,1.0,11/27,24.26%,ABCD3;PXMP2;SLC25A17;PEX2;ACBD5;PEX12;FIS1;PEX16;PEX7;PXMP4;PEX13
prerank,synaptic membrane adhesion (GO:0099560),0.5523395616163133,1.2168261129121967,0.2601054481546573,0.8983564039587603,1.0,3/14,9.14%,GPC6;GPC4;PTPRF
prerank,protein localization to organelle (GO:0033365),0.39440600880557963,1.216359070377734,0.1530373831775701,0.8986864389589339,1.0,24/133,12.85%,BMP4;SIX1;ANK2;BBS9;CSRP3;CNTLN;LMNA;STX5;TOR1AIP1;DDRGK1;RAB6A;ZNF423;GAK;ARL3;CNEP1R1;VAPA;SIX4;IFT122;RPA1;FAM83H;EHD1;PAF1;XPA;COG3
prerank,cellular response to alcohol (GO:0097306),0.4604981318613271,1.2161415280434937,0.21164772727272727,0.8980464132401096,1.0,9/42,9.05%,CDH1;SMO;CTNNA1;LRP6;GOLPH3;KLF9;JUP;PTGER2;GRAMD1C
prerank,relaxation of cardiac muscle (GO:0055119),0.5718983486234708,1.2160616098748078,0.27684563758389263,0.8969448025835624,1.0,5/13,7.14%,KCNJ2;ATP1B1;CAMK2D;GSN;P2RX4
prerank,cellular response to metal ion (GO:0071248),0.4015995687280857,1.2158972109928328,0.1876484560570071,0.8961276985569009,1.0,16/123,9.56%,CDH1;EGFR;SLC12A2;CLIC4;CAMK2D;BMP6;MEF2A;SYT8;TFAP2A;CHUK;JUN;P2RX4;IQGAP1;CDKN1B;CARF;DMTN
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.5353969600226525,1.2158365249275709,0.25833333333333336,0.8949300584386236,1.0,2/18,2.01%,STK39;CAMK2D
prerank,regulation of sprouting angiogenesis (GO:1903670),0.48036882432799777,1.2157897603146104,0.20485584218512898,0.8937066667481102,1.0,5/33,3.99%,BMPER;THBS1;RHOJ;KLF4;ITGA5
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.4248330275473674,1.2155035681842954,0.2144702842377261,0.8933852638671114,1.0,19/74,13.60%,BMP5;TGFB3;PHLDB2;GCNT2;BAMBI;SPRED2;TGFBR1;TGFBR2;TGFB1I1;WWTR1;IL17RD;FOXA1;GATA3;MTOR;NKX2-1;BCL9L;TGFB2;FOXC1;LDLRAD4
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),-0.31896272795564584,-1.2151644704029538,0.09813084112149532,0.6943770541313519,1.0,44/87,30.79%,NDUFA8;NDUFB3;COX17;NDUFS4;NDUFA6;IMMP2L;SCO1;PET100;NDUFS3;NDUFA12;NDUFC2;NDUFS2;NDUFAF4;NDUFB7;NDUFA1;COX20;NDUFB8;NDUFA3;UQCC2;NDUFB9;COX18;NDUFB4;TIMMDC1;SDHAF3;NDUFAF8;COA3;SLC25A33;NDUFS5;NDUFC1;CHCHD4;NDUFA10;SDHAF2;NDUFB11;UQCRFS1;NDUFA9;NDUFA5;NDUFS6;NDUFA11;SDHAF1;DMAC1;NDUFS1;TMEM126A;NDUFA2;BCS1L
prerank,ether lipid biosynthetic process (GO:0008611),0.6011444625286059,1.2150225281933893,0.2869718309859155,0.8937610405742514,1.0,7/10,23.44%,PEDS1;GNPAT;DHRS7B;AGPS;PLA2G4A;PEX7;FAR1
prerank,determination of heart left/right asymmetry (GO:0061371),0.4577061057291783,1.2148046506588281,0.21164772727272727,0.8931630964515624,1.0,6/43,8.03%,MICAL2;SMO;CCDC40;TGFBR2;STIL;GATA4
prerank,positive regulation of response to wounding (GO:1903036),-0.4185463298310693,-1.2147666032524183,0.1917808219178082,0.6936718129327101,1.0,9/24,10.33%,VTN;MYLK;OCLN;PTK2;GRN;ADRA2A;MDK;CLDN1;HBEGF
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.4351483978310112,1.2146542281555401,0.21646746347941567,0.892294573526036,1.0,19/66,21.05%,CDH1;LIMK2;PRKCD;ZIC1;HCLS1;MAVS;JUP;WWTR1;EIF2AK3;UBR5;RAN;TCP1;DMAP1;FLNA;PINX1;PIK3R2;MEPCE;EFCAB7;TGFB1
prerank,protein localization to Golgi apparatus (GO:0034067),0.495821728615548,1.2142703660422303,0.2470059880239521,0.8922707684901299,1.0,10/27,17.61%,VPS13A;VPS13C;RAB6A;GOLPH3;GAK;ZDHHC15;VPS13D;CSNK1D;GBF1;ARL1
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),-0.5042493033982678,-1.2140554707842408,0.22954545454545455,0.6938882449884037,1.0,8/11,27.95%,MERTK;CXCL12;GAS6;CCL19;IRF7;AXL;SELENOS;LILRB1
prerank,negative regulation of programmed cell death (GO:0043069),0.3690889884194839,1.213955315424434,0.12037037037037036,0.8920429728802101,1.0,41/355,7.24%,EGFR;BMP4;THBS1;MET;FSTL1;GRK5;CARD14;NGF;ARHGAP10;ANXA1;PTK2B;CD44;TCIM;WNT11;SHC1;TAX1BP1;SMAD6;IL10;BIRC7;ANXA4;GSK3B;NOTCH2;RIPK3;ARF4;GCLC;GATA1;SOCS2;DDRGK1;BIRC6;GDNF;NFKB1;DNAJC3;GOLPH3;KANK2;SERPINB9;TFAP2A;ERC1;PLK3;SON;STIL;RIPK2
prerank,embryonic heart tube morphogenesis (GO:0003143),0.45665572466893906,1.2139428671232493,0.22093023255813954,0.8907342881201354,1.0,9/44,11.91%,MICAL2;SMO;CCDC40;TGFBR2;STIL;HES1;GATA4;ACVR1;MEGF8
prerank,cell junction maintenance (GO:0034331),-0.4905461548800865,-1.2139176096213975,0.2506393861892583,0.6923572716366204,1.0,9/14,34.65%,CLDN1;MYADM;CHCHD10;CSF1R;NLGN2;CBLN1;PRTN3;PARD6A;F2R
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.5877134196619694,1.2136828713868826,0.27580372250423013,0.8903244168254077,1.0,2/10,2.98%,BMP5;LRP6
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.5506776178471321,1.2135098322907476,0.2628099173553719,0.8896011489164666,1.0,6/16,15.86%,DDX5;RSRC1;SRSF6;DDX17;DHX9;SCNM1
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.4593150380945543,1.213037147998111,0.20741758241758243,0.8898545698655005,1.0,2/48,0.15%,SLIT3;SLIT2
prerank,negative regulation of lipid storage (GO:0010888),-0.4627334620637401,-1.212947938326053,0.2178477690288714,0.6933615209804675,1.0,5/19,5.06%,OSBPL8;PPARA;ABCA1;PPARD;NR1H3
prerank,phospholipid metabolic process (GO:0006644),0.4222976268457159,1.2128302836677636,0.1939924906132666,0.889222507772457,1.0,16/71,18.17%,PLPPR2;TNFAIP8L3;PLPP3;PNPLA3;PIP5K1A;PLA2G4F;PLCD1;PLPP1;FDFT1;GNPAT;LCAT;AGPAT4;PLA2G4A;PLA2G15;AGPAT5;MBOAT1
prerank,regulation of cytokinesis (GO:0032465),0.42056058930809365,1.2127354684036151,0.1855541718555417,0.8882000670231106,1.0,18/78,12.45%,KIF13A;CIT;GIPC1;KLHL13;CDC25B;BIRC6;BECN1;PKP4;PLK3;RAB11FIP3;ENTR1;ZFYVE26;PKN2;CDC42;DRD3;SETD2;RHOA;PRKCE
prerank,negative regulation of hydrolase activity (GO:0051346),-0.35738157779942753,-1.2125829568030866,0.12307692307692308,0.6926182650919332,1.0,15/49,17.43%,CPEB2;F11R;MAP2;CST3;GPSM1;GMIP;LRCH1;DAB2IP;LRRK2;CAMK2A;EGLN1;SH3BP4;RASA4;NOS1;SH2D4A
prerank,sensory perception of light stimulus (GO:0050953),0.4191387882010049,1.2125710610259641,0.19201995012468828,0.887422087376707,1.0,17/87,19.44%,SLC4A10;PITPNA;EFEMP1;EYA4;EYA3;CRYBG3;MYO9A;DNAJC19;IMPG2;PAX6;POU6F2;ATF6;ARR3;WFS1;TULP2;COL11A1;OAT
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.4524002384153789,-1.2120139779380656,0.21842105263157896,0.6923800521984531,1.0,11/18,33.76%,RUVBL1;CCT5;RUVBL2;DCP2;CCT2;SHQ1;EXOSC10;NOP10;DKC1;NHP2;CCT8
prerank,regulation of cell migration (GO:0030334),0.36768183907677565,1.2119171919098992,0.09118852459016394,0.8883184830948292,1.0,53/382,8.45%,CDH1;SLIT2;EGFR;F3;THBS1;TMEFF2;CLIC4;DPYSL3;PDGFC;NTRK3;PHACTR1;SMO;ANXA1;FOXO3;PTK2B;SEMA3D;CYP1B1;SULF1;SEMA3C;PPP3CA;CCN1;PTPRU;LMO4;ITGB1;WNT11;SEMA3E;MGAT3;ADAM9;FAM107A;GCNT2;LMNA;SGK3;IGFBP5;DDRGK1;PDGFA;ZMYND8;TGFBR1;SYNE2;TWIST2;VCL;SERPINE2;MMP14;TRIP6;PLXNA2;FGF22;JAG1;RAP2C;ATM;FGF2;DUSP10;ADAM10;SRGAP2;SRGAP3
prerank,regulation of feeding behavior (GO:0060259),-0.5152188161996817,-1.2115976358614964,0.2505800464037123,0.6917053514703055,1.0,2/11,1.35%,LEPR;SGIP1
prerank,response to ethanol (GO:0045471),-0.48002823536951633,-1.211111443238731,0.2576832151300236,0.6911655947596397,1.0,7/14,13.31%,ADCY7;GRIN2A;GRIN2B;GRIN3A;GLRA1;SDF4;GRIN1
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.5091996065047654,1.21079094291931,0.24345146379044685,0.8895984366647611,1.0,9/23,16.96%,THBS1;GIPC1;EP300;TGFB1I1;CREBBP;RNF111;STK11;SNW1;CITED2
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.5091996065047654,1.21079094291931,0.24345146379044685,0.8895984366647611,1.0,9/23,16.96%,THBS1;GIPC1;EP300;TGFB1I1;CREBBP;RNF111;STK11;SNW1;CITED2
prerank,protein methylation (GO:0006479),0.466132516560405,1.2107477404789149,0.21982758620689655,0.8884547900540767,1.0,16/40,20.93%,CTCFL;RAB6A;METTL22;ETF1;METTL21C;EHMT2;EHMT1;SNRPD3;CARM1;PRMT6;PRMT2;GSPT1;EEF1AKMT1;CAMKMT;PRMT8;METTL21A
prerank,protein insertion into membrane (GO:0051205),0.47196922042584605,1.210490363979464,0.2413793103448276,0.8880574380254144,1.0,2/32,4.53%,EGFR;STX5
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.4199045327307368,1.2103767282716786,0.2186287192755498,0.8871196034537289,1.0,13/77,11.42%,BMP4;THBS1;TCF7L2;NR4A2;BIRC6;TGFBR1;CLU;ITGAV;GATA4;RB1;ACVR1;CSNK2A2;CSNK2A1
prerank,positive regulation of binding (GO:0051099),0.4151487360550587,1.2101356957472038,0.19777503090234858,0.8867073875195075,1.0,20/84,14.62%,BMP4;MET;TCF7L2;NGF;PKD1;GSK3B;BAMBI;RIPK2;IDE;HES1;USP33;SKI;MARK3;TAF1;KDM4D;FOXC1;ADD1;DDX11;LRP1;RAN
prerank,peptidyl-proline modification (GO:0018208),0.5078025236788125,1.210017980240501,0.25920245398773006,0.8857803395245021,1.0,2/25,2.37%,FKBP5;P3H2
prerank,negative regulation of biomineral tissue development (GO:0070168),-0.425476131056332,-1.2099251743097525,0.20347394540942929,0.6929153282537799,1.0,8/21,10.43%,NOS3;ENPP1;NOTCH1;SRGN;ASPN;GAS6;HEY2;BCOR
prerank,cell projection assembly (GO:0030031),0.513345495265341,1.2097581849804964,0.2462809917355372,0.8853758228800175,1.0,7/22,10.90%,PARVA;RHOJ;GSN;PDGFA;NCKAP1;RHOQ;CDC42
prerank,cellular response to interleukin-2 (GO:0071352),0.5814494484296708,1.209681840671812,0.2727272727272727,0.8830201082436437,1.0,2/11,2.46%,PTK2B;SHC1
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.5814494484296708,1.209681840671812,0.2727272727272727,0.8830201082436437,1.0,2/11,2.46%,PTK2B;SHC1
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.36054762161894854,1.2092514801365892,0.031031031031031032,0.8833014900460247,1.0,208/834,18.18%,EGFR;MICAL2;BMP4;KLF5;MET;SMAD9;RARB;ZFHX3;ZFPM2;TCF7L2;BMP5;PLAGL1;NFIB;SIX1;PKD1;HOXA5;TGFB3;HDAC4;FOXO3;GLI3;PBX1;PPP3CA;CCN1;GRHL1;NFIA;CSRP3;NFAT5;NR2F1;INHBA;BMP6;ISL1;KLF4;PID1;LRP6;MYOG;IL10;PHOX2A;KAT6B;ELF1;DCAF6;MEF2A;ABL1;MEOX2;ZFP64;EGR2;BMPR1A;DDIT3;CEBPZ;ARF4;NFE2L2;GATA1;KLF7;CTCFL;ZBED4;NR4A2;E2F5;DDRGK1;TCF20;FOXC2;GDNF;ATF1;NR4A3;NFKB1;NCK2;BPTF;PLSCR1;TNFSF11;GLIS1;HNF4A;HNF1A;BCLAF1;RARG;FOXD2;EP300;TFAP2A;HCLS1;MLLT10;JAG1;CAMTA2;TBL1X;MAVS;CHUK;JUN;RIPK2;ATM;KLF10;FGF2;KDM1A;KAT2A;CREBBP;GLIS2;JUP;HES1;CREB3L3;WWTR1;ETV5;GATA4;TEAD1;TAF6L;RHOQ;CALCOCO1;ZNF462;SMARCA4;TCERG1;KAT5;PAXBP1;THAP3;TCF3;NFKB2;E2F3;BCL11B;ATOH8;MED14;SKI;BCAS3;SSBP3;FOXA1;MRTFA;FOXK2;PRDM15;GATA3;NKX2-1;HDAC8;GABPB1;GABPB2;SLC30A9;BCL9L;PPP1R12A;RBMX;RNF10;IRF1;ACVR1;TLR4;ASXL2;SQSTM1;ZNF507;TGFB2;ZBTB49;ZMIZ1;TAF9;MYSM1;REST;SLC9A1;RXRA;STAT3;FOXC1;EHF;RNF111;GALR1;RFX5;KAT2B;LPIN2;CIITA;LRP5;BRD8;KMT2C;REL;DDX17;FOXM1;GLYR1;CEBPB;ZNF76;COPS5;MAP2K5;TFE3;KMT2D;TFEB;HOXB3;HTATIP2;CDK12;NRIP1;AATF;NAMPT;HCFC1;SBNO2;ELF4;ITGB1BP1;SNW1;JMJD6;DHX9;ZBTB18;CREBRF;PAX6;PRKDC;NFIX;ATRX;MED17;EAF2;CSRNP2;RORA;NR4A1;CITED2;LDB2;LDB1;ZNF513;STAT6;EPC1;KDM6B;ATF2;YY1;AR;E2F2;ATF6;ZMIZ2;ELF3;CSRNP1;INO80;TNIP1
prerank,neurotransmitter uptake (GO:0001504),-0.48800833695060264,-1.209202668081946,0.2429245283018868,0.6932809468069506,1.0,2/12,0.19%,ATP1A2;SLC1A3
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.4960018139822754,1.2089036387050294,0.25,0.8831621129493917,1.0,6/23,12.58%,VCP;NPLOC4;OS9;SEC13;UFD1;FAF2
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.5189793879422753,1.2087691017953826,0.24569640062597808,0.8823094223089867,1.0,1/21,0.15%,SLIT2
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.5862292395504446,1.2085536871257014,0.28114478114478114,0.8816953096338418,1.0,1/12,0.28%,F3
prerank,heart trabecula morphogenesis (GO:0061384),-0.44614585846014704,-1.208074859738312,0.24345549738219896,0.6948453954359671,1.0,8/18,6.53%,ENG;TGFBR3;TEK;RBP4;NOTCH1;BMP7;S1PR1;RBPJ
prerank,response to retinoic acid (GO:0032526),-0.3399210195776935,-1.2072678521662803,0.15765765765765766,0.6954131103399424,1.0,11/59,4.89%,LYN;WNT5B;WNT6;RBP4;ACER2;WNT5A;CTSH;PTK7;SETX;BRINP3;TBX1
prerank,sodium ion export across plasma membrane (GO:0036376),0.5620242907784534,1.2069341732200596,0.26405451448040884,0.8859117069623029,1.0,2/13,1.46%,SLC4A4;ATP1B1
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),-0.4381757858196994,-1.2060912274390245,0.22764227642276422,0.6970346823817664,1.0,7/23,13.72%,IGF1;EFNB2;PIEZO1;MEF2C;EDN1;MYOCD;PROX1
prerank,positive regulation of interleukin-8 production (GO:0032757),0.4536046824846751,1.2060569816433064,0.21978021978021978,0.8875265506475281,1.0,7/49,12.38%,F3;LBP;DDIT3;MAVS;BCL10;TLR4;STAT3
prerank,regulation of histone deacetylation (GO:0031063),0.5660791642928602,1.2059691294802333,0.26885245901639343,0.8865364687280364,1.0,2/13,3.83%,CAMK2D;ZBTB7B
prerank,negative regulation of signal transduction (GO:0009968),0.37582835179799823,1.2058840728976907,0.14331550802139037,0.8855168040087749,1.0,45/249,12.25%,EGFR;THBS1;TRABD2B;NXN;NTN1;BMP5;GLI3;SULF1;LRPAP1;NEDD4;TCIM;GRB10;HHIP;GPC3;WWP2;PRKCD;PALM;PID1;IL10;NR4A2;IGFBP5;VCP;KANK2;IRS1;MMP14;PTPN2;FGF2;TSKU;GLIS2;GATA4;AGTR2;GPR108;SULF2;GATA3;IFT122;NIBAN2;HERC4;NOG;RB1;ACVR1;CSNK2A2;CSNK2A1;MEGF8;NLK;KIF7
prerank,positive regulation of apoptotic process (GO:0043065),0.37082937463899834,1.2047091693783751,0.12668743509865005,0.8882040698761202,1.0,47/293,12.40%,SLIT2;BMP4;MAP3K5;RASSF2;NGF;HOXA5;TGFB3;FOXO3;CYP1B1;AKAP13;PAWR;PTGIS;ITGB1;ANO6;IP6K2;ABL1;DDIT3;TIAM2;ARHGEF6;CALHM2;TGFBR1;DIABLO;TRIO;CRADD;ARHGEF5;BCLAF1;RARG;CLU;TFAP2A;VAV2;JUN;ATM;BCL10;UNC13B;BCL6;MOAP1;GNA13;ERCC3;FOXA1;QRICH1;UBE2Z;AIFM2;OMA1;SQSTM1;TGFB2;REST;BNIP3
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.5758506340587727,1.2046091555055172,0.2643884892086331,0.887265893777665,1.0,2/11,9.37%,EZR;RDX
prerank,positive regulation of programmed cell death (GO:0043068),0.3723414972890924,1.2041265765385951,0.12434691745036573,0.8877324758631694,1.0,42/272,12.40%,SLIT2;BMP4;MAP3K5;RASSF2;NGF;HOXA5;TGFB3;FOXO3;CYP1B1;AKAP13;PAWR;ITGB1;ANO6;IP6K2;ABL1;TIAM2;ARHGEF6;CALHM2;DIABLO;TRIO;CRADD;ARHGEF5;BCLAF1;RARG;CLU;VAV2;JUN;ATM;BCL10;UNC13B;BCL6;MOAP1;GNA13;ERCC3;FOXA1;QRICH1;UBE2Z;AIFM2;OMA1;SQSTM1;REST;BNIP3
prerank,positive regulation of p38MAPK cascade (GO:1900745),-0.42232747157187583,-1.2036401091107591,0.20224719101123595,0.7023236063686668,1.0,4/22,9.28%,SASH1;MFHAS1;BMP2;SPHK1
prerank,response to X-ray (GO:0010165),0.5537338182297651,1.2035104354357689,0.29572649572649573,0.888592461370005,1.0,3/14,13.21%,ANXA1;ATM;XRCC5
prerank,regulation of cell cycle (GO:0051726),0.3717913784099184,1.2034027091095034,0.12174817898022892,0.8877046933890359,1.0,58/271,17.21%,BMP4;THBS1;GRK5;TCF7L2;PLAGL1;PKD1;INHBA;LRP6;NEK7;MYOG;BIRC7;NOTCH2;PDCD4;ABL1;TTC28;TGFBR1;EP300;TGM1;SON;JUN;ATM;TXLNG;BAP1;IQGAP1;ADAM10;CDKN1B;FBXL6;PER2;GATA3;UHRF2;PIM2;IRF1;CHEK1;RB1;CSNK2A2;CSNK2A1;TGFB2;ZBTB49;STAT3;BIRC3;KAT2B;FOXM1;THAP1;CDKN2D;STK11;PUM1;TMEM8B;HCFC1;PRKACA;PML;PRCC;CDKN3;NR4A1;FZD9;CITED2;GBF1;WHAMM;GADD45G
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.36368778030566534,1.2032598590565522,0.09773662551440329,0.8869263124396355,1.0,79/417,13.37%,FOXP2;BMP4;FOXP1;WWP1;ZFPM2;TCF7L2;FOXN3;FOXD1;HDAC4;GLI3;ZBTB16;RBFOX2;WNT11;SHC1;WWP2;HDAC9;CRY2;KLF4;FOXK1;RCOR3;KAT6B;L3MBTL3;BTAF1;MDFIC;PDCD4;ZNF148;DDIT3;ARID4A;GCLC;ATP8B1;ZNF423;ID4;SCMH1;TWIST2;HNF4A;ID1;BCLAF1;PRICKLE1;TFAP2A;MBTD1;FBXW11;CNOT7;JUN;FOXE1;KLF10;HDAC10;KDM1A;BAP1;GLIS2;BHLHE40;HES1;PHC2;TNFRSF4;SMARCA4;CDKN1B;KAT5;BCL6;SIX4;PER2;ATOH8;MBD1;FOXK2;GCFC2;GATA3;PHF12;NKX2-1;NIBAN2;IRF1;RB1;TLE2;USP47;REST;NFIL3;SPINDOC;ZBTB4;CIITA;XRCC5;CIPC;EHMT1
prerank,sphingosine metabolic process (GO:0006670),0.5416955442417011,1.2028768758728912,0.27712854757929883,0.886933351704569,1.0,2/17,2.51%,ACER3;PLPP3
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.567673829559416,1.2027491299428201,0.2582322357019064,0.8835514958486955,1.0,4/12,13.82%,ANAPC5;CDC16;RB1;NSMCE2
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.567673829559416,1.2027491299428201,0.2582322357019064,0.8835514958486955,1.0,4/12,13.82%,ANAPC5;CDC16;RB1;NSMCE2
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.567673829559416,1.2027491299428201,0.2582322357019064,0.8835514958486955,1.0,4/12,13.82%,ANAPC5;CDC16;RB1;NSMCE2
prerank,myelination in peripheral nervous system (GO:0022011),0.5633174645048835,1.2026558029186691,0.2775862068965517,0.8825725736587539,1.0,4/13,10.75%,ADGRG6;ARHGEF10;SKI;PARD3
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.36680737794343926,1.2020138786833319,0.12447698744769875,0.8835751572200724,1.0,85/327,19.19%,BNC2;VSX1;TCF7L1;ZFHX3;PRRX2;FOXN3;SIX1;ESR2;NFIA;USP13;EFEMP1;PITX3;IGSF1;KAT6B;FZD7;ABL1;DDIT3;CRABP2;TGFBR1;JMJD1C;ZNF423;TRRAP;EP300;ERC1;HCLS1;HDAC10;CREBBP;BHLHE40;FUS;WWTR1;GATA4;TAF6L;CHEK2;NFYA;CTR9;HMG20A;TCF3;NFKB2;GON4L;BRCA2;FOXK2;GPBP1L1;GCFC2;ZNHIT3;PHF12;RB1;ZBTB11;ZMIZ1;REST;NLK;NFIL3;STAT3;FOXC1;BAZ2A;ASCC1;ZBTB4;CEBPB;TGFBRAP1;SOX21;THAP1;KMT2D;GTF2IRD1;CARM1;TFEB;ATF7;HCFC1;SBNO2;PML;PCGF1;ATRX;SERTAD3;SAP30;RORA;LDB1;ACTR8;ATF2;CREBL2;POU6F2;SRRT;REXO4;CREM;SPIN4;NUP107;ZFAT;SP3
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.4959422666117873,1.2019543180475443,0.2589147286821705,0.8825396143201313,1.0,2/26,1.67%,ACER3;CYP1B1
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.5516792081880073,1.2018411544049847,0.26182432432432434,0.8816719361229656,1.0,3/14,4.49%,ATP1B1;WNK1;DMD
prerank,regulation of neuroinflammatory response (GO:0150077),-0.44015073312710457,-1.2014996008727608,0.22727272727272727,0.706911299459617,1.0,9/19,28.42%,IGF1;IL18;SPHK1;DAGLA;NUPR1;PTGS2;CD200;TREM2;MMP3
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.3573520744135458,1.2014348262992318,0.007,0.8818294007875612,1.0,349/1667,16.55%,FOXP2;EGFR;ZBTB7C;BMP4;FOXP1;MKX;KLF12;NR3C2;PBX3;KLF5;SLTM;MET;TFCP2L1;SMAD9;RARB;TCF7L1;ZFHX3;ZFPM2;TCF7L2;PRRX2;BMP5;TBX15;PRDM6;PLAGL1;NFIB;ZIC4;ZFHX4;SIX1;PKD1;HOXA5;TGFB3;FOXD1;HDAC4;FOXO3;DDX5;GLI3;ZBTB16;EZR;PBX1;ESR2;PPP3CA;CCN1;CAMK2D;GRHL1;NFIA;CSRP3;KLF3;NFAT5;NR2F1;INHBA;BMP6;WWP2;HDAC9;ISL1;CRY2;HOXA3;KLF4;CUX1;PID1;LRP6;SMAD6;SMYD2;PURG;FOXK1;FOXP4;SP140;SKIL;MYOG;NOBOX;PITX3;BARHL2;LHX2;PHOX2A;RCOR3;KAT6B;HOXB6;ELF1;ZBTB7B;ZIC1;DCAF6;ANXA4;MEF2A;ZNF148;ABL1;MEOX2;ZFP64;EGR2;HDGFL3;BMPR1A;DDIT3;CEBPZ;ARF4;TLE6;NFE2L2;ARID4A;GATA1;KLF7;CTCFL;TNRC6C;ZBED4;NR4A2;E2F5;DDRGK1;TCF25;TCF20;FOXC2;HOXA6;GDNF;ATF1;MED15;JMJD1C;NR4A3;NFKB1;ZNF8;ID4;KANK2;PIAS3;NCK2;BPTF;PLSCR1;TNFSF11;FOXO6;GLIS1;TWIST2;MOV10;HNF4A;HNF1A;ID1;BCLAF1;RARG;BAZ2B;FOXD2;PRRX1;EP300;TFAP2A;HOXB5;DLG1;PLK3;PIAS2;HCLS1;LBX1;MLLT10;USP2;OTUD7B;JAG1;CAMTA2;TBL1X;MAVS;CHUK;E2F6;JUN;RIPK2;FOXE1;HIVEP3;ATM;NR6A1;KLF10;ATP2B4;HDAC10;FGF2;TADA3;ZMYM5;KDM1A;KAT2A;RNF2;CREBBP;KLF9;GLIS2;JUP;BHLHE40;HES1;NFATC4;FUS;CREB3L3;WWTR1;ETV5;GATA4;HIF3A;JDP2;TEAD1;TAF6L;RHOQ;CALCOCO1;UBE2D3;CCNL2;ZNF462;MDM4;CBFB;SMARCA4;TCERG1;MNAT1;CARF;NFYA;KAT5;CTR9;PAXBP1;THAP3;DCAF1;BCL6;TOX4;TCF3;MXD1;NFKB2;PHF21A;SIX4;E2F3;PER2;FRK;BCL11B;ZNF585B;ZNF585A;PPM1A;ZKSCAN1;ATOH8;ARID4B;MED14;SKI;BCAS3;SSBP3;FOXA1;MRTFA;FOXK2;PRDM15;GATA3;TCF23;PHF12;NKX2-1;BRD9;HDAC8;GABPB1;GABPB2;SLC30A9;EBF4;BCL9L;NOG;ZNF383;TAF1;PPP1R12A;ZFP62;RBMX;RNF10;IRF1;RB1;ACVR1;TLR4;HSF5;ASXL2;SQSTM1;ZNF507;ZBTB49;BAZ1A;ZBTB37;ZMIZ1;TAF9;PEX2;PAF1;MYSM1;REST;SLC9A1;MTDH;CBX2;KLF16;NFIL3;RXRA;STAT3;WIZ;FOXC1;GATAD2B;EHF;RNF111;KDM3B;RTF1;PGBD1;GALR1;RFX5;HIVEP2;STAT5A;KAT2B;ZBTB4;LPIN2;EHMT2;CIITA;HES7;LRP5;BRD8;KMT2C;REL;DDX17;ZXDC;FOXM1;MGA;NCOA5;GLYR1;CEBPB;SOX21;ZNF76;COPS5;MAP2K5;TFE3;THAP1;KMT2D;BRD3;GTF2IRD1;LCOR;TFEB;ZBTB32;MYNN;PER3;HOXB3;HTATIP2;FOXL1;ATF7;ZXDB;CDK12;BRWD1;FBXL19;RBBP8;NRIP1;AATF;NAMPT;HCFC1;ZFX;SBNO2;ELF4;ELP4;ITGB1BP1;ZNF25;SNW1;JMJD6;DHX9;SRCAP;HOXC5;PCGF1;ZBTB18;CREBRF;PAX6;DUSP22;VPS72;MED27;ZNF496;PRKDC;NFIX;ZIC5;ELOA;HIRA;ATRX;MED17;DMAP1;EAF2
prerank,chemical synaptic transmission (GO:0007268),-0.2692361330708792,-1.2012089456515724,0.017543859649122806,0.7058260033108038,1.0,65/284,13.64%,SLC1A3;UNC13C;APOE;DTNA;PDE7B;NRXN1;GRM3;NOVA1;MBP;CACNA1E;CDH8;LIN7A;PRKAR2B;SLC6A1;CALM1;HSPA8;RIMS1;GRIK1;GRIN2A;GRM5;PLP1;GABRG3;GRM1;SNCA;PRKACB;GRM7;GRIA4;GRIA2;SLC1A1;SLC1A2;GRIA3;GRIN2B;PRKAR1B;SDCBP;GRID2;SYN1;GABRA1;GABRA2;ATXN3;APBA2;RIT2;GRIK2;PRKAR1A;GLRA1;GABRB2;GABARAP;GABRB1;CHRM3;NSG1;APBA1;KCND2;SLC12A5;HTR2A;RPS6KA1;CACNA1B;KCNQ3;CPLX1;DLGAP2;CHRM2;SST;GRIN1;CHRFAM7A;CHRNA7;HRH1;CACNB4
prerank,carbohydrate derivative transport (GO:1901264),-0.4515301211721682,-1.2010664579085673,0.20218579234972678,0.7043256480912574,1.0,8/18,16.98%,PLTP;NPC2;SLC29A1;SCARB1;MFSD2A;SLC25A19;SLC15A2;ABCG1
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),-0.29552079437228485,-1.2009210875742402,0.0660377358490566,0.7029193285317938,1.0,40/152,15.60%,ADGRL3;ADGRL4;ADCY5;CACNA1D;ADCY1;ABCA1;ADGRE5;GNAS;LGR4;ADCY7;CALCRL;ADCY2;PRKACB;RAMP2;S1PR1;ADRA2A;GPR37;PTGFR;GRM8;PTH1R;LPAR1;PDE2A;S1PR3;ADORA2A;ADGRG1;ADM;PSAP;ADCY4;CHRM2;P2RY12;LPAR2;IAPP;GPR37L1;ADGRB1;TBXA2R;ADGRL1;ADGRE1;ADCY3;ADCY8;VIPR2
prerank,regulation of B cell apoptotic process (GO:0002902),0.570621896033911,1.200199688578307,0.2804232804232804,0.8847182835859513,1.0,2/12,3.51%,FOXP1;IL10
prerank,oligodendrocyte development (GO:0014003),-0.45363099553719693,-1.1996997761297057,0.23501199040767387,0.7045938667804912,1.0,7/15,20.67%,PLP1;CNTNAP1;MYRF;EIF2B5;B4GALT5;TPPP;SOX10
prerank,copper ion transport (GO:0006825),-0.5044098509771427,-1.1995268928599927,0.25526932084309134,0.7032643141811324,1.0,9/11,28.99%,ATOX1;COX17;STEAP3;SLC31A1;SLC11A2;ATP7A;ATP7B;STEAP4;STEAP2
prerank,acylglycerol biosynthetic process (GO:0046463),0.5014265061625292,1.1991970611233183,0.25961538461538464,0.8867131359791869,1.0,8/23,15.95%,PLCE1;PNPLA3;MOGAT3;DGAT2L6;GPAT3;LPIN2;PLA2G4A;PLA2G15
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.4630397381683662,1.1991718443039212,0.24927113702623907,0.8855553645120667,1.0,5/37,5.21%,HMCN1;CXADR;ALCAM;NECTIN3;PVR
prerank,regulation of protein kinase B signaling (GO:0051896),0.38007660585369124,1.1987461200608933,0.15829694323144106,0.8856920559243471,1.0,24/193,8.03%,EGFR;F3;THBS1;MET;TCF7L2;NTRK3;TNFAIP8L3;ITGB1;FGFR1;STRN;GCNT2;DDIT3;PDGFA;TGFBR1;CD80;PHLPP2;IRS1;HCLS1;FGF22;P2RX4;PIK3AP1;FGF2;GAB2;GATA4
prerank,protein polyglutamylation (GO:0018095),-0.505594176832399,-1.1986580655043617,0.2620689655172414,0.7040316015242051,1.0,5/11,13.10%,TTLL7;TTLL4;TTLL11;TTLL5;CEP41
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.3639749818816643,1.198614621611046,0.10847107438016529,0.8848401984391006,1.0,93/366,19.19%,BNC2;VSX1;TCF7L1;ZFHX3;PRRX2;FOXN3;SIX1;FOXO3;ESR2;CCNA2;NFIA;USP13;EFEMP1;PITX3;IGSF1;KAT6B;FZD7;ABL1;DDIT3;GATA1;PDGFA;CRABP2;TGFBR1;JMJD1C;ZNF423;TRRAP;EP300;ERC1;HCLS1;HDAC10;CREBBP;BHLHE40;FUS;WWTR1;GATA4;TAF6L;CHEK2;NFYA;CTR9;HMG20A;TCF3;NFKB2;GON4L;BRCA2;FOXK2;GPBP1L1;GCFC2;ZNHIT3;PHF12;RB1;ZBTB11;REST;NLK;NFIL3;STAT3;FOXC1;BAZ2A;ASCC1;ZBTB4;EHMT2;CEBPB;TGFBRAP1;SOX21;THAP1;KMT2D;GTF2IRD1;CARM1;TFEB;ATF7;ORC5;HCFC1;SBNO2;PML;PCGF1;ATRX;SERTAD3;SAP30;RORA;LDB1;ACTR8;ATF2;CREBL2;POU6F2;CYFIP1;SRRT;REXO4;ATXN2;CREM;SPIN4;NUP107;RBM4B;ZFAT;SP3
prerank,positive regulation of cell communication (GO:0010647),-0.3946680316236604,-1.1983530117064338,0.20114942528735633,0.7030329946341702,1.0,11/28,21.51%,WLS;RIMS1;RIMS2;ANK3;GRIK2;EDN1;EDN3;CLSTN3;CLSTN1;PTPN23;SYT1
prerank,presynapse organization (GO:0099172),-0.52721738621321,-1.198222976306249,0.25339366515837103,0.7016177076382067,1.0,6/10,33.51%,WNT5A;LRRTM3;NLGN1;NLGN2;WNT7A;NLGN3
prerank,regulation of amyloid fibril formation (GO:1905906),-0.47086833592277166,-1.1979661559171821,0.22388059701492538,0.7005126411996752,1.0,6/15,14.28%,APOE;PFDN2;APP;PFDN5;CHRNA7;IAPP
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.4344152680676053,1.1977251626240721,0.22657342657342658,0.8865557610749448,1.0,15/52,15.77%,EGFR;SORBS1;ITGB1;CNST;ACSL3;DLG1;ATP2B4;AGR2;PLS1;SQSTM1;PRKCE;ZDHHC5;LRP1;PTPN9;WNK3
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.4610017321287701,1.1974676392903607,0.24275862068965517,0.8861970595312212,1.0,13/40,12.50%,TCF7L2;TGFB3;GCNT2;BAMBI;TGFBR1;TGFBR2;JAG1;TGFB1I1;WWTR1;MTOR;BCL9L;TGFB2;FOXC1
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.41067255114465717,1.1972607059695008,0.2,0.8856565720355654,1.0,35/80,24.44%,SGSM2;EHD3;STX5;VPS54;RAB6A;ERC1;VPS53;TMEM87B;RAB7B;RBSN;RGP1;VTI1A;TBC1D10A;WASHC1;SNX12;STX16;SNX32;TMEM87A;SNX2;GBF1;SPAG9;TBC1D5;ARL1;VPS51;RAB7A;VPS50;DCTN1;VPS29;BET1L;VPS26A;ARFRP1;TBC1D17;PIKFYVE;TRAPPC10;VPS52
prerank,regulation of lipase activity (GO:0060191),0.5379956122059415,1.1970110555226825,0.2755632582322357,0.8852316975662156,1.0,3/13,12.64%,PCSK5;RHOA;LMF1
prerank,regulation of protein neddylation (GO:2000434),-0.5134537301640881,-1.1966850307814363,0.26410835214446954,0.702545955911829,1.0,5/10,16.53%,HIF1A;RPL5;DCUN1D3;RPL11;EPAS1
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.4153118107513225,1.196421542086603,0.2205128205128205,0.8859629618945795,1.0,21/76,18.89%,HDAC4;TANK;FAM107A;BIRC7;PIAS3;MYCBP2;PRICKLE1;RIPK2;DCUN1D4;BCL10;FBXO4;COMMD1;BIRC3;AMER1;TSPYL5;SAE1;CENPX;HUWE1;TNIP1;WFS1;ANGPT1
prerank,cation transmembrane transport (GO:0098655),-0.3515081442158249,-1.1964125734193494,0.15172413793103448,0.7015769730733209,1.0,6/44,6.22%,ATP1A2;TRPM3;SLC6A9;SLC7A5;ABCC9;SLC38A5
prerank,acylglycerol homeostasis (GO:0055090),-0.4308756837513108,-1.19616338471523,0.2245430809399478,0.7005824852570852,1.0,5/20,9.17%,APOE;NR1H3;SCARB1;PNPLA8;IL18
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.48653195613587574,1.1960200245381845,0.2507418397626113,0.8861261761309054,1.0,4/27,4.49%,ANK2;AHNAK;CAMK2D;DMD
prerank,synaptic vesicle endocytosis (GO:0048488),-0.37858152363604763,-1.1959796523989128,0.1749271137026239,0.6993620811831164,1.0,17/33,25.16%,DNAJC6;DNM3;PICALM;SNCA;PIP5K1C;OPHN1;SNAP91;ITSN1;NLGN1;DNM1;NLGN2;SYT1;ITSN2;PACSIN1;CANX;SYT5;CDK5
prerank,regulation of actin filament polymerization (GO:0030833),0.4249378031417706,1.1956804012643125,0.21975308641975308,0.8859523691794826,1.0,15/69,14.16%,SLIT2;BAIAP2L1;PTK2B;CDC42EP5;PRKCD;NCK2;FCHSD1;HCLS1;NCKAP1;SSH3;WASHC5;PRKCE;CTTN;FCHSD2;CYRIB
prerank,cell differentiation in spinal cord (GO:0021515),-0.516465649503916,-1.1954762058965867,0.2511520737327189,0.6989129026249793,1.0,4/10,11.34%,SOX13;SOX6;ZC4H2;MDGA1
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.38270967960441654,1.1954233718230702,0.16247139588100687,0.8855521531012486,1.0,27/152,12.09%,RSPO3;EGFR;SULF1;WNK1;GPC3;TMEM198;BAMBI;UBE2B;PLEKHA4;VCP;TRPM4;NFKB1;TNKS2;TBL1X;JUP;SMARCA4;CSNK1G3;PPM1A;SKI;DISC1;SULF2;PRDM15;CSNK1E;UBR5;CSNK2A1;USP34;USP47
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.42896946825724475,1.1950803377783832,0.23978919631093545,0.8855382421748345,1.0,10/59,5.92%,CDH1;HMCN1;PKD1;NECTIN3;FAT2;MPZL2;ITGB1;DSG2;PVR;SDK1
prerank,response to purine-containing compound (GO:0014074),-0.45962523581931747,-1.1950268515163807,0.23383084577114427,0.6985393064789872,1.0,7/17,15.51%,TRPC3;ABCC9;P2RY1;NDUFS4;RYR2;VGF;P2RX7
prerank,positive regulation of ion transport (GO:0043270),0.4452525338187056,1.194586976858781,0.21418439716312057,0.8859387124253699,1.0,11/48,12.42%,FHL1;ANK2;ANO6;STIM2;GDNF;DLG1;P2RX4;CACNB2;CNKSR3;CRACR2A;SNX4
prerank,somite development (GO:0061053),0.5650020555683322,1.1943344960987303,0.2872340425531915,0.8855952666363263,1.0,2/11,4.19%,SMO;MEOX2
prerank,regulation of cellular response to stress (GO:0080135),0.3987569495412971,1.1930905111640102,0.1963855421686747,0.8885892950879932,1.0,23/115,14.82%,SLC38A2;CAMK2D;EIF4G1;NUP93;GSK3B;ABL1;EP300;ATM;CREBBP;SMG1;DYRK3;SEC13;MLST8;NUP188;MTOR;AIFM2;RPA1;RANBP2;DNAJB6;MAPK1;CEBPB;HSPA1L;ARMT1
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.4436851328353192,1.1930272312273646,0.24380165289256198,0.8875798386015699,1.0,11/50,14.68%,THBS1;NGF;CD44;KLF4;PAK2;CSNK2A1;USP47;DNAJB6;SFN;MAP2K5;CDKN2D
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.44627405117172975,1.1929792339807619,0.2538787023977433,0.8865127204431967,1.0,12/47,16.59%,DOCK5;EFNA5;ABL1;NRP1;LIMS2;DMTN;CDC42;TRIOBP;S100A10;ILK;ITGB1BP1;FLNA
prerank,sphingoid biosynthetic process (GO:0046520),0.5852091144554895,1.1929698920914824,0.28051001821493626,0.8840900621544701,1.0,1/11,0.61%,ACER3
prerank,sphingosine biosynthetic process (GO:0046512),0.5852091144554895,1.1929698920914824,0.28051001821493626,0.8840900621544701,1.0,1/11,0.61%,ACER3
prerank,negative regulation of telomere maintenance (GO:0032205),0.5343740760629104,1.1926056577437587,0.2816666666666667,0.8840405188947947,1.0,6/15,18.57%,SMG6;TNKS2;ATM;ERCC1;NBN;PINX1
prerank,microvillus organization (GO:0032528),0.5627419704998015,1.1923895708141325,0.2866043613707165,0.8834918517600506,1.0,5/13,7.01%,EZR;RAP1A;FXYD5;RAPGEF6;RAP2C
prerank,cellular response to increased oxygen levels (GO:0036295),-0.5086527452710601,-1.1920537778091367,0.23965141612200436,0.705510138221288,1.0,4/11,12.62%,FOXO1;FAS;ATP6AP1;ATP6V1A
prerank,monoacylglycerol metabolic process (GO:0046462),0.5632939742812281,1.1919775490491549,0.29557522123893804,0.8837309626414149,1.0,4/13,8.51%,MOGAT3;MGLL;DGAT2L6;ABHD6
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.44279445872349976,1.1918576012257025,0.2476060191518468,0.8828871794122106,1.0,9/47,12.28%,THBS1;AGTR1;PRKCD;PID1;TGFBR2;TLR6;ACOD1;TLR4;CD36
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.38571161345996874,1.1913627612296833,0.19473081328751432,0.8833172658885677,1.0,21/142,12.81%,SLC35G1;PLCE1;EDNRA;PTGDR;ADRA1B;CD55;AGTR1;CACNA1C;ABL1;TRPM4;ATP2B4;PTGER1;BDKRB1;PTGER2;CXCR4;FPR3;SELENOT;DRD3;CD36;CMKLR1;TRPC5
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.4796050332547559,-1.1896902422806264,0.2567237163814181,0.7108919382530767,1.0,5/13,15.58%,SHANK3;ADCY1;APP;CHRNA7;ADCY8
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.41856060816737045,-1.1894686187226629,0.2046783625730994,0.7096833071924853,1.0,6/24,16.03%,LPGAT1;CDS2;PNPLA8;GPAM;PGS1;SLC27A1
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.3573455060085676,1.1893409533082444,0.10638297872340426,0.8889769506954789,1.0,85/497,12.32%,FOXP2;BMP4;FOXP1;WWP1;SAMD4A;ZFPM2;TCF7L2;FOXN3;FOXD1;HDAC4;GLI3;ZBTB16;RBFOX2;WNT11;SHC1;WWP2;HDAC9;CRY2;KLF4;FOXK1;RCOR3;KAT6B;L3MBTL3;BTAF1;GSK3B;MDFIC;PDCD4;ZNF148;DDIT3;ARID4A;GCLC;IGFBP5;ATP8B1;SYNCRIP;ZNF423;ID4;SCMH1;TWIST2;HNF4A;ID1;BCLAF1;PRICKLE1;TFAP2A;MBTD1;FBXW11;CNOT7;PAIP2;JUN;FOXE1;KLF10;HDAC10;KDM1A;BAP1;GLIS2;BHLHE40;HES1;PHC2;TNFRSF4;TOB1;SMARCA4;CDKN1B;KAT5;BCL6;SIX4;RAD17;PER2;ATOH8;MBD1;FOXK2;GCFC2;GATA3;WAPL;PHF12;NKX2-1;NIBAN2;EIF2AK3;IRF1;RB1;TLE2;NANOS2;GTPBP4;USP47;REST;NFIL3;SPINDOC
prerank,cellular defense response (GO:0006968),0.45254819552486436,1.1886874641418652,0.2517580872011252,0.889875266974859,1.0,6/40,5.87%,PTK2B;LBP;ITGB1;KLRC2;ZNF148;BECN1
prerank,response to ATP (GO:0033198),-0.4448661556567344,-1.188679933145667,0.22764227642276422,0.7103436564394604,1.0,7/18,15.51%,TRPC3;ABCC9;P2RY1;HSP90B1;P2RY12;RYR3;P2RX7
prerank,fatty acid derivative biosynthetic process (GO:1901570),-0.3603114340900747,-1.1886152981903557,0.22424242424242424,0.7087136188443934,1.0,13/35,20.92%,PAM;ACSS3;FAR2;GGT5;ACLY;ACACA;ALOX12;GCDH;BDH1;GGT7;HMGCS2;AWAT2;GGT1
prerank,dicarboxylic acid transport (GO:0006835),0.4808268901749842,1.1885307089308832,0.2706766917293233,0.8892121534670956,1.0,2/28,3.93%,SLC26A7;GIPC1
prerank,regulation of phosphorylation (GO:0042325),0.3846534473136185,1.188292692382569,0.18896713615023475,0.8887821650362395,1.0,34/120,21.17%,EGFR;BMP4;THBS1;FN1;INHBA;NUP93;FZD7;EP300;MCM7;NRP1;BCL10;SEC13;CDKN1B;RAD17;NUP188;RANBP2;KDM4D;ILK;CDKN2D;EMP2;PML;LDB2;LDB1;ZBTB7A;AR;NUP107;AAAS;DSCAM;BTBD10;RAE1;NUP54;NUP98;EGF;EIF6
prerank,neurogenesis (GO:0022008),0.45364966728841094,1.1879965092017992,0.24147727272727273,0.8885525316888985,1.0,11/43,13.63%,ANXA1;SIX1;CIT;NTN5;DAGLB;BTBD3;SIX4;CXCR4;TGFB2;THOC2;BTBD2
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.4680473053338863,-1.1877962629048653,0.2660098522167488,0.7092337651141178,1.0,3/14,9.61%,TFRC;RIF1;NECTIN2
prerank,regulation of angiogenesis (GO:0045765),0.3746309158218758,1.187766699834816,0.18818380743982493,0.8880914681220342,1.0,17/192,2.85%,SMOC2;F3;BMPER;THBS1;ITGB8;ANXA3;HOXA5;CYP1B1;SULF1;RHOJ;PTGIS;ITGB1;PGF;ISL1;KLF4;HIPK1;SEMA3E
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.39093319822276357,1.1875901516336662,0.1970217640320733,0.887449580321944,1.0,24/136,11.30%,TCF7L2;PKD1;HDAC4;CYP1B1;PTGIS;TAX1BP1;WWP2;KLF4;ANXA4;DDIT3;ID1;CHUK;KDM1A;RNF2;GLIS2;BHLHE40;HES1;USP7;TNFRSF4;EIF2AK4;ACOD1;COMMD1;TAF1;RB1
prerank,phosphate ion homeostasis (GO:0055062),-0.5268779382294755,-1.1874550958851284,0.26506024096385544,0.7084510376267275,1.0,3/10,17.45%,ENPP1;XPR1;FGFR4
prerank,interleukin-27-mediated signaling pathway (GO:0070106),-0.4633052061803479,-1.1872823421528353,0.271264367816092,0.7071723072449441,1.0,9/13,31.53%,IL6ST;OAS2;IL27;STAT1;CANX;OASL;TYK2;CRLF1;IL27RA
prerank,regulation of dephosphorylation (GO:0035303),-0.4600284264566038,-1.18713168113402,0.24358974358974358,0.7058481896808271,1.0,9/15,26.84%,PPP1R16B;SRC;MTMR9;MTMR2;INPP5K;MTMR1;IGBP1;SMG7;SMG5
prerank,O-glycan processing (GO:0016266),0.44040880532093285,1.1867236216749601,0.2442953020134228,0.8891126745155711,1.0,11/54,14.64%,ST3GAL4;MUC6;B3GNT2;GALNT15;GALNT13;B3GNT6;GXYLT2;GCNT4;ST3GAL2;GALNT11;GALNT14
prerank,cellular potassium ion homeostasis (GO:0030007),0.5513924552563509,1.1864809136836465,0.2857142857142857,0.8887050057265128,1.0,3/13,1.46%,KCNJ2;SLC12A2;ATP1B1
prerank,leukocyte cell-cell adhesion (GO:0007159),0.49466381519202385,1.18611013235436,0.27565084226646247,0.88868722684868,1.0,3/24,2.35%,NT5E;EZR;ITGB1
prerank,cardiac conduction system development (GO:0003161),0.49432710772572896,1.1860290594749459,0.24580152671755726,0.8877379595724838,1.0,4/24,8.03%,BMP4;NOTCH2;BMPR1A;GATA4
prerank,autophagy of mitochondrion (GO:0000422),0.45855247206068445,1.1854538013434521,0.2402315484804631,0.8884421936319781,1.0,13/38,19.48%,WIPI2;ULK2;BECN1;ATG3;MARK2;SQSTM1;BNIP3;RB1CC1;AMBRA1;ATG2A;ATG7;ULK1;FIS1
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.3625206044934019,1.185233955243344,0.13702928870292888,0.8880075380693859,1.0,75/314,20.59%,FBXL7;FZR1;WWP1;NEDD4;UBE4B;WWP2;UBE2B;DDIT3;NFE2L2;RNF185;VCP;KLHL22;ANAPC5;FBXW11;NPLOC4;ANKZF1;TBL1X;ECRG4;ANAPC16;ERLIN1;OS9;UBE2D3;CDC16;FBXO4;UFD1;KAT5;FBXL6;FBXL20;TRIM25;TAF1;FBXO17;RB1;ERCC8;UBXN4;CUL4A;FAF2;UBE2W;BFAR;ECPAS;APPBP2;RAD23B;SMURF1;PSMC6;UBE4A;FBXL14;FBXL19;PML;UBE3D;TMUB1;FBXL4;UBE2S;FBXW5;PSMD8;SPOP;FEM1B;COP1;RNF122;FAF1;UBE2G1;FEM1C;FEM1A;HUWE1;PPP2R5C;PCNP;WFS1;PSMB1;SEL1L2;FBXL17;PSMD13;FBXL8;PSMD1;AURKA;PSMD7;KCTD17;PSMA8
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.392964190222826,-1.1850247740003654,0.195906432748538,0.7101898220019578,1.0,8/29,17.01%,ACSL1;ELOVL7;ELOVL6;ACLY;ACACA;HSD17B12;GCDH;ACSL5
prerank,Golgi localization (GO:0051645),0.5695594140885768,1.1844933572758676,0.2837370242214533,0.8894022502914684,1.0,3/11,15.49%,ARHGAP21;CDC42;ARCN1
prerank,ameboidal-type cell migration (GO:0001667),0.43669270998137777,1.1844272518887682,0.23424657534246576,0.8884353100240845,1.0,8/51,5.16%,CCN3;SEMA3D;SEMA3C;FAT2;GPC3;SEMA3E;PDXDC1;GDNF
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.5159354562952493,1.1843804255619665,0.2631578947368421,0.8873987540462531,1.0,6/19,15.85%,HIPK1;EP300;DYRK2;CDIP1;SNW1;PML
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.4483884655319903,1.1842790788467983,0.2640449438202247,0.8865418981835328,1.0,9/39,12.43%,THBS1;EFNA5;SEMA3E;GCNT2;FZD7;JAG1;DMTN;RHOA;CASK
prerank,regulation of filopodium assembly (GO:0051489),0.45873592781847883,1.184224887895488,0.24186704384724186,0.885533776834984,1.0,15/38,15.73%,DPYSL3;TGFB3;ARAP1;PRKCD;ARHGAP44;PALM;NRP1;RHOQ;DMTN;BCAS3;CDC42;FXR2;RAB5A;RAB17;TRPM2
prerank,negative regulation of neuroinflammatory response (GO:0150079),-0.47604011730038365,-1.183666670099161,0.2733990147783251,0.7122448149000635,1.0,3/14,7.47%,IGF1;GRN;SYT11
prerank,regulation of peptidase activity (GO:0052547),-0.43685181194599626,-1.1832895624669235,0.25692695214105793,0.7116113655411765,1.0,4/19,19.63%,CTSH;CST3;RCN3;PSMB8
prerank,erythrocyte differentiation (GO:0030218),-0.35993349862071006,-1.1831353355829348,0.19310344827586207,0.7102991680712304,1.0,19/44,24.11%,LYN;TGFBR3;MFHAS1;RPS14;KIT;RPS19;HSPA9;TAL1;ALAS1;CASP3;IKZF1;NCKAP1L;SLC25A38;KMT2E;JAK3;VEGFA;SH2B3;LYAR;MED1
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.3793545208144395,1.18280928571572,0.18272425249169436,0.8888944494588871,1.0,28/166,12.28%,EGFR;SMOC2;THBS1;SAMD4A;SORBS1;KLF4;GIPC1;NIBAN1;LARP4B;IRS1;CLU;PTPN2;P2RX4;TLR6;FGF2;CNEP1R1;DYRK2;BCAR3;PLD1;STARD4;FABP3;AGTR2;MTOR;STN1;SLC45A3;TLR4;ELOVL5;CD36
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.5683713251307722,1.1827393384267693,0.28422876949740034,0.8879346707225617,1.0,1/11,1.32%,ANXA1
prerank,iron ion transport (GO:0006826),-0.35220933968862445,-1.1826903676911744,0.19696969696969696,0.7098760878619447,1.0,11/47,14.74%,CP;FTH1;TFRC;SLC40A1;ATP6V1D;STEAP3;TTYH1;ATP6AP1;ATP6V1A;ATP6V0B;SLC11A2
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.5460363555417883,1.182395656264081,0.2884955752212389,0.8879411953829489,1.0,3/13,8.63%,B3GNT2;B4GAT1;B3GNT6
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.49623784547878724,1.1822883209287975,0.2868462757527734,0.8871285426986592,1.0,4/23,7.08%,SLC4A4;PFKFB2;NFKB1;GAPDHS
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.3515529156296756,1.1820400250351024,0.057057057057057055,0.8867446423708107,1.0,147/807,13.22%,FOXP2;BMP4;FOXP1;KLF12;WWP1;RARB;ZFHX3;ZFPM2;TCF7L2;PRDM6;FOXN3;FOXD1;HDAC4;FOXO3;DDX5;GLI3;ZBTB16;EZR;ESR2;RBFOX2;WNT11;SHC1;NR2F1;BMP6;WWP2;HDAC9;ISL1;CRY2;KLF4;CUX1;SMYD2;FOXK1;FOXP4;SKIL;RCOR3;KAT6B;L3MBTL3;ZBTB7B;BTAF1;MDFIC;MEF2A;PDCD4;ZNF148;DDIT3;TLE6;ARID4A;GCLC;GATA1;KLF7;NR4A2;TCF25;ATP8B1;FOXC2;NR4A3;NFKB1;ZNF8;ZNF423;ID4;KANK2;BPTF;SCMH1;GLIS1;TWIST2;HNF4A;ID1;BCLAF1;RARG;PRICKLE1;EP300;TFAP2A;DLG1;PLK3;MBTD1;FBXW11;USP2;OTUD7B;CNOT7;TBL1X;E2F6;JUN;FOXE1;NR6A1;KLF10;HDAC10;ZMYM5;KDM1A;RNF2;BAP1;CREBBP;GLIS2;BHLHE40;HES1;PHC2;ETV5;JDP2;TNFRSF4;UBE2D3;MDM4;CBFB;SMARCA4;TCERG1;CDKN1B;KAT5;CTR9;DCAF1;BCL6;TCF3;MXD1;PHF21A;SIX4;PER2;FRK;PPM1A;ATOH8;MBD1;SKI;FOXK2;GCFC2;GATA3;TCF23;PHF12;NKX2-1;HDAC8;NIBAN2;NOG;TAF1;IRF1;RB1;TLE2;PEX2;PAF1;USP47;REST;MTDH;CBX2;NFIL3;SPINDOC;RXRA;STAT3;FOXC1;GATAD2B;RTF1;ZBTB4;EHMT2;CIITA;XRCC5;CIPC
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.3519655730306329,1.1816600955904726,0.026026026026026026,0.8867810386682563,1.0,258/1082,17.41%,CDH1;EGFR;BMP4;KLF5;MET;RARB;MAP3K5;ZFHX3;ZFPM2;TCF7L2;BMP5;PLAGL1;NFIB;SIX1;PKD1;HOXA5;TGFB3;MLLT3;HDAC4;FOXO3;GLI3;ZBTB16;PBX1;ESR2;PPP3CA;CCN1;GRHL1;NFIA;CSRP3;WNT11;SHC1;NFAT5;NR2F1;INHBA;BMP6;ISL1;KLF4;PID1;LRP6;FOXK1;GDF6;MYOG;IL10;PITX3;LHX2;PHOX2A;KAT6B;ELOF1;ELF1;ZIC1;DCAF6;BAMBI;MDFIC;MEF2A;FZD7;ABL1;MEOX2;ZFP64;EGR2;BMPR1A;DDIT3;CEBPZ;ARF4;NFE2L2;GATA1;KLF7;CTCFL;ZBED4;NR4A2;E2F5;DDRGK1;TCF20;FOXC2;GDNF;ATF1;TGFBR1;NR4A3;NFKB1;ZNF423;CD80;NCK2;BPTF;PLSCR1;TNFSF11;GLIS1;HNF4A;HNF1A;BCLAF1;RARG;FOXD2;EP300;TFAP2A;FBXW11;HCLS1;MLLT10;TRIM44;JAG1;CAMTA2;TBL1X;MAVS;CHUK;JUN;TASP1;RIPK2;FOXE1;HIVEP3;ATM;KLF10;FGF2;TRIM45;TADA3;TGFB1I1;KDM1A;KAT2A;CREBBP;GLIS2;JUP;HES1;CREB3L3;WWTR1;ETV5;GATA4;TEAD1;TAF6L;RHOQ;CALCOCO1;BCL10;ZNF462;SMARCA4;TCERG1;CHEK2;SCAF8;NFYA;KAT5;FZD2;PAXBP1;THAP3;TCF3;NFKB2;SIX4;E2F3;BCL11B;PPM1A;ATOH8;MED14;BRCA2;SKI;BCAS3;SSBP3;FOXA1;MRTFA;FOXK2;PRDM15;GATA3;MTOR;QRICH1;NKX2-1;HDAC8;GABPB1;GABPB2;SLC30A9;MYRFL;NIBAN2;BCL9L;WDR43;PIM2;EIF2AK3;PPP1R12A;RBMX;RNF10;IRF1;CHEK1;RGMB;ACVR1;TLR4;ASXL2;USP22;SQSTM1;ZNF507;ZBTB49;USP21;ZMIZ1;TAF9;MYSM1;REST;SLC9A1;NFIL3;RXRA;STAT3;FOXC1;EHF;RNF111;GALR1;RFX5;KAT2B;LPIN2;CIITA;LRP5;BRD8;KMT2C;REL;DDX17;ZXDC;FOXM1;GLYR1;CEBPB;ZNF76;COPS5;MAP2K5;TFE3;KMT2D;TRIM16;LBHD1;TFEB;CAMK4;ILK;THOC5;HOXB3;HTATIP2;TAF15;WDR75;NRIP1;AATF;NAMPT;HCFC1;SBNO2;ELF4;XPC;ITGB1BP1;SNW1;MAP2K2;JMJD6;DHX9;PML;PRMT2;ZNF711;MAP3K12;ZBTB18;CREBRF;PAX6;ZNF496;PRKDC;NFIX;ATRX;MED17;EAF2;CSRNP2;SERTAD3;RORA;NR4A1;CITED2;LDB2;LDB1;ZNF513;STAT6;EPC1;KDM6B;ATF2
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.5948118369432495,1.1815841636234086,0.29213483146067415,0.8858466202562602,1.0,3/10,2.01%,STK39;NEDD4;CAMK2D
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.40008923923307205,-1.1814173368098042,0.23323615160349853,0.7118870936910884,1.0,13/26,22.95%,SLC30A10;PPARA;SNCA;CYBA;SLC5A3;GRIN1;ADGRB1;RAB27A;PARK7;SLC25A33;ABCB7;SLC18A2;SPHK2
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.4873162895855469,1.1811309030965729,0.2701863354037267,0.886200085264088,1.0,4/22,7.01%,RASSF2;PDGFC;PDGFA;RAP2C
prerank,positive regulation of protein phosphorylation (GO:0001934),0.3606910156838286,1.1810621105477512,0.13187954309449637,0.8852420647605425,1.0,45/348,7.98%,EGFR;BMP4;SLCO3A1;CARD14;RASSF2;NGF;PDGFC;BMP5;NTRK3;TGFB3;PTK2B;CD44;EFNA5;CCN1;LIMK2;KRAS;INHBA;BMP6;PGF;DDR2;DOCK7;EIF4G1;RAP1A;GDF6;GDF5;ITGA5;ABL1;BMPR1A;GATA1;NIBAN1;DDRGK1;PDGFA;TGFBR1;CD80;IL5;BMP15;HCLS1;FGF22;RAP2C;MAVS;RIPK2;ATP2B4;FGF2;NRP1;IQGAP1
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.38706986681724775,1.1801939452901797,0.18253968253968253,0.8869618652334014,1.0,17/151,8.03%,EGFR;BMPER;PDGFC;NTRK3;TNFAIP8L3;PTK2B;CD44;SHC1;GAREM1;RAP1A;GCNT2;NOTCH2;PDGFA;TNFSF11;FGF2;NRP1;GATA4
prerank,high-density lipoprotein particle assembly (GO:0034380),-0.5016612945330194,-1.1800254444919294,0.2725060827250608,0.7142253259016188,1.0,3/10,4.67%,APOE;ABCA1;PRKACB
prerank,aminoglycan catabolic process (GO:0006026),0.47988178076969323,1.1798250200737799,0.26758409785932724,0.887033891621738,1.0,8/28,12.99%,GPC6;GPC3;NAGLU;GPC4;SGSH;HPSE;GLB1;SDC4
prerank,regulation of epidermal cell differentiation (GO:0045604),0.49742264765181143,1.1797115299881984,0.27903225806451615,0.8862644746936544,1.0,8/21,21.17%,BMP4;KLF7;CBFB;SFN;SULT2B1;ZFP36L1;SFRP4;MAFG
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.44142775697888476,-1.179574275734723,0.22647058823529412,0.7137109712068167,1.0,10/18,30.66%,APOE;TMCC2;NSG1;ABCG1;APH1B;PSENEN;ADAM19;APH1A;NCSTN;ACHE
prerank,regulation of organelle organization (GO:0033043),0.41219661783385836,1.1794168991108918,0.24466750313676286,0.8860660894060848,1.0,24/80,15.17%,CLIC4;EZR;CAPN2;EHD3;DIAPH1;CAPN6;STX5;GOLPH3;ARHGEF5;TBC1D25;EP300;MAVS;MARK2;SPEF1;RDX;RBSN;SAR1B;PAK2;PARL;SQSTM1;MAPK1;CLEC16A;PRMT6;MAPK15
prerank,camera-type eye development (GO:0043010),0.4829853355166838,1.1794085314073646,0.2653061224489796,0.8849171455201582,1.0,7/25,10.78%,CYP1B1;STRA6;EFEMP1;CACNA1C;TSKU;SKI;IFT122
prerank,negative regulation of cell junction assembly (GO:1901889),0.48480746543497544,1.1792394920499507,0.2686335403726708,0.8842881066302415,1.0,5/25,10.01%,THBS1;PHLDB2;FAM107A;DMTN;BCAS3
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.4296342761542391,-1.1792249562484436,0.27807486631016043,0.7130398347470902,1.0,7/19,7.31%,IL34;CAMK1D;CSF1;PTK2;MAPK3;JAM3;MDK
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.4096174416262257,-1.1787067255939967,0.2413793103448276,0.7128078561351765,1.0,10/26,18.77%,SHANK3;SYNPO;SYNPO2;FHOD1;PLEK;RAC1;PFN1;LIMK1;ALMS1;ACTG1
prerank,regulation of mitotic nuclear division (GO:0007088),-0.34065062989349576,-1.1780881077505228,0.14583333333333334,0.7127619794940369,1.0,13/55,11.16%,IGF1;TGFA;PDGFRB;OBSL1;BMP7;INSR;IGF2;RGCC;LCMT1;EDN1;RCC1;CDK5RAP2;EDN3
prerank,response to UV (GO:0009411),0.4001445435835204,1.178066078445828,0.2054120541205412,0.886886956692993,1.0,22/95,18.17%,EGFR;SCARA3;NEDD4;UBE4B;PRKCD;UBE2B;EP300;KDM1A;CREBBP;EIF2AK4;ERCC3;TAF1;ERCC8;USP47;XPA;REV1;CDKN2D;USP1;MAPK8;WRN;YY1;INO80
prerank,endocrine system development (GO:0035270),0.5055912106718307,1.1779785833286562,0.26686656671664166,0.8860164955584829,1.0,6/21,10.60%,SIX1;WNT11;STRA6;TGFBR1;FOXE1;NKX2-1
prerank,epithelial cell migration (GO:0010631),0.4581601626933622,1.1774556163378243,0.2880116959064328,0.8865959819725502,1.0,10/37,12.41%,FSTL1;CYP1B1;FAT2;GIPC1;ABL1;KANK2;NRP1;PKN2;RHOA;S100A2
prerank,positive regulation of ruffle assembly (GO:1900029),-0.48047685928576733,-1.1773672924248186,0.2625570776255708,0.7132219294690385,1.0,6/13,20.13%,EPS8;EPS8L2;P2RY12;PFN1;PLEKHM1;NLGN1
prerank,membrane lipid catabolic process (GO:0046466),0.5750224979651224,1.1767914556878518,0.3067375886524823,0.8875900542585196,1.0,3/10,5.10%,CYP1B1;PDXDC1;NAGA
prerank,adherens junction organization (GO:0034332),0.43537039750140766,1.176254325023471,0.2587904360056259,0.8881844922224393,1.0,11/48,11.79%,CDH1;CDH11;NECTIN3;CTNNA1;PVR;VCL;JUP;CTNND1;CDH17;PAK2;CSK
prerank,NAD biosynthetic process (GO:0009435),0.5184835971437202,1.175933795492604,0.3109656301145663,0.8880676177541941,1.0,3/20,3.69%,PTGIS;NMNAT2;QPRT
prerank,regulation of mitotic cell cycle (GO:0007346),0.3757838817608517,1.1756319871041498,0.19775280898876405,0.887914088870421,1.0,49/171,23.72%,FZR1;SMOC2;PTPN3;NEK7;IL10;CDC25B;TTC28;ANAPC5;USP2;ANAPC16;IQGAP1;CDC16;CDKN1B;ERCC3;FOXA1;PKN2;PIM2;RB1;USP22;FOXC1;HECA;BTG3;THAP1;PSMC6;TMEM8B;XPC;PRKCA;UBE2S;PSMD8;GBF1;CKS1B;PSMB1;PSMD13;PSMD1;GAS1;PSMD7;PSMA8;TGFB1;PDXP;PSMD3;CUL7;PSMD2;CDK1;NEK6;ANGEL2;PSMC2;PKMYT1;ERCC2;PSMB2
prerank,histone methylation (GO:0016571),0.490806973761885,1.1755839776792947,0.2753846153846154,0.886905407181127,1.0,11/26,24.46%,SMYD2;CTCFL;CREBBP;EHMT2;EHMT1;CARM1;PRMT6;PRMT2;PRMT8;SIRT7;EZH2
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.5008911925515317,1.1750410804202673,0.2914012738853503,0.8875818996030538,1.0,4/22,11.56%,UBASH3A;EZR;PTPN2;PHPT1
prerank,cell-substrate junction assembly (GO:0007044),0.4660826241349804,1.1744065868538192,0.2664624808575804,0.8885038216318812,1.0,9/33,13.08%,FN1;SORBS1;KRT14;BCR;PIP5K1A;TRIP6;ITGB4;PLEC;CTTN
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.3719443882010782,-1.1736390417779587,0.2420749279538905,0.7226243499819289,1.0,6/32,10.80%,RPL30;DEFA6;PGLYRP1;RPS19;GAPDH;RPL39
prerank,phospholipid dephosphorylation (GO:0046839),0.45539852597999164,1.1735783189234625,0.27245508982035926,0.8900392059062412,1.0,9/37,15.60%,PLPPR2;PLPP3;MTMR12;OCRL;PLPP1;INPP5B;MTMR11;SYNJ1;PIP4P2
prerank,defense response to symbiont (GO:0140546),-0.29899016730435707,-1.1735074807063963,0.13978494623655913,0.7212433760266677,1.0,21/92,13.66%,SERINC3;SERINC5;BCL2;ABCC9;IRF2;SAMHD1;BST2;IFITM1;BCL2L1;NLRC5;IFIT2;AGBL4;TLR3;IFNAR2;IFITM3;MLKL;OAS2;RTP4;IFIT3;TLR7;CGAS
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.3586745436378448,1.1733125722592148,0.15463917525773196,0.8897464159189024,1.0,86/341,20.59%,FBXL7;FZR1;WWP1;NEDD4;FBXO10;UBE4B;WWP2;RNF115;UBE2B;RNF19A;DDIT3;NFE2L2;UBR4;RNF185;VCP;BIRC6;KLHL22;ANAPC5;FBXW11;NPLOC4;ARIH1;OTUD7B;TRIP12;TBL1X;TGFB1I1;ANAPC16;UBAP1;OS9;UBE2D3;CDC16;UFD1;KAT5;RNF168;USP33;TRIM25;ARIH2;TAF1;ERCC8;SQSTM1;RNF111;CUL4A;UBE2W;BFAR;TSG101;APPBP2;RAD23B;SMURF1;PSMC6;UBE4A;FBXL14;RNF146;FBXL19;PML;UBE3D;FBXL4;UBE2S;FBXW5;PSMD8;SPOP;FEM1B;COP1;RNF122;FAF1;UBE2G1;RNF114;ZRANB1;FEM1C;FEM1A;VPS37A;HUWE1;PPP2R5C;RNF144A;PCNP;NUB1;RC3H2;PSMB1;FBXL17;NTAN1;USP9X;CHFR;PSMD13;PSMD1;AURKA;PSMD7;KCTD17;PSMA8
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.3389600440613288,-1.173161204243052,0.20920502092050208,0.7205066207340696,1.0,18/57,17.78%,RPL38;RPL14;RPS24;RPS15;RPS16;RPL5;RPS19;RPS17;RPS7;NOC2L;EMG1;RPL35A;RPL26;RPS25;RIOK1;RPL11;DDX31;RPS28
prerank,macromolecule catabolic process (GO:0009057),0.4905373126308891,1.1727951539008243,0.2921174652241113,0.8902323615343786,1.0,9/26,21.07%,NEDD4;BECN1;LRSAM1;IDE;MTOR;SMURF1;TPP1;TGFB1;SH3GLB1
prerank,myotube differentiation (GO:0014902),-0.44249140042224494,-1.1718854814158777,0.25,0.7226518332972305,1.0,4/17,6.59%,IGF1;SORT1;ADAMTS15;MEF2C
prerank,regulation of cellular component biogenesis (GO:0044087),-0.3584026901687976,-1.1711167648465421,0.1956521739130435,0.723120143802872,1.0,9/39,6.88%,TJP1;APOE;RAPGEF2;TIE1;HSPA8;NOTCH1;GFAP;DAB2IP;RAPGEF1
prerank,positive regulation of neuron projection development (GO:0010976),-0.3067282940772402,-1.1707721574392973,0.12234042553191489,0.7223487717269315,1.0,24/85,10.51%,CAMK1D;LYN;APOE;ITGA6;PRKD1;RAPGEF2;WNT5A;PTK7;FUT9;SERPINI1;SETX;ATP1B2;BMP7;ROR2;TENM3;NDNF;DAB2IP;RAPGEF1;MDK;LRP8;RIT2;NTRK2;PLK5;TOX
prerank,lipid oxidation (GO:0034440),-0.4905979077294688,-1.1705979907997044,0.2651162790697674,0.7211523617580566,1.0,5/12,29.44%,PPARGC1A;ALOX12;ACOX1;ADIPOR2;ALOX5
prerank,stabilization of membrane potential (GO:0030322),0.5188434029427568,1.1704506500853773,0.29952456418383516,0.8967483825541809,1.0,2/16,5.21%,KCNK5;KCNK7
prerank,glucose import (GO:0046323),-0.474095524905198,-1.1700374222996817,0.2524752475247525,0.7210239650703247,1.0,2/13,1.73%,SLC2A1;SORT1
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.4133957150240908,1.16988823567305,0.23346303501945526,0.8974082201677791,1.0,13/78,11.08%,FZR1;GSK3B;RNF19A;NFE2L2;VCP;DDRGK1;CLU;PRICKLE1;PLK3;ARIH1;CSNK1E;ARIH2;TAF1
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.36415115053997876,1.1696759838344792,0.18133616118769882,0.8969352183812135,1.0,70/260,17.20%,NTN1;ABLIM3;PKD1;BBS9;EZR;PARVA;EXOC4;ITGB1;ANO6;RAP1A;FXYD5;GSN;RAPGEF6;EHD3;EMP1;PMP22;ARF4;CFAP70;ARHGEF6;PDE6D;GOLPH3;DZIP1;EXOC5;CEP164;PIP5K1A;ATAT1;SHTN1;VCL;ARL3;ABCC4;CEP131;RAB11FIP3;SSTR3;RAP2C;ABLIM2;OCRL;MKS1;FGD6;NRP1;SPEF1;SRGAP2;TMEM237;FUZ;TMEM231;DMTN;PCM1;PTPDC1;DISC1;KIF27;ARMC9;IFT122;EHD1;DNAH5;PIBF1;POC1B;CCDC66;GALNT11;ATP6V0D1;EMP2;IFT88;RAB17;DYNC2I2;RILPL1;FLNA;CEP89;CEP20;IFT80;GBF1;WHAMM;NUDCD3
prerank,activation of protein kinase activity (GO:0032147),-0.29579437732031766,-1.1696291761849773,0.16049382716049382,0.7205069972230926,1.0,27/106,9.21%,IGF1;OSBPL8;ADCY5;ADCY1;WNT5A;PRKAR2B;PPIA;PAK1;ADCY7;TNIK;CCDC88A;CARD10;NRK;ADCY2;PRKACB;INSR;RICTOR;PAK5;ADRA2A;MAP4K4;GHR;PRKAR1B;MALT1;GAS6;PRKAR1A;IL18;TLR3
prerank,actin cytoskeleton reorganization (GO:0031532),0.4168779436808105,1.169377044292874,0.25167336010709507,0.8967253335578964,1.0,15/63,9.56%,CXADR;PHACTR1;ANXA1;EZR;PARVA;SIPA1L1;GSN;ANTXR1;PIP5K1A;NRP1;CAPN10;MKLN1;CDC42BPG;GAB1;DMTN
prerank,protein localization to nucleus (GO:0034504),0.39307583231736254,1.1687017790777394,0.22655298416565164,0.8977405100481658,1.0,26/102,19.24%,BMP4;SIX1;NUP93;LMNA;TOR1AIP1;IPO7;PRICKLE1;CNEP1R1;SEC13;SIX4;E2F3;NUP188;TNPO2;PAF1;XPA;STAT3;MORC3;HEATR3;FAM53A;RAN;PML;WRN;ZBTB7A;PINX1;NUP107;IPO8
prerank,pre-miRNA processing (GO:0031054),-0.471817236753833,-1.1684039717482833,0.27735368956743,0.7223992217182251,1.0,5/14,22.46%,AGO1;LIN28B;AGO4;TARBP2;MRPL44
prerank,response to glucose (GO:0009749),0.43384282751433445,1.16787326592304,0.26005361930294907,0.899336608459993,1.0,13/46,17.85%,THBS1;TCF7L2;KCNB1;HNF4A;SLC39A14;UNC13B;EIF2B2;SELENOT;PRKAA1;EIF2B3;PRKACA;IRS2;TRA2B
prerank,positive regulation of biomineral tissue development (GO:0070169),0.44580664017346777,1.1677746558439288,0.2725988700564972,0.8985014300557166,1.0,8/40,7.70%,BMP4;TGFB3;CCN1;BMP6;ANO6;BMPR1A;TFAP2A;NELL1
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.5041051543185668,1.1677535373561445,0.2877813504823151,0.8974182086552438,1.0,2/20,1.83%,MET;MRAP
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.5037497934859437,1.1677120785406931,0.311336717428088,0.8963921357690444,1.0,2/17,2.62%,PCSK5;HDAC9
prerank,artery morphogenesis (GO:0048844),0.46735269872081475,1.167186499655907,0.283763277693475,0.8969021582026057,1.0,9/30,11.71%,BMP4;STRA6;BMPR1A;TGFBR1;JAG1;NRP1;HES1;NOG;TGFB2
prerank,amide transport (GO:0042886),0.4692070745616209,1.166668953305206,0.2872503840245776,0.8974470350248818,1.0,3/26,2.82%,SLC5A6;DISP1;ABCG2
prerank,lamellipodium assembly (GO:0030032),0.4783307593022391,1.1666395974360526,0.2897196261682243,0.8963938993760432,1.0,9/26,9.56%,ABLIM3;ITGB1;ARHGEF6;GOLPH3;VCL;ABLIM2;SPEF1;SRGAP2;DMTN
prerank,regulation of neurotransmitter transport (GO:0051588),-0.4540659904579931,-1.1659892851199496,0.25984251968503935,0.7276190458354646,1.0,9/16,15.26%,MCTP1;RIMS1;MEF2C;SYN1;FLOT1;CAMK2A;MCTP2;CPLX1;KCNMB4
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.4848988501744449,1.1658498401570427,0.29754601226993865,0.8978589811789923,1.0,9/26,20.46%,EGFR;GAREM1;IQGAP1;FOXC1;DUSP22;SYAP1;ZFP36L1;PTPN11;PTPN12
prerank,signal peptide processing (GO:0006465),0.5615132759387724,1.165759356358613,0.31226765799256506,0.8969971015595505,1.0,2/11,11.06%,PCSK5;PARL
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.3789189018088203,1.165360660001594,0.2054794520547945,0.8971780700321272,1.0,23/140,8.54%,SLIT2;PLCE1;ARHGAP21;ARHGAP10;ARHGAP20;ARHGDIB;ARAP1;AKAP13;RHOJ;ARHGAP44;ARHGAP31;ARAP2;BCR;TIAM2;ARHGEF6;TRIO;ARHGEF5;ITGAV;VAV2;OCRL;SRGAP2;SRGAP3;RHOQ
prerank,pyroptosis (GO:0070269),-0.4451430267636429,-1.164889786355652,0.2708860759493671,0.7291082302382602,1.0,7/15,26.53%,CASP4;AIM2;GSDME;GSDMD;CASP1;TREM2;ZBP1
prerank,negative regulation of GTPase activity (GO:0034260),-0.4063127423304742,-1.1648252878893108,0.21082621082621084,0.7275760929995102,1.0,9/22,16.17%,CPEB2;F11R;GPSM1;GMIP;LRCH1;DAB2IP;LRRK2;SH3BP4;RASA4
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.5636138822814896,1.1643715929196807,0.3285198555956679,0.8992678800673004,1.0,2/12,1.75%,UST;DSE
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.5505944262205794,1.164307463515915,0.3096446700507614,0.8983370090483231,1.0,2/12,6.15%,DPYSL3;CTPS2
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.46249028227493416,1.1640361454920265,0.2840409956076135,0.8981687456843286,1.0,6/31,5.96%,ZFPM2;DSP;ISL1;BMPR1A;TGFBR1;TNNI3
prerank,regulation of macromolecule metabolic process (GO:0060255),0.3703504579075524,1.1636633721880885,0.22706422018348624,0.8981977607002303,1.0,25/170,12.11%,CDH1;FOXP1;PRDM6;ATP1B1;COQ7;IL10;YBX3;ZFP64;AFF3;GDNF;TOB2;TRIM44;TRIM26;TSKU;NELL1;TOB1;MKLN1;CAVIN4;ZNF462;PCBP4;HMG20A;GNB3;ZNF507;MEGF8;REST
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.37988386185796585,-1.163633313708537,0.22822822822822822,0.7294892316190308,1.0,5/29,7.23%,ENG;TGFBR3;NOTCH1;S1PR1;BMP2
prerank,cilium assembly (GO:0060271),0.35884396658373563,1.1633456578151375,0.1922675026123302,0.8980696742694197,1.0,85/297,20.91%,RP1;ABLIM3;PKD1;BBS9;PARVA;EXOC4;DNAAF3;SFI1;ARL13A;GSN;EHD3;ARF4;CCDC40;CFAP70;PDE6D;DZIP1;EXOC5;CEP164;RPGRIP1;PAFAH1B1;ATAT1;ARL3;ABCC4;CEP131;RAB11FIP3;SSTR3;OCRL;MKS1;TMEM237;FUZ;TMEM231;PCM1;PTPDC1;DISC1;HAUS5;KIF27;ARMC9;CSNK1E;IFT122;CEP70;RSPH6A;TRIP11;TOGARAM1;CEP63;EHD1;CEP57;DNAH5;PIBF1;POC1B;CCDC66;CEP97;GALNT11;ATP6V0D1;IFT88;RAB17;PRKACA;CFAP46;CSNK1D;GORAB;DYNC2I2;DCTN3;RILPL1;FLNA;CEP89;CEP20;IFT80;GBF1;NUDCD3;DZIP1L;CNTRL;AKAP9;CDC14A;EHD2;NPHP1;TEKT2;CEP192;HYLS1;DCTN1;TRAF3IP1;EXOC7;EXOC1;ODF2;C2CD3;LZTFL1;RSPH9
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.4578843616142994,1.1632062483108052,0.27382753403933435,0.8974000180569032,1.0,5/30,5.45%,BMP4;MLLT3;INHBA;TNFRSF13B;PRRC2C
prerank,small GTPase mediated signal transduction (GO:0007264),0.38662456130439404,1.1630845981794071,0.24058323207776428,0.896618712823531,1.0,17/103,7.51%,PLCE1;NTN1;CCNA2;MRAS;SHC1;NRAS;KRAS;ARHGAP31;BCR;RAPGEF6;TIAM2;SHTN1;SHOC2;ARL3;JUN;RAB18;FGF2
prerank,positive regulation of signal transduction (GO:0009967),0.3613213968982446,1.162346906383384,0.19119226638023631,0.8979111911916062,1.0,49/238,13.07%,RSPO3;SMOC2;F3;CCN3;NTRK3;SMO;PTK2B;SORBS1;SULF1;GRB10;PTGIS;BMP6;ZBTB7B;C1QTNF12;ITGA5;ERFE;TGFBR1;CD80;CRADD;TNFSF11;IRS1;ITGAV;EP300;TRIM44;JAG1;NRP1;CREBBP;SLC39A14;LIMS2;CYP27B1;SMARCA4;DMTN;SKI;DISC1;SULF2;GATA3;ARMC9;CSNK2A1;DRD3;ASXL2;TGFB2;ZMIZ1;TTC23;KIF7;STAT3;AAK1;ZDHHC5;KAT2B;ITGB3
prerank,positive regulation of cell population proliferation (GO:0008284),0.35188758032942863,1.1613340873517182,0.14989733059548255,0.9000705341327502,1.0,51/423,8.30%,EGFR;BMP4;FOXP1;THBS1;ACER3;GRK5;ZFPM2;TCF7L2;PDGFC;BMP5;NTRK3;FN1;TGFB3;HDAC4;PTK2B;CCN1;FGFR1;SHC1;KRAS;BMP6;PGF;DDR2;PID1;GAREM1;GCNT2;BAMBI;CDC25B;BMPR1A;DDRGK1;PDGFA;TRPM4;GDNF;TGFBR1;NR4A3;TGFBR2;IRS1;HILPDA;ITGAV;CEP131;HCLS1;FGF22;CNOT7;CLCF1;FGF2;GAB2;MAP3K3;KDM1A;MVD;HES1;WWTR1;ADAM10
prerank,urogenital system development (GO:0001655),0.5521706775401878,1.1611976354160012,0.3247863247863248,0.8994068028863809,1.0,1/11,1.32%,ANXA1
prerank,positive regulation of axonogenesis (GO:0050772),0.4411304005061697,1.1609497996335354,0.292817679558011,0.8991210498545382,1.0,9/43,11.89%,SLIT2;NTN1;NGF;TIAM2;SHTN1;PLXNA2;ISLR2;ZFYVE27;RHOA
prerank,cytosolic calcium ion transport (GO:0060401),0.4720666590913988,1.1605618169513756,0.28362573099415206,0.8991979357062023,1.0,4/28,11.04%,SLC35G1;CACNA1C;MCUB;MICU1
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),-0.3212425723625958,-1.1605502376648718,0.193717277486911,0.7368825303732028,1.0,16/75,8.47%,PTPRM;SEMA6A;WNT4;TEK;COL4A3;CLDN5;HSPG2;DCN;NPR1;SPARC;DAB2IP;AGO1;STAB1;RGCC;ECSCR;THBS2
prerank,cellular response to cadmium ion (GO:0071276),0.47735040699842624,1.1594465892911825,0.28753993610223644,0.9016545254060854,1.0,3/24,7.13%,EGFR;CHUK;JUN
prerank,positive regulation of phosphorylation (GO:0042327),0.3602498500567779,1.1593939265610747,0.1849096705632306,0.9006853904480534,1.0,20/240,4.57%,SLC4A4;EGFR;BMP4;THBS1;SLCO3A1;MET;CARD14;NTRK3;EFNA5;CCN1;LMO4;LIMK2;FGFR1;KRAS;PGF;DDR2;FZD7;ABL1;PFKFB2;NIBAN1
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.529406039062043,1.1590982267946657,0.30134680134680136,0.9005167165840194,1.0,6/15,21.44%,TNRC6C;CNOT7;TOB1;TNRC6A;PABPC1;EIF4ENIF1
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.44077530046523483,-1.1589849100612315,0.26525198938992045,0.7398484185353917,1.0,5/16,7.23%,IGF1;IGFBP2;IGFBP3;IGFBP4;BMP2
prerank,macrophage differentiation (GO:0030225),0.5436071417809185,1.1583785005680574,0.3122866894197952,0.901785168336906,1.0,1/13,0.27%,BMP4
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.5048858168222237,1.1581628301289086,0.3210862619808307,0.9013413899573762,1.0,1/20,0.29%,FKBP5
prerank,glycoprotein catabolic process (GO:0006516),-0.4397275893973255,-1.1580849802241024,0.2759493670886076,0.7408565385630754,1.0,3/17,4.27%,ADAMTS12;ADAMTS9;STT3B
prerank,peroxisome organization (GO:0007031),0.48471790753278565,1.1576079917795596,0.30697674418604654,0.9020140733046564,1.0,9/25,20.64%,ABCD3;TMEM135;ACOT8;PEX2;PEX12;FIS1;PEX16;LONP2;PEX7
prerank,modified amino acid transport (GO:0072337),-0.44458811918407914,-1.157586749992553,0.27941176470588236,0.7405999881248087,1.0,2/15,0.33%,SLC6A13;SLC16A12
prerank,actomyosin structure organization (GO:0031032),0.40701628212157526,1.15688920733087,0.2591240875912409,0.9032847273476529,1.0,17/75,10.68%,PHACTR1;SORBS1;EPB41L5;KRT19;CSRP3;ITGB1;CIT;TMOD3;EPB41L2;CSRP2;ITGB5;FRMD6;CDC42BPG;FHOD3;SIX4;WDR1;EPB41L1
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.5124266439769245,1.1561385442991656,0.2980132450331126,0.9045572439990098,1.0,6/18,7.56%,ANXA1;RHOJ;HDAC9;FOXC2;FGF2;MAP3K3
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.3608182358546272,1.1550187531265024,0.20235546038543897,0.9071743380771352,1.0,60/234,17.62%,SLCO3A1;CARD14;ANXA3;EDA;SMO;HDAC4;ESR2;PLPP3;DDR2;LRP6;IL10;RIPK3;DDIT3;DDRGK1;NFKB1;ARHGEF5;TNFSF11;TAB3;CLU;EP300;ERC1;HCLS1;IL18RAP;TRIM26;MAVS;CHUK;RIPK2;TLR6;KDM1A;JUP;BCL10;SMARCA4;FZD2;TCF3;RAB7B;NFKB2;FOXA1;TRIM25;TAF1;TLR4;IKBKE;MTDH;CD36;ADAM8;STAT3;TRADD;TRAF5;COPS5;RNF31;TRIM41;TAF12;PRDX3;DHX9;MYD88;UBE2N;ROR1;CARD16;ATF2;ZBTB7A;EDA2R
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.490742957213936,-1.1546794267530869,0.30403800475059384,0.7474286416352715,1.0,4/12,9.54%,PPARA;ABCA1;NR1H3;ABCA5
prerank,neuromuscular process (GO:0050905),0.5349450764248449,1.1546279089695208,0.30782029950083195,0.9073690508804191,1.0,10/16,20.89%,STRA6;PAFAH1B1;MYCBP2;TIFAB;SHANK1;AGTPBP1;TPP1;CLN3;DCTN1;UBA5
prerank,negative regulation of stress fiber assembly (GO:0051497),0.47761689178806405,1.1545567871845952,0.3001555209953344,0.9064885122812869,1.0,5/24,4.65%,TMEFF2;MET;ARAP1;PHLDB2;RHPN2
prerank,V(D)J recombination (GO:0033151),0.5530426386306816,1.154549803544658,0.31022530329289427,0.9053932119562156,1.0,6/11,26.81%,DCAF1;TCF3;PRKDC;HMGB2;LIG4;LIG3
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.5645542616598974,1.1538866367730314,0.31478260869565217,0.9064560631036503,1.0,4/11,18.04%,DDIT3;CREB3L3;CEBPB;ATF6
prerank,regulation of protein binding (GO:0043393),0.38356246038572833,1.1537100167337446,0.23508771929824562,0.9059517557133617,1.0,24/114,15.65%,BMP4;TCF7L2;PKD1;HDAC4;LRPAP1;PRKCD;GSK3B;BAMBI;SLPI;RIPK2;IDE;MARK2;KDM1A;USP33;DISC1;MARK3;CSNK1E;TAF1;ADD1;DDX11;LRP1;RAN;ITGB1BP1;PRKACA
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.42724019469860575,-1.1535339827427804,0.2743589743589744,0.7491041105279252,1.0,3/18,4.19%,ACSL1;ELOVL7;ELOVL6
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.5066181986336422,1.153463563535979,0.30755711775043937,0.9055915343973718,1.0,5/17,12.58%,VCP;NPLOC4;OS9;UFD1;FAF2
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.567121722388077,1.1534350135879883,0.3089700996677741,0.9045734259126739,1.0,6/10,14.54%,CD9;PRKCD;SERPINE2;RDX;C1QTNF1;ADAMTS18
prerank,estrogen metabolic process (GO:0008210),0.5310585377321483,1.1533479589318094,0.31150159744408945,0.9037436782805571,1.0,3/15,10.46%,CYP1B1;SULT1A1;CYP19A1
prerank,response to cadmium ion (GO:0046686),0.47017639590333904,1.1530822226335649,0.30634920634920637,0.9034518368553988,1.0,3/26,7.13%,EGFR;CHUK;JUN
prerank,central nervous system myelination (GO:0022010),-0.48333873344517686,-1.152987058276265,0.2778993435448578,0.7490238371890698,1.0,6/11,20.67%,TENM4;PLP1;CNTNAP1;MYRF;B4GALT5;SOX10
prerank,response to nutrient levels (GO:0031667),0.5116741793292912,1.1520218116563194,0.30990415335463256,0.905725561834534,1.0,7/17,21.74%,EIF4G1;FAM107A;KCNB1;MTOR;PRKAA1;ULK1;SCTR
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.5396347434535447,1.1519669992961392,0.3176470588235294,0.9048060890447422,1.0,2/13,7.72%,CD44;KDM1A
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.3761905177709687,-1.1519002280777824,0.2268041237113402,0.7504604414862769,1.0,5/32,7.78%,CDK14;CDK17;TFDP2;BACH1;CDK15
prerank,protein O-linked glycosylation (GO:0006493),0.3946578053537736,1.1518041518204891,0.25547445255474455,0.904239047585343,1.0,19/96,14.64%,ST3GAL4;TMTC1;MUC6;B3GNT2;LARGE1;GALNT15;GALNT13;PLOD2;POGLUT3;POMGNT2;B4GAT1;B3GNT6;GXYLT2;GCNT4;DPM1;LARGE2;ST3GAL2;GALNT11;GALNT14
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.501966687026073,-1.1514767673229114,0.30155210643015523,0.7500303370160614,1.0,2/10,2.30%,ZEB2;RAPGEF2
prerank,cellular response to hormone stimulus (GO:0032870),0.4068434285548821,1.1504616223876556,0.28865979381443296,0.9073840685681068,1.0,13/69,12.38%,SLIT3;SLIT2;RAMP1;GATA1;SOCS2;NR4A3;SERPINB9;KLF9;RDX;BCAS3;ATP1A3;ATP1A1;STAT3
prerank,regulation of apoptotic process (GO:0042981),0.34415510323803605,1.150046574556538,0.11546184738955824,0.9076492503477421,1.0,98/676,12.40%,SLIT2;EGFR;BMP4;THBS1;FSTL1;MAP3K5;GRK5;CARD14;RASSF2;NGF;EGLN3;ARHGAP10;PERP;NDRG1;ANXA1;HOXA5;TGFB3;FOXO3;PTK2B;CD44;CYP1B1;AKAP13;PAWR;TCIM;FBXO10;ITGB1;WNT11;SHC1;TAX1BP1;ANO6;SMAD6;IL10;BIRC7;IP6K2;ANXA4;GSK3B;NOTCH2;ABL1;RIPK3;ARF4;GCLC;TIAM2;GATA1;ARHGEF6;SOCS2;VCP;DDRGK1;BIRC6;GDNF;CALHM2;DIABLO;NFKB1;TRIO;DNAJC3;GOLPH3;SERPINB9;CRADD;ARHGEF5;BCLAF1;RARG;CLU;TFAP2A;ERC1;PLK3;SON;VAV2;JUN;STIL;RIPK2;ATM;DDX42;CREBBP;FATE1;ADAM10;BCL10;UNC13B;BCL6;MOAP1;GNA13;SIX4;ERCC3;FOXA1;QRICH1;UBE2Z;PAK2;AIFM2;RBM25;NIBAN2;PIM2;NAA35;OMA1;SQSTM1;TAF9;USP47;REST;MTDH;BIRC3;BNIP3
prerank,positive regulation of synaptic transmission (GO:0050806),-0.3130666995836023,-1.149824245888614,0.18396226415094338,0.7532186473128238,1.0,27/72,25.14%,SHANK3;NRXN1;ADCY1;RIMS1;RIMS2;GRIN2A;SLC24A2;GRIN2B;CACNG4;FLOT1;GRIK2;CACNG7;APP;CHRNA7;ADCY8;CLSTN3;PRKCZ;CLSTN1;NLGN1;NLGN2;SYT1;BAIAP3;HAP1;STX1B;LGMN;CCL2;GPER1
prerank,positive regulation of transferase activity (GO:0051347),-0.2770641138080933,-1.1497004780905806,0.13934426229508196,0.7518539182587227,1.0,29/142,9.60%,FLT1;IGF1R;TEK;MERTK;PDGFRB;EPHA7;SERINC5;TIE1;KIT;KDR;EPHB4;ROR2;INSR;EPHB1;EPHA4;IGF2;MAPK3;RPS2;SERINC1;UBE2I;PRKCQ;PDGFRA;EPHA8;ERBB4;FLT4;NTRK2;PTGES3;DBI;HSP90AB1
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.38552331073388163,-1.14959411845301,0.24929971988795518,0.7504211403475158,1.0,11/27,16.98%,PRKCH;PPARA;ABCA1;CSF1;NR1H3;IL18;ABCA5;AGT;MAPK9;MSR1;ABCG1
prerank,positive regulation of protein transport (GO:0051222),0.40785793438760787,1.149483105281769,0.2609254498714653,0.9082553285213428,1.0,17/67,12.30%,TGFB3;EZR;BMP6;ADAM9;CNST;ACSL3;GOLPH3;ARHGEF5;PLK3;CEP131;EXPH5;SYTL4;UNC13B;PCM1;BCAS3;TGFB2;ADAM8
prerank,protein maturation (GO:0051604),0.3880709262176348,1.1494255156960862,0.26380368098159507,0.9073273212933691,1.0,18/95,15.15%,F3;PCSK5;DDI2;NAA40;PHEX;MMP16;MMP14;LIPT2;TASP1;ADAM10;DNAJB11;CCS;NAA35;LMF1;PITRM1;CPE;NFU1;XPNPEP3
prerank,vasoconstriction (GO:0042310),0.5454601012455026,1.1488016450643113,0.3204903677758319,0.9082632285608288,1.0,1/11,0.48%,EDNRA
prerank,monocyte differentiation (GO:0030224),0.5703484565867782,1.1481979370938402,0.32432432432432434,0.9090328400399834,1.0,1/10,0.27%,BMP4
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.48771594433291904,1.148148599441742,0.32298136645962733,0.9081268210130946,1.0,6/24,7.67%,PPP1R3B;SORBS1;PPP1R3C;GSK3B;IRS1;DYRK2
prerank,autophagy of nucleus (GO:0044804),0.5107484007887286,1.1480810853207712,0.31125827814569534,0.9072791631189753,1.0,7/16,19.21%,WIPI2;ULK2;ATG3;RB1CC1;ATG2A;ATG7;ULK1
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.4484006341557376,-1.1477969847548477,0.26700251889168763,0.7539798739557921,1.0,6/15,18.00%,RPL5;RPL23;RPS7;LIMK1;RPL11;PARK7
prerank,positive regulation of protein polymerization (GO:0032273),0.41580997573069794,1.1477721920603179,0.27892030848329047,0.9071702322499092,1.0,13/65,13.61%,MET;BAIAP2L1;PTK2B;CDC42EP5;NCK2;FCHSD1;CLIP1;SLAIN2;NCKAP1;TOGARAM1;PRKCE;CTTN;FCHSD2
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.40189948958976895,-1.1475877778850017,0.2809917355371901,0.7528111451319429,1.0,4/22,4.40%,APOE;PPARA;ZBTB20;PPARD
prerank,regulation of blood circulation (GO:1903522),0.4569921342675904,1.1472991259657594,0.3120567375886525,0.907669447022534,1.0,3/34,2.20%,KCNMB2;CAMK2D;AGTR1
prerank,microglial cell activation (GO:0001774),-0.4117480859386215,-1.147124397284959,0.2849162011173184,0.7524531572036967,1.0,10/21,25.29%,SNCA;GRN;MAPT;C1QA;APP;CX3CR1;ITGB2;TYROBP;AIF1;TREM2
prerank,positive regulation of cell motility (GO:2000147),0.36247330504496955,1.1467939666822944,0.20828789531079608,0.9081686770523342,1.0,25/205,6.45%,EGFR;F3;THBS1;NTN1;PDGFC;NTRK3;SMO;PTK2B;SEMA3D;SEMA3C;PPP3CA;CCN1;ITGB1;WNT11;SEMA3E;ADAM9;FAM107A;GCNT2;DDRGK1;PDGFA;TGFBR1;SYNE2;TWIST2;MMP14;TRIP6
prerank,regulation of osteoblast differentiation (GO:0045667),0.3915424903005654,1.1467384236581648,0.2773006134969325,0.9072448360217881,1.0,20/82,13.44%,BMP4;CRIM1;DDX5;CCN1;BMP6;DDR2;SMAD6;BAMBI;BMPR1A;TRPM4;TWIST2;SMOC1;NELL1;WWTR1;SKI;NOG;ACVR1;REST;CHRD;LRP5
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.44646909598839046,1.1465562578181283,0.31332357247437775,0.9067213445599888,1.0,12/35,11.56%,BAIAP2L1;NTRK3;PTK2B;ARHGDIB;SEMA3E;NOTCH2;ABL1;HCLS1;NRP1;BCAS3;CDC42;PHPT1
prerank,regulation of interleukin-4 production (GO:0032673),-0.4067294888453873,-1.1464912211729148,0.28125,0.7526548269983135,1.0,6/21,17.76%,LEF1;SLC7A5;PRKCQ;HAVCR2;SYK;PRKCZ
prerank,secondary palate development (GO:0062009),-0.43980284742897263,-1.1464081272501772,0.2776470588235294,0.7511719601222607,1.0,5/14,7.15%,LEF1;TGFBR3;CHD7;WNT5A;LRRC32
prerank,calcium ion transmembrane import into cytosol (GO:0097553),-0.3487476978074113,-1.145835957164959,0.2542372881355932,0.7512378643691874,1.0,12/41,16.62%,ITPR1;GRIN2A;SLC24A2;GRIN2B;SLC8A1;RYR2;HTR2A;CACNA2D1;GRIN1;RYR3;ERO1A;CCL19
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.5351484528745326,1.1457427021389435,0.3310810810810811,0.9082928542311816,1.0,5/14,18.44%,PKD1;IL10;CCDC22;FAF1;MDFI
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.4453059139514373,1.1454784666118514,0.30071942446043165,0.9080672449205712,1.0,3/38,3.92%,THBS1;BMP5;GSK3B
prerank,dermatan sulfate metabolic process (GO:0030205),0.5422178783322142,1.1450535449743189,0.3385416666666667,0.9083803848845315,1.0,2/13,1.75%,UST;DSE
prerank,regulation of calcium ion import (GO:0090279),-0.41058991534135725,-1.1449119333448237,0.28732394366197184,0.7522523063536991,1.0,7/21,24.48%,PDGFRB;CXCL12;SLC30A1;TRIM27;SPHK2;STC1;CCL2
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.3551548773315911,-1.1446765577026456,0.2262295081967213,0.7511763435991649,1.0,11/36,13.43%,SGMS1;PPIA;BCL2;TPD52L1;FAS;DAB2IP;DAPK2;TMBIM6;RPS3;CX3CR1;TRAF7
prerank,regulation of cell population proliferation (GO:0042127),0.344123073360631,1.1444929616021093,0.12261306532663317,0.9091010855550145,1.0,118/691,12.88%,EGFR;ZBTB7C;BMP4;THBS1;ACER3;TES;GRK5;TCF7L2;NGF;PDGFC;EGLN3;BMP5;NTRK3;FN1;WNT9A;SIX1;TGFB3;HDAC4;PTK2B;CYP1B1;ABI1;RBFOX2;PTPRU;AGTR1;P3H2;FGFR1;SHC1;KRAS;INHBA;BMP6;PGF;KLF4;SMAD6;SMYD2;GAREM1;MYOG;IL10;BIRC7;STRN;GCNT2;LMNA;BAMBI;CDC25B;BMPR1A;SGK3;DDRGK1;BIRC6;PDGFA;TRPM4;GDNF;TGFBR1;NR4A3;KANK2;NCK2;HNF4A;TGFBR2;IRS1;RARG;CLU;HILPDA;ITGAV;TFAP2A;CEP131;HCLS1;FGF22;JAG1;SSTR3;CNOT7;CELF1;PTPN2;JUN;CLCF1;IFI35;ECRG4;KLF10;FGF2;GAB2;TGFB1I1;BAP1;MVD;JUP;HES1;WWTR1;ADAM10;TOB1;CYP27B1;MDM4;FUZ;CDKN1B;BCL6;CGREF1;FABP3;SIX4;P3H1;FRK;SKI;NOX1;DIS3L2;GATA3;NIBAN2;PIM2;IRF1;CSNK2A1;BEX4;GTPBP4;NPR3;TGFB2;ZBTB49;RHOA;REST;IGFBP6;STAT3;PTPN14;PLPP1;SLURP1;HTR2B;STAT5A;KAT2B
prerank,negative regulation of viral life cycle (GO:1903901),-0.4467484029050818,-1.1443926312453383,0.279126213592233,0.7503987560823372,1.0,5/15,10.24%,LY6E;PPIA;BST2;IFITM1;IFITM3
prerank,regulation of cellular protein localization (GO:1903827),0.42186388192613994,1.1441328149541259,0.2937062937062937,0.9091359392281622,1.0,16/45,21.13%,GPC6;GPC3;NDEL1;VCP;GPC4;KDM1A;CSNK1E;SETD2;CCDC66;PRKAA1;GBF1;PTPN1;VCPIP1;MAP1A;HFE;EGF
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.47161658363335546,-1.144115734945622,0.3143507972665148,0.749547603700842,1.0,2/12,2.19%,NKD1;PROM1
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.3660241728538241,1.1438978469735046,0.22135706340378197,0.9088380925596861,1.0,49/173,20.30%,ANK2;CD55;ATL3;SPTAN1;ERGIC1;GOLGB1;SEC24B;ARF4;STX5;ERGIC2;DYNC1I1;TMED5;CNIH4;CNIH2;DCTN6;ATL2;TRAPPC3L;NSF;SEC13;LMAN2L;DYNC1LI2;VAPA;SEC22B;VTI1A;SAR1B;TRIP11;TRAPPC12;COG3;CAPZA1;TRAPPC4;CAPZA2;GOPC;SEC24A;ARCN1;DCTN3;BCAP29;COG5;TICAM2;GBF1;WHAMM;AREG;USO1;COPA;GOLT1A;DCTN1;SEC23A;VAPB;BET1L;TRAPPC6B
prerank,fatty acid elongation (GO:0030497),-0.4638230541619822,-1.143562748417756,0.3194103194103194,0.7495285384603655,1.0,3/13,9.35%,ELOVL7;ELOVL6;ELOVL4
prerank,regulation of fatty acid oxidation (GO:0046320),-0.4423584353984383,-1.1435590187829372,0.2755102040816326,0.7478699017469348,1.0,4/16,8.69%,PPARA;PRKAG2;PPARGC1A;ACADL
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.44988996377570095,1.1434949961054346,0.3089311859443631,0.9090513239802975,1.0,11/33,15.61%,THBS1;KLF4;MEOX2;ATP2B4;FGF2;JUP;AGTR2;RHOA;MAP2K5;STARD13;ITGB1BP1
prerank,positive regulation of cell migration (GO:0030335),0.3536874125024048,1.1434654928462762,0.2163308589607635,0.9080509588546404,1.0,28/253,6.45%,EGFR;F3;DOCK5;THBS1;PDGFC;NTRK3;FN1;SMO;PTK2B;SEMA3D;SEMA3C;PPP3CA;CCN1;ITGB1;WNT11;DDR2;SEMA3E;ADAM9;FAM107A;GCNT2;DDRGK1;PDGFA;TGFBR1;SYNE2;TWIST2;SHTN1;MMP14;TRIP6
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.33381377043098065,-1.1432724414376516,0.22988505747126436,0.7470432420948403,1.0,16/51,9.42%,LIMCH1;PPM1E;RAPGEF3;CD47;PAK1;CCDC88A;CCN2;EVL;ARHGEF15;SYNPO;RGCC;SYNPO2;FHOD1;LPAR1;PLEK;RAC1
prerank,regulation of protein tyrosine kinase activity (GO:0061097),-0.35132497036582644,-1.1431607075143133,0.254416961130742,0.7456747056850374,1.0,10/38,13.28%,IL34;GRM5;ACE;NEDD9;EPHA4;GPRC5B;LRP8;GAS6;APP;AGT
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.4913177940728054,1.1431376506317432,0.3015625,0.908011241140304,1.0,3/21,6.99%,SAMD4A;PAN3;CNOT7
prerank,regulation of cell cycle phase transition (GO:1901987),0.39137541766711964,1.1431000675645921,0.2850182704019488,0.9070696563147305,1.0,24/91,23.72%,FZR1;TCIM;ANAPC5;ATP2B4;ANAPC16;CDC16;CDKN1B;ERCC3;TAF1;PSMC6;XPC;UBE2S;PSMD8;PSMB1;PSMD13;PSMD1;PSMD7;PSMA8;PSMD3;PSMD2;CDK1;PSMC2;ERCC2;PSMB2
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.4449103637096985,-1.1430962629647623,0.29562982005141386,0.7442229914563288,1.0,8/16,14.32%,RANBP3L;PLCB1;IGFBP3;RIPOR2;MEF2C;BTG1;AKIRIN1;LRRC8A
prerank,detection of visible light (GO:0009584),0.5213991044199616,1.1429476202323539,0.3183279742765273,0.906480117438279,1.0,1/16,1.07%,RP1
prerank,dendrite self-avoidance (GO:0070593),-0.44455754212174964,-1.1429331676879089,0.30465116279069765,0.7430579907999407,1.0,5/16,10.98%,BSG;CNTN4;CNTN2;ROBO4;PALLD
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.4810763945196186,1.1428869367684333,0.3056426332288401,0.9056012055097555,1.0,8/24,11.12%,CYP1B1;SULF1;ISL1;GATA4;HPSE;NOX1;SULF2;EIF2AK3
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.4543428474819291,-1.14266979434637,0.3140096618357488,0.7422038095615662,1.0,6/14,28.56%,BCL2L1;TMBIM6;LRRK2;PARK7;SELENOS;XBP1
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.3874267138079749,1.1425794663863473,0.2838323353293413,0.9055167647385307,1.0,24/94,16.35%,MAP3K5;DDX5;CYP1B1;TMEM117;FHIT;PRKCD;ABL1;DDIT3;DIABLO;ATM;TNFRSF1B;CHEK2;MOAP1;QRICH1;IKBKE;BNIP3;CUL4A;SFN;CEBPB;ARL6IP5;STK11;ERN2;PML;PRKDC
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.3613123629831319,1.1423311859948562,0.24861878453038674,0.9052295854521233,1.0,44/166,18.62%,NR3C2;RARB;ESR2;NR2F1;HDAC9;NOTCH2;POLR1G;NR4A2;NR4A3;HNF4A;RARG;TBL1X;TAF1C;NR6A1;HDAC10;CREBBP;WWTR1;TEAD1;MNAT1;E2F3;ERCC3;TAF1;POLR1A;TAF9;CRCP;RXRA;KAT2B;POLR1H;GTF2F2;TAF15;POLR1F;RRN3;TAF12;SNW1;TAF1D;MED27;MED17;RORA;NR4A1;GTF2E1;AR;E2F2;BRF1;POLR2H
prerank,cardiac ventricle morphogenesis (GO:0003208),0.4289259827895564,1.1421112348371465,0.28695652173913044,0.9048059638412755,1.0,9/41,11.71%,BMP4;ISL1;BMPR1A;TNNI3;TGFBR2;JAG1;GATA4;GATA3;TGFB2
prerank,regulation of presynapse assembly (GO:1905606),0.49902441659633223,1.1420117414296336,0.32802547770700635,0.902976772492329,1.0,3/18,7.41%,GPC6;EIF4G1;GPC4
prerank,regulation of presynapse organization (GO:0099174),0.49902441659633223,1.1420117414296336,0.32802547770700635,0.902976772492329,1.0,3/18,7.41%,GPC6;EIF4G1;GPC4
prerank,gluconeogenesis (GO:0006094),-0.35450933281253716,-1.1418509907629106,0.26557377049180325,0.7429561587986475,1.0,11/39,15.19%,RBP4;PPARGC1A;MDH1;GAPDH;ALDOC;PGAM1;ENO2;ALDOA;CRTC2;PGM1;SLC25A11
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),-0.5016118933625475,-1.1417660532098535,0.2975929978118162,0.7415685862670003,1.0,7/10,20.17%,PDE4D;PDE2A;PDE11A;PDE3A;PDE3B;RNF157;APLNR
prerank,regulation of leukocyte activation (GO:0002694),-0.4587774292000626,-1.1415965991957293,0.3117206982543641,0.7404670720626159,1.0,3/14,5.24%,LYN;MFHAS1;MYO18A
prerank,regulation of macrophage chemotaxis (GO:0010758),0.4857933740197475,1.1414693314972453,0.33124018838304553,0.9036741443486306,1.0,3/21,3.12%,THBS1;PTK2B;MTUS1
prerank,positive regulation of endocytosis (GO:0045807),-0.3386112483732006,-1.1414448802411121,0.21660649819494585,0.7392758570793729,1.0,6/45,4.67%,VTN;APOE;SGIP1;B2M;NEDD4L;SNCA
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.44342983230572,-1.1413416596392254,0.26515151515151514,0.7379483638193373,1.0,9/15,33.76%,RUVBL1;CCT5;RUVBL2;CCT2;SHQ1;NOP10;DKC1;NHP2;CCT8
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.4857424945751482,-1.1412423330921517,0.29772727272727273,0.7365753371507051,1.0,3/11,10.71%,EFNB2;MEF2C;MYOCD
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.3476327492215478,-1.1409853143378437,0.2534722222222222,0.7355904033942468,1.0,17/40,28.47%,IGF1;TNFSF10;PDCD5;BCL2L1;BMF;AKT1;BIK;MLLT11;DNM1L;BAD;PLAUR;GPER1;TRIAP1;GHITM;HRK;PMAIP1;TP53
prerank,protein localization to membrane (GO:0072657),0.35902037246557034,1.1407504684378045,0.24052004333694474,0.9048991682465584,1.0,23/187,7.87%,CDH1;KCNB2;ANK2;ATP1B1;SLMAP;EZR;MRAP;RAMP1;LRP6;TTC7A;RAP1A;RAPGEF6;EHD3;KCNB1;RABEP1;FRMPD1;PIP5K1A;GAK;DLG1;ARL3;PRAM1;FGF13;JUP
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.34589523158061397,-1.1399491281661742,0.25510204081632654,0.7370613572522209,1.0,10/35,11.52%,ITGA1;PDGFRB;CALM1;NUAK1;PPP4R4;CALM3;CD300A;HSP90AB1;TIPRL;HSP90B1
prerank,lipid droplet organization (GO:0034389),0.48318728081639123,1.13986255819223,0.315625,0.906612057057872,1.0,7/22,16.58%,PNPLA3;ZFYVE1;HILPDA;RAB18;CDS1;FAF2;BSCL2
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.525226252215953,1.1398398272428658,0.35084745762711866,0.9056309602247372,1.0,5/13,12.11%,BMP5;NFKB1;ERLIN1;CYP27B1;REST
prerank,B cell differentiation (GO:0030183),0.4260776685798951,1.139671215858688,0.30097087378640774,0.9051180959616789,1.0,8/46,9.43%,HDAC4;ITGB1;HDAC9;IL10;PTPN2;CLCF1;DCAF1;TCF3
prerank,mitochondrion transport along microtubule (GO:0047497),-0.4606419709046684,-1.139488987031881,0.29238329238329236,0.736770384770102,1.0,5/13,18.56%,HIF1A;MAPT;UBB;SYBU;NEFL
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.47998086644362803,1.1388756408072462,0.3158756137479542,0.906553049616981,1.0,5/22,17.51%,NEDD4;RNF115;UBAP1;TSG101;VPS37A
prerank,tRNA wobble base modification (GO:0002097),0.5365148649641909,1.1386038571636288,0.3445378151260504,0.9063423409586429,1.0,8/14,23.15%,CTU2;MOCS3;MTO1;ELP4;GTPBP3;ALKBH8;KTI12;URM1
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.464229860716386,1.1385930373145619,0.3031674208144796,0.9053178159959552,1.0,7/29,15.85%,THBS1;INHBA;BCL10;AGTR2;PAK2;PPP2R1B;PML
prerank,negative regulation of catabolic process (GO:0009895),0.4256433570881521,1.1384982449965197,0.2885714285714286,0.9045687580482136,1.0,11/47,18.50%,EGFR;HDAC4;MDM4;SNX12;PRKAA1;BSCL2;FLNA;HMGCR;PFKFB1;AZIN1;ZDHHC7
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.4249196945704918,1.1382867257671037,0.2834008097165992,0.9041976684243491,1.0,17/49,21.17%,THBS1;GATA1;TNRC6C;NR4A3;MOV10;EP300;CBFB;RAB7B;KAT2B;KMT2C;KMT2D;PRMT6;ASH2L;TNRC6A;KMT2A;THPO;EIF6
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.4012244720745969,-1.1382713322903097,0.2966751918158568,0.7388219603148931,1.0,7/22,13.39%,AEBP1;APOE;MAP2;HSPA8;MAPT;EFEMP2;CHRNA7
prerank,cilium organization (GO:0044782),0.3572029740405247,1.1380042361741656,0.2502685284640172,0.9040552630993783,1.0,59/210,20.73%,ABLIM3;PKD1;BBS9;PARVA;EXOC4;GSN;EHD3;ARF4;CFAP70;PDE6D;DZIP1;EXOC5;CEP164;ATAT1;ARL3;ABCC4;CEP131;RAB11FIP3;SSTR3;FAM161B;OCRL;MKS1;TTC17;TMEM237;FUZ;TMEM231;PCM1;PTPDC1;DISC1;KIF27;ARMC9;IFT122;EHD1;DNAH5;PIBF1;POC1B;CCDC66;GALNT11;ATP6V0D1;IFT88;RAB17;DYNC2I2;RILPL1;FLNA;CEP89;CEP20;IFT80;GBF1;NUDCD3;DZIP1L;CDC14A;EHD2;TEKT2;HYLS1;TRAF3IP1;EXOC7;EXOC1;ODF2;LZTFL1
prerank,barbed-end actin filament capping (GO:0051016),0.49569891411530764,1.1379737675887365,0.32730263157894735,0.9020468175430766,1.0,7/18,14.38%,VILL;ADD3;GSN;TRIOBP;CAPZA1;ADD1;CAPZA2
prerank,actin filament capping (GO:0051693),0.49569891411530764,1.1379737675887365,0.32730263157894735,0.9020468175430766,1.0,7/18,14.38%,VILL;ADD3;GSN;TRIOBP;CAPZA1;ADD1;CAPZA2
prerank,epidermis development (GO:0008544),0.4106115989898209,1.1377193261083303,0.2837653478854025,0.9018044128432569,1.0,7/56,5.06%,DSP;GRHL1;KRT14;SPRR1A;KRTDAP;EMP1;CRABP2
prerank,negative regulation of protein polymerization (GO:0032272),0.4583188237985262,1.1371567129022104,0.32884902840059793,0.9024567857468573,1.0,2/27,2.76%,SLIT2;PRKCD
prerank,regulation of neurotransmitter secretion (GO:0046928),-0.37005523894475034,-1.13710200559547,0.2415902140672783,0.7407503830498374,1.0,11/32,12.04%,MCTP1;RIMS1;RIMS2;MEF2C;SYN1;SYT11;LRRK2;CAMK2A;MCTP2;SLC30A1;CPLX1
prerank,phospholipid biosynthetic process (GO:0008654),0.4461002575270509,1.1368422914882568,0.2925764192139738,0.9024141204850931,1.0,18/36,27.94%,DHDDS;SGMS2;PIP5K1A;MVD;FDPS;GNPAT;CPNE3;AGPAT4;AGPAT5;MBOAT1;CLN3;AGK;FADS1;FAR1;CPNE1;SRD5A3;HDHD5;DOLK
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.3909555464855788,1.1368320987336906,0.275,0.9013989304749389,1.0,25/88,23.72%,FBXL7;FBXW11;FBXO4;FBXL6;FBXL20;FBXO17;CUL4A;PSMC6;FBXL14;FBXL4;FBXW5;PSMD8;PSMB1;FBXL17;PSMD13;FBXL8;PSMD1;PSMD7;PSMA8;PSMD3;PSMD2;PSMC2;DMAC2;FBXL3;PSMB2
prerank,regulation of protein transport (GO:0051223),0.45430673734866656,1.1365212257197295,0.32680722891566266,0.9013121522681562,1.0,13/27,24.48%,DISP1;WWP2;NDEL1;ARFIP1;P3H1;GAPVD1;SNX12;PTPN1;CHP1;LLGL1;RHBDF1;DNAJC1;STXBP5L
prerank,peptidyl-lysine monomethylation (GO:0018026),0.5630851225039025,1.1363695332067538,0.3523489932885906,0.9007322367252595,1.0,6/10,28.14%,SMYD2;SETD2;EHMT1;METTL18;KMT5A;SETD4
prerank,negative regulation of oxidoreductase activity (GO:0051354),-0.49387500848144533,-1.1360096980945444,0.3089622641509434,0.7423706328731009,1.0,4/10,32.18%,SNCA;AOC3;MT3;HP
prerank,cellular response to mechanical stimulus (GO:0071260),0.4246161632174713,1.1358457283477466,0.30013831258644535,0.9012310076036045,1.0,9/46,12.40%,PIEZO2;NFKB1;CRADD;BCL10;IRF1;CHEK1;TLR4;SLC9A1;BNIP3
prerank,hepaticobiliary system development (GO:0061008),0.48989042741202116,1.13572528250519,0.33544303797468356,0.900573578414542,1.0,3/20,5.75%,MET;COBL;PRKCSH
prerank,monocarboxylic acid transport (GO:0015718),0.41410749405678465,1.134937263142802,0.2929427430093209,0.9020036476371351,1.0,12/51,12.35%,SLCO3A1;SLC5A6;SLC16A9;SLC16A1;SLCO2A1;ABCG2;ATP8B1;ABCC4;SLC26A6;SLC16A13;CD36;RXRA
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.3722423555928832,-1.134861527822058,0.26099706744868034,0.7440892497690047,1.0,11/28,18.42%,MAP2K6;NOD1;RPS27A;UBC;IRAK2;LACC1;TAB2;UBB;AAMP;TNFAIP3;RELA
prerank,cellular protein modification process (GO:0006464),0.3383121972560184,1.1345954350328502,0.093,0.9020579741054703,1.0,211/983,16.98%,STK39;FBXL7;MSLN;ST3GAL4;BMP4;DCLK1;THBS1;FSTL1;MAP3K5;GRK5;EGLN3;STK19;UST;FN1;ANXA1;PTPN3;PTP4A2;MARK1;PTK2B;ZBTB16;PPP3CA;CCN1;DSP;FBXO40;CAMK2D;PTPRU;FBXO10;LIMK2;WNT11;FGFR1;WNK1;GPC3;WWP2;PRKCD;HIPK1;MKNK2;COL3A1;NEK7;B3GNT2;LARGE1;ASB9;TGM3;ASB16;BCR;SPRR1A;GCNT2;WIPI2;DCAF6;GSK3B;PPM1H;ABL1;KLHL13;CDC25B;RIPK3;PLOD2;BMPR1A;CHST5;SGK3;ARF4;SIK3;IGFBP5;SOCS2;FBXW8;BIRC6;PHKA2;TLK1;DUSP16;MPI;ASB11;TGFBR1;DNAJC3;KLHL22;PRKCSH;BMP15;PHEX;TGFBR2;SIK2;PPEF2;TGM1;ATG3;FBXW11;WDTC1;UBE2F;TNKS2;CHUK;PTPN21;ATM;LOXL1;MARK2;DYRK2;DUSP10;BAP1;IP6K3;KTN1;LRRC41;HIF3A;ADAM10;ASB14;FBXO32;EIF2AK4;UBE2D3;B3GNT6;FBXO4;CDC42BPG;DYRK3;CLK2;CHEK2;PIGU;PTPRF;MACROD2;DAPP1;PRSS23;PTPRA;ASB1;CSNK1G3;P3H1;FRK;PPM1A;CCDC22;DUSP5;FBXL20;MARK3;MTOR;COMMD1;PAK4;CSNK1E;B4GALT7;PKN2;PAK2;GNMT;PIM2;TAF1;EIF2AK3;FBXO17;PPP1R12A;CHEK1;FBXW2;TRIOBP;ACVR1;CSNK2A1;ERCC8;PHPT1;GOLM1;TGFB2;CSK;USP25;IKBKE;NLK;PRKCE;AAK1;PTPN14;CUL4A;CSNK1A1;YES1;COG3;MAPK1;ST3GAL2;PPP5C;SRPK1;MORC3;METAP1D;DUSP11;PPP2R1B;COPS7B;PPP3CC;KLHL11;COPS5;DUSP12;PSMC6;CAMK4;ILK;FBXL14;UFL1;RAB5A;CPE;AMHR2;WSB2;CDK12;STK11;PPP4R1;MBTPS1;FBXL19;FAM20A;AMELX;PRKAA1;ERN2;CDK18;PRKCA;PRKACA;PTPN9;CSNK1D;NPC1;WNK3;COQ8A;CDKL2;MEX3B;MAP3K12;PRKDC;PPP4R2;CHM;FBXL4;UBE2S;MAP4K1;FBXW5;PSMD8;PIGH;TAOK3;FEM1B;JMJD4;PPP2CB;COP1
prerank,vesicle organization (GO:0016050),-0.34016452624756577,-1.134014369585084,0.2825278810408922,0.7449363526320024,1.0,12/46,18.34%,SORT1;FNBP1L;SRGN;CD34;AKTIP;ALS2;DNAJC13;HOOK1;WASL;EPS15;EXOC8;LAMTOR1
prerank,B cell homeostasis (GO:0001782),-0.5049857329114559,-1.1339086395002262,0.31042128603104213,0.743635689241458,1.0,4/10,6.59%,DOCK10;LYN;DOCK11;MEF2C
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.41464283093491483,-1.133822800897684,0.30666666666666664,0.742263137283421,1.0,10/19,33.76%,CORO2B;CEP120;CCT5;CCT2;TREM2;CEP135;CENPJ;DKC1;PTP4A3;CCT8
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.4144712419995041,1.1336835539906003,0.29551820728291317,0.9039886265943307,1.0,14/52,15.77%,EGFR;SORBS1;ITGB1;EPB41L2;DLG1;ATP2B4;AGR2;PLS1;SQSTM1;PRKCE;ZDHHC5;LRP1;PTPN9;WNK3
prerank,zymogen activation (GO:0031638),0.4386279669303478,1.133598412874085,0.3285917496443812,0.9032027849265255,1.0,7/39,11.64%,CYFIP2;PERP;MMP14;RIPK2;TBC1D10A;PRSS12;OMA1
prerank,regulation of protein autophosphorylation (GO:0031952),-0.35874185279227533,-1.1333122195538197,0.27181208053691275,0.7420955423617756,1.0,7/36,3.48%,ERRFI1;ENG;PDGFD;EPHA7;ENPP1;CALM1;RAP2A
prerank,positive regulation of ATP metabolic process (GO:1903580),0.44958381850309276,1.1328980427489135,0.33285094066570187,0.9043613118454379,1.0,5/32,7.08%,SLC4A4;PID1;PFKFB2;VCP;GAPDHS
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.4768193957675281,1.1323519804978908,0.3194029850746269,0.905027206992865,1.0,7/22,12.30%,PTPN3;ADAM9;IL10;TIMP2;TNFRSF1B;SH3D19;ADAM8
prerank,inhibitory synapse assembly (GO:1904862),-0.47453777233808764,-1.1322450114958007,0.3212669683257919,0.7436275746850617,1.0,4/11,9.37%,WNT5A;GABRA1;GABRA2;GABRB2
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.40876875964422044,1.1322225144206288,0.30241423125794153,0.9044052436952394,1.0,9/62,4.00%,NGF;MAPRE2;STK19;GPR4;AKAP13;SHC1;COL3A1;LPAR4;NOTCH2
prerank,homeostasis of number of cells (GO:0048872),0.5448727795299706,1.1320456697101535,0.3555956678700361,0.9039388349291271,1.0,1/12,0.45%,CCN3
prerank,regulation of Rho protein signal transduction (GO:0035023),0.4041932866364312,1.1318958523972866,0.2951885565669701,0.9033896101569697,1.0,11/72,5.57%,MET;ARHGEF28;GPR4;ARHGDIB;AKAP13;CCDC125;COL3A1;LPAR4;BCR;ABL1;KANK2
prerank,regulation of vasculogenesis (GO:2001212),-0.43977619978782845,-1.131793636322668,0.2960199004975124,0.7433496236320037,1.0,6/14,16.86%,RAPGEF2;KDR;CD34;HEY2;HEY1;RIN2
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.5234590543384351,1.1316222962278941,0.3441226575809199,0.9031411773314032,1.0,5/13,18.86%,DDRGK1;BFAR;UFL1;WFS1;PTPN1
prerank,clathrin-dependent endocytosis (GO:0072583),-0.3814984187400965,-1.1312992109824758,0.27170868347338933,0.7431600323921972,1.0,6/26,5.58%,DNAJC6;SGIP1;PICALM;FNBP1L;INPP5F;PIP5K1C
prerank,negative regulation of mitochondrion organization (GO:0010823),-0.36195457760692074,-1.1311456024304385,0.23893805309734514,0.742008087219998,1.0,9/33,16.65%,IGF1;TFRC;BCL2L1;MAPT;TMEM14A;VAT1;IAPP;AKT1;FLCN
prerank,inositol phosphate biosynthetic process (GO:0032958),0.5401563522503325,1.1311413911297175,0.3357271095152603,0.9035983323113614,1.0,4/11,8.07%,IP6K2;FGF2;IP6K3;PPIP5K2
prerank,sphingolipid catabolic process (GO:0030149),0.5188333949370175,1.131050812767298,0.3456998313659359,0.9028326483088633,1.0,2/15,3.31%,ACER3;PDXDC1
prerank,sulfur compound biosynthetic process (GO:0044272),0.37420495874678944,1.1298927898186417,0.2684085510688836,0.9053730990643737,1.0,13/104,8.62%,ST3GAL4;SLC26A2;UST;DSE;GLCE;B3GNT2;CHST13;CHST5;GCLC;PAPSS2;CDO1;SLC10A7;B4GAT1
prerank,negative regulation of multicellular organismal process (GO:0051241),0.3498544287255924,1.1297566077429133,0.2508214676889376,0.9047522369263379,1.0,35/199,11.66%,EGFR;BMP4;BMP5;NFIB;ARHGDIB;LRPAP1;WNT11;HDAC9;SMAD6;DOCK7;IL10;GSK3B;DDIT3;KLF7;SPRED2;FOXC2;ZNF423;ADAMTS5;ID1;RAB11FIP3;ATP2B4;DUSP10;ABHD6;IL17RD;ASB1;BRCA2;FOXA1;SRSF6;GATA3;NKX2-1;TIFAB;RB1;TLE3;TLR4;NPR3
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.39623568364766004,-1.129698779929734,0.28388746803069054,0.7446207528958159,1.0,9/22,16.54%,LYN;MFHAS1;NR1H3;DAB2IP;FLOT1;NINJ1;APPL2;TNFAIP3;TIRAP
prerank,regulation of neuron apoptotic process (GO:0043523),0.38119008118536335,1.1296913384183822,0.2822966507177033,0.9039364889010083,1.0,13/96,7.90%,NGF;EGLN3;SIX1;TGFB3;FOXO3;PTK2B;ISL1;KCNB1;DDIT3;GDNF;TFAP2A;CLCF1;NFATC4
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.44221481096611354,1.1295901457648685,0.3066104078762307,0.9032308725336091,1.0,15/40,20.05%,PTK2B;XPO1;CLU;CCDC22;COMMD1;TAF1;CSNK2A2;CSNK2A1;RAD23B;SMURF1;UFL1;PML;DESI1;NUB1;HFE
prerank,positive regulation of filopodium assembly (GO:0051491),0.4745474016146066,1.1295277433079596,0.31738437001594894,0.9024175363913709,1.0,8/24,10.90%,DPYSL3;TGFB3;ARAP1;PALM;NRP1;RHOQ;BCAS3;CDC42
prerank,magnesium ion transport (GO:0015693),0.5244822000160343,1.1293925011963537,0.34615384615384615,0.9018005176669559,1.0,5/12,17.47%,CNNM4;NIPAL2;NIPAL1;NIPA2;MRS2
prerank,sympathetic nervous system development (GO:0048485),0.5194065351044764,1.1290939426878988,0.33156028368794327,0.9016870314005113,1.0,4/15,16.85%,GDNF;NRP1;GATA3;FZD3
prerank,positive regulation of glycolytic process (GO:0045821),0.48728965580612293,1.1289100009607147,0.33386581469648563,0.9002626816127253,1.0,3/20,7.08%,SLC4A4;PFKFB2;GAPDHS
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.48728965580612293,1.1289100009607147,0.33386581469648563,0.9002626816127253,1.0,3/20,7.08%,SLC4A4;PFKFB2;GAPDHS
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.3882593466735311,1.128887733219115,0.2795969773299748,0.8993111617149645,1.0,16/78,12.47%,EGFR;SORBS1;MRAP;ITGB1;PID1;MMP14;DLG1;STX8;ATP2B4;PPFIA1;RHOQ;AGR2;PLS1;SQSTM1;PRKCE;ZDHHC5
prerank,cellular response to misfolded protein (GO:0071218),0.494082420685845,1.1286471900251507,0.31484502446982054,0.899058462540778,1.0,5/20,12.68%,RNF185;VCP;UFD1;UGGT2;UBE2W
prerank,negative regulation of cell population proliferation (GO:0008285),0.34544058922876725,1.1284709278839966,0.2255406797116375,0.898598457756347,1.0,68/351,12.88%,ZBTB7C;BMP4;CCN3;TES;NGF;BMP5;WNT9A;TGFB3;PTK2B;CYP1B1;ABI1;PTPRU;P3H2;INHBA;KLF4;SMAD6;SMYD2;MYOG;IL10;GDF5;STRN;LMNA;IGFBP5;KANK2;NCK2;HNF4A;RARG;TFAP2A;SSTR3;CNOT7;CELF1;PTPN2;IFI35;KLF10;TGFB1I1;DUSP10;NELL1;BAP1;HES1;TOB1;CYP27B1;MDM4;FUZ;CDKN1B;CGREF1;FABP3;P3H1;E2F3;PER2;FRK;SKI;DIS3L2;GATA3;B4GALT7;NIBAN2;PIM2;NOG;IRF1;GTPBP4;TGFB2;ZBTB49;PEX2;REST;IGFBP6;PTPN14;PLPP1;SLURP1;KAT2B
prerank,cellular response to tumor necrosis factor (GO:0071356),0.36091451430977545,1.1283685146951372,0.25,0.8979025012702829,1.0,38/175,20.76%,TNFRSF11B;CARD14;EDA;FOXO3;PTK2B;TANK;PID1;YBX3;TNFRSF13B;NFE2L2;TNFSF11;CHUK;TNFRSF4;TNFRSF1B;CDIP1;ACOD1;GATA3;HYAL3;TNFRSF14;BIRC3;TRADD;TRAF5;PSMC6;ERBIN;ILK;TNFRSF13C;DHX9;PSMD8;NPNT;EDA2R;ZFP36L1;ADAMTS7;PSMB1;PSMD13;PSMD1;PSMD7;PSMA8;CCL15
prerank,cortical cytoskeleton organization (GO:0030865),0.4272203142422782,1.1280647680887834,0.31955922865013775,0.8977953734525788,1.0,10/41,11.89%,FMNL2;EZR;PPP2R3C;DLG1;NCKAP1;RHOQ;FMNL3;FHOD3;RHOBTB1;RHOA
prerank,regulation of viral transcription (GO:0046782),-0.34905063648058315,-1.1279531712117394,0.2842809364548495,0.7481814879961428,1.0,15/39,22.65%,TRIM14;TRIM62;IFITM3;TRIM21;TRIM27;NELFCD;NELFA;POLR2K;TARBP2;LARP7;POLR2C;POLR2G;TRIM32;SUPT4H1;POLR2L
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.4943952132768493,1.1279443036395749,0.326158940397351,0.8971345140007743,1.0,4/18,11.87%,NUP93;DDX19B;NXF1;THOC2
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.5680926398924111,1.127557586556327,0.37076648841354726,0.896362075832677,1.0,3/10,10.90%,CDC42EP5;WASHC1;CDC42
prerank,regulation of pseudopodium assembly (GO:0031272),0.5680926398924111,1.127557586556327,0.37076648841354726,0.896362075832677,1.0,3/10,10.90%,CDC42EP5;WASHC1;CDC42
prerank,extracellular transport (GO:0006858),0.5255334055416306,1.1274354263472492,0.334525939177102,0.8957319405475466,1.0,4/13,13.59%,WWP2;CCDC40;SPAG17;TSG101
prerank,protein O-linked mannosylation (GO:0035269),0.4923169532790048,1.127285758403846,0.3354943273905997,0.8952074519792533,1.0,6/18,12.90%,TMTC1;LARGE1;POMGNT2;B4GAT1;DPM1;LARGE2
prerank,protein polymerization (GO:0051258),0.4142942500817601,1.1269634014843495,0.3147410358565737,0.8951387318827041,1.0,10/56,8.14%,COBL;FAM107A;GSN;DIAPH1;HDGFL3;MAP7D3;MSRB2;RNF135;FGF13;TTC17
prerank,negative regulation of immune effector process (GO:0002698),-0.4596370934567545,-1.1269182122691215,0.31873479318734793,0.7496875304872331,1.0,6/13,10.99%,CD47;GRN;RPS19;ENPP3;CD300A;HAVCR2
prerank,intracellular sterol transport (GO:0032366),-0.449236495712652,-1.1261433560424519,0.3497536945812808,0.7504889190493897,1.0,5/13,16.98%,ABCA1;NPC2;OSBP;RELCH;ABCG1
prerank,macrophage activation (GO:0042116),0.44304786581402444,1.12596407185357,0.31366906474820144,0.8971796219800111,1.0,4/34,7.28%,FOXP1;LBP;CLU;IFI35
prerank,negative regulation of synaptic transmission (GO:0050805),-0.39366499066138666,-1.1259405214778182,0.300531914893617,0.7494628086656742,1.0,11/23,34.71%,SLC24A2;SYT11;LRRK2;SLC30A1;GRIK3;MTMR2;CBLN1;ATAD1;ACHE;PLK2;SLC24A1
prerank,establishment of skin barrier (GO:0061436),0.5174768785232934,1.1246348526256087,0.3415061295971979,0.899223437802613,1.0,1/15,0.68%,MET
prerank,regulation of water loss via skin (GO:0033561),0.5174768785232934,1.1246348526256087,0.3415061295971979,0.899223437802613,1.0,1/15,0.68%,MET
prerank,protein import (GO:0017038),0.38856304620687265,1.1245348539294424,0.2846251588310038,0.8985307736079133,1.0,24/84,19.53%,ABCD3;NUP93;PXMP2;IPO7;SAMM50;CLU;PRICKLE1;SEC13;E2F3;SLC25A17;NUP188;TNPO2;PEX2;STAT3;HEATR3;ACBD5;FAM53A;RAN;PEX12;NUP107;HSPA4;IPO8;FIS1;PEX16
prerank,regulation of monooxygenase activity (GO:0032768),0.46473474227056366,1.1244167916431005,0.3273905996758509,0.8978808366532408,1.0,2/23,5.16%,EGFR;GDNF
prerank,transition metal ion homeostasis (GO:0055076),-0.3749817694939533,-1.124326812466055,0.2997032640949555,0.7525397855215729,1.0,4/28,4.23%,CP;B2M;PICALM;SLC40A1
prerank,cellular metal ion homeostasis (GO:0006875),0.3728196355611813,1.124325679138841,0.300357568533969,0.8971633652232084,1.0,9/102,3.79%,KCNJ2;SLC12A2;SLC24A3;ANK2;ATP1B1;ATP2C2;CSRP3;CLDN16;STIM2
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.3836538868196566,-1.1237450558759203,0.3017241379310345,0.7526260427934452,1.0,9/24,15.94%,MAP2K6;NOD1;RPS27A;UBC;IRAK2;TAB2;UBB;AAMP;TNFAIP3
prerank,positive regulation of vasculogenesis (GO:2001214),-0.480488820191596,-1.1235132789265103,0.34279475982532753,0.7517505785067721,1.0,3/10,4.54%,RAPGEF2;KDR;CD34
prerank,protein polyubiquitination (GO:0000209),0.34519494132818673,1.123412105135333,0.2249208025343189,0.899025241158003,1.0,77/297,22.28%,FBXL7;FZR1;WWP1;TRAF3IP2;NEDD4;FBXO40;FBXO10;UBE4B;NPEPPS;WWP2;RNF115;UBE2B;RNF19A;FBXW8;ANAPC5;FBXW11;ARIH1;TRIP12;TNKS2;LRSAM1;RNF135;FBXO32;UBE2D3;CDC16;FBXO4;CBFB;RNF168;MKRN1;FBXL20;ARIH2;TAF1;FBXO17;UBR5;FBXW2;ERCC8;UBE2W;BFAR;TRAF5;RNF31;SMURF1;PSMC6;UBE4A;PPIL2;FBXL14;RNF146;FBXL19;HERC6;UBE3D;FBXL4;UBE2S;FBXW5;PSMD8;SPOP;UBE2N;UBE2G1;RNF114;HUWE1;RNF144A;RC3H2;PSMB1;FBXL17;UNKL;CHFR;PSMD13;FBXL8;PSMD1;PSMD7;FBXW9;PSMA8;RNF14;FBXO11;PSMD3;TRAF3;RNF26;PSMD2;UBE2Q2;MIB2
prerank,nucleoside phosphate catabolic process (GO:1901292),-0.4563145158888543,-1.1233653845285183,0.3233082706766917,0.7506124903877335,1.0,4/13,8.05%,ENTPD1;ENPP1;ENTPD5;ENPP3
prerank,negative regulation of cell projection organization (GO:0031345),-0.33490078949263935,-1.1227168229132696,0.2697841726618705,0.7508117392993938,1.0,15/48,16.35%,EFNB2;APOE;RAPGEF2;DCC;EPHA4;GRIN2B;DENND5A;LPAR1;SPOCK1;CRMP1;MAG;CIB1;MINAR1;HDAC2;MYLIP
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),-0.28994640278590744,-1.1226319114098866,0.25,0.7494981355219968,1.0,23/101,11.16%,FLT1;ROBO1;IL34;CEMIP;PDGFRB;PDGFD;RAPGEF2;KIT;WNT5A;TPD52L1;CALM1;SNCA;CCNY;DAB2IP;ADRA2A;RGCC;PIK3R6;CALM3;LRRK2;SRC;EDN1;ETAA1;EDN3
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.5007330472375823,1.1223760986512756,0.36129032258064514,0.9012404135881713,1.0,3/16,7.31%,SMG6;TNKS2;ATM
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.4079660302467093,-1.1223527629022485,0.3025,0.7486848479267838,1.0,7/19,20.47%,MAOB;CYBA;PRDX4;CAT;PARK7;PRDX1;ACOX1
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.5666467279712695,1.1219855219011983,0.35528596187175043,0.9013653174014294,1.0,4/10,12.11%,EZR;CDC42;RHOA;MYO9A
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.5064149789218152,1.121648326745174,0.33223684210526316,0.9014367896659227,1.0,5/16,7.71%,PDGFC;ABL1;PDGFA;NR4A3;NRP1
prerank,regulation of cell-substrate junction assembly (GO:0090109),-0.3945513502521465,-1.1212672078233996,0.3161953727506427,0.7503785208626261,1.0,6/21,8.90%,LIMCH1;PEAK1;PTK2;GPM6B;MACF1;DUSP3
prerank,photoreceptor cell development (GO:0042461),0.5158368476382917,1.1208672487883795,0.3601340033500838,0.9027183379588543,1.0,2/14,6.52%,RP1;ARL3
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.39522108716672505,1.1206789999975448,0.3202614379084967,0.9023019592957903,1.0,14/65,10.94%,CD109;HTRA3;SMAD6;SKIL;BAMBI;SPRED2;TGFBR1;TGFBR2;TGFB1I1;IL17RD;PPM1A;SKI;NKX2-1;BCL9L
prerank,sodium ion homeostasis (GO:0055078),-0.39694037251796244,-1.1201248916343238,0.3116531165311653,0.7520229795374822,1.0,4/21,3.55%,ATP1A2;ATP1B3;NEDD4L;ATP1B2
prerank,actin filament network formation (GO:0051639),0.5444374896764624,1.1201054751333437,0.3339449541284404,0.9030731069809155,1.0,3/11,11.58%,COBL;FHOD3;PLS1
prerank,negative regulation of apoptotic process (GO:0043066),0.3382568818135196,1.1200315147233926,0.22188139059304704,0.9023242564468739,1.0,74/444,13.02%,EGFR;BMP4;THBS1;FSTL1;GRK5;CARD14;NGF;ARHGAP10;ANXA1;SIX1;TGFB3;PTK2B;CD44;TCIM;ITGB1;WNT11;SHC1;TAX1BP1;ISL1;PRKCD;KLF4;SMAD6;IL10;BIRC7;ANXA4;GSK3B;ITGA5;NOTCH2;ARF4;GCLC;GATA1;NR4A2;SOCS2;DDRGK1;BIRC6;GDNF;NFKB1;DNAJC3;GOLPH3;SERPINB9;TFAP2A;ERC1;PLK3;SON;HCLS1;STIL;CLCF1;RIPK2;NFATC4;GATA4;FATE1;ADAM10;SIX4;UBE2Z;PAK2;NIBAN2;PIM2;NAA35;RB1;CSNK2A2;CSNK2A1;SQSTM1;TAF9;USP47;MTDH;DNAJB6;ADAM8;BIRC3;BNIP3;SFN;APIP;HTR2B;MAPK1;BFAR
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.36010140582531897,1.1200298333030352,0.2674285714285714,0.9013479409709507,1.0,35/138,17.99%,NR3C2;RARB;ESR2;NR2F1;HDAC9;NOTCH2;NR4A2;NR4A3;HNF4A;RARG;TBL1X;NR6A1;HDAC10;CREBBP;WWTR1;TEAD1;MNAT1;E2F3;ERCC3;TAF1;TAF9;RXRA;KAT2B;GTF2F2;TAF15;TAF7L;TAF12;SNW1;MED27;MED17;RORA;NR4A1;GTF2E1;AR;E2F2
prerank,innate immune response in mucosa (GO:0002227),-0.4825236924440173,-1.1198882889887192,0.3227990970654628,0.7510991044993196,1.0,8/10,48.54%,DEFA6;RPL39;NOS2;IL4;CAMP;BPIFB1;DEFB1;LTF
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.4809905622624959,-1.1194378343004654,0.33710407239819007,0.7508962309999954,1.0,3/10,7.40%,LYN;GHR;STAT5B
prerank,eosinophil chemotaxis (GO:0048245),-0.4433207164964813,-1.1193738676107519,0.3020833333333333,0.7479889705831287,1.0,10/14,44.82%,CCL2;CCL5;CCL11;CCL4;CX3CL1;CCL7;CCL8;SCG2;CCL1;CCL3
prerank,eosinophil migration (GO:0072677),-0.4433207164964813,-1.1193738676107519,0.3020833333333333,0.7479889705831287,1.0,10/14,44.82%,CCL2;CCL5;CCL11;CCL4;CX3CL1;CCL7;CCL8;SCG2;CCL1;CCL3
prerank,regulation of chromosome segregation (GO:0051983),0.5058148580198754,1.119093978575276,0.3518821603927987,0.9031771276418874,1.0,8/16,20.49%,IHO1;KIF2C;CSNK2A2;CSNK2A1;PUM2;PUM1;SMC5;RMI2
prerank,response to unfolded protein (GO:0006986),-0.3245950473880198,-1.1188917980278656,0.24,0.7479211047533444,1.0,10/48,14.06%,HSPA8;ERN1;STT3B;DAB2IP;TMBIM6;HSPA9;HSP90AB1;OPTN;DNAJB5;PACRG
prerank,microtubule bundle formation (GO:0001578),0.42396429442862843,1.1187161098494571,0.3163841807909605,0.9034076442518919,1.0,12/42,19.08%,RP1;GAS2L2;CAPN6;CCDC40;CLIP1;SPEF1;RSPH6A;TOGARAM1;CCDC66;CFAP46;AAAS;CHP1
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.3645353340171933,1.1186021761003775,0.2963386727688787,0.9027769557504032,1.0,35/146,22.13%,FBXL7;FHL1;SFI1;CDC25B;CEP164;PAFAH1B1;CEP131;PCM1;HAUS5;RAD51C;CSNK1E;CEP70;CEP63;USP47;CEP57;PSMC6;PRKACA;CSNK1D;DCTN3;PSMD8;CNTRL;AKAP9;PINX1;PSMB1;CEP192;PSMD13;PSMD1;DCTN1;AURKA;PSMD7;PSMA8;ODF2;PSMD3;PSMD2;CDK1
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.3757404133453398,1.118273969542542,0.29318734793187345,0.9028407160517503,1.0,19/95,11.03%,THBS1;CD109;HTRA3;SMAD6;SKIL;GIPC1;BAMBI;SPRED2;TGFBR1;TGFBR2;EP300;TGFB1I1;CREBBP;IL17RD;PPM1A;SKI;NKX2-1;BCL9L;LTBP4
prerank,diol biosynthetic process (GO:0034312),0.5157071332619002,1.1180781504505537,0.35986159169550175,0.9024573910985284,1.0,1/15,0.61%,ACER3
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.4623925874972735,1.1180675106827525,0.3415384615384615,0.9015080624354955,1.0,8/26,11.12%,CYP1B1;SULF1;ISL1;GATA4;HPSE;NOX1;SULF2;EIF2AK3
prerank,long-chain fatty acid import into cell (GO:0044539),-0.4748475150113401,-1.1180575572732712,0.3123543123543124,0.7486582929573135,1.0,2/10,1.27%,ACSL1;SLC2A1
prerank,positive regulation of protein binding (GO:0032092),0.406601434978702,1.1180093989292783,0.3103448275862069,0.9007160051562432,1.0,14/56,14.62%,BMP4;TCF7L2;PKD1;GSK3B;BAMBI;ABL1;RIPK2;IDE;USP33;MARK3;TAF1;ADD1;LRP1;RAN
prerank,apical junction assembly (GO:0043297),0.4156953417534164,1.1178750738025611,0.30492676431424764,0.9001778896936363,1.0,15/53,11.89%,CTNNA1;MPP7;CLDN16;STRN;PDCD6IP;CLDN11;VCL;DLG1;POF1B;WDR1;PATJ;PARD3;PKN2;PAK2;RHOA
prerank,regulation of interferon-alpha production (GO:0032647),0.46769958717901555,1.1178271283397498,0.33707865168539325,0.8993409840043921,1.0,7/23,15.78%,IL10;MAVS;CHUK;RIPK2;TLR4;SETD2;DHX9
prerank,positive regulation of kinase activity (GO:0033674),0.37062917730957157,1.1173248397840154,0.3125734430082256,0.8999059618531063,1.0,10/107,3.34%,EGFR;MET;RASSF2;NTRK3;PTK2B;CCN1;LMO4;FGFR1;DDR2;RAP1A
prerank,positive regulation of protein modification process (GO:0031401),0.35394106507827744,1.1170404413108914,0.2582781456953642,0.8997720695734746,1.0,20/203,7.65%,EGFR;BMP4;TRABD2B;SLCO3A1;CARD14;NTRK3;EFNA5;RAMP1;CCN1;LIMK2;KRAS;PGF;PRKCD;ABL1;NIBAN1;RAB3GAP2;FGF22;MAVS;FGF2;CNEP1R1
prerank,negative regulation of protein secretion (GO:0050709),0.4263488952537939,1.1170193806268387,0.3218390804597701,0.8988730671548681,1.0,7/38,12.79%,CCN3;KCNB1;IRS1;RAB11FIP3;DRD3;REST;INHBB
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.4763105963495339,1.1167307156687991,0.3333333333333333,0.8987612068152623,1.0,3/20,1.46%,KCNJ2;SLC12A2;ATP1B1
prerank,regulation of telomere capping (GO:1904353),0.46962868128544344,1.1160926568702387,0.3359497645211931,0.8997105992623995,1.0,8/23,18.02%,NEK7;SMG6;TNKS2;ATM;USP7;MAPK1;MAPK15;NBN
prerank,amino acid import (GO:0043090),0.46726230859323714,1.116068914776789,0.3318042813455658,0.8988156371287075,1.0,3/21,5.71%,SLC47A1;SFXN1;SFXN2
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.4725584366045772,1.1158242665644458,0.3467094703049759,0.8985786209572904,1.0,6/20,5.96%,ANK2;ATP1B1;CAMK2D;CACNA1C;DMD;TNNI3
prerank,toxin transport (GO:1901998),0.5495436027338847,1.1154154112697088,0.3617391304347826,0.8988892997709168,1.0,3/10,8.30%,ANTXR1;ANTXRL;ADAM10
prerank,inflammatory response (GO:0006954),0.35692967491448685,1.1153496144190336,0.26356589147286824,0.8981363547771267,1.0,31/195,13.86%,THBS1;PTGDR;TRAF3IP2;ANXA1;HDAC4;CD44;AGTR1;HDAC9;MGLL;VNN1;NFKB1;CDO1;CHUK;RIPK2;TLR6;PTGER1;NFATC4;TNFRSF4;PTGER2;AGTR2;CXCR4;NOX1;FPR3;HYAL3;TLR4;ADAM8;STAT3;CMKLR1;CIITA;REL;CEBPB
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.3921111522104547,1.1147344229387934,0.30617283950617286,0.8990478961397353,1.0,9/75,7.71%,BMP4;F3;AGTR1;FGFR1;NRAS;PGF;TGFBR1;FGF2;NRP1
prerank,thyroid hormone generation (GO:0006590),0.5447019818020377,1.1146553517159645,0.3645833333333333,0.8982974654336605,1.0,3/10,12.94%,CPQ;FOXE1;DUOX1
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.5474425789552562,1.1146119446987501,0.35611510791366907,0.8965292552926812,1.0,3/10,12.84%,MPG;FTO;ASCC1
prerank,DNA dealkylation (GO:0035510),0.5474425789552562,1.1146119446987501,0.35611510791366907,0.8965292552926812,1.0,3/10,12.84%,MPG;FTO;ASCC1
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.4404636827248218,1.114348570995857,0.3245227606461087,0.8963963608673353,1.0,7/32,10.01%,THBS1;PHLDB2;SEMA3E;FAM107A;JAG1;DMTN;BCAS3
prerank,prostaglandin biosynthetic process (GO:0001516),-0.42363156744106184,-1.1136019502927879,0.2924281984334204,0.7599325390380716,1.0,9/18,17.95%,PTGDS;PTGS1;PNPLA8;PTGES3;EDN1;HPGDS;MIF;CD74;CBR1
prerank,regulation of chondrocyte differentiation (GO:0032330),0.45896523558074476,1.1132070305425321,0.32576985413290116,0.8989171027511575,1.0,6/24,5.26%,WNT9A;ZBTB16;EFEMP1;GDF6;GDF5;TGFBR1
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.4047489587975572,-1.112942198128238,0.29533678756476683,0.760185264802088,1.0,6/19,15.19%,VCAM1;KDR;GRM5;PTGFR;RYR2;ADGRL1
prerank,modification-dependent protein catabolic process (GO:0019941),0.3540701531198245,1.1128879537310365,0.27802197802197803,0.8989234917102026,1.0,43/193,19.48%,FBXL7;FZR1;NEDD4;FBXO10;UBE4B;UBE2B;RNF19A;UBR4;RNF185;BIRC6;ANAPC5;NPLOC4;ARIH1;TRIP12;ANAPC16;OS9;CDC16;UFD1;RNF168;USP33;TRIM25;ARIH2;TAF1;SQSTM1;RNF111;BFAR;SMURF1;UBE4A;FBXL14;RNF146;FBXL4;UBE2S;UBE2G1;RNF114;FEM1C;FEM1A;RNF144A;NUB1;RC3H2;LONP1;NTAN1;CHFR;PSMD13
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.5272513826690933,1.1124597220549268,0.3831932773109244,0.8992918953020541,1.0,1/11,2.20%,AGTR1
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.3667248406891466,-1.1122783254214526,0.2795031055900621,0.7605831241500888,1.0,4/30,2.27%,ENG;TGFBR3;NREP;ITGA3
prerank,regulation of neuron projection arborization (GO:0150011),-0.4298593729842342,-1.1119684756030235,0.3144963144963145,0.7598854289906346,1.0,4/15,9.04%,WNT5A;GRIP1;MACF1;MFSD2A
prerank,regulation of stress fiber assembly (GO:0051492),0.38641161088925724,1.1115690817618362,0.3147208121827411,0.901013013327237,1.0,19/74,12.17%,TMEFF2;MET;SORBS3;TGFB3;ARAP1;PHLDB2;WNT11;ABL1;RHPN2;TGFBR1;ARHGEF10;ARHGEF5;NRP1;PPFIA1;PAK2;CDC42;ASAP3;RHOA;SLC9A1
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.5069802017092716,1.1115587833545102,0.3577512776831346,0.9000872889013691,1.0,4/14,17.64%,PAICS;RFK;PFAS;GMPS
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.4718914810471275,1.1114715904997934,0.3200636942675159,0.8993770587738127,1.0,4/22,7.53%,NGF;NTRK3;RAP1A;KIDINS220
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.4144258758704204,-1.111436793749833,0.29975429975429974,0.7598632949747681,1.0,5/17,17.76%,SLC7A5;PRKCQ;HAVCR2;SYK;PRKCZ
prerank,positive regulation of lipid localization (GO:1905954),0.5190710888744864,1.1109348643281192,0.36261682242990656,0.9000196710760597,1.0,4/11,13.93%,NFKB1;HILPDA;IKBKE;LRP1
prerank,protein-containing complex assembly (GO:0065003),0.3437300227605269,1.1108967537437127,0.27167019027484146,0.899191679044559,1.0,56/259,16.17%,FBXL7;REPS2;TCF7L1;TCF7L2;FN1;PTK2B;ANO6;SEC24B;GSK3B;DMD;STX5;TRRAP;CNIH2;SAMM50;MATN1;EP300;BIN2;MAGI1;CREBBP;HES1;ADAM10;NSF;TEAD1;MDM4;SMARCA4;SEC13;MNAT1;KAT5;TLE4;DMTN;SEC22B;SAR1B;TUBGCP4;PARD3;BCL9L;TLE3;TLE2;SLC9A1;CSNK1A1;TRADD;CAPZA1;SPG7;AMER1;TRAPPC4;MCU;KMT2D;CAPZA2;STOML2;SEC24A;ITGB1BP1;PPP6R3;SHANK1;CSNK1D;DHX9;PML;ANKRD28
prerank,regulation of gluconeogenesis (GO:0006111),0.4553672585921524,1.1105808759242362,0.3395348837209302,0.8991264221590681,1.0,7/27,10.98%,C1QTNF12;ERFE;EP300;PTPN2;USP7;CLK2;GNMT
prerank,respiratory system development (GO:0060541),0.43976936857198323,1.109973413946861,0.34534534534534533,0.9000468938426262,1.0,5/32,7.51%,BMP4;DISP1;STRA6;CCDC40;FGF2
prerank,positive regulation of cell development (GO:0010720),0.4396908817670936,1.1097564081722837,0.34497816593886466,0.8997004843508283,1.0,2/31,3.48%,BMP4;MYOG
prerank,cell projection organization (GO:0030030),0.45238765027346406,1.1095389004877938,0.3426791277258567,0.8993908749637147,1.0,8/30,10.90%,PARVA;RHOJ;ITGB1;GSN;PDGFA;NCKAP1;RHOQ;CDC42
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.38829019674304205,-1.109384632927713,0.2991913746630728,0.7641739561446188,1.0,11/22,18.42%,LYN;PICALM;EPHA4;LRRTM3;CASP3;CHRNA7;RANBP9;GSAP;GSK3A;ABCG1;RELA
prerank,positive regulation of type I interferon production (GO:0032481),0.3864175964720712,1.1089911373571528,0.32951653944020354,0.9000792447063539,1.0,24/73,19.95%,POLR3D;NFKB1;EP300;MAVS;CHUK;RIPK2;RNF135;CREBBP;NFKB2;IRF1;TLR4;SETD2;CRCP;POLR3GL;XRCC5;POLR3B;DHX9;PRKDC;MYD88;STAT6;IRAK1;POLR2H;PTPN11;MRE11
prerank,regulation of receptor binding (GO:1900120),-0.48670785838581465,-1.1086605716033775,0.33636363636363636,0.7647996590905417,1.0,4/10,18.19%,B2M;GREM2;ATP2A2;ADAM15
prerank,protein depolymerization (GO:0051261),0.45288852984469186,1.108322673885723,0.34597875569044007,0.9011197960393271,1.0,2/27,3.64%,MICAL2;GSN
prerank,acetylcholine receptor signaling pathway (GO:0095500),-0.4036061663228067,-1.1082474530206416,0.32463768115942027,0.7645195046861051,1.0,11/20,27.76%,PLCB1;CHRM3;CHRM2;CHRNA7;CDK5R1;GRK2;LYPD1;AGRN;LY6H;RGS8;LY6G6D
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.48680512105033114,1.1080505342227844,0.34125636672325976,0.9010095684276125,1.0,4/18,5.95%,AGTR1;ABL1;GDNF;RFK
prerank,wound healing (GO:0042060),0.39336894011103757,1.1076091970840016,0.3147410358565737,0.9013750139312942,1.0,16/62,13.07%,AHNAK2;PPP3CA;DSP;COL3A1;FZD7;PDGFA;TGFBR1;FGF2;TSKU;GATA4;SYTL4;HPSE;NOG;TGFB2;PLEC;ITGB3
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.35000722404707285,-1.107525101265448,0.29605263157894735,0.765073720747039,1.0,8/36,10.01%,WNT5A;HIF1A;PARP14;CSF1;CASP4;NLRC5;GAS6;EDN1
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.41489577922627274,1.1067035015346447,0.32599724896836313,0.9030568813715987,1.0,13/48,16.59%,DOCK5;CUX1;ABL1;FBXW8;NRP1;LIMS2;DMTN;CDC42;TRIOBP;S100A10;ILK;PRKDC;FLNA
prerank,natural killer cell mediated immunity (GO:0002228),0.498250751131659,1.1064662260086566,0.36348408710217756,0.9028142410106454,1.0,2/15,3.47%,RAET1E;KLRC2
prerank,cytoplasmic sequestering of protein (GO:0051220),0.5208613570156381,1.106357333123554,0.35738831615120276,0.9021939937913708,1.0,5/13,22.51%,PKD1;GOPC;FLNA;MDFI;SUFU
prerank,androgen metabolic process (GO:0008209),-0.41012047734727275,-1.1062240106654668,0.31675392670157065,0.7671194787350851,1.0,8/18,28.32%,SPP1;HSD17B4;HSD17B7;HSD17B11;HSD17B10;SRD5A1;MED1;SHH
prerank,negative regulation of type I interferon production (GO:0032480),0.42204093045833146,1.1061210326147008,0.329004329004329,0.9019748512886123,1.0,10/40,13.63%,TAX1BP1;IL10;NPLOC4;MAVS;RNF135;UFD1;ACOD1;TRIM25;IKBKE;REL
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.38225751329881597,1.105980293337086,0.33921815889029006,0.9014376968136679,1.0,22/80,19.16%,PLPP3;ERGIC1;ARF4;ERGIC2;RAB6A;ARF3;GOLPH3;KIF1C;KLC1;PITPNB;NSF;SEC22B;KIF2C;COG3;ATP9A;NBAS;ARCN1;GBF1;ATP9B;KIF18A;KIF2A;COPA
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.39637114711435883,1.1056358230017447,0.3252361673414305,0.9015242822204368,1.0,15/60,18.85%,SMOC2;KLF4;NEK7;TNKS2;ATM;FGF2;FBXO4;RFC5;MAPK1;XRCC5;MAPK15;TCP1;POLG2;ACD;PRKD2
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.45937495116734417,1.1055516400618584,0.32983508245877063,0.9008083043612596,1.0,3/27,3.27%,GPR4;AGTR1;LPAR4
prerank,regulation of B cell proliferation (GO:0030888),-0.3290514468932114,-1.1051077096588557,0.2828282828282828,0.7688286254862639,1.0,14/44,17.31%,LYN;BCL2;AHR;TFRC;TNFRSF21;CD81;MEF2C;VAV3;CD300A;CD38;NCKAP1L;TIRAP;MIF;CD74
prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.33148143784536394,-1.104527840360043,0.2777777777777778,0.7689519971876316,1.0,11/47,6.57%,IGF1R;PHLPP1;TGFBR3;FOXO1;PPIA;RAP2A;EPHB1;FAS;DAB2IP;MAPK3;MAP4K4
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.38264784709000255,-1.1043777258990584,0.3228346456692913,0.7678436139761402,1.0,8/24,20.27%,DACH1;RPS3;DFFA;BLM;BMPR2;TERF2IP;ACVRL1;H1-0
prerank,histone H3 acetylation (GO:0043966),0.41985286390373094,1.1039268200292498,0.34763948497854075,0.9047993929720346,1.0,15/40,18.84%,KAT6B;SGF29;TADA3;KAT2A;TAF6L;BRD1;BRCA2;TAF9;KAT2B;TRIM16;TAF12;LDB1;KAT14;YEATS2;TADA1
prerank,protein modification by small protein conjugation (GO:0032446),0.3366372688278323,1.1034787934283783,0.27561475409836067,0.9051554170982897,1.0,99/361,21.69%,FBXL7;WWP1;NEDD4;FBXO10;WWP2;ASB9;BIRC7;NUP93;RNF138;KLHL13;EGR2;UBE2B;NFE2L2;VCP;DDRGK1;FBXW8;BIRC6;TRPM4;ASB11;PIAS3;HERC2;MYCBP2;PIAS2;ATG3;FBXW11;ARIH1;TRIM44;UBE2F;TRIM26;RNF135;TRIM7;ANAPC16;DCUN1D4;USP7;HIF3A;OS9;FBXO32;UBE2D3;BCL10;CDC16;FBXO4;CTR9;RNF168;ASB1;MOCS3;MKRN1;CCDC22;NUP188;UHRF2;COMMD1;UBE2Z;ARIH2;RANBP2;PEX2;PAF1;RNF111;CUL4A;RTF1;UBE2W;NSMCE2;SMURF1;TRIM41;UFL1;SAE1;FBXO25;PRKDC;UBE2S;FBXW5;UBE2N;UBE2G1;HUWE1;RNF144A;GAN;PCNP;NUB1;DTX3;TRIM47;PEX12;NUP107;AAAS;FBXL17;VCPIP1;RNF212B;ATG7;USP9X;CHFR;RAE1;UVSSA;NUP54;KLHL18;PIAS1;UBA5;RNF14;SUMO1;NUP98;FBXO11;CUL7;RNF38;RNF26
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.4757075172849219,-1.1032123733019281,0.35147392290249435,0.7697189520628767,1.0,4/10,6.83%,NEXMIF;NOTCH1;NOTCH4;RGCC
prerank,negative regulation of cell aging (GO:0090344),-0.42632310927325345,-1.102342285241632,0.31842105263157894,0.7706439456348376,1.0,4/16,9.25%,SLC30A10;AKT3;CDK6;YBX1
prerank,positive regulation of T cell proliferation (GO:0042102),-0.3158797829932103,-1.1021826933704169,0.2885375494071146,0.7695503245094671,1.0,8/55,9.17%,IGF1;IGFBP2;VCAM1;TFRC;IL6ST;IGF2;RPS3;IL18
prerank,ERBB2 signaling pathway (GO:0038128),0.44233649312601353,1.1021035851971723,0.34532374100719426,0.908103826366426,1.0,2/31,2.46%,EGFR;SHC1
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.44244603857132336,1.102043319478454,0.345679012345679,0.9073516295106423,1.0,5/27,4.65%,TMEFF2;MET;ARAP1;PHLDB2;RHPN2
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.3122872347942185,-1.1018029932893476,0.26778242677824265,0.7690756371736848,1.0,25/57,22.39%,GRIN2A;GRIA4;GRIA2;GRIA3;GRIN2B;MEF2C;CACNG4;DAPK1;CAMK2A;CACNG7;APP;LRRC7;DLGAP2;NPTXR;GRIN1;CAMK2B;NETO1;GSG1L;NEFL;NLGN1;LYNX1;SHISA9;NLGN2;SHISA6;MAPK8IP2
prerank,histone deacetylation (GO:0016575),0.41861088176583483,1.1016105555756572,0.335243553008596,0.9076715703913631,1.0,9/43,12.67%,HDAC4;HDAC9;RCOR3;TBL1X;HDAC10;PER2;HDAC8;REST;BAZ2A
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.35887262089785815,1.1012558907706722,0.3095512082853855,0.9077240024103593,1.0,14/138,5.85%,GUCY2C;EGFR;MET;NGF;NTRK3;PTK2B;ABI1;PTPRU;FGFR1;SHC1;DDR2;POLR1G;TRIO;EPHB6
prerank,spindle assembly (GO:0051225),0.3964272574906736,1.1009784129207805,0.31640625,0.9076242957375513,1.0,22/67,19.71%,MAPRE2;NEK7;ARHGEF10;CHEK2;HAUS5;MISP;TUBGCP4;TOGARAM1;CEP63;RHOA;TUBGCP5;PIBF1;SMC1A;CSNK1D;FLNA;STAG2;INO80;KIF2A;SPICE1;AAAS;CEP192;TUBGCP6
prerank,early endosome to late endosome transport (GO:0045022),0.4791165983860518,1.1009022630764378,0.3729903536977492,0.9068996130875204,1.0,10/20,23.38%,EEA1;ANKRD27;BECN1;STX8;RAB5A;EMP2;HOOK2;RAB7A;RILP;WDR81
prerank,regulation of protein kinase C signaling (GO:0090036),-0.4364699873764739,-1.1008794353154094,0.3604060913705584,0.7702724951763628,1.0,9/14,22.95%,ADGRV1;WNT5A;DGKD;FLT4;MYADM;DGKG;CD40;VEGFA;SPHK2
prerank,regulation of defense response to virus by host (GO:0050691),0.4437866785614827,1.100429828759255,0.3544891640866873,0.9073724997802869,1.0,5/30,8.41%,TRAF3IP2;ZDHHC11;TRIM44;MAVS;EIF2AK4
prerank,response to exogenous dsRNA (GO:0043330),-0.4103668853853513,-1.1000734173184405,0.3246753246753247,0.7709653178689423,1.0,5/18,13.66%,RFTN1;FLOT1;TLR3;SLC3A2;CGAS
prerank,protein localization to synapse (GO:0035418),0.5315551538328847,1.1000152574269575,0.37628865979381443,0.9076710529489133,1.0,6/12,20.34%,BSN;NPHS1;ZDHHC15;SHANK1;PCLO;DLG4
prerank,actin filament polymerization (GO:0030041),0.4530392867698078,1.0999305866420008,0.34281437125748504,0.9069972927387555,1.0,7/29,10.81%,COBL;FAM107A;GSN;DIAPH1;MSRB2;TTC17;WASHC5
prerank,mesoderm development (GO:0007498),-0.40993173226540974,-1.099685195487084,0.3359375,0.77053647589038,1.0,11/18,28.71%,TBX3;TIE1;TBX1;BMX;IKZF1;HCK;VEGFA;BTK;GDF11;MEST;TCF15
prerank,macrophage chemotaxis (GO:0048246),-0.4839238924221429,-1.0996533187734865,0.34782608695652173,0.7691240263312767,1.0,5/10,34.82%,EDNRB;TAFA4;CCL2;CCL5;CXCL17
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.5146156170991434,1.0991237276497032,0.36902800658978585,0.9084807700345728,1.0,4/13,11.08%,DDIT3;GATA1;PER2;TAF1
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.3595011560378076,-1.0990385435445058,0.28273809523809523,0.7693984895749222,1.0,15/30,30.54%,DACH1;SRC;CERS1;BMPR2;TENT4B;DCP2;ACVRL1;HNRNPU;TEN1;GNL3L;EXOSC10;CTC1;HNRNPA1;TP53;PIF1
prerank,regulation of type I interferon production (GO:0032479),0.3748589121870659,1.0986091598838201,0.337888198757764,0.9090153016777501,1.0,39/84,27.10%,TAX1BP1;POLR3D;NFKB1;EP300;NPLOC4;MAVS;RNF135;CREBBP;UFD1;NFKB2;ACOD1;TRIM25;IRF1;CRCP;IKBKE;POLR3GL;XRCC5;POLR3B;DHX9;PRKDC;MYD88;STAT6;POLA1;IRAK1;POLR2H;MRE11;TRAF3IP1;OTUD5;TRAF3;RNF26;UBE2L6;PTPN22;IFIH1;POLR3K;IRF3;POLR1C;ILRUN;POLR3G;TBK1
prerank,negative regulation of inflammatory response (GO:0050728),-0.2624529262918698,-1.0984399916533096,0.1956521739130435,0.7696168344440604,1.0,47/182,16.70%,IGF1;LYN;TEK;ADCY5;APOE;MFHAS1;PPARA;ADCY1;GNG2;PRKAR2B;ADCY7;CALCRL;ADCY2;PPARD;PRKACB;NR1H3;RAMP2;C1QTNF3;MYH9;GGT5;GRN;PRKAR1B;GPS2;RPS19;MDK;SIRPA;PTH1R;ENPP3;CYSLTR1;PRKAR1A;SRC;TNFRSF1A;ADORA2A;ADM;CYSLTR2;ADCY4;IAPP;NR1H4;PLCG1;ADCY3;ADCY8;VIPR2;TNFAIP3;LRFN5;SYK;METRNL;TYRO3
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.38043301708760113,-1.0983228414534196,0.29842931937172773,0.768411426083668,1.0,6/24,8.46%,TEK;KDR;RAMP2;NDNF;GAS6;GATA2
prerank,hexose biosynthetic process (GO:0019319),-0.33494482279985516,-1.0982579299416537,0.3367003367003367,0.7670991107358982,1.0,11/42,15.19%,RBP4;PPARGC1A;MDH1;GAPDH;ALDOC;PGAM1;ENO2;ALDOA;CRTC2;PGM1;SLC25A11
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.40368715517850196,1.0980018001725498,0.35405405405405405,0.9099043856497113,1.0,17/48,18.62%,ELOF1;POLR1G;EP300;TAF1C;KAT2A;SF3B1;CHEK1;POLR1A;ZMIZ1;KAT2B;POLR1H;POLR1F;TAF1D;ZMIZ2;ARID1A;ATAD2;POLR2H
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.40836942577420615,1.0978075122504725,0.34782608695652173,0.9095471329320595,1.0,9/48,7.56%,THBS1;ANXA1;RHOJ;FGFR1;HDAC9;FOXC2;P2RX4;FGF2;MAP3K3
prerank,establishment of apical/basal cell polarity (GO:0035089),0.5158695744253791,1.0972966954672068,0.371900826446281,0.9101717970093341,1.0,5/14,12.11%,EZR;PATJ;CDC42;RHOA;MYO9A
prerank,catecholamine metabolic process (GO:0006584),0.5040834757810148,1.0972816109189014,0.3601340033500838,0.9092914088165411,1.0,1/14,1.15%,SNCAIP
prerank,amino acid import across plasma membrane (GO:0089718),0.4555609872717807,1.0967619709311003,0.34728682170542635,0.9098810828973176,1.0,2/24,3.14%,SLC47A1;SLC7A2
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.413031183033047,-1.0965006906055208,0.32167832167832167,0.770751864347454,1.0,7/16,10.01%,IGF1;TGFBR3;NOTCH1;RBPJ;MEF2C;ERBB4;EDN1
prerank,establishment of mitotic spindle orientation (GO:0000132),0.46168470183155447,1.0964148896810935,0.3374233128834356,0.9100036039881171,1.0,5/23,10.26%,ITGB1;NDEL1;PAFAH1B1;FBXW11;MISP
prerank,protein localization to chromosome (GO:0034502),0.4350004432860903,1.0963177723878819,0.3514705882352941,0.9093613795643667,1.0,12/34,18.57%,TNKS2;WAPL;MRNIP;RB1;RPA1;IFFO1;XRCC5;ATRX;MCM9;ACD;TPP1;PINX1
prerank,neuromuscular synaptic transmission (GO:0007274),0.4760546644564627,1.0963166464430343,0.3717532467532468,0.9084391965478125,1.0,6/18,16.23%,ERC2;FCHSD1;KIF1B;ERC1;FCHSD2;CHRNB1
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.3476033358049935,1.096311585206847,0.2840300107181136,0.9075363169860483,1.0,24/214,8.03%,EGFR;BMPER;PDGFC;NTRK3;FN1;TNFAIP8L3;PTK2B;CD44;EZR;CCN1;SHC1;GAREM1;RAP1A;GCNT2;NOTCH2;SPRED2;PDGFA;ARHGEF5;DLG1;PTPN2;FGF2;DUSP10;NRP1;GATA4
prerank,regulation of endothelial cell proliferation (GO:0001936),0.3756510195198349,1.0952443389365931,0.34638196915776986,0.9096921535354608,1.0,6/88,2.60%,BMP4;F3;THBS1;SULF1;NRAS;PGF
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.46892975890680266,1.0952080708114698,0.36875,0.9088921723825638,1.0,2/21,5.09%,GUCY2C;ADCY9
prerank,Rap protein signal transduction (GO:0032486),-0.4719336081565293,-1.0947745652625325,0.3609022556390977,0.7739817721942919,1.0,4/10,6.88%,RAPGEF3;RAPGEF2;RAP2A;RAPGEF1
prerank,proteolysis (GO:0006508),0.3398996485590506,1.0944812693282873,0.29239130434782606,0.9101374949410324,1.0,38/252,13.54%,F3;TRABD2B;PCSK5;CAPN5;HTRA3;NPEPPS;BMP1;CPA5;CAPN2;DDI2;CAPN6;CPQ;CPA4;CPA3;HTRA1;PHEX;TMPRSS2;MMP16;MMP14;TBL1X;TASP1;IDE;NLN;CPB1;CAPN10;SPPL2A;ADAM10;ERAP1;FBXL6;LAP3;PARL;XPNPEP1;FBXW2;USP25;PGPEP1;SPG7;PITRM1;NAPSA
prerank,bile acid biosynthetic process (GO:0006699),-0.38406426652090614,-1.0944068142689352,0.3352272727272727,0.7736289312514686,1.0,12/24,26.94%,CYP7B1;CYP27A1;OSBP;HSD17B4;OSBPL1A;SCP2;CH25H;HSD17B10;SLC27A2;CYP46A1;OSBPL6;OSBPL7
prerank,dopamine metabolic process (GO:0042417),-0.40214989026919096,-1.0942684429465732,0.33884297520661155,0.7725343508398962,1.0,5/18,8.37%,MOXD1;MAOA;MAOB;SNCA;COMT
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.4065157602332327,1.094121027720142,0.36187845303867405,0.91024357089693,1.0,14/48,16.35%,HIPK1;ABL1;EP300;ATM;DYRK2;TNFRSF1B;CDIP1;CHEK2;MOAP1;IKBKE;SFN;SNW1;PML;PRKDC
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.41164817004654297,-1.094050215641554,0.341645885286783,0.7716462379665276,1.0,12/16,44.95%,TNFRSF21;VSIR;JAK3;DLL1;TYROBP;LILRB1;FCGR2B;PDCD1LG2;IL23A;FOXP3;IL23R;IL12B
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.4859438807270854,-1.093878244885539,0.37155963302752293,0.7706568391769699,1.0,2/10,8.17%,ENPP2;PNPLA8
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.4134833708599734,-1.0937826362253182,0.35128205128205126,0.7694491916903942,1.0,5/16,15.27%,APOE;HIF1A;SCARB1;NOS1AP;AKT1
prerank,regulation of chromatin organization (GO:1902275),0.5016766368934596,1.093769218815301,0.36115843270868825,0.9103708588826069,1.0,4/14,12.51%,MLLT3;TLK1;SETD5;METTL4
prerank,regulation of hormone secretion (GO:0046883),0.47889038714097465,1.0936445329479942,0.36710963455149503,0.9098017340493787,1.0,1/15,1.32%,ANXA1
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.512331567084027,1.0934762776511529,0.3670668953687822,0.9093467796756994,1.0,2/15,1.75%,UST;DSE
prerank,regulation of proteolysis (GO:0030162),0.40621993226957026,1.092992120511124,0.35561497326203206,0.9098824875193452,1.0,8/48,11.21%,CYFIP2;PERP;SERPINE2;FBXW11;TBC1D10A;LTBP4;PARL;IST1
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.5437474933021348,1.0929647418162656,0.3981981981981982,0.9090472955159521,1.0,2/10,7.65%,FN1;TSKU
prerank,protein localization to vacuole (GO:0072665),-0.4282181886256831,-1.0929236118868046,0.34306569343065696,0.7704007133105744,1.0,5/13,20.12%,CD81;MFSD1;GLMP;SH3BP4;RTN4
prerank,insulin secretion (GO:0030073),0.48009259671703614,1.0928803882288536,0.383739837398374,0.9083701166207687,1.0,3/19,11.13%,ANXA1;SNX19;SELENOT
prerank,cellular component assembly (GO:0022607),0.3389394993329454,1.0926178031354186,0.3135593220338983,0.9082287535830439,1.0,45/253,13.31%,REPS2;DPYSL3;BAIAP2L1;RP1;CALD1;PTK2B;EZR;BSN;PAWR;PARVA;RHOJ;CHAF1B;FAM107A;KRT14;GSN;CCDC40;PDGFA;ESPN;P3H4;MATN1;NCKAP1;MAGI1;CREBBP;HES1;TEAD1;SPEF1;LIMS2;RHOQ;MDM4;MNAT1;SPAG17;DMTN;ZFYVE27;TUBGCP4;PARD3;CDC42;RSPH6A;TOGARAM1;PLS1;RHOA;MYO9A;TLCD2;CAPZA1;SPG7;ADD1
prerank,fatty acid transport (GO:0015908),-0.417200345837949,-1.0924997781496826,0.3477088948787062,0.7700382599796205,1.0,6/17,16.03%,ACSL1;APOE;PPARD;MFSD2A;FABP5;SLC27A1
prerank,skeletal muscle tissue development (GO:0007519),0.43370831709158075,1.0924348957375414,0.34643377001455605,0.9078414821478458,1.0,6/32,9.98%,SIX1;CSRP3;MYOG;EGR2;SIX4;SKI
prerank,regulation of response to cytokine stimulus (GO:0060759),0.4815320456942725,1.0921364228583916,0.3719512195121951,0.9078355432931992,1.0,8/19,18.44%,KLF4;ELF1;MAVS;CBFB;TAF9;MAP2K5;DHX9;IRAK1
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),-0.4544830302946307,-1.0918316120548937,0.35294117647058826,0.7704786007343191,1.0,5/12,15.27%,PPARA;FUT9;MDK;ASS1;AKT1
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.4685547434891102,1.0914936428146447,0.36942675159235666,0.9088437578992833,1.0,5/18,14.95%,NPLOC4;UFD1;BIRC3;PUM2;PUM1
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.34669591409975425,-1.0914159902451597,0.30357142857142855,0.7702266185178216,1.0,4/32,2.82%,APOE;PPARA;PRKAG2;ZBTB20
prerank,Golgi to plasma membrane transport (GO:0006893),0.40839074898005945,1.0913951678648774,0.3472803347280335,0.9082388515252321,1.0,12/47,11.59%,STXBP6;EXOC4;KIF13A;RABEP1;GOLPH3;EXOC5;ARL3;NSF;OSBPL5;CCDC22;COMMD1;GGA2
prerank,fatty acid catabolic process (GO:0009062),0.3856594450764609,1.0900032200524234,0.36658031088082904,0.9113839221892389,1.0,15/67,13.69%,ABCD3;BDH2;EHHADH;ACADM;AUH;HACL1;ECHDC1;ACOT8;PECR;DECR1;SLC25A17;PEX2;LPIN2;ACBD5;NUDT7
prerank,positive regulation of glucose import (GO:0046326),-0.3881938341561362,-1.0897296351159895,0.3333333333333333,0.773644110728711,1.0,5/21,4.91%,IGF1;PIK3R1;OSBPL8;OCLN;INSR
prerank,diterpenoid metabolic process (GO:0016101),0.3928820399089147,1.0894336341606128,0.34395750332005315,0.9121738857913888,1.0,8/55,7.50%,GPC6;ADH7;GPC3;STRA6;RBP1;RLBP1;GPC4;PECR
prerank,negative regulation of phosphatase activity (GO:0010923),0.45219945644793313,1.0893295479538205,0.3759512937595129,0.9115543780068522,1.0,11/25,22.45%,CRY2;GSK3B;BOD1L1;PPP1R36;TGFB2;STYXL1;CHP1;FKBP1B;URI1;MASTL;PPP1R1B
prerank,protein modification by small protein removal (GO:0070646),0.33841236866403535,1.0889903636464209,0.29242262540021347,0.9116665156064511,1.0,95/252,26.02%,CCNA2;USP13;ADRB2;FOXK1;USP46;VCP;USP24;TGFBR1;TRRAP;BECN1;EP300;JOSD1;OTUD1;USP2;OTUD7B;USP49;TADA3;KAT2A;BAP1;USP7;MDM4;USP32;USP10;UFD1;USP33;FOXK2;GATA3;ASXL2;USP22;USP34;USP3;USP25;USP21;RHOA;USP47;MYSM1;BIRC3;KAT2B;COPS7B;COPS5;RAD23B;PSMC6;USP4;HCFC1;STAMBP;USP1;PSMD8;POLB;OTUD3;DESI2;DESI1;ACTR8;ZRANB1;YY1;OTUB1;CLSPN;AR;INO80;TNIP1;PSMB1;VCPIP1;SENP3;USP9X;PSMD13;USP48;PSMD1;HGS;PSMD7;OTUD5;STAM2;PSMA8;USP31;USP37;PSMD3;TRAF3;PSMD2;CDK1;SENP8;SENP1;PSMC2;SMAD2;USP36;PSMB2;RHOT1;IFIH1;INO80D;UIMC1;USP28;YOD1;PSMD14;APC;UCHL3;TOMM20;COPS6;MCRS1
prerank,negative regulation of anoikis (GO:2000811),-0.4303656457956295,-1.0889719748359645,0.37170263788968827,0.7743887434071491,1.0,5/14,9.09%,TLE1;BCL2;PTK2;NOTCH1;SRC
prerank,positive regulation of transport (GO:0051050),-0.28833564923954785,-1.088426403214642,0.24338624338624337,0.7744972121001726,1.0,16/85,9.03%,CAMK1D;MERTK;APOE;NEDD4L;CD47;IL15RA;SNCA;ACTB;NR1H3;SGK1;CYBA;SIRPA;GAS6;GATA2;FLOT1;CALR
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.42196658219084854,1.0880213385310022,0.37554585152838427,0.9136669714387005,1.0,6/35,7.71%,MET;SEMA3D;SEMA3C;SEMA3E;PLXNA2;NRP1
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.39829663762418194,1.0876255753358646,0.33787465940054495,0.9139274003690899,1.0,14/52,14.65%,MBNL1;DDX5;RBFOX2;MBNL2;CELF1;SRSF6;RBM25;SRSF12;RBMX;REST;RBM8A;DDX17;HNRNPL;FXR2
prerank,regulation of calcium-mediated signaling (GO:0050848),-0.3749648447939685,-1.0874865851979645,0.34911242603550297,0.7756931914462333,1.0,6/25,10.28%,ITPR1;RIT2;PLEK;LRRK2;MAPT;CDH13
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.37644654566423885,-1.08685183768443,0.3510971786833856,0.7760574353189679,1.0,11/26,25.29%,LGR4;GPS2;FLOT1;TLR3;LRRC14;APPL2;TYRO3;SMPDL3B;IRF7;NFKBIL1;TREM2
prerank,response to iron ion (GO:0010039),-0.4532162745528452,-1.0864617728110608,0.35058823529411764,0.7757429125891808,1.0,4/12,4.67%,B2M;BCL2;HIF1A;SNCA
prerank,cellular response to retinoic acid (GO:0071300),-0.32694871618497817,-1.0856781182649502,0.29818181818181816,0.7764328056049997,1.0,8/42,4.89%,LYN;WNT5B;WNT6;WNT5A;PTK7;SETX;BRINP3;TBX1
prerank,regulation of smooth muscle cell migration (GO:0014910),0.4650373494606876,1.0850216108236128,0.39,0.9206642233130085,1.0,5/20,7.71%,SLIT2;BMPR1A;IGFBP5;PDGFA;NRP1
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.4131954462909425,1.0848178297130016,0.36336779911373707,0.920344006025903,1.0,5/39,4.43%,THBS1;ANO6;IL10;PDCD4;NFE2L2
prerank,icosanoid metabolic process (GO:0006690),0.41457362054526103,1.0840006525167847,0.37052341597796146,0.921789357346583,1.0,6/40,8.51%,CYP1B1;PTGIS;PON3;MGLL;DAGLB;CYP2S1
prerank,cardiac muscle contraction (GO:0060048),0.42402126551108565,1.0838533782394897,0.3786259541984733,0.9213116438220849,1.0,6/34,5.96%,ATP1B1;CAMK2D;CSRP3;GSN;DMD;TNNI3
prerank,engulfment of apoptotic cell (GO:0043652),0.4951592973361787,1.0836157913493025,0.3652037617554859,0.9210556796573907,1.0,3/15,10.66%,THBS1;XKR4;RHOBTB1
prerank,microtubule polymerization (GO:0046785),0.43413474023387655,1.0835748794069515,0.3609898107714702,0.9202552404870961,1.0,10/29,19.71%,HDGFL3;NDEL1;MAP7D3;SLAIN2;FGF13;TUBGCP4;TUBGCP5;CSNK1D;AKAP9;TUBGCP6
prerank,negative regulation of protein metabolic process (GO:0051248),0.39777099788262144,1.082801680012135,0.3361581920903955,0.92157133138986,1.0,11/48,17.79%,EGFR;NFKB1;CLU;ITGAV;MDM4;SNX12;INHBB;ITGB3;FLNA;HMGCR;AZIN1
prerank,regulation of actin nucleation (GO:0051125),0.5215175357987056,1.0826801813344726,0.38671209540034074,0.9210309645089765,1.0,4/12,17.14%,GSN;ARFIP1;WASHC5;WHAMM
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.3771328086989867,1.0822059388413816,0.3389830508474576,0.9214271355183621,1.0,19/69,18.88%,UBE4B;RNF185;VCP;NPLOC4;ANKZF1;ERLIN1;OS9;UFD1;TRIM25;EDEM2;FBXO17;UBXN4;FAF2;ECPAS;PSMC6;UBE4A;TMUB1;WFS1;SEL1L2
prerank,regulation of mast cell activation (GO:0033003),-0.4719128024465169,-1.0821862274359366,0.37303370786516854,0.785036223074697,1.0,3/10,12.34%,LYN;NECTIN2;CD84
prerank,positive regulation of B cell proliferation (GO:0030890),-0.3639010860833675,-1.0821714260969284,0.36990595611285265,0.7836125630409781,1.0,10/29,17.31%,BCL2;TFRC;CD81;MEF2C;VAV3;CD38;NCKAP1L;TIRAP;MIF;CD74
prerank,cytoplasmic microtubule organization (GO:0031122),0.4041844543209835,1.0820912663205275,0.3782312925170068,0.9208293148935226,1.0,11/54,12.19%,CLIP4;EZR;LIMK2;CLIP1;DLG1;PLK3;SLAIN2;PCM1;TUBGCP4;RHOA;TUBGCP5
prerank,peptidyl-glutamic acid modification (GO:0018200),-0.3818961415682493,-1.0820009111514948,0.3371757925072046,0.7826103354270684,1.0,9/24,19.61%,TTLL7;TTLL4;TTLL11;TTLL5;PARP1;AGBL4;CEP41;VKORC1;AGBL5
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.4527610312527365,1.0815812413779373,0.35130970724191063,0.921404680305992,1.0,4/24,7.89%,PTK2B;CYP1B1;IL10;HES1
prerank,cristae formation (GO:0042407),-0.36068088034335677,-1.081551093489988,0.34674922600619196,0.7824842807197063,1.0,10/27,16.02%,ATP5F1B;ATP5PF;ATP5F1E;ATP5ME;ATP5MC1;MICOS13;ATP5F1D;APOO;ATP5MC2;ATP5F1A
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.4564535728791692,1.0815152336600882,0.375,0.9207088295247612,1.0,2/22,1.46%,ANK2;ATP1B1
prerank,regulation of ERAD pathway (GO:1904292),0.5227210080535406,1.0812499203684294,0.3985637342908438,0.920565496285832,1.0,3/11,11.86%,USP13;RNF185;USP25
prerank,regulation of cation transmembrane transport (GO:1904062),-0.3557323405164402,-1.081212028045874,0.34185303514376997,0.7820020293332516,1.0,7/29,8.92%,CACNA1D;KCNIP4;FGF12;KCNIP3;KCNAB1;KCNIP1;CD63
prerank,negative regulation of transport (GO:0051051),-0.3141409527928993,-1.0811680348215487,0.3282442748091603,0.7806920888576396,1.0,9/51,7.47%,PRKD1;MCTP1;DYSF;SNCA;NR1H3;BST2;NDFIP2;SIRPA;SYT11
prerank,cellular response to arsenic-containing substance (GO:0071243),0.4814840480549152,1.0808246472606517,0.3798319327731092,0.9208987837508149,1.0,2/15,4.82%,MKNK2;VCP
prerank,nucleoside salvage (GO:0043174),0.5185176371040094,1.0808159350090638,0.3890784982935154,0.9200293675869334,1.0,3/10,7.43%,UPP2;TK2;TK1
prerank,protein deubiquitination (GO:0016579),0.3380214387493009,1.0806691560248411,0.30960086299892126,0.9195481060284303,1.0,90/242,25.76%,CCNA2;USP13;ADRB2;FOXK1;USP46;VCP;USP24;TGFBR1;TRRAP;BECN1;EP300;JOSD1;OTUD1;USP2;OTUD7B;USP49;TADA3;KAT2A;BAP1;USP7;MDM4;USP32;USP10;UFD1;USP33;FOXK2;GATA3;ASXL2;USP22;USP34;USP3;USP25;USP21;RHOA;USP47;MYSM1;BIRC3;KAT2B;COPS5;RAD23B;PSMC6;USP4;HCFC1;STAMBP;USP1;PSMD8;POLB;OTUD3;DESI2;ACTR8;ZRANB1;YY1;OTUB1;CLSPN;AR;INO80;TNIP1;PSMB1;VCPIP1;USP9X;PSMD13;USP48;PSMD1;MINDY2;HGS;PSMD7;OTUD5;STAM2;PSMA8;USP31;USP37;PSMD3;TRAF3;PSMD2;CDK1;SENP8;PSMC2;SMAD2;USP36;PSMB2;RHOT1;IFIH1;INO80D;UIMC1;USP28;YOD1;PSMD14;APC;UCHL3;TOMM20
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.41597392974191627,-1.0801401305687235,0.37092731829573933,0.7822387806552488,1.0,7/16,21.65%,CXCL12;TPT1;BCL2L1;RPS3;NACC2;TRIM32;CCAR2
prerank,plasma membrane organization (GO:0007009),0.3872603337848725,1.080073289146671,0.35834411384217335,0.9203889395604067,1.0,11/61,9.97%,AHNAK2;ANK2;ANO6;DMKN;PLSCR1;CAVIN2;A4GALT;BIN2;SYTL4;NSF;CXCR4
prerank,Golgi organization (GO:0007030),0.36020030131130154,1.0800697313824628,0.3592814371257485,0.9195067822848668,1.0,38/112,22.13%,ARHGAP21;ATL3;GOLGB1;RAB43;STX5;FBXW8;ATP8B1;TMED5;GOLPH3;GAK;PLK3;NPLOC4;ATL2;LMAN2L;BCAS3;SEC22B;VTI1A;CDC42;TRIP11;RAB30;TRAPPC12;CSNK1A1;COG3;STX16;CSNK1D;TICAM2;GBF1;ARL1;HUWE1;VPS51;PLEKHM2;VCPIP1;SYNE1;LYSMD3;BET1;CUL7;TBC1D20;CDK1
prerank,Golgi ribbon formation (GO:0090161),0.5015673667318821,1.080048307910887,0.3797250859106529,0.918671676953216,1.0,5/13,13.81%,TMED5;GOLPH3;VTI1A;TRIP11;STX16
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.4802548664909702,1.079864787033677,0.38552188552188554,0.9183048632720738,1.0,5/16,17.88%,MRAP;SLC39A14;ACP3;PRKCA;PDE6H
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.45996552904150184,-1.0788929016702464,0.3888888888888889,0.7843847342869039,1.0,2/10,1.82%,ST3GAL1;ST6GAL1
prerank,cellular glucose homeostasis (GO:0001678),-0.32352210063609976,-1.078759806054754,0.3161512027491409,0.7833184575570552,1.0,13/41,16.12%,IGF1R;PIK3R1;FOXO1;ZBTB20;HIF1A;ERN1;PPARGC1A;GAS6;PRKAA2;HK2;LRRC8A;ADCY8;HK1
prerank,positive regulation of focal adhesion assembly (GO:0051894),-0.39690396349902873,-1.0778860038413218,0.3674033149171271,0.7843943808537748,1.0,6/19,15.66%,TEK;KDR;MAP4K4;RAC1;MYOC;PPM1F
prerank,positive regulation of secretion by cell (GO:1903532),0.3764922262968261,1.077790777540899,0.34403080872913994,0.9232765886423584,1.0,12/70,9.35%,SLC12A2;TGFB3;EZR;BMP6;ADAM9;KCNB1;GOLPH3;P2RX4;EXPH5;SYTL4;UNC13B;RAB27B
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.39619043604009174,-1.0777701929852288,0.36134453781512604,0.7832585784707844,1.0,3/18,2.68%,SLC2A1;PRKAG2;OCLN
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.5085982505107669,1.0776461259267247,0.3895870736086176,0.9228038210805705,1.0,2/12,5.51%,ISL1;CD80
prerank,regulation of protein kinase activity (GO:0045859),0.3624283617737531,1.0771727200348171,0.36823104693140796,0.9233018501151623,1.0,17/106,13.21%,PLCE1;RASSF2;PTK2B;CCN1;DDR2;LRP6;RAP1A;RAP2C;SMCR8;IQGAP1;WWTR1;PAK2;MRNIP;RB1;CEP85;SFN;XRCC5
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.40814002413497336,1.076248538572004,0.38746438746438744,0.9250895226122016,1.0,9/41,10.12%,CD44;PTPRU;PLPP3;IL10;GCNT2;TNFSF11;DENND6A;MAGI1;FOXA1
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.3737328952811797,1.0761818258719973,0.3642297650130548,0.9243596765669396,1.0,19/72,16.52%,PLAGL1;NDRG1;CRADD;EP300;PLK3;CNOT7;ATM;MDM4;USP10;CHEK2;CDKN1B;PCBP4;KAT5;RBL2;SFN;FOXM1;CARM1;PML;ATRX
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),-0.2785658237606439,-1.0760862227275205,0.29608938547486036,0.7864915303831751,1.0,17/90,9.98%,LEPR;IGF1R;ACSL1;PPARGC1B;ESRRG;GATM;GNAS;PRDM16;ELOVL6;EBF2;PPARGC1A;GJA1;MFN2;ACADL;IL18;LPIN1;IL4R
prerank,long-chain fatty acid biosynthetic process (GO:0042759),-0.3713831034221545,-1.0758444685453692,0.3569620253164557,0.7857681606459521,1.0,14/23,40.71%,ELOVL6;ACOT7;ALOX12;PTGS2;ASAH2;GPX4;ACSBG1;ALOX5;LTA4H;CYP2E1;HPGD;CYP1A1;LTC4S;GSTP1
prerank,negative regulation of neurogenesis (GO:0050768),-0.34212626531632534,-1.0756164955664427,0.3582554517133956,0.7849459208233626,1.0,12/34,23.80%,B2M;RAPGEF2;NOTCH1;ARHGDIA;LINGO1;EFNB3;MAG;APPL2;OMG;RTN4;PTN;RTN4R
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.4025519024423944,1.0750168718901107,0.37585733882030176,0.9268691391473993,1.0,5/48,4.49%,ANK2;PTK2B;CAMK2D;DIAPH1;DMD
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.42681987356390194,-1.0749418180587287,0.4005037783375315,0.7854100672188837,1.0,8/13,22.60%,DCN;IDS;NCAN;CSPG5;CSPG4;HEXB;VCAN;BGN
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.4696890386348933,1.0747430162021385,0.3722871452420701,0.9267961062792138,1.0,7/19,14.55%,CLIC4;DLG1;MARK2;PATJ;PARD3;DLG2;ERBIN
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.42445420272981216,1.0746234264221992,0.3890532544378698,0.9262415948549132,1.0,13/33,22.28%,DDX5;DDRGK1;EP300;KDM1A;CBFB;CARM1;UFL1;PRMT2;AR;UFSP2;UBA5;RNF14;SAFB2
prerank,regulation of cellular localization (GO:0060341),-0.31995460074451826,-1.074567171653372,0.32269503546099293,0.7850989205200744,1.0,13/46,15.66%,LYN;ADCY5;PARD6G;MAP2;PARP1;LRRK2;HSP90AB1;BRSK2;FES;STXBP4;TRIM46;NR1H4;PPM1F
prerank,negative regulation of cytokine production (GO:0001818),0.3414658308555092,1.0743522539767538,0.3604004449388209,0.9261312457588872,1.0,27/163,12.79%,THBS1;FN1;ANXA1;EZR;TAX1BP1;INHBA;HDAC9;KLF4;IL10;ANXA4;PDCD4;DDIT3;NPLOC4;OTUD7B;MAVS;TLR6;RNF135;UFD1;KAT5;ASB1;ACOD1;TRIM25;TLR4;IKBKE;CMKLR1;PIBF1;INHBB
prerank,negative regulation of neuron projection development (GO:0010977),-0.313308666177901,-1.074201212474708,0.33073929961089493,0.7847587921802107,1.0,21/56,21.04%,EFNB2;APOE;DCC;EPHA4;ARHGDIA;DENND5A;LINGO1;LPAR1;SPOCK1;EFNB3;CRMP1;MAG;CIB1;MINAR1;HDAC2;MYLIP;OMG;TRPV4;RTN4;NLGN1;PTPRO
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.37024206729687037,-1.0741733376392462,0.3514285714285714,0.7834192546522472,1.0,7/25,13.61%,B2M;KIT;WNT5A;SLC7A5;MALT1;LACC1;TRAF2
prerank,cellular calcium ion homeostasis (GO:0006874),0.35037345023418354,1.0738186769502052,0.34717416378316035,0.9267621338609899,1.0,23/133,15.85%,SLC35G1;SLC24A3;ANK2;ATP1B1;CAMK2D;ATP2C2;CSRP3;STIM2;TNNI3;ATP2B4;SLC10A7;MCUB;MICU1;DRD3;HTR2B;TRPC5;MCU;RMDN3;STOML2;SLC8B1;PRKACA;TRPC7;PML
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.4773509195005148,1.073803470101987,0.3685950413223141,0.9259092372374131,1.0,5/17,10.75%,EIF4G1;SPRED2;PPEF2;DMTN;PARD3
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.4429237173757451,-1.0737117845626816,0.38663484486873506,0.78328632922151,1.0,4/12,8.48%,GJD3;CALM1;PDE4D;CALM3
prerank,cardiac muscle cell action potential (GO:0086001),0.44484850799532205,1.0735801068620388,0.4,0.9256350634149789,1.0,5/30,4.49%,KCNJ2;ANK2;ATP1B1;CACNA1C;DMD
prerank,transcription by RNA polymerase I (GO:0006360),0.42781828455758664,1.073403584316674,0.37774524158125916,0.9252291950007403,1.0,12/34,18.62%,POLR1G;TAF1C;MNAT1;ERCC3;TTF1;TAF1;POLR1A;POLR1H;POLR1F;RRN3;TAF1D;POLR2H
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.27058980802924654,-1.0733143934441551,0.2909090909090909,0.7830217670679515,1.0,28/117,16.35%,LYN;ADCY5;ADCY1;GNG2;PRKAR2B;ADCY7;CALCRL;ADCY2;PRKACB;RAMP2;MYH9;GGT5;CD81;PRKAR1B;PTH1R;CYSLTR1;PRKAR1A;SRC;ADORA2A;ADM;CYSLTR2;ADCY4;IAPP;PLCG1;ADCY3;ADCY8;VIPR2;SYK
prerank,platelet degranulation (GO:0002576),0.35980389958087666,1.0733013318563722,0.37132784958871917,0.924643447240483,1.0,20/118,12.28%,PCDH7;THBS1;FN1;CD109;TGFB3;LHFPL2;CD9;PDGFA;CLU;VCL;ABCC4;FAM3C;SYTL4;GTPBP2;RAB27B;WDR1;ISLR;SERPING1;TGFB2;CD36
prerank,"phagocytosis, engulfment (GO:0006911)",0.42975223623802056,1.073264128227309,0.37727910238429174,0.9238599013061182,1.0,8/36,12.28%,THBS1;GULP1;GSN;BIN2;XKR4;RHOBTB1;CDC42;CD36
prerank,regulation of transforming growth factor beta production (GO:0071634),0.4608490684676546,1.0726087883315125,0.3721311475409836,0.924820880530139,1.0,5/18,11.71%,ITGB8;FN1;ITGAV;CD46;TGFB2
prerank,positive regulation of proteolysis (GO:0045862),0.393494510048227,1.0725706024923924,0.3602150537634409,0.9240570670818719,1.0,10/55,12.30%,CYFIP2;PERP;TANK;ADAM9;FBXW11;TNFRSF1B;TBC1D10A;IST1;SH3D19;ADAM8
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.42082016948228984,-1.0718024193060018,0.36533957845433257,0.7856770588589561,1.0,4/14,6.96%,SEMA7A;KIT;WNT5A;GPRC5B
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.4540323072626676,1.0714912213992867,0.38769230769230767,0.9263473916064892,1.0,4/23,3.95%,ANK2;PTK2B;CAMK2D;DIAPH1
prerank,gastrulation (GO:0007369),0.48747213793518296,1.071239773173755,0.3863275039745628,0.9262341297582412,1.0,7/15,23.83%,GPC3;NR4A3;MEGF8;LRP5;LMBRD1;SMAD2;TASOR
prerank,histone H2A monoubiquitination (GO:0035518),-0.4127158545591731,-1.0710211135618313,0.36511627906976746,0.7865202075006935,1.0,6/17,16.29%,PCGF5;KDM2B;BCOR;DDB1;RYBP;DDB2
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",-0.3767346904246053,-1.0700471477923643,0.38461538461538464,0.7878982203463998,1.0,11/25,18.66%,GRIN2A;GRIN2B;MEF2C;GRID2;LRRK2;GLRA1;GRIN1;AKT1;GSK3A;INSYN2A;ARRB2
prerank,ephrin receptor signaling pathway (GO:0048013),-0.290075045814012,-1.0699500054375328,0.30275229357798167,0.7867650745416133,1.0,33/82,21.44%,EFNB2;LYN;EPHA7;CHN1;PAK1;EPHB4;PTK2;ACTB;EPHB1;EPHA4;GRIN2B;SDCBP;EPHA8;VAV3;MMP2;SRC;RAC1;EFNB3;SDC2;EFNB1;GRIN1;WASL;APH1B;PSENEN;ARPC3;ITSN1;ACTG1;GIT1;RASA1;AP2S1;CDK5R1;DNM1;AP2M1
prerank,regulation of microglial cell activation (GO:1903978),-0.4242632212041186,-1.0694915671860397,0.3638676844783715,0.7866782272699455,1.0,6/15,25.69%,GRN;SYT11;SPHK1;TTBK1;TREM2;PTPRC
prerank,icosanoid secretion (GO:0032309),0.5026367795922297,1.0694692834877348,0.40319715808170514,0.9304755132396305,1.0,3/12,11.48%,ANXA1;ABCC4;DRD3
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.3872924722810869,1.0690650308892466,0.3815104166666667,0.9308370682789336,1.0,24/58,26.81%,HERC2;ATM;KAT5;RNF168;ERCC1;ERCC8;IFFO1;XRCC5;NSMCE2;PRKDC;POLB;UBE2N;KDM2A;ZBTB7A;POLA1;NBN;SMC5;MRE11;SUMO1;HMGB2;UIMC1;PSMD14;LIG4;LIG3
prerank,membrane assembly (GO:0071709),-0.33823631829096046,-1.0687534330151316,0.338368580060423,0.7873305957194973,1.0,7/34,8.81%,NRXN1;PICALM;IL1RAPL1;UGCG;RFTN1;ANK3;FLOT1
prerank,superoxide metabolic process (GO:0006801),0.4357243023041337,1.0685202562403566,0.3721973094170404,0.9315111944086579,1.0,1/29,0.16%,SH3PXD2A
prerank,defense response to virus (GO:0051607),-0.27182401282134194,-1.068408145023176,0.3253012048192771,0.7869055684238467,1.0,22/100,13.66%,SERINC3;SERINC5;BCL2;ABCC9;IRF2;SAMHD1;BST2;IFITM1;BCL2L1;NLRC5;IFIT2;AGBL4;TLR3;IFNAR2;IFITM3;ZDHHC1;MLKL;OAS2;RTP4;IFIT3;TLR7;CGAS
prerank,base-excision repair (GO:0006284),0.4040537692264653,1.0682266815228618,0.3814866760168303,0.9314502607811977,1.0,22/48,27.90%,MPG;APEX2;SMUG1;MBD4;RPA1;USP47;XPA;RFC5;POLD3;PRMT6;POLB;WRN;HUWE1;TDG;UNG;APEX1;RFC1;ERCC5;XRCC1;LIG3;NTHL1;POLQ
prerank,regulation of kinase activity (GO:0043549),0.3643789679141099,1.0681831259897898,0.3786764705882353,0.9306900371095033,1.0,7/89,2.74%,EGFR;PLCE1;MET;NTRK3;LMO4;FGFR1;DDR2
prerank,protein sumoylation (GO:0016925),0.3944334473097258,1.068101078528523,0.3867403314917127,0.9300292939413112,1.0,17/49,21.10%,NUP93;EGR2;TRPM4;PIAS3;PIAS2;NUP188;RANBP2;NSMCE2;SAE1;NUP107;AAAS;RNF212B;RAE1;NUP54;PIAS1;SUMO1;NUP98
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.2591339615057814,-1.068078739997834,0.27835051546391754,0.786445584235876,1.0,20/161,7.31%,BICC1;MCC;IGFBP2;SOX13;APOE;ZNRF3;TMEM64;FZD6;NKD1;TLE1;WNT5A;IGFBP4;NKD2;TBX18;SOX17;DAB2IP;AXIN2;NOTUM;BMP2;MDK
prerank,regulation of monocyte differentiation (GO:0045655),0.49958971646156897,1.0679226899283587,0.38316151202749144,0.9296501890425819,1.0,1/14,0.32%,FOXP1
prerank,regulation of telomere maintenance (GO:0032204),0.4398212615496061,1.0677791355353659,0.37947122861586313,0.9292027334941411,1.0,10/26,19.95%,SMG6;SMG1;USP7;ERCC1;HDAC8;XRCC5;PML;ATRX;NBN;MRE11
prerank,protein modification process (GO:0036211),0.3686256737970793,1.0671570550888079,0.3660377358490566,0.9301295083202632,1.0,23/76,16.72%,WWP2;TGM3;ABL1;RIPK3;PLOD2;PHKA2;PHEX;TGM1;ATG3;BAP1;UBE2D3;CSNK1G3;B4GALT7;GNMT;FBXW2;USP25;YES1;DUSP12;CPE;PRKDC;PPP4R2;UBE2S;PIGH
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.44953543227253756,1.0670001720649311,0.39067524115755625,0.929684361302443,1.0,3/23,9.81%,CCN3;IFI35;PPM1A
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.488635167920966,1.0669816303297615,0.3944636678200692,0.9288602931072452,1.0,5/14,16.96%,PPP3CA;PPTC7;PPP2R2D;PPP5C;PPP2CB
prerank,axon guidance (GO:0007411),0.33593419849232564,1.066865063149524,0.36801752464403065,0.9282939046375676,1.0,31/201,9.97%,SLIT3;SLIT2;NTN1;SMO;NFIB;ALCAM;EFNA5;SEMA3D;EZR;SEMA3C;SPTAN1;GRB10;UNC5C;PDLIM7;SHC1;SEMA3E;NTN5;NOTCH2;KLF7;GDNF;EPHB6;PLXNA2;GAB2;NRP1;NTN3;TMEFF1;GAB1;PTPRA;USP33;EMB;CXCR4
prerank,termination of RNA polymerase I transcription (GO:0006363),0.43155457731682056,1.0668021599486295,0.38563049853372433,0.9275901432495648,1.0,10/30,18.62%,POLR1G;TAF1C;MNAT1;ERCC3;TTF1;POLR1A;POLR1H;POLR1F;TAF1D;POLR2H
prerank,negative regulation of tumor necrosis factor production (GO:0032720),-0.32522204787837994,-1.0666265447841496,0.34527687296416937,0.7890311402149985,1.0,11/41,18.17%,IGF1;CD34;SIRPA;SYT11;GAS6;HAVCR2;TRIM27;CHRNA7;NR1H4;TNFAIP3;VSIR
prerank,anion transmembrane transport (GO:0098656),0.37918123827467637,1.066523703017936,0.37711313394018203,0.9275163138096381,1.0,7/67,5.71%,SLC23A1;SLC23A2;SLC5A6;LRRC8D;SLC7A2;SFXN1;SFXN2
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.4703139855952421,1.0664758005398496,0.380718954248366,0.9267831636761893,1.0,9/19,22.98%,LBP;PIK3AP1;TLR4;PRKCE;TICAM2;IRAK1;LY96;ITGAM;RAB11FIP2
prerank,regulation of epithelial cell proliferation (GO:0050678),0.3649624348695459,1.0662587048192058,0.37733499377334995,0.9265360026234509,1.0,9/85,7.68%,EGFR;BMP4;TCF7L2;BMP5;BMP6;GDF5;NR4A3;FGF2;DUSP10
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.36951031172238147,1.0661946332273446,0.35578144853875476,0.9258527132843252,1.0,16/80,11.62%,PLCE1;DPYSL3;TGFB3;ARAP1;CDC42EP5;PALM;NDEL1;NRP1;NCKAP1;RHOQ;FUZ;ENTR1;BCAS3;WASHC1;CDC42;BRK1
prerank,motile cilium assembly (GO:0044458),0.5088639907904798,1.066053841982041,0.40540540540540543,0.9253949766967262,1.0,3/12,11.52%,DNAAF3;CCDC40;RSPH6A
prerank,protein phosphorylation (GO:0006468),0.31957294252218416,1.0655932133616146,0.32088799192734613,0.92577926582742,1.0,107/479,16.56%,STK39;EGFR;BMP4;DCLK1;MAP3K5;GRK5;STK19;PKD1;MARK1;PTK2B;ABI1;CCNA2;CAMK2D;LIMK2;WNT11;FGFR1;WNK1;CIT;DDR2;PRKCD;HIPK1;EFEMP1;MKNK2;NEK7;GDF6;BCR;GSK3B;ABL1;CDC25B;RIPK3;BMPR1A;SGK3;ULK2;SIK3;BIRC6;TLK1;TGFBR1;TGFBR2;SIK2;STK16;ERC1;CHUK;ATM;MAP3K3;MARK2;DYRK2;SMG1;IP6K3;ADAM10;EIF2AK4;CDC42BPG;DYRK3;CLK2;CHEK2;CSNK1G3;FRK;CAD;MARK3;MTOR;PAK4;CSNK1E;PKN2;PAK2;PIM2;TAF1;EIF2AK3;CHEK1;ACVR1;CSNK2A2;CSNK2A1;TLR4;TGFB2;CSK;IKBKE;NLK;PRKCE;AAK1;CSNK1A1;MAPK1;SRPK1;MORC3;CAB39;VRK3;CAMK4;ILK;RIOK2;AMHR2;HTATIP2;CDK12;STK11;PPP4R1;FAM20A;MAPK15;PRKAA1;ERN2;CDK18;PRKCA;PRKACA;CSNK1D;WNK3;COQ8A;CDKL2;MEX3B;MAP3K12;PRKDC;MAP4K1;TOP1
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.32115070816839086,-1.065392823085487,0.3377049180327869,0.7910797823495151,1.0,11/43,18.17%,IGF1;CD34;SIRPA;SYT11;GAS6;HAVCR2;TRIM27;CHRNA7;NR1H4;TNFAIP3;VSIR
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.439587271412879,1.0648522924703436,0.38461538461538464,0.927055378872512,1.0,5/25,10.36%,EXT1;B3GNT2;B4GAT1;B3GNT6;NDST1
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),-0.31359147765623957,-1.0645280834319453,0.3424657534246575,0.7921089828753592,1.0,11/46,7.50%,ALDH1A1;NOVA1;LGR4;NOVA2;NOTCH1;PLCL1;NR1H3;MAP2K6;ACVR2B;RBPJ;PLCL2
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.5078706396744654,1.0644603781644932,0.4124783362218371,0.9273246250199175,1.0,5/11,11.71%,GDF6;TGFBR1;TGFBR2;ACVR1;TGFB2
prerank,tRNA wobble uridine modification (GO:0002098),0.5046567335592299,1.064424443909936,0.4166666666666667,0.9265746848581767,1.0,8/14,23.15%,CTU2;MOCS3;MTO1;ELP4;GTPBP3;ALKBH8;KTI12;URM1
prerank,regulation of protein sumoylation (GO:0033233),0.46379476390056074,1.0643880769933403,0.392,0.9258242560751142,1.0,4/17,15.57%,HDAC4;PIAS3;ZMIZ1;SAE1
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.34363297235126966,-1.0642073835145125,0.3732394366197183,0.7916120299159841,1.0,6/36,8.90%,MECOM;FOXO1;PPIA;GPS2;SIRPA;DUSP3
prerank,"phototransduction, visible light (GO:0007603)",0.5042971503510404,1.064186230369126,0.40893470790378006,0.9255373158863028,1.0,1/14,1.07%,RP1
prerank,myoblast fusion (GO:0007520),0.5148379765421754,1.0641375329117972,0.40932642487046633,0.924827964288232,1.0,4/12,12.53%,CD9;ADAM12;ADAMTS5;PTGFRN
prerank,Notch signaling pathway (GO:0007219),-0.2976704344752409,-1.063732940260133,0.308300395256917,0.7916004913261763,1.0,15/59,10.66%,SORBS2;NOTCH3;MAML2;MAML3;DTX4;NOTCH1;PLXND1;NOTCH4;RBPJ;JAG2;BMP2;MDK;HEY2;YBX1;DTX1
prerank,signal transduction by p53 class mediator (GO:0072331),0.425459324600988,1.0633575453974276,0.37987987987987987,0.9261685621678737,1.0,5/30,8.84%,NDRG1;DDX5;FHIT;MDM4;USP10
prerank,inositol phosphate metabolic process (GO:0043647),0.3882881439262747,1.063021174645128,0.3702127659574468,0.9262571463045569,1.0,11/46,9.62%,PLCE1;INPP4A;IP6K2;PLCB3;NUDT4;PLCD3;OCRL;FGF2;IP6K3;PPIP5K2;PLCD1
prerank,cellular sodium ion homeostasis (GO:0006883),-0.4118435536942505,-1.0630154923888515,0.38213399503722084,0.7922247277015367,1.0,4/15,3.55%,ATP1A2;ATP1B3;NEDD4L;ATP1B2
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.4098200372928166,1.0627968835134913,0.3855072463768116,0.9259868762376412,1.0,10/37,10.61%,TGFB3;IL10;PDCD4;BMPR1A;IGFBP5;NR4A3;JUN;FGF2;CDKN1B;HTR1B
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.3744654210850292,1.0627504522835467,0.39276807980049877,0.9252637562727338,1.0,5/76,3.27%,PLCE1;GPR4;ADRA1B;AGTR1;LPAR4
prerank,gonad development (GO:0008406),-0.32294188809628205,-1.062026017518696,0.337037037037037,0.7936014559280246,1.0,8/41,10.52%,NR2F2;WNT4;KIT;WNT5A;SALL1;MAMLD1;GATA6;BASP1
prerank,prostanoid biosynthetic process (GO:0046457),-0.42171581764547017,-1.0618974090493363,0.3910891089108911,0.7925951399625722,1.0,7/15,17.31%,PTGDS;PTGS1;PNPLA8;PTGES3;EDN1;MIF;CD74
prerank,cellular response to interleukin-12 (GO:0071349),-0.3072675876847075,-1.0615677041394136,0.34317343173431736,0.7921204821577548,1.0,19/48,21.09%,PLCB1;CD47;PPIA;CNN2;LMNB1;SIRPA;HSPA9;AIP;PSME2;BOLA2;CFL1;MIF;RPLP0;SNRPA1;RALA;SOD2;HNRNPDL;LCP1;TALDO1
prerank,response to endoplasmic reticulum stress (GO:0034976),0.35492722570279645,1.0614259455457786,0.3555291319857313,0.9280817989925336,1.0,16/107,11.12%,THBS1;MAP3K5;TMEM117;GSK3B;DDIT3;NIBAN1;RNF185;VCP;DDRGK1;ERP27;JUN;CREB3L3;OS9;AGR2;QRICH1;EIF2AK3
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.45815567359476284,1.0613893927488862,0.4064,0.9273308509660532,1.0,4/20,9.07%,SMAD9;NFE2L2;EP300;CARF
prerank,positive regulation of cell adhesion (GO:0045785),0.36701640892081083,1.0612675511405452,0.3893805309734513,0.9268214109267379,1.0,18/74,17.84%,VIT;ZFHX3;PPP3CA;ADAM9;FOXC2;ITGAV;ATM;MAGI1;AGR2;TGFB2;ADAM8;RSU1;CHRD;TFE3;PRKCA;CITED2;NPNT;TPM1
prerank,protein autophosphorylation (GO:0046777),0.3400542882043359,1.0609839230319116,0.3685393258426966,0.9267655243339581,1.0,28/157,11.12%,STK39;EGFR;GRK5;PTK2B;CAMK2D;FGFR1;DDR2;MKNK2;GSK3B;ABL1;RIPK3;ULK2;SIK2;STK16;ATM;MAP3K3;MARK2;SMG1;EIF2AK4;CLK2;CHEK2;CAD;MARK3;MTOR;PAK2;PIM2;TAF1;EIF2AK3
prerank,polarized epithelial cell differentiation (GO:0030859),0.49770088433505694,1.0609726793235688,0.4006514657980456,0.9259420479276814,1.0,4/13,12.11%,EZR;CDC42;RHOA;MYO9A
prerank,organic hydroxy compound transport (GO:0015850),-0.33836276012329597,-1.060963650369124,0.3504823151125402,0.79242039272476,1.0,9/36,14.43%,SLCO2B1;NCOA1;SLCO1C1;RBP4;NPC2;OSBP;SLC5A3;STARD5;NR1H4
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.4302657001198225,1.0609424267921876,0.4064327485380117,0.9251696683673805,1.0,5/27,7.07%,GRB10;PRKCD;PID1;IRS1;PTPN2
prerank,regulation of Notch signaling pathway (GO:0008593),0.3643663188150886,1.0608605862642566,0.38017565872020076,0.9245360851777658,1.0,19/76,15.67%,EGFR;CCN3;TCIM;WWP2;EP300;MMP14;JAG1;CREBBP;CD46;NIBAN2;TGFB2;ZMIZ1;STAT3;AAK1;KAT2B;GALNT11;YJEFN3;ITGB1BP1;SNW1
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.39414531719166274,-1.0602809860389228,0.37994722955145116,0.7929134270052622,1.0,6/20,13.61%,IL1R1;B2M;CD81;MALT1;IL18;TRAF2
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.4347108889755382,-1.0602217310537998,0.3739130434782609,0.7903079222398821,1.0,1/12,0.18%,IGF1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.4347108889755382,-1.0602217310537998,0.3739130434782609,0.7903079222398821,1.0,1/12,0.18%,IGF1
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.33331408804728524,1.0601596596081309,0.3612040133779264,0.9256495376384748,1.0,30/182,12.77%,BMP4;FOXP1;SLC24A3;ITGB8;SMO;LRPAP1;WWP2;KLF4;NOTCH2;ZNF148;BMPR1A;TNRC6C;DDRGK1;NFKB1;MOV10;CNOT7;CELF1;ATP2B4;FGF2;SMCR8;ADAM10;ATOH8;CD46;TAF1;RB1;RBL2;TGFB2;REST;SNX12;RBMS3
prerank,positive regulation of actin nucleation (GO:0051127),0.5179743244568498,1.0600653756547302,0.4043321299638989,0.9250465289519709,1.0,6/11,18.12%,GSN;NCKAP1;BRK1;FCHSD2;WHAMM;CYFIP1
prerank,nervous system development (GO:0007399),0.3200721859617061,1.0598256604432899,0.33675564681724846,0.9248621216636859,1.0,46/429,8.39%,CDH1;WWP1;CRIM1;PCDHB16;DCLK1;MET;MBNL1;NGF;PDGFC;FN1;SMO;ZIC4;PKD1;HDAC4;ZBTB16;EFNA5;RBFOX2;INHBA;NTN5;PCDHB13;GSN;ZIC1;NOTCH2;PMP22;EGR2;GLRB;ADGRG6;GDNF;TGFBR1;SDK1;DAGLB;EP300;JAG1;STIL;ECRG4;NAGLU;FGF13;FGF2;NELL1;NCKAP1;GLIS2;HES1;WWTR1;SDCBP2;BTBD3;TEAD1
prerank,positive regulation of mitochondrion organization (GO:0010822),-0.3019740190237912,-1.0598178055877177,0.34763948497854075,0.7901717453883016,1.0,26/57,28.47%,DCN;KDR;TNFSF10;PPARGC1A;PDCD5;BMF;CHCHD10;BOK;HIP1R;SPIRE1;GSK3A;PARK7;RALA;BIK;CAMKK2;MLLT11;DNM1L;HTT;BAD;PLAUR;GPER1;TREM2;HRK;BAK1;PMAIP1;TP53
prerank,regulation of protein dephosphorylation (GO:0035304),-0.3317927472110544,-1.0596481560187803,0.3758620689655172,0.7892816543278071,1.0,14/37,23.48%,MFHAS1;PPIA;CALM1;PPP1R16B;CALM3;PPP2R5A;TIPRL;HSP90B1;ENSA;PPP1R7;CDCA2;HTT;SMPD1;PIN1
prerank,lamellipodium organization (GO:0097581),0.42422066648601864,1.05943193800439,0.39123867069486407,0.9251277457780804,1.0,8/29,9.56%,ABLIM3;ITGB1;ARHGEF6;GOLPH3;VCL;ABLIM2;SPEF1;DMTN
prerank,hippo signaling (GO:0035329),-0.3561883649394908,-1.0591849058893852,0.37393767705382436,0.7891730482327389,1.0,12/26,30.07%,TJP1;TEAD2;AMOTL1;CASP3;STK3;TEAD4;YAP1;TJP2;TEAD3;YWHAB;DCHS1;LATS2
prerank,cellular response to interleukin-15 (GO:0071350),-0.42773096104911906,-1.0587786358551403,0.4116222760290557,0.7875485265884653,1.0,4/13,10.34%,PLCB1;IL15RA;STAT5B;GRB2
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.42773096104911906,-1.0587786358551403,0.4116222760290557,0.7875485265884653,1.0,4/13,10.34%,PLCB1;IL15RA;STAT5B;GRB2
prerank,vacuolar acidification (GO:0007035),0.45209625789896074,1.0582658270871894,0.39906832298136646,0.927576019233667,1.0,7/21,19.06%,ATP6V0A4;ATP6V0A1;ATP6V0E1;ATP6V1H;ATP6V0D1;TMEM199;CLN3
prerank,striated muscle contraction (GO:0006941),-0.30535659193619397,-1.0581936585449225,0.34572490706319703,0.7878499751349193,1.0,12/53,16.64%,ATP1A2;DTNA;STAC;KCNQ1;ALDOA;SLC8A1;RYR2;RCSD1;MYH14;ARHGEF11;CASQ2;NOS1
prerank,positive regulation of immune system process (GO:0002684),0.47510835750364394,1.0581393730843247,0.42105263157894735,0.9271017040147999,1.0,1/16,1.32%,ANXA1
prerank,positive regulation of cell growth (GO:0030307),0.3610113476193255,1.0575354150582879,0.3877551020408163,0.9278891276803559,1.0,15/96,12.09%,EGFR;NTN1;NGF;EIF4G1;TGFBR1;KLHL22;SHTN1;MMP14;ADAM10;ISLR2;ZFYVE27;CDC42;CSNK2A1;TGFB2;USP47
prerank,hyaluronan catabolic process (GO:0030214),0.4717243479581124,1.0574246354067662,0.4097560975609756,0.9273458238400417,1.0,9/18,21.05%,CD44;HEXA;FGF2;SPAM1;HYAL3;SLC9A1;CEMIP2;CHP1;TGFB1
prerank,ribosomal subunit export from nucleus (GO:0000054),0.508133454817694,1.0573002065470454,0.4301948051948052,0.9268350262219649,1.0,7/13,21.17%,XPO1;SDAD1;ABCE1;LSG1;RAN;LTV1;EIF6
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.3561615359279144,-1.0571957244401395,0.3710691823899371,0.789250462650565,1.0,14/29,37.82%,NR1H3;PNPLA8;DBI;TMEM86B;PLA2G4E;MBOAT7;PLA2G4C;LPCAT3;PLA2G5;PLBD1;LPCAT2;PLB1;NR1H2;PLA2G3
prerank,negative regulation of cell development (GO:0010721),-0.36034545959266945,-1.056109983400145,0.38580246913580246,0.7911115452204625,1.0,3/25,3.99%,IGF1;B2M;NOTCH1
prerank,cellular iron ion homeostasis (GO:0006879),-0.30631252612843024,-1.0558835447148343,0.34375,0.7903875918381426,1.0,13/55,16.33%,CP;FTH1;TFRC;SLC40A1;FTL;ATP6AP1;CAND1;SLC22A17;ATP6V1A;SLC11A2;BOLA2;NUBP1;GLRX3
prerank,cellular response to estrogen stimulus (GO:0071391),0.4883110669566647,1.0558819587491872,0.428099173553719,0.9299223762032692,1.0,4/14,17.97%,SERPINB9;BCAS3;NCOA4;AR
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.5247055747454159,1.0558243801052993,0.40555555555555556,0.929222365471239,1.0,4/11,16.84%,YBX3;RIPK3;BIRC3;FZD9
prerank,heart contraction (GO:0060047),0.40256369501728795,1.0555209855679575,0.39850746268656717,0.9292288224014631,1.0,5/41,5.96%,SGCD;ATP1B1;CSRP3;DMD;TNNI3
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.4305414653703259,-1.05548672306958,0.4202247191011236,0.7901249070977987,1.0,4/13,6.47%,ENG;KDR;COL4A1;NOTCH4
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.3457606354285927,-1.0549594888126483,0.3617021276595745,0.7902761647141568,1.0,13/30,19.10%,NOS3;TNFSF10;FAS;BCL2L1;CFLAR;FAIM;RFFL;FAIM2;TRAF2;TNFAIP3;PARK7;BRCA1;ARHGEF2
prerank,glucose metabolic process (GO:0006006),-0.2990443196375525,-1.0549560601349417,0.33725490196078434,0.7889454590792964,1.0,13/58,15.19%,APOD;RBP4;PPARD;PPARGC1A;MDH1;GAPDH;ALDOC;PGAM1;ENO2;ALDOA;CRTC2;PGM1;SLC25A11
prerank,prostaglandin metabolic process (GO:0006693),-0.35969717154137293,-1.0548000071011108,0.3664772727272727,0.7880574745106596,1.0,10/26,21.55%,PTGDS;PTGS1;PNPLA8;PTGES3;EDN1;HPGDS;MIF;CD74;ACOX1;PTGS2
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.5017715293263034,1.054111213770007,0.4326241134751773,0.9322584350610378,1.0,6/12,21.11%,UPP2;TK2;TK1;CAD;UCK2;UMPS
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.4276990700505929,1.053565821875178,0.4011887072808321,0.9328700665886469,1.0,6/30,6.37%,NGF;STK19;SHC1;NOTCH2;SHOC2;ITGAV
prerank,organic hydroxy compound biosynthetic process (GO:1901617),-0.31377178341531015,-1.0533626076343678,0.3581081081081081,0.7906638934350559,1.0,13/44,19.21%,CYP7B1;PRKAG2;CYP27A1;SC5D;INSIG2;OSBP;HSD17B4;OSBPL1A;ALOX12;SCP2;PARK7;CH25H;HSD17B10
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.42811377107769155,-1.053349312776864,0.3817733990147783,0.7893558290057013,1.0,4/13,6.57%,PPARA;NOS3;TMSB4X;PPARGC1A
prerank,regulation of sodium ion transport (GO:0002028),0.4082655894212418,1.053338584600887,0.3877551020408163,0.9326676409176887,1.0,10/34,15.77%,SLMAP;NEDD4;WNK1;DLG1;P2RX4;ATP2B4;CNKSR3;ATP1A1;SNTA1;WNK3
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.36894835707058754,1.0531510808937279,0.3806532663316583,0.9323495551472795,1.0,7/80,6.17%,THBS1;SAMD4A;SLC2A13;PRKCD;NIBAN1;LARP4B;CLU
prerank,regulation of protein export from nucleus (GO:0046825),0.449954522427376,1.0528943179287644,0.43343653250773995,0.9321967328434462,1.0,2/23,3.92%,TCF7L2;GSK3B
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.4272604714610421,1.0525782153343797,0.4259541984732824,0.9322675514044869,1.0,3/30,3.02%,KCNJ2;ANK2;CACNA1C
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.3785792280668871,1.0522243708804528,0.39295392953929537,0.9324300767672556,1.0,14/54,15.85%,PLAGL1;CRADD;EP300;PLK3;CNOT7;ATM;MDM4;CHEK2;CDKN1B;PCBP4;RBL2;SFN;CARM1;PML
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.34272835754087705,-1.0520665934476023,0.35294117647058826,0.7915301303942254,1.0,7/32,3.72%,IL1RAPL1;NEDD4L;RAPGEF2;HECW2;RAP2A;TNIK;OBSL1
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.4242410895132661,1.0520468003298173,0.4279141104294479,0.9320518872345321,1.0,9/29,14.70%,ISL1;DDRGK1;KANK2;STRN3;CBFB;FOXA1;KMT2D;CARM1;UFL1
prerank,positive regulation of biosynthetic process (GO:0009891),0.4036737307613488,1.051730690907276,0.3972413793103448,0.9320658097646703,1.0,3/40,1.57%,BMP4;TGFB3;SORBS1
prerank,histone mRNA metabolic process (GO:0008334),-0.3520087704370803,-1.0511709652917363,0.38,0.7926650362918591,1.0,9/27,18.89%,LSM1;SNRPB;UPF1;SNRPF;TENT4B;SLBP;LSM10;DCP2;SNRPG
prerank,regulation of lamellipodium organization (GO:1902743),0.4872059613162633,1.0511620855932227,0.4214162348877375,0.9328380382665188,1.0,3/14,10.90%,CD44;DMTN;CDC42
prerank,positive regulation of axon extension (GO:0045773),0.44124378574163436,1.0510824374183212,0.4166666666666667,0.9322381539829759,1.0,6/22,11.91%,NTN1;SHTN1;NRP1;ISLR2;ZFYVE27;MEGF8
prerank,eye morphogenesis (GO:0048592),0.4563165510249889,1.0506391074435526,0.41379310344827586,0.9325581282601069,1.0,7/19,12.38%,COL5A2;MFAP5;EFEMP1;RARG;SKI;IFT122;STAT3
prerank,cellular response to inorganic substance (GO:0071241),-0.3796265806951702,-1.0504828715711447,0.38421052631578945,0.7932727291329426,1.0,6/21,14.84%,FOXO1;GUCY1B1;KCNC2;NSMCE3;BLM;RTF2
prerank,diol metabolic process (GO:0034311),-0.38371088122029645,-1.0501911424425112,0.3793103448275862,0.7926657567154879,1.0,10/19,24.41%,NOS3;CALM1;DEGS2;SPHK1;AKT1;PLPP2;SGPP1;PTS;SPHK2;ASAH2
prerank,protein monoubiquitination (GO:0006513),0.41201824241229357,1.0496783224648858,0.41836734693877553,0.9344037772897,1.0,10/36,18.69%,UBE2B;KLHL22;UBE2D3;CTR9;TRIM25;PAF1;UBE2W;UBE3D;HUWE1;PEX12
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.4231969509811498,1.049306565052733,0.37797619047619047,0.9345961997588519,1.0,7/26,12.28%,KLF4;CLU;P2RX4;TLR6;AGTR2;TLR4;CD36
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.3684346525773766,1.0491258189763009,0.3961783439490446,0.9342913825114278,1.0,5/80,2.78%,THBS1;MAP3K5;NGF;CD44;KLF4
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.36972522917444767,1.0489197042039613,0.4099616858237548,0.9340117090094698,1.0,20/76,19.08%,CYP1B1;PTGIS;TAX1BP1;KLF4;IL10;ANXA4;DDIT3;CHUK;USP7;CCDC22;ACOD1;COMMD1;CMKLR1;MAP2K5;ERBIN;UFL1;PRMT2;FAF1;IRAK1;CHP1
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.48496292356884874,1.0487406229499483,0.4,0.9336770235752445,1.0,2/14,6.07%,CD55;TGFBR2
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.4546303400023758,1.0484121494294918,0.4190938511326861,0.9337539301406558,1.0,5/17,7.71%,DOCK5;DOCK7;IGFBP5;NR4A3;NRP1
prerank,hyaluronan metabolic process (GO:0030212),0.44442768661833504,1.048098230859425,0.4055299539170507,0.9337652898887044,1.0,11/23,22.22%,CD44;HEXA;FGF2;ABCC5;SPAM1;HYAL3;SLC9A1;CEMIP2;CHP1;TGFB1;HAS1
prerank,regulation of trans-synaptic signaling (GO:0099177),-0.336185745043638,-1.0478971474625354,0.3532934131736527,0.7978037324454611,1.0,17/33,21.02%,LRRC4C;NRG3;GRIK1;GRID2;LRP8;GRIK2;LRRC4;CACNA1B;FABP5;CX3CR1;ABR;NTF3;NLGN1;PSMC5;EIF4EBP2;GRIK3;NLGN2
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.4239307905541101,1.047896219906147,0.3930722891566265,0.9334634942789514,1.0,4/27,7.08%,MAP3K5;NFKB1;FBXW11;CHUK
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.41850622363859097,-1.0478720008186393,0.38613861386138615,0.7965263319411523,1.0,6/13,15.89%,CALM1;ANK3;PDE4D;CALM3;SLC8A1;CASQ2
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.4251841528681985,1.0475638440957604,0.3918918918918919,0.9335349444856635,1.0,7/25,12.28%,KLF4;CLU;P2RX4;TLR6;AGTR2;TLR4;CD36
prerank,cyclooxygenase pathway (GO:0019371),-0.45599280213325244,-1.0475409144562198,0.4107142857142857,0.7961327674882662,1.0,6/10,21.55%,PTGDS;PTGS1;PTGES3;HPGDS;CBR1;PTGS2
prerank,negative regulation of protein phosphorylation (GO:0001933),0.33621873247632234,1.0473419314232213,0.4090395480225989,0.9333244972293577,1.0,23/150,11.30%,SLIT2;RASSF2;NTRK3;PLPP3;PRKCD;PID1;LRP6;SMAD6;EIF4G1;DMD;NIBAN1;SPRED2;DNAJC3;NCK2;PPEF2;SMCR8;WWTR1;DMTN;CNKSR3;PARD3;PAK2;NOG;RB1
prerank,protein mannosylation (GO:0035268),0.44220261440014375,1.047216880173414,0.4122257053291536,0.9328455824187218,1.0,6/22,12.90%,TMTC1;LARGE1;POMGNT2;B4GAT1;DPM1;LARGE2
prerank,regulation of inclusion body assembly (GO:0090083),0.5034470263916593,1.047159008410394,0.4109347442680776,0.9321875506905819,1.0,1/11,1.15%,SNCAIP
prerank,protein stabilization (GO:0050821),0.33605016498564727,1.0469736041611333,0.40555555555555556,0.9318858027952811,1.0,32/168,13.41%,RASSF2;ANK2;ATP1B1;PARVA;USP13;PLPP3;PRKCD;UBE2B;COA8;CLU;EP300;USP2;TRIM44;TBL1X;USP7;MDM4;TELO2;CHEK2;SWSAP1;CTNND1;USP33;P3H1;HPS4;PIM2;TAF1;GTPBP4;TAF9;NLK;WIZ;AAK1;COG3;MORC3
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.41814345861089497,1.0466614144177306,0.4,0.9318969539652874,1.0,9/31,13.44%,CRIM1;SMAD6;BAMBI;TRPM4;TWIST2;SKI;NOG;CHRD;LRP5
prerank,establishment of protein localization to membrane (GO:0090150),0.3680338174580155,1.046593295897124,0.39809782608695654,0.9312685885809343,1.0,15/66,18.50%,EGFR;NECTIN3;ZDHHC11;RAB3GAP2;FRMPD1;ATG3;SEC63;PARD3;ZDHHC23;ZDHHC15;NPC1;GOLGA7;CHM;VPS37A;ZDHHC7
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.47320582699434466,1.0464955765578652,0.41638225255972694,0.9306981167358309,1.0,2/14,5.51%,ANXA1;CD80
prerank,positive regulation of type 2 immune response (GO:0002830),-0.42123700152905885,-1.0461512135898103,0.38929440389294406,0.7985918790068781,1.0,4/14,17.76%,CD81;IL18;CD74;PRKCZ
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.46607951532945613,1.0458405155497483,0.4429530201342282,0.931613360350691,1.0,6/17,20.31%,DHDDS;MVD;ALG13;ALG14;ALG9;ALG3
prerank,establishment of spindle orientation (GO:0051294),0.42609144582253716,1.0458230061734624,0.3978978978978979,0.9308375970294152,1.0,5/28,10.26%,ITGB1;NDEL1;PAFAH1B1;FBXW11;MISP
prerank,regulation of cellular protein catabolic process (GO:1903362),0.4645677298466701,1.0458013589664872,0.41818181818181815,0.9300659091316212,1.0,6/18,17.08%,EZR;NELL1;RDX;RGP1;AMER1;FAF1
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.5154886283572565,1.0455522532881558,0.426890756302521,0.929955595963496,1.0,2/10,2.92%,GRB10;PID1
prerank,cellular response to fatty acid (GO:0071398),0.4880723875570442,1.0454382944617275,0.42095914742451157,0.9294363699831043,1.0,2/12,6.10%,PID1;IRS1
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.4750216776003956,1.0454241068234778,0.42225859247135844,0.9286554274533282,1.0,6/15,23.49%,TLR6;TLR4;CD36;MYD88;NLRP2B;PYDC1
prerank,regulation of neuron death (GO:1901214),-0.27861745658080694,-1.045305063060545,0.37185929648241206,0.799722957310604,1.0,22/82,13.61%,EFNB2;PICALM;WNT5A;DCC;CSF1;TRIM2;CD34;SNCA;EPHB1;CTSZ;GRIN2B;PPARGC1A;MEF2C;GRID2;LRRK2;MAPT;EGR1;C1QA;UBB;FAIM2;CHRNA7;TRAF2
prerank,positive regulation of growth (GO:0045927),0.3728267329343393,1.0448951729819156,0.3984375,0.929261328467013,1.0,11/64,12.09%,EGFR;EIF4G1;TGFBR1;KLHL22;MMP14;ADAM10;AGR2;CDC42;CSNK2A1;TGFB2;USP47
prerank,plasma membrane repair (GO:0001778),0.48159631641566675,1.0447812667950855,0.43103448275862066,0.9287637806522134,1.0,1/13,0.50%,AHNAK2
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.4327537257502546,1.0446542579157947,0.42138364779874216,0.9282992964916371,1.0,4/27,5.02%,PDGFC;FN1;DDR2;PDGFA
prerank,peptidyl-tyrosine modification (GO:0018212),0.3792568686916993,1.044617060263652,0.414021164021164,0.927600720013395,1.0,7/56,4.13%,EGFR;PTK2B;ABI1;FGFR1;DDR2;EFEMP1;ABL1
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),-0.4420243576813083,-1.044138105086677,0.4066193853427896,0.8016506159895236,1.0,4/11,30.27%,BLM;DONSON;FBH1;GMNN
prerank,retinoid metabolic process (GO:0001523),0.3661492907692924,1.0440238499537495,0.4198966408268734,0.9283812189355173,1.0,10/71,8.51%,GPC6;CYP1B1;ADH7;GPC3;STRA6;RBP1;SCPEP1;RLBP1;GPC4;CYP2S1
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.4817589625905002,1.0439364478769475,0.4114583333333333,0.9269822694719247,1.0,3/12,15.61%,EFNA5;DMTN;ITGB1BP1
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.4817589625905002,1.0439364478769475,0.4114583333333333,0.9269822694719247,1.0,3/12,15.61%,EFNA5;DMTN;ITGB1BP1
prerank,positive regulation of viral genome replication (GO:0045070),-0.34811850184373044,-1.043481912241789,0.3707165109034268,0.8021151299302308,1.0,8/29,16.75%,PPARA;TOP2B;PPIA;ADARB1;DDB1;PPIE;NR5A2;TARBP2
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.41426450364136075,-1.0427629935525402,0.4154929577464789,0.8027823896121062,1.0,5/13,15.73%,NOTCH1;RBPJ;HEY2;RYR2;GSK3A
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.4893698196805243,1.042729345712966,0.43333333333333335,0.9295467121614923,1.0,3/13,7.31%,DDX5;SPRED2;ATM
prerank,regulation of cellular protein metabolic process (GO:0032268),0.38529327988443707,1.0426630292922332,0.40053404539385845,0.9289159171061451,1.0,6/47,5.36%,FOXO3;AGTR1;INHBA;KLF4;EIF4G1;NFKB1
prerank,long-chain fatty acid transport (GO:0015909),-0.34752112728657303,-1.042539366038792,0.363905325443787,0.8020181838230688,1.0,10/30,13.42%,ACSL1;APOE;PRKAG2;CPT1A;ACACA;ACACB;MFSD2A;PRKAA2;FABP5;RPS6KB1
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.4681630462664214,1.0422429223508183,0.4115586690017513,0.9292155972952941,1.0,4/17,8.98%,TGFB3;IL10;PDCD4;CDKN1B
prerank,positive regulation of vascular permeability (GO:0043117),-0.43954271297024894,-1.042047863401789,0.4441860465116279,0.8021339711769329,1.0,4/12,12.07%,TJP1;OCLN;PDE2A;PDE3A
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.4981898771365913,1.0415248107788333,0.4338919925512104,0.9303847127194768,1.0,4/10,24.36%,JUN;CITED2;HSPA1A;IMPACT
prerank,acetyl-CoA metabolic process (GO:0006084),-0.4037183185395196,-1.0413067069204869,0.41625615763546797,0.8028366155683071,1.0,8/15,25.42%,ACLY;ACACA;ACACB;ACSS1;HMGCS2;PPCS;MVK;DIP2A
prerank,regulation of cell division (GO:0051302),0.3623965713730454,1.041071860491995,0.42023346303501946,0.9308422274090582,1.0,14/72,12.74%,MLLT3;KIF13A;KLHL13;TLE6;BIRC6;BECN1;PLK3;RAB11FIP3;ENTR1;ZFYVE26;PRDM15;SETD2;SFN;HTR2B
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.506104321885819,1.0409674854879982,0.41711229946524064,0.9303011242825441,1.0,4/10,13.44%,PDGFA;TGFBR2;CHRD;LRP5
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.3780346586816078,1.040842321082493,0.42183288409703507,0.9298070087529492,1.0,20/52,23.62%,ABLIM3;NPEPPS;BAP1;UBE2D3;HPS4;ARIH2;CSNK2A2;SFN;PPP3CC;RNF31;HSPA1L;SAE1;MAPK8;HUWE1;NMT1;BBC3;SH3GLB1;PPP1R13B;YWHAH;USP36
prerank,central nervous system neuron differentiation (GO:0021953),-0.3283061719330903,-1.0407286721231443,0.375,0.8031246218474863,1.0,20/33,28.26%,MAP2;OPHN1;GRID2;ZC4H2;NTRK2;MAPT;SPOCK1;TOX;MDGA1;FAIM2;PROX1;ATP7A;KNDC1;LHX1;CBLN1;NPY;CEND1;LMX1A;WNT2;MDGA2
prerank,N-terminal protein amino acid modification (GO:0031365),0.4892782099754211,1.0406774066462081,0.4509466437177281,0.9294172570879861,1.0,4/14,19.65%,NAA40;NAA35;METAP1D;METAP1
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.3870521355438865,-1.0402897640134814,0.4260204081632653,0.8031270669422204,1.0,6/19,8.81%,TJP1;NEXMIF;NOTCH1;NOTCH4;RGCC;FLOT1
prerank,negative regulation of blood pressure (GO:0045776),-0.4024355188891972,-1.0401559615717877,0.3903002309468822,0.8021614796630814,1.0,5/13,16.64%,NOS3;BMPR2;GPR37L1;PRCP;NOS1
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.4344604033011965,1.0393865012823036,0.4238095238095238,0.9321295669453282,1.0,5/23,8.90%,HDAC4;C1QTNF12;ERFE;EP300;CLK2
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.40337703342570963,-1.0389953232985496,0.405,0.8039909885649993,1.0,2/15,6.76%,IGF1;BCL2L1
prerank,carboxylic acid catabolic process (GO:0046395),0.4943804762258591,1.0389623482674442,0.43828264758497315,0.9324343220512263,1.0,3/12,16.48%,PON3;ACOT8;GNPDA2
prerank,positive regulation of cyclase activity (GO:0031281),-0.4070891349371616,-1.0384714101427543,0.3945409429280397,0.8040976098007846,1.0,5/14,16.64%,CACNA1D;NOS3;MAPK3;STIM1;NOS1
prerank,regulation of actomyosin structure organization (GO:0110020),0.48096785849123835,1.038460961728819,0.4109347442680776,0.9329414727846851,1.0,4/13,12.17%,AKAP13;CDC42;ASAP3;SLC9A1
prerank,positive regulation of cation channel activity (GO:2001259),-0.3120207031775175,-1.0384552024382037,0.38943894389438943,0.8028284541964643,1.0,7/40,8.48%,SHANK3;CALM1;TMSB4X;ANK3;STAC;CTSS;CALM3
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.44605189268232814,1.0384545913547345,0.4144736842105263,0.9321448464412867,1.0,6/22,11.24%,DUSP10;KAT2A;CBFB;BCL6;CD46;IRF1
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.3816410647560546,-1.0384296597964475,0.41732283464566927,0.8016001214453747,1.0,9/18,21.02%,SHANK3;NRXN1;RIMS1;RIMS2;GRIN1;CHRNA7;PRKCZ;NLGN1;NLGN2
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.490219776365606,1.0384263589237792,0.4408014571948998,0.9314077378659468,1.0,2/11,4.74%,LRP6;NR4A2
prerank,cardiac muscle cell differentiation (GO:0055007),0.44059308251655066,1.0381371759977365,0.41037735849056606,0.9313459845064183,1.0,2/21,1.82%,CXADR;AKAP13
prerank,regulation of nervous system process (GO:0031644),-0.3773213101383292,-1.0381025584350818,0.3863013698630137,0.8012419870034163,1.0,6/18,14.12%,NOS3;APP;DLGAP2;NPTXR;CHRNA7;TMEM108
prerank,embryonic axis specification (GO:0000578),0.4742947365384848,1.0377447426034077,0.4352,0.9316008593900968,1.0,3/15,7.19%,COBL;SMAD6;STIL
prerank,purine ribonucleotide metabolic process (GO:0009150),-0.27736361236788354,-1.0376197699640974,0.3803418803418803,0.8012919766495938,1.0,12/68,13.91%,TPST1;ENPP1;ACBD6;ACLY;PDE9A;ACOT7;LRRK2;HINT1;DBI;ACSF2;SULT4A1;TPST2
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.3577617781816931,-1.0375077958625318,0.39226519337016574,0.8002879665444073,1.0,6/26,10.08%,MFHAS1;NR1H3;CYBA;FLOT1;TLR3;NINJ1
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.44601777536078446,-1.0373043773718296,0.4253393665158371,0.7995629195486429,1.0,4/11,19.33%,NOVA1;NOVA2;PCBP1;RASA1
prerank,apoptotic cell clearance (GO:0043277),0.4203602483062781,1.0367429337227583,0.41545189504373176,0.9334918636702532,1.0,7/30,13.93%,THBS1;ANXA1;ITGAV;XKR4;RHOBTB1;ITGB3;LRP1
prerank,sphingolipid metabolic process (GO:0006665),-0.2693587978787434,-1.0366834057004606,0.34415584415584416,0.7999618345282118,1.0,21/108,9.35%,ST6GALNAC3;CERS4;PRKD1;ENPP2;SGMS1;ACER2;ELOVL7;UGCG;CERK;ELOVL6;DEGS2;SPTSSA;SMPD3;GM2A;SERINC1;CERT1;CTSA;GAL3ST1;SPNS2;SPHK1;ELOVL4
prerank,positive regulation of interferon-alpha production (GO:0032727),0.4533446719451467,1.0364525966560274,0.4215686274509804,0.9334389943674725,1.0,10/19,27.10%,MAVS;CHUK;RIPK2;TLR4;SETD2;DHX9;IFIH1;IRF3;TLR8;TBK1
prerank,membrane lipid biosynthetic process (GO:0046467),0.3780369601807073,1.0362518590730723,0.404,0.933145936058487,1.0,11/58,12.99%,ST3GAL4;ACER3;PLPP3;SGMS2;SPTSSB;CERS6;CERS5;VAPA;ELOVL5;PLPP1;ST3GAL2
prerank,positive regulation of mRNA processing (GO:0050685),0.436956874914296,1.0360024462804553,0.4128,0.9330207354565578,1.0,9/21,28.22%,RBMX;PAF1;SNW1;TRA2B;NUP98;LEO1;NCBP2;CELF3;CIRBP
prerank,regulation of macrophage migration (GO:1905521),0.5047707442584646,1.0359569560917437,0.43042671614100186,0.9323363592911519,1.0,2/10,3.12%,PTK2B;MTUS1
prerank,substrate-dependent cell migration (GO:0006929),0.47581362146950223,1.035945298657861,0.4339622641509434,0.9315552051217731,1.0,3/14,7.71%,NTN1;SHTN1;NRP1
prerank,regulation of glycolytic process (GO:0006110),0.3631260261211925,1.0358290532133538,0.4176548089591568,0.9310541770048744,1.0,10/68,12.14%,SLC4A4;HDAC4;NUP93;PFKFB2;EP300;GAPDHS;SEC13;NUP188;RANBP2;PRXL2C
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.42416270675798384,-1.0354551881647,0.4013921113689095,0.802039955660286,1.0,3/12,9.48%,LYN;ELF2;CD300A
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.40249648492088574,1.034910802702642,0.4267425320056899,0.932678389344407,1.0,11/36,20.83%,FHIT;F8A1;GIPC1;DDRGK1;USP7;USP25;TAF9;TLK2;MAP1A;HFE;N4BP1
prerank,apoptotic process (GO:0006915),0.32977204839378893,1.0348748125895684,0.42934196332254587,0.9319896913366438,1.0,36/203,12.87%,CYFIP2;EGLN3;PLAGL1;PTK2B;ZBTB16;EFNA5;PAWR;CIT;PRKCD;GDF6;NOTCH2;PDCD4;MAGI3;ARHGEF6;DIABLO;PLSCR1;RFK;TGFBR2;BCLAF1;EP300;PLK3;YARS1;NCKAP1;CDIP1;ERCC3;BCL2L13;CXCR4;MTOR;PAK4;AIFM2;IRF1;CHEK1;BNIP3;PRKCE;TRPC5;TRADD
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.46073888444176614,1.034735784784029,0.4128289473684211,0.9315628026092522,1.0,2/18,3.02%,MET;CCDC125
prerank,positive regulation of cell differentiation (GO:0045597),0.3212367184278572,1.0341715459428404,0.41595744680851066,0.9322766498745392,1.0,28/237,5.36%,BMP4;CDON;BOC;NGF;HOXA5;TGFB3;ZBTB16;VWC2;CCN1;AGTR1;CTNNA1;FGFR1;BMP6;ISL1;DDR2;RAP1A;GDF6;MYOG;GDF5;GCNT2;BAMBI;MEF2A;ABL1;BMPR1A;TRPM4;GDNF;TGFBR1;NFKB1
prerank,ribosomal small subunit assembly (GO:0000028),-0.39998767037593963,-1.0341408471542224,0.4058679706601467,0.8043132119220308,1.0,5/16,7.23%,RPS14;RPS27;RPS15;RPS5;RPS19
prerank,phosphorylation (GO:0016310),0.31287699474701397,1.0338199843102993,0.4193877551020408,0.9323845178506592,1.0,93/385,17.53%,STK39;DCLK1;MAP3K5;GRK5;STK19;MARK1;PTK2B;CAMK2D;LIMK2;WNT11;FGFR1;WNK1;PRKCD;HIPK1;MKNK2;NEK7;BCR;GSK3B;ABL1;CDC25B;BMPR1A;SGK3;SIK3;BIRC6;TLK1;TGFBR1;SHPK;TGFBR2;SIK2;CHUK;ATM;MARK2;DYRK2;IP6K3;ADAM10;EIF2AK4;CDC42BPG;DYRK3;CLK2;CHEK2;FRK;MARK3;MTOR;PAK4;CSNK1E;PKN2;PAK2;PIM2;TAF1;EIF2AK3;CHEK1;ACVR1;CSNK2A1;DGKA;TGFB2;CSK;IKBKE;NLK;STAT3;PRKCE;AAK1;CSNK1A1;HTR2B;MAPK1;SRPK1;MORC3;CAMK4;ILK;AMHR2;CDK12;STK11;PPP4R1;FAM20A;PRKAA1;ERN2;CDK18;PRKCA;PRKACA;CSNK1D;WNK3;COQ8A;CDKL2;MEX3B;MAP3K12;PRKDC;MAP4K1;TOP1;TAOK3;MAPK8;VRK2;MAPKAPK2;GMFG;TLK2
prerank,regulation of axon guidance (GO:1902667),0.5159320379527087,1.0337978422185694,0.4388111888111888,0.9316654041504724,1.0,3/10,13.58%,MYCBP2;NRP1;TUBB2B
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),-0.3305295396421491,-1.0335243698313445,0.3764705882352941,0.8033773804502262,1.0,5/29,9.64%,ACBD6;ACLY;ACOT7;DBI;ACSF2
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),-0.3305295396421491,-1.0335243698313445,0.3764705882352941,0.8033773804502262,1.0,5/29,9.64%,ACBD6;ACLY;ACOT7;DBI;ACSF2
prerank,positive regulation of protein secretion (GO:0050714),0.3605868932948085,1.0335072205174634,0.39851485148514854,0.9316650306983201,1.0,15/69,12.30%,TCF7L2;TGFB3;EZR;BMP6;ISL1;ADAM9;GOLPH3;EXPH5;CAPN10;SYTL4;AACS;UNC13B;TLR4;TGFB2;ADAM8
prerank,T cell mediated immunity (GO:0002456),0.4797468091288781,1.033278784051456,0.4117647058823529,0.9315127746725291,1.0,4/13,10.17%,CD55;GNL1;JAG1;CD46
prerank,iron ion homeostasis (GO:0055072),-0.2943689873853326,-1.0330428985442646,0.42084942084942084,0.8034201620330486,1.0,15/58,16.33%,CP;B2M;FTH1;PICALM;TFRC;SLC40A1;FTL;ATP6AP1;CAND1;SLC22A17;ATP6V1A;SLC11A2;BOLA2;NUBP1;GLRX3
prerank,response to interleukin-6 (GO:0070741),0.49988717972512786,1.0326227509371182,0.425414364640884,0.9325617960478731,1.0,3/10,5.36%,PTGIS;PID1;NFKB1
prerank,ethanol metabolic process (GO:0006067),0.49183188146568096,1.0324960618859331,0.4430379746835443,0.9321040538522444,1.0,2/12,3.41%,ADH7;SULT1A1
prerank,limb development (GO:0060173),0.41093965397384474,1.0323797171493982,0.4124809741248097,0.9316358416883228,1.0,9/28,12.88%,PCSK5;GLI3;SMOC1;KAT2A;IFT122;NOG;MEGF8;IQCE;KAT2B
prerank,negative regulation of response to stimulus (GO:0048585),0.3680738858058267,1.032238294332676,0.4205607476635514,0.9312134071580683,1.0,8/60,7.56%,SLIT2;HHIP;KLF4;COL3A1;VPS13C;KLF7;CLU;MAP3K3
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.4404573459853433,1.032209771483359,0.4301948051948052,0.9304918190410181,1.0,4/20,8.30%,ADAM9;NFKB1;SPPL2A;ADAM10
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.4273554781688714,1.0319331912432872,0.4098613251155624,0.9304751808869951,1.0,1/23,0.15%,SLIT2
prerank,regulation of protein polymerization (GO:0032271),-0.3240333450734249,-1.0317133821348927,0.38387096774193546,0.8057925742950826,1.0,9/35,19.33%,ARHGAP28;ESAM;MAP2;COTL1;MAPT;PFN1;TTBK1;TPPP;RASA1
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.4337478383784727,1.0316377526671914,0.41054313099041534,0.930481001855005,1.0,1/21,0.32%,FOXP1
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.4017962099853939,1.0314357178353732,0.41251778093883357,0.930210115753251,1.0,16/40,26.30%,PRKCD;SMYD2;ABL1;BCLAF1;SMG1;FXR2;ARMT1;USP1;UBE2N;FEM1B;FMR1;WDR76;SIRT7;KMT5A;CASP9;UBE2V1
prerank,neural crest cell migration (GO:0001755),0.3980977948159099,1.03130250255923,0.42410714285714285,0.9297726085016703,1.0,6/36,7.71%,FN1;SEMA3D;SEMA3C;SEMA3E;GDNF;NRP1
prerank,negative regulation of developmental growth (GO:0048640),-0.33576545113544337,-1.0306228447747154,0.41566265060240964,0.8074253257053179,1.0,8/30,15.87%,NKD1;MAP2;PTCH1;DCC;MAG;SEMA3G;TRIM46;RNF6
prerank,regulation of postsynapse organization (GO:0099175),-0.34672081527487386,-1.030610143376139,0.42120343839541546,0.8061683056721906,1.0,9/28,10.81%,SHANK3;IL1RAPL1;PPFIA2;WNT5A;EPHA4;ABHD17C;CDKL5;LRRK2;ABI3
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.41557479645871737,1.0303275982526852,0.4494875549048316,0.9315929837827568,1.0,5/28,7.07%,GRB10;PRKCD;PID1;IRS1;PTPN2
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.440757436547426,-1.0301552411935526,0.4432314410480349,0.8061595852703811,1.0,2/11,1.62%,SLC30A10;PPARA
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.4197334439348446,-1.0298996601572932,0.4439140811455847,0.805570214539784,1.0,4/13,13.91%,TPST1;ENPP1;SULT4A1;TPST2
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.37804023534126086,-1.0298288406260017,0.424,0.8044806780151177,1.0,5/17,7.31%,IL34;TENM4;NOTCH1;BMP2;MDK
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.3868183063938658,1.029648229076991,0.4165477888730385,0.9325607946848385,1.0,12/46,17.42%,PNPLA3;DDHD1;PLD1;DGKA;ABHD4;ABHD5;GPAT3;GNPAT;AGPAT4;PLA2G4A;LCLAT1;AGPAT5
prerank,regulation of striated muscle contraction (GO:0006942),-0.34607443046855485,-1.0295229195953477,0.41887905604719766,0.8039703313435903,1.0,2/27,3.34%,ATP1A2;CALM1
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.3787780182771202,1.029422893466898,0.40705563093622793,0.932399880305167,1.0,9/47,8.90%,PTGIS;C1QTNF12;ERFE;NFKB1;EP300;WDTC1;ATP2B4;ERLIN1;CLK2
prerank,regulation of p38MAPK cascade (GO:1900744),-0.3181570417005916,-1.0293705756709064,0.380327868852459,0.8031393319882607,1.0,6/35,9.28%,SASH1;PHLPP1;MFHAS1;DAB2IP;BMP2;SPHK1
prerank,axonal fasciculation (GO:0007413),-0.42219149208032003,-1.029086485120626,0.42409638554216866,0.8025770334306525,1.0,6/12,20.66%,CNTN4;EPHA4;NRCAM;RTN4;CDK5R1;AMIGO1
prerank,post-translational protein modification (GO:0043687),0.31703041302234547,1.029064300503138,0.4281282316442606,0.9325387949669955,1.0,42/332,11.71%,FBXL7;MSLN;BMP4;FSTL1;FN1;PTP4A2;ZBTB16;CCN1;FBXO40;FBXO10;GPC3;ASB9;ASB16;DCAF6;KLHL13;IGFBP5;SOCS2;FBXW8;ASB11;DNAJC3;KLHL22;PRKCSH;BMP15;FBXW11;WDTC1;UBE2F;KTN1;LRRC41;HIF3A;ADAM10;ASB14;FBXO32;FBXO4;PRSS23;ASB1;CCDC22;FBXL20;COMMD1;FBXO17;FBXW2;ERCC8;GOLM1
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.3849595653651856,-1.0285922335969429,0.42997542997543,0.8026806382865324,1.0,3/17,12.27%,KCNAB1;ANK3;NOS1AP
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.418570860920734,1.0285274952382566,0.42901234567901236,0.933132001017753,1.0,3/28,4.13%,MAPRE2;GAS2L2;ABL1
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.46912578981238506,1.0285101009019408,0.435,0.9323840547566467,1.0,4/17,5.11%,KCNJ2;ANK2;CACNA1C;TRPM4
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.490934548427607,1.028430355989348,0.4416058394160584,0.9317829199235032,1.0,3/12,10.93%,STX19;STX11;SNAP23
prerank,calcium ion transport (GO:0006816),0.34170577826779014,1.0283751291676702,0.4216725559481743,0.9311417420051402,1.0,17/113,9.48%,SLC24A3;PKD1;ANK2;RAMP1;ATP2C2;TRPM6;ANO6;CACNA1C;NALCN;STIM2;MCOLN3;TRPM4;ITGAV;P2RX4;ATP2B4;CYP27B1;CACNB2
prerank,negative regulation of DNA binding (GO:0043392),0.41553296603003587,1.0282431592711645,0.4311111111111111,0.9307161773823449,1.0,5/28,9.73%,SMO;GATA1;JUN;KDM1A;PER2
prerank,regulation of myoblast differentiation (GO:0045661),0.4082875304980865,1.0281576037358813,0.42380261248185774,0.9301709209224153,1.0,3/32,3.48%,BMP4;BOC;MYOG
prerank,myeloid leukocyte differentiation (GO:0002573),0.3647482361486764,1.0272983570843366,0.421875,0.9317349800903735,1.0,6/65,7.52%,BMP4;FOXP1;TNFSF11;TGFBR2;EP300;GAB2
prerank,glycolytic process (GO:0006096),-0.3426257008585129,-1.0271286526404748,0.39820359281437123,0.8053714675506849,1.0,11/28,18.12%,GAPDH;ALDOC;PGAM1;PGAM4;ENO2;ALDOA;HK2;PFKM;PGM1;HK1;PKM
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.40616570436170324,1.0269317784900904,0.4281391830559758,0.9318948317584215,1.0,5/33,11.56%,UBASH3A;EZR;PTPN2;BCL10;PHPT1
prerank,cellular protein localization (GO:0034613),0.3168965206117368,1.0268263966547018,0.43894736842105264,0.9313934031301466,1.0,72/285,19.23%,EGFR;ANK2;PTPRU;SGSM2;KIF13A;CSRP3;WNT11;CNTLN;GRTP1;WIPI2;ARF4;RAB43;DMD;STX19;STX5;STX11;RAB3GAP2;RAB6A;ARF3;TLK1;TMED5;TBC1D13;AP3B1;HERC2;ID1;TBC1D25;VCL;STX8;RAB18;AP2A1;EIF2D;SNX31;ARFIP1;SGSM3;NSF;SEC13;PIGU;RIC3;SAR1B;TBC1D10A;GGA2;EHD1;COG3;TBC1D2B;CTTN;VIPAS39;STX16;ZDHHC15;SMURF1;RAB5A;CPE;USP4;EMP2;SNX17;RAB17;ARCN1;VPS26C;RRAGB;FLNA;RAB22A;AMOT;TICAM2;TBC1D5;TBC1D8B;ARL1;USO1;AP4M1;ACD;ANGPT1;COPA;SNX13;NPHP1
prerank,regulation of cellular component organization (GO:0051128),0.3350088804936797,1.0267161748360008,0.44469525959367945,0.930877498835717,1.0,28/135,15.41%,PLCE1;SNCAIP;MLLT3;NEDD4;CAMK2D;AGTR1;STON1;FAM107A;RAP1A;ABL1;SGK3;SOCS2;ANGPTL7;BAP1;MTOR;PAK4;SETD5;LTBP4;CD36;METTL4;SNX12;WFDC1;STON2;RAB5A;STK11;SNX17;HCFC1;RAB17
prerank,negative regulation of metabolic process (GO:0009892),-0.29324497203933675,-1.0265993486861256,0.41729323308270677,0.8055765789414203,1.0,11/54,7.50%,ALDH1A1;NOVA1;LGR4;NOVA2;NOTCH1;PLCL1;NR1H3;MAP2K6;ACVR2B;RBPJ;PLCL2
prerank,protein homotetramerization (GO:0051289),-0.3017578056333071,-1.0264908343587948,0.3860294117647059,0.8046143138370344,1.0,19/49,19.30%,ALDH1A2;B2M;HCN1;SAMHD1;AQP4;ACACA;ACACB;ALDH9A1;ALDOA;UPB1;RYR3;CRYZ;APPL2;KCNJ12;GBP5;CBY1;ALDH1A3;HSD17B10;SOD2
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),-0.2992999217231707,-1.0262245162226575,0.4044943820224719,0.8040372308057085,1.0,13/54,8.46%,APOE;PRKD1;NOS3;KDR;AKT3;HIF1A;ETS1;TMSB4X;ATP5F1B;ANGPT2;MEF2C;RGCC;GATA2
prerank,negative regulation of axonogenesis (GO:0050771),-0.3497861725990393,-1.026162479283242,0.40672782874617736,0.8029486105690654,1.0,11/27,20.12%,MAP2;DCC;ARHGDIA;LINGO1;EFNB3;MAG;SEMA3G;TRIM46;RNF6;OMG;RTN4
prerank,negative regulation of cell cycle process (GO:0010948),0.37000201220807566,1.025830470455974,0.44415243101182655,0.9325317955298289,1.0,20/61,22.56%,BMP4;E2F6;RRM2;RNF2;WAPL;CHEK1;NANOS2;EHMT2;EHMT1;MGA;RBBP8;SUZ12;EPC1;CBX5;RBBP4;UXT;NME6;YAF2;PHC3;EED
prerank,membrane depolarization during action potential (GO:0086010),-0.34354690400952226,-1.025168085676529,0.4116022099447514,0.8044062222920423,1.0,3/26,1.75%,ATP1A2;CACNA1D;SCN7A
prerank,negative regulation of protein depolymerization (GO:1901880),-0.3575078984492471,-1.024762297919096,0.43304843304843305,0.8042446182856182,1.0,11/24,29.55%,PLEKHH2;NAV3;CLASP2;ATXN7;CIB1;ARHGEF2;TPX2;CAMSAP2;STMN2;CAMSAP1;TAOK1
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.2631999004390703,-1.0243113581399235,0.4117647058823529,0.8041582535505472,1.0,25/94,23.03%,PLCB1;RPS6KA5;IL1R1;ST18;PELI2;NOD1;MAPK3;RPS27A;UBC;IRAK2;TAB2;EGR1;PSMB10;UBB;BTRC;PSME2;RELA;PSMB3;TNIP2;PSMB4;PSMB8;PSMC5;TAB1;PSME1;PSMA7
prerank,cellular response to decreased oxygen levels (GO:0036294),0.3641982709927959,1.0241379441856957,0.4410994764397906,0.9363448744219166,1.0,10/65,12.40%,EGLN3;NDRG1;PTGIS;NPEPPS;LMNA;HILPDA;MDM4;MTOR;ADAM8;BNIP3
prerank,retinoic acid metabolic process (GO:0042573),-0.4137112717164611,-1.024027628136105,0.43283582089552236,0.803660993946585,1.0,2/14,1.91%,ALDH1A2;CYP26B1
prerank,negative regulation of ion transport (GO:0043271),0.43666055206483084,1.0239630112535076,0.4623493975903614,0.9360069401531779,1.0,3/24,2.50%,PTK2B;NEDD4;WNK1
prerank,negative regulation of cellular protein localization (GO:1903828),-0.3225253408834085,-1.0239620298774454,0.3979933110367893,0.802602710456475,1.0,7/34,10.30%,MFHAS1;PICALM;NEDD4L;GPM6B;RIPOR2;MAPT;ANKRD13A
prerank,T cell differentiation (GO:0030217),-0.31253320590561656,-1.0237186863060976,0.3901639344262295,0.8020289512743598,1.0,9/40,11.38%,LEPR;CHD7;SOX13;KIT;JAG2;RHOH;LFNG;NHEJ1;TCF7
prerank,bile acid metabolic process (GO:0008206),-0.34637706277780156,-1.0235665561557141,0.4117647058823529,0.8011720108675665,1.0,12/27,26.94%,CYP7B1;CYP27A1;OSBP;HSD17B4;OSBPL1A;SCP2;CH25H;HSD17B10;SLC27A2;CYP46A1;OSBPL6;OSBPL7
prerank,regulation of immune response (GO:0050776),0.3325878767639558,1.0234207062063427,0.4361078546307151,0.9366289381903238,1.0,19/135,12.39%,FOXP1;CXADR;ITGB1;RAET1E;COL3A1;RIPK3;TREML1;PVR;PLSCR1;RNF135;SPPL2A;BCL6;ERAP1;GPR108;PDCD1;IRF1;TGFB2;CSK;BIRC3
prerank,microtubule-based transport (GO:0099111),0.4714513467631313,1.0231061446770353,0.43214285714285716,0.9366464491562663,1.0,3/13,9.10%,DYNC1I1;CCDC40;SPAG17
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.3776742608308785,-1.0230700449303585,0.43157894736842106,0.8013301881550405,1.0,4/18,9.09%,ST18;IL6ST;IL6R;SRC
prerank,cell cycle G2/M phase transition (GO:0044839),0.331756394744471,1.023043103959709,0.43317972350230416,0.9360245784162553,1.0,34/130,21.08%,FBXL7;CCNA2;SFI1;CDC25B;PPP1R12B;CEP164;PAFAH1B1;PLK3;CEP131;FBXW11;CHEK2;MNAT1;FBXL6;PCM1;HAUS5;CSNK1E;CEP70;PPP1R12A;CEP63;CEP57;FOXM1;PRKACA;CSNK1D;PPME1;DCTN3;CNTRL;AKAP9;FBXL17;CEP192;FBXL8;DCTN1;AURKA;ODF2;MASTL
prerank,regulation of organelle assembly (GO:1902115),0.35576305172053657,1.023036357896127,0.4163568773234201,0.9352641393740431,1.0,19/73,15.17%,EZR;RABEP2;GSN;PDCD6IP;TBC1D13;ATG3;STIL;SGSM3;CEP295NL;RDX;NPRL3;TBC1D10A;TRAPPC12;KIF9;TBC1D2B;TSG101;RAB5A;IFT88;MAPK15
prerank,excitatory postsynaptic potential (GO:0060079),-0.383466641785438,-1.0229822559163808,0.4332425068119891,0.8003047157718198,1.0,9/19,18.66%,GRIN2A;GRIN2B;MEF2C;GRID2;LRRK2;GRIN1;AKT1;GSK3A;ARRB2
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.34573297642677303,1.0229708049408688,0.436183395291202,0.9346605270856785,1.0,20/87,11.89%,PTK2B;EFNA5;EZR;ARHGDIB;PRKCD;SEMA3E;ARHGAP44;FAM107A;NOTCH2;ABL1;PDGFA;ARHGEF5;IQGAP1;RHOQ;MLST8;DMTN;MTOR;RHOBTB1;PHPT1;RHOA
prerank,negative regulation of protein modification process (GO:0031400),0.3583884939765339,1.0229133396229726,0.4359637774902975,0.9340258246642842,1.0,8/79,4.57%,SLIT2;NTRK3;PLPP3;PID1;LRP6;GSK3B;DMD;NIBAN1
prerank,regulation of steroid metabolic process (GO:0019218),-0.35820504227140426,-1.0228801348439402,0.4140845070422535,0.7993487925051976,1.0,8/23,26.17%,APOE;ACADL;NR1H4;ABCG1;LAMTOR1;STUB1;RORC;ABCA2
prerank,regulation of potassium ion transport (GO:0043266),0.4173999392139877,1.0226585437893392,0.42857142857142855,0.9338850760222378,1.0,3/31,1.56%,FHL1;ANK2;PTK2B
prerank,DNA repair (GO:0006281),0.3152222421523632,1.0226041862379192,0.44142259414225943,0.9332402729672246,1.0,87/284,22.38%,MPG;FTO;ABL1;UBE2B;IGHMBP2;VCP;APEX2;TRRAP;HERC2;EYA3;ATM;BAP1;APLF;CHEK2;FAAP24;MNAT1;KAT5;RNF168;EID3;RAD17;SMUG1;ERCC3;RAD52;BRCA2;ERCC1;COMMD1;RAD51C;CSNK1E;SLC30A9;MBD4;CHEK1;RPA1;ERCC8;SETD2;USP3;RAD51AP1;FANCM;USP47;XPA;RFC5;CHD1L;ASCC1;PPP5C;SMC1A;CHRNA4;XRCC5;EXD2;INTS3;RAD23B;POLD3;DDX1;CDKN2D;PRMT6;RBBP8;XPC;CENPX;PRKDC;USP1;POLB;UBE2N;MAPK8;ACTR8;WRN;HUWE1;POLA1;NBN;INO80;REXO4;VCPIP1;ALKBH5;PWWP3A;MRE11;PMS2;RMI2;WDHD1;TDG;SUMO1;XRCC2;RECQL5;UNG;ATR;MTA1;FANCA;CDK1;RNASEH2A;RAD9B;APEX1
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.3595672376091091,-1.0221939933850044,0.425414364640884,0.7998977002158976,1.0,5/22,9.89%,CACNA1D;ADGRV1;GRM3;CAP2;EDNRB
prerank,regulation of protein secretion (GO:0050708),0.34263424623363875,1.0218920872074757,0.4575087310826543,0.9342598176687851,1.0,19/119,9.73%,SLC12A2;TGFB3;EZR;DISP1;BMP6;KCNS3;CACNA1C;ADAM9;RAP1A;KCNB1;ITPR2;GOLPH3;HNF4A;EXPH5;ARFIP1;SYTL4;UNC13B;P3H1;PER2
prerank,zinc ion transmembrane transport (GO:0071577),-0.36337048437880776,-1.0215970179428715,0.41968911917098445,0.800327600208552,1.0,7/22,14.69%,SLC30A10;SLC39A10;SLC39A8;SLC39A7;SLC30A4;SLC30A1;SLC39A3
prerank,negative regulation of immune response (GO:0050777),-0.24654638874943052,-1.0215916020534188,0.432,0.7991222467563613,1.0,35/154,16.70%,LYN;ADCY5;ADCY1;GNG2;PRKAR2B;ADCY7;CALCRL;ADCY2;PRKACB;RAMP2;MYH9;GGT5;PRKAR1B;PTH1R;ENPP3;CYSLTR1;PRKAR1A;SRC;CD300A;ADORA2A;HAVCR2;ADM;CYSLTR2;TRIM21;ADCY4;TRIM27;SAMSN1;IAPP;PLCG1;ADCY3;ADCY8;VIPR2;TNFAIP3;SYK;TYRO3
prerank,positive regulation of interferon-beta production (GO:0032728),0.40352793405323306,1.0215190459672543,0.447887323943662,0.9344862892211743,1.0,14/33,27.10%,POLR3D;MAVS;RIPK2;RNF135;IRF1;TLR4;POLR3B;DHX9;PTPN11;IFIH1;IRF3;POLR3G;TLR8;TBK1
prerank,7-methylguanosine RNA capping (GO:0009452),0.4084756565594416,1.021359817477038,0.4310850439882698,0.9333352902829014,1.0,4/31,13.96%,RNMT;MNAT1;ERCC3;GTF2F2
prerank,7-methylguanosine mRNA capping (GO:0006370),0.4084756565594416,1.021359817477038,0.4310850439882698,0.9333352902829014,1.0,4/31,13.96%,RNMT;MNAT1;ERCC3;GTF2F2
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.3090175089552513,1.0211369854198027,0.43377148634984836,0.9331235945611411,1.0,66/509,9.97%,EGFR;F3;NR3C2;THBS1;MET;TCF7L2;PDGFC;NTRK3;FN1;TNFAIP8L3;TRAF3IP2;ADRA1B;AKAP13;NEDD4;TCIM;ITGB1;WNT11;FGFR1;SHC1;NFAT5;ALPK1;ADRB2;P2RX2;STRN;GCNT2;WNT16;PDCD4;DDIT3;PDGFA;TGFBR1;GOLPH3;CD80;BECN1;TNFSF11;TAB3;IRS1;BCLAF1;ITGAV;EP300;TRIP6;HCLS1;FGF22;TRIM44;GOLT1B;MAVS;CHUK;P2RX4;PIK3AP1;RIPK2;IFI35;TLR6;FGF2;GAB2;MAP3K3;SMCR8;IQGAP1;IRAK4;BCAR3;BCL10;SEC13;MLST8;GAB1;VAPA;HPSE;PPM1A;CCDC22
prerank,protein dephosphorylation (GO:0006470),0.3359037998517545,1.0204850945776573,0.4435483870967742,0.934069360814124,1.0,38/135,18.96%,EYA2;PTPN3;PPP3CA;PTPRU;PPTC7;PPM1H;DUSP16;PPEF2;EYA4;FBXW11;EYA3;PTPN2;PTPN21;PPP2R2D;DUSP10;PTPRF;DAPP1;PTPRA;PPM1A;DUSP5;PPP1R12A;PHPT1;PTPN14;PPP5C;DUSP11;PPP2R1B;PPP3CC;DUSP12;STK11;PPP4R1;PTPN9;DUSP22;PPP4R2;PPP2CB;PPP2R5C;PTPRD;PTPN1;ILKAP
prerank,regulation of cell-matrix adhesion (GO:0001952),0.3589122818914976,1.020453106470297,0.4313222079589217,0.9333786820952272,1.0,13/64,12.43%,THBS1;PTK2B;EFNA5;SEMA3E;GSK3B;VCL;JAG1;JUP;PTPRA;RHOA;SLC9A1;CD36;CASK
prerank,positive regulation of developmental process (GO:0051094),0.3213694068836795,1.0204221801724764,0.42194570135746606,0.9326807707954319,1.0,16/164,6.02%,BMP4;BMP5;COBL;FOXD1;ZBTB16;PHLDB2;FGFR1;ISL1;BMP1;LMNA;DDHD1;BMPR1A;TLE6;TRPM4;GDNF;FOXO6
prerank,positive regulation of dendritic spine development (GO:0060999),-0.3658939989965452,-1.020286840451498,0.3994708994708995,0.8012869076992427,1.0,3/20,7.38%,SHANK3;APOE;LRP8
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.372058606730569,-1.0199194815612689,0.4154727793696275,0.8010883825195648,1.0,6/20,16.45%,NR2F2;MYOCD;INCA1;IPO5;CDKN1C;HHEX
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.3592328239114329,1.019717577913009,0.4351851851851852,0.9337886088560498,1.0,15/63,16.35%,PLAGL1;CRADD;EP300;PLK3;CNOT7;ATM;MDM4;CHEK2;CDKN1B;PCBP4;RBL2;SFN;CARM1;PML;PRKDC
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.2595643419105692,-1.0195932029314174,0.42038216560509556,0.8007215421626777,1.0,27/116,16.35%,LYN;ADCY5;ADCY1;GNG2;PRKAR2B;ADCY7;CALCRL;ADCY2;PRKACB;RAMP2;MYH9;GGT5;PRKAR1B;PTH1R;CYSLTR1;PRKAR1A;SRC;ADORA2A;ADM;CYSLTR2;ADCY4;IAPP;PLCG1;ADCY3;ADCY8;VIPR2;SYK
prerank,glycolipid metabolic process (GO:0006664),0.37798334805243383,1.0194621430697914,0.43537414965986393,0.9337195877115746,1.0,5/47,5.93%,ST3GAL4;ESYT3;ESYT2;NAGA;HEXA
prerank,regulation of translation (GO:0006417),0.32751801310602685,1.0194457819947358,0.44640883977900553,0.9329938780971051,1.0,51/173,24.36%,THBS1;SAMD4A;FOXO3;EIF4G3;EIF4G1;NIBAN1;IGFBP5;SYNCRIP;LARP4B;CNOT7;PAIP2;TOB1;EIF2AK4;PLD1;MTRF1;EIF2B2;MTOR;EIF2AK3;NANOS2;ETF1;TRAP1;DDX1;FXR2;EIF4E2;DHX9;GSPT1;PRKDC;YTHDF3;MTIF2;CYFIP1;ZCCHC4;ATXN2;RBM4B;UPF3A;METAP1;EIF4G2;PUM3;METTL18;EIF6;EIF4ENIF1;PUS7;EIF3E;CSDE1;FMR1;LARP1;CAPRIN1;MTG2;PCIF1;RBM4;NCBP2;IMPACT
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.2738586070135425,-1.0191330261373601,0.42081447963800905,0.8006483725545104,1.0,20/75,15.39%,DCDC2;CTNNA2;MAP2;DCC;ACTB;BAIAP2;CNTN4;ANK3;MEF2C;OPHN1;MFSD2A;PLPPR4;APP;ZDHHC17;SDC2;BRSK2;APBB1;ADGRB1;S100A6;SLITRK4
prerank,peptidyl-arginine modification (GO:0018195),-0.4066205607841536,-1.0185077374185108,0.4482758620689655,0.8012162678896957,1.0,4/15,18.00%,ART3;PADI2;PRMT1;PARK7
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.32750277507037906,-1.0183522044542113,0.42038216560509556,0.8004089536772113,1.0,15/32,29.55%,NAV3;MAP2;SNCA;CLASP2;ATXN7;CIB1;TUBB4A;ARHGEF2;TPX2;CAMSAP2;FKBP4;STMN2;STMN1;CAMSAP1;TAOK1
prerank,histone ubiquitination (GO:0016574),0.4362116423589642,1.0183415384273626,0.4384,0.9350664047207488,1.0,8/21,24.06%,UBE2B;CTR9;USP22;PAF1;UBE2N;HUWE1;LEO1;WAC
prerank,positive regulation of cell death (GO:0010942),0.36834880344374377,1.0182750978984907,0.45345744680851063,0.934481769279434,1.0,9/59,8.98%,BMP4;MAP3K5;EIF4G1;GSK3B;RARG;CLU;CELF1;RIPK2;CDKN1B
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.4544884340208003,1.0182246444361027,0.4483333333333333,0.9338339136691147,1.0,2/17,7.72%,CD44;KDM1A
prerank,amino sugar biosynthetic process (GO:0046349),0.49201578916029753,1.0179963296754349,0.4575971731448763,0.9336310468667579,1.0,8/12,31.38%,NANP;GNPDA2;GNPNAT1;UAP1;GFPT1;RENBP;UAP1L1;AMDHD2
prerank,regulation of neuron migration (GO:2001222),-0.34564223746833456,-1.017898457952648,0.4,0.8003425359277341,1.0,9/26,13.36%,SEMA6A;CTNNA2;RAPGEF2;NEXMIF;DAB2IP;MDK;CAMK2A;ADGRG1;CAMK2B
prerank,negative regulation of biosynthetic process (GO:0009890),-0.3786729019691166,-1.0174636272539168,0.4095238095238095,0.8003460463839769,1.0,8/16,25.14%,SLC30A10;PPARA;ASXL3;PARK7;ABCB7;SLC18A2;EMILIN1;GPER1
prerank,regulation of cell size (GO:0008361),0.42534911929629937,1.017454170942029,0.4447900466562986,0.9342898284437341,1.0,6/23,11.89%,EZR;RARG;VAV2;RDX;MTOR;RHOA
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.39041773210789393,-1.017415280834849,0.4421052631578947,0.7992489420732561,1.0,5/15,16.39%,TNK2;DGKD;HIP1R;SNAP91;WASL
prerank,translational termination (GO:0006415),0.3454679969860877,1.0173972510379665,0.4365361803084223,0.9336736631335494,1.0,36/95,26.27%,MRPL33;MRPL48;MRPL32;MRPL14;MRRF;MRPL21;MTRF1;MRPS31;MRPL38;GFM2;ETF1;MRPL57;ABCE1;MTRF1L;MRPS28;MRPS35;MRPS22;MRPL20;MRPS10;GSPT1;MRPL47;MRPS27;MRPS30;MRPS23;MRPL9;MRPS24;MRPL52;MRPS33;MRPS18B;MRPS7;PTCD3;MRPL10;MRPL39;MRPS5;MRPS34;MRPS18C
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.32724078520396677,1.016639050960975,0.45918367346938777,0.9348148644532361,1.0,26/151,13.11%,ST3GAL4;ACER3;PCSK5;PLPP3;INHBA;SGMS2;LARGE1;NFS1;DMD;SPTSSB;GOLPH3;NANP;CDO1;B3GNT6;CERS6;CERS5;TYW1;VAPA;MOCS3;CSNK2A2;CSNK2A1;TYW5;ELOVL5;PLPP1;ST3GAL2;LPIN2
prerank,positive regulation of protein kinase activity (GO:0045860),-0.24619478214232113,-1.016307873452008,0.3969465648854962,0.8010718569497137,1.0,41/148,16.82%,IL34;PRKAG2;RAPGEF2;PAK1;CALM1;TNIK;CCDC88A;CSF1;PTK2;GRM5;NRK;ACE;SNCA;INSR;PAK5;IL6R;DAB2IP;NEDD9;EPHA4;ADRA2A;MAP4K4;GPRC5B;LRP8;GAS6;CALM3;SRC;HSP90AB1;TAB2;EGR1;ETAA1;CIB1;AGT;MMD;ALS2;TTBK1;INCENP;SLC27A1;PIH1D1;CCL19;CENPE;STK3
prerank,neural crest cell development (GO:0014032),-0.3023281994514333,-1.0158294725330774,0.4157706093189964,0.8011259385880641,1.0,11/44,12.03%,SEMA6A;CDH2;SEMA7A;SEMA6D;TBX1;RADIL;TAPT1;SEMA5B;ERBB4;SEMA3G;SEMA6B
prerank,protein glycosylation (GO:0006486),0.3344397978584134,1.0156215394640467,0.44226327944572746,0.9367859902984762,1.0,19/125,12.99%,ST3GAL4;MGAT4C;FUT8;MGAT3;B3GNT2;LARGE1;GCNT2;PLOD2;MPI;POMGNT2;B4GAT1;B3GNT6;GCNT4;B4GALT1;B4GALT7;DPM1;COG3;LARGE2;ST3GAL2
prerank,regulation of cell differentiation (GO:0045595),0.32699722119444186,1.015351375131614,0.4526795895096921,0.9367582082511552,1.0,26/148,16.36%,ZFHX3;NGF;SIX1;DDX5;PHLDB2;FGFR1;ISL1;KLF4;GDNF;TGFBR1;TFAP2A;SMOC1;CREBBP;CBFB;BCL6;GATA3;LTBP4;GNB3;REST;DDX17;CEBPB;EMP2;SUZ12;PRKACA;PTHLH;CDK5RAP1
prerank,positive regulation of lyase activity (GO:0051349),-0.39643067125482073,-1.0146676514448543,0.4125874125874126,0.8029773882826333,1.0,5/14,18.00%,CACNA1D;NOS3;STIM1;NOS1;PARK7
prerank,regulation of establishment of endothelial barrier (GO:1903140),-0.3948649110167876,-1.0144269341754226,0.43989071038251365,0.8024468494642272,1.0,4/17,10.04%,CLDN5;F11R;S1PR3;TNFRSF1A
prerank,ERAD pathway (GO:0036503),0.34420335526614254,1.0144112048905733,0.44387755102040816,0.9384642737778889,1.0,17/83,14.43%,USP13;UBE4B;RNF185;VCP;NPLOC4;ANKZF1;ERLIN1;OS9;UFD1;TRIM25;FBXO17;UBXN4;UGGT2;FAF2;ECPAS;PSMC6;UBE4A
prerank,phosphatidic acid metabolic process (GO:0046473),0.3771863478848906,1.0141989535082248,0.43802816901408453,0.9382546372508934,1.0,12/48,17.42%,PNPLA3;DDHD1;PLD1;DGKA;ABHD4;ABHD5;GPAT3;GNPAT;AGPAT4;PLA2G4A;LCLAT1;AGPAT5
prerank,regulation of inflammatory response (GO:0050727),0.31921750516322056,1.0140864465578838,0.45076586433260396,0.9377813965820594,1.0,29/190,12.87%,FOXP1;CCN3;GPR4;ANXA1;AGTR1;PTGIS;ISL1;PRKCD;KLF4;IL10;PDCD4;MGLL;SHPK;DAGLB;NLRP6;CELF1;PTPN2;PIK3AP1;IFI35;IL17RA;TNFRSF1B;BCL6;ACOD1;GATA3;RB1;TLR4;IL16;BIRC3;TRADD
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.37665345394879435,1.0139511057107788,0.43283582089552236,0.9373651484258162,1.0,18/49,25.19%,ISL1;SMAD6;GSK3B;ANKRD27;CLU;EP300;PPM1A;CDC42;LDLRAD4;ULK1;PMEPA1;TRAF3IP1;PTGER4;NLRP2B;PYDC1;SVIP;IMPACT;DACT1
prerank,acute-phase response (GO:0006953),0.48753363688575235,1.0134728977394636,0.46234676007005254,0.9378747775126681,1.0,3/12,13.86%,LBP;PLSCR1;CEBPB
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.42424473086259307,-1.0133207384218557,0.44835680751173707,0.8041290269524224,1.0,5/12,19.74%,APOE;PFDN2;PFDN5;IAPP;PFDN6
prerank,response to peptide (GO:1901652),0.39906824507120736,1.0130562644383982,0.45440956651718983,0.9381978607903129,1.0,12/33,23.83%,ANXA1;IRS1;EIF2B2;STAT3;STAT5A;ERBIN;EIF2B3;STAT6;NOD2;PRNP;STAT4;AGER
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.46233651807355747,1.0129687988599316,0.44873949579831934,0.9376734282867384,1.0,3/14,13.35%,EHHADH;ACOT8;ACOX3
prerank,double-strand break repair (GO:0006302),0.3253512243991297,1.0125791248241223,0.44308035714285715,0.9379022074415064,1.0,41/158,18.20%,REV3L;RNF138;VCP;HERC2;EYA3;ATM;BAP1;APLF;CHEK2;SWSAP1;KAT5;RNF168;ZFYVE26;RAD52;BRCA2;ERCC1;RAD51C;RPA1;IFFO1;RAD51AP1;KDM4D;PPP5C;XRCC5;EXD2;NSMCE2;AP5S1;DDX1;RBBP8;PRKDC;POLB;UBE2N;MAPK8;ACTR8;WRN;KDM2A;YY1;MCM9;POLA1;NBN;INO80;SMC5
prerank,neuron fate commitment (GO:0048663),0.4808325570437103,1.0125626613079484,0.4565587734241908,0.9371845526003176,1.0,2/14,5.26%,ISL1;TGFBR1
prerank,translesion synthesis (GO:0019985),0.3840098591220653,1.0125484631687964,0.45428156748911463,0.9364499660487962,1.0,10/42,14.34%,REV3L;VCP;NPLOC4;USP10;UFD1;TRIM25;RPA1;RFC5;REV1;POLD3
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.42654595530514966,1.0123079084876025,0.443217665615142,0.936261585959324,1.0,7/21,10.61%,IL10;BMPR1A;IGFBP5;NR4A3;JUN;FGF2;HTR1B
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.3711291148291417,1.012104943972584,0.43945578231292515,0.9360357288432876,1.0,3/57,1.21%,CYFIP2;MAP3K5;PERP
prerank,regulation of dendrite development (GO:0050773),0.39325837453827717,1.0119055227951381,0.4616457461645746,0.935780693007231,1.0,5/37,3.92%,BMP5;COBL;MARK1;NEDD4;GSK3B
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.44909915432641134,1.0114699167436612,0.451559934318555,0.9353914900715202,1.0,7/17,16.64%,SOCS2;IRS1;SMARCA4;STAT3;STAT5A;BRWD1;IRS2
prerank,cellular response to interleukin-7 (GO:0098761),0.44909915432641134,1.0114699167436612,0.451559934318555,0.9353914900715202,1.0,7/17,16.64%,SOCS2;IRS1;SMARCA4;STAT3;STAT5A;BRWD1;IRS2
prerank,organelle assembly (GO:0070925),0.3081213309823366,1.0112788213588002,0.4727646454265159,0.9351490573625045,1.0,97/385,20.75%,MAPRE2;ABLIM3;PKD1;BBS9;PARVA;EXOC4;TMOD3;NEK7;GSN;WIPI2;EHD3;ARF4;ULK2;RAB43;CFAP70;PDCD6IP;PDE6D;PRRC2C;DZIP1;EXOC5;CEP164;ZFYVE1;BECN1;ATAT1;ARL3;ABCC4;ATG3;CEP131;BIN2;RAB11FIP3;SSTR3;OCRL;MKS1;TMEM237;CDS1;FUZ;TMEM231;PCM1;PTPDC1;DISC1;HAUS5;HPS4;KIF27;ARMC9;TUBGCP4;IFT122;IST1;CEP63;EHD1;TUBGCP5;DNAH5;PIBF1;POC1B;RB1CC1;CCDC66;TSG101;GALNT11;ATP6V0D1;AMBRA1;IFT88;RAB17;CSNK1D;DYNC2I2;RILPL1;BSCL2;FLNA;CEP89;ATG2A;CEP20;IFT80;GBF1;NUDCD3;EDC3;VPS37A;TMOD4;YTHDF3;DZIP1L;INO80;ATXN2;CDC14A;YTHDF2;RAB7A;EHD2;ATG7;ULK1;TEKT2;TUBGCP6;HYLS1;TRAF3IP1;HGS;STAM2;EXOC7;EXOC1;CHMP4A;CHMP4B;LZTFL1;ATG16L1
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.3283244872283228,1.010984734601758,0.4532871972318339,0.9351597940039874,1.0,34/129,21.08%,FBXL7;CCNA2;SFI1;CDC25B;PPP1R12B;CEP164;PAFAH1B1;PLK3;CEP131;FBXW11;CHEK2;MNAT1;FBXL6;PCM1;HAUS5;CSNK1E;CEP70;PPP1R12A;CEP63;CEP57;FOXM1;PRKACA;CSNK1D;PPME1;DCTN3;CNTRL;AKAP9;FBXL17;CEP192;FBXL8;DCTN1;AURKA;ODF2;MASTL
prerank,polyol metabolic process (GO:0019751),0.36735109854216436,1.0106722862392252,0.44273743016759776,0.9352211913073363,1.0,10/46,9.62%,PLCE1;INPP4A;IP6K2;PLCB3;NUDT4;PLCD3;OCRL;IP6K3;PPIP5K2;PLCD1
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.40706040016748657,1.0104288235038306,0.45982142857142855,0.9351191439852765,1.0,11/32,18.62%,POLR1G;TAF1C;MNAT1;ERCC3;TAF1;POLR1A;POLR1H;POLR1F;RRN3;TAF1D;POLR2H
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.3016860253176964,-1.0091673205522291,0.4053030303030303,0.8142116494048788,1.0,8/46,8.90%,SEMA6A;TIMP3;LYN;DAB2IP;FBLN1;SIRPA;WNK2;DUSP3
prerank,protein localization to cell-cell junction (GO:0150105),-0.39906941902434057,-1.009035655343604,0.4723618090452261,0.8133309966937334,1.0,4/15,4.83%,TJP1;F11R;CGNL1;ACTB
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.3557319242253647,-1.0088335281225531,0.43641618497109824,0.8126564151633958,1.0,6/22,16.45%,NR2F2;MYOCD;INCA1;IPO5;CDKN1C;HHEX
prerank,inositol lipid-mediated signaling (GO:0048017),0.37308166562997747,1.0084623036648668,0.4602739726027397,0.9394264768197547,1.0,9/50,7.52%,PLCE1;NGF;TNFAIP8L3;EZR;FGFR1;PLCB3;PLCD3;IRS1;GAB2
prerank,RNA metabolic process (GO:0016070),-0.2517240565437694,-1.008415285770836,0.42953020134228187,0.8125377094909131,1.0,34/127,22.87%,RBPMS;RBMS1;ATXN1;NOVA1;SETX;APOBEC1;HNRNPA0;AGO1;ADARB2;CELF2;METTL14;ADARB1;ELAVL4;FASTKD2;LSM1;AGO4;HNRNPH3;PABPN1;RNASE4;POLR2K;METTL3;PAPOLG;DDX54;PCBP1;RNASEL;POLR2C;DDX24;POLR2G;HNRNPU;MRPL44;POLR2L;NUFIP1;TP53RK;TFIP11
prerank,regulation of transmembrane transport (GO:0034762),0.40549396326166287,1.008213620261451,0.45403111739745405,0.9393048945331518,1.0,3/31,2.62%,KCNJ2;NEDD4;WWP2
prerank,glycerophospholipid metabolic process (GO:0006650),-0.27484118038245386,-1.006967033605656,0.4419642857142857,0.8151436634611323,1.0,9/75,6.30%,PLCB1;GPCPD1;PDGFRB;SERINC5;PLA1A;ABHD3;ENPP6;ABHD12;SERINC1
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),-0.4163155085085438,-1.0066473911491949,0.44956140350877194,0.814807423762232,1.0,2/11,8.02%,PRKCQ;MALT1
prerank,response to reactive oxygen species (GO:0000302),0.3701857481606401,1.0065826563870184,0.43526170798898073,0.9427431632899437,1.0,6/54,7.13%,EGFR;ADAM9;COA8;PLK3;CHUK;JUN
prerank,positive regulation of cellular process (GO:0048522),0.30345154374154776,1.006421546907273,0.4959758551307847,0.9423724350096648,1.0,62/565,8.32%,EGFR;BMP4;THBS1;ACER3;GRK5;ZFHX3;PDGFC;BMP5;NTRK3;FN1;TGFB3;HDAC4;PTK2B;PPP3CA;LBP;FGFR1;SHC1;KRAS;BMP6;PGF;ISL1;PRKCD;LRP6;GAREM1;EIF4G1;P2RX2;GCNT2;LMNA;BAMBI;FZD7;CDC25B;EGR2;DDRGK1;PDGFA;TRPM4;GDNF;TGFBR1;KLHL22;TGFBR2;IRS1;BCLAF1;HILPDA;ITGAV;MMP14;TGM1;CEP131;HCLS1;FGF22;CNOT7;CELF1;P2RX4;CLCF1;RIPK2;ATM;FGF2;GAB2;MVD;HES1;WWTR1;CAPN10;ADAM10;TNFRSF1B
prerank,antigen receptor-mediated signaling pathway (GO:0050851),-0.24213416509631983,-1.0062861863343082,0.4434782608695652,0.8145463819162729,1.0,40/163,21.15%,PIK3R1;PDE4B;FYB1;BCL2;PAK1;INPP5D;RFTN1;TNFRSF21;TEC;MEF2C;PRKCQ;MALT1;PDE4D;VAV3;CD38;MOG;PAG1;TAB2;PSMB10;BMX;BTRC;PSME2;PLCG1;BLNK;EIF2B5;NCKAP1L;LAT2;SYK;THEMIS;RELA;PSMB3;TXK;PIK3CD;PSMB4;PSMB8;LCP2;FYB2;ICOSLG;PSMC5;CD276
prerank,cellular response to sterol (GO:0036315),0.4671613641492862,1.0060367488077921,0.4440619621342513,0.94259448892453,1.0,3/13,9.05%,SMO;LRP6;GRAMD1C
prerank,brain morphogenesis (GO:0048854),-0.4224645627584195,-1.0058951412089718,0.46813186813186813,0.8143602027173724,1.0,2/12,1.99%,SHANK3;CTNNA2
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),-0.4264946337742408,-1.0058594163094485,0.4541176470588235,0.8132592922913825,1.0,3/11,6.99%,LYN;ANK3;PRKCQ
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.44185380610669867,1.0055723583646254,0.4611727416798732,0.9430397025364917,1.0,5/18,11.36%,CTNNA1;GSK3B;MDFIC;OTUD7B;POLR1A
prerank,regulation of anoikis (GO:2000209),-0.37271149414997795,-1.0051164240534725,0.43717277486910994,0.8140329506425407,1.0,5/19,9.09%,TLE1;BCL2;PTK2;NOTCH1;SRC
prerank,regulation of complement activation (GO:0030449),0.3893954249675001,1.0048522510155045,0.4711815561959654,0.9440632533058076,1.0,6/40,11.05%,CFH;CD55;CLU;CR1L;CD46;SERPING1
prerank,plasma membrane invagination (GO:0099024),0.4094835467763284,1.0048072267124935,0.4538904899135447,0.9434224317455202,1.0,7/29,12.28%,GULP1;SNX18;GSN;BIN2;CDC42;RHOA;CD36
prerank,regulation of T cell cytokine production (GO:0002724),0.45433781560323305,1.0047150506837952,0.45058626465661644,0.9428896678702439,1.0,3/15,8.32%,CD55;TRPM4;TNFRSF1B
prerank,negative regulation of cell cycle (GO:0045786),0.35484976555953124,1.0044377445862187,0.45397225725094575,0.9428487286201664,1.0,12/73,13.89%,BMP4;PTPN3;INHBA;IL10;PDCD4;IPO7;CDKN1B;GATA3;RB1;FOXC1;HECA;BTG3
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.4445475379161775,1.0040903283346903,0.4368770764119601,0.9429997145387876,1.0,7/16,31.01%,RBMX;SNW1;TRA2B;NUP98;CELF3;CIRBP;PRDX6
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.4949880393917909,1.0038294417378528,0.46557971014492755,0.9429320594961575,1.0,2/10,2.50%,CYP1B1;WNK1
prerank,response to organophosphorus (GO:0046683),-0.3909139744003458,-1.0036039166444746,0.44110275689223055,0.8167263694594097,1.0,5/16,15.51%,TRPC3;ABCC9;NDUFS4;VGF;P2RX7
prerank,hemopoiesis (GO:0030097),0.33931678121979497,1.0035929797817664,0.4407185628742515,0.9427917710137539,1.0,12/87,6.86%,BMP4;ZBTB16;MFAP5;INHBA;HIPK1;MKNK2;IL10;NOTCH2;TNFRSF13B;PRRC2C;TGFBR2;JAG1
prerank,regulation of epithelial cell differentiation (GO:0030856),0.44432435848688046,1.003233821580081,0.4565587734241908,0.94295778493298,1.0,6/17,21.17%,DSPP;KLF7;GATA3;CEBPB;PRKX;MAFG
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.40578597569661007,1.002940195701315,0.4625748502994012,0.9429024295859664,1.0,11/30,24.06%,FHIT;GIPC1;DDRGK1;USP7;TAF9;TLK2;MAP1A;HFE;N4BP1;SVIP;WAC
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.427290975334215,-1.0029190069461287,0.44575471698113206,0.8173352140078844,1.0,7/11,24.77%,ST18;FAS;PIH1D1;PARK7;CAAP1;PRR7;PLAUR
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.39375369447505026,1.0028402072848648,0.46208869814020026,0.9424125633613604,1.0,13/37,20.83%,FHIT;GIPC1;DDRGK1;USP7;TAF1;CSNK2A2;CSNK2A1;TAF9;PML;TLK2;MAP1A;HFE;N4BP1
prerank,regulation of cellular respiration (GO:0043457),-0.3718608560811244,-1.0027339042620447,0.46403712296983757,0.8166488144499536,1.0,3/17,3.90%,CBFA2T3;IFNAR1;PRDM16
prerank,positive regulation of cell aging (GO:0090343),-0.42564436239712977,-1.002707714393008,0.4411764705882353,0.8155252832114216,1.0,4/11,13.66%,B2M;YPEL3;ABI3;CGAS
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.4698585471155205,1.00261428438115,0.4698581560283688,0.9422231847897561,1.0,3/13,9.48%,ANK2;CACNA1C;CACNB2
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.4335691196790753,-1.002431428270674,0.4955555555555556,0.8150807895952148,1.0,5/10,18.00%,KLF15;MYOCD;PRKAA2;FLCN;PARK7
prerank,neutrophil migration (GO:1990266),-0.28968163068814884,-1.0024162733064472,0.47058823529411764,0.8139126138814783,1.0,13/58,19.62%,PECAM1;PDE4B;BSG;PPIA;PIP5K1C;EDN1;PPIB;EDN3;NCKAP1L;SYK;CCL19;ITGB2;PIK3CD
prerank,negative regulation of cellular component movement (GO:0051271),-0.3907576607452463,-1.0019080473007067,0.4468599033816425,0.814022257691286,1.0,4/15,7.95%,FRMD5;TGFBR3;FBLN1;SPOCK3
prerank,regulation of rRNA processing (GO:2000232),0.44988154111564854,1.00188245582793,0.4663299663299663,0.9433672250340749,1.0,11/16,29.89%,WDR43;KAT2B;RIOK2;WDR75;YTHDF2;METTL18;SIRT7;USP36;HEATR1;UTP15;NUDT16
prerank,regulation of endocytosis (GO:0030100),-0.28451237937386026,-1.0015432905815882,0.452991452991453,0.8137565497126581,1.0,14/61,11.10%,APOE;PRKD1;PICALM;NEDD4L;MCTP1;SNCA;OPHN1;SYT11;RIT2;FLOT1;SRC;SPHK1;CDH13;HIP1
prerank,cardiac myofibril assembly (GO:0055003),0.4435723087762029,1.001256902434351,0.4642857142857143,0.944219063081325,1.0,4/15,8.89%,CSRP3;NEBL;MEF2A;FHOD3
prerank,hexose metabolic process (GO:0019318),-0.3061949241262498,-1.0011987202144716,0.43630573248407645,0.813450168312354,1.0,8/39,16.94%,APOD;PPARD;ALDOC;ALDOA;CHST1;PGM1;HK1;FUCA2
prerank,organelle organization (GO:0006996),0.3055455083861891,1.0005668484125705,0.48918640576725025,0.9452222579592365,1.0,94/388,20.65%,MICAL2;PLCE1;FMNL2;ABCD3;ARHGAP21;ARHGAP10;CXADR;MARK1;STRIP2;ATL3;PNPLA3;GOLGB1;TMEM135;VPS13C;DIAPH1;RAB43;SPTSSB;PDCD6IP;FBXW8;ATP8B1;MTX3;TMED5;GOLPH3;GAK;HILPDA;NPLOC4;DOP1B;ATL2;FAM161B;RAB18;FGD6;MTX2;TTC17;PITPNB;NCKIPSD;DYRK3;FMNL3;LMAN2L;HPS3;VAPA;DMTN;BCAS3;PAK4;SAR1B;GABPB1;CDC42;EIF2AK3;SH3D19;TRIP11;RAB30;PEX2;TRAPPC12;KIF9;FAF2;CSNK1A1;COG3;VPS13D;MTFR1;BRWD1;STOML2;MAPK15;HCFC1;PRDX3;CSNK1D;YME1L1;AGTPBP1;BSCL2;POLG2;TICAM2;GBF1;ZRANB1;PCLO;ARL1;HUWE1;YTHDF3;TPM1;TMCC1;VPS51;MCOLN1;YTHDF2;PEX12;PLEKHM2;RAB7A;LONP1;PEX16;LONP2;SLC25A36;VAPB;SYNE1;LYSMD3;ODF2;PEX7;CHMP4A;CHMP4B
prerank,protein tetramerization (GO:0051262),-0.27875367360157216,-1.0004752909444885,0.4488888888888889,0.8141965541376289,1.0,22/67,16.55%,ALDH1A2;B2M;HCN1;SNCA;SAMHD1;CPSF6;AQP4;GRIN2B;ACACA;ACACB;ALDH9A1;ALDOA;KCNC1;UPB1;GRIN1;RYR3;CRYZ;APPL2;KCNJ12;GBP5;CBY1;ALDH1A3
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.34307604968670935,-1.0003412131053828,0.45645645645645644,0.8133388895319531,1.0,12/25,28.47%,TNFSF10;PDCD5;BMF;BIK;MLLT11;DNM1L;BAD;PLAUR;GPER1;HRK;PMAIP1;TP53
prerank,positive regulation of multicellular organismal process (GO:0051240),0.30602170413134866,1.0002711696546716,0.48171368861024033,0.9452609371966448,1.0,52/308,12.79%,BMP4;PDGFC;SMO;SIX1;TGFB3;FOXD1;ZBTB16;ADRA1B;LRPAP1;GRB10;LBP;INHBA;BMP1;ADRB2;IL10;GCNT2;ZBTB7B;BAMBI;BMPR1A;TLE6;TRPM4;GDNF;TGFBR1;TGFBR2;HILPDA;FGF2;DECR1;TGFB1I1;TSKU;KDM1A;KAT2A;SCD;WWTR1;CYP27B1;SIX4;PER2;CXCR4;MTOR;SHLD1;NIBAN2;BCL9L;NOG;ACVR1;OMA1;TGFB2;REST;CD36;SNX4;FOXC1;CMKLR1;HTR2B;INHBB
prerank,muscle contraction (GO:0006936),0.33001421767103434,1.0001669662622734,0.4739952718676123,0.9447819639062406,1.0,12/126,6.53%,EDNRA;SORBS3;CALD1;SORBS1;MYBPC2;MYOM3;TMOD3;DMD;TNNI3;VCL;CHRNG;CHRNE
prerank,glycerol metabolic process (GO:0006071),-0.42810255113305995,-1.0000343350587877,0.47294117647058825,0.8129803769237222,1.0,2/10,8.29%,GK;COQ2
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.3645618623179683,-1.000018149794678,0.4465753424657534,0.8118413497665816,1.0,7/20,15.73%,BCL2;DCC;FAS;BCL2L1;CASP3;BOK;GSK3A
prerank,cellular response to interferon-gamma (GO:0071346),-0.2570178563952154,-0.9995883430427512,0.45077720207253885,0.8117513949476637,1.0,35/88,25.92%,B2M;VCAM1;WNT5A;CD47;GBP7;IRF2;GBP4;NCAM1;AQP4;TRIM62;GAPDH;SIRPA;DAPK1;RPL13A;CAMK2A;MT2A;OAS2;TRIM21;CAMK2B;SP100;GBP5;GBP2;CCL19;HCK;FCGR1A;CASP1;TRIM8;STAT1;IRF7;AIF1;GBP3;CCL2;PTAFR;OASL;CCL25
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.4621521510445897,0.9993331911690758,0.4725663716814159,0.9461647988743386,1.0,3/12,4.49%,ATP1B1;WNK1;DMD
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.33806327930999186,-0.9988586702804416,0.48158640226628896,0.8124905834902679,1.0,7/29,9.04%,APOE;PPARA;ZBTB20;LPGAT1;NR1H3;SCARB1;MFSD2A
prerank,mitochondrial translational termination (GO:0070126),0.3439334175569609,0.9980519993053313,0.4602203182374541,0.9487071752881746,1.0,33/88,26.27%,MRPL33;MRPL48;MRPL32;MRPL14;MRRF;MRPL21;MTRF1;MRPS31;MRPL38;GFM2;MRPL57;MTRF1L;MRPS28;MRPS35;MRPS22;MRPL20;MRPS10;MRPL47;MRPS27;MRPS30;MRPS23;MRPL9;MRPS24;MRPL52;MRPS33;MRPS18B;MRPS7;PTCD3;MRPL10;MRPL39;MRPS5;MRPS34;MRPS18C
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.3773394305135088,-0.997841598580257,0.44794188861985473,0.8140029664538959,1.0,7/16,22.48%,PARP14;INPP5F;BCL3;NF2;LEPROT;SH2B3;SOCS1
prerank,insulin receptor signaling pathway (GO:0008286),0.3554195402078879,0.9976301787604348,0.4967741935483871,0.9490415819571327,1.0,18/69,14.10%,SORBS1;GRB10;ATP6V0A4;SHC1;GSK3B;FOXC2;IRS1;PTPN2;IDE;SLC39A14;BCAR3;ATP6V0A1;RHOQ;GAB1;ATP6V0E1;C2CD5;ATP6V1H;ATP6V0D1
prerank,amyloid fibril formation (GO:1990000),-0.2884433246168118,-0.9975412271330665,0.4666666666666667,0.8136715149754422,1.0,16/51,17.90%,HSPG2;B2M;CST3;SNCA;TSPAN5;ITM2B;RPS27A;UBC;MAPT;APP;TGFBI;UBB;IAPP;GGA3;APH1B;PSENEN
prerank,protein K48-linked deubiquitination (GO:0071108),0.4147406687511904,0.9973611418240034,0.46322378716744916,0.9490090927434842,1.0,11/23,20.84%,OTUD7B;BAP1;USP33;USP34;USP25;OTUD3;OTUB1;VCPIP1;MINDY2;OTUD5;USP37
prerank,monocarboxylic acid biosynthetic process (GO:0072330),-0.2824312284635285,-0.9967490738554959,0.4530612244897959,0.8145740239878705,1.0,15/59,19.21%,ALDH1A2;CYP7B1;CYP27A1;GATM;ACLY;ACACA;ELOVL4;OSBP;HSD17B4;OSBPL1A;SCP2;ALDH1A3;PARK7;CH25H;HSD17B10
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.34314689353270655,0.9967111689289805,0.4791929382093317,0.9499965554001519,1.0,23/84,17.85%,MBNL1;DDX5;RBFOX2;MBNL2;SON;CELF1;PCBP4;SRSF6;RBM25;SRSF12;RBMX;REST;RBM8A;SRPK1;RBM39;DDX17;HNRNPL;FXR2;SNW1;JMJD6;SFSWAP;ZBTB7A;TRA2B
prerank,ribosome assembly (GO:0042255),-0.29625342363065016,-0.9964649956903201,0.4541984732824427,0.814076475084393,1.0,14/47,17.78%,RPS14;RPS27;RPS15;RPS5;RPL5;RPS19;RPL3;RPL24;RPL23A;TRAF7;RPL11;MRPS11;RPLP0;RPS28
prerank,Ras protein signal transduction (GO:0007265),0.3233146865646321,0.996462252151981,0.4839080459770115,0.9498842954814621,1.0,22/137,9.75%,PLCE1;NTN1;ARHGDIB;CCNA2;CDC42EP5;MRAS;AGTR1;SHC1;NRAS;KRAS;RAP1A;RAPGEF6;SHTN1;SHOC2;RAP2C;JUN;FGF2;NCKAP1;SGSM3;PLD1;GNA13;RIT1
prerank,response to sterol (GO:0036314),0.47889607630040765,0.9963402999254736,0.4853195164075993,0.949441826960502,1.0,5/11,22.94%,TGFBR1;TGFBR2;RORA;TGFB1;SMAD2
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.3759351052026475,0.9962255624580737,0.47042640990371387,0.9489944745114933,1.0,7/43,8.00%,BMP4;CCN1;BMP6;DDR2;BMPR1A;NELL1;WWTR1
prerank,sensory perception of taste (GO:0050909),0.4901104363111557,0.9959470879637554,0.48080438756855576,0.9489159374448389,1.0,2/10,12.28%,PKD2L1;CD36
prerank,nucleosome organization (GO:0034728),0.3677971072167798,0.9953103850091005,0.47831978319783197,0.9497849404580639,1.0,15/55,20.04%,CHAF1B;KAT6B;BPTF;NAP1L2;SMARCA4;SETD2;PAF1;SRCAP;VPS72;ATRX;DMAP1;INO80;ARID1A;SMARCD2;ZNHIT1
prerank,focal adhesion assembly (GO:0048041),0.4263301793805695,0.9951851030059499,0.4819672131147541,0.9493113262176067,1.0,4/21,6.45%,SORBS1;BCR;PIP5K1A;TRIP6
prerank,regulation of macrophage activation (GO:0043030),0.39896592169248185,0.9951138263521421,0.48125937031484256,0.9487406843928069,1.0,4/30,7.33%,THBS1;LBP;SHPK;TLR6
prerank,cellular response to growth factor stimulus (GO:0071363),0.32124851492953094,0.9951087648095669,0.49943630214205187,0.9480057305223941,1.0,17/151,7.98%,EGFR;BMP4;SMAD9;NTRK3;ANXA1;CD44;SHC1;BMP6;KLF4;GAREM1;RAP1A;BMPR1A;TGFBR1;TGFBR2;KIDINS220;NRP1;IQGAP1
prerank,ribosomal large subunit assembly (GO:0000027),-0.3416514410412767,-0.9950085218697612,0.44984802431610943,0.8167383992406124,1.0,8/24,17.45%,RPL5;RPL3;RPL24;FASTKD2;RPL23A;TRAF7;RPL11;RPLP0
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.33581523293268106,-0.9946200465159849,0.46875,0.8166282663613325,1.0,6/25,9.60%,EPHA4;RPL5;RPL23;OPHN1;RPS7;HSP90AB1
prerank,negative regulation of supramolecular fiber organization (GO:1902904),-0.270446258344364,-0.9945725910816853,0.4594594594594595,0.815567443680377,1.0,18/72,14.84%,PLEKHH2;SHANK3;APOE;KANK3;NAV3;SSH2;MAP2;HSPA8;SNCA;PFDN2;MYADM;CLASP2;PFDN5;ATXN7;CIB1;PFN1;IAPP;HIP1R
prerank,positive regulation of cellular catabolic process (GO:0031331),0.3224181493203136,0.9943563745381083,0.4817351598173516,0.9491608139850798,1.0,28/132,15.22%,SLC4A4;FOXO3;EZR;PRKCD;ADAM9;GSK3B;DXO;PFKFB2;DAGLB;MOV10;IRS1;CNOT7;GAPDHS;TNFRSF1B;KAT5;RDX;PIM2;SH3D19;PRXL2C;MTDH;ADAM8;BNIP3;ABHD5;AMER1;TFEB;UFL1;STK11;PRKAA1
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),-0.3293347786874318,-0.9943171153596342,0.4378698224852071,0.8150993359007707,1.0,15/32,32.74%,CEMIP;TRPC3;SNCA;GRIN1;PLCG1;P2RX7;APLNR;CASQ1;GPER1;AKAP6;CAPN3;P2RX5;TRPC1;P2RX3;RAMP3
prerank,protein-containing complex disassembly (GO:0032984),0.36526564534279876,0.9942977322378155,0.47106325706594887,0.9485765654001237,1.0,10/54,13.70%,LRP6;WIPI2;GSK3B;VCP;FZD2;LIX1;CSNK1A1;TSG101;VIPAS39;AMER1
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.4747056767189243,0.9939522289340074,0.46880907372400754,0.9479508100654764,1.0,2/10,7.36%,AP2A2;AP2A1
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.4747056767189243,0.9939522289340074,0.46880907372400754,0.9479508100654764,1.0,2/10,7.36%,AP2A2;AP2A1
prerank,glycoprotein metabolic process (GO:0009100),0.3657316098374044,0.9935747515386235,0.47297297297297297,0.9481513414625862,1.0,11/53,12.99%,ST3GAL4;FUT8;LARGE1;GOLPH3;PRKCSH;B3GNT6;HPSE;B4GALT7;FBXO17;GANC;ST3GAL2
prerank,response to muscle stretch (GO:0035994),0.4536231105843061,0.9934946491694849,0.4784110535405872,0.9475997500947335,1.0,3/15,4.49%,CSRP3;GSN;DMD
prerank,cytoskeleton organization (GO:0007010),0.33225075206053256,0.9931855416193729,0.4811764705882353,0.9476043402021023,1.0,7/114,2.14%,MICAL2;PLCE1;FMNL2;ARHGAP10;MARK1;STRIP2;PPP2R3C
prerank,regulation of exocytosis (GO:0017157),0.3715140465444611,0.9931233348161388,0.4842249657064472,0.9470264111253954,1.0,6/46,9.35%,STXBP6;ANXA1;EXPH5;SYTL4;NSF;RAB27B
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.43013289735677773,-0.9929340773997912,0.46534653465346537,0.817533367813896,1.0,2/10,4.67%,APOD;SNCA
prerank,regulation of protein modification process (GO:0031399),-0.2939447627040029,-0.9927928261897212,0.44814814814814813,0.8167299891848117,1.0,19/50,23.48%,LYN;PPP1R16B;CCDC88A;PTK2;GRM5;IGF2;ASPSCR1;NDUFS4;PPIB;SPRED1;FLCN;FNIP2;PLXNB2;HPF1;ATG14;ROPN1L;CCAR2;SOCS1;PIN1
prerank,steroid biosynthetic process (GO:0006694),-0.2814123033102632,-0.9923516910878825,0.4588235294117647,0.8167489625334046,1.0,19/56,26.94%,CYP7B1;PRKAG2;CYP27A1;SC5D;INSIG2;OSBP;HSD17B4;OSBPL1A;SCP2;HSD11B1;CH25H;HSD17B10;SRD5A1;SLC27A2;PRLR;CYP46A1;OSBPL6;FDXR;OSBPL7
prerank,negative regulation of endothelial cell migration (GO:0010596),0.3883175289400335,0.9922481921750891,0.46714285714285714,0.9485039367061656,1.0,6/36,9.66%,SLIT2;THBS1;ATP2B4;FGF2;JUP;AGTR2
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.43177519816277277,-0.9921761131438245,0.48372093023255813,0.816065974648493,1.0,2/10,5.06%,LPGAT1;NR1H3
prerank,protein deacetylation (GO:0006476),0.3774324239169176,0.9912796645219236,0.4658119658119658,0.9502344973800851,1.0,14/41,24.73%,HDAC4;HDAC9;RCOR3;TBL1X;HDAC10;BAZ2A;FLNA;MORF4L2;BRMS1L;MIER2;MTA1;PRDM5;SIRT7;HDAC5
prerank,cellular response to DNA damage stimulus (GO:0006974),0.30473778722546774,0.9910412708746011,0.508298755186722,0.9501015767957611,1.0,104/336,22.40%,FOXP1;TANK;GNL1;ABL1;UBE2B;DDIT3;IGHMBP2;VCP;TRRAP;SUSD6;HERC2;PLK3;TRIP12;ATM;DYRK2;MCM7;BOD1L1;TNFRSF1B;APLF;USP10;CHEK2;MNAT1;MACROD2;RNF168;EID3;BCL6;MOAP1;RAD17;ERCC3;RAD52;ERCC1;RAD51C;CSNK1E;MBD4;NRDE2;TAF1;MRNIP;UBR5;CHEK1;RPA1;ERCC8;CEP63;USP3;RAD51AP1;TAF9;IKBKE;USP47;XPA;RFC5;CHD1L;CUL4A;SFN;ZBTB4;SMC1A;CHRNA4;XRCC5;INTS3;DDX11;UFL1;STK11;RBBP8;MAPK15;AATF;XPC;PML;PRKDC;CBX1;POLB;TAOK3;ALKBH7;WRN;ASH2L;ATF2;MAPKAPK2;ZBTB40;TLK2;YY1;OTUB1;MCM9;POLA1;NBN;CBX5;INO80;SMC5;REXO4;VCPIP1;PWWP3A;MRE11;ZBTB38;RMI2;WDHD1;SUMO1;MASTL;XRCC2;ALKBH8;RECQL5;UNG;ATR;PIDD1;FANCA;CDK1;RAD9B;APEX1;FMR1
prerank,intracellular protein transport (GO:0006886),0.3049846763351267,0.9910239307944473,0.5114107883817427,0.9494157042547222,1.0,74/304,19.24%,PKD1;SGSM2;KIF13A;GRTP1;NUP93;GIPC1;XPO1;EGR2;ARF4;RAB43;STX19;STX5;STX11;LTBP2;RAB3GAP2;RAB6A;ARF3;TLK1;TMED5;TBC1D13;AP3B1;AP4E1;IPO7;HERC2;PRICKLE1;TBC1D25;STX8;RAB18;AP2A1;EIF2D;SNX31;ARFIP1;SGSM3;NSF;SEC13;E2F3;HPS4;NUP188;AP4B1;SAR1B;TBC1D10A;TNPO2;GGA2;EHD1;STAT3;TBC1D2B;CTTN;C2CD5;HEATR3;VIPAS39;STX16;SMURF1;FAM53A;RAN;RAB5A;SNX17;RAB17;ARCN1;VPS26C;RAB22A;TICAM2;DESI1;TBC1D5;TBC1D8B;ARL1;USO1;AP4M1;ACD;RAB7A;NUP107;CHP1;COPA;SNX13;IPO8
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.4584832546572476,0.9907163466484821,0.4810126582278481,0.9494573867492213,1.0,2/13,1.91%,SOAT1;RAMP1
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.42676463516553115,0.9906059916664472,0.4976452119309262,0.9490158408491512,1.0,4/21,12.25%,SMO;ARMC9;TTC23;KIF7
prerank,positive regulation of inflammatory response (GO:0050729),-0.2600250689497082,-0.9904735718618721,0.5,0.8192218488659223,1.0,20/86,13.32%,OSMR;WNT5A;CD47;ETS1;SNCA;IL6ST;CD81;GRN;GPRC5B;RPS19;MDK;PDE2A;IL18;TLR3;TNFRSF1A;NINJ1;APP;NAPEPLD;AGT;TLR7
prerank,cellular response to UV-A (GO:0071492),-0.40865575860185677,-0.9901878399568367,0.47045454545454546,0.8188747467781777,1.0,7/11,46.92%,MMP2;CERS1;MMP3;MME;OPN5;MMP9;OPN1SW
prerank,response to metal ion (GO:0010038),0.34216592097888004,0.9899821668505313,0.47538860103626945,0.9498789020210904,1.0,5/67,3.16%,THBS1;NDRG1;NEDD4;PPP3CA;ADAM9
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.4039097925015985,-0.9898705670196766,0.49539170506912444,0.8185078281766317,1.0,8/13,35.72%,NOS3;ALDH4A1;NOS1;GLUD1;NOS2;GAD1;DAO;ARG1
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.38808490503404147,-0.9893203288296276,0.4950980392156863,0.8187623315531487,1.0,7/16,13.28%,IGF1;TRPC3;IL6ST;PARP1;PDE9A;EDN1;AGT
prerank,protein ubiquitination (GO:0016567),0.3000987834813896,0.9892898563681327,0.5334008097165992,0.9508645613175126,1.0,108/471,19.48%,FBXL7;WWP1;NEDD4;FBXO40;FBXO10;UBE4B;NPEPPS;WWP2;ASB9;BIRC7;RNF138;KLHL13;RNF115;UBE2B;RNF19A;NFE2L2;RNF185;VCP;FBXW8;BIRC6;ASB11;KLHL22;HERC2;MYCBP2;ATG3;FBXW11;ARIH1;TRIM44;TRIP12;TNKS2;TRIM26;RNF141;LRSAM1;RNF135;TRIM7;ANAPC16;USP7;HIF3A;OS9;FBXO32;UBE2D3;BCL10;CDC16;FBXO4;CBFB;CTR9;RNF168;ASB1;MKRN1;CCDC22;FBXL20;UHRF2;COMMD1;UBE2Z;TRIM25;ARIH2;TAF1;FBXO17;RNF10;UBR5;FBXW2;ERCC8;USP22;PEX2;PAF1;RNF111;CUL4A;RTF1;UBE2W;BFAR;RNF31;SMURF1;PSMC6;UBE4A;PPIL2;TRIM41;FBXL14;RNF146;FBXL19;FBXO25;HERC6;UBE3D;PRKDC;FBXL4;UBE2S;FBXW5;PSMD8;SPOP;UBE2N;RNF122;UBE2G1;RNF114;HUWE1;RNF144A;GAN;PCNP;NUB1;DTX3;TRIM47;RC3H2;PEX12;PSMB1;FBXL17;VCPIP1;UNKL;USP9X;CHFR;PSMD13
prerank,protein localization to cell junction (GO:1902414),0.41868425515315394,0.9891634622585805,0.4801223241590214,0.9504550874342798,1.0,3/22,2.68%,BSN;DSP;NPHS1
prerank,mRNA destabilization (GO:0061157),0.3871828429298382,0.9891266034319781,0.4804630969609262,0.9498206869587861,1.0,10/38,18.68%,FTO;MOV10;CELF1;ZC3H12D;DIS3L2;PUM1;YTHDF3;ZFP36L1;YTHDF2;RC3H2
prerank,positive regulation of telomere maintenance (GO:0032206),0.3947645730087763,0.9889725995786235,0.4794520547945205,0.9494783925769603,1.0,10/31,19.95%,NEK7;TNKS2;ATM;ERCC1;MAPK1;MAPK15;PML;ATRX;NBN;MRE11
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.39499184371364204,0.9888181284605498,0.4889867841409692,0.9491374096390803,1.0,11/29,21.60%,TANK;CHUK;TLR6;UBE2D3;TLR4;IKBKE;BIRC3;TICAM2;LY96;FADD;TRAF3
prerank,chromatin organization (GO:0006325),0.32343272082601243,0.9875921957924292,0.47985781990521326,0.9515630458666319,1.0,37/132,19.60%,TCF7L1;HDAC4;BPTF;BAZ2B;HDAC10;KAT2A;TAF6L;SMARCA4;HMG20A;FOXA1;SETD5;HDAC8;RB1;SETD2;BAZ1A;MYSM1;KDM4D;CHD1L;BAZ2A;KAT2B;EHMT1;DDX11;BRWD1;PBRM1;LRWD1;HCFC1;ATRX;TOP1;KDM6B;ZBTB7A;FAM50A;INO80;ARID1A;SMARCD2;RBBP4;HMGN2;PWWP3A
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.3385199662787638,0.9873880594416574,0.484548825710754,0.9513248233232948,1.0,19/84,22.77%,FZR1;ANAPC5;ECRG4;ANAPC16;CDC16;RB1;PSMC6;UBE2S;PSMD8;PSMB1;PSMD13;PSMD1;AURKA;PSMD7;PSMA8;PSMD3;PSMD2;CDK1;PSMC2
prerank,negative regulation of protein kinase B signaling (GO:0051898),-0.30175941012090257,-0.987100839303655,0.4742268041237113,0.8233374393535923,1.0,20/38,33.38%,PHLPP1;PPARA;CIB1;AKT1;FLCN;THEM4;ARRB2;PHLDA3;INPP5K;TRIB3;SH2B3;PIK3CB;GPER1;PLEKHA1;EPHA2;HYAL2;SFRP5;PKHD1;DAG1;RACK1
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.37035281792814523,0.9868165991432795,0.4641350210970464,0.9520231797575673,1.0,9/38,12.28%,PTGIS;KLF4;CLU;P2RX4;TLR6;ATP2B4;AGTR2;TLR4;CD36
prerank,T cell proliferation (GO:0042098),-0.40367540980054273,-0.9866624903927124,0.48426150121065376,0.8233524160384835,1.0,3/13,12.41%,CADM1;CTPS1;PPP3CB
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.3919422258494841,0.9863914271525543,0.4795763993948563,0.9523712098907122,1.0,6/33,9.52%,HOXA5;FOXO3;INHBA;GATA1;BRD1;RAB7B
prerank,regulation of focal adhesion assembly (GO:0051893),0.3561532659515261,0.9863777407413401,0.4795244385733157,0.9516686468093865,1.0,13/54,13.09%,THBS1;EFNA5;PHLDB2;FAM107A;ABL1;VCL;NRP1;PTPRA;DMTN;BCAS3;RHOA;SLC9A1;S100A10
prerank,negative regulation of interleukin-1 production (GO:0032692),-0.3462591601283703,-0.9862718319305155,0.45054945054945056,0.823164648790874,1.0,5/23,19.13%,IGF1;GAS6;CX3CR1;TNFAIP3;GIT1
prerank,regulation of insulin secretion (GO:0050796),0.3317632842164273,0.9862612166418692,0.4963855421686747,0.9512450450632082,1.0,13/101,8.37%,CCN3;TCF7L2;EFNA5;ISL1;KCNS3;CACNA1C;RAP1A;KCNB1;ITPR2;HNF4A;IRS1;CAPN10;AACS
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.3571003588506491,-0.9861823262477617,0.52,0.8222035472087632,1.0,4/18,6.42%,APOE;CTSC;CD81;VGLL4
prerank,receptor internalization (GO:0031623),-0.29796032869454625,-0.9860712928463417,0.4664310954063604,0.8213180264899393,1.0,12/44,11.12%,DNM3;PICALM;GRK3;TFRC;CALCRL;SNCA;RAMP2;CD81;ARRB1;GTF2H2;GRB2;ADM
prerank,regulation of JUN kinase activity (GO:0043506),0.3894785119858867,0.9858970525437478,0.5,0.9514264266402224,1.0,6/33,7.68%,MAP3K5;PDCD4;ARHGEF5;PPEF2;TLR6;DUSP10
prerank,establishment of mitotic spindle localization (GO:0040001),0.40094685331934893,0.9856504949939998,0.4585152838427948,0.9512935495704372,1.0,5/28,10.26%,ITGB1;NDEL1;PAFAH1B1;FBXW11;MISP
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.34045830387180276,-0.9856458338842997,0.49411764705882355,0.8212876963365975,1.0,5/24,5.83%,VTN;EPN2;HIF1A;TMEM204;DAB2IP
prerank,positive regulation of interleukin-17 production (GO:0032740),-0.3518867431383283,-0.9854383094330573,0.505524861878453,0.820682923851392,1.0,6/22,14.43%,RFTN1;SLC7A5;PRKCQ;IL18;SPHK1;NR1H4
prerank,Golgi inheritance (GO:0048313),0.46827446179033616,0.9849795717122621,0.4965277777777778,0.9522162499792212,1.0,5/11,22.13%,STX5;PLK3;GBF1;VCPIP1;CDK1
prerank,alpha-linolenic acid metabolic process (GO:0036109),-0.4140918327318558,-0.9849378416466911,0.4821002386634845,0.8208425269611811,1.0,5/12,20.47%,ACSL1;FADS2;HSD17B4;SCP2;ACOX1
prerank,regulation of immune effector process (GO:0002697),0.38318306634761234,0.9847041552243848,0.5043478260869565,0.9522048003287341,1.0,6/41,11.05%,CFH;CD55;CLU;CR1L;CD46;SERPING1
prerank,retinal metabolic process (GO:0042574),0.4676433805698194,0.9845780934335131,0.4769503546099291,0.9517847378310116,1.0,1/12,1.67%,CYP1B1
prerank,histone H4 acetylation (GO:0043967),0.3663188336506186,0.9840102413583554,0.49145299145299143,0.9524841239539049,1.0,16/47,17.41%,NAA40;TRRAP;EP300;MSL1;TADA3;KANSL2;BRCA2;ZZZ3;KANSL1;BRD8;TRIM16;HCFC1;DMAP1;EPC1;MORF4L2;ATF2
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.31573338466234196,0.9833103407180912,0.5119182746878547,0.9535114750366058,1.0,38/149,18.85%,SLCO3A1;CARD14;EDA;RIPK3;DDRGK1;NFKB1;TNFSF11;TAB3;CLU;EP300;ERC1;IL18RAP;CHUK;RIPK2;TLR6;BCL10;RAB7B;NFKB2;TRIM25;TLR4;MTDH;CD36;ADAM8;STAT3;TRADD;TRAF5;RNF31;PRDX3;DHX9;MYD88;UBE2N;ROR1;CARD16;ZBTB7A;EDA2R;AR;IRAK1;PRKD2
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.4247928148556142,-0.9832568770031639,0.4874141876430206,0.8239989184371663,1.0,5/10,27.29%,CALM1;CALM3;CBARP;GPR35;CRHR1
prerank,bone development (GO:0060348),-0.30624594910095626,-0.9831075598030007,0.5121107266435986,0.8231757880238285,1.0,10/39,11.07%,RANBP3L;TGM2;CYP26B1;GNAS;RPL13;NOTUM;GJA1;DYM;PPIB;MYOC
prerank,fatty acid transmembrane transport (GO:1902001),-0.35104762230137176,-0.9829890739674491,0.48787061994609165,0.8223249558244821,1.0,6/19,11.01%,SLC2A1;PRKAG2;CPT1A;ACACA;ACACB;PRKAA2
prerank,lymphocyte chemotaxis (GO:0048247),0.3948645532066944,0.9829362530385581,0.46915351506456243,0.9536909247140376,1.0,1/34,0.48%,SLC12A2
prerank,receptor catabolic process (GO:0032801),0.4033684430048402,0.9829068923278934,0.4762684124386252,0.9530437431778451,1.0,4/24,7.36%,NEDD4;AP2A2;BECN1;AP2A1
prerank,cellular response to oxygen-containing compound (GO:1901701),0.30278213116276065,0.982767251845548,0.5296566077003122,0.9526725348295884,1.0,37/291,10.44%,SLIT2;EGFR;WNT9A;PTK2B;EZR;LBP;WNT11;PRKCD;PID1;ADAM9;RAP1A;MYOG;IL10;CAPN2;IP6K2;FZD7;PDCD4;IGFBP5;VCP;NR4A3;NFKB1;CD80;SHPK;IRS1;CHUK;JUN;P2RX4;ATM;ATP2B4;TNFRSF1B;BCL10;KAT5;CTR9;DMTN;SLC26A6;ACOD1;MTOR
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.45353060413264346,0.9827306843959055,0.5025380710659898,0.9520271187536682,1.0,5/15,15.28%,EDA;LRP6;FOXC1;AMELX;ANKRD11
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.4080962046590293,0.982555125326652,0.4792626728110599,0.9517405471201418,1.0,2/24,1.56%,PKD1;PTK2B
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.4638974437922998,0.9825261850402295,0.4748700173310225,0.9510860360017261,1.0,8/13,27.20%,UPP2;SMUG1;MBD4;TDG;UNG;NT5M;NT5C;NTHL1
prerank,RNA export from nucleus (GO:0006405),0.3318069596284385,0.9820981796905481,0.5030599755201959,0.9514598016835677,1.0,36/100,26.23%,NUP93;SMG6;DDX19B;U2AF1L4;SMG1;CASC3;SEC13;SRSF5;NUP188;SRSF6;NXF1;SRRM1;RANBP2;THOC2;RBM8A;SRSF11;RAN;THOC5;ZC3H11A;NUP107;AAAS;CHTOP;ALKBH5;RAE1;NUP54;NUP98;CPSF4;FYTTD1;ALYREF;NCBP2;GLE1;UPF3B;SRSF7;FIP1L1;NUP37;XPO5
prerank,brain development (GO:0007420),0.31874194000052936,0.9818291987074128,0.5120274914089347,0.9514120881046598,1.0,14/136,7.20%,SLC23A1;PBX3;ZFHX3;NFIB;PBX1;ADGRL2;ZIC1;EGR2;BPTF;GRIN2C;PAFAH1B1;TGFBR2;FBXW11;RAB18
prerank,negative regulation of MAP kinase activity (GO:0043407),0.369790731156998,0.9815879810530288,0.4780821917808219,0.9512860189248522,1.0,3/44,4.05%,BMP4;PRKCD;PDCD4
prerank,positive regulation of cell-matrix adhesion (GO:0001954),-0.29026072045125,-0.9815440599848283,0.5017421602787456,0.8250290084197323,1.0,13/42,16.86%,TEK;KDR;CSF1;PLEKHA2;CDK6;MAP4K4;RAC1;EFEMP2;CDH13;MYOC;CIB1;PPM1F;RIN2
prerank,regulation of axonogenesis (GO:0050770),0.36211476050859104,0.9813662899417831,0.5033647375504711,0.951077162850264,1.0,7/51,7.57%,SLIT2;NGF;SIPA1L1;GSK3B;TIAM2;PLXNA2;MARK2
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),-0.3181748494082283,-0.9812649080769409,0.48632218844984804,0.8246090044976757,1.0,15/31,27.33%,SYT7;ADRA2A;SYT11;SYT12;SYT9;CACNA1I;SYT13;CBARP;SYT15;SYT1;SYT5;DOC2B;STXBP3;SYT17;SYT2
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.4736451557237741,0.9805100813307019,0.5034965034965035,0.9524609083244633,1.0,1/11,1.25%,SCARA3
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.4003326194579328,-0.9803715331213946,0.46153846153846156,0.8257340496941988,1.0,3/12,4.91%,IGF1R;SETX;INSR
prerank,regulation of RNA export from nucleus (GO:0046831),0.4664477259137165,0.9799012103867869,0.4753521126760563,0.95325951740472,1.0,7/11,28.54%,NRDE2;SETD2;DHX9;NCBP2;AKAP8L;NUP153;KHDRBS1
prerank,DNA metabolic process (GO:0006259),0.3028779502143774,0.9797332284020941,0.5383001049317944,0.9529461529562735,1.0,75/270,22.38%,NT5E;TCF7L2;MPG;UBE2B;IGHMBP2;VCP;TRRAP;ATM;MCM7;USP7;MNAT1;KAT5;EID3;NOC3L;TOP3A;RAD17;SMUG1;ERCC3;RAD52;DFFB;ERCC1;UHRF2;RAD51C;CSNK1E;STN1;MBD4;CHEK1;RPA1;USP3;RAD51AP1;XPA;RFC5;CHD1L;SMC1A;CHRNA4;XRCC5;EXD2;INTS3;POLD3;RAN;RBBP8;LRWD1;ORC5;XPC;PRKDC;TOP1;POLB;UBE2N;WRN;POLA1;NBN;INO80;REXO4;ACD;TOP1MT;LONP1;PRIM2;PWWP3A;MRE11;RMI2;WDHD1;TDG;SUMO1;XRCC2;ZNF445;RECQL5;UNG;ATR;RNASEH1;MCM6;FANCA;CDK1;RNASEH2A;RAD9B;APEX1
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.3188020091673127,0.9795267854758954,0.4845605700712589,0.952724416243909,1.0,39/129,21.59%,EGFR;WNK1;GPC3;TMEM198;BAMBI;UBE2B;PLEKHA4;VCP;TRPM4;NFKB1;TNKS2;TBL1X;JUP;CSNK1G3;PPM1A;PRDM15;CSNK1E;UBR5;USP34;USP47;AMER1;PSMC6;ILK;RNF146;CSNK1D;JRK;PSMD8;FZD9;CSNK1G1;PSMB1;PSMD13;PSMD1;PSMD7;PSMA8;SFRP4;TGFB1;EGF;CAPRIN2;PSMD3
prerank,anterior/posterior axis specification (GO:0009948),-0.3697901523200776,-0.9794305452793719,0.46782178217821785,0.8269454683079076,1.0,2/15,2.38%,WLS;TBX3
prerank,positive regulation of myelination (GO:0031643),0.4696105897760692,0.9794015009475666,0.5009208103130756,0.9523131932524977,1.0,4/11,11.22%,EGR2;TNFRSF1B;PARD3;RNF10
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.3727021503903487,0.9793530632355518,0.49791376912378305,0.9517144436456966,1.0,11/39,20.05%,TCF7L2;ISL1;TNFSF11;CAPN10;AACS;SELENOT;MCU;IRS2;TM7SF3;ADCYAP1;HFE
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.4126497669130966,0.9792640988383524,0.48330683624801274,0.9512251232693446,1.0,3/20,5.26%,BMP4;PDCD4;TGFBR1
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.31653239000392297,-0.9791632715568821,0.4732142857142857,0.8265069519458602,1.0,5/29,7.50%,RPS14;RPS21;RPS16;RPS19;RPS8
prerank,regulation of actin polymerization or depolymerization (GO:0008064),-0.3274057926984705,-0.9791229159893847,0.48427672955974843,0.8254692621109536,1.0,3/28,3.83%,ARHGAP28;ESAM;CXCL12
prerank,nucleic acid metabolic process (GO:0090304),0.34642947195657925,0.9791004999932406,0.5070603337612324,0.9509167698036417,1.0,17/69,21.64%,NT5E;RBFOX2;DXO;HNRNPH1;RBMX;EXD2;DUSP11;GTF2F2;HNRNPL;DDX1;RAN;WRN;ATXN2;POLR2H;HNRNPM;HNRNPA3;RECQL5
prerank,positive regulation of autophagy (GO:0010508),-0.2653242597283681,-0.9786798418644879,0.5477386934673367,0.8255565831469472,1.0,16/81,12.87%,RNF152;PRKD1;FOXO1;DCN;KDR;GPSM1;TRIM14;DAPK1;LRRK2;PRKAA2;OPTN;PIK3C2A;TRIM21;ORMDL3;TRIM27;SH3BP4
prerank,organophosphate ester transport (GO:0015748),0.4005926008342505,0.9784773403692983,0.46771653543307085,0.9516963000926049,1.0,5/24,8.53%,TNFAIP8L3;PITPNA;PITPNC1;PITPNB;OSBPL5
prerank,regulation of T cell proliferation (GO:0042129),0.3451418569482651,0.9780044930211883,0.4852150537634409,0.952120080456483,1.0,10/61,15.37%,ANXA1;IL10;RIPK3;CD80;NCK2;TNFRSF1B;CD46;SDC4;CEBPB;TNFRSF13C
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.3363249753428675,-0.9778628376700297,0.48404255319148937,0.826490516036876,1.0,8/23,16.30%,PARP1;RPS27A;UBC;DDB1;UBB;COPS8;DDB2;CETN2
prerank,replicative senescence (GO:0090399),0.4675317862703853,0.9778267788018589,0.5085910652920962,0.9518521330502352,1.0,4/12,11.29%,WNT16;ATM;CHEK2;CHEK1
prerank,protein processing (GO:0016485),0.3283288806970718,0.9776324278499703,0.5054545454545455,0.9515845891792376,1.0,18/102,16.09%,F3;PCSK5;DDI2;PHEX;TMPRSS2;MMP16;MMP14;ADAM10;MYRFL;PRSS12;PARL;OMA1;SPG7;PITRM1;CPE;STOML2;XPNPEP3;YME1L1
prerank,negative regulation of DNA replication (GO:0008156),0.4654742689389756,0.9773807060359249,0.5043478260869565,0.9514521102062473,1.0,3/13,11.61%,RAD17;WAPL;GTPBP4
prerank,positive regulation of TORC1 signaling (GO:1904263),0.4440501897865803,0.9772993654631349,0.5111821086261981,0.9509442759538377,1.0,5/16,16.13%,SIK3;KLHL22;TELO2;CLEC16A;RRAGB
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.32321452996772776,0.9771372596836232,0.5046948356807511,0.950609647744348,1.0,18/118,11.46%,BMPER;FMNL2;EFNA5;PHLDB2;NEDD4;SIPA1L1;ARHGAP44;PID1;GSK3B;PDLIM5;GDNF;FGF2;MARK2;TANC2;BCL6;PAK2;BCL9L;SH3D19
prerank,regulation of synapse organization (GO:0050807),-0.324406857350471,-0.9770289854271239,0.5069637883008357,0.8275659659680061,1.0,10/26,15.39%,IL1RAPL1;CTNNA2;WNT5A;EPHA4;MEF2C;ABHD17C;CDKL5;MDGA1;CAMK2B;SLITRK4
prerank,regulation of brown fat cell differentiation (GO:0090335),0.4404638612007084,0.9764106450164732,0.4873524451939292,0.9516547890255891,1.0,3/16,3.83%,SIX1;FTO;ZBTB7B
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.44317257426192863,0.9761990827693793,0.4787234042553192,0.9514650073432356,1.0,3/13,7.51%,ZFPM2;BMPR1A;FGF2
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.3663396489281949,0.9761907723505555,0.5041322314049587,0.9507782935364106,1.0,13/44,19.11%,FTO;TNRC6C;MOV10;CNOT7;CELF1;TOB1;NANOS2;PUM1;YTHDF3;TNRC6A;ZFP36L1;YTHDF2;PABPC1
prerank,regulation of cell motility (GO:2000145),0.3179969132635237,0.9761404521584522,0.5160523186682521,0.9502100031060964,1.0,19/121,11.89%,EGFR;NTN1;LMO4;CCDC125;MGAT3;LMNA;DIAPH1;ABL1;SGK3;MEMO1;SERPINE2;PLXNA2;FGF22;FGF2;GATA3;PKN2;BEX4;PHPT1;RHOA
prerank,regulation of acute inflammatory response (GO:0002673),-0.3592826434834825,-0.9758926622034372,0.5025773195876289,0.8292839526049303,1.0,2/18,5.30%,OSMR;IL6ST
prerank,pyruvate metabolic process (GO:0006090),0.35504755519924114,0.9758784392296411,0.4951590594744122,0.9501140607489469,1.0,5/52,7.08%,ME1;SLC16A1;PFKFB2;NR4A3;GAPDHS
prerank,dendritic spine morphogenesis (GO:0060997),-0.38127814744410127,-0.9757943333447132,0.47743467933491684,0.8283798398605969,1.0,3/15,5.10%,DOCK10;SHANK3;EPHB1
prerank,smooth muscle cell differentiation (GO:0051145),0.4627311963884678,0.9756377000775031,0.49155405405405406,0.9499895243535783,1.0,1/12,0.27%,BMP4
prerank,positive regulation of neuroinflammatory response (GO:0150078),-0.4110566992095834,-0.975076336896237,0.47549019607843135,0.8292189455905761,1.0,8/12,44.82%,IL18;TTBK1;NUPR1;TREM2;STAP1;TNF;TAFA3;CCL3
prerank,T cell homeostasis (GO:0043029),0.48581806588162424,0.9744420459854454,0.5018115942028986,0.9522183812235091,1.0,2/10,4.21%,PPP2R3C;RIPK3
prerank,synaptic vesicle exocytosis (GO:0016079),-0.3008833007000386,-0.9742607996352723,0.49645390070921985,0.8301950349602143,1.0,20/40,27.33%,UNC13C;RIMS1;RIMS2;SNCA;PIP5K1C;SYT7;CPLX1;BLOC1S6;SNAP25;UNC13A;STX3;SYT1;STX1B;SNAPIN;SYT5;DOC2B;CDK5;SNAP29;RAB3A;SYT2
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.3308386549906382,0.9742582173481485,0.528395061728395,0.9519338836765978,1.0,34/96,26.14%,NUP93;SMG6;DDX19B;U2AF1L4;SMG1;CASC3;SEC13;SRSF5;NUP188;SRSF6;NXF1;SRRM1;RANBP2;THOC2;RBM8A;SRSF11;THOC5;ZC3H11A;NUP107;AAAS;CHTOP;ALKBH5;RAE1;NUP54;NUP98;CPSF4;FYTTD1;ALYREF;NCBP2;GLE1;UPF3B;SRSF7;FIP1L1;NUP37
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.41417995777526107,0.9739835622277996,0.49760765550239233,0.9518588234301554,1.0,5/20,11.79%,MRAP;PID1;PPFIA1;RHOQ;CSK
prerank,regulation of vasculature development (GO:1901342),0.410955309988058,0.9732894095676043,0.5,0.9528130792858751,1.0,1/26,0.36%,BMPER
prerank,response to insulin (GO:0032868),-0.25391176963089496,-0.9730809591884767,0.4915254237288136,0.8320377789110155,1.0,21/80,19.52%,TBC1D4;PIK3R1;SORT1;FOXO1;ENPP1;CPEB2;INSR;LPIN3;PARP1;MYO5A;INSIG2;LPIN1;RPS6KB1;PDE3B;AKT1;GSK3A;SLC27A1;PKM;PRKCI;SLC25A33;RAB15
prerank,UV protection (GO:0009650),0.480643084026756,0.9726383133559809,0.4908759124087591,0.9536611856933029,1.0,1/10,1.25%,SCARA3
prerank,axon development (GO:0061564),-0.2611194705633463,-0.9725948832636904,0.48945147679324896,0.8321685960836119,1.0,23/78,20.66%,NREP;CTNNA2;DCC;PLP1;GRM7;ACTB;BAIAP2;CNTN4;ANK3;MAPT;PLPPR4;APP;ZDHHC17;BRSK2;APBB1;ADGRB1;S100A6;SLITRK4;NRCAM;NEFH;RTN4;CDK5R1;AMIGO1
prerank,positive regulation of neuron death (GO:1901216),0.3679159494437023,0.9721650617383187,0.5146443514644351,0.9540856674203947,1.0,10/46,12.11%,MAP3K5;FOXO3;GSK3B;DDIT3;CLU;TFAP2A;TLR6;TLR4;TGFB2;REST
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.342983190507327,0.9717353917806953,0.4993678887484197,0.9543733488809711,1.0,9/73,12.38%,THBS1;LBP;ISL1;CLU;MAVS;BCL10;TLR4;ADAM8;STAT3
prerank,regulation of secretion (GO:0051046),-0.3926784934074714,-0.9713391527911329,0.47804878048780486,0.8343037188162096,1.0,4/13,11.09%,MYO6;SGK1;KCNQ1;OAS2
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.46534938444539287,0.9712803653014938,0.48186528497409326,0.9540700338419487,1.0,7/12,21.35%,GSK3B;ATP2B4;DYRK2;RCAN1;HOMER2;CHP1;PRNP
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.46534938444539287,0.9712803653014938,0.48186528497409326,0.9540700338419487,1.0,7/12,21.35%,GSK3B;ATP2B4;DYRK2;RCAN1;HOMER2;CHP1;PRNP
prerank,negative regulation of histone methylation (GO:0031061),-0.42001520775954965,-0.9710393972418344,0.49148936170212765,0.833943596170627,1.0,4/10,18.30%,JARID2;BCOR;MTF2;BRCA1
prerank,protein heterooligomerization (GO:0051291),0.43532899973945166,0.970995643003006,0.4834983498349835,0.9540395666729471,1.0,2/17,2.08%,PKD1;TMEM120A
prerank,negative regulation of dephosphorylation (GO:0035305),-0.36009058260256355,-0.970773700788192,0.4921052631578947,0.8335498696858448,1.0,7/18,28.00%,MFHAS1;PPP1R16B;ENSA;SH2D4A;INPP5K;PPP1R35;YWHAB
prerank,transcription by RNA polymerase II (GO:0006366),0.3008184711089928,0.9707080900612575,0.5437100213219617,0.9540458986426634,1.0,63/305,17.12%,NR3C2;RNMT;RARB;MLLT3;DDX5;ESR2;NR2F1;HDAC9;ELOF1;ZBTB7B;NOTCH2;NR4A2;NR4A3;NFKB1;RPAP1;HNF4A;RARG;PRRX1;TBL1X;TAF1C;TTF2;NR6A1;HDAC10;CREBBP;WWTR1;TEAD1;CBFB;MNAT1;SCAF8;NFYA;CTR9;E2F3;ERCC3;MBD1;TAF1;RBMX;TRIP11;SETD2;TAF9;PAF1;RXRA;RTF1;KAT2B;SNAPC5;INTS3;INTS8;GTF2F2;SNRPD3;CDK12;TAF15;TAF12;ELP4;SNW1;SNAPC4;MED27;NFIX;ELOA;MED17;EAF2;RORA;NR4A1;GTF2E1;AFF4
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.38699999861481915,0.9707062962685455,0.5213549337260678,0.953345419825526,1.0,11/30,21.60%,TANK;CHUK;TLR6;UBE2D3;TLR4;IKBKE;BIRC3;TICAM2;LY96;FADD;TRAF3
prerank,regulation of double-strand break repair (GO:2000779),0.37127378072076644,0.9706169804602773,0.5078236130867709,0.9528571880353958,1.0,12/39,17.74%,TRIP12;KDM1A;MRNIP;UBR5;CHEK1;SETD2;RAD51AP1;DDX11;FOXM1;PML;PPP4R2;OTUB1
prerank,regulation of hydrolase activity (GO:0051336),0.3388934373406761,0.9705997057528801,0.5109677419354839,0.9521938015619884,1.0,13/71,7.45%,EFNA5;SIPA1L1;ARHGAP44;RAPGEF6;ADAP1;RAB3GAP2;ARHGEF5;PAFAH1B1;FBXW11;PLXNA2;VAV2;OCRL;FGD6
prerank,muscle tissue morphogenesis (GO:0060415),0.4329682281489273,0.9703722640850848,0.4974271012006861,0.9520444291700187,1.0,1/16,0.27%,BMP4
prerank,response to molecule of bacterial origin (GO:0002237),0.3449262700604079,0.97022808450889,0.4922879177377892,0.951695746238383,1.0,11/69,15.51%,FOXP1;LBP;SMAD6;IL10;SLPI;CYP27B1;ACOD1;TLR4;CYRIB;ERBIN;PRDX3
prerank,alanine transport (GO:0032328),-0.4312977216000012,-0.9700800872379972,0.5102040816326531,0.8340764226854028,1.0,3/10,23.33%,SLC6A6;SLC6A17;SLC36A2
prerank,histone H2B ubiquitination (GO:0033523),0.4714696938440127,0.9697267612175982,0.5026362038664324,0.9522384588148358,1.0,4/10,24.06%,CTR9;PAF1;LEO1;WAC
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),-0.30998710245353595,-0.9695724150661851,0.49852507374631266,0.8342526680237559,1.0,12/33,16.35%,LYN;ACER2;NEXMIF;PTK2;JAM3;EPHA8;DPP4;CIB1;P2RY12;PDE3B;NCKAP1L;SYK
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.4260623792140227,0.9695551549270164,0.5016447368421053,0.9519535748043584,1.0,5/18,15.70%,EZR;RDX;SNX12;MAPK1;MAP2K2
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.3353696905861267,0.9694789669069214,0.5175,0.9514416861841878,1.0,3/78,1.93%,EGFR;PKD1;CCNA2
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.41330045463627957,0.969319713108828,0.4832,0.9511399266707288,1.0,4/20,8.54%,MRAP;PID1;PPFIA1;RHOQ
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.33842910720445146,0.9690428887935845,0.5218446601941747,0.9511848305292221,1.0,16/86,13.61%,MET;BAIAP2L1;PTK2B;CDC42EP5;NCK2;FCHSD1;CLU;CLIP1;SLAIN2;NCKAP1;WDR1;RB1;TOGARAM1;PRKCE;CTTN;FCHSD2
prerank,regulation of cellular ketone metabolic process (GO:0010565),-0.27184871475360656,-0.9688875565544245,0.5407725321888412,0.8349159392082749,1.0,16/61,24.08%,PPARA;PRKAG2;PSMB10;NR1H4;PSME2;PDK2;OAZ1;SIRT5;FGFR4;PSMB3;PSMB4;PSMB8;PSMC5;PSME1;PSMA7;PSMD5
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.31906894296205207,0.9686677512137927,0.5112426035502958,0.9513814461441287,1.0,27/112,14.79%,SMAD9;TGFB3;ITGB1;SMAD6;COL3A1;ADAM9;GDF5;GCNT2;BAMBI;BMPR1A;LTBP2;TGFBR1;TGFBR2;ID1;JUN;ITGB5;SKI;PARD3;ACVR1;TGFB2;RHOA;ZMIZ1;NLK;TGFBRAP1;SMURF1;ARHGEF18;AMHR2
prerank,regulation of ion transport (GO:0043269),0.33752839064771883,0.9685972996242286,0.5156838143036386,0.9508699968376524,1.0,13/76,13.19%,KCNJ2;NEDD4;WNK1;WWP2;SYT8;GDNF;P2RX4;KCNJ15;DRD3;ATP1A1;ITGB3;KCNJ9;CHRNA4
prerank,error-free translesion synthesis (GO:0070987),0.40455350483081826,0.9685727342996191,0.49417637271214643,0.9502211167909697,1.0,6/22,13.24%,VCP;NPLOC4;UFD1;RPA1;RFC5;REV1
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.34052651895824815,0.9684061933803325,0.5147625160462131,0.9499414052143191,1.0,7/67,4.13%,EGFR;PTK2B;ABI1;FGFR1;DDR2;EFEMP1;ABL1
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.44989684532114965,0.9682425434398291,0.5090252707581228,0.949619078189521,1.0,2/14,5.51%,ISL1;CD80
prerank,positive regulation of neuron differentiation (GO:0045666),-0.30303031751515935,-0.968110252032219,0.4983388704318937,0.8357361687539233,1.0,7/40,8.53%,TCF4;ZEB1;BRINP3;MEF2C;GPRC5B;BMP2;ZC4H2
prerank,negative regulation of TOR signaling (GO:0032007),-0.3011262467423724,-0.9679862133611009,0.49,0.8349119828970177,1.0,9/36,16.65%,RNF152;SPAAR;TMEM127;PRKAA2;TNFAIP8L1;SH3BP4;MINAR1;GSK3A;FLCN
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.4651301716424545,0.9679132051887177,0.5079365079365079,0.9496663820786939,1.0,2/11,7.14%,P2RX2;P2RX4
prerank,positive regulation of receptor internalization (GO:0002092),-0.34203687373430736,-0.9678175943757746,0.505464480874317,0.8342140427565155,1.0,7/22,20.96%,INSR;ARRB1;CD63;NTF3;ARRB2;GREM1;VEGFA
prerank,regulation of keratinocyte differentiation (GO:0045616),-0.3364524771376744,-0.9677816403127935,0.5309973045822103,0.8331793616167331,1.0,2/24,0.90%,ERRFI1;PRKCH
prerank,negative regulation of gene expression (GO:0010629),0.29698532953407275,0.9676973336601178,0.5841269841269842,0.949469172903398,1.0,44/302,13.13%,BMP4;FOXP1;SLC24A3;SAMD4A;ITGB8;SMO;WWP2;HDAC9;KLF4;IL10;DXO;NOTCH2;ZNF148;BMPR1A;TNRC6C;IGFBP5;DDRGK1;SYNCRIP;NFKB1;MOV10;CNOT7;PAIP2;CELF1;ATP2B4;FGF2;ZC3H12D;SMCR8;ADAM10;TOB1;ASB1;ATOH8;DIS3L2;CD46;TAF1;EIF2AK3;RB1;RBL2;NANOS2;TGFB2;REST;SNX12;RBMS3;KAT2B;LSM2
prerank,response to organic cyclic compound (GO:0014070),0.35241457342958254,0.9673535577054251,0.5102880658436214,0.9496075614289343,1.0,13/52,15.73%,ANXA1;CYP1B1;IGFBP5;SOCS2;CYP27B1;STRN3;FOXA1;CYP19A1;DRD3;STAT3;CDKN2D;ARL6IP5;TRPM2
prerank,negative regulation of JNK cascade (GO:0046329),-0.32058416357712394,-0.9672972280168678,0.5016393442622951,0.8332606518087772,1.0,4/31,8.90%,MECOM;GPS2;SIRPA;DUSP3
prerank,regulation of chemokine production (GO:0032642),0.3754342827990248,0.967289195402197,0.48755490483162517,0.9490674839340877,1.0,1/36,0.32%,FOXP1
prerank,membrane depolarization (GO:0051899),-0.31414090747394274,-0.9672608691921808,0.5064935064935064,0.8322352897267038,1.0,10/32,18.09%,SCN7A;CACNA1E;SCN1A;CACNG4;CACNA1B;SCN3A;CACNB4;CACNA1I;P2RX7;SCN2A
prerank,manganese ion transport (GO:0006828),-0.388687485312311,-0.9672414030604222,0.4975728155339806,0.8311719992888267,1.0,7/14,14.74%,SLC30A10;TRPC3;SLC39A8;ATP2C1;TRPC4;TRPC6;SLC11A2
prerank,regulation of DNA recombination (GO:0000018),0.38403638712845073,0.9668487150827748,0.5075757575757576,0.9494336109504555,1.0,9/32,20.85%,IL10;KDM1A;KPNA1;CHEK1;SETD2;RAD51AP1;PPP4R2;MRE11;SHLD2
prerank,positive regulation of interferon-gamma production (GO:0032729),-0.29606880779834666,-0.9668308838404345,0.5155709342560554,0.831125910801884,1.0,12/48,21.87%,IL1R1;PDE4B;SLC7A5;PDE4D;IL18;TLR3;TRIM27;TLR7;TXK;IL27;CD276;FZD5
prerank,ribonucleoprotein complex assembly (GO:0022618),-0.23375029050918195,-0.9667384279671289,0.56,0.8302253143231382,1.0,34/132,18.89%,RPS14;RPL38;SETX;RPS27;RPS15;RPS5;CPSF6;RPL5;CELF2;RPS19;SF1;PTGES3;RPL3;RPL24;HSP90AB1;WDR77;EIF4H;SRSF9;RPL23A;SNRPB;TRAF7;YTHDC1;SNRPF;XAB2;RPL11;MRPS11;GEMIN7;TARBP2;RPLP0;CDC73;GEMIN5;RPS28;CELF6;SNRPG
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.45972805822880847,0.9663430153123223,0.511504424778761,0.9499424865044915,1.0,3/10,3.54%,ZBTB16;GDF6;GDF5
prerank,iron-sulfur cluster assembly (GO:0016226),-0.33504417188763297,-0.9662715130313412,0.5223880597014925,0.8303662125669145,1.0,18/24,39.54%,HSCB;HSPA9;CIAO3;ISCA1;BOLA2;NUBP1;GLRX3;LYRM4;ABCB7;ISCA2;IBA57;MMS19;GLRX5;FXN;NUBPL;CIAO1;CIAPIN1;NDOR1
prerank,negative regulation of locomotion (GO:0040013),-0.40057997514964727,-0.9662029908857777,0.4951923076923077,0.8294337925469975,1.0,4/12,8.90%,FRMD5;FBLN1;SPOCK3;DUSP3
prerank,regulation of humoral immune response (GO:0002920),0.3678849048736804,0.9661661863481713,0.5185185185185185,0.9496557552371844,1.0,6/44,11.05%,CFH;CD55;CLU;CR1L;CD46;SERPING1
prerank,phosphatidylcholine metabolic process (GO:0046470),-0.2652709926023191,-0.965949660358313,0.48292682926829267,0.8289535809369009,1.0,15/70,18.40%,ENPP2;ABHD3;NR1H3;LPIN3;SLC44A1;PNPLA8;MFSD2A;DBI;LPIN1;SLC44A2;STARD7;SLC27A1;TMEM86B;PLA2G4E;MBOAT7
prerank,regulation of histone H3-K9 acetylation (GO:2000615),-0.41293147323227153,-0.9654674925147478,0.5044444444444445,0.8291021187556304,1.0,5/10,25.64%,RAPGEF3;PIH1D1;BRCA1;SPHK2;SMARCB1
prerank,negative regulation of cell adhesion (GO:0007162),0.3349636466233892,0.9654436646902365,0.5114213197969543,0.9507566739307063,1.0,11/72,11.89%,CDH1;CYP1B1;ARHGDIB;GCNT2;FZD7;PLXNA2;JAG1;ADAM10;DMTN;GTPBP4;RHOA
prerank,arachidonate transport (GO:1903963),0.47615602779999755,0.965373087750689,0.5088967971530249,0.9495271258568743,1.0,1/10,1.32%,ANXA1
prerank,arachidonic acid secretion (GO:0050482),0.47615602779999755,0.965373087750689,0.5088967971530249,0.9495271258568743,1.0,1/10,1.32%,ANXA1
prerank,positive regulation of DNA binding (GO:0043388),0.38315995597050834,0.9653400433319423,0.50231124807396,0.948903023764912,1.0,7/31,12.50%,NGF;HES1;SKI;GATA3;NIBAN2;RB1;FOXC1
prerank,negative regulation of protein kinase activity (GO:0006469),-0.25863529825583115,-0.9651252143692093,0.5401069518716578,0.8288238369151804,1.0,24/88,21.99%,PTPRB;PPM1E;PRKAG2;PPIA;PTPRT;SNCA;DAB2IP;GSKIP;ADARB1;DUSP3;SLC8A1;SPRED1;TRIM27;AKT1;CDKN1C;PPM1F;TARBP2;DUSP26;PARK7;RTRAF;PTPRO;INPP5K;TRIB3;TAB1
prerank,regulation of cellular response to heat (GO:1900034),0.3336367449805876,0.9649223357109815,0.5299363057324841,0.9492026955407918,1.0,24/77,21.73%,CAMK2D;NUP93;GSK3B;EP300;ATM;CREBBP;SEC13;MLST8;NUP188;MTOR;RPA1;RANBP2;DNAJB6;MAPK1;HSPA1L;MAPKAPK2;NUP107;AAAS;CHORDC1;RAE1;NUP54;NUP98;AKT1S1;ATR
prerank,tRNA modification (GO:0006400),0.3475209241702281,0.9647813598606347,0.5046357615894039,0.9488428008550446,1.0,21/62,23.15%,TRMT13;METTL6;CTU2;TYW1;MOCS3;PUS10;METTL1;ELP5;TYW5;MTO1;GTPBP3;QTRT2;QTRT1;TRDMT1;ALKBH8;TRMT61A;PUS7;TRMT12;AARS1;DUS2;URM1
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.27344081687923455,-0.9647607924279132,0.5296610169491526,0.828661847220396,1.0,15/54,17.45%,NSA2;RPL14;RPL5;RPL3;RPL24;NOC2L;RPL23A;TRAF7;SNU13;RPL7A;RPL35A;RPL26;LAS1L;RPL11;RPLP0
prerank,nuclear pore complex assembly (GO:0051292),0.4636618785581321,0.9646612973120781,0.5095320623916811,0.9484467147215555,1.0,4/10,21.10%,NUP93;TMEM170A;NUP107;NUP98
prerank,establishment of protein localization to mitochondrion (GO:0072655),-0.28893703780416324,-0.9644513014089153,0.5186567164179104,0.8283732178035172,1.0,13/46,20.12%,MFN2;HK2;AIP;TIMM44;GRPEL1;TIMM13;AKT1;HK1;TSPO;TOMM7;TOMM40L;RALA;CHCHD4
prerank,defense response to protozoan (GO:0042832),-0.4013064052515019,-0.96419227455992,0.5036496350364964,0.8278988860466935,1.0,6/12,26.45%,GBP7;GBP4;GBP2;CD40;BATF;BATF2
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.29211887372190504,0.964013692305071,0.5674562306900103,0.9493374681736781,1.0,49/390,8.54%,EGFR;MET;CYFIP2;ARHGEF28;NGF;PDGFC;NTRK3;PTK2B;SORBS1;EFNA5;SULF1;ABI1;RBFOX2;GRB10;FGFR1;ATP6V0A4;SHC1;SIPA1L1;PGF;DDR2;ADRB2;GSK3B;POLR1G;AP2A2;SOCS2;SPRED2;FOXC2;PDGFA;NR4A3;FLRT2;NCK2;EPHB6;IRS1;SHOC2;ITGAV;FGF22;HNRNPH1;VAV2;PTPN2;IDE;AP2A1;FGF2;NRP1;NCKAP1;NFATC4;SLC39A14;BCAR3;ATP6V0A1;RHOQ
prerank,negative regulation of cyclase activity (GO:0031280),-0.3789459711643674,-0.9639430377898702,0.5147058823529411,0.8274658982220806,1.0,3/14,9.89%,ADGRV1;GRM3;EDNRB
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.33820882945393566,0.9632220571343056,0.5250320924261874,0.9505458797733232,1.0,29/73,27.73%,HDAC4;POLR1G;CTCFL;EP300;TAF1C;KAT2A;SF3B1;POLR1A;KAT2B;POLR1H;POLR1F;SUZ12;TAF1D;EPC1;POLR2H;RBBP4;MPHOSPH8;TDG;MTA1;EED;TASOR;EZH2;HDAC5;DDX21;SMARCA5;POLR1C;PHF19;GLMN;CTCF
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.3290541679794227,0.963213587898572,0.5206310679611651,0.94988345514834,1.0,37/100,24.42%,FHIT;GSK3B;GIPC1;XPO1;RNF19A;VCP;DDRGK1;CLU;PRICKLE1;ARIH1;USP7;COMMD1;CSNK1E;ARIH2;TAF1;TAF9;CSNK1A1;RAD23B;UFL1;CSNK1D;COP1;DESI1;TLK2;RNF144A;NUB1;MAP1A;HFE;PIAS1;N4BP1;RNF14;SUMO1;TRIB2;WAC;HSPA1A;ANKIB1;RCHY1;RNF217
prerank,calcium import into the mitochondrion (GO:0036444),0.48025356302075317,0.9631940112611576,0.5106007067137809,0.9492490796579011,1.0,5/10,26.17%,MCUB;MICU1;MCU;MICU3;SLC25A23
prerank,DNA duplex unwinding (GO:0032508),0.35487687435577336,0.963176788067967,0.513262599469496,0.9485995264317887,1.0,19/50,22.29%,ANXA1;MCM7;ERCC3;RPA1;XPA;CHD1L;CUL4A;DDX11;RAD23B;DDX1;XPC;DHX9;WRN;MCM9;NBN;MRE11;RECQL5;MCM6;MCMDC2
prerank,positive regulation of intracellular transport (GO:0032388),0.37432292085880375,0.962663545954081,0.5092198581560283,0.9491287111019073,1.0,8/38,14.93%,NEDD4;PLK3;CEP131;CAPN10;PCM1;BCAS3;EHD1;STK11
prerank,negative regulation of defense response (GO:0031348),0.3293859273888667,0.962466520225161,0.5132075471698113,0.9488987998606097,1.0,11/77,11.53%,CCN3;PTGIS;ISL1;PRKCD;KLF4;IL10;PTPN2;ACOD1;GATA3;RB1;TRAFD1
prerank,response to lipid (GO:0033993),0.32597814287409826,0.9624149601093186,0.5398550724637681,0.9483428918186234,1.0,20/105,14.68%,FOXP1;ANXA1;FOXO3;LBP;SMAD6;SOCS2;SLPI;RARG;SCD;CYP27B1;STRN3;FOXA1;CYP19A1;TLR4;CD36;RXRA;STAT3;TRIM16;ERBIN;CDKN2D
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.4191434693822061,-0.9620641206165566,0.5412844036697247,0.8310699544002661,1.0,7/10,18.39%,GPR37;LRRK2;GPR37L1;STK26;PDE8A;PARK7;TXN
prerank,positive regulation of phospholipase activity (GO:0010518),0.4047915396213886,0.962044086199945,0.5292307692307693,0.9485048995298409,1.0,6/22,9.69%,NTRK3;AGTR1;FGFR1;ARF4;FGF2;GNA13
prerank,ear morphogenesis (GO:0042471),0.41902217656682955,0.9619758708412182,0.5080906148867314,0.9479726757505946,1.0,5/20,11.02%,SIX1;ZIC1;TFAP2A;TIFAB;NOG
prerank,cardiac cell development (GO:0055006),0.4720959329147109,0.9618435576441059,0.5207956600361664,0.9476014809802624,1.0,2/11,6.86%,CXADR;JAG1
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.33055900640552194,0.9618283774540638,0.5222222222222223,0.9469578432961061,1.0,18/88,11.46%,STXBP6;VPS13A;EXOC4;GOLGB1;VPS13C;RABEP1;CLINT1;EXOC5;AP4E1;ARL3;DOP1B;AP2A1;OSBPL5;CCDC22;AP4B1;COMMD1;SNAP23;SH3D19
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.3408060417943235,0.9617905612947201,0.522077922077922,0.9463442283498621,1.0,15/67,13.07%,CYFIP2;PTK2B;SULF1;ABI1;PGF;NCK2;ITGAV;VAV2;NRP1;NCKAP1;PAK2;CDC42;BRK1;RHOA;ITGB3
prerank,endomembrane system organization (GO:0010256),0.3027235283395858,0.961605679104468,0.5420353982300885,0.9461182027805267,1.0,43/178,18.72%,ARHGAP21;ATL3;GOLGB1;NUP93;SUN3;RAB43;SPTSSB;FBXW8;ATP8B1;TMED5;GOLPH3;GAK;A4GALT;NPLOC4;DOP1B;ATL2;LMAN2L;VAPA;BCAS3;WASHC5;CDC42;EIF2AK3;TRIP11;SQSTM1;RAB30;TLCD2;TRAPPC12;CSNK1A1;COG3;MAPK15;HOOK2;CSNK1D;TMEM170A;RAB22A;TICAM2;GBF1;ARL1;HUWE1;LEMD3;TMCC1;VPS51;PLEKHM2;SYNGR2
prerank,peptide metabolic process (GO:0006518),0.33488356622491233,0.9612791342254188,0.5240572171651495,0.9461728811183905,1.0,11/75,11.06%,PCSK5;NPEPPS;MGAT3;DMD;CPQ;IDE;NLN;CARNMT1;MMACHC;ERAP1;PARL
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.4566503844710295,0.9612447954321195,0.5278745644599303,0.945569135517342,1.0,3/11,11.95%,CD44;KDM1A;TAF9
prerank,positive regulation of developmental growth (GO:0048639),-0.28221246768223357,-0.9610455598524703,0.5333333333333333,0.8325595733736104,1.0,20/49,22.18%,PLCB1;SEMA7A;NEDD4L;RIMS1;RIMS2;INSR;GHR;MACF1;CDKL5;MAPT;PPIB;LIMK1;RNF157;TWF2;UNC13A;CPNE5;DLL1;SYT1;CPNE9;ITSN2
prerank,regulation of defense response (GO:0031347),0.3389004305358788,0.960163713319357,0.5255754475703325,0.9474120646207479,1.0,12/76,9.44%,FOXP1;ANXA1;AGTR1;MGLL;SHPK;DAGLB;NLRP6;CELF1;PIK3AP1;RNF135;BCL6;ERAP1
prerank,regulation of intracellular signal transduction (GO:1902531),0.2913789956136729,0.9598152766076485,0.6028368794326241,0.9475396283675634,1.0,85/420,15.41%,EGFR;MOB3B;RASSF2;NTRK3;ARHGAP21;ARHGAP10;ARHGAP20;EZR;ARHGDIB;ARAP1;AKAP13;RHOJ;HIPK1;ARHGAP44;ARHGAP31;SMYD2;ARAP2;BCR;TIAM2;ARHGEF6;TRIO;ARHGEF5;PIP5K1A;TNFSF11;ITGAV;EP300;DLG1;PLK3;USP2;VAV2;OCRL;ATM;DYRK2;GATA4;CASTOR2;USP7;AKAP12;SRGAP2;SRGAP3;RHOQ;MDM4;TELO2;CHEK2;MLST8;KAT5;TOP3A;GNA13;RAD17;MTOR;PAK4;PAK2;CDC42;TAF1;ULK4;CHEK1;RPA1;CSNK2A2;CSNK2A1;SQSTM1;PAK1IP1;RHOA;TAF9;MYO9A;RFC5;NEK8;BIRC3;CMKLR1;PRKAR2A;INPP5B;MAPK1;GPAT3;EHMT2;TRAF5;STYXL1;EHMT1;ARHGAP5;ARHGEF18;ARHGAP17;UFL1;STK11;TAF15;RBBP8;PRKAA1;TAF12;STARD13
prerank,protein neddylation (GO:0045116),0.4423051616624991,0.9597322306716285,0.5025041736227045,0.9470593303979302,1.0,2/13,7.97%,UBE2F;DCUN1D4
prerank,positive regulation of cell-substrate junction organization (GO:0150117),-0.33588622276084745,-0.9595779584242188,0.52,0.835198103103536,1.0,7/24,11.07%,PIK3R1;TEK;KDR;MAP4K4;DUSP3;RAC1;MYOC
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.37718124475720594,-0.9591229427732973,0.5239294710327456,0.8351758666908001,1.0,2/14,8.05%,ENPP1;ENPP3
prerank,long-term synaptic potentiation (GO:0060291),0.4055149401216633,0.9588323548631109,0.5234375,0.9485382446994168,1.0,5/21,14.37%,PTK2B;GRIN2C;NFATC4;CRHR2;MPP2
prerank,RNA splicing (GO:0008380),0.3218202944257362,0.9583062014846994,0.5285359801488834,0.949123271797026,1.0,29/95,22.20%,MBNL1;SNRNP48;SYNCRIP;FUS;TCERG1;RSRC1;PRPF3;PPIG;NRDE2;SF3B2;SF3B1;SRRM1;RBM8A;SRPK1;SRSF11;SNRPD3;CDK12;SCNM1;SCAF11;TRA2B;NOL3;GEMIN2;DDX47;PRPF6;TXNL4A;ZCRB1;RNPC3;SNRPD2;SNRPD1
prerank,positive regulation of dephosphorylation (GO:0035306),-0.3193781218176507,-0.9582486486849712,0.525679758308157,0.8363163418934224,1.0,12/27,23.48%,PPIA;CALM1;PPP1R16B;BMP2;CALM3;SRC;PPP2R5A;MTMR9;PPP1R7;CDCA2;SMPD1;PIN1
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.4116279112358285,0.9582014126321089,0.4942339373970346,0.9486999679681226,1.0,3/20,2.85%,SEMA3D;SEMA3C;SEMA3E
prerank,organophosphate biosynthetic process (GO:0090407),0.36932075169797346,0.9580621619093502,0.525399129172714,0.9483588797398187,1.0,12/37,18.17%,IP6K2;NFS1;PIP5K1A;FGF2;IP6K3;PPIP5K2;MOCS3;PNPO;GNPAT;AGPAT4;AGPAT5;MBOAT1
prerank,regulation of extracellular matrix organization (GO:1903053),-0.37747693079743827,-0.9579970741052366,0.5064935064935064,0.8358449245633662,1.0,5/15,13.28%,AEBP1;TIE1;NOTCH1;EFEMP2;AGT
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.267857519426194,-0.9572240601116824,0.5375,0.8367291110053034,1.0,24/62,28.56%,PPIA;BCL2;CXCL12;TPT1;BCL2L1;TMBIM6;LRRK2;SRC;NOC2L;NME5;NDUFS3;AKT1;PARK7;ARHGEF2;SOD2;TRIM32;CCAR2;PLAUR;SELENOS;RTKN2;DNAJA1;HYOU1;ENO1;XBP1
prerank,phosphatidylinositol metabolic process (GO:0046488),-0.2389394621378686,-0.9570702573342711,0.55625,0.8360549223318581,1.0,36/109,25.46%,PLCB1;INPP4B;PIK3R1;PDGFRB;PIP5K1B;LPGAT1;INPP5D;PLEKHA2;INPP5F;PIP5K1C;PIK3R6;PLEK;BMX;PIK3C2A;MTMR10;PLCG1;SLC27A1;PIK3R5;MTMR9;PLA2G4E;MBOAT7;CSF1R;PIK3CD;PITPNM1;RAB14;PTPN13;MTMR2;INPP5K;MTMR1;INPP5J;PIK3CG;TPTE;PLA2G4C;CDIPT;PIK3CB;PIP4K2B
prerank,protein alkylation (GO:0008213),0.4072907271225335,0.9568993225737236,0.5184,0.9503883566054041,1.0,10/22,20.93%,METTL22;ETF1;METTL21C;SNRPD3;PRMT2;GSPT1;EEF1AKMT1;CAMKMT;PRMT8;METTL21A
prerank,negative regulation of protein localization to membrane (GO:1905476),0.3968889731588573,0.9567937424610711,0.5086342229199372,0.9499664985990359,1.0,5/24,9.56%,MRAP;PID1;PPFIA1;RHOQ;DMTN
prerank,mitotic nuclear division (GO:0140014),0.338361858880868,0.9565957148575719,0.5375494071146245,0.9497664894531773,1.0,21/71,19.32%,SMC4;NDEL1;ARHGEF10;KLHL22;PPP2R2D;CHEK2;MISP;TOGARAM1;RHOA;PIBF1;SMC1A;RAN;UBE2S;FLNA;STAG2;INO80;KIF18A;KIF2A;SPICE1;AAAS;CEP192
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.29373156823106467,0.9563689829357911,0.5575692963752665,0.9496214975764914,1.0,53/248,16.18%,EGFR;TCF7L2;MLLT3;CTNND2;GLI3;PTPRU;WNT11;WNK1;GPC3;LRP6;TMEM198;GSK3B;BAMBI;FZD7;UBE2B;DDIT3;TLE6;PLEKHA4;VCP;TRPM4;NFKB1;PRICKLE1;TNKS2;TBL1X;JUP;WWTR1;FUZ;TLE4;CTNND1;CSNK1G3;PPM1A;PRDM15;CSNK1E;NOG;UBR5;TLE3;TLE2;USP34;USP47;IGFBP6;CSNK1A1;RBMS3;AMER1;PSMC6;INVS;ILK;STK11;RNF146;CSNK1D;JRK;LRP4;LMBR1L;FRZB
prerank,modification-dependent macromolecule catabolic process (GO:0043632),-0.41995859078588604,-0.9563631662826686,0.5208791208791209,0.8367921106732634,1.0,3/10,12.33%,RPS27A;UBC;UBB
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.3332949140858056,-0.9563443381911368,0.5111731843575419,0.835758403212389,1.0,5/24,8.91%,NR1H3;AQP11;BCL2L1;TMBIM6;LRRK2
prerank,negative regulation of nervous system development (GO:0051961),-0.3546548487250321,-0.9560158934949223,0.5139240506329114,0.8354641388150674,1.0,4/17,14.88%,B2M;NOTCH1;ROBO2;APPL2
prerank,mononuclear cell differentiation (GO:1903131),0.3944906693007752,0.9554839137523922,0.5053110773899848,0.9510340347066373,1.0,1/24,0.27%,BMP4
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.413594615250564,0.9550868390108607,0.5332278481012658,0.9512615802584932,1.0,7/22,15.02%,NOL11;SMARCA4;MTOR;WDR43;EIF2AK3;DDX11;WDR75
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.3061868446247641,-0.9549863552290935,0.5032894736842105,0.8368280738927301,1.0,16/33,25.14%,TGFA;CCDC88A;ADRA2A;DGKD;HBEGF;HIP1;AGT;HIP1R;AKT1;CNOT9;DOK1;AFAP1L2;NUP62;HAP1;PLAUR;GPER1
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.3654949049464632,0.9545942267388707,0.520336605890603,0.9517590061330191,1.0,4/39,7.07%,EGFR;PTPN3;RNF115;PTPN2
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.31089483407150414,-0.9545509536520623,0.5158227848101266,0.8368179628085022,1.0,12/30,29.53%,HSPA8;ENTPD5;HSPA9;PTGES3;DNAJB5;ERO1A;CHCHD4;CCT2;SDF2L1;DNAJB14;HSPE1;ST13
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.4062522280084987,-0.954401680759508,0.5197215777262181,0.8360727311410511,1.0,3/11,6.59%,LYN;RAPGEF2;MEF2C
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.3849475650179157,-0.9543891668316844,0.508557457212714,0.8350174955595733,1.0,3/13,9.89%,ADGRV1;GRM3;EDNRB
prerank,proteoglycan metabolic process (GO:0006029),0.3916821996848444,0.9535284561899903,0.5128983308042488,0.9535741876257212,1.0,8/26,14.86%,HS3ST4;SULF1;CHST13;HPSE;SULF2;B4GALT7;B3GALT6;FOXL1
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.32666442635191806,-0.9532851645538131,0.4972375690607735,0.8366294874309896,1.0,2/26,0.73%,IGF1;FHL2
prerank,mRNA transport (GO:0051028),0.32266695441802373,0.9531664819016679,0.5506715506715507,0.9537764824651298,1.0,36/101,26.14%,NUP93;SMG6;DDX19B;U2AF1L4;SMG1;CASC3;SEC13;SRSF5;NUP188;SRSF6;NXF1;SRRM1;RANBP2;THOC2;RBM8A;SRSF11;THOC5;ZFP36L1;ZC3H11A;NUP107;AAAS;CHTOP;ALKBH5;RAE1;NUP54;NUP98;CPSF4;FMR1;FYTTD1;ALYREF;NCBP2;GLE1;UPF3B;SRSF7;FIP1L1;NUP37
prerank,inner ear morphogenesis (GO:0042472),0.3981431024871718,0.9529958929458429,0.5249621785173979,0.9535288698807085,1.0,5/22,10.99%,SIX1;ZIC1;TFAP2A;MYO3B;TIFAB
prerank,regulation of urine volume (GO:0035809),-0.41178076799365776,-0.952947799789164,0.5324384787472036,0.8363452335086415,1.0,4/10,21.53%,NPR1;ADM;HAS2;INPP5K
prerank,peptidyl-lysine dimethylation (GO:0018027),0.4204446513816412,0.9527920350188174,0.5179153094462541,0.9533403686374252,1.0,7/18,20.94%,SMYD2;SETD2;EHMT2;EHMT1;KMT2D;SETD1B;KMT2A
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.2739546835240593,-0.9523832695558729,0.5625,0.8366831701159363,1.0,15/55,13.99%,BCL2;TPD52L1;TNFSF10;FAS;DAB2IP;WWOX;BCL2L1;RPS3;TNFSF12;GSDME;BMF;AGT;TRAF7;TRAF2;BOK
prerank,positive regulation of signaling (GO:0023056),-0.29663090621505583,-0.9520920953000013,0.5540983606557377,0.836331459907266,1.0,8/37,11.16%,WLS;RIMS1;RIMS2;SNCA;INPP5F;GRIK2;EDN1;EDN3
prerank,keratan sulfate metabolic process (GO:0042339),0.3756916421661226,0.952062992912437,0.5305514157973175,0.9543000143774674,1.0,8/31,12.99%,ST3GAL4;B3GNT2;CHST5;HEXA;B4GAT1;B4GALT1;GLB1;ST3GAL2
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.40461784540325174,-0.9519865597084772,0.5237020316027088,0.8355397028828181,1.0,4/11,16.03%,NR1H3;SCARB1;MFSD2A;SLC27A1
prerank,positive regulation of calcium ion transport (GO:0051928),-0.29698677770356263,-0.9518707872519723,0.5165562913907285,0.8347399178823508,1.0,6/36,6.21%,MYLK;CACNA1D;PDGFRB;TRPC3;CXCL12;ATP2B1
prerank,UV-damage excision repair (GO:0070914),0.45594690743998445,0.9514398854941702,0.512962962962963,0.9551473875969799,1.0,6/12,18.17%,ERCC1;XPA;POLD3;XPC;POLA1;INO80
prerank,hydrogen peroxide catabolic process (GO:0042744),-0.39559960567361474,-0.9513477453007546,0.511520737327189,0.834893456127722,1.0,3/11,18.50%,PRDX4;CAT;PRDX1
prerank,regulation of tumor necrosis factor production (GO:0032680),0.3156926297455998,0.9512526699654398,0.5448113207547169,0.9548995059497623,1.0,7/112,7.04%,FOXP1;THBS1;LBP;ISL1;IL10;CLU;MAVS
prerank,chromosome organization (GO:0051276),0.3170311224894641,0.9512389995946174,0.529126213592233,0.9542653954655013,1.0,23/99,19.82%,TCF7L1;TCF7L2;ABL1;HDAC10;SMARCA4;HMG20A;HDAC8;XPA;CUL4A;EHMT1;COPS7B;COPS5;RAD23B;BRWD1;LRWD1;XPC;LDB1;ZBTB7A;FAM50A;MTHFR;HMGN2;PWWP3A;RAE1
prerank,C-terminal protein amino acid modification (GO:0018410),-0.40534255450547824,-0.9510780458763685,0.5535714285714286,0.8345194940189943,1.0,4/11,14.60%,AGBL4;ATG12;LCMT1;ICMT
prerank,pattern recognition receptor signaling pathway (GO:0002221),-0.27156281736319543,-0.9510383697583911,0.5464684014869888,0.8335536299028719,1.0,16/56,13.32%,NOD1;UNC93B1;CTSB;RPS27A;UBC;CTSS;TLR3;IRAK2;LACC1;TAB2;SFTPA2;SFTPA1;HSP90B1;UBB;CTSL;TLR7
prerank,mismatch repair (GO:0006298),0.3904272828200466,0.950870580434532,0.5415335463258786,0.9544669161781741,1.0,10/27,22.16%,ABL1;ERCC1;RPA1;SETD2;POLD3;XPC;MCM9;PMS2;TDG;RNASEH2A
prerank,triglyceride catabolic process (GO:0019433),0.41106892674532103,0.9508375191521466,0.5303776683087028,0.9538703973184087,1.0,2/19,9.61%,PNPLA3;FABP3
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.4464429048201583,0.9507755299206979,0.5377532228360957,0.953351729466831,1.0,6/11,20.71%,ELOF1;CHEK1;ZMIZ1;ZMIZ2;ARID1A;CDCA4
prerank,cellular response to amino acid starvation (GO:0034198),0.33326691386930724,0.9507459754272116,0.5314136125654451,0.9527482866643819,1.0,19/71,17.41%,MAP3K5;DAPL1;CASTOR2;EIF2AK4;SEC13;MLST8;NPRL3;MTOR;EIF2AK3;ATP6V0E1;MAPK1;ATP6V1H;CEBPB;ATP6V0D1;TFEB;MIOS;RRAGB;MAPK8;ATF2
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.43451277023053614,0.9503320208281927,0.5043177892918825,0.9530827490404242,1.0,6/14,18.86%,DDRGK1;AGR2;BFAR;COPS5;UFL1;PTPN1
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.43846613273207147,0.9503175527712544,0.5210084033613446,0.9524426328589071,1.0,3/14,11.83%,FUS;MRNIP;RAD51AP1
prerank,glycosaminoglycan catabolic process (GO:0006027),0.3510265114426466,0.950163286281262,0.5262449528936743,0.9521440083005004,1.0,15/55,12.99%,GPC6;CD44;GPC3;HEXA;NAGLU;GPC4;FGF2;SGSH;HPSE;SPAM1;HYAL3;GLB1;SLC9A1;ARSB;SDC4
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.3745828713090815,-0.9496516440968444,0.5410628019323671,0.8358023600505028,1.0,2/14,6.00%,ERN1;CPSF6
prerank,acylglycerol catabolic process (GO:0046464),0.37804532151437154,0.9495413034366837,0.5289747399702823,0.9529940472659472,1.0,4/30,9.61%,PNPLA3;MGLL;ABHD6;FABP3
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),-0.25953814365671013,-0.9494229526246692,0.5263157894736842,0.8352611434931577,1.0,15/71,12.51%,ADAMTS12;CTSH;OTUD7A;CTSC;CTSZ;CTSB;RPS27A;UBC;ATXN3;MALT1;RSPRY1;CTSS;DDB1;UBB;CTSL
prerank,synaptic vesicle cycle (GO:0099504),-0.30809588905354557,-0.9492275311402049,0.5451895043731778,0.8347163149401634,1.0,16/30,33.90%,RIMS1;SNCA;PIP5K1C;SYT7;CPLX1;SNAP25;NLGN1;SLC18A2;SNAPIN;SLC32A1;CDK5;RAB3A;WNT7A;SLC17A8;PLD2;OTOF
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.38879504668284226,-0.9492131249274709,0.5565819861431871,0.8336840480424118,1.0,10/13,45.69%,ISCA1;BOLA2;GLRX3;ISCA2;MMS19;GLRX5;CIAO1;YAE1;CIAO2A;LTO1
prerank,positive regulation of GTPase activity (GO:0043547),0.3018120328809101,0.9491302582238968,0.5938189845474614,0.9532897650157302,1.0,29/188,10.06%,NTRK3;MAPRE2;ARAP1;SGSM2;ITGB1;WNT11;SIPA1L1;GRTP1;CCDC125;DOCK7;RAP1A;SNX18;BCR;RAPGEF6;GSK3B;TIAM2;NDEL1;ARHGEF10;TBC1D13;ARHGEF5;PIP5K1A;TBC1D25;PKP4;SGSM3;BCAR3;SRGAP2;ARHGAP42;BCAS3;RGP1
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.43574276174283283,0.9482453031780838,0.511986301369863,0.9547175089722937,1.0,2/14,7.33%,CARD14;TLR6
prerank,positive regulation of T cell differentiation (GO:0045582),0.36526854717134233,0.9482391572453847,0.5161290322580645,0.9540678550608344,1.0,8/36,12.30%,GLI3;VNN1;DUSP10;BCL6;CD46;GATA3;ZMIZ1;ADAM8
prerank,positive regulation of organelle assembly (GO:1902117),-0.2846758685581484,-0.948237747651241,0.5342960288808665,0.8350393946370906,1.0,6/44,6.86%,ASAP1;CNOT6L;CEP120;CCDC88A;TAPT1;SDCBP
prerank,"base-excision repair, AP site formation (GO:0006285)",0.4330321996712973,0.9481625666698456,0.530278232405892,0.9535749938085456,1.0,7/17,23.94%,MPG;SMUG1;MBD4;ACD;TDG;UNG;ERCC5
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.3188555769161567,0.9478196532228388,0.5453474676089517,0.9537059147619726,1.0,8/108,5.66%,F3;MAP3K5;NGF;EGLN3;GSN;VCP;DIABLO;CRADD
prerank,mitotic cell cycle phase transition (GO:0044772),0.29535804235084695,0.9476793583536223,0.5902702702702702,0.9533802740159762,1.0,40/204,16.57%,FBXL7;CCNA2;INHBA;SFI1;CDC25B;PPP1R12B;CEP164;PAFAH1B1;PLK3;CEP131;FBXW11;PPP2R2D;CDC16;CHEK2;CDKN1B;MNAT1;FBXL6;E2F3;PCM1;TACC3;HAUS5;CSNK1E;PIM2;CEP70;PPP1R12A;RB1;ACVR1;CEP63;CEP57;CUL4A;FOXM1;CDKN2D;PRKACA;CSNK1D;CDKN3;PPME1;DCTN3;GSPT1;UBE2S;CCND3
prerank,protein secretion (GO:0009306),0.3410762715441462,0.947573131429792,0.5481283422459893,0.952956099091894,1.0,5/56,5.50%,PCSK5;ANXA1;LTBP2;SNX19;GOLPH3
prerank,acylglycerol metabolic process (GO:0006639),-0.2960472599359094,-0.9474391216380409,0.5481727574750831,0.8359708753723223,1.0,13/37,20.74%,APOE;DGKB;DGKI;GK;ABHD12;DGKD;DGKG;PGS1;DGKE;PNPLA2;DGAT1;AWAT2;LPL
prerank,B cell proliferation (GO:0042100),-0.35921203821049974,-0.9473881853161212,0.550761421319797,0.8350192115179811,1.0,3/17,6.59%,BCL2;CTPS1;MEF2C
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.3400487964079303,0.9471009670562855,0.5466491458607096,0.9533464909486286,1.0,16/62,18.62%,MLLT3;ELOF1;MNAT1;CTR9;ERCC3;SETD2;PAF1;RTF1;GTF2F2;CDK12;ELP4;ELOA;EAF2;AFF4;NELFE;POLR2H
prerank,body fluid secretion (GO:0007589),-0.3672915821541285,-0.9470348660655141,0.5469107551487414,0.8349086632377273,1.0,4/15,12.08%,NPR1;SLC22A4;ERBB4;SLC22A2
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.39537768010056806,-0.9467684340002608,0.5347721822541966,0.834510922062023,1.0,5/12,15.07%,CYBA;SLC5A3;GRIN1;ADGRB1;RAB27A
prerank,cellular response to organic cyclic compound (GO:0071407),0.3064690975470967,0.9461731753183998,0.5647193585337915,0.9547467397424,1.0,16/141,9.87%,CDH1;EGFR;EZR;CYP1B1;CTNNA1;RAP1A;MYOG;DIAPH1;IGFBP5;NR4A3;GOLPH3;P2RX4;JUP;KAT5;DMTN;SLC26A6
prerank,negative regulation of catalytic activity (GO:0043086),-0.3080227771375188,-0.946113433109058,0.5280898876404494,0.8351128824293118,1.0,10/24,32.18%,NOTCH1;NES;CAMK2A;CAND1;NOS1;CCAR2;TP53;MT3;PLN;HP
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.46933214046767946,0.9459081401135877,0.5304659498207885,0.95469998908713,1.0,2/10,14.11%,KLF4;MAP2K5
prerank,negative regulation of viral process (GO:0048525),-0.2632682498381365,-0.9456376940488108,0.5587044534412956,0.8352040989676868,1.0,16/57,21.78%,PPIA;TRIM14;BST2;TRIM62;IFITM1;IFITM3;OAS2;TRIM21;TRIM27;PROX1;TRIM6;LARP7;RNASEL;TRIM8;TRIM32;STAT1
prerank,dendritic cell differentiation (GO:0097028),-0.32789500383096554,-0.945211472938521,0.5238095238095238,0.835164237205125,1.0,9/22,27.95%,LYN;GAS6;CCL19;BATF;AXL;PRTN3;TREM2;BATF2;LILRB1
prerank,regulation of epithelial cell migration (GO:0010632),0.3413084477371886,0.9451192657118472,0.5361111111111111,0.9558512624430675,1.0,3/51,2.10%,DOCK5;BMPER;RHOJ
prerank,negative regulation of B cell activation (GO:0050869),0.4055571551082439,0.9450456886217282,0.5394321766561514,0.9553556784263796,1.0,4/21,7.31%,INHBA;IL10;TNFRSF13B;ATM
prerank,endocytic recycling (GO:0032456),0.3504936494089958,0.944565441334916,0.563249001331558,0.9557923279707594,1.0,20/50,21.16%,EHD3;ANKRD27;RAB11FIP3;SNX31;VPS53;ENTR1;CCDC22;WASHC1;EHD1;SNX4;SNX12;SNX17;RAB17;VPS26C;VPS51;RAB7A;EHD2;VPS50;VPS29;VPS26A
prerank,intracellular lipid transport (GO:0032365),-0.33688936872741365,-0.9442103284236333,0.5506493506493506,0.8365829470399173,1.0,7/21,11.01%,PRKAG2;NPC2;CPT1A;ACACA;ACACB;CERT1;PRKAA2
prerank,monocarboxylic acid catabolic process (GO:0072329),-0.338034173109378,-0.9440766931233306,0.5702702702702702,0.8358482242030921,1.0,8/21,22.29%,CYP26B1;PPARD;LPIN3;LPIN1;AGXT;NUDT19;ACOX1;HOGA1
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.45682515064359375,0.94403596367307,0.5296229802513465,0.9563789454122694,1.0,4/11,13.66%,NOL11;SMARCA4;MTOR;DDX11
prerank,neutrophil chemotaxis (GO:0030593),-0.2755309210477805,-0.94403128644518,0.5836431226765799,0.8348939935534472,1.0,12/53,19.62%,PDE4B;BSG;PPIA;PIP5K1C;EDN1;PPIB;EDN3;NCKAP1L;SYK;CCL19;ITGB2;PIK3CD
prerank,membrane repolarization (GO:0086009),0.4347549211473454,0.9435932209247063,0.5280701754385965,0.9567671660141062,1.0,2/15,1.46%,KCNJ2;ATP1B1
prerank,regulation of cell-cell adhesion (GO:0022407),0.36157863122263645,0.943450815339406,0.5236051502145923,0.9563875571098905,1.0,2/39,1.63%,CDH1;EFNA5
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.46134940452848594,0.9433357795763943,0.5319148936170213,0.9559909214774476,1.0,4/10,16.70%,TLR6;TLR4;CD36;MYD88
prerank,embryonic hemopoiesis (GO:0035162),-0.39699074139879653,-0.9433016922701196,0.5550351288056206,0.83558182294323,1.0,3/12,9.54%,KIT;KDR;TAL1
prerank,N-glycan processing (GO:0006491),-0.34539954572350384,-0.9432970340579612,0.5347043701799485,0.834548134178087,1.0,4/18,5.07%,ST8SIA4;MAN1C1;MAN2A2;ST8SIA6
prerank,development of primary male sexual characteristics (GO:0046546),0.36603533433006896,0.9427277161067247,0.5324858757062146,0.9567694340029296,1.0,8/34,11.71%,LHFPL2;INHBA;GATA1;GATA4;SIX4;GATA3;WNT2B;TGFB2
prerank,actin filament organization (GO:0007015),0.30598076918258754,0.9426227871645932,0.5782312925170068,0.9563289090321385,1.0,22/151,11.89%,DPYSL3;BAIAP2L1;COBL;VILL;ABI1;SHROOM3;TMOD3;NEBL;GAS2L2;GSN;TLE6;FAT1;MPRIP;DLG1;POF1B;FHOD3;DMTN;RHOBTB1;CDC42;TRIOBP;PLS1;RHOA
prerank,reticulophagy (GO:0061709),0.44369334515538544,0.9426011680408708,0.5170068027210885,0.9557040101665205,1.0,7/12,20.89%,ULK2;DDRGK1;RB1CC1;UFL1;ATG2A;ULK1;UBA5
prerank,DNA replication (GO:0006260),0.31730793603633395,0.9424218640150368,0.5604790419161677,0.955448289099773,1.0,35/105,23.39%,REV3L;IGHMBP2;MCMBP;ATM;MCM7;KAT5;TOP3A;RAD17;CHEK1;RPA1;BAZ1A;RFC5;REV1;RBBP8;ORC5;TOP1;POLG2;POLB;WRN;MCM9;POLA1;CLSPN;NBN;TOP1MT;MRE11;RMI2;WDHD1;RECQL5;ATR;MCM6;CDK1;RNASEH2A;RAD9B;NT5M;RFC1
prerank,negative regulation of T cell proliferation (GO:0042130),0.3769498968252902,0.9423928781173401,0.5305810397553516,0.95484655616749,1.0,5/28,13.86%,IL10;CD80;TNFRSF14;SDC4;CEBPB
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.33711689391244465,0.942001492609341,0.5647798742138365,0.955063772148079,1.0,6/73,5.66%,F3;NGF;EGLN3;VCP;DIABLO;CRADD
prerank,generation of neurons (GO:0048699),0.29819759785962346,0.9419352267867365,0.597574421168688,0.9545483855809119,1.0,30/190,11.87%,MET;WNT9A;SIX1;MARK1;WNT11;FGFR1;CIT;DOCK7;LHX2;WNT16;FZD7;NR4A2;ACSL3;PAFAH1B1;FGF13;MARK2;NRP1;BHLHE40;HES1;POMGNT2;ITM2C;FZD2;SIX4;PER2;CEP85L;ATOH8;DISC1;WNT2B;TGFB2;THOC2
prerank,negative regulation of response to external stimulus (GO:0032102),0.3106265304452091,0.9418204021234895,0.5578069129916567,0.9541594011267412,1.0,15/105,12.43%,CCN3;CD109;PTGIS;ISL1;PRKCD;KLF4;IL10;PTPN2;FGF2;ACOD1;GATA3;RB1;DRD3;TRAFD1;CASK
prerank,cytoplasmic translational initiation (GO:0002183),0.41727229137310795,0.9417753029661803,0.5225505443234837,0.9535958064559301,1.0,10/17,29.08%,EIF4G1;EIF2D;EIF2B3;EIF2S2;EIF3A;DHX29;RBM4;EIF4B;EIF4A1;EIF4A2
prerank,establishment of vesicle localization (GO:0051650),0.41628578011668343,0.9412952695584687,0.5629139072847682,0.954054557155928,1.0,3/18,9.27%,LIMK2;F8A1;SPG11
prerank,response to amino acid starvation (GO:1990928),0.32914979156819607,0.9409053025784788,0.5398692810457516,0.9543050185641562,1.0,19/72,17.41%,MAP3K5;DAPL1;CASTOR2;EIF2AK4;SEC13;MLST8;NPRL3;MTOR;EIF2AK3;ATP6V0E1;MAPK1;ATP6V1H;CEBPB;ATP6V0D1;TFEB;MIOS;RRAGB;MAPK8;ATF2
prerank,blood circulation (GO:0008015),0.3499561661736881,0.940572938225649,0.5405027932960894,0.9543907950744764,1.0,6/49,6.31%,SGCD;AGTR1;MEOX2;GCLC;TNNI3;SCPEP1
prerank,negative regulation of cellular component organization (GO:0051129),0.33181811241305637,0.9404895168498247,0.5636132315521628,0.9539371493871631,1.0,11/74,13.21%,TMEFF2;BMP6;ISL1;GSK3B;CLU;EP300;LRSAM1;RDX;CDC42;DNAJB6;XRCC5
prerank,regulation of wound healing (GO:0061041),0.35959199728843044,0.9401789674387449,0.5537790697674418,0.9540161069384557,1.0,9/42,12.94%,CD109;ANXA1;ITGB1;FGF2;DMTN;SRSF6;CASK;PRKCE;DUOX1
prerank,positive regulation of histone methylation (GO:0031062),-0.33026167646328536,-0.9397626780760223,0.5292553191489362,0.8421738284842787,1.0,3/24,5.45%,AUTS2;JARID2;RIF1
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.4077072038826146,0.9397165794280133,0.5477707006369427,0.9544618735930142,1.0,4/20,8.81%,PLOD2;GCLC;PLSCR1;FPGS
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.38474976109605447,0.9395229715921721,0.5128983308042488,0.9542500853398729,1.0,4/27,5.97%,CD44;NFAT5;NR4A3;TNFSF11
prerank,proteasomal protein catabolic process (GO:0010498),0.2944959907227012,0.9386238098678769,0.6019522776572668,0.9556416489419522,1.0,45/201,20.59%,WWP1;NEDD4;UBE4B;WWP2;DDI2;UBE2B;DDIT3;NFE2L2;RNF185;VCP;KLHL22;FBXW11;TBL1X;UBE2D3;KAT5;ERCC8;CUL4A;UBE2W;BFAR;APPBP2;RAD23B;SMURF1;PSMC6;FBXL19;PML;UBE3D;FBXW5;PSMD8;SPOP;FEM1B;COP1;RNF122;FAF1;UBE2G1;FEM1C;HUWE1;PPP2R5C;PCNP;PSMB1;FBXL17;PSMD13;PSMD1;PSMD7;KCTD17;PSMA8
prerank,snRNA metabolic process (GO:0016073),0.4208672327313225,0.9385223008704975,0.5441176470588235,0.9552316974155306,1.0,8/17,31.08%,ZCCHC8;INTS3;INTS8;MEPCE;INTS9;INTS1;INTS2;INTS12
prerank,cellular response to interleukin-1 (GO:0071347),-0.2284821459393892,-0.9383481722452349,0.6548672566371682,0.8446437617525667,1.0,32/143,20.90%,PLCB1;RPS6KA5;IL1R1;ADAMTS12;ST18;CD47;HIF1A;PELI2;NOD1;DAB2IP;MAPK3;SIRPA;RPS27A;UBC;IRAK2;TAB2;EGR1;PSMB10;UBB;UPF1;BTRC;PSME2;GBP2;CCL19;RELA;PSMB3;TNIP2;PSMB4;PSMB8;CD40;PSMC5;HAS2
prerank,positive regulation of lipid catabolic process (GO:0050996),0.4105588505710423,0.9383350746085778,0.56,0.9549782361297932,1.0,5/19,16.64%,PRKCD;DAGLB;IRS1;ABHD5;IRS2
prerank,axonemal dynein complex assembly (GO:0070286),0.37298551316979006,0.9379496815124996,0.5395569620253164,0.9551891237862454,1.0,4/28,12.37%,DNAAF3;CCDC40;DNAH8;DNAH5
prerank,regulation of secretion by cell (GO:1903530),0.3423038152572612,0.9376217683292403,0.5518617021276596,0.9553152907152377,1.0,6/54,9.71%,SNCAIP;ANXA1;DISP1;ARFIP1;NSF;P3H1
prerank,response to interleukin-4 (GO:0070670),-0.39688336982765615,-0.9376198789409402,0.5480984340044742,0.8453538489716992,1.0,1/10,0.37%,LEF1
prerank,ubiquinone metabolic process (GO:0006743),0.42912076452653847,0.9375913548501227,0.5415282392026578,0.9547358606830332,1.0,7/15,24.75%,COQ7;COQ10B;AIFM2;COQ8A;PDSS2;UBIAD1;COQ6
prerank,regulation of lipid metabolic process (GO:0019216),-0.24560254447378926,-0.9373026976799861,0.6145251396648045,0.8450588753200987,1.0,16/88,11.78%,NCOA1;PPARA;PRKAG2;TBL1XR1;NPC2;ELOVL6;PPARD;C1QTNF2;GPS2;ACACA;SC5D;ACACB;GGPS1;PSAP;NR1D2;GPAM
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.4294137957331061,0.9370145761218156,0.5184563758389261,0.9553341997717165,1.0,4/14,12.50%,PGF;NRP1;GAB1;FOXC1
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.3660830747910354,0.9366934411887039,0.5290055248618785,0.9554627716571706,1.0,11/38,15.78%,BMP6;POLR3D;PLSCR1;IFI35;ACOD1;ADAM8;POLR3B;PUM2;PUM1;PRKCA;DHX9
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.42235326197842493,0.9361405945089288,0.5523156089193825,0.9560646289497147,1.0,5/15,11.71%,FGFR1;MFRP;CELF1;USP22;TGFB2
prerank,negative regulation of protein ubiquitination (GO:0031397),0.348280527621877,0.9359592736933627,0.5658073270013568,0.95582905238698,1.0,15/50,24.18%,NXN;ABL1;PER2;HDAC8;TAF1;GTPBP4;SQSTM1;UFL1;USP4;PINX1;CHP1;N4BP1;SVBP;SIRT7;HSPA1A
prerank,regulation of adaptive immune response (GO:0002819),-0.35248075771116916,-0.9358848686192832,0.5333333333333333,0.8474147932142173,1.0,5/18,12.89%,ADCY7;AHR;IL6ST;TRIM27;SAMSN1
prerank,cell junction assembly (GO:0034329),0.31302615962962643,0.9358542302645899,0.5780487804878048,0.9554194204485055,1.0,6/100,3.05%,CDH1;PCDHB16;CDH11;FN1;CTNND2;PCDHB13
prerank,phosphate-containing compound metabolic process (GO:0006796),0.2970763752878808,0.9357088355648994,0.6180021953896817,0.9551191715949626,1.0,41/198,15.95%,PLCE1;PLPPR2;TNFAIP8L3;PPP3CA;LIMK2;PLPP3;INPP4A;IP6K2;PFKFB2;PLCB3;NUDT4;DUSP16;PLCD3;SHPK;PFKP;OCRL;DUSP10;IP6K3;PPIP5K2;ACP3;PLA2G4F;PLCD1;PPM1A;DUSP5;MTOR;PAK2;GPI;STAT3;PLPP1;ACYP1;HTR2B;INPP5B;DUSP12;SLC20A1;G6PC3;LCAT;PLCH2;SYNJ1;PLA2G4A;COQ8A;PLA2G15
prerank,regulation of macrophage differentiation (GO:0045649),-0.36213932343303007,-0.9354311510053764,0.553030303030303,0.8474868916677858,1.0,3/15,10.55%,IL34;CSF1;C1QC
prerank,neural crest cell differentiation (GO:0014033),-0.34399752474470097,-0.9353276159460624,0.5428571428571428,0.8466601937326949,1.0,3/18,6.59%,CDH2;TAPT1;MEF2C
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.43720321651634053,0.9352568457937458,0.5428082191780822,0.9555014338248977,1.0,3/12,17.64%,PAICS;PFAS;GMPS
prerank,cellular biogenic amine catabolic process (GO:0042402),0.4599735383932724,0.9350797162874838,0.5638297872340425,0.9552256116879327,1.0,1/10,1.25%,SMOX
prerank,dephosphorylation (GO:0016311),0.30426722734926714,0.9349573415500101,0.5837155963302753,0.9548594328916783,1.0,36/147,18.96%,PLPPR2;PTPN3;PPP3CA;PTPRU;PLPP3;PPM1H;DUSP16;PPEF2;FBXW11;PTPN21;DUSP10;ACP3;PTPRF;DAPP1;PTPRA;PPM1A;DUSP5;PPP1R12A;PHPT1;PTPN14;PLPP1;PPP5C;DUSP11;PPP2R1B;PPP3CC;DUSP12;STK11;PPP4R1;PTPN9;PPP4R2;PSPH;PPP2CB;PPP2R5C;PTPRD;PTPN1;ILKAP
prerank,negative regulation of platelet activation (GO:0010544),0.4240310881488882,0.934567361722796,0.5331179321486268,0.9551174515520001,1.0,5/16,6.41%,CD9;PRKCD;THBD;PDGFA;SERPINE2
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.331429482960362,0.9344910522424827,0.5485498108448928,0.9546488791909062,1.0,5/69,7.04%,THBS1;LBP;ISL1;CLU;MAVS
prerank,regulation of stem cell proliferation (GO:0072091),-0.34503664470436624,-0.9343406429282876,0.5177664974619289,0.8479438870438082,1.0,3/17,7.25%,ACE;FBLN1;GJA1
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.3494372466627899,-0.9341429321543915,0.5175879396984925,0.8474158519190353,1.0,7/17,29.84%,ADRA2A;MFSD2A;PDE3B;AKT1;APOC1;GPLD1;SORL1
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.35912197984264355,0.9340832086102697,0.5451936872309899,0.9548634749856314,1.0,18/36,24.78%,E2F6;RRM2;RNF2;CHEK1;EHMT2;EHMT1;MGA;RBBP8;SUZ12;EPC1;CBX5;RBBP4;UXT;YAF2;PHC3;EED;EZH2;RING1
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.3039135203980993,-0.9320066077400521,0.5692771084337349,0.8515629773465943,1.0,8/28,15.58%,SHANK3;APOE;ADCY1;EPHA4;NSG1;APP;CHRNA7;ADCY8
prerank,regulation of mitochondrial fission (GO:0090140),-0.31691450011984396,-0.9319824768706471,0.5729166666666666,0.850571981253598,1.0,5/24,9.36%,DCN;KDR;INF2;LRRK2;MAPT
prerank,cellular response to cytokine stimulus (GO:0071345),0.2824698679657541,0.9319242851456785,0.665989847715736,0.9590845104941615,1.0,58/416,12.94%,STK39;F3;SLC12A2;DPYSL3;FN1;ANXA1;FOXO3;IL22RA1;GRB10;PTGIS;LBP;ITGB1;SHC1;NFAT5;WNK1;TANK;PID1;IL10;YBX3;GSK3B;NFE2L2;SOCS2;SYNCRIP;NFKB1;CD80;IL5;SHPK;TNFSF11;HCLS1;IL18BP;PTPN2;CHUK;CLCF1;FGF2;GAB2;IRAK4;TNFRSF1B;USP10;CDKN1B;BCL6;SLC26A6;CXCR4;ACOD1;GATA3;HYAL3;RBMX;IRF1;TLR4;CSK;RHOA;IL16;CD36;STAT3;PTPN14;FOXC1;STAT5A;TRADD;DUOX1
prerank,regulation of hemopoiesis (GO:1903706),0.4512421850410961,0.9318432958682019,0.5361552028218695,0.958605297381566,1.0,3/10,12.09%,CREBBP;CBFB;MYSM1
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.32526872093229386,0.9317275904981785,0.5436156763590392,0.9582314722105664,1.0,8/69,7.90%,NGF;SIX1;TGFB3;PTK2B;ISL1;GDNF;CLCF1;NFATC4
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.4016651078993693,0.9313651085685338,0.5589171974522293,0.9584027010476225,1.0,7/19,21.13%,KLF4;NFKB1;GATA3;MAP2K5;MAPK8;WFS1;EGF
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.42009342525908505,0.9311222412493156,0.5463917525773195,0.9582756299128938,1.0,3/16,5.21%,RAET1E;KLRC2;PVR
prerank,nuclear pore organization (GO:0006999),0.4229110818181905,0.930958754661904,0.5719237435008665,0.9580052624322447,1.0,5/14,21.10%,NUP93;TMEM170A;NUP107;NUP54;NUP98
prerank,positive regulation of peptidase activity (GO:0010952),0.4010278548832018,0.930827213761141,0.529886914378029,0.9576540163913186,1.0,3/20,4.86%,TANK;VCP;DDRGK1
prerank,mitotic spindle assembly (GO:0090307),0.3573903488154366,0.9306431681065517,0.557909604519774,0.9574328736305199,1.0,13/42,19.32%,ARHGEF10;CHEK2;MISP;TOGARAM1;RHOA;PIBF1;SMC1A;FLNA;STAG2;KIF2A;SPICE1;AAAS;CEP192
prerank,regulation of translational initiation (GO:0006446),0.336151418699328,0.9304034992770953,0.5834445927903872,0.9573442981573957,1.0,24/63,25.75%,EIF4G3;EIF4G1;DNAJC3;NCK2;PAIP2;EIF2AK4;EIF2B2;EIF2AK3;CEBPB;DDX1;YTHDF3;MTIF2;YTHDF2;EIF4G2;EIF3E;CSDE1;FMR1;LARP1;RBM4;NCBP2;IMPACT;EIF4B;GLE1;YTHDF1
prerank,synapse organization (GO:0050808),0.30240160933063553,0.9300774874826043,0.5883748517200474,0.9574098248522703,1.0,14/125,9.48%,CDH1;PCDHB16;GPC6;CTNND2;NEDD4;SEMA3E;PCDHB13;CAST;SDK1;GPC4;PPFIA1;UNC13B;PTPRF;CACNB2
prerank,cellular protein catabolic process (GO:0044257),-0.26650323234081563,-0.9295572459664755,0.6052631578947368,0.8554058685445534,1.0,9/59,8.45%,ADAMTS12;CTSH;CTSC;DAB2IP;CTSZ;CTSB;MALT1;RSPRY1;CTSS
prerank,oxoacid metabolic process (GO:0043436),-0.31587066221270105,-0.9287672220292366,0.5751445086705202,0.8562339127594291,1.0,8/27,17.20%,TPST1;ENPP1;DDO;SULT4A1;AGXT;PPA1;TPST2;MIF
prerank,positive regulation of insulin secretion (GO:0032024),0.3602456514413506,0.928347022968129,0.5759768451519537,0.9607189802938771,1.0,5/36,8.37%,TCF7L2;ISL1;TRPM4;CAPN10;AACS
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.2702595701627171,-0.9282767322100188,0.5734767025089605,0.856339028944966,1.0,17/46,21.09%,PLCB1;PPIA;CNN2;LMNB1;HSPA9;AIP;PSME2;BOLA2;CFL1;MIF;RPLP0;SNRPA1;RALA;SOD2;HNRNPDL;LCP1;TALDO1
prerank,regulation of actin filament-based process (GO:0032970),0.3258981345687402,0.9279362103962532,0.5645994832041343,0.9609828725342808,1.0,18/70,14.97%,EFNA5;EZR;PRKCD;ARHGAP44;FAM107A;ABL1;PDGFA;ARHGEF5;IQGAP1;RHOQ;MLST8;DMTN;MTOR;RHOBTB1;RHOA;LRP1;ARHGAP17;RND3
prerank,regulation of pH (GO:0006885),0.4551198676343865,0.9276600886508061,0.559040590405904,0.9609547047697965,1.0,3/11,12.17%,ATP6V0A4;ATP1A4;SLC9A1
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.41365828846333264,0.9273717545411426,0.5306799336650083,0.9609496781453049,1.0,4/16,4.49%,ANK2;CAMK2D;CACNA1C;DMD
prerank,bone morphogenesis (GO:0060349),0.4229125683223034,0.9272893414809955,0.5661016949152542,0.9604890144569892,1.0,4/14,13.44%,LRP6;TFAP2A;SKI;LRP5
prerank,adenine nucleotide transport (GO:0051503),0.4150180591992003,0.9269694758031674,0.5561224489795918,0.9605569169111516,1.0,4/17,10.63%,LRRC8D;ABCC4;SLC25A17;ABCC5
prerank,glial cell differentiation (GO:0010001),0.37920980474473004,0.926938539516841,0.5581761006289309,0.9599804943148494,1.0,3/28,5.15%,NFIB;EGR2;ADGRG6
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.42030021762387115,0.9269093445938099,0.5303292894280762,0.9594041667164926,1.0,9/14,31.25%,SEC24B;SEC13;SEC24A;SEC23A;TBC1D20;SEC24D;SEC31A;SEC24C;RAB1A
prerank,regulation of mRNA stability (GO:0043488),0.30244279602900415,0.9268597174471231,0.6080459770114942,0.9588692451132405,1.0,44/145,22.77%,SAMD4A;PRKCD;EIF4G1;FTO;XPO1;GDNF;CELF1;FUS;PCBP4;EXOSC7;SERBP1;TENT5D;ZC3H14;PUM2;PSMC6;VIP;FXR2;PUM1;TAF15;PRKCA;PSMD8;MAPKAPK2;EXOSC5;YTHDF3;TENT5C;ZFP36L1;YTHDF2;RC3H2;FASTKD1;PSMB1;PABPC1;PSMD13;PSMD1;PSMD7;PSMA8;EIF4ENIF1;PSMD3;EXOSC4;PSMD2;DCP1A;APEX1;FMR1;PSMC2;LARP1
prerank,purine ribonucleotide transport (GO:0015868),0.4179317987659289,0.9266383405499498,0.5434782608695652,0.9587404303974694,1.0,4/16,10.63%,LRRC8D;ABCC4;SLC25A17;ABCC5
prerank,RNA destabilization (GO:0050779),0.406422580554758,0.9264910503986483,0.5700934579439252,0.9584055083978628,1.0,9/18,25.75%,FTO;DXO;CELF1;PUM1;YTHDF3;YTHDF2;ZC3H18;ROCK1;YTHDF1
prerank,mitochondrial translation (GO:0032543),0.3115354089573381,0.926327808795336,0.5843091334894613,0.9581352422328369,1.0,36/104,26.27%,MRPL33;MRPL48;EARS2;MRPL32;MRPL14;MRRF;MRPL21;MTRF1;MRPS31;MRPL38;GFM2;MRPL57;MTRF1L;MRPS28;MRPS35;MRPS22;MRPL20;MRPS10;MRPL47;NDUFA7;MRPS27;MTIF2;MRPS30;MRPS23;MRPL9;MRPS24;MRPL52;MRPS33;MRPS18B;MRPS7;PTCD3;MRPL10;MRPL39;MRPS5;MRPS34;MRPS18C
prerank,lipid transport (GO:0006869),0.31455478691804795,0.9258928247198451,0.6082725060827251,0.9584955068208332,1.0,14/97,10.01%,SLCO3A1;ABCD3;TNFAIP8L3;PITPNA;LBP;SLCO2A1;PITPNC1;ATP8B1;ABCC4;PITPNB;SLC27A3;OSBPL5;FABP3;SLC25A17
prerank,negative regulation of JUN kinase activity (GO:0043508),0.4498712643259455,0.9258006299417771,0.5557522123893806,0.9580648980446218,1.0,2/10,7.68%,PDCD4;DUSP10
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.45377883546974157,0.9255924844579211,0.5331010452961672,0.9578911821007563,1.0,2/10,9.01%,NPLOC4;UFD1
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.40473024425638826,0.9253214700987845,0.5557432432432432,0.9578248752535237,1.0,4/20,8.90%,C1QTNF12;ERFE;EP300;CLK2
prerank,positive regulation of hormone secretion (GO:0046887),-0.3526155079383041,-0.9251959608839216,0.5590551181102362,0.8627107602417353,1.0,4/17,11.16%,C1QTNF3;SPP1;EDN1;EDN3
prerank,regulation of histone methylation (GO:0031060),0.440483894734124,0.9251481317184111,0.5631399317406144,0.9575579170756688,1.0,6/13,19.35%,CTCFL;CTR9;PAF1;MTHFR;CHTOP;NNMT
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.41420431937321667,0.9251207491784734,0.5605536332179931,0.9569735759540483,1.0,3/17,5.21%,RAET1E;KLRC2;PVR
prerank,acyl-CoA metabolic process (GO:0006637),-0.2893268460091285,-0.9250729553054701,0.5833333333333334,0.8619322098113668,1.0,6/35,9.64%,ACBD6;ACACA;ACACB;ACOT7;DBI;ACSF2
prerank,activation of GTPase activity (GO:0090630),0.31482493180207055,0.9249962072347577,0.5943970767356882,0.9566032667686268,1.0,17/89,10.66%,NTRK3;SGSM2;SIPA1L1;GRTP1;CCDC125;DOCK7;BCR;TIAM2;ARHGEF10;TBC1D13;ARHGEF5;PIP5K1A;TBC1D25;SGSM3;ARHGAP42;BCAS3;TBC1D10A
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.3179628905461808,-0.924935189818314,0.5431754874651811,0.8611807943758732,1.0,6/24,16.62%,ITPR1;RYR2;HTR2A;RYR3;ERO1A;CCL19
prerank,regulation of GTPase activity (GO:0043087),0.29568798733727436,0.9241951457330086,0.6084538375973304,0.9577669193886785,1.0,28/177,10.06%,MAPRE2;EFNA5;ARAP1;SGSM2;ITGB1;WNT11;WNK1;SIPA1L1;ARHGAP44;RAP1A;SNX18;RAPGEF6;GSK3B;NDEL1;ADAP1;RAB3GAP2;ARHGEF5;PKP4;PLXNA2;VAV2;OCRL;FGD6;SGSM3;BCAR3;SRGAP2;RDX;BCAS3;RGP1
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.41062465752863475,0.9241227506108661,0.5485436893203883,0.9572796762750186,1.0,5/16,17.13%,ANK2;DDRGK1;VAPA;BCAP29;GBF1
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.3452853525147104,0.9240521972687471,0.5491573033707865,0.9568138932159624,1.0,7/46,8.44%,TMEFF2;FN1;PARVA;ANTXR1;ITGAV;NRP1;SRGAP2
prerank,response to ionizing radiation (GO:0010212),0.3259745482843975,0.9240032320666206,0.5661103979460848,0.9562943820860371,1.0,15/70,18.17%,ANXA1;TANK;EYA3;ATM;CLK2;KAT5;RNF168;MRNIP;RAD51AP1;KDM4D;INTS3;STK11;PRKAA1;COP1;INO80
prerank,calcium ion transport into cytosol (GO:0060402),-0.33601580216633253,-0.9236155346272201,0.5678670360110804,0.8632274402437884,1.0,11/21,21.94%,GRIN2A;GRIN2B;SLC8A1;RYR2;CACNA2D1;GRIN1;JPH2;JPH1;TRPV4;JPH4;JPH3
prerank,regulation of exosomal secretion (GO:1903541),0.4049860853189976,0.9235069779376421,0.5460218408736349,0.956714254632375,1.0,7/19,20.26%,PDCD6IP;SDC4;ATP9A;TSG101;SDC1;RAB7A;HGS
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.36975919710994304,0.9233943186453947,0.5583203732503889,0.9563281683506778,1.0,2/29,2.76%,SLIT2;PRKCD
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.4511525093631586,0.9231356515335474,0.551094890510949,0.9562894504466859,1.0,3/10,10.06%,ANXA2;NELL1;RGP1
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.4463964563343249,0.9229720089124398,0.5568965517241379,0.9560353126728415,1.0,2/11,13.20%,IL10;CIITA
prerank,regulation of TORC1 signaling (GO:1903432),0.3697544291718082,0.9226678331104039,0.5522598870056498,0.9560376317366001,1.0,10/33,16.13%,SIK3;KLHL22;ATM;SMCR8;CASTOR2;DYRK3;TELO2;CLEC16A;STK11;RRAGB
prerank,myofibril assembly (GO:0030239),0.35474789448036825,0.9226366033649265,0.5449591280653951,0.9554765873503724,1.0,7/42,10.00%,KRT19;CSRP3;TMOD3;CSRP2;FHOD3;SIX4;WDR1
prerank,smooth muscle contraction (GO:0006939),0.4321684872433849,0.9225172760981749,0.5451505016722408,0.9551112930963644,1.0,1/14,0.48%,EDNRA
prerank,inner dynein arm assembly (GO:0036159),0.44367106806170725,0.9222310534969664,0.5535390199637024,0.9551115478890685,1.0,1/11,4.70%,CCDC40
prerank,Fc receptor signaling pathway (GO:0038093),-0.23255758312252076,-0.9222049681740343,0.6530612244897959,0.8656165212490848,1.0,35/110,24.08%,LYN;PIK3R1;KIT;PAK1;CALM1;TEC;MAPK3;PPP3R1;PRKCQ;MALT1;VAV3;RAC1;TAB2;GRB2;PSMB10;PPP3CB;BTRC;MAPK9;PSME2;PLCG1;VAV1;LAT2;SYK;RELA;PSMB3;PSMB4;PSMB8;LCP2;PSMC5;TAB1;PSME1;PSMA7;BTK;MAP3K1;PSMD5
prerank,proton transmembrane transport (GO:1902600),-0.286258691229286,-0.9220929559201225,0.5689655172413793,0.8648286528129608,1.0,2/36,4.76%,ATP1A2;ATP5F1B
prerank,muscle cell development (GO:0055001),0.3598192995942034,0.921886191421408,0.5602409638554217,0.9552371904409843,1.0,6/30,7.89%,CXADR;ANK2;NEBL;DMD;KDM1A;HES1
prerank,endoplasmic reticulum organization (GO:0007029),0.3191550181571082,0.9217002921044313,0.5706806282722513,0.9550114122037111,1.0,12/72,11.12%,ATL3;TLE6;STX5;SPTSSB;GAK;SHTN1;DOP1B;ATL2;RAB18;LMAN2L;VAPA;EIF2AK3
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.4040825472850321,0.9213503188330475,0.549618320610687,0.955152941085521,1.0,3/19,4.65%,EXT1;GLCE;HS6ST2
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.44445763529702986,0.9212841592542843,0.5481481481481482,0.954679897235188,1.0,3/11,12.11%,IL10;NR4A3;REST
prerank,regulation of DNA binding (GO:0051101),0.34736863330959966,0.9209274385617818,0.592087312414734,0.9548500617172017,1.0,13/44,21.13%,NGF;SMO;JUN;KDM1A;HES1;SKI;FOXC1;MAPK8;ZBTB7A;MDFI;SUMO1;TGFB1;EGF
prerank,regulation of coagulation (GO:0050818),-0.39857561907077244,-0.9208988868474021,0.5579710144927537,0.8666661286240293,1.0,8/11,46.06%,HS3ST5;HRG;F2R;EPHB2;FOXA2;GP1BA;F2RL1;F2
prerank,regulation of mitochondrial membrane permeability (GO:0046902),-0.3413504496110851,-0.9208500207966953,0.5900783289817232,0.8656962634799219,1.0,10/18,31.13%,BCL2;BCL2L1;CAMK2A;THEM4;SLC25A4;BAD;BAK1;PMAIP1;NAIF1;HEBP2
prerank,protein O-linked glycosylation via serine (GO:0018242),0.46079652956963757,0.9200224838818998,0.5622837370242214,0.9561494389551634,1.0,4/10,23.96%,GALNT13;POGLUT3;POGLUT2;GALNT4
prerank,retrograde axonal transport (GO:0008090),0.4110348403032241,0.9199269159692172,0.5546075085324232,0.9557331407261395,1.0,5/16,19.64%,PAFAH1B1;FBXW11;KIF1C;DLG2;MAP1A
prerank,regulation of phosphate metabolic process (GO:0019220),0.4068370408997747,0.9198784293527487,0.5399673735725938,0.9552131580584503,1.0,4/16,11.20%,SMG6;MCM7;RAD17;GNB3
prerank,regulation of protein localization to cell surface (GO:2000008),-0.2915464348633726,-0.9196507132075508,0.5934426229508196,0.8675258150530109,1.0,4/33,9.60%,PICALM;NEDD4L;GPM6B;HSP90AB1
prerank,granulocyte differentiation (GO:0030851),-0.34744796653472787,-0.9195138679136388,0.5673575129533679,0.8668168623875295,1.0,4/18,11.06%,LEF1;CBFA2T3;TAL1;DEK
prerank,ruffle organization (GO:0031529),-0.36054737605001214,-0.9192725094594367,0.5789473684210527,0.8663225306536408,1.0,9/16,28.72%,PLEK;RAC1;AIF1L;CSF1R;ARF6;INPP5K;AIF1;CORO1B;PLEKHA1
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.3710278035051445,-0.9192185476643528,0.5935960591133005,0.8653839310015646,1.0,2/13,8.38%,RNF152;SPAAR
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.29625929590993616,-0.919089372642153,0.5929203539823009,0.8646576157995958,1.0,15/30,22.61%,DCN;UGDH;NDNF;IDS;CSGALNACT1;CHST3;CHSY3;NCAN;CSPG5;CSPG4;HEXB;CHSY1;VCAN;BGN;DSEL
prerank,sterol metabolic process (GO:0016125),-0.26162937519115087,-0.9188770099452138,0.6077586206896551,0.8640942265424513,1.0,12/60,12.35%,CYP7B1;APOE;PRKAG2;CYP26B1;CYP27A1;ABCA1;PPARD;SC5D;INSIG2;ABCA5;LIPA;OSBPL1A
prerank,cellular response to leucine (GO:0071233),0.4564077472922895,0.9184500052671246,0.5665467625899281,0.9570580573806872,1.0,2/10,10.44%,KLHL22;MTOR
prerank,response to leucine (GO:0043201),0.4564077472922895,0.9184500052671246,0.5665467625899281,0.9570580573806872,1.0,2/10,10.44%,KLHL22;MTOR
prerank,protein kinase A signaling (GO:0010737),0.4333243358970304,0.9179873109665679,0.5527638190954773,0.9574704890974686,1.0,3/12,15.65%,EZR;RDX;PRKACA
prerank,negative regulation of fat cell differentiation (GO:0045599),-0.29302524029613664,-0.9177107217742823,0.5885885885885885,0.8659017754758979,1.0,8/34,9.96%,RUNX1T1;FOXO1;ENPP1;WNT5A;CCDC85B;GPS2;GATA2;LRP3
prerank,regulation of small molecule metabolic process (GO:0062012),-0.30519667920116345,-0.9174171066168297,0.5890804597701149,0.8655108414269571,1.0,6/28,14.64%,APOE;PPARA;PDK1;ACADL;NR1H4;PDK2
prerank,nuclear envelope organization (GO:0006998),0.39702220405527605,0.9173897216944163,0.5640194489465153,0.9581624715213912,1.0,3/20,4.72%,NUP93;SUN3;TOR1AIP1
prerank,negative regulation of binding (GO:0051100),0.31663342490864704,0.9172696953365037,0.5667506297229219,0.957802075026988,1.0,13/81,11.61%,SMO;LRPAP1;PRKCD;BTAF1;GSK3B;SLPI;JUN;KDM1A;USP33;DISC1;WAPL;CSNK1E;GTPBP4
prerank,energy reserve metabolic process (GO:0006112),-0.33474406328292255,-0.9172321492959666,0.5882352941176471,0.8648882450011719,1.0,3/19,2.81%,LEPR;PRKAG2;GBE1
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.2903260632320265,0.9172306815926526,0.6233480176211453,0.9572516992092454,1.0,48/185,23.72%,FZR1;PKD1;SFI1;CEP164;ANAPC5;PAFAH1B1;CEP131;ANAPC16;CDC16;ERCC3;PCM1;HAUS5;CSNK1E;CEP70;CEP63;CEP57;PSMC6;RIOK2;XPC;PRKACA;CSNK1D;DCTN3;UBE2S;PSMD8;CNTRL;INO80;AKAP9;ZFP36L1;MAD2L1BP;CDC14A;PSMB1;CEP192;PSMD13;PSMD1;DCTN1;AURKA;PSMD7;PSMA8;ODF2;KLHL18;PSMD3;PSMD2;CDK1;NEK6;PSMC2;HAUS1;ERCC2;PSMB2
prerank,regulation of DNA metabolic process (GO:0051052),0.3437583057695204,0.9171994634889369,0.5677966101694916,0.9566987385616622,1.0,17/44,26.33%,PDGFA;SMG6;SMG1;KPNA1;HDAC8;XRCC5;USP1;UBE2N;NBN;MPHOSPH8;MPV17;SIRT7;ALYREF;YLPM1;WDR18;UBE2V1;WDR70
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.32536160416438575,-0.9171302329391978,0.556497175141243,0.8640819973495817,1.0,8/22,16.30%,PARP1;RPS27A;UBC;GTF2H2;DDB1;UBB;DDB2;CETN2
prerank,positive regulation of innate immune response (GO:0045089),0.36988825431474304,0.9169741539437085,0.5947901591895803,0.956550018976838,1.0,8/30,15.78%,LBP;POLR3D;PLSCR1;MAVS;IFI35;ADAM8;POLR3B;DHX9
prerank,sensory perception of chemical stimulus (GO:0007606),-0.35314013910222836,-0.9164430178160651,0.5666666666666667,0.864738287607414,1.0,3/15,16.76%,GNAS;ADCY3;UBR3
prerank,regulation of glucose metabolic process (GO:0010906),0.3601018631111929,0.9163035213738392,0.5667655786350149,0.9574350415405672,1.0,10/34,17.48%,FOXK1;IRS1;USP7;FOXK2;GNMT;GNB3;SLC45A3;IRS2;RORA;ADIPOR1
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.41164781555695623,0.9161929456949105,0.5646481178396072,0.957037380874746,1.0,4/16,19.15%,PAICS;PFAS;GMPS;AMPD3
prerank,negative regulation of transposition (GO:0010529),0.42020590396972946,0.9157581723148748,0.5746388443017657,0.9573527602014258,1.0,2/16,6.23%,MOV10;TDRD9
prerank,negative regulation of ATP metabolic process (GO:1903579),0.3979681181565471,0.9155240624734712,0.5751633986928104,0.9572033433843158,1.0,2/17,2.92%,HDAC4;PID1
prerank,negative regulation of interleukin-6 production (GO:0032715),-0.31047458426218283,-0.9153662196717564,0.6058981233243967,0.8663235954985375,1.0,7/27,16.06%,C1QTNF3;ARRB1;SIRPA;SYT11;GAS6;TNFAIP3;NCKAP1L
prerank,negative regulation of angiogenesis (GO:0016525),0.3127499101862017,0.91531656546195,0.5902439024390244,0.9570310815441561,1.0,6/84,2.85%,THBS1;SLC12A2;HOXA5;SULF1;KLF4;SEMA3E
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.3998993559824482,0.9150491759905419,0.5532591414944356,0.9569840344683082,1.0,3/20,7.14%,NT5E;ANO6;P2RX4
prerank,protein heterotetramerization (GO:0051290),0.4223436784083707,0.915046730490863,0.5549915397631133,0.9563650952659823,1.0,5/13,21.49%,PKD1;FARSA;CBR4;CPSF7;NUDT21
prerank,regulation of vesicle-mediated transport (GO:0060627),-0.24005260771239223,-0.9150412612398567,0.6896551724137931,0.8660343845824328,1.0,29/91,21.82%,PICALM;RIMS2;INPP5F;SYT7;MAPK3;SCARB1;OPHN1;RIT2;LRRK2;SRC;SPHK1;CDH13;HIP1;CPLX1;LGI3;ABL2;FES;SCFD1;RNF139;HIP1R;DNAJC13;SYK;HCK;RALA;AP2S1;RAB15;SYT1;RAB3C;RUFY2
prerank,positive regulation of cell projection organization (GO:0031346),0.3021059230555727,0.9146341139901678,0.6115606936416185,0.956670688935326,1.0,13/115,7.57%,SLIT2;DPYSL3;NGF;NTRK3;PTK2B;CUX1;RAP1A;TIAM2;FBXW8;EP300;PLXNA2;KIDINS220;MARK2
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.38975520095663146,0.9144823294126396,0.5778120184899846,0.9563587157539615,1.0,8/22,24.00%,CRY2;GSK3B;BOD1L1;STYXL1;FKBP1B;MASTL;PPP1R1B;ROCK1
prerank,regulation of immunoglobulin production (GO:0002637),0.3896935194207599,0.9144680128519016,0.5734597156398105,0.9557669766544216,1.0,4/23,12.13%,IL10;CLCF1;TNFRSF4;GPI
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),-0.29132661799832993,-0.9144671466668157,0.587248322147651,0.8664007687541009,1.0,5/37,7.45%,APOD;PPARA;HIF1A;ADCY7;SIRPA
prerank,regulation of mitochondrion organization (GO:0010821),0.3359761239654519,0.9144364635559605,0.5858310626702997,0.9552192820576334,1.0,16/47,24.08%,PID1;GSK3B;GOLPH3;EP300;PARL;CSNK2A2;OMA1;SQSTM1;CYRIB;PRMT6;FIS1;RHOT2;SIRT7;USP36;RHOT1;MUL1
prerank,protein autoubiquitination (GO:0051865),0.3286259348715853,0.9143354657293468,0.5943775100401606,0.9548315321763007,1.0,14/61,17.04%,WWP2;RNF115;UBE2B;RNF185;RNF141;LRSAM1;UBE2D3;UHRF2;RNF10;ERCC8;BFAR;RNF146;UBE3D;RNF122
prerank,mRNA export from nucleus (GO:0006406),0.30839354479785275,0.9142149805705847,0.6085365853658536,0.9544796471561777,1.0,34/102,26.14%,NUP93;SMG6;DDX19B;U2AF1L4;SMG1;CASC3;SEC13;SRSF5;NUP188;SRSF6;NXF1;SRRM1;RANBP2;THOC2;RBM8A;SRSF11;THOC5;ZC3H11A;NUP107;AAAS;CHTOP;ALKBH5;RAE1;NUP54;NUP98;CPSF4;FYTTD1;ALYREF;NCBP2;GLE1;UPF3B;SRSF7;FIP1L1;NUP37
prerank,positive regulation of small molecule metabolic process (GO:0062013),-0.36124182689965884,-0.9142145487037755,0.5790754257907542,0.8659691443661482,1.0,5/15,15.27%,PPARA;PPARD;PPM1K;ADM;AKT1
prerank,lymphocyte differentiation (GO:0030098),0.3230577012735907,0.9142084769542153,0.6007802340702211,0.9538710231228178,1.0,10/68,10.39%,HDAC4;PBX1;ITGB1;HDAC9;IL10;PTPN2;CLCF1;DCAF1;TCF3;GATA3
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.4112201837150033,0.9141063544556007,0.5658783783783784,0.9534705094167096,1.0,3/15,11.95%,CD44;KDM1A;TAF9
prerank,regulation of steroid biosynthetic process (GO:0050810),0.44550961652151977,0.9140386357722524,0.5996503496503497,0.952988160795846,1.0,1/11,1.04%,BMP5
prerank,positive regulation of cellular metabolic process (GO:0031325),0.3028838515697886,0.913804786150827,0.5950118764845606,0.9528833148637743,1.0,13/98,10.39%,THBS1;AGTR1;INHBA;ANXA2;KLF4;PID1;EIF4G1;TGFBR2;LIPT2;NSF;STARD4;ACOD1;GATA3
prerank,negative regulation of blood coagulation (GO:0030195),0.3506371606550848,0.9136373677341971,0.5718390804597702,0.952615417044874,1.0,4/38,6.41%,F3;THBD;PDGFA;SERPINE2
prerank,positive regulation of cell cycle process (GO:0090068),-0.23664567419107307,-0.9135581535827973,0.6378378378378379,0.8664951350077278,1.0,9/91,6.83%,IGF1;TGFA;PDGFRB;MAP3K20;CEP120;INSR;IGF2;SVIL;RGCC
prerank,calcium ion homeostasis (GO:0055074),0.3079503171660096,0.913381619570853,0.5860409145607701,0.9525761796685699,1.0,10/95,8.58%,SLC24A3;ANK2;ATP1B1;ATP2C2;CSRP3;STIM2;TNNI3;ATP2B4;SLC10A7;CYP27B1
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.3950430167219594,-0.9132096194648873,0.5991091314031181,0.8662877944237046,1.0,5/10,22.48%,PARP14;INPP5F;NF2;SH2B3;SOCS1
prerank,regulation of protein ubiquitination (GO:0031396),0.3066866672920598,0.912856592046921,0.6174334140435835,0.9530715568935004,1.0,27/108,19.08%,NXN;FAM107A;BIRC7;TGFBR1;MYCBP2;PRICKLE1;RIPK2;BCL10;FBXO4;PER2;COMMD1;HDAC8;WASHC1;GTPBP4;SQSTM1;BIRC3;AMER1;UFL1;USP4;TSPYL5;CENPX;UBE2N;HUWE1;WFS1;PINX1;ANGPT1;CHP1
prerank,response to peptide hormone (GO:0043434),0.3442467714849799,0.9125152022519961,0.5754189944134078,0.9531552072721656,1.0,11/43,18.37%,ANXA1;ZBTB7B;IGFBP5;IRS1;EIF2B2;STAT3;STAT5A;TRIM16;EIF2B3;STAT6;ZFP36L1
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.31779533558827794,0.9122539095079587,0.6078431372549019,0.9530903064701244,1.0,8/75,10.47%,PLCE1;GRK5;MRAP;MGLL;FRMPD1;SLC39A14;USP33;KCTD8
prerank,regulation of chemotaxis (GO:0050920),0.3692684472460219,0.9121702645800954,0.5589080459770115,0.9526624271568233,1.0,5/30,9.97%,THBS1;MYCBP2;PTPN2;P2RX4;CXCR4
prerank,monocyte chemotaxis (GO:0002548),-0.2952844521568151,-0.911919329250998,0.6422018348623854,0.8683037451918992,1.0,3/32,7.23%,FLT1;IL6R;RPS19
prerank,glutathione biosynthetic process (GO:0006750),0.4469524174891266,0.911794785701391,0.5764499121265377,0.9528970327088094,1.0,3/11,21.36%,GCLC;MGST2;GSS
prerank,regulation of autophagosome assembly (GO:2000785),0.3627752959221727,0.9116669882770454,0.6150442477876106,0.9525595017065791,1.0,15/33,23.78%,RAB3GAP2;LRSAM1;SMCR8;NPRL3;SEC22B;FEZ2;RAB5A;IFT88;CHMP4A;CHMP4B;SH3GLB1;TMEM39A;NPRL2;PIKFYVE;PHF23
prerank,protein export from nucleus (GO:0006611),0.3714269716088546,0.911522488501085,0.5663026521060842,0.9522866943906497,1.0,4/27,5.16%,PKD1;XPO1;EGR2;DUSP16
prerank,negative regulation of neuron death (GO:1901215),0.3089575913006766,0.9114406443768427,0.6060240963855422,0.9518442049508252,1.0,11/93,8.32%,NGF;SIX1;TGFB3;PTK2B;ISL1;EIF4G1;GSK3B;GDNF;CLCF1;NFATC4;TNFRSF1B
prerank,histone H3-K9 demethylation (GO:0033169),0.4406201026220652,0.9114195455262176,0.5714285714285714,0.9512784078147564,1.0,4/11,12.60%,JMJD1C;KDM1A;KDM4D;KDM3B
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.3609167376710495,-0.9100759858197057,0.5710900473933649,0.8715002055404352,1.0,4/14,8.99%,RAPGEF2;PRKAR2B;PRKAR1B;PRKAR1A
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.39465711194956865,-0.9100601272247196,0.6022222222222222,0.87049992241356,1.0,2/10,6.09%,PCGF5;IGF2
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.4210341113749948,0.9100185762140255,0.571912013536379,0.9536312907895192,1.0,3/12,11.95%,CD44;KDM1A;TAF9
prerank,protein K48-linked ubiquitination (GO:0070936),-0.2674254908436035,-0.9093624974293668,0.6345381526104418,0.871097695867294,1.0,13/54,18.54%,RNF152;NEDD4L;UBE2E2;KLHL3;UBE2A;RFFL;RNF187;RNF6;TNFAIP3;TOPORS;ZNRF1;KBTBD7;HACE1
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),-0.3576162480609575,-0.9090754316172324,0.5771971496437055,0.8707489411140331,1.0,10/14,37.48%,CD81;RPS3;NECTIN2;RELA;KCNN4;TRAT1;CD226;TESPA1;LCK;RAB29
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.40722793711901967,0.9082658975220893,0.5636363636363636,0.9566619245736788,1.0,3/18,4.68%,USP13;DDIT3;RNF185
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.37730621978154755,-0.9081593371477228,0.5672371638141809,0.8718872383038895,1.0,7/12,38.30%,CCT5;GNL3;CCT2;GNL3L;DKC1;CCT8;CCT7
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.3245961648502239,0.9080244389586233,0.6005221932114883,0.9565828536903378,1.0,16/64,18.62%,MLLT3;ELOF1;MNAT1;CTR9;ERCC3;SETD2;PAF1;RTF1;GTF2F2;CDK12;ELP4;ELOA;EAF2;AFF4;NELFE;POLR2H
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.40191387237984944,-0.9076464419578626,0.5911214953271028,0.8720312616627967,1.0,5/10,32.43%,CX3CR1;ARRB2;PTPRC;LILRB1;FCGR2B
prerank,positive regulation of histone modification (GO:0031058),-0.29966427695407744,-0.9074740161193915,0.5811688311688312,0.871359457804468,1.0,13/33,25.34%,RPS6KA5;MAPK3;PPARGC1A;ARRB1;RUVBL2;NOS1;BRCA1;ING2;APLNR;CTBP1;TET1;TADA2B;SART3
prerank,negative regulation of reproductive process (GO:2000242),0.40548958485478803,0.907452061142225,0.5538720538720538,0.9571831313757273,1.0,2/17,1.78%,SULF1;ARHGDIB
prerank,regulation of cell-substrate adhesion (GO:0010810),0.34461794860503975,0.9073529472559024,0.5854700854700855,0.9567786445595646,1.0,7/42,12.77%,VIT;GCNT2;FZD7;DMTN;AGR2;RHOA;RSU1
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.4403162379659301,0.9071075278301828,0.5766550522648084,0.9566906056104401,1.0,2/11,9.48%,CAMK2D;CACNB2
prerank,negative regulation by host of viral process (GO:0044793),0.438438279296928,0.9069915456752545,0.5646630236794171,0.9563063197822371,1.0,2/10,9.46%,EIF2AK4;VAPA
prerank,platelet aggregation (GO:0070527),-0.29194715184864695,-0.9065735989569724,0.5855263157894737,0.8723634083338662,1.0,9/33,9.38%,PPIA;GNAS;TLN1;ACTB;MYH9;PDGFRA;PLEK;MYL12A;MYL9
prerank,positive regulation of lymphocyte activation (GO:0051251),-0.30308755175082686,-0.9053002493031954,0.5730994152046783,0.8742952613723666,1.0,4/28,7.45%,CD47;SH3KBP1;PRKCQ;SIRPA
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.31540147516486017,-0.9045977513660485,0.6199460916442049,0.8738715104998017,1.0,3/23,6.32%,TFDP2;BCL2;PPP3R1
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.31540147516486017,-0.9045977513660485,0.6199460916442049,0.8738715104998017,1.0,3/23,6.32%,TFDP2;BCL2;PPP3R1
prerank,myeloid cell differentiation (GO:0030099),-0.26929565146608536,-0.9045945946555013,0.6405228758169934,0.8728491246671306,1.0,14/47,18.61%,LYN;MFHAS1;RPS14;KIT;SNRK;RPS19;HSPA9;TAL1;CASP3;IKZF1;SLC25A38;TIRAP;KMT2E;JAK3
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.30566931512126616,-0.9043763223712101,0.5685131195335277,0.8723432767103984,1.0,15/25,25.14%,CCDC88A;RBPJ;DGKD;HIP1;AGT;HIP1R;AKT1;CNOT9;DOK1;RTN4;AFAP1L2;NUP62;HAP1;PLAUR;GPER1
prerank,negative regulation of receptor internalization (GO:0002091),0.4370714309947239,0.9039763738231357,0.5691768826619965,0.9621291934356745,1.0,5/12,20.34%,LRPAP1;RIN3;ANKRD13D;ATXN2;DLG4
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.3715885959803238,0.9037334373010207,0.5874439461883408,0.962048228019779,1.0,6/28,15.96%,NGF;DIABLO;CRADD;MOAP1;TRADD;CASP8AP2
prerank,Rho protein signal transduction (GO:0007266),0.33203147107147557,0.9033963086600255,0.6123822341857336,0.9621407170667902,1.0,5/53,2.20%,NTN1;ARHGDIB;CDC42EP5;RHOJ;AGTR1
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.4133583550961253,0.9031074346767556,0.5757575757575758,0.9621261813055443,1.0,7/15,29.89%,ZC3H12D;LACTB2;NYNRIN;RNASEH1;POP1;ZC3H12A;NUDT16
prerank,negative regulation of translation (GO:0017148),0.31138353127940044,0.9030421110033336,0.6022304832713755,0.9616508406802746,1.0,25/87,24.24%,SAMD4A;FTO;IGFBP5;SYNCRIP;CNOT7;PAIP2;CELF1;TOB1;EIF2AK4;EIF2AK3;NANOS2;FXR2;PUM1;EIF4E2;YTHDF3;YTHDF2;EIF4ENIF1;PUS7;EIF3E;FMR1;LARP1;CAPRIN1;PCIF1;ROCK1;RBM4
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.3697852234450836,-0.9030081656200072,0.5776699029126213,0.8745406715413135,1.0,3/13,13.26%,CD81;SEC16B;BRSK2
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.38445344869954884,0.9027629883085182,0.575516693163752,0.9616359918399263,1.0,5/21,11.22%,ADAM9;SPPL2A;ADAM10;ERAP1;RBMX
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.335479199389106,0.9027382710848363,0.5937072503419972,0.9604654814695195,1.0,16/50,22.40%,EIF4G1;NUP93;SEC13;NUP188;RANBP2;PUM2;PUM1;TNRC6A;POLR2H;NUP107;AAAS;IPO8;RAE1;NUP54;NUP98;FMR1
prerank,regulation of gene silencing by RNA (GO:0060966),0.335479199389106,0.9027382710848363,0.5937072503419972,0.9604654814695195,1.0,16/50,22.40%,EIF4G1;NUP93;SEC13;NUP188;RANBP2;PUM2;PUM1;TNRC6A;POLR2H;NUP107;AAAS;IPO8;RAE1;NUP54;NUP98;FMR1
prerank,positive regulation of interleukin-12 production (GO:0032735),-0.30034302131893054,-0.9023544946166046,0.6238244514106583,0.8750093870963358,1.0,6/31,16.62%,PLCB1;MDK;TLR3;SYK;TIRAP;CCL19
prerank,regulation of glucose import (GO:0046324),0.36263303760065296,0.9021460696963002,0.5903614457831325,0.9610818314960475,1.0,8/30,8.54%,SORBS1;GRB10;PID1;C1QTNF12;ERFE;IRS1;CAPN10;RHOQ
prerank,cellular response to leucine starvation (GO:1990253),0.4468499774804384,0.9019025937799916,0.5661764705882353,0.9609628061064933,1.0,3/10,16.13%,EIF2AK4;MTOR;RRAGB
prerank,keratan sulfate biosynthetic process (GO:0018146),0.36520444893064186,0.9015639255070169,0.6058732612055642,0.9611215536570786,1.0,5/26,10.18%,ST3GAL4;B3GNT2;CHST5;B4GAT1;B4GALT1
prerank,regulation of autophagy (GO:0010506),0.28301401262130044,0.9014932662591144,0.6627027027027027,0.9606572880757774,1.0,43/216,15.22%,MET;FOXO3;EIF4G3;DAPL1;NEDD4;EXOC4;USP13;EIF4G1;FOXK1;IL10;GSK3B;ABL1;DDIT3;KLHL22;TAB3;EP300;ATM;SMCR8;ATP6V0A1;USP10;MLST8;KAT5;USP33;FOXK2;MTOR;WASHC1;PIM2;CSNK2A2;ATP6V0E1;MTDH;STAT3;BNIP3;HTR2B;RB1CC1;ATP6V1H;ATP6V0D1;WDR41;TFEB;UFL1;SNX32;STK11;MAPK15;PRKAA1
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.3319120587004389,0.9012819728238916,0.6052998605299861,0.9605163455428097,1.0,7/51,8.44%,DCLK1;NGF;TRIO;ANKRD27;SHTN1;NCKAP1;SRGAP2
prerank,hematopoietic stem cell differentiation (GO:0060218),0.4462992768812164,0.901263139645525,0.5782442748091603,0.9599481002051317,1.0,3/10,16.01%,MLLT3;UFL1;LMBR1L
prerank,positive regulation of neurogenesis (GO:0050769),0.3204573000766409,0.9009285588960071,0.6050632911392405,0.9600245876357835,1.0,7/68,7.72%,SLIT2;NGF;CUX1;TIAM2;FBXW8;PLXNA2;KDM1A
prerank,microtubule nucleation (GO:0007020),0.3861703349957456,0.9008884318845527,0.5940438871473355,0.9595180891584818,1.0,7/20,19.71%,NDEL1;SLAIN2;TUBGCP4;TUBGCP5;CSNK1D;AKAP9;TUBGCP6
prerank,synapse assembly (GO:0007416),0.31478914561917265,0.9008441217810375,0.5933774834437087,0.9590103144159748,1.0,3/67,3.05%,CDH1;PCDHB16;PCDHB13
prerank,calcium ion import (GO:0070509),-0.2987079881477178,-0.9007490274626574,0.5952380952380952,0.8776615442912283,1.0,9/28,19.08%,CACNA1D;CACNA1E;SLC8A1;CACNA1B;TRPC4;CACNA1I;MCUR1;ATP2A2;TRPV4
prerank,cellular response to hexose stimulus (GO:0071331),-0.30508963528266997,-0.9003997759960856,0.6097560975609756,0.8774145889504124,1.0,5/23,11.01%,IGF1R;ZBTB20;ERN1;GAS6;PRKAA2
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.31145830884423487,-0.9003231858462398,0.587012987012987,0.876569039390787,1.0,8/23,24.89%,PARP14;NR1H3;NLRC5;HSP90AB1;TXK;STAT1;SOCS1;CDC37
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.43271703585035093,0.9001090322406992,0.5938628158844765,0.959989203546374,1.0,1/11,0.81%,SOAT1
prerank,cell cycle G1/S phase transition (GO:0044843),0.32640107795152906,0.9000414483210873,0.6129458388375165,0.9595289786121997,1.0,13/61,16.33%,CCNA2;INHBA;PLK3;CDKN1B;MNAT1;E2F3;PIM2;RB1;ACVR1;CUL4A;CDKN2D;CDKN3;GSPT1
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.43903475062222924,0.8999017057601673,0.592128801431127,0.9592408271782378,1.0,4/10,24.35%,PAF1;NUDT21;LEO1;NCBP2
prerank,regulated exocytosis (GO:0045055),0.2887780670548896,0.8997101737081894,0.6574279379157428,0.9590556150841911,1.0,19/173,10.12%,PCDH7;THBS1;FN1;CD109;TGFB3;LHFPL2;CD9;SYT8;DNAJC5;PDGFA;CLU;VCL;ABCC4;FAM3C;SYTL4;GTPBP2;RAB27B;WDR1;ISLR
prerank,positive regulation of MAP kinase activity (GO:0043406),0.31982023913705215,0.8995254328034965,0.6033376123234917,0.9588419839426428,1.0,9/66,7.51%,EGFR;MAP3K5;PDGFC;FGFR1;PDGFA;ARHGEF5;TNFSF11;TLR6;FGF2
prerank,aspartate family amino acid catabolic process (GO:0009068),-0.3289289268406179,-0.8994638285295083,0.5956873315363881,0.8774649172114024,1.0,4/19,16.13%,DDO;ALDH7A1;ASPA;GCDH
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.3889936998843748,0.8994211565400688,0.576271186440678,0.9584377264856813,1.0,5/19,11.02%,ZFPM2;BMPR1A;TGFBR1;FGF2;NOG
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.3348939767823853,-0.8993818844970153,0.6053333333333333,0.8766372532536868,1.0,8/18,29.16%,PLCB1;CHRM3;CHRM2;CDK5R1;GRK2;AGRN;RGS8;GNA15
prerank,negative regulation of interleukin-17 production (GO:0032700),0.43479914925042307,0.8990039138772438,0.5676156583629893,0.9587099574522611,1.0,2/10,11.44%,DDIT3;TLR4
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.338244215514386,0.8989672494143969,0.6084010840108401,0.9581804587044586,1.0,3/43,4.22%,EGFR;PTPN3;RNF115
prerank,lipid modification (GO:0030258),0.34890184497065785,0.89885280362922,0.5722543352601156,0.9578218368478026,1.0,2/37,2.51%,PLPPR2;PLPP3
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.4366047411084548,0.8988144424196898,0.5760286225402504,0.9572986381528351,1.0,2/10,7.28%,LBP;IFI35
prerank,neutrophil degranulation (GO:0043312),0.2737387059768668,0.8986227554617439,0.7177914110429447,0.9570926222798591,1.0,67/425,13.43%,ANXA3;RAB44;CD44;CD55;DSP;SPTAN1;NRAS;ANXA2;TMC6;PRKCD;ANO6;PYGB;RAP1A;GSN;DIAPH1;STOM;DNAJC5;UBR4;AP2A2;CYSTM1;VCP;RAB6A;VNN1;SLPI;NFKB1;DNAJC3;VCL;ITGAV;HMOX2;BIN2;RAP2C;PDAP1;RAB18;IGF2R;TIMP2;JUP;IQGAP1;ADAM10;TNFRSF1B;ATP6V0A1;ACP3;PLD1;BRI3;VAPA;HPSE;FRK;B4GALT1;DERA;SNAP23;IST1;KCMF1;OSTF1;CRACR2A;ARL8A;GLB1;RHOA;GPI;CD36;ADAM8;TOM1;FAF2;ARSB;MAPK1;PLEKHO2;COMMD9;XRCC5;CPNE3
prerank,carbohydrate homeostasis (GO:0033500),0.32154852450698757,0.8986161432901675,0.6186107470511141,0.9565046087592491,1.0,17/67,18.27%,TCF7L2;CRY2;KCNB1;KLF7;HNF4A;HNF1A;IRS1;PTPN2;SELENOT;STAT3;MCU;STK11;PRKAA1;SLC8B1;PAX6;ADIPOR1;WFS1
prerank,response to growth factor (GO:0070848),0.3352325493276711,0.8979260176927822,0.5991440798858774,0.9573567042547904,1.0,9/41,14.79%,SHC1;KLF4;BMPR1A;TGFBR1;TGFBR2;ACVR1;CPNE3;MAP2K5;AMHR2
prerank,positive regulation of monooxygenase activity (GO:0032770),-0.2996078723949672,-0.8978069940290437,0.6368715083798883,0.8792857312236287,1.0,8/26,18.00%,APOE;HIF1A;SCARB1;NOS1AP;AKT1;ATP7A;CDH3;PARK7
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.36973126428876396,-0.8976565016992033,0.597254004576659,0.878569411670747,1.0,2/12,9.03%,CYP26B1;CALR
prerank,prostanoid metabolic process (GO:0006692),-0.36467297749351135,-0.8969332241332422,0.6066350710900474,0.879139353050016,1.0,3/13,20.47%,PTGS1;HPGDS;ACOX1
prerank,recombinational repair (GO:0000725),0.31151655508564574,0.8966680490969442,0.6264009962640099,0.9593745908141745,1.0,37/77,30.32%,REV3L;RNF138;SWSAP1;ZFYVE26;RAD52;BRCA2;RAD51C;RPA1;RAD51AP1;KDM4D;EXD2;NSMCE2;AP5S1;RBBP8;UBE2N;WRN;YY1;MCM9;NBN;INO80;SMC5;MRE11;XRCC2;RECQL5;ERCC5;ZSWIM7;PSMD14;MEIOB;XRCC1;LIG3;RFWD3;POLQ;RAD51B;SPIDR;SEM1;NSMCE1;TONSL
prerank,cell chemotaxis (GO:0060326),0.32280617067113543,0.8962623633897134,0.5935828877005348,0.9596220942404801,1.0,7/60,7.71%,CCN3;PARVA;AGTR1;PRKCD;PIP5K1A;BIN2;NRP1
prerank,regulation of cell cycle process (GO:0010564),0.29746123671632985,0.8962145398655322,0.6358313817330211,0.9590984682273515,1.0,16/104,12.16%,KIF13A;KLHL13;BIRC6;BECN1;PLK3;RAB11FIP3;IHO1;TXLNG;ENTR1;ZFYVE26;CDC42;CHEK1;CSNK2A2;CSNK2A1;SETD2;CEP85
prerank,oligosaccharide metabolic process (GO:0009311),0.3400937001393243,0.8961944896656019,0.5930555555555556,0.9585445315563305,1.0,3/46,5.10%,ST3GAL4;FUT8;NAGA
prerank,cellular amino acid catabolic process (GO:0009063),-0.23744463053139822,-0.8959558618793475,0.6933962264150944,0.8803188638543531,1.0,22/87,24.02%,NOS3;DDO;BCKDHB;ALDH7A1;QDPR;IVD;ACAD8;BCKDHA;ASPA;SLC25A44;ALDH4A1;ABAT;GCDH;SARDH;NOS1;GSTZ1;HSD17B10;HOGA1;HIBADH;SHMT2;KYNU;GLUD1
prerank,neuron development (GO:0048666),0.2925808057967476,0.8957345761502425,0.660092807424594,0.9589259778306856,1.0,12/141,6.52%,VSX1;PBX3;RP1;PBX1;NEDD4;WNK1;DOCK7;GSK3B;HDGFL3;GDNF;CDNF;ARL3
prerank,positive regulation of cytokine production (GO:0001819),0.2748294841522435,0.8956627143600234,0.7098831030818279,0.9584738249830467,1.0,44/292,14.25%,F3;FOXP1;ANXA1;CYP1B1;SULF1;LBP;ISL1;IL10;ZBTB7B;DDIT3;POLR3D;NFKB1;CD80;HILPDA;EP300;MAVS;RIPK2;TLR6;IL17RA;KAT2A;CREBBP;GATA4;BCL10;RAB7B;HPSE;NFKB2;NOX1;CD46;SULF2;GATA3;EIF2AK3;IRF1;TLR4;IL16;CRCP;TNFRSF14;POLR3GL;STAT3;PIBF1;HTR2B;XRCC5;CEBPB;CYRIB;POLR3B
prerank,neutrophil activation involved in immune response (GO:0002283),0.272564515598441,0.8954514426728605,0.7247706422018348,0.9583010321827192,1.0,67/428,13.43%,ANXA3;RAB44;CD44;CD55;DSP;SPTAN1;NRAS;ANXA2;TMC6;PRKCD;ANO6;PYGB;RAP1A;GSN;DIAPH1;STOM;DNAJC5;UBR4;AP2A2;CYSTM1;VCP;RAB6A;VNN1;SLPI;NFKB1;DNAJC3;VCL;ITGAV;HMOX2;BIN2;RAP2C;PDAP1;RAB18;IGF2R;TIMP2;JUP;IQGAP1;ADAM10;TNFRSF1B;ATP6V0A1;ACP3;PLD1;BRI3;VAPA;HPSE;FRK;B4GALT1;DERA;SNAP23;IST1;KCMF1;OSTF1;CRACR2A;ARL8A;GLB1;RHOA;GPI;CD36;ADAM8;TOM1;FAF2;ARSB;MAPK1;PLEKHO2;COMMD9;XRCC5;CPNE3
prerank,ketone body metabolic process (GO:1902224),0.4313401435722511,0.8950939418525979,0.5901639344262295,0.9584946979133406,1.0,2/10,8.37%,BDH2;AACS
prerank,cytokine-mediated signaling pathway (GO:0019221),0.2695713533170094,0.8949514908075928,0.75730110775428,0.9581998924716242,1.0,71/532,13.26%,TNFRSF11B;F3;CARD14;FN1;EDA;TRAF3IP2;ANXA1;IL17RE;FOXO3;PTK2B;CD44;CAMK2D;IL22RA1;GRB10;PITPNA;LBP;ITGB1;SHC1;ANXA2;PRKCD;MID1;IL10;IP6K2;PDCD4;TNFRSF13B;SOCS2;NFKB1;CD80;IL5;TNFSF11;TAB3;IRS1;FBXW11;IL18RAP;IL18BP;TRIM26;CHUK;CLCF1;RIPK2;IFI35;IL17RA;FGF2;GAB2;MAP3K3;IRAK4;TNFRSF4;TNFRSF1B;CDIP1;SMARCA4;CDKN1B;CTR9;BCL6;GATA3;TRIM25;PAK2;CDC42;IRF1;SQSTM1;CSK;IL16;TNFRSF14;CD36;STAT3;BIRC3;FOXC1;STAT5A;TRADD;CAPZA1;DUOX1;CIITA;TRAF5
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.3865997948715945,0.89460612397118,0.5987460815047022,0.9583323105728557,1.0,2/21,3.78%,FOXP1;ELF1
prerank,leukotriene biosynthetic process (GO:0019370),-0.3558713284593991,-0.8945592623388119,0.5976744186046512,0.882353072149672,1.0,8/14,31.50%,GGT5;MGST3;GGT7;GGT1;PLA2G5;ALOX5AP;ALOX5;LTA4H
prerank,peptidyl-lysine methylation (GO:0018022),0.3692975764905631,0.8944892384574682,0.5973254086181278,0.9579958173557325,1.0,8/26,20.97%,SMYD2;SETD2;METTL21C;EHMT2;EHMT1;EEF1AKMT1;METTL21A;METTL18
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.3951430371224321,0.8943956346736122,0.5910596026490066,0.9575836580236755,1.0,9/18,25.78%,PTK2B;SHTN1;BCAS3;CYRIB;LLGL1;RAP1B;ROCK1;RUFY3;ARFGEF1
prerank,mitochondrial fission (GO:0000266),-0.3456488476446329,-0.8940035034532663,0.6176470588235294,0.8825733919970672,1.0,5/16,21.94%,DNM3;SLC25A46;DNM1;DNM1L;MTFP1
prerank,neutrophil mediated immunity (GO:0002446),0.2721413624357194,0.8934285377126475,0.7313585291113381,0.959026442624962,1.0,68/432,13.43%,ANXA3;RAB44;CD44;CD55;DSP;SPTAN1;NRAS;ANXA2;TMC6;PRKCD;ANO6;PYGB;RAP1A;GSN;DIAPH1;STOM;DNAJC5;UBR4;AP2A2;CYSTM1;VCP;RAB6A;VNN1;SLPI;NFKB1;DNAJC3;VCL;ITGAV;HMOX2;BIN2;RAP2C;PDAP1;RAB18;IGF2R;TIMP2;JUP;IQGAP1;IRAK4;ADAM10;TNFRSF1B;ATP6V0A1;ACP3;PLD1;BRI3;VAPA;HPSE;FRK;B4GALT1;DERA;SNAP23;IST1;KCMF1;OSTF1;CRACR2A;ARL8A;GLB1;RHOA;GPI;CD36;ADAM8;TOM1;FAF2;ARSB;MAPK1;PLEKHO2;COMMD9;XRCC5;CPNE3
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.34537571671882766,0.8933543970408714,0.6102941176470589,0.9585789861692611,1.0,1/36,0.19%,EGFR
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.37604156692750534,0.8932232448709967,0.5819295558958653,0.9582463134602466,1.0,4/21,4.49%,ANK2;CAMK2D;CACNA1C;DMD
prerank,myelination (GO:0042552),0.3366246378052486,0.8929279915986802,0.5936199722607489,0.9582314361135714,1.0,9/46,10.75%,ACER3;PMP22;MARVELD1;ADGRG6;ARHGEF10;CXCR4;SKI;EIF2B2;PARD3
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.3309694346774102,0.8926186504805849,0.6131191432396251,0.9582598298298302,1.0,3/51,2.80%,THBS1;PGF;ANO6
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.3782204812649451,0.8924967055212523,0.60882800608828,0.9579254673695353,1.0,4/24,11.71%,FOXO3;DDIT3;TFAP2A;TGFB2
prerank,glycoprotein biosynthetic process (GO:0009101),0.3074774946931921,0.8924814822815925,0.6189873417721519,0.9573686369123272,1.0,7/79,5.50%,ST3GAL4;B3GNT2;LARGE1;GCNT2;CHST13;MPI;GOLPH3
prerank,response to interferon-beta (GO:0035456),-0.31346496341653346,-0.8923996855272496,0.5753424657534246,0.8851909494939789,1.0,5/22,10.24%,BST2;IFITM1;AIM2;IFNAR2;IFITM3
prerank,mitochondrial transport (GO:0006839),-0.2542007777304581,-0.8921447036743201,0.6653992395437263,0.8847225545300226,1.0,14/53,18.26%,BCL2;BCL2L1;MFN2;TMEM14A;AIP;TIMM44;TMEM14C;TIMM13;STARD3;COX18;TSPO;SLC25A4;SLC25A24;TOMM7
prerank,regulation of MAP kinase activity (GO:0043405),0.3026864943288477,0.8916407391331272,0.6424314660309892,0.9584524180923581,1.0,9/92,7.51%,EGFR;BMP4;PDGFC;FGFR1;PRKCD;PDGFA;TNFSF11;PPEF2;FGF2
prerank,histone H3-K36 demethylation (GO:0070544),-0.3860696687941044,-0.8914971063332237,0.5862831858407079,0.8851685485261072,1.0,2/10,4.79%,KDM7A;KDM2B
prerank,activation of adenylate cyclase activity (GO:0007190),0.35004920832060377,0.8913584054754801,0.6090775988286969,0.9584287051034356,1.0,3/35,5.09%,EDNRA;ADRB2;ADCY9
prerank,regulation of mRNA catabolic process (GO:0061013),0.29487315611522386,0.8911542177287558,0.6533018867924528,0.9582294210424552,1.0,35/121,22.77%,SAMD4A;PRKCD;EIF4G1;XPO1;MOV10;CNOT7;PCBP4;EXOSC7;SERBP1;ZC3H14;PUM2;PSMC6;FXR2;PUM1;PRKCA;PSMD8;MAPKAPK2;EXOSC5;YTHDF3;ZFP36L1;YTHDF2;RC3H2;PSMB1;PABPC1;PSMD13;PSMD1;PSMD7;PSMA8;PSMD3;EXOSC4;PSMD2;DCP1A;APEX1;FMR1;PSMC2
prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.3516348912073518,-0.8908541392683937,0.6285714285714286,0.885587578178692,1.0,6/15,13.28%,IGF1;IL6ST;PARP1;PDE9A;EDN1;AGT
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.43340457292149503,0.8901786903158894,0.5975609756097561,0.9596229255093628,1.0,1/11,0.45%,THBS1
prerank,actin nucleation (GO:0045010),-0.32843777837234567,-0.8899055407209223,0.6297297297297297,0.8867906959307413,1.0,15/21,41.18%,IQGAP2;LMOD1;TRIM27;SPIRE1;ARPC3;ARPC5L;ARPC1A;SPIRE2;ACTR2;SCIN;ARPC4;LMOD3;JMY;ARPC5;MAGEL2
prerank,tRNA metabolic process (GO:0006399),-0.3324008814456537,-0.8898054714628008,0.5913705583756346,0.8859974806284737,1.0,7/17,28.49%,DTD2;POP5;SARS1;DTD1;POP7;DARS2;RPP21
prerank,negative regulation of kinase activity (GO:0033673),-0.24999509626513022,-0.8897930235191902,0.6747967479674797,0.8850015675800967,1.0,19/62,21.99%,PPM1E;PRKAG2;PPIA;SNCA;GSKIP;MAPT;PPP2R5A;SPRED1;TRIM27;AKT1;CDKN1C;PPM1F;TARBP2;PARK7;RTRAF;HNRNPU;INPP5K;TRIB3;TAB1
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.418327735781885,0.8895187786664088,0.5849056603773585,0.9604049239409367,1.0,2/13,10.89%,KCNB1;HYAL3
prerank,response to steroid hormone (GO:0048545),0.35445301997485645,0.8890009556270808,0.6295224312590448,0.9608622282436436,1.0,2/31,1.44%,THBS1;TGFB3
prerank,diacylglycerol metabolic process (GO:0046339),0.37886954810433854,0.8888635059987506,0.5852895148669797,0.9605752867012869,1.0,1/23,0.44%,PLCE1
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.3493562513636677,0.8884319396266982,0.6070901033973413,0.960270183296561,1.0,14/32,28.44%,NUP93;SEC13;NUP188;RANBP2;RAN;NUP107;AAAS;RAE1;NUP54;NUP98;XPOT;NUP37;NUP153;NUP88
prerank,tRNA export from nucleus (GO:0006409),0.3493562513636677,0.8884319396266982,0.6070901033973413,0.960270183296561,1.0,14/32,28.44%,NUP93;SEC13;NUP188;RANBP2;RAN;NUP107;AAAS;RAE1;NUP54;NUP98;XPOT;NUP37;NUP153;NUP88
prerank,amide biosynthetic process (GO:0043604),0.33148124927461353,0.8877685707442587,0.6381766381766382,0.9610605772350294,1.0,7/47,8.67%,PCSK5;SGMS2;DMD;SPTSSB;NANP;CERS6;CERS5
prerank,response to lipopolysaccharide (GO:0032496),0.2882506052095085,0.8874853780794579,0.6795016987542469,0.9610814074618924,1.0,27/138,17.43%,FOXP1;LBP;SMAD6;ADAM9;IL10;PDCD4;SLPI;NFKB1;CD80;SHPK;TNFRSF1B;CYP27B1;BCL10;CTR9;ACOD1;TLR4;RHOA;PAF1;ERBIN;TRIM41;SBNO2;PRDX3;MYD88;TICAM2;CARD16;MAPK8;MAPKAPK2
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.3425149139754185,0.8873704947838081,0.5809379727685325,0.9607517111256919,1.0,6/33,10.59%,TCF7L2;IL10;CAST;NFE2L2;GATA3;PAK4
prerank,neuron projection extension (GO:1990138),0.35144837645090665,0.8871793585696301,0.6006051437216339,0.9605801725844958,1.0,11/32,19.28%,ALCAM;ULK2;NRP1;IQGAP1;EIF2AK4;SPG11;MAP1B;LLPH;CYFIP1;ULK1;USP9X
prerank,neuron projection regeneration (GO:0031102),-0.3905622619013867,-0.8870146513678132,0.6442516268980477,0.8901960238868446,1.0,3/10,23.06%,NREP;OMG;PTN
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.3268512492900706,-0.8870047417507305,0.6052631578947368,0.8891953378682661,1.0,9/18,27.11%,ADAMTS9;STT3B;SAMHD1;FBXO6;AOAH;FUCA1;NEU2;FBXO44;FBXO2
prerank,neuropeptide signaling pathway (GO:0007218),-0.2544792536536412,-0.8868176571455119,0.7421875,0.888581063678449,1.0,7/58,11.17%,SORT1;RAPGEF2;GPR37;SORCS2;CYSLTR1;GLRA1;CYSLTR2
prerank,negative regulation of cholesterol transport (GO:0032375),0.433304679345798,0.8866007446216102,0.6314814814814815,0.9611989863390822,1.0,1/10,5.36%,NFKB1
prerank,negative regulation of innate immune response (GO:0045824),-0.2851220637063619,-0.8862503805719335,0.6498422712933754,0.8888261613741142,1.0,10/34,16.70%,SAMHD1;GRN;RPS19;NLRC5;A2M;USP18;TRIM21;TNFAIP3;METTL3;TYRO3
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.3395598652442696,0.8856085729867288,0.6115007012622721,0.9626302696022899,1.0,6/36,6.05%,TCF7L2;PPP3CA;WNT11;PLCB3;TNRC6C;MOV10
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),-0.32549143724643664,-0.8854851397197804,0.6300268096514745,0.8895500298261276,1.0,13/19,38.79%,SRC;TENT4B;DCP2;HNRNPU;TEN1;GNL3L;EXOSC10;CTC1;HNRNPA1;PIF1;HNRNPC;NAT10;TERF2
prerank,positive regulation of stress fiber assembly (GO:0051496),0.33186527514652225,0.8850629897489304,0.6024590163934426,0.9631906538191528,1.0,8/44,7.71%,SORBS3;TGFB3;WNT11;ABL1;TGFBR1;ARHGEF10;ARHGEF5;NRP1
prerank,kinetochore organization (GO:0051383),-0.35614438796822856,-0.8849334801306183,0.6082949308755761,0.889771140889282,1.0,8/13,41.05%,CENPE;CENPA;DLGAP5;NUF2;NDC80;POGZ;MIS12;CDT1
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.38205644347797474,0.8846392908962192,0.6036585365853658,0.9634473905441553,1.0,5/20,10.88%,TNRC6C;MOV10;CNOT7;CELF1;NRDE2
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.30418154413776743,0.88459003517307,0.6649810366624526,0.9629620444970637,1.0,21/87,20.29%,CD44;RBFOX2;FGFR1;SPRED2;FLRT2;SHOC2;FGF22;HNRNPH1;FGF2;KLB;CEP57;MAPK1;GTF2F2;DSTYK;ITGB1BP1;FGF18;NR4A1;ZFP36L1;POLR2H;PTPN11;HNRNPM
prerank,regulation of interferon-gamma production (GO:0032649),-0.24632815661194232,-0.8845105634866209,0.7083333333333334,0.8896985622575273,1.0,13/71,14.43%,IL1R1;PDE4B;CD47;SLC7A5;SIRPA;GAS6;PDE4D;IL18;TLR3;HAVCR2;TRIM27;TLR7;NR1H4
prerank,cellular respiration (GO:0045333),-0.2707923666654568,-0.8844002487804602,0.6642857142857143,0.8889112794470828,1.0,22/41,34.94%,SDHA;PPARGC1A;UQCR10;UQCRH;ME3;NDUFS4;ATP5F1D;MTLN;COX10;CYCS;UQCRC2;UQCRB;UQCRFS1;NDUFA5;COX4I2;ETFRF1;NDUFS1;MTFR2;SIRT3;SDHB;LYRM7;BLOC1S1
prerank,negative regulation of secretion by cell (GO:1903531),0.34204149778955617,0.884215264486854,0.6158273381294964,0.9631319758240965,1.0,2/38,1.32%,STXBP6;ANXA1
prerank,regulation of tube diameter (GO:0035296),0.4120146029382777,0.8840963823849216,0.5982456140350877,0.9622011495670011,1.0,3/13,6.31%,AGTR1;GCLC;SCPEP1
prerank,vascular process in circulatory system (GO:0003018),0.4120146029382777,0.8840963823849216,0.5982456140350877,0.9622011495670011,1.0,3/13,6.31%,AGTR1;GCLC;SCPEP1
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.36752117959696695,-0.8840748224510668,0.6189376443418014,0.8886084988607016,1.0,5/12,12.51%,CTSH;LMO2;CTSB;CTSS;CTSL
prerank,positive regulation of B cell activation (GO:0050871),-0.2549485045039715,-0.8838349148068931,0.6961538461538461,0.8881264287515863,1.0,14/50,18.58%,BCL2;TFRC;SH3KBP1;RIF1;CD81;MEF2C;VAV3;CD38;NCKAP1L;SYK;TIRAP;MIF;CD74;TNIP2
prerank,positive regulation of response to external stimulus (GO:0032103),0.29078360590803637,0.8837624584279596,0.6651216685979142,0.9623045270816079,1.0,21/128,15.78%,THBS1;GPR4;AGTR1;BMP6;PDCD4;THBD;POLR3D;PLSCR1;LRSAM1;IFI35;IL17RA;ACOD1;TLR4;IL16;ADAM8;TRADD;POLR3B;PUM2;PUM1;PRKCA;DHX9
prerank,cellular response to glucose stimulus (GO:0071333),-0.28216663428305916,-0.8837302734333397,0.6276276276276276,0.8873757929539919,1.0,5/30,11.01%,IGF1R;ZBTB20;ERN1;GAS6;PRKAA2
prerank,regulation of lipid kinase activity (GO:0043550),-0.36761657648647994,-0.88336458235986,0.6190476190476191,0.8872287497997907,1.0,3/11,13.00%,PIK3R1;PPP2R5A;WDR91
prerank,positive regulation of JNK cascade (GO:0046330),0.3113030287473073,0.8832810578685846,0.6404066073697586,0.9626571603845552,1.0,5/70,4.03%,MAP3K5;RASSF2;PTK2B;WNT16;FZD7
prerank,membrane lipid metabolic process (GO:0006643),-0.3192118178266298,-0.8832364721377753,0.6203208556149733,0.8864941172045421,1.0,11/22,25.39%,ST3GAL6;CERK;SERINC1;GAL3ST1;SPHK1;ST6GALNAC4;SMPDL3B;SPHK2;AGMO;B4GALT4;TEX2
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.4049739171802747,0.8832213735284589,0.5822784810126582,0.9622024508757928,1.0,6/13,20.71%,ELOF1;CHEK1;ZMIZ1;ZMIZ2;ARID1A;CDCA4
prerank,regulation of cellular metabolic process (GO:0031323),0.33050919740080553,0.8830586709690886,0.6204986149584487,0.9619603820132832,1.0,7/45,11.20%,CYP1B1;PID1;COQ7;ARF4;MKLN1;PARL;GNB3
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.3651735000200821,0.8828172355222237,0.6213292117465224,0.9618393743063745,1.0,4/30,3.27%,GPR4;AKAP13;COL3A1;LPAR4
prerank,regulation of G0 to G1 transition (GO:0070316),0.3374149554590376,0.8828166660461872,0.5988538681948424,0.9612566801327964,1.0,18/38,24.78%,E2F6;RRM2;RNF2;CHEK1;EHMT2;EHMT1;MGA;RBBP8;SUZ12;EPC1;CBX5;RBBP4;UXT;YAF2;PHC3;EED;EZH2;RING1
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.3476692032028542,0.8823011521121084,0.6137724550898204,0.9617910375531359,1.0,6/31,13.86%,IL10;TNFRSF13B;CD80;ATM;SDC4;CEBPB
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.3167355649358747,0.8822013372810465,0.626984126984127,0.9613929754320616,1.0,9/59,9.94%,TCF7L2;TNRC6C;MED15;NFKB1;MOV10;BCLAF1;JUN;CBFB;MED14
prerank,regulation of response to external stimulus (GO:0032101),0.2933416794508248,0.8821186866777251,0.6608187134502924,0.9609806455456648,1.0,18/121,12.39%,FOXP1;ANXA1;CD55;AGTR1;MGLL;SHPK;DAGLB;NLRP6;CELF1;P2RX4;PIK3AP1;RNF135;BCL6;ERAP1;CXCR4;IRF1;CD36;BIRC3
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.4079763480212536,0.8819156534042228,0.6003401360544217,0.9608090009501226,1.0,5/13,20.89%,SAE1;DESI2;DESI1;ATG7;UBA5
prerank,bicellular tight junction assembly (GO:0070830),0.3345449837129151,0.8810874474841703,0.6227709190672154,0.9619187930419829,1.0,10/46,10.80%,MPP7;CLDN16;STRN;PDCD6IP;CLDN11;DLG1;POF1B;PATJ;PARD3;PAK2
prerank,phosphatidylcholine biosynthetic process (GO:0006656),-0.2809158938337171,-0.8810260564862417,0.6721311475409836,0.8903596709088202,1.0,8/32,16.03%,ABHD3;LPIN3;SLC44A1;MFSD2A;LPIN1;SLC44A2;STARD7;SLC27A1
prerank,regulation of ATP biosynthetic process (GO:2001169),-0.3420034979159482,-0.8810071850959209,0.6256281407035176,0.8894000120376635,1.0,6/16,16.65%,PPARA;TMSB4X;PPARGC1A;PARP1;DNAJC30;FLCN
prerank,negative regulation of cell activation (GO:0050866),-0.34687932703863567,-0.8808393486887341,0.6272040302267002,0.8887029335666441,1.0,3/14,7.21%,APOE;NOS3;PDGFRA
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.41319529708883007,0.8806567711231487,0.6183986371379898,0.9622799507632558,1.0,1/13,2.25%,PTGIS
prerank,chromatin assembly or disassembly (GO:0006333),0.4226650632223745,0.8806565696561486,0.6048109965635738,0.9616963971242242,1.0,2/11,10.68%,CHAF1B;HDAC8
prerank,positive regulation of TOR signaling (GO:0032008),0.34001275117091656,0.8805720902504216,0.6035911602209945,0.961276553730024,1.0,10/40,16.13%,SIK3;KLHL22;GOLPH3;SMCR8;SEC13;TELO2;MLST8;CLEC16A;MIOS;RRAGB
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.3946943340884712,0.8794599426747647,0.6153846153846154,0.9629645620641185,1.0,4/17,18.30%,ANK2;SNTA1;KCNE4;AKAP9
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.3892909917634957,0.8793663411089113,0.6020408163265306,0.9625713895447433,1.0,3/17,7.71%,SLIT2;FGF2;NRP1
prerank,peptide hormone secretion (GO:0030072),0.36675020294438315,0.8792424277858472,0.6209553158705701,0.9622490360179495,1.0,4/26,14.53%,ANXA1;SNX19;LTBP4;VIP
prerank,positive regulation of cilium assembly (GO:0045724),-0.3299474367829046,-0.8789808069088391,0.6476964769647696,0.8917604371598631,1.0,3/18,5.34%,CEP120;CCDC88A;TAPT1
prerank,positive regulation of MAPK cascade (GO:0043410),0.2760276500211198,0.8788590154810706,0.7348242811501597,0.9624460752470839,1.0,16/245,4.00%,EGFR;BMPER;PDGFC;NTRK3;TNFAIP8L3;PTK2B;CD44;ADRA1B;FGFR1;SHC1;ADRB2;GAREM1;MID1;RAP1A;GCNT2;NOTCH2
prerank,positive regulation of translation (GO:0045727),0.2995103743759073,0.8785849237202276,0.6682634730538922,0.9624217155227782,1.0,22/94,22.77%,THBS1;SAMD4A;YBX3;NIBAN1;LARP4B;PLD1;MTOR;MPV17L2;FXR2;DHX9;PRKDC;JMJD4;MRPS27;YTHDF3;ZCCHC4;YTHDF2;UPF3A;TRUB2;EIF6;EIF3E;FMR1;LARP1
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.2823072358541412,-0.8785650558592686,0.6686390532544378,0.8916435797758836,1.0,13/31,28.47%,TFDP2;BCL2;PPP3R1;CHCHD10;BOK;HIP1R;GSK3A;BAD;TFDP1;BAK1;YWHAB;PMAIP1;TP53
prerank,glucose homeostasis (GO:0042593),0.30349555710021664,0.8781048155560244,0.639751552795031,0.9628156274629334,1.0,18/83,16.20%,TCF7L2;LRRC8D;CRY2;FOXK1;KCNB1;KLF7;HNF4A;HNF1A;IRS1;PTPN2;FOXK2;SELENOT;STAT3;MCU;STK11;PRKAA1;SLC8B1;PAX6
prerank,cellular response to interleukin-4 (GO:0071353),-0.3766657885420661,-0.8780727966859866,0.6455981941309256,0.8917095398065893,1.0,1/10,0.37%,LEF1
prerank,ovarian follicle development (GO:0001541),0.4089339826351034,0.8778987066069168,0.5958904109589042,0.9626623210426364,1.0,4/13,13.86%,INHBA;EIF2B2;INHBB;CEBPB
prerank,mitochondrial translational elongation (GO:0070125),0.3026912849087047,0.877796497292544,0.6678921568627451,0.9622914880630188,1.0,30/88,26.27%,MRPL33;MRPL48;MRPL32;MRPL14;MRPL21;MRPS31;MRPL38;GFM2;MRPL57;MRPS28;MRPS35;MRPS22;MRPL20;MRPS10;MRPL47;MRPS27;MRPS30;MRPS23;MRPL9;MRPS24;MRPL52;MRPS33;MRPS18B;MRPS7;PTCD3;MRPL10;MRPL39;MRPS5;MRPS34;MRPS18C
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.40876259543983684,0.8775261338667296,0.6037414965986394,0.9622691086586985,1.0,1/15,1.25%,SMOX
prerank,serine family amino acid metabolic process (GO:0009069),0.39253613560714884,0.8773637354118758,0.5789473684210527,0.962016515903289,1.0,4/16,16.83%,GCLC;CDO1;SEPSECS;PSPH
prerank,protein deacylation (GO:0035601),0.3664924299083884,0.8769915345587193,0.5942947702060222,0.9621921677541754,1.0,3/23,12.73%,HDAC4;HDAC10;ABHD17B
prerank,regulation of neuron differentiation (GO:0045664),0.3059360058678216,0.8768133789667966,0.6275510204081632,0.9619782524636782,1.0,5/76,2.39%,ZFHX3;NGF;SIX1;VWC2;FGFR1
prerank,regulation of fatty acid biosynthetic process (GO:0042304),-0.30189227499333876,-0.8766947875466946,0.6501457725947521,0.893808657282656,1.0,10/26,25.21%,PRKAG2;LPGAT1;NR1H3;ACADL;PRKAA2;BRCA1;TRIB3;ERLIN2;APOC1;ADIPOR2
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.38423615458312127,0.8766783041993181,0.6139240506329114,0.9616794740790298,1.0,2/17,2.58%,CD55;BMP6
prerank,histone H4-K16 acetylation (GO:0043984),0.3810343099822948,0.8765678153243597,0.5933884297520661,0.9613409507495047,1.0,9/19,26.02%,MSL1;KANSL2;KANSL1;HCFC1;KMT2A;KANSL3;PHF20;WDR5;MCRS1
prerank,axonogenesis (GO:0007409),0.2705877252242408,0.8764915163544994,0.7271750805585392,0.9609251032095313,1.0,29/237,9.97%,SLIT3;SLIT2;EFNA5;SEMA3D;EZR;SEMA3C;SPTAN1;GRB10;UNC5C;PDLIM7;SHC1;ISL1;SEMA3E;DOCK7;NOTCH2;ULK2;KLF7;GDNF;EPHB6;SHTN1;GAB2;NRP1;NTN3;GAB1;SPG11;PTPRA;USP33;EMB;CXCR4
prerank,signal transduction in response to DNA damage (GO:0042770),0.3245006797383891,0.8763120314393501,0.6495132127955494,0.9607094275255259,1.0,9/49,11.74%,NDRG1;ABL1;ATM;MDM4;USP10;CHEK2;RAD17;CHEK1;CEP63
prerank,cellular lipid catabolic process (GO:0044242),-0.286732296028796,-0.8759316863808833,0.6446280991735537,0.8944437104681479,1.0,6/27,9.71%,ENPP2;PPARD;ABHD12;LPIN3;ACADL;LPIN1
prerank,regulation of fatty acid beta-oxidation (GO:0031998),-0.3500317876399488,-0.8755072040294405,0.6198547215496368,0.8943386173103781,1.0,4/14,15.27%,PPARA;MFSD2A;MTLN;AKT1
prerank,mitotic spindle organization (GO:0007052),0.2817090194784915,0.8754912511019851,0.6929223744292238,0.9618114234001768,1.0,39/153,22.38%,TBCE;XPO1;NDEL1;DYNC1I1;VCP;ARHGEF10;PAFAH1B1;CLIP1;CENPQ;DCTN6;STIL;SEC13;CHEK2;DYNC1LI2;RMDN1;MISP;KIF2C;RANBP2;TOGARAM1;RHOA;NEK9;PIBF1;SMC1A;SPC24;RAN;FLNA;STAG2;KIF18A;KIF2A;SPICE1;NUP107;AAAS;CEP192;AURKA;SKA2;NUP98;CENPU;SUN2;NEK6
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.2987816950711547,-0.8753598157212622,0.6153846153846154,0.8936666531079434,1.0,6/26,16.62%,ITPR1;RYR2;HTR2A;RYR3;ERO1A;CCL19
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),-0.34828615600994883,-0.8752873003725308,0.5919811320754716,0.8928496530746168,1.0,4/13,7.31%,AKT3;ITGA4;IGF2;MDK
prerank,TOR signaling (GO:0031929),-0.29698965191359844,-0.8751896904628667,0.651595744680851,0.8920486793358355,1.0,11/26,24.11%,CCDC88A;PRR5L;RICTOR;EIF4EBP1;TIPRL;RPS6KB1;AKT1;FLCN;EIF4EBP2;PRR5;MEAK7
prerank,response to thyroid hormone (GO:0097066),-0.3528941613151786,-0.8750808752051183,0.62877030162413,0.8913171438179845,1.0,5/13,12.51%,CTSH;LMO2;CTSB;CTSS;CTSL
prerank,negative regulation of interferon-gamma production (GO:0032689),0.35884145223187947,0.8750195533142294,0.5921259842519685,0.9621919560838523,1.0,3/23,11.44%,INHBA;DDIT3;TLR4
prerank,cellular protein-containing complex assembly (GO:0034622),-0.21025981991483286,-0.8745973282965509,0.8454545454545455,0.8914079476095976,1.0,59/160,27.39%,TCF4;FMOD;SGIP1;PICALM;RPL38;PDE4DIP;SNCA;CYBA;DNAI4;SRC;PTGES3;MAPT;HSP90AB1;NSG1;IMMP2L;HIP1;PIK3C2A;EIF4H;COX7A2;HOPX;TRAF2;SMAD1;POMP;SMAD3;HIP1R;CASQ2;CENPE;EPS15;NUP205;PTGES3L;AP2S1;ADRM1;BIN1;PFDN6;RTN4;CHCHD4;HIGD1B;AP2M1;EID2;OTUD6B;RAB5IF;NSG2;MAPK8IP2;HIGD2A;DRC1;CCT2;CENPA;UVRAG;PRLR;CASQ1;SHQ1;FKBP1A;NRG1;GPX4;VAMP3;DNAJB14;MKKS;DNAJC28;DNAAF2
prerank,positive regulation of bone resorption (GO:0045780),-0.3732831810375998,-0.8744112800507292,0.6399082568807339,0.8908039558466133,1.0,5/11,16.35%,SPP1;ATP6AP1;TNFRSF11A;PLEKHM1;SYK
prerank,protein acetylation (GO:0006473),0.35533026571422416,0.8743779674563142,0.637329286798179,0.9629197716164595,1.0,6/30,12.88%,NAA40;EP300;CREBBP;KAT5;NAA35;KAT2B
prerank,nitric oxide biosynthetic process (GO:0006809),0.405398892660145,0.874172680412718,0.610726643598616,0.9627512489784005,1.0,1/13,1.67%,CYP1B1
prerank,acyl-CoA biosynthetic process (GO:0071616),-0.33458557598150285,-0.8741475996682687,0.6279683377308707,0.8903796566726824,1.0,6/16,25.42%,ACLY;ACACA;GCDH;ACSS1;PPCS;DIP2A
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.2752944357340121,0.8736157312506719,0.7129032258064516,0.96330601264428,1.0,21/190,11.48%,SLIT2;CCN3;THBS1;CIT;TANK;PDE10A;UBE2B;DDIT3;PHLPP2;PPEF2;OTUD7B;IFI35;ATP2B4;USP10;PPM1A;CCDC22;NPRL3;PRDM15;MARK3;CARD19;DRD3
prerank,protein homooligomerization (GO:0051260),0.29125445061880423,0.8730257434380506,0.6698224852071006,0.9639435654323522,1.0,22/114,15.73%,KCNJ2;DISP1;TMEM120A;ATL3;EHD3;PDCD6IP;TRPM4;ATL2;RNF135;TK1;FUS;PKD2L1;BCL10;GNMT;MICU1;RBMX;EHD1;APIP;MPP2;CLYBL;JMJD6;TRPM2
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.27215150905285107,-0.8729986126354121,0.7041800643086816,0.891741066507594,1.0,16/37,28.47%,BCL2;BCL2L1;RPS7;RPS3;GSDME;BMF;UBB;BOK;NACC2;NUPR1;DNM1L;BAD;MSX1;FBH1;PMAIP1;TP53
prerank,blood vessel endothelial cell migration (GO:0043534),0.3735008968659282,0.8725487552763836,0.6051364365971108,0.9643271257124855,1.0,4/22,7.71%,SLIT2;ID1;FGF2;NRP1
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.3575030584097237,0.8725382661431429,0.6268656716417911,0.963774016386381,1.0,11/31,14.55%,EZR;PDCD6IP;DLG1;MARK2;WDR1;PARD3;CDC42;RHOA;MYO9A;DLG2;ERBIN
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.40026817521483987,0.8722442498356457,0.6046099290780141,0.9637708860057429,1.0,5/14,17.29%,PCBP4;SRSF6;SRSF12;RBMX;SFSWAP
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.39370292202146084,0.8716308142784214,0.6111111111111112,0.9644392172910894,1.0,8/16,30.02%,MOV10;ZC3H12D;ZFP36L1;ZC3H12A;KHSRP;ZFP36L2;TARDBP;ZFP36
prerank,intermediate filament organization (GO:0045109),0.3849009027170829,0.8710996290196789,0.6108374384236454,0.9649138149418445,1.0,2/17,3.50%,DSP;KRT14
prerank,negative regulation of lyase activity (GO:0051350),-0.3330477948385835,-0.8700105061629195,0.6421568627450981,0.8970089949739367,1.0,2/16,1.74%,ADGRV1;GRM3
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.34260009999054125,0.8699632956832423,0.6174785100286533,0.9665598407016508,1.0,3/35,3.02%,MET;ARHGAP44;CCDC125
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.39833322416499634,0.8698032482249726,0.6351575456053068,0.9663214016211962,1.0,6/15,21.13%,TLR6;IL17RA;TLR4;STAT3;MYD88;NOD2
prerank,phasic smooth muscle contraction (GO:0014821),0.41391075026306334,0.869625766347583,0.6211072664359861,0.9661091259533994,1.0,3/10,12.74%,GDNF;TIFAB;HTR2B
prerank,positive regulation of fat cell differentiation (GO:0045600),0.3273341562257047,0.8694262147774547,0.6408163265306123,0.9659085311947294,1.0,15/47,18.37%,SIX1;ZBTB16;ZBTB7B;TRPM4;CDS1;ASXL2;CMKLR1;LRP5;CEBPB;TFE3;CARM1;FRZB;SYAP1;CREBL2;ZFP36L1
prerank,RNA catabolic process (GO:0006401),0.33553324284680175,0.8691764540608666,0.6414835164835165,0.9658308063969394,1.0,20/46,30.02%,DXO;PABPC4;ZC3H12D;RNASE6;EXOSC7;DIS3L2;NANOS2;LSM2;YTHDF2;RNASEH1;RNASEH2A;SIDT2;HSPA1A;AGO3;PNPT1;ZFP36L2;NUDT16L1;DNA2;NUDT16;ZFP36
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.30551522409424453,0.8690544214281787,0.6553524804177546,0.9654852272714116,1.0,13/72,13.96%,RBFOX2;FGFR1;SPRED2;FLRT2;SHOC2;FGF22;HNRNPH1;FGF2;KLB;NOG;CEP57;MAPK1;GTF2F2
prerank,negative regulation of macroautophagy (GO:0016242),0.3572125057909138,0.8690135197605919,0.6207951070336392,0.9649905538477531,1.0,11/26,23.78%,SMG1;SMCR8;MTOR;SEC22B;FEZ2;CLEC16A;CHMP4A;CHMP4B;TMEM39A;USP36;PHF23
prerank,Golgi to lysosome transport (GO:0090160),0.41450870172950155,0.8689667461927094,0.5892547660311959,0.9645096689870193,1.0,5/11,19.06%,EHD3;GAK;RBSN;AP4M1;CLN3
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.3373652824541232,0.8688481187595948,0.625,0.9642086673640896,1.0,9/35,18.45%,NEK7;TNKS2;ATM;FBXO4;MAPK1;XRCC5;MAPK15;TCP1;ACD
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.36038431413088085,0.8686448891169184,0.6086286594761171,0.9640746426819059,1.0,10/25,24.10%,SCAF8;SETD5;WDR43;THOC5;EAF2;LDB1;ZNF326;HTATSF1;CCNT1;ALYREF
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.34727594677919366,-0.8686116909094621,0.6577017114914425,0.8991187499761987,1.0,3/14,8.92%,PRKD1;LOXL3;CD63
prerank,neurotransmitter transport (GO:0006836),0.3096926373618856,0.8679387991317459,0.6611464968152866,0.9649614690195185,1.0,7/73,9.04%,SLC38A2;SLC38A1;DNAJC5;SLC17A7;PPFIA1;SLC6A16;UNC13B
prerank,cellular copper ion homeostasis (GO:0006878),-0.3385345929392419,-0.8678731769626713,0.640625,0.8997470621473714,1.0,5/14,16.90%,ATOX1;MT2A;APP;SLC31A1;ATP7A
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.4279043772997456,0.8675456528604575,0.6274509803921569,0.9651683839198746,1.0,1/10,1.75%,DSE
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.34101237502177023,0.8675167255917834,0.6351550960118169,0.9646505260802674,1.0,9/32,18.45%,NEK7;TNKS2;ATM;FBXO4;MAPK1;XRCC5;MAPK15;TCP1;ACD
prerank,heterocycle biosynthetic process (GO:0018130),0.4026933212281334,0.8667779958286191,0.6266891891891891,0.9655450055046458,1.0,3/14,9.49%,NFS1;PYCR1;MOCS3
prerank,positive regulation of response to stimulus (GO:0048584),0.3322105404491682,0.8666279721926076,0.6283309957924264,0.9652743384479883,1.0,12/40,18.54%,PRKCD;CD80;BCLAF1;MAVS;GATA3;TGFB2;TAF9;ILK;FXR2;DHX9;HOMER1;IL15
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.39962736682980277,0.8662767352969026,0.6197654941373534,0.965417870657177,1.0,1/14,0.45%,THBS1
prerank,regulation of actin filament-based movement (GO:1903115),0.42568558350562424,0.8661047887105598,0.6245674740484429,0.9651726670100866,1.0,1/10,1.46%,ANK2
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.35017573569446125,0.8660323264802491,0.6163328197226502,0.964757743335677,1.0,5/27,11.26%,MARK1;GSK3B;NDEL1;DISC1;ULK4
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.2885753175078757,-0.866007313688918,0.683076923076923,0.9027218737419288,1.0,9/26,15.94%,MAP2K6;NOD1;RPS27A;UBC;IRAK2;TAB2;UBB;AAMP;TNFAIP3
prerank,regulation of viral genome replication (GO:0045069),-0.24658567534055548,-0.8659866419363085,0.7670682730923695,0.9017676023423038,1.0,14/56,18.76%,PPARA;PPIA;BST2;IFITM1;ADARB1;IFITM3;OAS2;DDB1;PROX1;PPIE;NR5A2;TARBP2;TRIM6;RNASEL
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.30772524591036027,0.8658688945386532,0.6666666666666666,0.9644983137617941,1.0,8/65,10.90%,EGFR;PTPN3;ARAP1;RNF115;PTPN2;BCAR3;AGR2;CDC42
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.34218782292008737,-0.8657207495797449,0.642512077294686,0.901328005717114,1.0,2/14,7.42%,ENTPD1;ENTPD5
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.30702809146995286,0.8655096527600277,0.6739690721649485,0.9646377941961107,1.0,11/70,12.87%,NGF;INHBA;HIPK1;GSK3B;DIABLO;CRADD;ITGAV;TNFRSF1B;MOAP1;TGFB2;TRADD
prerank,protein K63-linked deubiquitination (GO:0070536),0.34400015412017504,0.8654676158752128,0.6305343511450382,0.9641518667199279,1.0,8/31,17.36%,USP13;OTUD1;OTUD7B;USP7;USP33;USP25;STAMBP;ZRANB1
prerank,nitric oxide metabolic process (GO:0046209),0.3996842460215953,0.8654557540562925,0.6388888888888888,0.9636040236980341,1.0,1/14,1.67%,CYP1B1
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.31891323538389804,-0.8651934026413692,0.6721763085399449,0.9014466533764063,1.0,4/18,11.15%,SHANK3;NRXN1;CACNG4;CACNG7
prerank,piRNA metabolic process (GO:0034587),0.38379301504692237,0.8649234542284737,0.6122448979591837,0.9640578223730064,1.0,4/19,17.80%,TDRD9;TDRD12;MAEL;PIWIL4
prerank,camera-type eye morphogenesis (GO:0048593),-0.3853989021132802,-0.8645548415236948,0.654627539503386,0.9017943798062256,1.0,3/10,5.13%,SHROOM2;KDM2B;TENM3
prerank,negative regulation of signaling (GO:0023057),-0.2950890499669516,-0.8645003638520115,0.6536312849162011,0.9009120108026513,1.0,5/25,11.03%,IGFBP3;SOCS5;KIF26A;GLRA1;OPTN
prerank,regulation of interferon-beta production (GO:0032648),0.3300191203085898,0.8636715676613204,0.6689466484268126,0.9659186738158673,1.0,19/46,29.05%,POLR3D;MAVS;RIPK2;RNF135;IRF1;TLR4;REL;POLR3B;DHX9;YY1;PTPN11;TRAF3;IFIH1;IRF3;POLR3G;TLR8;TBK1;RNF216;PPM1B
prerank,regulation of AMPA receptor activity (GO:2000311),-0.297447890788907,-0.8633581210917254,0.6712328767123288,0.9023231647626618,1.0,10/25,22.39%,SHANK3;MEF2C;CACNG4;CACNG7;GSG1L;NLGN1;SHISA9;NLGN2;SHISA6;MAPK8IP2
prerank,neurotrophin signaling pathway (GO:0038179),0.373031510085401,0.8629619694368483,0.6264090177133655,0.966765042194722,1.0,4/21,10.38%,NGF;RAP1A;KIDINS220;ZFYVE27
prerank,arachidonic acid metabolic process (GO:0019369),0.34241870015289694,0.8629280550624703,0.6424418604651163,0.9662596994612642,1.0,5/35,8.51%,CYP1B1;PTGIS;MGLL;DAGLB;CYP2S1
prerank,regulation of leukocyte migration (GO:0002685),0.3867946429607289,0.8626252595939753,0.6138279932546374,0.9662705913298504,1.0,1/16,1.32%,ANXA1
prerank,cellular response to lectin (GO:1990858),0.2900371822396324,0.8625159350876764,0.6901072705601907,0.9653458303779072,1.0,12/104,8.66%,NRAS;KRAS;PRKCD;MUC6;KLRC2;NFKB1;TAB3;EP300;FBXW11;CHUK;CREBBP;BCL10
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.2900371822396324,0.8625159350876764,0.6901072705601907,0.9653458303779072,1.0,12/104,8.66%,NRAS;KRAS;PRKCD;MUC6;KLRC2;NFKB1;TAB3;EP300;FBXW11;CHUK;CREBBP;BCL10
prerank,glycerolipid catabolic process (GO:0046503),-0.31924630955776545,-0.8621416405566807,0.659217877094972,0.9039501470467053,1.0,3/19,4.59%,GPCPD1;ENPP6;ABHD12
prerank,inositol phosphate dephosphorylation (GO:0046855),0.41037352928520276,0.8620203309322882,0.6220183486238532,0.9651442713594255,1.0,3/11,15.53%,OCRL;INPP5B;SYNJ1
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.41037352928520276,0.8620203309322882,0.6220183486238532,0.9651442713594255,1.0,3/11,15.53%,OCRL;INPP5B;SYNJ1
prerank,DNA modification (GO:0006304),0.3697437114788852,0.8615983378479334,0.6393700787401575,0.965382972789115,1.0,8/22,21.90%,MPG;SMUG1;MBD4;EXOSC5;ACD;TDG;UNG;EXOSC4
prerank,regulation of mitochondrial fusion (GO:0010635),0.4126079220275743,0.861569831105334,0.6208112874779541,0.9648680898188831,1.0,4/11,17.63%,PID1;OMA1;BNIP3;HUWE1
prerank,DNA strand elongation (GO:0022616),0.3913535984424001,0.8613750259111101,0.64,0.9646906478031464,1.0,8/18,25.54%,MCM7;GINS3;POLD3;POLA1;NBN;MRE11;MCMDC2;TERT
prerank,detection of light stimulus involved in sensory perception (GO:0050962),-0.38108697761542804,-0.8611781412179891,0.6428571428571429,0.9039852501152456,1.0,7/10,50.96%,CEP250;CACNA2D4;GNAT1;REEP6;TULP1;GNAT2;CACNA1F
prerank,detection of light stimulus involved in visual perception (GO:0050908),-0.38108697761542804,-0.8611781412179891,0.6428571428571429,0.9039852501152456,1.0,7/10,50.96%,CEP250;CACNA2D4;GNAT1;REEP6;TULP1;GNAT2;CACNA1F
prerank,regulation of chromosome organization (GO:0033044),0.3696558882337675,0.8611560681827587,0.6236220472440945,0.9645506209184265,1.0,6/22,13.21%,SMG6;SMG1;WAPL;HDAC8;RB1;XRCC5
prerank,positive regulation of T cell activation (GO:0050870),-0.23913908673931977,-0.861088502711006,0.6996047430830039,0.9031791166348373,1.0,9/62,7.45%,VCAM1;CD47;TFRC;IL6ST;CD81;PRKCQ;RHOH;MDK;SIRPA
prerank,protein import into nucleus (GO:0006606),0.30653603142331365,0.8608774449578869,0.6766623207301173,0.9645382527830066,1.0,15/66,15.06%,NUP93;IPO7;PRICKLE1;KPNA1;SEC13;E2F3;RGPD1;NUP188;TNPO2;RANBP2;STAT3;HEATR3;FAM53A;RAN;KPNA4
prerank,regulation of cardiac muscle contraction (GO:0055117),0.34029607452803473,0.8607882602384486,0.637410071942446,0.9641459960933044,1.0,4/34,7.14%,ANK2;ATP1B1;TNNI3;P2RX4
prerank,cellular response to oxidative stress (GO:0034599),0.2848641056361674,0.8605536257893955,0.6923976608187135,0.9640831755094218,1.0,13/118,8.02%,EGFR;FOXO3;PRKCD;MGAT3;WNT16;ABL1;NFE2L2;VKORC1L1;CHUK;JUN;PYCR1;GPX8;ETV5
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.28905439877954053,0.8604654361611385,0.6905615292712067,0.9636922304158217,1.0,12/105,8.66%,NRAS;KRAS;PRKCD;MUC6;KLRC2;NFKB1;TAB3;EP300;FBXW11;CHUK;CREBBP;BCL10
prerank,calcium ion import across plasma membrane (GO:0098703),-0.3342263738730671,-0.8603758925329995,0.6409638554216868,0.903657986035111,1.0,5/14,24.30%,SLC24A2;SLC8A1;CACNA2D1;TRPV4;TRPV2
prerank,determination of left/right symmetry (GO:0007368),0.32844144898079036,0.8597060954071349,0.6633380884450785,0.9646178891937232,1.0,8/37,18.79%,SMO;CCDC40;STIL;MEGF8;DNAH5;GALNT11;CITED2;PKD1L1
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.2711218594428849,0.8596493956371649,0.7417943107221007,0.9641670571002171,1.0,33/186,16.18%,TRABD2B;NXN;TCF7L2;MLLT3;GLI3;PTPRU;GRB10;WNT11;LRP6;GSK3B;DDIT3;TLE6;PRICKLE1;TSKU;WWTR1;FUZ;TLE4;CTNND1;NOG;TLE3;TLE2;NLK;IGFBP6;CSNK1A1;RBMS3;AMER1;LRP1;PSMC6;INVS;STK11;LRP4;LMBR1L;FRZB
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.3907743189899264,0.8595545933242925,0.6353322528363047,0.9637867448129463,1.0,4/15,12.30%,ADAM9;TNFRSF1B;SH3D19;ADAM8
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.35833987597613526,0.8591041852395983,0.620414673046252,0.9640934877990515,1.0,3/24,2.85%,SEMA3D;SEMA3C;SEMA3E
prerank,metallo-sulfur cluster assembly (GO:0031163),-0.3049309902035861,-0.8590435143008929,0.6568627450980392,0.9054475344856242,1.0,16/22,39.54%,HSCB;HSPA9;CIAO3;ISCA1;NUBP1;LYRM4;ABCB7;ISCA2;IBA57;MMS19;GLRX5;FXN;NUBPL;CIAO1;CIAPIN1;NDOR1
prerank,positive regulation of protein localization to membrane (GO:1905477),0.2848878110683324,0.859018545578986,0.701840490797546,0.9636789970147668,1.0,25/98,19.97%,EGFR;SORBS1;ITGB1;KCNB1;DLG1;ATP2B4;AGR2;PLS1;SQSTM1;PRKCE;ZDHHC5;SFN;C2CD5;PPP3CC;LRP1;ITGB1BP1;PTPN9;WNK3;TCAF2;MAPK8;NMT1;CHP1;MIEF1;FIS1;BBC3
prerank,positive regulation of protein ubiquitination (GO:0031398),0.29852893203993236,0.8587470055316327,0.6666666666666666,0.9636519332477602,1.0,19/80,18.89%,FAM107A;BIRC7;MYCBP2;PRICKLE1;RIPK2;KDM1A;DCUN1D4;BCL10;FBXO4;COMMD1;FANCM;BIRC3;AMER1;TSPYL5;CENPX;UBE2N;HUWE1;WFS1;ANGPT1
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.34390005321500194,-0.858463280924503,0.6947890818858561,0.9056094386228682,1.0,2/14,5.30%,OSMR;IL6ST
prerank,apoptotic mitochondrial changes (GO:0008637),-0.27792215777848467,-0.8581632935635175,0.6848484848484848,0.9052534072134771,1.0,13/32,23.85%,BCL2;BCL2L1;IFIT2;ERBB4;CAMK2A;HK2;BOK;THEM4;SOD2;BIK;DNM1L;CCAR2;BAD
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.3076063017729779,0.8580735309197042,0.66,0.9643537438767356,1.0,8/60,9.94%,TCF7L2;TNRC6C;MED15;NFKB1;MOV10;HNF1A;CBFB;MED14
prerank,receptor signaling pathway via STAT (GO:0097696),0.355860954682058,0.8579410514176744,0.6610169491525424,0.9640471510202551,1.0,10/25,20.96%,PKD1;SOCS2;CLCF1;CTR9;STAT3;STAT5A;STAMBP;STAT6;PIAS1;THPO
prerank,DNA conformation change (GO:0071103),0.385435254818443,0.8578988312189254,0.6084745762711864,0.9635597933718408,1.0,5/17,18.62%,ABL1;TOP3A;ERCC3;TOP1;TOP1MT
prerank,mitotic cytokinesis (GO:0000281),0.32179453666467,0.857248575858955,0.6689847009735744,0.9642516503994923,1.0,5/47,6.58%,CIT;SNX18;PDCD6IP;ARL3;SON
prerank,negative regulation of neuron differentiation (GO:0045665),-0.31094863266688255,-0.8568107022670072,0.6740331491712708,0.9071577178213122,1.0,5/22,10.66%,B2M;BMP7;CNTN4;CALR;DTX1
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.3875537370042142,0.8567632661254428,0.6252129471890971,0.9646206972035822,1.0,1/15,1.02%,NGF
prerank,regulation of microtubule nucleation (GO:0010968),-0.3758269759209441,-0.8565318137940714,0.6372315035799523,0.9066902597980178,1.0,5/10,33.47%,PAK1;GIT1;ARHGEF7;MECP2;HSPA1B
prerank,"transcription, DNA-templated (GO:0006351)",0.2682421131704576,0.8564203370388977,0.7451403887688985,0.9646827076529675,1.0,42/207,18.62%,RNMT;MLLT3;FOXO3;DDX5;ZBTB7B;MEF2A;NR4A2;NFKB1;RPAP1;TAF1C;TTF2;CBFB;MNAT1;NFYA;CTR9;ERCC3;MBD1;TTF1;TAF1;RBMX;TRIP11;TAF9;PAF1;CRCP;POLR3GL;RTF1;BAZ2A;PPP5C;GTF2F2;THAP1;TAF15;TAF12;NFIX;ELOA;EAF2;GTF2E1;AFF4;EPC1;NELFE;CREBL2;BRF1;POLR2H
prerank,tight junction assembly (GO:0120192),0.32080466050666023,0.8563158489265419,0.6603518267929634,0.9643271036909666,1.0,10/49,10.80%,MPP7;CLDN16;STRN;PDCD6IP;CLDN11;DLG1;POF1B;PATJ;PARD3;PAK2
prerank,heterochromatin assembly (GO:0031507),-0.3038630827145313,-0.8562314685908027,0.6813471502590673,0.9063108612134458,1.0,9/20,32.52%,MBD2;SMCHD1;ZNFX1;HELLS;SUV39H1;CENPV;RRP8;BEND3;HMGA2
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.277753390464329,0.8561840508884789,0.7230255839822024,0.9640391232304815,1.0,39/148,20.49%,HIPK1;SMYD2;EP300;PLK3;USP2;ATM;DYRK2;USP7;MDM4;CHEK2;MLST8;KAT5;TOP3A;RAD17;MTOR;TAF1;CHEK1;RPA1;CSNK2A2;CSNK2A1;PAK1IP1;TAF9;RFC5;EHMT2;EHMT1;STK11;TAF15;RBBP8;PRKAA1;TAF12;PML;WRN;PPP2R5C;NBN;RBBP4;MRE11;AURKA;NOP2;RMI2
prerank,regulation of cation channel activity (GO:2001257),0.29551048978261835,0.8558227115319653,0.6983729662077597,0.9641749610531563,1.0,10/89,7.50%,ANK2;PTK2B;SLMAP;AHNAK;CAMK2D;ITGB1;DMD;CNIH2;DLG1;FGF13
prerank,establishment of protein localization to extracellular region (GO:0035592),-0.26108013135392705,-0.8557297041517928,0.7081967213114754,0.9063596126692883,1.0,15/39,28.27%,ABCA1;TANGO2;OLFM2;STEAP3;RCN3;NECAB3;RAB15;RAB3C;CANX;MIA2;COPG2;MIA3;RAB13;RAB3A;SEL1L
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.3646606765850918,0.8556581536747586,0.6336477987421384,0.9639247629437603,1.0,4/20,19.15%,PAICS;PFAS;GMPS;AMPD3
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.2934553541042637,0.8556038582360577,0.6962962962962963,0.9634893184235719,1.0,7/93,4.03%,MAP3K5;RASSF2;PTK2B;MID1;GDF6;WNT16;FZD7
prerank,positive regulation of protein acetylation (GO:1901985),-0.359302552926142,-0.8554662985142392,0.6504629629629629,0.9059019532096032,1.0,6/12,29.55%,RAPGEF3;PRKAA2;TERF2IP;DIP2A;FAM161A;TAOK1
prerank,"base-excision repair, gap-filling (GO:0006287)",0.3370497525148132,0.8552004655168287,0.6632801161103048,0.9636800504028866,1.0,14/35,27.20%,MPG;SMUG1;MBD4;RPA1;RFC5;POLD3;POLB;TDG;UNG;APEX1;RFC1;XRCC1;LIG3;NTHL1
prerank,quinone biosynthetic process (GO:1901663),0.3961264944136443,0.8550383224798366,0.6144781144781145,0.9634521327030202,1.0,6/14,24.75%,COQ7;COQ10B;COQ8A;PDSS2;UBIAD1;COQ6
prerank,positive regulation of histone deacetylation (GO:0031065),-0.35440864832107116,-0.8549469763778988,0.6397984886649875,0.9059817257060041,1.0,5/12,21.35%,PRKD1;ING2;APLNR;VEGFA;CTBP1
prerank,positive regulation of exosomal secretion (GO:1903543),0.38965889868894243,0.8547060112761219,0.6585365853658537,0.9635261792388518,1.0,8/15,26.75%,PDCD6IP;SDC4;TSG101;SDC1;RAB7A;HGS;SNF8;ATP13A2
prerank,ATP-dependent chromatin remodeling (GO:0043044),-0.2579965621370135,-0.8541964753221635,0.7132867132867133,0.9065179176959015,1.0,4/42,5.25%,CECR2;MBD2;ACTB;SMARCA2
prerank,apical protein localization (GO:0045176),-0.3771469785604782,-0.8541351752145038,0.655421686746988,0.9056867664886536,1.0,4/10,6.79%,SHROOM2;MAL;ACTB;JAM3
prerank,nucleocytoplasmic transport (GO:0006913),-0.2608443677019744,-0.853762163038738,0.6941580756013745,0.9054901958193047,1.0,11/40,18.89%,ATXN1;BACH2;ANP32A;MALT1;SNRPB;SNRPF;PHAX;GEMIN7;GEMIN5;NUP205;SNRPG
prerank,regulation of response to oxidative stress (GO:1902882),-0.3564309727923771,-0.8537371915573411,0.6729166666666667,0.904569234546014,1.0,5/11,31.13%,MCTP1;GGT7;STOX1;ALOX5;HEBP2
prerank,regulation of erythrocyte differentiation (GO:0045646),0.3368110984628826,0.8529648903133872,0.6465256797583081,0.9663290268233811,1.0,4/35,4.55%,HOXA5;FOXO3;INHBA;GATA1
prerank,maturation of SSU-rRNA (GO:0030490),-0.267215567208845,-0.8527671092270256,0.7142857142857143,0.9055866260695822,1.0,11/34,18.62%,RPS14;RPS16;RPS19;RPS8;SNU13;RIOK1;TSR3;MRPS11;RPS28;NGDN;NOB1
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.35464461747899567,0.852005512657219,0.6467817896389325,0.9675491559865591,1.0,5/25,12.38%,FOXO3;INHBA;GATA1;BRD1;STAT3
prerank,receptor metabolic process (GO:0043112),0.3053519799433617,0.8519118674586493,0.6821282401091405,0.9671765056436145,1.0,6/53,5.87%,NEDD4;RAMP1;ITGB1;CD9;EHD3;BECN1
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.36528289044086926,0.8517644925912389,0.6562009419152276,0.9669094621371231,1.0,3/20,7.77%,BMP5;WDTC1;ERLIN1
prerank,embryonic digit morphogenesis (GO:0042733),-0.3228048184488906,-0.8515659244726377,0.6649484536082474,0.9070412494248188,1.0,4/18,6.37%,TBX3;MAP3K20;SALL1;OSR1
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.34687185879746507,0.8515078366303054,0.6395348837209303,0.9668355386930964,1.0,3/28,4.38%,MAP3K5;TMEM117;DDIT3
prerank,T cell receptor signaling pathway (GO:0050852),-0.21020493543428323,-0.851368016075052,0.8604651162790697,0.9064901799196288,1.0,31/138,21.15%,PIK3R1;PDE4B;FYB1;PAK1;INPP5D;RFTN1;TNFRSF21;TEC;PRKCQ;MALT1;PDE4D;MOG;PAG1;TAB2;PSMB10;BTRC;PSME2;PLCG1;EIF2B5;THEMIS;RELA;PSMB3;TXK;PIK3CD;PSMB4;PSMB8;LCP2;FYB2;ICOSLG;PSMC5;CD276
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.35173953042200984,0.8507561399628828,0.6533923303834809,0.9677414651840914,1.0,3/26,6.56%,MET;CLIP1;SLAIN2
prerank,regulation of stem cell population maintenance (GO:2000036),0.370925363090785,0.8506196096819227,0.6368243243243243,0.967471656691764,1.0,6/18,21.20%,KAT2A;TAF6L;WDR43;REST;CNOT3;NCOA3
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.3943339792018631,0.8505953342069097,0.6318681318681318,0.9669615555903839,1.0,5/13,20.25%,PRPF3;SRSF12;LSM2;USP4;PRPF6
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.3473515037730634,0.8500187052926037,0.6395705521472392,0.967489801247011,1.0,7/26,8.54%,SORBS1;C1QTNF12;ERFE;NR4A3;IRS1;CAPN10;RHOQ
prerank,regulation of catecholamine secretion (GO:0050433),-0.2864020112843335,-0.8499054653468935,0.6948640483383686,0.9085564679981553,1.0,14/29,27.33%,SNCA;SYT7;SYT11;SYT12;SYT9;SYT13;KCNA2;GRK2;SYT15;SYT1;CHGA;SYT5;SYT17;SYT2
prerank,B cell activation (GO:0042113),0.3012869722394896,0.8498678715596756,0.6814044213263979,0.9672321824766649,1.0,8/68,9.43%,HDAC4;ITGB1;HDAC9;IL10;PTPN2;CLCF1;DCAF1;TCF3
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.37373486190210115,-0.8497374489725223,0.6540084388185654,0.907884451474025,1.0,2/10,5.45%,JARID2;RIF1
prerank,regulation of programmed cell death (GO:0043067),0.2700151381461769,0.8494433187797696,0.7452725250278087,0.9675090617944135,1.0,21/161,12.40%,ACER3;PERP;NDRG1;FBXO10;ABL1;RIPK3;VCP;KANK2;CRADD;RARG;CLU;ATM;DDX42;CREBBP;BCL6;MOAP1;AIFM2;RBM25;OMA1;BIRC3;BNIP3
prerank,histone H2A acetylation (GO:0043968),0.37899797448465006,0.848856704595323,0.6467661691542289,0.9680343523206353,1.0,6/16,17.35%,NAA40;TRRAP;BRD8;DMAP1;EPC1;MORF4L2
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.32080147101326645,0.8486588421217147,0.6624293785310734,0.9678450806513239,1.0,8/45,13.20%,CD44;CAMK2D;PRKCD;MID1;TRIM26;TRIM25;IRF1;CIITA
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.2631491619947821,-0.8484760745138106,0.7320261437908496,0.9093617872211089,1.0,8/37,11.59%,CEMIP;PRKAG2;CALM1;BMP7;CALM3;SPHK1;APP;SPRED1
prerank,positive regulation of cell killing (GO:0031343),-0.3318792729442354,-0.8483963591980157,0.6658476658476659,0.9085606897524585,1.0,4/13,16.35%,WNT5A;CYBA;RAC1;SYK
prerank,histone H4-K5 acetylation (GO:0043981),0.3872867597621799,0.8482820734741133,0.6176470588235294,0.9674770024585647,1.0,7/15,26.02%,KANSL2;KANSL1;HCFC1;KANSL3;PHF20;WDR5;MCRS1
prerank,histone H4-K8 acetylation (GO:0043982),0.3872867597621799,0.8482820734741133,0.6176470588235294,0.9674770024585647,1.0,7/15,26.02%,KANSL2;KANSL1;HCFC1;KANSL3;PHF20;WDR5;MCRS1
prerank,toll-like receptor signaling pathway (GO:0002224),0.28957320043248247,0.8482209222411761,0.70595690747782,0.9670390586415979,1.0,13/84,12.39%,SCARA3;LBP;TAB3;CHUK;PIK3AP1;RIPK2;TLR6;IRAK4;UBE2D3;BCL10;TLR4;CD36;BIRC3
prerank,negative regulation of mRNA processing (GO:0050686),0.38609105092207174,0.8480393459621716,0.631578947368421,0.9668421348082722,1.0,5/15,17.29%,PCBP4;SRSF6;SRSF12;RBMX;SFSWAP
prerank,response to axon injury (GO:0048678),0.37832870490225856,0.8478027729065327,0.6231404958677685,0.9667422805502326,1.0,2/18,7.14%,DPYSL3;P2RX4
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.384605084335946,0.8477906445943694,0.642495784148398,0.9662156277105154,1.0,2/16,4.88%,CLDN16;CLDN11
prerank,glycogen metabolic process (GO:0005977),0.34426037247217384,0.8473592980257951,0.6271428571428571,0.9664646041539869,1.0,4/27,4.98%,PPP1R3C;PYGB;GSK3B;PHKA2
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.32281446846458783,-0.8471175921327707,0.642691415313225,0.9101970890602732,1.0,6/15,16.66%,PRKCH;CSF1;IL18;AGT;MAPK9;MSR1
prerank,cellular response to nutrient levels (GO:0031669),0.3056815182666649,0.8465399777748126,0.69140625,0.9674792534140999,1.0,18/62,19.21%,EIF4G1;FAM107A;WIPI2;KCNB1;ZFYVE1;KLF10;USP33;MTOR;VPS41;INHBB;EHMT2;CLEC16A;TFEB;PRKAA1;RRAGB;WRN;ATG7;ULK1
prerank,regulation of cell adhesion (GO:0030155),0.2752733178678931,0.8463763727234843,0.7353279631760644,0.9672389280999819,1.0,31/129,19.69%,ZFHX3;GPR4;PTK2B;EFNA5;ARHGDIB;PPP3CA;ABL1;PKP4;ITGAV;PLXNA2;ATM;ADAM10;CXCR4;PPP1R12A;ADAM8;RSU1;CHRD;TFE3;ITGB1BP1;PRKCA;PLAU;TPM1;EPHB3;YTHDF2;PRKD2;ANGPT1;PRKX;PLXNA3;DSCAM;CELSR2;PTPN11
prerank,response to interleukin-1 (GO:0070555),0.29793013316972417,0.8463214658332088,0.6746231155778895,0.9667856178437485,1.0,10/73,11.95%,ANXA1;HDAC4;PTGIS;TANK;NFKB1;USP10;ACOD1;HYAL3;RBMX;TAF9
prerank,inositol phosphate catabolic process (GO:0071545),0.3999253972144457,0.8457739460651474,0.6355311355311355,0.967297971504769,1.0,3/12,15.53%,OCRL;INPP5B;SYNJ1
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.32894417692326716,-0.8455446103312882,0.6983372921615202,0.9124675068081091,1.0,4/15,16.03%,NR1H3;SCARB1;MFSD2A;SLC27A1
prerank,calcium ion import into cytosol (GO:1902656),-0.325223905566977,-0.8449095068698034,0.6575682382133995,0.9127517137848576,1.0,5/15,24.30%,SLC24A2;SLC8A1;CACNA2D1;TRPV4;TRPV2
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.3169318547039568,-0.8448923383923694,0.7,0.9118140257638855,1.0,6/18,18.61%,PPARA;DUSP3;PAG1;ASS1;AKT1;JAK3
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.28489252891147876,0.8448792382757652,0.7015834348355664,0.9684459204200855,1.0,21/95,17.10%,LBP;ADAM9;IL10;PDCD4;NFKB1;CD80;SHPK;TNFRSF1B;BCL10;CTR9;ACOD1;TLR4;RHOA;PAF1;CYRIB;TRIM41;SBNO2;MYD88;TICAM2;CARD16;MAPK8
prerank,microtubule depolymerization (GO:0007019),-0.3175448996004276,-0.8447981727568041,0.6941176470588235,0.9110041800872883,1.0,7/17,28.22%,STMN4;STMN3;NCKAP5;KIF18B;STMN2;KIF19;STMN1
prerank,regulation of astrocyte differentiation (GO:0048710),0.39411952664848277,0.8438207499957578,0.6393162393162393,0.9698559594561195,1.0,4/12,11.02%,SERPINE2;CLCF1;HES1;NOG
prerank,cellular response to lipid (GO:0071396),0.26573695106404915,0.8436708446308498,0.7725274725274726,0.9695839977691051,1.0,26/191,12.06%,EGFR;WNT9A;PTK2B;LBP;WNT11;PID1;ADAM9;MYOG;IL10;FZD7;PDCD4;NFKB1;CD80;SHPK;IRS1;ATM;TNFRSF1B;BCL10;KAT5;CTR9;ACOD1;TLR4;RHOA;ATP1A3;ATP1A1;PAF1
prerank,glycerolipid metabolic process (GO:0046486),0.4066734309937996,0.8431472105764923,0.6561338289962825,0.9700328450412685,1.0,4/11,15.95%,PNPLA3;PIP5K1A;DGKA;PLA2G15
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.3197918056168915,0.8430549740269688,0.6580381471389646,0.9696596940489166,1.0,15/45,23.67%,FOXO3;GCNT2;ZC3H7A;PUM2;PUM1;MATR3;CYFIP1;ATXN2;RBM4B;METAP1;PUM3;METTL18;NUDT21;LARP1;PCIF1
prerank,selective autophagy (GO:0061912),0.3094901247997843,0.8428856621433551,0.6785714285714286,0.9693951759913285,1.0,17/56,19.21%,ULK2;DYNC1I1;DDRGK1;BECN1;ATM;DYNC1LI2;SQSTM1;RB1CC1;ACBD5;UFL1;AMBRA1;IFT88;LGALS8;UBE2N;ATG2A;RAB7A;ULK1
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.3548911641084723,-0.8426828926326906,0.6584821428571429,0.914228239070263,1.0,2/11,9.42%,PAK1;RAC1
prerank,cellular response to interleukin-6 (GO:0071354),-0.28203765820850224,-0.8425427457709922,0.6914285714285714,0.9135763412826068,1.0,6/26,9.09%,ST3GAL6;ST18;PTPRT;IL6ST;IL6R;SRC
prerank,intestinal lipid absorption (GO:0098856),-0.3579287172611695,-0.8421767353693682,0.6547619047619048,0.9133239385782539,1.0,1/11,3.65%,UGCG
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.24988704676228085,-0.8412541381305677,0.7608695652173914,0.9142102532666073,1.0,10/49,14.02%,SGMS1;BCL2;DAPK2;BCL2L1;SRC;GSDME;BMF;NOC2L;BOK;NDUFS3
prerank,protein targeting to membrane (GO:0006612),0.28898706588244016,0.8409489875137905,0.7299077733860343,0.9724864405384227,1.0,23/83,20.96%,ABCD3;ZDHHC11;PXMP2;ATG3;SEC63;SLC25A17;PARD3;ZDHHC23;PEX2;ACBD5;ZDHHC15;GOLGA7;CHM;VPS37A;ZDHHC7;PEX12;FIS1;PEX16;RABGEF1;GET3;CHMP4A;CHMP4B;SIL1
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.3732736929676398,0.840825927976115,0.6823338735818476,0.9721674367464506,1.0,1/17,0.27%,BMP4
prerank,phospholipid transport (GO:0015914),0.30554610990229564,0.8406843683498494,0.6875871687587168,0.9718836594165118,1.0,7/52,8.53%,TNFAIP8L3;ATP10A;PITPNA;PITPNC1;ATP8B1;PITPNB;OSBPL5
prerank,positive regulation of viral life cycle (GO:1903902),-0.2994599111235392,-0.8406222170556664,0.7117346938775511,0.9144615432325066,1.0,9/22,31.37%,LGALS1;DDB1;KPNA2;TYRO3;CD74;AXL;CHMP2B;VPS4A;P4HB
prerank,synaptic vesicle membrane organization (GO:0048499),0.3676994601287502,0.8404378618144235,0.6546052631578947,0.9717658645439466,1.0,3/17,10.93%,STX19;STX11;SNAP23
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.3245362754925656,0.8404140019285326,0.6751412429378532,0.9712599736658124,1.0,5/37,10.08%,ENTPD6;PABPC4;RNASE6;EXOSC7;DFFB
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.39161491268817417,0.8400373838299273,0.6678507992895204,0.9714370947846419,1.0,2/13,2.75%,ITGB1;CD9
prerank,positive regulation of immune effector process (GO:0002699),0.3362918970666261,0.839950772091828,0.6795665634674922,0.9710682571638324,1.0,3/27,10.17%,LBP;IL10;CD46
prerank,heme catabolic process (GO:0042167),0.39850258070141253,0.8396920854129508,0.6660869565217391,0.9704651240958215,1.0,2/14,6.80%,ABCG2;HMOX2
prerank,porphyrin-containing compound catabolic process (GO:0006787),0.39850258070141253,0.8396920854129508,0.6660869565217391,0.9704651240958215,1.0,2/14,6.80%,ABCG2;HMOX2
prerank,histone lysine demethylation (GO:0070076),0.3445053046556087,0.8395267146508584,0.6540284360189573,0.9701976567098108,1.0,8/25,18.95%,JMJD1C;RIOX2;KDM1A;KDM4D;KDM3B;KDM6B;KDM2A;RIOX1
prerank,sensory perception of smell (GO:0007608),-0.3533748045656844,-0.8394989269560503,0.6836283185840708,0.9157736688967443,1.0,3/11,26.77%,ADCY3;UBR3;MKKS
prerank,myotube cell development (GO:0014904),0.39981865985774084,0.8393326214721707,0.6548672566371682,0.9699964940467763,1.0,2/10,9.98%,SIX1;SKI
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.29450735979736725,-0.8392200227906849,0.7121951219512195,0.9153496705986672,1.0,7/21,21.81%,SLC30A10;PPARA;SIRT5;PARK7;BRCA1;ABCB7;SLC18A2
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.28711077558348624,0.8391647520896003,0.7067484662576687,0.9697819094079986,1.0,12/88,11.40%,SAMD4A;IGFBP5;SYNCRIP;NFKB1;SERPINE2;CNOT7;PAIP2;NELL1;TOB1;RGP1;EIF2AK3;NANOS2
prerank,methylguanosine-cap decapping (GO:0110156),-0.3641747553943404,-0.8388926547375809,0.6735632183908046,0.915073009019192,1.0,5/10,30.23%,LSM1;DCP1B;DCP2;PATL2;PATL1
prerank,phospholipid translocation (GO:0045332),0.33978299967497194,0.8386987154194354,0.6406727828746177,0.9701433123099069,1.0,4/28,5.80%,ATP10A;ANO6;ATP8B1;PLSCR1
prerank,negative regulation of ossification (GO:0030279),0.3486049899154955,0.8386250071310881,0.6635220125786163,0.9697209842601717,1.0,3/23,5.11%,PTK2B;SMAD6;TRPM4
prerank,fatty-acyl-CoA metabolic process (GO:0035337),-0.3075709726866712,-0.8377192292073369,0.6876790830945558,0.9163968255791651,1.0,6/20,19.34%,FAR2;ACLY;ACACA;HSD17B4;GCDH;DGAT1
prerank,protein complex oligomerization (GO:0051259),0.290009516795059,0.8377038632069777,0.6923076923076923,0.9708654683051036,1.0,23/85,19.65%,LRRC8D;TMEM120A;ATL3;EHD3;PDCD6IP;ATL2;RNF135;FUS;BCL10;MICU1;RBMX;EHD1;SLC9A1;MCU;MPP2;STOML2;JMJD6;YME1L1;HOMER1;NOL3;CUTC;CPSF7;PRMT8
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.35381206929984477,0.8376371104430409,0.6718995290423861,0.9704505852090505,1.0,3/23,7.89%,CYP1B1;IL10;HES1
prerank,regulation of calcium ion transport (GO:0051924),-0.24184566987746847,-0.8373973654110234,0.8008474576271186,0.9160599556790696,1.0,13/54,16.64%,MYLK;CACNA1D;BCL2;EPB41;ADRA2A;ATP2B1;CAMK2A;CACNA2D1;CD84;CAMK2B;TRPC6;STIM1;NOS1
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.2902478999515932,0.8369675874745269,0.6829896907216495,0.9711669301742064,1.0,13/69,13.40%,PLCE1;NGF;EZR;FGFR1;PLCB3;PLCD3;IRS1;GAB2;PLCD1;GATA3;RHOA;HTR2B;PI4KB
prerank,negative regulation of bone mineralization (GO:0030502),0.3904591987861887,0.8363063936038901,0.6778169014084507,0.971873970591266,1.0,2/13,5.11%,PTK2B;TRPM4
prerank,regulation of intracellular transport (GO:0032386),-0.26264483271458683,-0.8361312585586453,0.7631578947368421,0.9174385480924192,1.0,11/38,21.10%,MAP2;INPP5F;LAMP1;LRRK2;SCFD1;RNF139;DNAJC30;NEFH;LCP1;DYNLT2B;SPAG5
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.39964659480070625,0.8360270778281118,0.6714031971580817,0.9718404387584073,1.0,4/11,13.44%,PDGFA;TGFBR2;CHRD;LRP5
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.35175694571806104,0.8355893888268741,0.657556270096463,0.9720877449769236,1.0,3/23,5.21%,RAET1E;KLRC2;PVR
prerank,nuclear export (GO:0051168),0.28786703181203704,0.8355228920457483,0.7012820512820512,0.97167220710879,1.0,22/80,19.82%,PKD1;XPO1;EGR2;U2AF1L4;CASC3;SRSF5;NUP188;SRSF6;NXF1;SRRM1;THOC2;RBM8A;SRSF11;SMURF1;LSG1;RAN;THOC5;DESI1;ZC3H11A;CHP1;CHTOP;RAE1
prerank,lipid droplet formation (GO:0140042),0.4045945998371454,0.8354258848627505,0.6527545909849749,0.9713080287591007,1.0,3/10,16.58%,ZFYVE1;CDS1;BSCL2
prerank,positive regulation by host of viral transcription (GO:0043923),-0.32245578598702324,-0.8353675672980071,0.7019230769230769,0.9179331211788585,1.0,1/15,0.37%,LEF1
prerank,endodermal cell fate commitment (GO:0001711),0.41036163488586475,0.8350325565495458,0.6446886446886447,0.9714857006431169,1.0,3/10,12.62%,CTR9;PAF1;RTF1
prerank,cardiac muscle cell development (GO:0055013),0.35967893918244354,0.8349673411873999,0.6639871382636656,0.971082492843756,1.0,4/20,8.89%,CXADR;CSRP3;PDLIM5;FHOD3
prerank,regulation of fibroblast proliferation (GO:0048145),0.3150699819718563,0.8349658633948974,0.6680384087791496,0.9705431143113425,1.0,8/45,13.41%,PDGFC;FN1;DDR2;PDGFA;SKI;B4GALT7;PEX2;MORC3
prerank,t-circle formation (GO:0090656),0.4113104438004258,0.8347986511373258,0.6474694589877836,0.9692194070327443,1.0,5/10,29.77%,ERCC1;WRN;NBN;EXO1;DNA2
prerank,telomere maintenance via telomere trimming (GO:0090737),0.4113104438004258,0.8347986511373258,0.6474694589877836,0.9692194070327443,1.0,5/10,29.77%,ERCC1;WRN;NBN;EXO1;DNA2
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.4113104438004258,0.8347986511373258,0.6474694589877836,0.9692194070327443,1.0,5/10,29.77%,ERCC1;WRN;NBN;EXO1;DNA2
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.3481950601134349,0.8347110702831957,0.668769716088328,0.968831540638702,1.0,4/24,11.62%,PLCE1;NCKAP1;CDC42;BRK1
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.3868777481591624,0.8346880645202691,0.6481481481481481,0.968329821659116,1.0,2/13,3.83%,SIX1;ZBTB7B
prerank,regulation of dopamine secretion (GO:0014059),-0.28805297598359586,-0.8346388996872799,0.6927374301675978,0.9183261208382026,1.0,12/25,27.33%,SNCA;SYT7;SYT11;SYT12;SYT9;SYT13;KCNA2;SYT15;SYT1;SYT5;SYT17;SYT2
prerank,regulation of embryonic development (GO:0045995),-0.2626353486493082,-0.8344885491206221,0.7272727272727273,0.9176822267375403,1.0,11/34,20.75%,PLCB1;INSR;SOX17;CLASP2;NR2C2;CFL1;RBM19;B4GALT5;RAB14;NPHP3;POGLUT1
prerank,organonitrogen compound catabolic process (GO:1901565),0.2989034186379978,0.8342261332526291,0.6990920881971465,0.9686338340960633,1.0,13/57,19.78%,NPEPPS;PDXDC1;CPQ;LRSAM1;IDE;GADL1;ERAP1;MTOR;PLA2G4A;PLA2G15;GNPDA2;TPP1;SMPD2
prerank,exit from mitosis (GO:0010458),-0.3518350527117497,-0.8341472910533867,0.6968973747016707,0.917425625056974,1.0,1/12,0.78%,EPS8
prerank,positive regulation of extracellular matrix organization (GO:1903055),-0.3060412875786539,-0.8337513311751956,0.6866840731070496,0.917201262448164,1.0,10/18,26.60%,RGCC;BMP2;EFEMP2;FSCN1;CLASP2;SMAD3;COLGALT1;EMILIN1;RUNX1;IER3IP1
prerank,double-strand break repair via homologous recombination (GO:0000724),0.2848556288407726,0.8336621943637643,0.7210144927536232,0.9691517643425313,1.0,39/95,28.29%,REV3L;RNF138;MCM7;SWSAP1;ZFYVE26;RAD52;BRCA2;RAD51C;RPA1;RAD51AP1;FANCM;KDM4D;EXD2;NSMCE2;AP5S1;RBBP8;UBE2N;WRN;YY1;MCM9;NBN;INO80;SMC5;MRE11;XRCC2;RECQL5;MCM6;MCMDC2;ERCC5;ZSWIM7;PSMD14;MEIOB;XRCC1;LIG3;FANCB;MCM2;RFWD3;POLQ;RAD51B
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.2792227828717724,0.8334667572747795,0.7407847800237812,0.9689603875438952,1.0,19/113,12.57%,TRABD2B;MPP7;EIF4G1;GSK3B;VCP;IL5;CLU;ATM;TLR6;UNC13B;ERCC3;ERCC1;RPA1;TLR4;BRK1;XPA;CD36;CHD1L;CUL4A
prerank,histone H3-K4 trimethylation (GO:0080182),0.40467908291205124,0.8331962391003177,0.660245183887916,0.9689163958104027,1.0,4/11,20.94%,CTR9;KMT2D;SETD1B;KMT2A
prerank,neuron projection morphogenesis (GO:0048812),0.26968466299237864,0.8328176904638047,0.752046783625731,0.9690582812656643,1.0,16/137,8.44%,DCLK1;NGF;ALCAM;CTNND2;ISL1;DOCK7;MEF2A;KLF7;TRIO;ANKRD27;SHTN1;NCKAP1;IQGAP1;BTBD3;EIF2AK4;SRGAP2
prerank,positive regulation of viral process (GO:0048524),-0.23863101800198513,-0.8326386927861766,0.7982832618025751,0.9183513999642998,1.0,18/60,22.88%,PPARA;PPIA;ADARB1;DDB1;KPNA2;NELFCD;PPIE;NELFA;POLR2K;NR5A2;TYRO3;TARBP2;POLR2C;HACD3;POLR2G;SUPT4H1;POLR2L;AXL
prerank,negative regulation of cell communication (GO:0010648),-0.2962040380902233,-0.8325995916017767,0.7082228116710876,0.9174662641216921,1.0,4/21,9.15%,IGFBP3;SOCS5;KIF26A;GLRA1
prerank,zinc ion transport (GO:0006829),-0.3000357095351357,-0.8324393934649955,0.6931216931216931,0.9167899234056458,1.0,6/21,14.69%,SLC30A10;SLC39A8;SLC39A7;SLC30A4;SLC30A1;SLC39A3
prerank,regulation of sister chromatid cohesion (GO:0007063),0.39713148836348305,0.8316431715063038,0.625,0.9707060106688856,1.0,4/12,13.66%,WAPL;HDAC8;RB1;DDX11
prerank,pore complex assembly (GO:0046931),0.3622344449132976,0.8315802670505154,0.6731391585760518,0.9702848324189158,1.0,3/19,8.30%,ANO6;NUP93;ADAM10
prerank,membrane protein proteolysis (GO:0033619),0.3277970068593979,0.8312364068759645,0.6746268656716418,0.9703674333110778,1.0,12/37,21.05%,ADAM9;NFKB1;SPPL2A;ADAM10;ERAP1;PARL;RBMX;NAPSA;MBTPS1;CLPP;BACE2;TGFB1
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.3812920859129518,0.830994049676306,0.6649746192893401,0.9702712481998242,1.0,4/15,17.91%,IGSF1;SKI;ACVR1;LEMD3
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.291920881643257,0.8306392725121103,0.7144638403990025,0.9703823180308594,1.0,20/72,21.56%,TAX1BP1;HIPK1;ELF1;TRIM44;PTPN2;CHUK;SPPL2A;CBFB;BIRC3;TRADD;ABCE1;RNF31;VRK2;IRAK1;PTPN1;PTPN11;PIAS1;SUMO1;FADD;IFNGR2
prerank,positive regulation of telomere capping (GO:1904355),0.36419490560660356,0.8300334512360851,0.6449511400651465,0.970960489829783,1.0,4/17,15.17%,NEK7;TNKS2;MAPK1;MAPK15
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.405124974989884,0.8286744292067155,0.6495575221238938,0.9728891490226919,1.0,7/11,31.38%,GNPDA2;GNPNAT1;UAP1;GFPT1;RENBP;UAP1L1;AMDHD2
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.38294791132639466,0.8278853314963449,0.6649029982363316,0.9737347011454878,1.0,7/13,28.32%,OS9;EDEM2;UBAC2;BCAP31;SVIP;YOD1;DERL2
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.3551630276032901,0.8278620716602224,0.6834862385321101,0.9727017772500353,1.0,6/21,12.57%,ERCC3;ERCC1;RPA1;XPA;CHD1L;CUL4A
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.3551630276032901,0.8278620716602224,0.6834862385321101,0.9727017772500353,1.0,6/21,12.57%,ERCC3;ERCC1;RPA1;XPA;CHD1L;CUL4A
prerank,dicarboxylic acid metabolic process (GO:0043648),0.2989223275144485,0.8277485375728195,0.697054698457223,0.9723652905433359,1.0,11/52,19.90%,ME1;GCLC;ACOT8;FPGS;D2HGDH;OGDH;NIT2;MTHFD2;MTHFR;MTHFD2L;GOT1
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.4026165728026726,0.8276548529827471,0.6341911764705882,0.9719973861878185,1.0,5/10,28.32%,OS9;UBAC2;SVIP;YOD1;DERL2
prerank,peptidyl-amino acid modification (GO:0018193),-0.3500112229399387,-0.8274425154278493,0.6847058823529412,0.9253701392419761,1.0,3/10,16.90%,TTLL4;FKBP7;ATP7A
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.33894341300378816,0.8273452040337348,0.6807228915662651,0.9720562919901126,1.0,9/29,18.54%,PKD1;SOCS2;CLCF1;CTR9;STAT3;STAT5A;STAMBP;STAT6;IL15
prerank,long-chain fatty acid metabolic process (GO:0001676),0.2984805987218673,0.8273267851197577,0.7285902503293807,0.9715513634293487,1.0,8/64,8.50%,CYP1B1;PNPLA3;MGLL;ACSL3;DAGLB;HACL1;ACOT8;SLC27A3
prerank,branched-chain amino acid metabolic process (GO:0009081),-0.30597039760847167,-0.8271730395788812,0.7,0.9239239419885666,1.0,7/20,22.48%,BCKDHB;IVD;ACAD8;BCKDHA;SLC25A44;HSD17B10;HIBADH
prerank,branched-chain amino acid catabolic process (GO:0009083),-0.30597039760847167,-0.8271730395788812,0.7,0.9239239419885666,1.0,7/20,22.48%,BCKDHB;IVD;ACAD8;BCKDHA;SLC25A44;HSD17B10;HIBADH
prerank,nucleoside diphosphate metabolic process (GO:0009132),-0.3179002191073567,-0.8267876094082157,0.7279596977329975,0.9236883709506474,1.0,2/15,7.42%,ENTPD1;ENTPD5
prerank,ceramide metabolic process (GO:0006672),0.3020127644947581,0.8262833820175152,0.6968085106382979,0.9729144232800829,1.0,6/49,8.67%,ACER3;PLPP3;SGMS2;SPTSSB;CERS6;CERS5
prerank,regulation of phospholipase C activity (GO:1900274),0.37789827173596,0.8262410842959952,0.666110183639399,0.972477467715102,1.0,4/15,7.51%,NTRK3;FGFR1;ABL1;FGF2
prerank,positive regulation of microtubule polymerization (GO:0031116),0.3410262737473713,0.8262189556532534,0.7069219440353461,0.97198426400314,1.0,3/28,6.56%,MET;CLIP1;SLAIN2
prerank,GPI anchor biosynthetic process (GO:0006506),0.3256025313372225,0.8260025192596311,0.6721311475409836,0.9718306768084702,1.0,8/30,18.91%,PIGB;PIGL;PIGU;PIGN;DPM1;PIGH;PGAP2;GPAA1
prerank,negative regulation of B cell proliferation (GO:0030889),0.39087677390926356,0.8252415995752949,0.6355633802816901,0.9726889222031724,1.0,3/11,7.31%,IL10;TNFRSF13B;ATM
prerank,regulation of cell development (GO:0060284),0.3195347595611231,0.8251378226636046,0.6898016997167139,0.9723441111069937,1.0,6/36,9.73%,HDAC9;DOCK7;NOTCH2;BHLHE40;HES1;PER2
prerank,GPI anchor metabolic process (GO:0006505),0.3339274787432247,0.8248101871612764,0.6640986132511556,0.9724075624652629,1.0,7/26,17.19%,PIGB;PIGL;PIGU;PIGN;DPM1;PIGH;PGAP2
prerank,genitalia development (GO:0048806),0.395169136577171,0.8241827258965803,0.6429840142095915,0.9730161550825225,1.0,4/12,12.29%,PKD1;STRA6;TIFAB;DNAJC19
prerank,negative regulation of response to wounding (GO:1903035),0.3631309944515684,0.8232494908154384,0.6694352159468439,0.9741712096875317,1.0,3/19,12.43%,CD109;FGF2;CASK
prerank,glutathione derivative biosynthetic process (GO:1901687),-0.2967185527469773,-0.8231379957755043,0.7283950617283951,0.9285669301230157,1.0,8/20,28.30%,MGST3;ESD;HPGDS;GSTZ1;GSTK1;GSTA3;GSTA4;GSTT1
prerank,glutathione derivative metabolic process (GO:1901685),-0.2967185527469773,-0.8231379957755043,0.7283950617283951,0.9285669301230157,1.0,8/20,28.30%,MGST3;ESD;HPGDS;GSTZ1;GSTK1;GSTA3;GSTA4;GSTT1
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),-0.2083183585611544,-0.8227605986011323,0.9097222222222222,0.92825441546422,1.0,34/109,24.08%,LYN;PIK3R1;PAK1;CALM1;TEC;MAPK3;PPP3R1;PRKCQ;MALT1;VAV3;RAC1;TAB2;GRB2;PSMB10;PPP3CB;BTRC;MAPK9;PSME2;PLCG1;VAV1;LAT2;SYK;RELA;PSMB3;PSMB4;PSMB8;LCP2;PSMC5;TAB1;PSME1;PSMA7;BTK;MAP3K1;PSMD5
prerank,regulation of cilium movement (GO:0003352),0.3979794106795029,0.8223733495080564,0.651252408477842,0.9751875985625381,1.0,1/10,4.70%,CCDC40
prerank,cellular response to ATP (GO:0071318),-0.3238084917870374,-0.8223529708196107,0.7146341463414634,0.9280264618320644,1.0,5/14,15.51%,P2RY1;HSP90B1;P2RY12;RYR3;P2RX7
prerank,regulation of trophoblast cell migration (GO:1901163),0.3758424811283876,0.8222355481090059,0.6526138279932546,0.9748888764438043,1.0,1/14,1.78%,ARHGDIB
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.3940263482880472,0.8221648613020278,0.6454545454545455,0.9744753688442398,1.0,1/11,1.60%,CD44
prerank,response to organonitrogen compound (GO:0010243),0.31599965554488074,0.8221595770919413,0.7054597701149425,0.9739511360013993,1.0,5/38,11.48%,GLRB;RNF185;VCP;MTOR;DRD3
prerank,cardiac ventricle development (GO:0003231),0.35194945728364524,0.8221454623536572,0.6848184818481848,0.9734424025509365,1.0,6/20,10.39%,STRA6;TMEM65;HES1;GATA4;MDM4;GATA3
prerank,regulation of gene silencing by miRNA (GO:0060964),0.2932123968320478,0.8220098021030049,0.7192307692307692,0.973140866890356,1.0,20/62,23.34%,EIF4G1;NUP93;SEC13;NUP188;RANBP2;STAT3;PUM2;PUM1;DHX9;TNRC6A;POLR2H;NUP107;AAAS;IPO8;RAE1;NUP54;TGFB1;NUP98;FMR1;PPARG
prerank,protein localization to phagophore assembly site (GO:0034497),-0.3520896539125985,-0.8218675745932712,0.6928934010152284,0.9279191662805708,1.0,3/11,10.06%,WIPI1;MFN2;PACS2
prerank,positive regulation of reproductive process (GO:2000243),0.325748471780406,0.8218173671677677,0.6822995461422088,0.9729550738279705,1.0,6/31,14.53%,LHFPL2;INHBA;HYAL3;INHBB;TACR3;VIP
prerank,dendritic cell chemotaxis (GO:0002407),0.3792123368135202,0.8211237260356257,0.6577181208053692,0.9737044275863244,1.0,4/14,19.53%,TRPM4;CXCR4;TRPM2;CCR1
prerank,positive regulation of heart rate (GO:0010460),0.36153014911867454,0.8210808925325652,0.6661184210526315,0.973243274460962,1.0,2/17,5.11%,ADRA1B;TRPM4
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.3828293052914168,0.8209727819599174,0.6690140845070423,0.972900605236099,1.0,2/13,7.52%,KLRC2;GAB2
prerank,negative regulation of cellular metabolic process (GO:0031324),0.31451013302144176,0.8203666045683042,0.6862745098039216,0.9734762966088862,1.0,11/37,20.34%,LRPAP1;NFKB1;ITGAV;TFAP2A;ITGB3;TRAP1;RIN3;AATF;ANKRD13D;ATXN2;DLG4
prerank,cellular response to UV (GO:0034644),0.2836820324730982,0.819988903981722,0.7177215189873418,0.9736306164718447,1.0,17/76,18.17%,NEDD4;PRKCD;EP300;KDM1A;CREBBP;EIF2AK4;ERCC1;HYAL3;TAF1;CHEK1;USP47;XPA;STK11;XPC;CARD16;YY1;INO80
prerank,myelin assembly (GO:0032288),0.4011164908669743,0.8199400113102757,0.685251798561151,0.9731815159261128,1.0,2/10,4.17%,CD9;PMP22
prerank,primary alcohol metabolic process (GO:0034308),0.34223461060248594,0.8193486055323201,0.6927899686520376,0.9736967025781716,1.0,5/25,12.92%,CYP1B1;ADH7;PECR;GDPD3;NAAA
prerank,filopodium assembly (GO:0046847),0.36394802292515216,0.8193279861635174,0.6704545454545454,0.9732013203103266,1.0,4/16,8.44%,EZR;FGD6;SPEF1;SRGAP2
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.26094272520921574,-0.819156094879666,0.7413249211356467,0.932052639102566,1.0,9/29,18.76%,WNT5A;SAMHD1;NLRC5;HSP90AB1;IFNAR2;USP18;METTL3;TRIM6;RNASEL
prerank,carbohydrate catabolic process (GO:0016052),-0.2535544377626228,-0.8191276293570551,0.7800687285223368,0.931138123181474,1.0,12/38,18.12%,GAPDH;ALDOC;PGAM1;PGAM4;ENO2;ALDOA;HK2;PFKM;MAN2C1;PGM1;HK1;PKM
prerank,negative regulation of cellular amide metabolic process (GO:0034249),-0.21494234250878252,-0.8186591946995342,0.8888888888888888,0.931040036798291,1.0,12/84,9.28%,IGF1;APOE;RTN1;GAPDH;CNOT8;DAPK1;RPL13A;RPS3;CALR;NTRK2;YBX1;SPHK1
prerank,membrane raft organization (GO:0031579),0.3775762734373562,0.8186489607646237,0.6736111111111112,0.9738802413056069,1.0,6/15,19.06%,ANXA2;S100A10;EMP2;YJEFN3;NPC1;CLN3
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.3343652256640708,0.8183995753886992,0.7236255572065379,0.9737609618484349,1.0,10/29,26.08%,RAB6A;TRAPPC3L;NSF;VTI1A;COG3;COG5;COPA;TRAPPC10;COPB1;NAPG
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.34962325326911337,-0.8180353550999061,0.674364896073903,0.9312388689529064,1.0,3/10,10.88%,PODXL;PIEZO1;DPP4
prerank,endothelial cell differentiation (GO:0045446),0.3883114537111812,0.8177681443427863,0.6872852233676976,0.9743455256844152,1.0,2/12,6.86%,FSTL1;JAG1
prerank,response to cAMP (GO:0051591),-0.25810199266121614,-0.8177670891245624,0.7724137931034483,0.9307560477448955,1.0,8/37,9.91%,RAPGEF3;RAPGEF2;HCN1;AHR;RAPGEF1;PDE2A;KCNQ1;NDUFS4
prerank,ncRNA export from nucleus (GO:0097064),0.31651751525483246,0.817705692403026,0.7010159651669086,0.9739315138017722,1.0,14/36,26.95%,NUP93;SEC13;NUP188;RANBP2;RAN;NUP107;AAAS;RAE1;NUP54;NUP98;XPOT;NCBP2;NUP37;NUP153
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.37463347262342644,0.8174526781014233,0.6779964221824687,0.9738359784991448,1.0,3/13,11.02%,FSTL1;CD46;NOG
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.34476173778015606,0.817425577735554,0.6804281345565749,0.9733503521345841,1.0,4/23,7.44%,F8A1;DYNC1I1;KIF1B;KIF1C
prerank,regulation of phospholipase activity (GO:0010517),0.39494409869940444,0.8172926844338477,0.6856649395509499,0.9730668162856054,1.0,1/10,2.39%,FGFR1
prerank,cellular response to starvation (GO:0009267),0.26675038606459306,0.8170676152610296,0.785876993166287,0.9729319417304453,1.0,32/147,17.41%,MAP3K5;FOXO3;DAPL1;WIPI2;ZFYVE1;BECN1;SIK2;KLF10;CASTOR2;EIF2AK4;SEC13;MLST8;USP33;NPRL3;MTOR;VPS41;EIF2AK3;ATP6V0E1;INHBB;MAPK1;EHMT2;ATP6V1H;CLEC16A;CEBPB;ATP6V0D1;TFEB;PRKAA1;MIOS;RRAGB;MAPK8;WRN;ATF2
prerank,regulation of cilium assembly (GO:1902017),-0.23139257793625817,-0.8170483479524859,0.8054298642533937,0.9311334314074734,1.0,16/62,15.11%,DCDC2;USP6NL;CEP120;CCDC88A;TAPT1;TBC1D8;CDKL5;CDK10;TBC1D2;TBC1D16;ODF2L;DYNC2LI1;TBC1D1;RABGAP1;TBC1D14;CCP110
prerank,negative regulation of chemokine production (GO:0032682),0.3759687469111296,0.8167276826592268,0.6818181818181818,0.9729908994656148,1.0,2/14,3.51%,KLF4;IL10
prerank,positive regulation of behavior (GO:0048520),0.4050889928943161,0.816574146683549,0.669051878354204,0.9727370006084711,1.0,2/10,5.36%,STRA6;NR4A3
prerank,negative regulation of protein binding (GO:0032091),0.28848126065322005,0.8162040886473622,0.7351421188630491,0.9728632250146763,1.0,10/71,10.71%,LRPAP1;PRKCD;ADRB2;GSK3B;SLPI;KDM1A;PTPRF;USP33;DISC1;CSNK1E
prerank,negative regulation of translational initiation (GO:0045947),0.38626270235647847,0.8161983153112384,0.6862745098039216,0.9723523858455557,1.0,6/13,24.24%,PAIP2;EIF2AK4;EIF3E;FMR1;LARP1;RBM4
prerank,positive regulation of hydrolase activity (GO:0051345),0.2660120354493724,0.8160824578700454,0.7894131185270425,0.9720364582413782,1.0,21/137,13.09%,MAPRE2;ARAP1;SGSM2;ITGB1;WNT11;RAP1A;SNX18;RAPGEF6;GSK3B;RIPK3;NDEL1;PKP4;SGSM3;BCAR3;SRGAP2;BCAS3;RGP1;ASAP3;RHOA;RSU1;S100A10
prerank,fibrinolysis (GO:0042730),-0.33234931403012125,-0.8157879272791597,0.7058823529411765,0.9324425747724238,1.0,8/13,46.06%,PLAT;PLAUR;HRG;PLG;SERPINB2;CPB2;GP1BA;F2
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.35199716451916585,0.8156430805843885,0.6698113207547169,0.9722916321446663,1.0,1/21,1.02%,NGF
prerank,error-prone translesion synthesis (GO:0042276),0.3430185437368461,0.8154664387740406,0.6677471636952999,0.9720846059171339,1.0,4/21,13.24%,REV3L;RPA1;RFC5;REV1
prerank,negative regulation of receptor binding (GO:1900121),0.39148658602283626,0.8152841725856511,0.6678966789667896,0.971890884622568,1.0,3/10,11.02%,IL10;PTPRF;NOG
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.3138431230379737,0.8148269055722742,0.6977715877437326,0.9722214486658375,1.0,6/42,13.56%,WARS2;EARS2;YARS1;CARS2;NARS2;FARSA
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.362779368911866,0.8147672926658058,0.6638795986622074,0.9717937338595831,1.0,6/16,21.69%,FOXK1;FOXK2;GNB3;RORA;ADIPOR1;PDK3
prerank,regulation of microtubule polymerization (GO:0031113),0.31396029095000133,0.8146840495316289,0.706777316735823,0.9714198102475808,1.0,4/40,6.56%,MET;ABL1;CLIP1;SLAIN2
prerank,epithelial cell development (GO:0002064),-0.2879031380488791,-0.8146717524485354,0.75,0.9335396807603462,1.0,4/20,15.00%,WNT5B;ACTA2;DACT2;RILPL2
prerank,renal filtration (GO:0097205),0.3937599435157734,0.8146126942754315,0.6780575539568345,0.9710136549797042,1.0,4/10,17.50%,SULF1;SULF2;XPNPEP3;TBC1D8B
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.38371215076474663,0.8146024456225092,0.6683760683760683,0.9705041075791448,1.0,2/12,11.44%,MUC6;TLR4
prerank,sensory perception of mechanical stimulus (GO:0050954),0.28352866170764257,0.8145554479959294,0.7644882860665845,0.9700722584416015,1.0,6/85,7.14%,PIEZO2;ATP6V0A4;P2RX2;TFAP2A;TBL1X;P2RX4
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.28395974098033094,0.8141984927592729,0.7426751592356687,0.970187153990455,1.0,14/73,12.93%,CYFIP2;ABI1;PRKCD;ABL1;NR4A3;VAV2;NCKAP1;NCKIPSD;WIPF2;CDC42;BRK1;PRKCE;YES1;MAPK1
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.38149622854884613,0.8134034915894824,0.695,0.9710780318357093,1.0,3/11,7.46%,LMNA;P2RX4;ATP2B4
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.34824965946082825,0.8132281758940653,0.6975206611570248,0.9708787341776111,1.0,5/20,12.45%,LBP;BCL10;TLR4;MTDH;PRKCE
prerank,phagosome maturation (GO:0090382),0.313354790741517,0.8129037756968177,0.7001434720229556,0.9709447612024072,1.0,9/35,19.26%,ATP6V0A4;RAB43;ATP6V0A1;ATP6V0E1;ATP6V1H;ATP6V0D1;MCOLN1;RAB7A;ATP6V1G1
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.3607052441315766,0.8128370633237565,0.6893687707641196,0.9705333399798484,1.0,1/16,2.67%,RAET1E
prerank,mitochondrial membrane organization (GO:0007006),0.32174575237641356,0.8125378193910219,0.7074235807860262,0.9705193291460094,1.0,8/32,13.10%,MTX3;SAMM50;DNAJC11;MTX2;MICOS10;IMMT;BNIP3;SPG7
prerank,positive regulation of rRNA processing (GO:2000234),0.39350179371292016,0.8125197204318394,0.6786941580756014,0.9700360448441661,1.0,6/10,29.63%,WDR43;RIOK2;WDR75;SIRT7;HEATR1;UTP15
prerank,epithelium development (GO:0060429),0.2675034889680674,0.8114108543446565,0.7833333333333333,0.9714608045697068,1.0,9/107,7.19%,SMO;SIX1;PKD1;BDH2;ANXA4;MEOX2;KANK2;VCL;STIL
prerank,negative regulation of DNA recombination (GO:0045910),-0.24479792816159573,-0.8111121952274792,0.7922535211267606,0.9390124803575629,1.0,12/43,26.27%,RIF1;SMCHD1;CGAS;BLM;POLR2K;TERF2IP;POLR2C;H1-0;POLR2G;POLR2L;SHLD3;FBH1
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.298868271216086,0.8105736968949274,0.7315068493150685,0.9724098469359251,1.0,14/52,24.73%,SAMD4A;PAN3;CNOT7;EXOSC7;LSM2;PNLDC1;EDC3;EXOSC5;RC3H2;CNOT3;EXOSC4;DCP1A;CNOT11;EXOSC1
prerank,regulation of necroptotic process (GO:0060544),0.3394899988574137,0.810538521954685,0.6996904024767802,0.9719522668198174,1.0,3/23,4.80%,YBX3;RIPK3;PDCD6IP
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.38907573243152427,0.8104385678532566,0.6829679595278246,0.9715994191043901,1.0,2/12,4.00%,PTK2B;NOTCH2
prerank,regulation of fat cell differentiation (GO:0045598),0.2842663464754081,0.8103695258912958,0.7509627727856226,0.9711945843064111,1.0,19/74,18.37%,ZFPM2;ZBTB16;FTO;TRPM4;TRIO;WWTR1;CDS1;GATA3;GNB3;ASXL2;CMKLR1;LRP5;CEBPB;CARM1;FRZB;RORA;SYAP1;CREBL2;ZFP36L1
prerank,receptor-mediated endocytosis (GO:0006898),0.261963085130682,0.8100658122910861,0.7886658795749705,0.9712029338665725,1.0,16/132,7.73%,NEDD4;RAMP1;PDLIM7;ITGB1;CD9;COLEC11;LRP6;ADRB2;HPX;AP2A2;CLTB;GPR107;AP4E1;GAK;AP2A1;IGF2R
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.37320710592706385,0.8096698984175323,0.6916524701873935,0.9714021717596931,1.0,6/15,24.46%,DDRGK1;DYRK3;PAF1;ATAD5;KLHL18;EZH2
prerank,inner mitochondrial membrane organization (GO:0007007),-0.2391651983041176,-0.809356928015298,0.8,0.9411712488360663,1.0,12/47,16.02%,ATP5F1B;ATP5PF;ATP5F1E;HSPA9;ATP5ME;ATP5MC1;MICOS13;ATP5F1D;APOO;TIMM13;ATP5MC2;ATP5F1A
prerank,adipose tissue development (GO:0060612),-0.34219322944725283,-0.8089078878792284,0.7136258660508084,0.9410077924891418,1.0,6/11,28.56%,ARID5B;SH3PXD2B;PGRMC2;RORC;DYRK1B;XBP1
prerank,chromatin assembly (GO:0031497),0.3131577640913129,0.8087954415889937,0.7040673211781207,0.9724398350121133,1.0,11/38,27.73%,CHAF1B;KAT6B;NAP1L2;PAF1;ATRX;RBBP4;HMGB2;BRD2;BAHD1;SMARCA5;CTCF
prerank,T cell activation (GO:0042110),0.2878205345843251,0.8086346720970095,0.7420212765957447,0.9722077938027989,1.0,8/69,10.39%,CXADR;CD44;PPP3CA;NCK2;PTPN2;TNFRSF4;EIF2AK4;GATA3
prerank,negative regulation of autophagosome assembly (GO:1902902),0.3814120739735374,0.8083412237114309,0.6854700854700855,0.9721698223780358,1.0,7/13,23.78%,SMCR8;SEC22B;FEZ2;CHMP4A;CHMP4B;TMEM39A;PHF23
prerank,tRNA transport (GO:0051031),0.3149555085205452,0.8083202055858023,0.7159420289855073,0.9716847221508494,1.0,14/35,26.95%,NUP93;SEC13;NUP188;RANBP2;RAN;NUP107;AAAS;RAE1;NUP54;NUP98;XPOT;TOMM20;NUP37;NUP153
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.34006431700196293,0.8082682674405431,0.6892744479495269,0.9712689794010619,1.0,4/22,11.48%,AHNAK;DMD;CACNB2;DRD3
prerank,ubiquinone biosynthetic process (GO:0006744),0.36790359811618845,0.8080177951264689,0.6862416107382551,0.9711939400074519,1.0,2/15,5.43%,COQ7;COQ10B
prerank,regulation of protein-containing complex assembly (GO:0043254),0.27064954985197903,0.8079636905251438,0.7757225433526012,0.9707719155681243,1.0,14/110,12.46%,TRABD2B;ISL1;MPP7;GSN;GSK3B;VCP;CLU;EP300;SAR1B;CDC42;RB1;BRK1;CD36;KIF9
prerank,cellular response to light stimulus (GO:0071482),0.2849157261949158,0.807819631810983,0.7247119078104993,0.9705221687132459,1.0,19/66,25.39%,NEDD4;PRKCD;EP300;KDM1A;CREBBP;EIF2AK4;TAF1;USP47;YY1;INO80;N4BP1;ATR;SAG;FMR1;RHO;GNB1;PDE6A;USP28;CASP9
prerank,fluid transport (GO:0042044),0.3806083679284232,0.8077716482778244,0.6884681583476764,0.9700966553960559,1.0,4/12,19.47%,AQP6;SLC26A6;AQP9;PDPN
prerank,negative regulation of developmental process (GO:0051093),0.2821944665881726,0.8075895138789647,0.7483530961791831,0.969912435784217,1.0,4/69,4.55%,BMP4;NFIB;WNT11;KLF7
prerank,response to light stimulus (GO:0009416),0.29644604918913914,0.8072711184222033,0.7403973509933774,0.9699278453936356,1.0,9/55,17.10%,UBE4B;CRY2;UBE2B;ERCC3;ERCC8;REV1;CDKN2D;USP1;MAPK8
prerank,cardiac atrium morphogenesis (GO:0003209),0.3615567245816394,0.8069461217652852,0.6847457627118644,0.9699711017493234,1.0,5/16,11.71%,ISL1;NOTCH2;GATA4;NOG;TGFB2
prerank,striated muscle cell development (GO:0055002),-0.319809442563708,-0.8068270330913933,0.720873786407767,0.9436389714124267,1.0,3/14,7.80%,PGM5;TMOD1;LMOD1
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.2722581102939563,0.8060890362159681,0.7722289890377588,0.9709520509267688,1.0,28/95,23.71%,SFI1;CEP164;PAFAH1B1;CEP131;MKS1;PCM1;HAUS5;CSNK1E;CEP70;CEP63;CEP57;CEP97;PRKACA;CSNK1D;DCTN3;CEP89;CNTRL;AKAP9;NPHP1;CEP192;DCTN1;ODF2;C2CD3;CDK1;B9D1;HAUS1;NPHP4;IQCB1
prerank,nuclear membrane disassembly (GO:0051081),0.374921252910755,0.8059730562342531,0.695,0.9706393059051563,1.0,7/14,26.22%,CNEP1R1;NEK9;PRKCA;DCTN1;CDK1;NEK6;AKAP8L
prerank,negative regulation of immune system process (GO:0002683),-0.30859567822963857,-0.8057191584799053,0.7242268041237113,0.944611440478128,1.0,1/16,0.63%,LYN
prerank,positive regulation of macrophage migration (GO:1905523),0.3518933383243035,0.8056437006480962,0.705229793977813,0.9707184956640093,1.0,4/19,12.93%,THBS1;P2RX4;CMKLR1;MAPK1
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.2667425080231913,0.8054182313069735,0.7913669064748201,0.9706077849410033,1.0,10/107,8.27%,SLC24A3;ANK2;ATP1B1;ATP2C2;CSRP3;STIM2;TNNI3;ATP2B4;SLC10A7;SLC39A14
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.2931767527112028,0.8052560823024123,0.7389558232931727,0.970376414046265,1.0,6/53,12.74%,ANXA1;CHRM5;SSTR3;AGTR2;HTR1B;HTR2B
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.2868208840227336,-0.8050682261654328,0.746268656716418,0.9447446488582246,1.0,4/20,10.06%,TGM2;BCL2;SELENOK;PACS2
prerank,chromatin remodeling (GO:0006338),0.27095551009588426,0.8049822340136007,0.7660606060606061,0.9703391768227009,1.0,27/100,19.10%,HDAC4;BPTF;BAZ2B;KAT2A;TAF6L;SMARCA4;FOXA1;RB1;BAZ1A;MYSM1;KDM4D;CHD1L;GATAD2B;BAZ2A;KAT2B;PBRM1;HCFC1;SRCAP;ATRX;TOP1;ACTR8;KDM6B;ZBTB7A;INO80;ARID1A;SMARCD2;RBBP4
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.3211087292216,-0.8049461932896164,0.7129840546697038,0.9440073427007714,1.0,5/13,18.42%,FUT9;ETS1;MDK;ITGB2;RELA
prerank,regulation of catabolic process (GO:0009894),0.3504015953706575,0.8043949170848262,0.6723076923076923,0.9708347593014478,1.0,5/18,20.26%,ITGB1;CHEK2;FAF1;ZDHHC7;HGS
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.3320763776162078,0.8042236516708136,0.6933744221879815,0.9706377831649424,1.0,3/26,5.11%,EFNA5;KLF7;TRPM4
prerank,sphingolipid biosynthetic process (GO:0030148),0.28243487977524506,0.8041221212515995,0.7612903225806451,0.9703108932822666,1.0,9/71,9.46%,ACER3;PLPP3;SGMS2;LARGE1;SPTSSB;A4GALT;CERS6;CERS5;VAPA
prerank,mitochondrion morphogenesis (GO:0070584),0.387666973562425,0.8039798299946148,0.6924460431654677,0.9700461764822065,1.0,1/11,2.92%,PID1
prerank,regulation of protein processing (GO:0070613),-0.2912268739914564,-0.8037445821558246,0.7466307277628033,0.9451145764665457,1.0,4/21,14.48%,CCBE1;NKD2;LRRK2;RNF139
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.3737584671983421,0.8036937948144276,0.6589018302828619,0.9700374456661077,1.0,3/12,7.98%,NPHS1;JAG1;IQGAP1
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.3370814804345544,0.8036920414524426,0.6961240310077519,0.9695308903319316,1.0,3/23,5.96%,ISL1;DSG2;TNNI3
prerank,regulation of gastrulation (GO:0010470),0.36223118857399694,0.8035190447821672,0.7178217821782178,0.9693058498772412,1.0,1/14,1.84%,PHLDB2
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.2812371222439806,0.8029229782378977,0.7581699346405228,0.9697985554095494,1.0,8/70,8.68%,TMEFF2;FN1;PARVA;ANTXR1;ITGAV;NRP1;SRGAP2;POF1B
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.2999646034137201,-0.802709566867961,0.7291666666666666,0.9459734109821321,1.0,6/17,16.35%,PODXL;PIEZO1;CIB1;P2RY12;NCKAP1L;SYK
prerank,mRNA stabilization (GO:0048255),0.3060433356751614,0.8021763279031452,0.739803094233474,0.970555480974214,1.0,15/40,22.77%,YBX3;GDNF;SYNCRIP;FUS;TENT5D;VIP;TAF15;DHX9;MYD88;MAPKAPK2;TENT5C;PABPC1;EIF4ENIF1;ANGEL2;LARP1
prerank,protein acylation (GO:0043543),-0.2492296702021552,-0.8014263209065811,0.8041958041958042,0.9471378802069964,1.0,8/38,14.42%,FOXO1;ZDHHC14;SELENOK;SPHK1;PORCN;ZDHHC1;ZDHHC17;ZDHHC13
prerank,response to cytokine (GO:0034097),0.2632554169393264,0.8012099516973589,0.8129988597491448,0.9717233865961628,1.0,33/141,18.58%,DPYSL3;ANXA1;HDAC4;NFAT5;PID1;COL3A1;ADAM9;AFF3;PLSCR1;HCLS1;IL18BP;PTPN2;TIMP2;ADAM10;CYP27B1;CXCR4;SETD2;RHOA;TAF9;IKBKE;STAT3;PTPN14;CIITA;REL;PRKCA;PTPN9;PML;MYD88;MAPK8;MAPKAPK2;NUB1;IRAK1;DDOST
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.3546694142749628,0.8011761877863157,0.6941176470588235,0.9712613527016796,1.0,2/17,6.88%,KCNB1;SLC4A8
prerank,embryonic heart tube development (GO:0035050),0.3637534154975673,0.8011410854522473,0.6972789115646258,0.9708098884264594,1.0,5/14,16.96%,HES1;IFT122;ACVR1;MEGF8;CITED2
prerank,organelle fusion (GO:0048284),0.3358962156415651,0.8010564017503621,0.7206349206349206,0.9704443062908658,1.0,4/22,19.48%,EEA1;SPG7;MIEF1;FIS1
prerank,autophagosome assembly (GO:0000045),0.29226081707507806,0.8010201079754143,0.7442489851150202,0.9699942741515759,1.0,13/52,20.75%,WIPI2;ULK2;RAB43;BECN1;ATG3;RB1CC1;SMURF1;AMBRA1;ATG2A;RAB7A;ATG7;ULK1;ATG16L1
prerank,C4-dicarboxylate transport (GO:0015740),0.3749010414218896,0.8009947467716417,0.6928327645051194,0.9695372947107471,1.0,2/14,8.98%,LRRC8D;SLC25A14
prerank,cellular response to pH (GO:0071467),0.3573655318363724,0.8009527765519456,0.6885813148788927,0.9691168104613495,1.0,5/17,24.36%,PKD2L1;SLC9A1;MCOLN1;CHP1;IMPACT
prerank,negative regulation of glycolytic process (GO:0045820),0.38777497610892525,0.8004647755887621,0.7096774193548387,0.9689263666817405,1.0,1/10,1.50%,HDAC4
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.38777497610892525,0.8004647755887621,0.7096774193548387,0.9689263666817405,1.0,1/10,1.50%,HDAC4
prerank,regulation of metal ion transport (GO:0010959),-0.30643030631475476,-0.8003152192560471,0.7506702412868632,0.9480107540771066,1.0,6/16,15.73%,SLC30A10;BCL2;EPB41;CACNA2D1;CAMK2B;STIM1
prerank,determination of bilateral symmetry (GO:0009855),-0.26329784066168854,-0.800267208819218,0.8041543026706232,0.9471313810168963,1.0,7/25,21.00%,NOTCH1;TBX1;ZIC3;BBS7;CFAP53;NPHP3;DLL1
prerank,negative regulation of axon extension (GO:0030517),0.3268899490381471,0.799819317003195,0.7171561051004637,0.9695518145971297,1.0,3/30,2.85%,SEMA3D;SEMA3C;SEMA3E
prerank,cochlea morphogenesis (GO:0090103),-0.3467790261625796,-0.7997286234214308,0.7383177570093458,0.9470584498957386,1.0,2/10,5.41%,TBX1;TBX18
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.36540617075460397,0.7996061245161401,0.6792763157894737,0.969416559652514,1.0,8/14,33.54%,ZDHHC5;PUM2;PUM1;ZCCHC3;DDX60;USP15;ANKRD17;TLR5
prerank,natural killer cell activation (GO:0030101),0.34102130647777823,0.7991922263354595,0.7204968944099379,0.9696369715666701,1.0,4/23,15.50%,PBX1;NFIL3;IL21R;ELF4
prerank,RNA 3'-end processing (GO:0031123),0.28185819492955927,0.798296354099051,0.7426376440460948,0.9707278151748316,1.0,22/69,25.72%,U2AF1L4;CASC3;SRSF5;SRSF6;SRRM1;THOC2;RBM8A;SRSF11;THOC5;ZC3H11A;CPSF7;CHTOP;NUDT21;CPSF4;MTPAP;ALYREF;NCBP2;CSTF2;CSTF1;UPF3B;SRSF7;FIP1L1
prerank,regulation of autophagy of mitochondrion (GO:1903146),-0.2913205274897567,-0.7979265943597219,0.7581521739130435,0.9492945153287612,1.0,6/19,21.87%,GSK3A;PARK7;CAMKK2;DNM1L;HTT;FZD5
prerank,tRNA methylation (GO:0030488),0.31135849865002513,0.7977918681776638,0.7397058823529412,0.971087157991433,1.0,11/34,22.52%,TRMT13;METTL6;METTL1;TRMT1L;MTO1;GTPBP3;DALRD3;TRDMT1;ALKBH8;TRMT61A;TRMT12
prerank,negative regulation of fibroblast proliferation (GO:0048147),-0.2923394454908189,-0.7976560608756665,0.739946380697051,0.9487884327134748,1.0,3/18,9.48%,FTH1;DAB2IP;CD300A
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.3742032449603272,0.7970453634571282,0.696551724137931,0.9718617510020169,1.0,3/12,7.67%,SORBS1;IRS1;DYRK2
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.3796893987591997,0.7968163349526288,0.6890034364261168,0.9717493668655031,1.0,3/12,12.58%,WDTC1;ERLIN1;PIBF1
prerank,protein localization to chromatin (GO:0071168),0.3550070116342351,0.7967219526692069,0.7072,0.9714115895209346,1.0,5/18,17.80%,SGF29;WAPL;MRNIP;LRWD1;MCM9
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.370534934515927,0.7966669469605393,0.6782449725776966,0.9709914848629,1.0,4/11,26.96%,RESF1;MPHOSPH8;TASOR;TRIM28
prerank,regulation of stem cell differentiation (GO:2000736),0.2701706145176192,0.7963432681945214,0.8032378580323786,0.9710139471732375,1.0,28/89,23.72%,ABL1;BMPR1A;GATA1;GDNF;JAG1;HES1;CBFB;TCF3;GATA3;PSMC6;PRKDC;PSMD8;LDB1;YTHDF2;PSMB1;PSMD13;PSMD1;PSMD7;PSMA8;KMT2A;MYB;NUDT21;PSMD3;PUS7;PSMD2;PSMC2;HOXB4;PSMB2
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.2673795692637344,-0.7951759985582446,0.811046511627907,0.9519781627092431,1.0,12/31,20.51%,SHANK3;PPFIA2;EPHA4;LRP8;LRRK2;ABI3;CAMK2B;LZTS3;CFL1;NLGN1;ABI2;CDK5R1
prerank,regulation of protein localization (GO:0032880),-0.23456649741216734,-0.7947714230850972,0.873015873015873,0.9517135802503779,1.0,12/58,15.66%,RABGAP1L;PICALM;MAP2;TRIM14;PARP1;HSP90AB1;TRIM21;CTSD;TRIM27;MMD;TRIM46;PPM1F
prerank,cellular response to gamma radiation (GO:0071480),0.3479218047544885,0.7943311725742186,0.7084745762711865,0.9739271456721518,1.0,8/17,23.69%,ATM;KDM1A;XRCC5;TSPYL5;WRN;TLK2;ATR;TMEM109
prerank,positive regulation of JUN kinase activity (GO:0043507),0.33516341270482863,0.7939661536021569,0.7084639498432602,0.9740258760203419,1.0,3/23,7.33%,MAP3K5;ARHGEF5;TLR6
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.35193356227186406,0.793842062773985,0.6815181518151815,0.973727733085958,1.0,1/17,1.46%,ANK2
prerank,mRNA catabolic process (GO:0006402),0.3067453811334069,0.7923428915110224,0.7628294036061026,0.9757488832663935,1.0,7/44,13.42%,DDX5;DXO;ZC3H12D;DIS3L2;NANOS2;LSM2;NBAS
prerank,respiratory chain complex IV assembly (GO:0008535),-0.2858737754013529,-0.7923224455514692,0.7573333333333333,0.9548467387008485,1.0,8/21,20.53%,COX17;SCO1;PET100;COX20;COX10;COX18;COA3;COA6
prerank,granulocyte chemotaxis (GO:0071621),0.2912885852005946,0.7919311207452401,0.7371273712737128,0.9759294605388641,1.0,2/55,1.32%,CXADR;ANXA1
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.29409009563371347,0.7919169620191203,0.7435897435897436,0.9754450480252718,1.0,10/53,17.01%,PKD1;F8A1;XPO1;DDRGK1;COMMD1;RAD23B;PSMC6;UFL1;PRKACA;DESI1
prerank,regulation of axon extension (GO:0030516),0.31010420177740633,0.791874474376878,0.75,0.9750141058224212,1.0,6/37,10.38%,NTN1;GSK3B;ABL1;SHTN1;ISLR2;ZFYVE27
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.26628148850213484,-0.791135008085508,0.7816091954022989,0.9558905524857866,1.0,5/25,14.45%,HSPA8;HSPA9;PTGES3;DNAJB5;ERO1A
prerank,COPII vesicle coating (GO:0048208),0.28414338483996254,0.7906039921479691,0.7526595744680851,0.9755681433215745,1.0,30/61,29.13%,SEC24B;STX5;CNIH2;NSF;SEC13;SEC22B;SAR1B;TRAPPC4;SEC24A;PPP6R3;CSNK1D;ANKRD28;AREG;USO1;SEC23A;TRAPPC6B;BET1;PPP6C;TBC1D20;TRAPPC6A;TRAPPC10;PPP6R1;GORASP1;PEF1;SEC16A;TFG;SEC24D;PREB;SEC31A;CUL3
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.28414338483996254,0.7906039921479691,0.7526595744680851,0.9755681433215745,1.0,30/61,29.13%,SEC24B;STX5;CNIH2;NSF;SEC13;SEC22B;SAR1B;TRAPPC4;SEC24A;PPP6R3;CSNK1D;ANKRD28;AREG;USO1;SEC23A;TRAPPC6B;BET1;PPP6C;TBC1D20;TRAPPC6A;TRAPPC10;PPP6R1;GORASP1;PEF1;SEC16A;TFG;SEC24D;PREB;SEC31A;CUL3
prerank,vesicle coating (GO:0006901),0.28414338483996254,0.7906039921479691,0.7526595744680851,0.9755681433215745,1.0,30/61,29.13%,SEC24B;STX5;CNIH2;NSF;SEC13;SEC22B;SAR1B;TRAPPC4;SEC24A;PPP6R3;CSNK1D;ANKRD28;AREG;USO1;SEC23A;TRAPPC6B;BET1;PPP6C;TBC1D20;TRAPPC6A;TRAPPC10;PPP6R1;GORASP1;PEF1;SEC16A;TFG;SEC24D;PREB;SEC31A;CUL3
prerank,"DNA-templated transcription, termination (GO:0006353)",0.2836656786622731,0.790482304776018,0.7831021437578815,0.9752714833544216,1.0,25/68,26.42%,POLR1G;TAF1C;TTF2;MNAT1;SCAF8;ERCC3;TTF1;POLR1A;POLR1H;SNRPD3;POLR1F;TAF1D;POLR2H;CPSF7;NUDT21;CPSF4;ERCC2;MAZ;NCBP2;CSTF2;SNRPE;CSTF1;POLR3K;FIP1L1;POLR1C
prerank,stress-activated MAPK cascade (GO:0051403),0.28281730826699786,0.7904724792876933,0.7691326530612245,0.9747826379143766,1.0,7/61,7.24%,MAP3K5;ARHGEF6;NFKB1;TAB3;FBXW11;CHUK;RIPK2
prerank,regulation of myelination (GO:0031641),0.3199201363827193,0.7902466044954103,0.7189952904238619,0.9746597399217951,1.0,5/25,11.22%,EGR2;TNFRSF1B;PARD3;EIF2AK3;RNF10
prerank,cell proliferation in forebrain (GO:0021846),0.38973892663422594,0.7900064319289529,0.6783088235294118,0.9745625732473734,1.0,2/10,9.89%,DOCK7;PCM1
prerank,regulation of Golgi organization (GO:1903358),0.3597057951356189,0.7898749571190264,0.7152103559870551,0.9742675678867292,1.0,7/17,18.30%,EHD3;STX5;RBSN;MAPK1;MAP2K2;ARMH3;AKAP9
prerank,regulation of innate immune response (GO:0045088),0.2911950754530722,0.7893733238308477,0.761528326745718,0.9745757737026449,1.0,13/57,15.78%,POLR3D;PLSCR1;IFI35;RNF135;ERAP1;ACOD1;IRF1;TRAFD1;ADAM8;BIRC3;ABCE1;POLR3B;DHX9
prerank,spermatid development (GO:0007286),-0.25441531061539324,-0.7891906030651379,0.8140243902439024,0.9581504144618639,1.0,13/32,38.42%,NECTIN2;NME5;CIB1;CDYL;ZMYND15;ING2;MKKS;YTHDC2;DPY19L2;CCDC63;RSPH1;SOX30;JAM2
prerank,regulation of cell projection organization (GO:0031344),-0.3164085923945779,-0.78898645970312,0.7333333333333333,0.9575021917795776,1.0,4/13,16.62%,MACF1;MFSD2A;ERMN;CCL19
prerank,negative regulation of lymphocyte activation (GO:0051250),-0.2762597375117256,-0.788484680409135,0.7783783783783784,0.9573744644396668,1.0,9/21,34.75%,DUSP3;PAG1;SAMSN1;TNFAIP3;JAK3;LAPTM5;GPNMB;FCGR2B;FOXJ1
prerank,ncRNA 3'-end processing (GO:0043628),0.3708843571310438,0.7881676515556478,0.7035175879396985,0.9760695484862398,1.0,8/14,33.58%,INTS8;TOE1;ELAC2;INTS2;PTCD1;INTS12;SSB;INTS6
prerank,cellular amide metabolic process (GO:0043603),-0.204152111904907,-0.7881642650792766,0.935672514619883,0.9569445945759596,1.0,14/102,12.58%,AEBP1;ST3GAL1;PCCA;ST6GAL1;CERK;SMPD3;ACBD6;MTHFS;ACOT7;DBI;ACSF2;ALDH1L1;NAPEPLD;ORMDL3
prerank,positive regulation of immunoglobulin production (GO:0002639),0.3128507858114587,0.7881371960969632,0.7105643994211288,0.9756120487328822,1.0,5/31,12.13%,IL10;CLCF1;TNFRSF4;SHLD1;GPI
prerank,intraciliary retrograde transport (GO:0035721),0.3755406222058904,0.7877710656525232,0.7011494252873564,0.9757163420690288,1.0,7/12,26.18%,IFT122;TTC21A;DYNC2I2;DYNC2H1;WDR35;TTC21B;DYNC2I1
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.31239743435657563,-0.7875246549543239,0.7587822014051522,0.9570122339169111,1.0,6/15,21.17%,SPCS3;SRP14;RYR2;SEC61G;SPCS1;ZFAND2A
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.2638000451821515,-0.7872906254506277,0.7523809523809524,0.9564683365925254,1.0,8/29,17.28%,AGO1;LIN28B;AGO4;SMAD1;SMAD3;METTL3;TARBP2;SPOUT1
prerank,mRNA methylation (GO:0080009),-0.30521832277997873,-0.787191208344969,0.7735368956743003,0.9556825743423094,1.0,5/15,29.31%,METTL14;METTL16;METTL3;TRMT61B;ZC3H13
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.27937617560957323,0.787009217215374,0.7798982188295165,0.9764654285205989,1.0,27/67,24.11%,RABEP2;ATP8B1;TBC1D13;ATG3;P2RX4;SGSM3;PLD1;RDX;DMTN;TBC1D10A;CDC42;TBC1D2B;FXR2;RAB5A;IFT88;MAPK15;RAB17;TRPM2;TBC1D5;ABITRAM;TBC1D20;MYO10;FMR1;TBC1D17;ODAD3;TBC1D19;CAPZB
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.3817068471644532,0.7867384131564081,0.6968085106382979,0.9763911116658184,1.0,1/10,2.80%,ANO6
prerank,cellular response to lipopolysaccharide (GO:0071222),0.2614007143182198,0.7866362076438177,0.8146811070998796,0.9760551176004417,1.0,22/101,17.10%,LBP;ADAM9;IL10;PDCD4;NFKB1;CD80;SHPK;TNFRSF1B;BCL10;CTR9;ACOD1;TLR4;RHOA;PAF1;MTDH;PRKCE;TRIM41;SBNO2;MYD88;TICAM2;CARD16;MAPK8
prerank,glucan catabolic process (GO:0009251),0.35726664780751616,0.7863308159629064,0.6977848101265823,0.9760601461159716,1.0,6/15,21.05%,PYGB;PHKA2;MGAM;PHKB;PHKA1;GAA
prerank,MAPK cascade (GO:0000165),0.24265700857083947,0.7860979348537612,0.8954451345755694,0.975949242909846,1.0,26/295,7.56%,EGFR;MET;MAP3K5;PTPN3;MRAS;SPTAN1;FGFR1;SHC1;NRAS;KRAS;MEF2A;PDE6D;PDGFA;GDNF;NFKB1;IL5;IRS1;SHOC2;ITGAV;DLG1;FBXW11;FGF22;CHUK;FGF13;FGF2;MAP3K3
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.3654763382195165,0.7860917443565713,0.6926994906621392,0.9754617561061782,1.0,3/13,7.67%,SORBS1;IRS1;DYRK2
prerank,regulation of histone modification (GO:0031056),-0.3226994957416581,-0.7860609420195386,0.7405660377358491,0.9566626442530356,1.0,5/13,18.91%,IGF2;MYOCD;FLCN;PARK7;HPF1
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.28915467609531686,-0.7859401091441349,0.7578125,0.9558928601534625,1.0,1/18,0.63%,LYN
prerank,melanosome organization (GO:0032438),0.3266800267713273,0.7857580133441935,0.71875,0.9755475756109099,1.0,4/26,11.60%,KIF13A;AP3B1;HPS4;PMEL
prerank,cellular response to nitrogen compound (GO:1901699),0.34253250267048374,0.7857496298441845,0.7085987261146497,0.97506442884765,1.0,4/20,16.52%,DDI2;ATP2B4;DDX11;ATRX
prerank,female gonad development (GO:0008585),-0.28977941613761626,-0.785345423021442,0.8016759776536313,0.9559222977836047,1.0,2/19,2.57%,NR2F2;KIT
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.30804315585440434,0.7851577529997719,0.7317436661698957,0.9755052117884461,1.0,15/36,26.20%,NECTIN3;KIF13A;GOLPH3;NSF;GGA2;RILPL1;GOLGA7;RAB7A;ARFRP1;SYS1;VAMP4;GOLGA4;GORASP1;BBS2;RAB10
prerank,protein targeting to lysosome (GO:0006622),0.3423600327577434,0.78511657059813,0.7213375796178344,0.9750656192009723,1.0,8/20,25.05%,NEDD4;CLU;NCOA4;AP4M1;RAB7A;HGS;M6PR;LAMP2
prerank,protein transport (GO:0015031),0.24111559505754318,0.784972566860891,0.893305439330544,0.9748099382017068,1.0,72/332,19.26%,RAMP1;SGSM2;KIF13A;ATP6V0A4;GRTP1;ARF4;RAB43;STX19;STX5;STX11;LTBP2;RAB3GAP2;RAB6A;ARF3;TLK1;TMED5;TBC1D13;GOLPH3;AP3B1;HERC2;CLU;TBC1D25;STX8;LRSAM1;RAB18;AP2A1;EIF2D;SNX31;ARFIP1;SGSM3;SLC10A7;NSF;ATP6V0A1;SEC13;LMAN2L;TANGO6;SAR1B;TBC1D10A;ATP6V0E1;GGA2;EHD1;CD36;TOM1;SNX4;TBC1D2B;CTTN;ATP6V1H;VIPAS39;STX16;LRP1;ATP6V0D1;ARL6IP5;RAB5A;SNX17;RAB17;ARCN1;VPS26C;GOLGA7;RAB22A;TICAM2;TBC1D5;TBC1D8B;ARL1;USO1;AP4M1;MCOLN1;ACD;RAB7A;RUFY1;COPA;SNX13;ATP6V1G1
prerank,triglyceride metabolic process (GO:0006641),-0.23076527480137432,-0.7848235683228263,0.8768115942028986,0.9558214522760905,1.0,11/48,20.74%,APOE;LPGAT1;GK;LPIN3;LPIN1;GPAM;FABP5;PNPLA2;DGAT1;FABP7;LPL
prerank,cobalamin metabolic process (GO:0009235),0.3508738616082665,0.7841691209682438,0.7298747763864043,0.9756303756524297,1.0,7/17,25.04%,MMACHC;CD320;MMADHC;LMBRD1;MMAB;ABCC1;MTRR
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.3356829798761158,0.7840832495037435,0.7254290171606864,0.9752737118037985,1.0,7/20,16.20%,DDRGK1;EP300;GATA3;NIBAN2;RB1;FOXC1;PAX6
prerank,positive regulation of immune response (GO:0050778),0.2819101978558273,0.7833178902762175,0.7825520833333334,0.9760190760050674,1.0,15/64,22.29%,IL10;POLR3D;PLSCR1;IFI35;EIF2AK4;CD46;TGFB2;ADAM8;POLR3B;DHX9;IL15;NOD2;MYB;FADD;ITGAM
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.27164759072437794,0.7829126013294841,0.7972972972972973,0.976151840821217,1.0,28/85,24.42%,USP13;GSK3B;RNF19A;RNF185;VCP;DDRGK1;CLU;PRICKLE1;ARIH1;CSNK1E;ARIH2;TAF1;CSNK1A1;PSMC6;CSNK1D;COP1;RNF144A;NUB1;PIAS1;RNF14;SUMO1;FMR1;TRIB2;PSMC2;HSPA1A;ANKIB1;RCHY1;RNF217
prerank,sterol biosynthetic process (GO:0016126),-0.2508029571912951,-0.7823469301372665,0.842948717948718,0.9589838688760868,1.0,11/33,24.01%,PRKAG2;ACLY;SC5D;GGPS1;INSIG2;HSD17B7;CH25H;ACAT2;IDI1;MVK;DHCR24
prerank,coenzyme A metabolic process (GO:0015936),-0.31050393057838505,-0.7823106345930522,0.735,0.9580751714692548,1.0,5/14,22.09%,ACLY;ACOT7;PANK1;PPCS;DCAKD
prerank,lytic vacuole organization (GO:0080171),-0.2546256919201349,-0.7820194586353328,0.803076923076923,0.9575984828319123,1.0,6/32,10.68%,ABCA1;CLVS2;GRN;CLVS1;LRRK2;AKTIP
prerank,mesenchyme morphogenesis (GO:0072132),0.3446230032277101,0.7818696356750527,0.7317880794701986,0.9773607108848291,1.0,6/17,11.71%,ISL1;BMPR1A;MDM4;NOG;ACVR1;TGFB2
prerank,protein N-linked glycosylation (GO:0006487),0.2777488283189313,0.7814761655195467,0.7749360613810742,0.9775035043718581,1.0,9/66,12.04%,MGAT4C;FUT8;MGAT3;ALG13;B4GALT1;B4GALT7;UGGT2;ASGR2;DPM1
prerank,cholesterol transport (GO:0030301),0.29989011800285015,0.7805677645958812,0.7468175388967468,0.9784832339669789,1.0,8/45,15.76%,SOAT1;CLU;TSKU;OSBPL5;STARD4;CD36;LCAT;NPC1
prerank,metanephric mesenchyme development (GO:0072075),0.37620808684430146,0.780375078106081,0.7082601054481547,0.9783125309177374,1.0,2/10,9.70%,SIX1;SIX4
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.27277174785258385,0.7801847909087156,0.8005215123859192,0.9781306528809539,1.0,13/70,12.93%,CYFIP2;ABI1;PRKCD;ABL1;VAV2;NCKAP1;NCKIPSD;WIPF2;CDC42;BRK1;PRKCE;YES1;MAPK1
prerank,cellular response to hypoxia (GO:0071456),0.2558996172452279,0.7797974175316255,0.8323699421965318,0.9782469820493409,1.0,11/126,8.71%,EGLN3;NDRG1;PTGIS;NPEPPS;LMNA;HILPDA;EP300;PLK3;CREBBP;HIF3A;MDM4
prerank,cardiocyte differentiation (GO:0035051),0.3775110374188312,0.7796637574527235,0.6989247311827957,0.977951431423296,1.0,3/10,17.35%,AKAP13;TGFB2;KDM6B
prerank,lysosome localization (GO:0032418),-0.2410247698032526,-0.7796581618208499,0.8469055374592834,0.9604312823578008,1.0,14/37,27.22%,KIT;MYH9;ARL8B;KXD1;PLEKHM1;FLCN;LAMTOR1;PIK3CD;CHGA;BORCS6;PIK3CG;SNAPIN;KLC2;RAB3A
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.2685898544299968,0.7790884805883198,0.7964601769911505,0.9783752380207682,1.0,26/85,23.72%,WNT11;FZD7;AP2A2;PRICKLE1;CELSR3;AP2A1;FZD2;CDC42;RHOA;DAAM1;SMURF1;PSMC6;PSMD8;FZD3;PSMB1;RYK;PSMD13;CELSR2;PSMD1;PSMD7;PSMA8;PSMD3;PSMD2;PSMC2;CELSR1;PSMB2
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.339521132356245,0.778964874113907,0.7168,0.9780768341338941,1.0,3/21,10.71%,CDC25B;DYRK3;RAD51C
prerank,establishment of melanosome localization (GO:0032401),-0.28296297210674315,-0.7789310646654912,0.7974025974025974,0.9605904719121486,1.0,6/19,17.67%,SHROOM2;MYO5A;BLOC1S6;RAB27A;BLOC1S5;BBS7
prerank,regulation of biosynthetic process (GO:0009889),-0.33268637024770004,-0.7786245291428393,0.7457212713936431,0.9601426588822244,1.0,4/11,29.44%,SNCA;SLC25A33;SPHK2;ALOX5
prerank,aggrephagy (GO:0035973),-0.2599780874556355,-0.7785147252654022,0.7987987987987988,0.9593637321456479,1.0,8/27,18.85%,VIM;DYNLL2;RPS27A;UBC;DYNLL1;UBB;PARK7;DYNC1I2
prerank,glycogen catabolic process (GO:0005980),0.35914518704418325,0.7783046805381346,0.7140549273021002,0.9786467948472416,1.0,6/15,21.05%,PYGB;PHKA2;RB1CC1;PHKB;PHKA1;GAA
prerank,regulation of interleukin-1 beta production (GO:0032651),0.2768583253965831,0.7781011560882375,0.787531806615776,0.9785028455526465,1.0,7/66,12.38%,FOXP1;ISL1;RIPK2;TLR6;TLR4;CD36;STAT3
prerank,sister chromatid segregation (GO:0000819),0.3099517178384213,0.7779230756343538,0.7311669128508124,0.9783030127290432,1.0,7/31,18.33%,SMC4;KLHL22;RB1;SMC1A;RAN;INO80;KIF18A
prerank,regulation of amyloid-beta clearance (GO:1900221),0.353275446180666,0.7777420078400408,0.745928338762215,0.9781038967620991,1.0,4/16,17.11%,LRPAP1;CLU;LRP1;HMGCR
prerank,second-messenger-mediated signaling (GO:0019932),0.26511076945865397,0.7772729815593886,0.7924757281553398,0.978354820950644,1.0,12/82,12.74%,PLCE1;AGTR1;NUDT4;TRPM4;TNFSF11;P2RX4;AGTR2;RCAN1;CXCR4;EIF2AK3;CD36;HTR2B
prerank,mRNA processing (GO:0006397),0.23832509359740917,0.7771543906027412,0.886435331230284,0.9780583627779361,1.0,82/287,24.40%,RNMT;DDX5;RBM6;SNRNP48;SYNCRIP;SON;HNRNPH1;ZCCHC8;CELF1;U2AF1L4;USP49;SNRPB2;DDX42;FUS;CASC3;SRRM2;TCERG1;MNAT1;ERCC3;RSRC1;PRPF3;GCFC2;SRSF5;SRSF6;SF3B2;SF3B1;SRSF12;SRRM1;RBMX;THOC2;PRPF40B;RBM8A;LSM2;ESS2;SRSF11;GTF2F2;SNRPD3;HNRNPL;THOC5;SNRNP70;PRKACA;SNW1;DHX9;PRCC;SCAF11;GPKOW;TRA2B;SRRT;GEMIN2;POLR2H;ZC3H11A;RBM4B;CPSF7;PABPC1;CWC22;PHF5A;CHTOP;ALKBH5;PRPF6;HNRNPM;TXNL4A;ZCRB1;PPIL1;RNPC3;NUDT21;HNRNPUL1;HNRNPA3;RBM5;CPSF4;SNRNP27;SNRPD2;SNRPD1;SNRNP40;AQR;RBMX2;ERCC2;PNN;U2SURP;ALYREF;RBM4;NCBP2;CSTF2
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.28404184266366206,-0.7768551043013411,0.784,0.9611143645857441,1.0,6/20,19.74%,HIF1A;HSP90AB1;EGR1;DCUN1D3;EPAS1;DNAJB2
prerank,apoptotic nuclear changes (GO:0030262),-0.26235153695960234,-0.7764802296265015,0.800531914893617,0.9607973921115488,1.0,7/24,20.27%,CECR2;CASP3;DFFA;BLCAP;ACVR1C;FOXL2;H1-0
prerank,mitotic nuclear membrane organization (GO:0101024),0.28218907872381255,0.7764691567243771,0.7688172043010753,0.9781780209819538,1.0,13/51,22.13%,NUP93;LMNA;SEC13;LBR;NUP188;IST1;RAN;NUP107;CHMP4A;CHMP4B;SUMO1;NUP98;CDK1
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.28218907872381255,0.7764691567243771,0.7688172043010753,0.9781780209819538,1.0,13/51,22.13%,NUP93;LMNA;SEC13;LBR;NUP188;IST1;RAN;NUP107;CHMP4A;CHMP4B;SUMO1;NUP98;CDK1
prerank,positive regulation of interleukin-2 production (GO:0032743),0.3126304858526858,0.7763969681876262,0.7340590979782271,0.977793445447771,1.0,2/25,5.51%,ANXA1;CD80
prerank,alpha-amino acid catabolic process (GO:1901606),-0.26354975249913476,-0.7763699482075828,0.8285714285714286,0.9600258944946009,1.0,7/29,23.66%,DDO;ALDH4A1;SARDH;GSTZ1;HSD17B10;HOGA1;KYNU
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.3377506362483128,-0.775936552971353,0.7544642857142857,0.9598057857385135,1.0,3/10,16.13%,ACADL;IVD;GCDH
prerank,negative regulation of stem cell differentiation (GO:2000737),0.3633537682403226,0.7758512354427314,0.7238938053097345,0.9781857743059745,1.0,4/12,18.64%,JAG1;HES1;REST;YTHDF2
prerank,intracellular cholesterol transport (GO:0032367),-0.3038049564963964,-0.7757459844753598,0.7571059431524548,0.959177952263393,1.0,5/15,16.98%,ABCA1;NPC2;OSBP;RELCH;ABCG1
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.3439556352454988,0.7753625319452314,0.7394822006472492,0.9784845303233086,1.0,3/18,6.88%,RAP1A;GSK3B;SLC4A8
prerank,dendrite morphogenesis (GO:0048813),0.3034954812526966,0.7751229009814458,0.7562776957163959,0.9783593009409142,1.0,4/35,4.55%,PHACTR1;CTNND2;MEF2A;KLF7
prerank,mRNA 3'-end processing (GO:0031124),0.270987860158598,0.7751027746318535,0.8058375634517766,0.9779022765151021,1.0,28/78,25.72%,U2AF1L4;CASC3;SCAF8;SRSF5;SRSF6;SRRM1;THOC2;PAF1;RBM8A;SRSF11;THOC5;ZC3H11A;CPSF7;PABPC1;CHTOP;GRSF1;NUDT21;CPSF4;MTPAP;LEO1;ALYREF;NCBP2;CSTF2;AHCYL1;CSTF1;UPF3B;SRSF7;FIP1L1
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.3271310871306579,0.7750542946168474,0.7304747320061256,0.9774891642484419,1.0,6/22,16.96%,DUSP16;DUSP10;PPM1A;DUSP5;PPP5C;PPP2CB
prerank,lipid homeostasis (GO:0055088),-0.2189361202870577,-0.7749705590646802,0.9,0.959471441830934,1.0,13/57,18.12%,APOE;ABCA1;ZBTB20;NR1H3;PNPLA8;PRKAA2;NR1D2;ORMDL3;RCN3;ABCB4;ABCG1;PNPLA2;USF2
prerank,regulation of multicellular organismal development (GO:2000026),0.3214620497351453,0.7749544974728142,0.7515822784810127,0.9771760986391295,1.0,6/25,13.37%,TRIP12;KAT2A;HPSE;GATA3;MYSM1;EHMT1
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.36559195821599255,0.7748242008750498,0.7289879931389366,0.976884797008638,1.0,5/12,22.38%,CNEP1R1;NEK9;PRKCA;CDK1;NEK6
prerank,cholesterol efflux (GO:0033344),0.3353192213656844,0.7746149859553436,0.7531645569620253,0.9767479311667638,1.0,1/20,0.81%,SOAT1
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.3420623185181893,0.7745079919732607,0.729818780889621,0.9764352032575784,1.0,2/18,6.17%,SLC2A13;CLU
prerank,pentose-phosphate shunt (GO:0006098),0.3730354435286328,0.7742762353379166,0.707667731629393,0.9763206273705903,1.0,4/11,16.91%,SHPK;DERA;RPIA;RBKS
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.274352764859345,0.7742064317066287,0.8010471204188482,0.9759304565158923,1.0,23/70,23.72%,ABL1;GATA1;CBFB;TCF3;GATA3;FOXC1;PSMC6;PRKDC;PSMD8;LDB1;YTHDF2;PSMB1;PSMD13;PSMD1;PSMD7;PSMA8;KMT2A;MYB;PSMD3;PUS7;PSMD2;PSMC2;PSMB2
prerank,glycosphingolipid metabolic process (GO:0006687),0.28902926304087107,0.7730730783337594,0.7837465564738292,0.9772246706705001,1.0,5/42,6.49%,ESYT3;ESYT2;LARGE1;HEXA;A4GALT
prerank,peptide catabolic process (GO:0043171),0.3200686591713645,0.7725922936120438,0.7606060606060606,0.9775039276395703,1.0,5/23,11.32%,NPEPPS;CPQ;IDE;ERAP1;XPNPEP1
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.26962412477916875,0.772333233330465,0.7997399219765929,0.9774099078762634,1.0,13/71,12.93%,CYFIP2;ABI1;PRKCD;ABL1;VAV2;NCKAP1;NCKIPSD;WIPF2;CDC42;BRK1;PRKCE;YES1;MAPK1
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.29868405028640405,0.7716368378223061,0.7710674157303371,0.9780499008172705,1.0,5/41,7.78%,CYP1B1;MGLL;DAGLB;ACOT8;SCD
prerank,autophagosome organization (GO:1905037),0.2831826219047006,0.771606079708914,0.7698630136986301,0.9776054479098797,1.0,12/50,20.75%,WIPI2;ULK2;RAB43;BECN1;ATG3;RB1CC1;AMBRA1;ATG2A;RAB7A;ATG7;ULK1;ATG16L1
prerank,telomere maintenance in response to DNA damage (GO:0043247),-0.3405011776686447,-0.7715979742847228,0.7723214285714286,0.9636999022908773,1.0,7/10,41.18%,RIF1;TERF2IP;TFIP11;DCLRE1B;TERF2;DCLRE1A;DCLRE1C
prerank,neural tube development (GO:0021915),0.34713582385577924,0.7710204653002984,0.7260940032414911,0.9780160568096173,1.0,2/15,7.19%,PKD1;STIL
prerank,positive regulation of glucose metabolic process (GO:0010907),0.3555983306710226,0.7707387933434278,0.7222222222222222,0.9779910348730331,1.0,5/14,19.35%,IRS1;PTPN2;SLC45A3;IRS2;NNMT
prerank,homologous chromosome segregation (GO:0045143),0.32701769481834386,0.7706469923263969,0.7172859450726979,0.9776411840000009,1.0,6/20,26.42%,IHO1;ANKRD31;RNF212B;CENPC;SIRT7;MEIOB
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.32792409552950585,-0.7701804061143904,0.7184466019417476,0.9649516812182909,1.0,6/11,20.52%,GRK3;ARRB1;GTF2H2;ADM;ARRB2;GRK2
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.3226108950145674,0.7700807352382033,0.7532679738562091,0.9780582595092848,1.0,5/22,11.97%,EDEM3;RNF185;OS9;EDEM2;UGGT2
prerank,cholesterol homeostasis (GO:0042632),0.27338461068352377,0.7700664751489776,0.7974522292993631,0.9775926055700396,1.0,13/64,16.81%,SOAT1;HDAC9;HNF4A;PLA2G12B;TSKU;FABP3;EHD1;LRP5;LCAT;TTC39B;NPC1;CYP39A1;RORA
prerank,carnitine metabolic process (GO:0009437),-0.31981548056552134,-0.7699484715634143,0.7459954233409611,0.9643585777226956,1.0,3/12,8.69%,CPT1A;ALDH9A1;ACADL
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.31290500991668074,-0.7697612041635225,0.7701421800947867,0.9637016478047673,1.0,7/12,34.25%,TAPT1;INSIG2;ANKRD13C;RER1;KDELR3;KDELR1;KDELR2
prerank,mammary gland development (GO:0030879),0.3310048236966268,0.7697526880675559,0.7318611987381703,0.9776144736077633,1.0,2/21,3.83%,TGFB3;ZBTB7B
prerank,dorsal/ventral pattern formation (GO:0009953),0.32451966126786114,0.7697479433892557,0.735632183908046,0.9771322853062934,1.0,6/20,19.80%,BMPR1A;NOG;ACVR1;NBL1;MDFI;GLI2
prerank,NIK/NF-kappaB signaling (GO:0038061),0.2693199100786799,0.7693216869484053,0.7997481108312342,0.9772606878049186,1.0,19/72,23.72%,CARD14;FBXW11;CHUK;TLR6;NFKB2;BIRC3;REL;PSMC6;PSMD8;IRAK1;PSMB1;PSMD13;PSMD1;PSMD7;PSMA8;PSMD3;PSMD2;PSMC2;PSMB2
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.26474263046840013,0.7692015226794163,0.8091133004926109,0.9769633651533023,1.0,21/83,20.61%,SFI1;CEP164;PAFAH1B1;CEP131;DYRK3;PCM1;HAUS5;CSNK1E;CEP70;CEP63;CEP57;PRKACA;CSNK1D;DCTN3;ATAD5;CNTRL;AKAP9;CEP192;DCTN1;AURKA;ODF2
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.3321565499431957,-0.7689315109949271,0.7435294117647059,0.9640370237765782,1.0,4/10,15.66%,CORO2B;NDFIP2;MAPT;PPM1F
prerank,cell junction organization (GO:0034330),0.26918412642609685,0.7685270165841056,0.8017565872020075,0.9775469500168987,1.0,12/71,12.92%,CXADR;TGFB3;CTNND2;SEMA3E;SDK1;PPFIA1;LIMS2;CDC42;TGFB2;RHOA;MYO9A;CAPZA1
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.3360151857171386,0.7684414587683894,0.7337770382695508,0.9772017539145613,1.0,5/19,16.35%,PPP2R3C;MMP14;GATA3;ZMIZ1;PRKDC
prerank,peptidyl-lysine trimethylation (GO:0018023),0.3126592493812726,0.7683578281714714,0.773071104387292,0.97684578620329,1.0,7/26,20.94%,CTR9;SETD5;SETD2;METTL21C;KMT2D;SETD1B;KMT2A
prerank,homotypic cell-cell adhesion (GO:0034109),0.29893185504764536,0.7682479725200697,0.7804532577903682,0.9765416891102824,1.0,5/39,6.28%,FN1;PLPP3;GATA1;DSC2;VCL
prerank,regulation of execution phase of apoptosis (GO:1900117),0.3679579201513275,0.7682341231577281,0.7312614259597806,0.9760728270615777,1.0,1/11,2.25%,PTGIS
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.3755456337379061,0.7676161177102206,0.7260536398467433,0.9765514639773574,1.0,1/10,2.98%,LRP6
prerank,regulation of establishment of planar polarity (GO:0090175),0.2630385471773567,0.7674470621049008,0.8022528160200251,0.976332689977063,1.0,26/88,23.72%,WNT11;FZD7;AP2A2;PRICKLE1;CELSR3;AP2A1;SPEF1;FZD2;CDC42;RHOA;DAAM1;SMURF1;PSMC6;PSMD8;FZD3;PSMB1;PSMD13;CELSR2;PSMD1;PSMD7;PSMA8;PSMD3;PSMD2;PSMC2;CELSR1;PSMB2
prerank,receptor recycling (GO:0001881),0.37194879021122773,0.7671495409516491,0.7252173913043478,0.976304157931584,1.0,1/10,3.88%,EHD3
prerank,nuclear body organization (GO:0030575),0.3567335327267466,0.7669683680510542,0.71875,0.9761184715699706,1.0,3/12,15.85%,DYRK3;SERBP1;PML
prerank,negative regulation of MAPK cascade (GO:0043409),0.2647154677098738,0.7669225403721267,0.8043478260869565,0.9757114125684639,1.0,11/87,11.44%,BMP4;EZR;PRKCD;SPRED2;PPEF2;DLG1;PTPN2;DUSP10;PRDM15;CNKSR3;TLR4
prerank,DNA packaging (GO:0006323),0.34529951652397767,0.7667815764583726,0.7246376811594203,0.97542655481957,1.0,1/16,2.87%,CHAF1B
prerank,iron ion transmembrane transport (GO:0034755),-0.34098333018545474,-0.7661674263542451,0.7516930022573364,0.9671931187329856,1.0,4/10,20.14%,SLC40A1;SLC39A8;SLC11A2;ABCB7
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.33690771815082143,-0.7660317381948143,0.7767857142857143,0.9664467289720065,1.0,1/10,0.90%,PRKCH
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.33028923631151375,0.765865084365378,0.7829457364341085,0.9763397162141498,1.0,5/22,8.05%,CAMK2D;MEF2A;NR4A3;P2RX4;LMCD1
prerank,positive regulation of protein deacetylation (GO:0090312),0.3537372847378725,0.7658095063979343,0.7413509060955519,0.9759376795431678,1.0,1/14,3.83%,ZBTB7B
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.29571519159228543,0.76562679658662,0.7720797720797721,0.9757445961527593,1.0,11/38,23.44%,UBN1;CABIN1;CENPQ;CENPX;HIRA;ATRX;RBBP4;OIP5;CENPU;ASF1B;CENPC
prerank,melanosome localization (GO:0032400),-0.27200678534520323,-0.7655304076416064,0.8306878306878307,0.9662310789899469,1.0,6/21,17.67%,SHROOM2;MYO5A;BLOC1S6;RAB27A;BLOC1S5;BBS7
prerank,ncRNA metabolic process (GO:0034660),0.30417375986214085,0.7655240761065583,0.7729885057471264,0.97541759336932,1.0,9/37,20.41%,TDRD9;TDRD12;ZCCHC8;DDX17;RAN;DROSHA;MAEL;PIWIL4;MEPCE
prerank,regulation of lymphocyte differentiation (GO:0045619),0.34011266440008664,0.7655172555860162,0.7456140350877193,0.9749428135597556,1.0,7/18,28.23%,ABL1;PRKDC;ZFP36L1;IKZF3;CD2;CCR2;ZFP36L2
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.32533183888525247,0.7652706583982958,0.7110016420361248,0.9748282889267579,1.0,4/21,9.94%,HNF1A;BCLAF1;JUN;MED14
prerank,translational elongation (GO:0006414),0.2590947930332995,0.7651840966335289,0.8404761904761905,0.9744906918107972,1.0,32/101,26.27%,MRPL33;MRPL48;MRPL32;MRPL14;MRPL21;GTPBP2;MRPS31;MRPL38;GFM2;MRPL57;MRPS28;MRPS35;MRPS22;MRPL20;MRPS10;MRPL47;MRPS27;MRPS30;MRPS23;MRPL9;MRPS24;MRPL52;MRPS33;MRPS18B;MRPS7;PTCD3;MRPL10;MRPL39;MRPS5;EEFSEC;MRPS34;MRPS18C
prerank,COPII-coated vesicle budding (GO:0090114),0.2702024177404667,0.7651235798046551,0.7931937172774869,0.974097785908305,1.0,28/68,26.70%,SEC24B;STX5;CNIH2;NSF;SEC13;VAPA;SEC22B;SAR1B;TRAPPC4;SEC24A;PPP6R3;CSNK1D;ANKRD28;AREG;USO1;SEC23A;VAPB;TRAPPC6B;BET1;PPP6C;TBC1D20;TRAPPC6A;TRAPPC10;PPP6R1;GORASP1;PEF1;SEC16A;TFG
prerank,positive regulation of lipid storage (GO:0010884),0.3247172386972356,0.7647605543564165,0.7470686767169179,0.9741722430922802,1.0,4/21,12.07%,NFKB1;HILPDA;EHD1;IKBKE
prerank,epithelial cell morphogenesis (GO:0003382),0.34333735237254487,0.7646779974834969,0.7455138662316476,0.9738134374938131,1.0,1/17,0.68%,MET
prerank,monocarboxylic acid metabolic process (GO:0032787),0.25132663963667745,0.7646563789580219,0.8407720144752714,0.9733708949764406,1.0,11/117,9.73%,ME1;SLC5A6;SLC16A1;ADH7;VNN1;ACSL3;SCPEP1;HACL1;CYP2S1;CPT1C;PER2
prerank,regulation of protein localization to centrosome (GO:1904779),0.37355889024585415,0.7645899707197059,0.7204116638078902,0.9729908277233221,1.0,1/10,3.92%,GSK3B
prerank,DNA recombination (GO:0006310),0.2982501313830915,0.7645527045890859,0.7839046199701938,0.9725586307804858,1.0,13/37,26.40%,IGHMBP2;HDAC10;RAD52;ERCC1;RAD51C;RPA1;WRN;MRE11;XRCC2;RECQL5;DMC1;LIG4;EXO1
prerank,sterol homeostasis (GO:0055092),0.271772936692073,0.764395334382158,0.8045977011494253,0.9723132888916344,1.0,13/65,16.81%,SOAT1;HDAC9;HNF4A;PLA2G12B;TSKU;FABP3;EHD1;LRP5;LCAT;TTC39B;NPC1;CYP39A1;RORA
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.3106682455876527,-0.7635178211866628,0.7884130982367759,0.9681889467469222,1.0,2/13,10.01%,KDR;EDN1
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.3290200898311155,-0.7631592694301839,0.7661469933184856,0.9677610998313239,1.0,7/10,40.41%,SACS;DNAJA4;DNAJB2;SORL1;HSPA1B;DNAJB8;DNAJB1
prerank,aerobic respiration (GO:0009060),-0.2796557916845997,-0.7630771953460277,0.7984084880636605,0.966946817839612,1.0,6/20,20.98%,UQCR10;UQCRH;ME3;ATP5F1D;UQCRC2;UQCRB
prerank,positive regulation of nervous system process (GO:0031646),0.3329934626605052,0.7628532614339665,0.759075907590759,0.9742427715738924,1.0,5/18,11.22%,EGR2;TNFRSF1B;UNC13B;PARD3;RNF10
prerank,regulation of mRNA processing (GO:0050684),0.3048147228787197,0.7624783195073092,0.7593423019431988,0.9743193963407504,1.0,10/32,22.28%,SLTM;SON;SRPK1;RBM39;JMJD6;DHX9;ZFP36L1;CWC22;CPSF4;SAFB2
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.32091954010509954,0.7617418280829429,0.7335375191424196,0.9750033091139028,1.0,8/21,23.14%,FATE1;MCUB;MICU1;MCU;SLC8B1;FIS1;BCAP31;MICU3
prerank,regulation of nuclear division (GO:0051783),-0.2785502075392949,-0.7613908878015571,0.8144578313253013,0.9685123524172257,1.0,5/20,26.32%,OBSL1;RCC1;MKI67;PIN1;L3MBTL1
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.2651643349083538,-0.7613078022268086,0.8108882521489972,0.9676799737034759,1.0,15/24,38.79%,PARP1;SRC;TENT4B;DCP2;HNRNPU;TEN1;GNL3L;EXOSC10;CTC1;HNRNPA1;PIF1;ERCC4;HNRNPC;NAT10;TERF2
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.24900574586661475,0.7603956023117647,0.852112676056338,0.9766063712716927,1.0,18/125,13.39%,TBCE;XPO1;NDEL1;DYNC1I1;PAFAH1B1;CLIP1;CENPQ;DCTN6;STIL;SEC13;DYNC1LI2;RMDN1;TACC3;KIF2C;RANBP2;SETD2;NEK9;SPC24
prerank,regulation of interleukin-10 production (GO:0032653),-0.22773362019200027,-0.760180024912978,0.8754098360655738,0.9683294143598157,1.0,9/44,21.11%,CD47;CD34;TNFRSF21;SYK;PRKCZ;VSIR;JAK3;DLL1;TYROBP
prerank,spliceosomal complex assembly (GO:0000245),0.2853046886932535,0.7598716142036951,0.7859154929577464,0.976946958622076,1.0,16/46,22.20%,LUC7L2;CELF1;GCFC2;SRSF5;SRSF6;SF3B1;SRPK1;DDX1;SCAF11;NOL3;LUC7L;PRPF6;TXNL4A;RBM5;SNRPD2;SNRPD1
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.35108546979797545,0.7597953903847577,0.7223168654173765,0.9765845672544559,1.0,7/13,27.18%,CPSF7;NUDT21;CPSF4;NCBP2;CSTF2;FIP1L1;CPSF4L
prerank,positive regulation of DNA recombination (GO:0045911),-0.2553386259642053,-0.7596807101685347,0.8402366863905325,0.9681011118931674,1.0,3/27,7.55%,TFRC;RIF1;PARP1
prerank,peptidyl-methionine modification (GO:0018206),0.3678824784983364,0.7593779560265073,0.7525773195876289,0.9767524931131951,1.0,12/12,63.24%,METAP1D;METAP1;NAA15;METAP2;NAA16;NAA20;NAA60;APOA2;APOA1;NAA25;PDF;NAA30
prerank,sulfur amino acid metabolic process (GO:0000096),0.3086296939968765,0.7589052547338853,0.7476923076923077,0.9769580892702651,1.0,3/24,8.18%,GCLC;CDO1;GADL1
prerank,immunoglobulin mediated immune response (GO:0016064),-0.32819853011110073,-0.7578620517154159,0.7855579868708972,0.9697803890701008,1.0,2/10,17.31%,CD81;CD74
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.30574846392503313,0.7578268810755204,0.7881844380403458,0.9781118946536655,1.0,5/31,12.97%,NFS1;PYCR1;MOCS3;CYP19A1;FDFT1
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.32317117153033253,0.757653174414818,0.7538699690402477,0.9779077999193762,1.0,3/22,7.31%,DDX5;SPRED2;ATM
prerank,placenta development (GO:0001890),-0.30860923278185515,-0.7575217719353533,0.771889400921659,0.9693406852974633,1.0,4/12,30.60%,PTK2;E2F7;ADAM19;E2F8
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.2992122694733846,0.756678295834736,0.7786144578313253,0.9789009307875088,1.0,4/33,4.77%,TGFB3;IL10;PDCD4;IGFBP5
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.3580916891495082,0.7565036549743315,0.7412353923205343,0.978695158327696,1.0,1/13,3.72%,BMS1
prerank,histone mRNA catabolic process (GO:0071044),-0.2932807845031089,-0.7563928084933921,0.779746835443038,0.9700152454089802,1.0,4/15,16.61%,LSM1;UPF1;TENT4B;DCP2
prerank,DNA methylation (GO:0006306),0.31848330442064104,0.7559289018762935,0.7547770700636943,0.979079566690927,1.0,6/23,16.54%,METTL4;BAZ2A;EHMT2;EHMT1;ATRX;DMAP1
prerank,positive regulation of defense response (GO:0031349),0.25881387797352007,0.7557772568444713,0.8545006165228114,0.9788277460430921,1.0,18/89,18.54%,GPR4;AGTR1;PDCD4;POLR3D;PLSCR1;LRSAM1;IFI35;IL17RA;TLR4;IL16;ADAM8;TRADD;POLR3B;DHX9;FEM1A;MGST2;TNIP1;IL15
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.28976851126640163,-0.755670780892667,0.806282722513089,0.9701120840816091,1.0,1/17,2.96%,LPGAT1
prerank,regulation of synapse assembly (GO:0051963),0.2842200252557992,0.7553131437026414,0.8097826086956522,0.9790405480503186,1.0,4/46,7.41%,GPC6;EIF4G1;PDLIM5;GPC4
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.32602119639625915,-0.755176737384862,0.7314814814814815,0.9698634043845894,1.0,1/10,3.01%,KDR
prerank,negative regulation of bone remodeling (GO:0046851),-0.3188382669967116,-0.7550478754113306,0.7494356659142212,0.9691310749755246,1.0,4/11,28.00%,P2RX7;TNFAIP3;GREM1;CARTPT
prerank,stem cell differentiation (GO:0048863),0.28763749666647687,0.7550147613792684,0.773371104815864,0.9789942896775455,1.0,9/39,16.01%,MLLT3;LRP6;TGFB2;SETD2;HTR2B;SOX21;UFL1;PUM1;LMBR1L
prerank,regulation of mRNA polyadenylation (GO:1900363),0.3356863564048535,0.7543389039206335,0.7310344827586207,0.9795596980240966,1.0,7/17,24.35%,CTR9;ZC3H14;NELFE;CPSF7;NUDT21;CCNT1;NCBP2
prerank,regulation of protein localization to cell periphery (GO:1904375),0.3424372944804448,0.7541505818388836,0.7487603305785124,0.9793636202847295,1.0,6/18,19.06%,MMP14;STX8;MISP;AR;ZDHHC7;CLN3
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.3442870001311702,0.7532938257092929,0.7529215358931552,0.9802080570439196,1.0,7/16,19.06%,TBC1D25;MTRF1;ETF1;BNIP3;CLEC16A;GSPT1;CLN3
prerank,regulation of cytoplasmic transport (GO:1903649),-0.31730789896908257,-0.75309861952489,0.7702702702702703,0.9708945381975936,1.0,4/11,15.17%,MAPK3;LRRK2;SRC;DNAJC13
prerank,negative regulation of organelle assembly (GO:1902116),0.2893339199028673,0.7529584058973506,0.7784090909090909,0.9802266463532737,1.0,8/35,13.88%,LIMK2;KAT2A;SMCR8;SEC22B;KAT2B;FEZ2;STYXL1;CEP97
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.27968048861819494,-0.7528034182401208,0.8131578947368421,0.9703737310736413,1.0,5/19,13.36%,IL1RAPL1;OBSL1;LRP8;CDKL5;CAMK2B
prerank,negative regulation of cilium assembly (GO:1902018),0.3465287162173265,0.7524852757087446,0.7318339100346021,0.9804445700312456,1.0,1/12,2.27%,LIMK2
prerank,superoxide anion generation (GO:0042554),-0.3093497195696115,-0.7524751668686026,0.78239608801956,0.9698436117670911,1.0,5/13,23.44%,CYBA;ALOX12;NCF2;TAFA4;NOX4
prerank,regulation of T cell differentiation (GO:0045580),0.2926969899888951,0.7523400806147744,0.7897058823529411,0.9801965280238265,1.0,6/33,14.48%,ABL1;KAT2A;CBFB;GATA3;ZMIZ1;CAMK4
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.36685555460353975,0.7523220218441347,0.7389770723104057,0.9797451231041971,1.0,4/10,18.17%,WIZ;STOML2;ATRX;INO80
prerank,leukotriene metabolic process (GO:0006691),-0.27494719664184514,-0.7509270317934904,0.850253807106599,0.9710516274325275,1.0,8/19,31.50%,GGT5;MGST3;ALOX12;GGT1;PLA2G5;ALOX5AP;ALOX5;LTA4H
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.3592866489021774,0.7507685873104969,0.7642980935875217,0.9815994070224161,1.0,7/13,31.38%,GNPDA2;GNPNAT1;UAP1;GFPT1;RENBP;UAP1L1;AMDHD2
prerank,purine-containing compound biosynthetic process (GO:0072522),0.3061451869876345,0.7503741835417949,0.7853881278538812,0.9817051511039591,1.0,5/25,19.28%,PAICS;PRPS2;GMPS;AMPD3;ADA
prerank,sphingoid metabolic process (GO:0046519),0.354497523619093,0.7502804170369783,0.7383015597920277,0.9813568048557069,1.0,3/12,12.92%,PLPP3;PLPP1;NAAA
prerank,regulation of oxidoreductase activity (GO:0051341),0.3516808278175498,0.7501730631472426,0.7406779661016949,0.9810339528580241,1.0,1/13,4.13%,ABL1
prerank,regulation of interleukin-17 production (GO:0032660),-0.2428022992941544,-0.7500574724213631,0.8511904761904762,0.9713273880550941,1.0,8/31,18.17%,RFTN1;SLC7A5;PRKCQ;IL18;SPHK1;NR1H4;NCKAP1L;VSIR
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.31903637197412826,0.7498439405961336,0.8076923076923077,0.9810629126068674,1.0,4/22,8.58%,RBP1;VKORC1L1;RLBP1;CYP27B1
prerank,gas transport (GO:0015669),0.3670809133463894,0.74957857664127,0.7312925170068028,0.9809809769962551,1.0,1/10,4.60%,AQP6
prerank,cholesterol metabolic process (GO:0008203),0.2681658120913396,0.7495531658824639,0.8151041666666666,0.980540086661317,1.0,14/68,17.11%,SOAT1;FDX1;TSKU;MVD;FDPS;OSBPL5;LBR;EBP;RXRA;FDFT1;LCAT;SNX17;SULT2B1;HMGCR
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.37776515988009896,0.7494129592601645,0.7555147058823529,0.9802788093676017,1.0,2/10,3.99%,GRB10;ITGA5
prerank,regulation of interleukin-2 production (GO:0032663),0.27931087877691,0.7489294632672997,0.8028776978417266,0.9805294907810224,1.0,3/43,5.51%,ANXA1;EZR;CD80
prerank,positive regulation of interleukin-6 production (GO:0032755),0.2659318518914995,0.7487838592323933,0.8239074550128535,0.9802655220967033,1.0,10/68,12.38%,LBP;ISL1;MAVS;TLR6;IL17RA;BCL10;RAB7B;TLR4;IL16;STAT3
prerank,myeloid cell activation involved in immune response (GO:0002275),0.33075495018498324,0.7487770261142334,0.7532258064516129,0.9797973273073465,1.0,2/18,7.28%,LBP;IFI35
prerank,vasodilation (GO:0042311),-0.30534913616058834,-0.7485214891506783,0.7858823529411765,0.9724970929218508,1.0,6/13,25.14%,NOS3;KCNMA1;NOS1;SOD2;ADRB1;GPER1
prerank,proteoglycan biosynthetic process (GO:0030166),0.29942442084702636,0.7484350170359136,0.8094534711964549,0.9798287546656854,1.0,3/31,4.11%,EXT1;GLCE;CHST13
prerank,cellular response to oxygen levels (GO:0071453),-0.3315260771365377,-0.7483206879389804,0.7703016241299304,0.9718455808549034,1.0,4/10,21.12%,ATP6AP1;ATP6V1A;NDUFS2;CPEB4
prerank,positive regulation of cellular component organization (GO:0051130),0.2520503400588695,0.7481895356478816,0.8760233918128655,0.9797049741248874,1.0,9/107,6.17%,TRABD2B;TGFB3;ATP10A;GPC3;MPP7;GSK3B;VCP;TGFBR1;CLU
prerank,protein-DNA complex disassembly (GO:0032986),-0.2874900624710587,-0.7478414440043916,0.8039702233250621,0.9715544702655711,1.0,9/16,35.85%,RPL23;SET;SMARCD1;SMARCE1;SMARCD3;SMARCB1;GRWD1;NFE2;HMGA1
prerank,protein oxidation (GO:0018158),0.35881642717695617,0.7470649942852364,0.7302977232924693,0.9808766121542811,1.0,3/11,15.51%,LOXL1;LOXL4;PRDX3
prerank,cellular polysaccharide catabolic process (GO:0044247),0.33749364243931235,0.7469553499627254,0.7307692307692307,0.9805562068683568,1.0,6/16,21.05%,PYGB;PHKA2;MGAM;PHKB;PHKA1;GAA
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.3042596984711456,0.7467663530291198,0.7677224736048266,0.9803542874703127,1.0,11/29,22.77%,GDNF;FUS;TENT5D;NBAS;VIP;TAF15;TENT5C;PABPC1;EIF4ENIF1;FMR1;LARP1
prerank,negative regulation of hippo signaling (GO:0035331),0.34827739794082896,0.7464242628452488,0.7534246575342466,0.9803927204161063,1.0,2/12,10.41%,CIT;MARK3
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.2932181312907364,-0.74594249370608,0.7841726618705036,0.9732611670587973,1.0,3/13,9.17%,LAMP1;GAS6;IL18
prerank,cellular response to insulin stimulus (GO:0032869),0.24772508022439105,0.7456097127302712,0.87995337995338,0.9811091073170944,1.0,23/124,14.10%,SORBS1;GRB10;ATP6V0A4;SHC1;HDAC9;GSK3B;FOXC2;IRS1;PTPN2;IDE;CAPN10;SLC39A14;BCAR3;ATP6V0A1;RHOQ;GAB1;ATP6V0E1;INHBB;KAT2B;LPIN2;C2CD5;ATP6V1H;ATP6V0D1
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.3411602512776263,0.7454417822544164,0.7516666666666667,0.9808606976397343,1.0,5/15,22.36%,CHEK2;RAD17;ATF2;MRE11;RAD9B
prerank,fatty acid biosynthetic process (GO:0006633),-0.20784352442150664,-0.745290183006222,0.9128630705394191,0.9731955204187439,1.0,23/63,29.44%,ELOVL7;ABHD3;ELOVL6;ACLY;ACACA;ACOT7;ELOVL4;ALOX12;FADS3;TECRL;LPL;HACD3;PTGS2;HACD2;ASAH2;LIAS;DECR2;GPX4;ACSBG1;OXSM;XBP1;ELOVL2;ALOX5
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.3253652085562021,-0.7450822485871228,0.7899543378995434,0.972534660819586,1.0,4/10,22.71%,HK2;PFKM;HK1;PFKL
prerank,renal absorption (GO:0070293),0.3668882192236481,0.7449524505470704,0.7722419928825622,0.9811048686628342,1.0,2/10,6.07%,GSN;HNF1A
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.24337739295478258,0.7449048205051353,0.875725900116144,0.9806967437738446,1.0,38/124,23.77%,TCF7L2;PPP3CA;WNT11;FZD7;PLCB3;TNRC6C;AP2A2;MOV10;PRICKLE1;CELSR3;AP2A1;FZD2;CDC42;RHOA;NLK;DAAM1;SMURF1;PSMC6;FRZB;PSMD8;FZD9;FZD3;TNRC6A;PSMB1;RYK;PSMD13;CELSR2;PSMD1;PSMD7;PSMA8;NFATC1;SFRP4;PSMD3;PSMD2;PSMC2;CELSR1;PSMB2;GNB1
prerank,morphogenesis of an epithelium (GO:0002009),-0.25490221116664047,-0.7446993269211066,0.8386243386243386,0.972108319739803,1.0,8/25,22.98%,KDM2B;ACTB;TBX18;LIN7C;ARHGAP12;ACTG1;SOX10;LHX1
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.2571424818356475,0.7446178344067009,0.8497474747474747,0.9801748940462678,1.0,21/78,21.07%,SEC24B;DYNC1I1;AP2A2;DCTN6;AP2A1;KLC1;SEC13;DYNC1LI2;SAR1B;KIF2C;CAPZA1;CAPZA2;SEC24A;DCTN3;KIF18A;KIF2A;RAB7A;DCTN1;SEC23A;FCER1G;CTSF
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.2571424818356475,0.7446178344067009,0.8497474747474747,0.9801748940462678,1.0,21/78,21.07%,SEC24B;DYNC1I1;AP2A2;DCTN6;AP2A1;KLC1;SEC13;DYNC1LI2;SAR1B;KIF2C;CAPZA1;CAPZA2;SEC24A;DCTN3;KIF18A;KIF2A;RAB7A;DCTN1;SEC23A;FCER1G;CTSF
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.34306379660765024,0.7444760284187004,0.7797202797202797,0.9798791783515602,1.0,5/16,23.83%,RIPK3;CYRIB;KLRD1;FADD;AGER
prerank,macrophage activation involved in immune response (GO:0002281),0.34318572360044197,0.743943046484241,0.7571189279731994,0.980149109588016,1.0,2/13,7.28%,LBP;IFI35
prerank,neuron projection organization (GO:0106027),0.3380912986211374,0.7430250720123894,0.739413680781759,0.9810170518583218,1.0,6/15,21.35%,GSK3B;PLS1;ATP1A3;MAP1A;DCTN1;PRNP
prerank,termination of RNA polymerase II transcription (GO:0006369),-0.2425687898898345,-0.7421070443344483,0.8511326860841424,0.9746501103057447,1.0,9/33,19.79%,SETX;PABPN1;SNRPB;SNRPF;SLBP;WDR33;LSM10;SNRPG;MED18
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.23777588028245542,0.7421063046196479,0.8994350282485876,0.9818602569413654,1.0,35/158,16.97%,TRAF3IP2;AKAP13;ALPK1;TAB3;GOLT1B;MAVS;CHUK;RIPK2;TLR6;MAP3K3;IRAK4;BCL10;VAPA;PPM1A;CCDC22;TRIM25;PIM2;RHOA;IKBKE;MTDH;BIRC3;HTR2B;TRADD;PPP5C;TRAF5;REL;RNF31;SLC20A1;DDX1;FLNA;MYD88;UBE2N;ROR1;TICAM2;CARD16
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.3673354516495361,0.7420930183489062,0.7606382978723404,0.9814087813457432,1.0,3/10,16.85%,KDM1A;DISC1;FZD3
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.27003558032330943,0.7416526638773334,0.8214285714285714,0.9815488128674437,1.0,12/51,18.57%,NEK7;SMG6;TNKS2;ATM;FBXO4;STN1;MAPK1;XRCC5;MAPK15;TCP1;ACD;PINX1
prerank,cellular glucan metabolic process (GO:0006073),0.3624837102107859,0.7415696110001113,0.7447183098591549,0.9811982537922763,1.0,2/11,3.92%,PPP1R3C;GSK3B
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.2616930427311587,0.7414696446745059,0.8474148802017655,0.9808490059037563,1.0,5/75,5.88%,BMP4;PRKCD;LRP6;ABL1;IPO7
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.2352450977135031,0.7413042959869636,0.8967813540510544,0.9805905975878114,1.0,43/172,20.43%,PNPLA3;INPP4A;DDHD1;PLEKHA4;ARF3;PLSCR1;PIP5K1A;MTMR12;PITPNM3;OCRL;FGF2;ETNK1;PLD1;CDS1;SELENOI;CSNK2A2;CSNK2A1;DGKA;ABHD4;VAC14;ABHD5;GPAT3;LPIN2;GNPAT;PI4KB;CPNE3;LCAT;RAB5A;AGPAT4;PIK3C2B;SYNJ1;PLA2G4A;LCLAT1;SLC44A5;AGPAT5;PITPNM2;CEPT1;SLC44A3;CLN3;RUFY1;FIG4;PIK3R2;AGK
prerank,water transport (GO:0006833),-0.3050919416388309,-0.7411067947794722,0.8060747663551402,0.9750666578229928,1.0,2/12,6.29%,AQP4;AQP11
prerank,fatty acid metabolic process (GO:0006631),0.24646155186374422,0.7408780234528062,0.8752997601918465,0.9807336712967272,1.0,21/115,17.48%,ABCD3;PNPLA3;PON3;ACSL3;ACADM;HACL1;ACOT8;SLC27A3;CPT1C;PER2;PEX2;CD36;NAAA;LPIN2;GNPAT;ACBD5;PLA2G15;MCAT;ALKBH7;CBR4;ADIPOR1
prerank,positive regulation of isotype switching (GO:0045830),-0.28673728593794995,-0.7406727286878139,0.8107416879795396,0.9747086307320852,1.0,2/15,5.45%,TFRC;RIF1
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.2985630511984896,0.740569874468254,0.7903726708074534,0.9807225106473344,1.0,3/29,5.21%,RAET1E;KLRC2;PVR
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.3295579479610189,0.7402414027337255,0.7783417935702199,0.9807273946369711,1.0,4/16,16.72%,PIGB;PIGL;PIGN;PIGH
prerank,cellular response to fluid shear stress (GO:0071498),0.3478356532593112,0.7402214796876984,0.7402826855123675,0.9802854825816676,1.0,2/12,4.43%,KLF4;NFE2L2
prerank,defense response to bacterium (GO:0042742),0.2496025313446479,0.7402086890002568,0.8760529482551144,0.9798376845046421,1.0,8/105,8.70%,ANXA3;LBP;SHC1;PRKCD;SLPI;MAVS;TLR6;RNASE6
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.2976414854610234,-0.7396392537965727,0.8018867924528302,0.9750993370192287,1.0,1/14,1.31%,AUTS2
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.30913918882879166,0.7396260220663543,0.7726550079491256,0.9801704803217695,1.0,6/23,15.60%,MTMR12;OCRL;INPP5B;MTMR11;SYNJ1;PIP4P2
prerank,mitochondrion organization (GO:0007005),-0.1783939805028647,-0.7394145971999058,0.9905660377358491,0.9744737252652624,1.0,43/165,22.07%,DNM3;NOS3;AKT3;ATP5F1B;PPARGC1A;BCL2L1;PARP1;IFIT2;CHCHD2;MFN2;PYROXD2;LRRK2;ALAS1;IMMP2L;HK2;AIP;RAB38;COX7A2;TIMM44;MYH14;ATP5F1D;CHCHD10;TRAK2;TIMM13;NIPSNAP2;GABPA;ATP7A;MGME1;SIRT5;PARK7;TSPO;SLC25A4;TOMM7;SLC25A33;HSD17B10;CYCS;CHCHD4;BIK;DNM1;DNM1L;HIGD1B;MTFP1;RAB5IF
prerank,hemidesmosome assembly (GO:0031581),0.3598910992988178,0.7390523323283402,0.7673992673992674,0.9804884085900328,1.0,3/11,13.05%,KRT14;ITGB4;PLEC
prerank,nuclear membrane reassembly (GO:0031468),0.2671760251000032,0.738690126619029,0.8174496644295302,0.9805408948286711,1.0,13/54,22.13%,NUP93;LMNA;SEC13;LBR;NUP188;IST1;RAN;NUP107;CHMP4A;CHMP4B;SUMO1;NUP98;CDK1
prerank,regulation of protein kinase A signaling (GO:0010738),0.3136396969222676,0.7384001039981528,0.8058103975535168,0.9804940125165585,1.0,4/20,12.76%,TCIM;ADRB2;AKAP12;PRKAR2A
prerank,negative regulation of proteolysis (GO:0045861),0.2840381784959289,0.7382702852337794,0.8107714701601164,0.9802161891725686,1.0,4/34,7.84%,PTPN3;IL10;SERPINE2;TIMP2
prerank,cilium movement (GO:0003341),0.2672597456566958,0.7382144787935108,0.8179347826086957,0.9798263402329705,1.0,6/48,12.37%,CCDC40;CFAP70;SPEF1;SPAG17;RSPH6A;DNAH5
prerank,regulation of cellular component size (GO:0032535),0.29933122967484577,0.7380995086212419,0.7897990726429676,0.979513302203747,1.0,5/30,10.44%,EZR;RARG;VAV2;RDX;MTOR
prerank,lipid biosynthetic process (GO:0008610),0.2528494433840208,0.7374772452083738,0.8527980535279805,0.9799558725798028,1.0,15/77,18.17%,ABCD3;PIP5K1A;SCD;MVD;CYP19A1;FDFT1;GNPAT;AGPS;AGPAT4;PRKAA1;MCAT;CBR4;HMGCR;AGPAT5;MBOAT1
prerank,cardiolipin metabolic process (GO:0032048),-0.2996832485135043,-0.7372472090754748,0.7853658536585366,0.9763211590366394,1.0,5/13,29.67%,PNPLA8;PGS1;SLC27A1;PLA2G5;HADHA
prerank,cellular response to chemical stress (GO:0062197),0.2497584207663365,0.7371736767947955,0.8494492044063647,0.9799185650720477,1.0,13/96,10.46%,FOXO3;LRRC8D;MGAT3;ABL1;NFE2L2;VKORC1L1;PYCR1;ATM;GPX8;ETV5;RAD52;NOX1;CCS
prerank,negative regulation of viral entry into host cell (GO:0046597),0.3490377199027468,0.7368342297007938,0.7827586206896552,0.9799213897193092,1.0,3/12,13.20%,GSN;TRIM26;CIITA
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.3563042991018723,0.7359233085513491,0.7633451957295374,0.9807349331422639,1.0,2/10,8.83%,ZBTB7B;CBFB
prerank,response to tumor necrosis factor (GO:0034612),0.2529971412298222,0.7355568953561538,0.8693586698337292,0.9807928677810928,1.0,18/91,18.75%,TANK;PID1;ADAM9;YBX3;NFE2L2;AFF3;CHUK;ADAM10;ACOD1;GATA3;HYAL3;TRADD;ERBIN;DHX9;NPNT;ZFP36L1;NUB1;ADAMTS7
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.2886259197686899,-0.7353839755019437,0.8213457076566125,0.9777902893359512,1.0,3/15,8.81%,RAPGEF3;RIPOR2;FLOT1
prerank,plasma membrane tubulation (GO:0097320),0.3478117883250488,0.7353827974482442,0.7696078431372549,0.9805680613375694,1.0,5/13,20.64%,CAVIN2;BIN2;WHAMM;EHD2;CHMP4A
prerank,phagosome acidification (GO:0090383),0.2972893561981939,0.7349162262285439,0.7849624060150376,0.9807311331260525,1.0,7/26,19.26%,ATP6V0A4;ATP6V0A1;ATP6V0E1;ATP6V1H;ATP6V0D1;RAB7A;ATP6V1G1
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.24013838341590124,0.7343443990321171,0.863905325443787,0.9810945361308625,1.0,24/119,15.53%,TTC7A;INPP4A;IP6K2;PLEKHA4;SOCS2;ARF3;PIP5K1A;MTMR12;PITPNM3;OCRL;FGF2;SMG1;IP6K3;PIGB;CDS1;PIGL;PIGU;PIGN;DPM1;VAC14;PI4KB;RAB5A;PIK3C2B;SYNJ1
prerank,positive regulation of transmembrane transport (GO:0034764),0.3474999856492858,0.7341011483338994,0.7770800627943485,0.9809725113976713,1.0,5/13,17.79%,ANO6;NR4A3;SLC26A6;C2CD5;AZIN1
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.2701747942649771,0.7341008832735355,0.8277254374158816,0.9805063445905849,1.0,8/54,14.89%,NXN;PIAS3;PER2;HDAC8;GTPBP4;SQSTM1;UFL1;USP4
prerank,positive regulation of catalytic activity (GO:0043085),-0.22855077424544112,-0.7340487205691939,0.8774193548387097,0.9785639873359252,1.0,9/37,17.90%,IGF2;MAPK3;NHEJ1;SLC5A3;CIB1;ABL2;ATP7A;FGFR4;PSENEN
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.297173573652033,-0.7338725890785278,0.8228155339805825,0.9779024536709991,1.0,6/13,22.36%,EAPP;NELFCD;NELFA;LARP7;HNRNPU;SUPT4H1
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.2569210982463283,0.7335897417812123,0.844139650872818,0.980770679240602,1.0,25/76,24.42%,GSK3B;RNF19A;VCP;DDRGK1;CLU;PRICKLE1;ARIH1;CCDC22;CSNK1E;ARIH2;TAF1;CSNK1A1;SMURF1;CSNK1D;COP1;RNF144A;NUB1;PIAS1;RNF14;SUMO1;TRIB2;HSPA1A;ANKIB1;RCHY1;RNF217
prerank,centromere complex assembly (GO:0034508),-0.22939666169152273,-0.7335720334694384,0.9023569023569024,0.9773572383871548,1.0,20/36,39.68%,RUVBL1;CENPP;KNL1;CENPE;MIS18BP1;HELLS;CENPI;CENPV;CENPA;NPM1;DLGAP5;MIS18A;CENPL;ITGB3BP;CENPN;CENPM;RSF1;POGZ;CENPS;MIS12
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.35586480108099294,0.7331675478269758,0.7638640429338104,0.9808923798688587,1.0,5/11,27.03%,ATL2;VCPIP1;VAPB;STX18;BNIP1
prerank,inorganic ion transmembrane transport (GO:0098660),0.3511903112122748,0.7330179907930197,0.7685512367491166,0.9806365420358787,1.0,2/12,8.41%,TRPM4;PKD2L1
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.3137964875933834,-0.7326523748517523,0.810304449648712,0.9775865287342606,1.0,1/11,3.62%,AHR
prerank,regulation of macrophage cytokine production (GO:0010935),0.3354506160678681,0.7326454525628519,0.7770034843205574,0.9807062897383069,1.0,1/13,1.44%,TGFB3
prerank,cellular macromolecule catabolic process (GO:0044265),0.27391336692993534,0.7324793480318503,0.8246318607764391,0.9804954546767348,1.0,7/49,11.16%,PABPC4;IDE;RNASE6;CHEK2;EXOSC7;DFFB;FBXO17
prerank,protein catabolic process (GO:0030163),-0.20614950705206483,-0.7313725823845337,0.9456066945606695,0.9783703734998174,1.0,5/59,5.83%,APOE;ADAMTS9;HSPA8;STT3B;DAB2IP
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.296202922355265,0.7313026126950071,0.8222222222222222,0.9816694524199614,1.0,5/30,14.72%,CD44;CLU;KDM1A;CDKN2D;THOC5
prerank,muscle filament sliding (GO:0030049),0.2794548377574149,0.7310956800135581,0.8282828282828283,0.9810407381913626,1.0,3/38,5.96%,MYBPC2;DMD;TNNI3
prerank,actin-myosin filament sliding (GO:0033275),0.2794548377574149,0.7310956800135581,0.8282828282828283,0.9810407381913626,1.0,3/38,5.96%,MYBPC2;DMD;TNNI3
prerank,negative regulation by host of viral transcription (GO:0043922),0.3429984934415523,0.7305238369006238,0.7951388888888888,0.9813973047235786,1.0,2/12,12.11%,JUN;REST
prerank,lysosome organization (GO:0007040),-0.22923606084324943,-0.7302793325183609,0.871875,0.9788130909719166,1.0,6/36,10.68%,ABCA1;CLVS2;GRN;CLVS1;LRRK2;AKTIP
prerank,JNK cascade (GO:0007254),0.28124085250959746,0.7301064054895874,0.8256130790190735,0.9815077045877636,1.0,4/40,7.24%,MAP3K5;ARHGEF6;TAB3;RIPK2
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.356638478060653,0.729893465515588,0.7934595524956971,0.9813320540351312,1.0,3/10,18.30%,DLGAP4;CACNG5;AKAP9
prerank,response to amino acid (GO:0043200),-0.24270229300459295,-0.7291870018984885,0.8552631578947368,0.9792357181814346,1.0,15/31,31.30%,SPAAR;TMBIM6;GLRA1;SLC38A9;IPO5;SH3BP4;GRIN1;LAMTOR1;GLRA3;CPEB4;MEAK7;LAMTOR2;XBP1;RPTOR;LAMTOR5
prerank,cellular response to calcium ion (GO:0071277),0.25780408967874413,0.7291610727869692,0.8670076726342711,0.9819024536564827,1.0,7/67,9.56%,CLIC4;CAMK2D;MEF2A;SYT8;IQGAP1;CARF;DMTN
prerank,cellular response to acid chemical (GO:0071229),-0.2468746667484202,-0.7282034375946257,0.85,0.979551266290714,1.0,12/27,31.30%,SPAAR;GLRA1;SLC38A9;IPO5;SH3BP4;LAMTOR1;VEGFA;CPEB4;LAMTOR2;XBP1;RPTOR;LAMTOR5
prerank,amyloid-beta metabolic process (GO:0050435),0.33195877925008027,0.727996785949536,0.7508305647840532,0.9830393570576633,1.0,2/16,7.32%,MGAT3;IDE
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.3453508798896912,0.7275279458733843,0.7692307692307693,0.9832291242518365,1.0,9/12,32.05%,FUZ;ZDHHC7;TRAF3IP1;CELSR1;RAB10;LAMA5;VANGL2;SCRIB;AHI1
prerank,regulation of telomerase activity (GO:0051972),0.2715760979925295,0.7275272166714315,0.8384401114206128,0.9827647185705156,1.0,10/45,18.57%,KLF4;NEK7;SMG6;ATM;MAPK1;XRCC5;MAPK15;TCP1;ACD;PINX1
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.2756378826567633,0.727155172881454,0.8278805120910384,0.9828029610889962,1.0,10/42,17.81%,VCP;USP10;TRIM25;RPA1;RFC5;REV1;POLD3;CDKN2D;WRN;POLA1
prerank,divalent inorganic cation homeostasis (GO:0072507),0.29982690536363954,0.7269693177672387,0.8048048048048048,0.9825717933369581,1.0,2/25,2.18%,CNNM2;CNNM4
prerank,response to hydroxyurea (GO:0072710),0.3629609773621787,0.726938779342111,0.7914338919925512,0.9821527529134161,1.0,4/11,22.40%,DDI2;DDX11;ATRX;FMR1
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.32067628223097555,0.7266208920351794,0.7849117174959872,0.9821244272780256,1.0,2/17,5.12%,NFE2L2;VNN1
prerank,coenzyme A biosynthetic process (GO:0015937),-0.30737574987874616,-0.726451945861829,0.8300492610837439,0.9789164160140732,1.0,4/11,22.09%,ACOT7;PANK1;PPCS;DCAKD
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),-0.30737574987874616,-0.726451945861829,0.8300492610837439,0.9789164160140732,1.0,4/11,22.09%,ACOT7;PANK1;PPCS;DCAKD
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),-0.30737574987874616,-0.726451945861829,0.8300492610837439,0.9789164160140732,1.0,4/11,22.09%,ACOT7;PANK1;PPCS;DCAKD
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.35882942550207114,0.7260411965520933,0.7760141093474426,0.982455739509611,1.0,5/10,31.47%,SAG;RHO;GNB1;PDE6A;CNGB1
prerank,establishment of protein localization to organelle (GO:0072594),0.25403995953305564,0.7257444651956619,0.8634020618556701,0.9824334950020054,1.0,13/72,14.62%,NUP93;IPO7;PRICKLE1;LRSAM1;SEC13;E2F3;NUP188;TNPO2;STAT3;HEATR3;ZDHHC15;FAM53A;RAN
prerank,positive regulation of stem cell proliferation (GO:2000648),0.3215707811254398,0.7252370299568374,0.773524720893142,0.9827033588126468,1.0,2/17,7.72%,LTBP3;KDM1A
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.29187036563428537,-0.7241312905245528,0.8019559902200489,0.980821258806468,1.0,2/13,5.83%,EPN2;DAB2IP
prerank,tetrapyrrole metabolic process (GO:0033013),0.3214611196219452,0.7237407612016005,0.7956600361663653,0.9842736451035757,1.0,7/18,25.04%,MMACHC;CD320;MMADHC;LMBRD1;MMAB;ABCC1;MTRR
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.27286092107187987,-0.7236925790600328,0.8511166253101737,0.9804425654485268,1.0,6/18,19.30%,PPIA;HIF1A;NME5;AKT1;PARK7;SOD2
prerank,regulation of lymphocyte migration (GO:2000401),-0.30686219640666906,-0.7235688947576744,0.7657004830917874,0.9796800756083018,1.0,7/10,44.75%,AKT1;WASL;MIA3;STK10;JAM2;CCR6;SPN
prerank,leukocyte tethering or rolling (GO:0050901),0.31839893088915244,0.723557998312721,0.7862838915470495,0.9840658727352024,1.0,2/17,5.50%,ITGB1;GOLPH3
prerank,regulation of defense response to virus (GO:0050688),0.32962229575167007,0.7235443874513726,0.8156521739130435,0.9836184848292199,1.0,8/14,29.05%,DHX9;IFNLR1;TRAF3IP1;TRAF3;RNF26;ILRUN;RNF216;PPM1B
prerank,cellular response to hydroxyurea (GO:0072711),0.36335530363392715,0.7234852240178684,0.7783985102420856,0.9832266864499392,1.0,4/10,22.40%,DDI2;DDX11;ATRX;FMR1
prerank,I-kappaB phosphorylation (GO:0007252),0.349327211875904,0.7224914321473613,0.7859712230215827,0.9841620092486205,1.0,3/10,11.44%,ERC1;CHUK;TLR4
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.2495976342050862,0.7224193948506452,0.8808618504435995,0.9837912300590494,1.0,21/79,21.07%,SEC24B;DYNC1I1;AP2A2;DCTN6;AP2A1;KLC1;SEC13;DYNC1LI2;SAR1B;KIF2C;CAPZA1;CAPZA2;SEC24A;DCTN3;KIF18A;KIF2A;RAB7A;DCTN1;SEC23A;FCER1G;CTSF
prerank,regulation of lysosomal lumen pH (GO:0035751),-0.29867204379721624,-0.7223467948227206,0.8284313725490197,0.9802425740591216,1.0,2/12,8.91%,GRN;LRRK2
prerank,glutamine family amino acid metabolic process (GO:0009064),0.2814532488250851,0.7204561455153063,0.8522388059701492,0.9860067477339839,1.0,9/33,19.90%,GCLC;PYCR1;FPGS;KYAT1;CAD;GLUL;NIT2;OAT;GOT1
prerank,triglyceride biosynthetic process (GO:0019432),0.31140022989834726,0.7204323250130464,0.793918918918919,0.9855775373765198,1.0,4/18,13.11%,PNPLA3;MOGAT3;GPAT3;LPIN2
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.31041647719176335,0.7202590321253833,0.8062913907284768,0.9844354783708318,1.0,2/20,7.31%,KLHL22;ATM
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.31041647719176335,0.7202590321253833,0.8062913907284768,0.9844354783708318,1.0,2/20,7.31%,KLHL22;ATM
prerank,spindle assembly checkpoint signaling (GO:0071173),0.31041647719176335,0.7202590321253833,0.8062913907284768,0.9844354783708318,1.0,2/20,7.31%,KLHL22;ATM
prerank,central nervous system neuron axonogenesis (GO:0021955),0.3349333110785693,0.7201983791038945,0.7785588752196837,0.9840570849625948,1.0,2/12,5.98%,EPHB6;MYCBP2
prerank,regulation of establishment of protein localization to telomere (GO:0070203),-0.30498827530826433,-0.7196778340142366,0.8233890214797136,0.9823964691674557,1.0,5/11,38.30%,CCT5;CCT2;DKC1;CCT8;CCT7
prerank,mRNA metabolic process (GO:0016071),0.24706903692855153,0.719358540996525,0.8895631067961165,0.9847209374349009,1.0,19/90,19.50%,DDX5;DXO;SON;CELF1;ZC3H12D;TCERG1;PRPF3;DIS3L2;SRSF5;SF3B2;NANOS2;LSM2;SRSF11;SNRPD3;PRKACA;SCAF11;GEMIN2;YTHDF2;ALKBH5
prerank,positive regulation of lamellipodium organization (GO:1902745),0.2816705027132594,0.7191121537050605,0.8223201174743024,0.9845898613668123,1.0,1/32,0.44%,PLCE1
prerank,male gonad development (GO:0008584),0.27901649669864437,0.7189461041813164,0.8161244695898161,0.9843586014902951,1.0,7/34,11.71%,INHBA;GATA1;GATA4;SIX4;GATA3;WNT2B;TGFB2
prerank,positive regulation of superoxide anion generation (GO:0032930),0.33635826119980516,0.7184686136411251,0.7967213114754098,0.9845465672623089,1.0,1/13,2.76%,PRKCD
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.2640821474788789,-0.718235678749674,0.845360824742268,0.9831616503492003,1.0,5/18,19.03%,MSRA;ASPG;ASS1;ASPA;SMS
prerank,negative regulation of centrosome duplication (GO:0010826),-0.30535591716707766,-0.7180872721410925,0.8363228699551569,0.9824475789538153,1.0,4/11,18.30%,CDK5RAP2;MDM1;RBM14;BRCA1
prerank,regulation of platelet aggregation (GO:0090330),0.32287043491215855,0.7178624351972409,0.785483870967742,0.9849078386908132,1.0,7/17,15.65%,CD9;PRKCD;SERPINE2;DMTN;C1QTNF1;ADAMTS18;PRKCA
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.29689940216435257,0.7177153458354562,0.8125,0.98464320830774,1.0,5/24,14.68%,CD44;CLU;KDM1A;TAF9;CDKN2D
prerank,protein homotrimerization (GO:0070207),0.33155886647084576,0.7176159795825997,0.8033333333333333,0.9838427941454909,1.0,1/14,1.76%,DISP1
prerank,protein trimerization (GO:0070206),0.33155886647084576,0.7176159795825997,0.8033333333333333,0.9838427941454909,1.0,1/14,1.76%,DISP1
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.26803219629125946,-0.7170724976529147,0.8557457212713936,0.9827115818763359,1.0,2/18,3.01%,DCN;KDR
prerank,negative regulation of transferase activity (GO:0051348),0.29531188156873084,0.7168470224036715,0.8215339233038348,0.9844113200401785,1.0,7/28,18.57%,GSK3B;ABL1;CDKN1B;PHPT1;PRDX3;IRS2;PINX1
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.3127482991293838,-0.7167470646279746,0.8386363636363636,0.9812656086731978,1.0,3/11,10.50%,AGO1;NOTCH4;AGO4
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.3127482991293838,-0.7167470646279746,0.8386363636363636,0.9812656086731978,1.0,3/11,10.50%,AGO1;NOTCH4;AGO4
prerank,lymphocyte migration (GO:0072676),-0.23845455341471136,-0.7165411873639389,0.8934707903780069,0.9805749259107684,1.0,19/32,46.10%,S1PR1;CCL19;CCL2;CCL25;MYO1G;CCL5;CCL11;ZAP70;CCL4;CRTAM;CX3CL1;CCL7;CCL8;MSMP;CCR6;CCL1;CCL3;TBX21;XCL1
prerank,programmed necrotic cell death (GO:0097300),0.31689111368949746,0.7162754560490618,0.7996485061511424,0.9847128621579545,1.0,6/18,20.38%,RIPK3;TLR4;TRPM7;ALKBH7;TICAM2;LY96
prerank,regulation of cellular amide metabolic process (GO:0034248),0.2843413811327632,0.7160795919370664,0.8251445086705202,0.9845121043320155,1.0,2/32,2.76%,FOXO3;PRKCD
prerank,transcription preinitiation complex assembly (GO:0070897),0.3385003525026565,0.715402752626817,0.7972972972972973,0.9849438296366541,1.0,3/12,15.29%,TAF1;TAF7L;TAF12
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.3408389377719976,0.7151932326664596,0.7896613190730838,0.9847685820082552,1.0,5/12,23.09%,SEC63;GET3;CHMP4A;CHMP4B;SEC61A2
prerank,regulation of cholesterol esterification (GO:0010872),0.3493403410938002,0.7151426806894761,0.7902946273830156,0.9843694344563608,1.0,2/10,9.08%,AGTR1;STARD4
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.2541533362274165,0.7146922263915718,0.8725868725868726,0.9844882103010114,1.0,13/59,16.94%,TANK;TAB3;ERC1;CHUK;RIPK2;BCL10;TLR4;BIRC3;TRADD;REL;RNF31;NKIRAS2;TICAM2
prerank,positive regulation of cellular component movement (GO:0051272),0.3017717177295837,0.7146907983056481,0.8112,0.9840326602224021,1.0,8/24,19.47%,NTN1;TGFBR1;PHPT1;DUOX1;TUBB2B;STK11;CCDC25;PDPN
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.29075541838575497,0.7136452127327173,0.8009331259720062,0.9849543519794793,1.0,3/26,11.44%,INHBA;PTPN2;TLR4
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.32232386991337797,0.7136273238935895,0.7921440261865794,0.9845257898791225,1.0,6/16,22.29%,MCM7;RPA1;WRN;RECQL5;MCM6;MCMDC2
prerank,multivesicular body assembly (GO:0036258),0.2870819300238968,0.7136004318086242,0.8116591928251121,0.9841131235970296,1.0,8/30,20.65%,PDCD6IP;IST1;TSG101;VPS37A;HGS;STAM2;CHMP4A;CHMP4B
prerank,cranial nerve development (GO:0021545),0.3503737511788833,0.7132147197244572,0.8161512027491409,0.9841890264519567,1.0,3/11,10.99%,ISL1;TFAP2A;TIFAB
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.2500445675944649,0.7125101102360933,0.8841698841698842,0.9846655486325602,1.0,23/73,23.72%,ABL1;GATA1;CBFB;TCF3;GATA3;FOXC1;PSMC6;PRKDC;PSMD8;LDB1;YTHDF2;PSMB1;PSMD13;PSMD1;PSMD7;PSMA8;KMT2A;MYB;PSMD3;PUS7;PSMD2;PSMC2;PSMB2
prerank,ESCRT complex disassembly (GO:1904896),-0.30590661980902867,-0.7123097627634376,0.8188073394495413,0.9837155497800562,1.0,5/10,30.46%,CHMP1A;CHMP7;CHMP1B;CHMP2B;VPS4A
prerank,ESCRT III complex disassembly (GO:1904903),-0.30590661980902867,-0.7123097627634376,0.8188073394495413,0.9837155497800562,1.0,5/10,30.46%,CHMP1A;CHMP7;CHMP1B;CHMP2B;VPS4A
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.34528927384165703,0.7120805639744483,0.7982456140350878,0.9847467525395993,1.0,3/10,11.95%,PIH1D2;ZNHIT3;TAF9
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.25198132535213214,-0.7115213914095163,0.855072463768116,0.9836865108595276,1.0,5/21,13.72%,MDK;NES;TOX;CX3CR1;PROX1
prerank,sulfur amino acid catabolic process (GO:0000098),0.3495478365955014,0.7114847912364478,0.7943262411347518,0.9850346028694816,1.0,4/10,27.32%,GADL1;MTRR;ADO;CTH
prerank,digestive tract morphogenesis (GO:0048546),0.335810175074535,0.711334808321323,0.8214285714285714,0.984766967107296,1.0,2/14,10.03%,STRA6;AGR2
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.27389411715728873,-0.7107309835044675,0.8404761904761905,0.9836530201378066,1.0,5/16,17.61%,NR1H3;SCARB1;MFSD2A;SLC27A1;PNPLA2
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.2697193527266004,0.7106082433062102,0.8231098430813124,0.9852793362184341,1.0,6/39,8.27%,F8A1;NDEL1;DYNC1I1;PAFAH1B1;FBXW11;TANC2
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.27136582401306547,-0.7102108118859599,0.8467532467532467,0.9833261141179563,1.0,5/16,24.15%,RIF1;SMCHD1;PNKP;SETMAR;SHLD3
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.25745250154129334,-0.7101898485141708,0.8756613756613757,0.9824457742922083,1.0,8/21,28.56%,BCL2L1;TMBIM6;LRRK2;BOK;PARK7;SELENOS;PMAIP1;XBP1
prerank,histone lysine methylation (GO:0034968),0.2845657139880969,0.7100497581281418,0.8299418604651163,0.9855520289137448,1.0,9/33,25.39%,SMYD2;EHMT2;KMT2D;ASH2L;SETD1B;KMT2A;PRDM5;EZH2;WDR5
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.2718501288100994,0.7097155744884295,0.8477011494252874,0.9855348459046388,1.0,8/40,17.04%,PID1;ABL1;VCP;PYCR1;ARL6IP5;STOML2;PRDX3;RNF122
prerank,negative regulation of RNA splicing (GO:0033119),-0.2583403687302793,-0.7094193735981034,0.8732057416267942,0.9824171106242009,1.0,5/19,12.57%,RPS13;TMBIM6;RNPS1;SRSF9;PTBP2
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.2367579162419767,0.708954790464945,0.9134615384615384,0.9860657911308163,1.0,20/104,17.01%,CCNA2;LRP6;ADRB2;ABL1;PPEF2;TELO2;CDKN1B;MNAT1;RB1;GTPBP4;RHOA;LRP5;TSG101;CAB39;CDKN2D;CDK12;MAP2K2;CDKN3;CCND3;SYAP1
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.2188935309605111,0.7088945680506127,0.9657020364415863,0.9856856402971154,1.0,74/264,24.40%,DDX5;RBM6;SNRNP48;SYNCRIP;HNRNPH1;ZCCHC8;U2AF1L4;USP49;SNRPB2;DDX42;FUS;CASC3;SRRM2;RSRC1;PRPF3;GCFC2;SRSF5;SRSF6;SF3B2;SF3B1;SRSF12;SRRM1;RBMX;PRPF40B;RBM8A;SRPK1;LSM2;ESS2;SRSF11;DDX17;GTF2F2;SNRPD3;HNRNPL;DDX1;SNRNP70;GEMIN8;SNW1;DHX9;SCNM1;PRCC;SCAF11;GPKOW;TRA2B;SRRT;GEMIN2;POLR2H;RBM4B;CPSF7;PABPC1;CWC22;PHF5A;PRPF6;HNRNPM;TXNL4A;ZCRB1;PPIL1;RNPC3;NUDT21;HNRNPUL1;HNRNPA3;RBM5;CPSF4;SNRNP27;SNRPD2;SNRPD1;SNRNP40;AQR;RBMX2;PNN;U2SURP;ALYREF;RBM4;NCBP2;CSTF2
prerank,import into nucleus (GO:0051170),0.2487614620428121,0.7087084923930322,0.8674388674388674,0.9854600301412746,1.0,20/73,22.20%,NUP93;IPO7;PRICKLE1;SEC13;E2F3;NUP188;TNPO2;STAT3;HEATR3;SNRPD3;FAM53A;RAN;HTATIP2;GEMIN8;GEMIN2;NUP107;IPO8;EIF4ENIF1;SNRPD2;SNRPD1
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.301758252522599,0.7086595897631154,0.824390243902439,0.9850655654962078,1.0,2/21,7.31%,KLHL22;ATM
prerank,regulation of nervous system development (GO:0051960),0.26806818451301206,0.7086293487139731,0.8654970760233918,0.9846495250621997,1.0,6/37,13.29%,DOCK7;BHLHE40;HES1;TNFRSF1B;PER2;HES7
prerank,regulation of extracellular matrix disassembly (GO:0010715),-0.2775614284800916,-0.7085771341584765,0.8638743455497382,0.9824091479893963,1.0,5/15,17.45%,CST3;DPP4;FSCN1;CLASP2;FGFR4
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.27738929878133756,-0.70843259944957,0.8375,0.9816809631659352,1.0,4/15,12.58%,SMPD3;SPHK1;TNFRSF1A;ORMDL3
prerank,lymphocyte proliferation (GO:0046651),-0.24958032308967443,-0.7080430233994651,0.888,0.9812166735787405,1.0,8/22,25.69%,BCL2;CTPS1;MEF2C;PPP3CB;HELLS;CD40;PIK3CG;PTPRC
prerank,endoderm development (GO:0007492),-0.2926914985165211,-0.7074645257200873,0.8277634961439588,0.9809537792468841,1.0,6/13,29.32%,SOX17;SOX7;LHX1;DUSP4;LAMC1;TBX20
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.3101328006216293,0.7073402044725078,0.823327615780446,0.9858389504746319,1.0,4/18,11.97%,RNF185;OS9;EDEM2;UGGT2
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.3475959159272145,0.707111638161812,0.7853309481216458,0.9856757141789351,1.0,3/10,12.74%,PARD3;PLPP1;HTR2B
prerank,positive regulation of interleukin-13 production (GO:0032736),-0.3061872509885257,-0.7057137515860107,0.8226164079822617,0.9819284188832308,1.0,5/10,36.61%,IL18;PRKCZ;SPHK2;TSLP;IL4
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.30623444965955765,-0.7055890196074819,0.8296943231441049,0.9811675898287998,1.0,3/10,24.95%,MMGT1;EMC3;EMC8
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.34374919059451,0.7048592709584086,0.7829716193656093,0.9880853838075605,1.0,8/11,30.13%,STAT3;PUM2;PUM1;DHX9;FMR1;XPO5;ZFP36;FXR1
prerank,glucose catabolic process to pyruvate (GO:0061718),0.29131835161424047,0.703900657944233,0.8188736681887366,0.9883501720931159,1.0,5/24,12.13%,FOXK1;GAPDHS;PFKP;FOXK2;GPI
prerank,canonical glycolysis (GO:0061621),0.29131835161424047,0.703900657944233,0.8188736681887366,0.9883501720931159,1.0,5/24,12.13%,FOXK1;GAPDHS;PFKP;FOXK2;GPI
prerank,regulation of isotype switching (GO:0045191),0.31785033128227325,0.7035389838631242,0.8065573770491803,0.9883303912686995,1.0,2/14,10.63%,IL10;SHLD1
prerank,regulation of keratinocyte proliferation (GO:0010837),0.29370772946084034,0.7025395166278344,0.8348348348348348,0.989138406649101,1.0,7/22,18.37%,NOTCH2;TGM1;KLF9;SRSF6;CASK;AREG;ZFP36L1
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.24186025661483876,0.702436502949256,0.8924205378973105,0.9888048099833942,1.0,6/88,6.17%,TRABD2B;MPP7;GSK3B;PDCD6IP;VCP;CLU
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.21969276447338543,0.7021465057739271,0.9428263214670982,0.9887100021589801,1.0,42/208,16.97%,TRAF3IP2;AKAP13;TANK;ALPK1;TAB3;OTUD7B;GOLT1B;MAVS;CHUK;RIPK2;TLR6;MAP3K3;IRAK4;BCL10;USP10;VAPA;PPM1A;CCDC22;TRIM25;CARD19;PIM2;SQSTM1;RHOA;IKBKE;MTDH;BIRC3;HTR2B;TRADD;PPP5C;TRAF5;REL;RNF31;SLC20A1;DDX1;UFL1;FLNA;MYD88;UBE2N;RORA;ROR1;TICAM2;CARD16
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.2944466415447803,0.7019365454523576,0.8472012102874432,0.9885144494465189,1.0,8/25,20.34%,LRPAP1;ITGAV;ITGB3;NEU3;RIN3;ANKRD13D;ATXN2;DLG4
prerank,mRNA modification (GO:0016556),-0.24302407834960016,-0.7016600223343541,0.890625,0.9844482374779484,1.0,8/22,32.70%,METTL14;METTL16;METTL3;TRUB1;RPUSD2;TRMT61B;ZC3H13;DKC1
prerank,cell part morphogenesis (GO:0032990),0.33204517699964303,0.7014746718763446,0.7985865724381626,0.9886335092265969,1.0,1/13,2.92%,PID1
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.30757705940937263,-0.7011968128652457,0.8554778554778555,0.9840103017834865,1.0,5/10,38.30%,CCT5;CCT2;DKC1;CCT8;CCT7
prerank,receptor clustering (GO:0043113),-0.2353592056628988,-0.7003064371692455,0.8986301369863013,0.9840152042469057,1.0,8/27,24.31%,NRXN1;ITGA4;LRRC7;MUSK;ITGB2;NLGN1;PTN;AGRN
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.313938315755262,0.6995202951461662,0.8233333333333334,0.990566233765816,1.0,2/18,10.71%,CDC25B;RAD51C
prerank,secondary alcohol metabolic process (GO:1902652),0.2751347100024373,0.6994470768190643,0.8541076487252125,0.9902021217312095,1.0,8/42,16.53%,SOAT1;FDX1;TSKU;OSBPL5;EBP;RXRA;LCAT;SULT2B1
prerank,neutrophil activation (GO:0042119),0.33678066631072345,0.6991575365893179,0.8184931506849316,0.9901054989538594,1.0,1/12,2.76%,PRKCD
prerank,regulation of cytokine production (GO:0001817),0.2291902507232878,0.6989903261209934,0.9324796274738067,0.9898573680816484,1.0,11/126,10.39%,FOXP1;ANXA1;HDAC9;IL10;RIPK3;HILPDA;KAT2A;TNFRSF1B;BCL6;ASB1;GATA3
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.26501919567198856,0.6979850910828708,0.8624484181568088,0.9906710819763426,1.0,7/42,11.83%,KDM1A;FUS;SHLD1;MRNIP;CHEK1;SETD2;RAD51AP1
prerank,response to muramyl dipeptide (GO:0032495),-0.28674344283062525,-0.6978150678630639,0.8789237668161435,0.9856717850957657,1.0,2/12,5.54%,VIM;NOD1
prerank,erythrocyte development (GO:0048821),0.3443494531536336,0.6974423086326467,0.8096947935368043,0.9908772927807517,1.0,3/10,17.52%,GATA1;DMTN;ZBTB7A
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.3000755887067106,0.6971634329771338,0.8375796178343949,0.9907546119711663,1.0,5/21,18.30%,ANK2;SNTA1;KCNE4;FLNA;AKAP9
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.28888198816481175,0.6970041080094278,0.8440366972477065,0.9904964577711703,1.0,9/27,20.38%,TAB3;TLR6;IRAK4;TLR4;CD36;MYD88;TNIP1;IRAK1;LY96
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.27169901546578334,0.6969512125844225,0.8541076487252125,0.990121517623811,1.0,6/38,10.95%,TANK;OTUD7B;USP10;PPM1A;CCDC22;CARD19
prerank,synaptic vesicle recycling (GO:0036465),-0.22531572916728068,-0.6961169831032711,0.8971428571428571,0.9865638645222096,1.0,18/31,33.51%,SNCA;PIP5K1C;SYT7;OPHN1;NLGN1;NLGN2;SYT1;PACSIN1;CANX;SYT5;CDK5;RAB3A;SYT2;SNCB;WNT7A;SNCG;PLD2;NLGN3
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.1876158448410357,-0.6956088220994044,0.9858490566037735,0.9861762584023605,1.0,23/74,24.73%,HIF1A;NOTCH1;ELOB;ELOC;RBPJ;BACH1;RPS27A;UBC;PSMB10;EGLN1;UBB;PSME2;EPAS1;EGLN2;PSMB3;PSMB4;PSMB8;PSMC5;VEGFA;PSME1;PSMA7;PSMD5;ARNT
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.28739813491928856,0.6954193300477568,0.8330781010719756,0.9915536926815374,1.0,5/25,12.13%,FOXK1;GAPDHS;PFKP;FOXK2;GPI
prerank,protein palmitoylation (GO:0018345),-0.22618984153103766,-0.6953113946836217,0.8984615384615384,0.9855913387757104,1.0,7/30,14.42%,ZDHHC14;SELENOK;PORCN;ZDHHC1;ZDHHC17;ZDHHC4;ZDHHC13
prerank,maturation of LSU-rRNA (GO:0000470),-0.23560497910569747,-0.695072476230031,0.8959537572254336,0.9849453791212572,1.0,5/26,15.71%,NSA2;SNU13;RPL7A;NIFK;LAS1L
prerank,long-term memory (GO:0007616),0.29804440998465914,0.6947586507059998,0.8461538461538461,0.9919050572998764,1.0,7/19,21.35%,KAT2A;NFATC4;EIF2AK4;CAMK4;SHANK1;LDLR;PRNP
prerank,membrane organization (GO:0061024),0.21640701386981792,0.6938749783394472,0.967948717948718,0.992568348118918,1.0,17/227,7.73%,EGFR;REPS2;ANK2;ADRB2;NUP93;SUN3;AP2A2;STX11;CLTB;TOR1AIP1;PDCD6IP;RABEP1;GAK;A4GALT;OCRL;AP2A1;IGF2R
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.35102050562234144,0.6935712570146053,0.7963302752293578,0.992038414998988,1.0,1/10,2.76%,PRKCD
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.35102050562234144,0.6935712570146053,0.7963302752293578,0.992038414998988,1.0,1/10,2.76%,PRKCD
prerank,nuclear transport (GO:0051169),0.3113283882571254,0.693544491099421,0.8087520259319287,0.9916204381305435,1.0,5/16,21.32%,XPO1;RSRC1;AAAS;NUP98;PSIP1
prerank,positive regulation of chromosome organization (GO:2001252),0.3110895395265885,0.6928393206050115,0.8044982698961938,0.9920226101161341,1.0,5/15,19.95%,DDX11;PML;ATRX;NBN;MRE11
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.3372142082457834,0.6927081383609472,0.8293515358361775,0.9917308339373527,1.0,7/12,27.35%,STAT3;TGFB1;NCOR1;TERT;IL6;ESR1;ZC3H12A
prerank,dendritic cell migration (GO:0036336),-0.2634185853868628,-0.6910619991506315,0.8676844783715013,0.9881092849121869,1.0,1/16,0.78%,EPS8
prerank,response to histamine (GO:0034776),0.3457659349927756,0.6901074430460974,0.8164665523156089,0.9943450506721828,1.0,2/10,11.48%,DIAPH1;DRD3
prerank,global genome nucleotide-excision repair (GO:0070911),0.28261362652246846,0.6896937505843106,0.8405365126676602,0.9943936626223461,1.0,8/26,15.55%,ERCC3;ERCC1;XPA;CHD1L;RNF111;CUL4A;RAD23B;XPC
prerank,cellular response to cAMP (GO:0071320),0.2795213840358795,0.6890156722190021,0.8563049853372434,0.9947505792193571,1.0,5/30,9.87%,EZR;RAP1A;IGFBP5;DMTN;SLC26A6
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.3346268978709581,0.6877389270853258,0.8220640569395018,0.9958487117759222,1.0,4/10,16.64%,IRS1;SLC45A3;PRKCE;IRS2
prerank,sterol transport (GO:0015918),0.30064364182084163,0.6874111952813565,0.8341384863123994,0.9957834619123143,1.0,6/19,19.79%,OSBPL5;CD36;LCAT;NPC1;ARV1;LDLR
prerank,regulation of cholesterol transport (GO:0032374),-0.24323394981693885,-0.6870379294725972,0.8859416445623343,0.9912063554630377,1.0,9/20,27.41%,NR1H3;ABCA5;ABCB4;TSPO;LAMTOR1;APOC1;ABCA2;OSBPL6;NAXE
prerank,regulation of centrosome cycle (GO:0046605),0.29671346703831114,0.6870231133098039,0.8398133748055988,0.9957734227263046,1.0,5/21,20.65%,PDCD6IP;CEP131;FBXW5;AURKA;CHMP4B
prerank,telomere maintenance via telomerase (GO:0007004),0.27871710115683823,0.6869636136234096,0.8551401869158879,0.9953908307374484,1.0,10/28,25.54%,TELO2;RPA1;PPP6R3;ANKRD28;ACD;PINX1;MRE11;PPP6C;RFC1;TERT
prerank,phospholipid homeostasis (GO:0055091),0.33605405634720104,0.686853945874889,0.8116438356164384,0.9950659833972108,1.0,3/11,12.36%,HNF4A;FABP3;TLCD2
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.25248678235648797,0.6868442402613363,0.8863328822733424,0.9946248528963222,1.0,18/54,26.45%,TAX1BP1;HIPK1;PTPN2;CHUK;SPPL2A;BIRC3;TRADD;RNF31;CARD16;FADD;NLRP2B;PYDC1;ADAM17;HSPA1A;UBE2K;CASP8;CLIP3;CPNE1
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.3075048741922287,0.6866343599753745,0.8426229508196721,0.9944226781827704,1.0,1/17,2.80%,ANO6
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.2649004669412415,0.6864557714792288,0.8618233618233618,0.9941890467252764,1.0,5/36,12.14%,CYP1B1;IL10;HES1;PIGU;NLK
prerank,nucleotide-excision repair (GO:0006289),0.23035817480997794,0.686140053524608,0.9251207729468599,0.9941142143250213,1.0,23/101,18.62%,EP300;USP7;MNAT1;ERCC3;BRCA2;ERCC1;COMMD1;SLC30A9;RPA1;ERCC8;XPA;RFC5;CHD1L;RNF111;CUL4A;COPS7B;COPS5;RAD23B;POLD3;XPC;POLB;POLA1;POLR2H
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.289277380317994,0.6857554386256853,0.8539682539682539,0.9941324515401826,1.0,1/22,1.74%,CD55
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.2831511229827996,0.6856917527255705,0.8627450980392157,0.9937559370374822,1.0,9/25,23.82%,TCERG1;RNF168;WDR43;CDK12;EAF2;LDB1;NELFE;RECQL5;LEO1
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.23452738457100342,-0.6851893143890032,0.9255952380952381,0.9921071622542252,1.0,4/28,7.75%,CTSC;PTK2;DAB2IP;ECSCR
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.2809962939439244,-0.6850307158976142,0.8694581280788177,0.9913559924063099,1.0,3/14,11.56%,GPS2;GAS6;RFFL
prerank,ncRNA transcription (GO:0098781),0.3141257871391892,0.684967138784445,0.82174688057041,0.9941638414914961,1.0,6/13,30.66%,POLR1G;BRF1;SNAPC2;SIRT7;ANG;SPIN1
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.27696102239781206,0.6848874448938839,0.8624260355029586,0.9938114443048514,1.0,1/30,0.90%,ABCD3
prerank,outer dynein arm assembly (GO:0036158),0.30247363341147926,0.6846016536136933,0.8588850174216028,0.9936857334059521,1.0,2/15,12.37%,DNAH8;DNAH5
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.29842534319937236,0.6845035485329932,0.8313856427378965,0.9933548976489357,1.0,5/15,17.60%,ATL2;RAB18;ZFYVE27;TMEM170A;RTN3
prerank,innate immune response (GO:0045087),0.21287098240589833,0.6839319718540386,0.974025974025974,0.9935456778856715,1.0,28/217,13.63%,PTK2B;LBP;COLEC11;ALPK1;KLRC2;ZDHHC11;TREML1;VNN1;SLPI;TRIM26;MAVS;CHUK;RIPK2;RNF135;IRAK4;ANKHD1;CYP27B1;BCL10;RNASE6;FRK;TRIM25;TLR4;SETD2;YES1;CAPZA1;SRPK1;CIITA;REL
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.28651409707608244,0.6832027923174883,0.856071964017991,0.9939276382487541,1.0,2/24,4.49%,CAMK2D;DMD
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.3094123661425124,0.6828632949777065,0.810671256454389,0.9938673788760766,1.0,7/14,31.48%,DDX1;TSEN54;CPSF4;CSTF2;RTCB;TRPT1;TSEN2
prerank,histone H2A ubiquitination (GO:0033522),0.2990621519074397,0.6828412613044694,0.8424657534246576,0.9934416965809667,1.0,3/17,9.20%,UBE2B;RNF2;RNF168
prerank,anterograde axonal transport (GO:0008089),0.26820271236102444,0.6821769107900225,0.8677325581395349,0.9937775799365574,1.0,6/37,14.37%,AP3B1;KIF1B;KIF1C;RAB27B;MAPK8IP3;DLG2
prerank,DNA damage checkpoint signaling (GO:0000077),0.27597705324080746,0.6820076626080466,0.851963746223565,0.9935278299421484,1.0,9/28,22.95%,ATM;CHEK2;RAD17;CHEK1;CEP63;CLSPN;NBN;ATR;HINFP
prerank,organelle fission (GO:0048285),-0.2336394657990001,-0.6819034665735241,0.9064171122994652,0.9934835099829293,1.0,6/24,21.94%,DNM3;SEC16B;PEX19;DNM1;DNM1L;MTFP1
prerank,neuromuscular process controlling balance (GO:0050885),0.3312786131483409,0.6818088303925421,0.8483245149911817,0.9933102012086974,1.0,5/12,19.06%,PAFAH1B1;TIFAB;SHANK1;TPP1;CLN3
prerank,lipid translocation (GO:0034204),0.292265578233026,0.6818040235799823,0.8374792703150912,0.992868685085341,1.0,2/21,4.94%,ATP10A;ATP8B1
prerank,myeloid dendritic cell activation (GO:0001773),0.32349928532459427,0.6817965258739066,0.8155172413793104,0.9924298427906822,1.0,2/12,14.48%,TGFBR2;CAMK4
prerank,regulation of aerobic respiration (GO:1903715),-0.2707267957447219,-0.6811985216649077,0.8863636363636364,0.9932565765155403,1.0,6/15,23.46%,CBFA2T3;COX7A2;ATP7A;UQCC2;SLC25A33;SHMT2
prerank,RNA processing (GO:0006396),0.2154964396676119,0.6802693595463325,0.9656699889258029,0.993765157865616,1.0,33/176,16.45%,MBNL1;RBM6;SNRNP48;SYNCRIP;SON;PABPC4;HNRNPH1;ZCCHC8;CELF1;FUS;TCERG1;RSRC1;PRPF3;PPIG;SRSF5;NRDE2;SF3B2;SF3B1;SRRM1;RBM8A;SRPK1;RBM39;SRSF11;DUSP11;DDX17;SNRPD3;HNRNPL;CDK12;TSEN54;DROSHA;PRKACA;SCNM1;SCAF11
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.20747823277279143,-0.680220598954647,0.9375,0.9932909957707261,1.0,14/39,27.56%,FAN1;PARP1;RPS27A;UBC;GTF2H2;DDB1;UBB;DDB2;GTF2H4;OGG1;POLD1;RFC2;RPA3;POLD2
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.2360370488425133,0.679791086642618,0.916243654822335,0.9938602887185015,1.0,13/72,14.34%,EP300;USP7;MNAT1;ERCC3;ERCC1;RPA1;ERCC8;XPA;RFC5;CUL4A;COPS7B;COPS5;POLD3
prerank,mesoderm formation (GO:0001707),0.30739263443681364,0.6792899398092168,0.8358714043993232,0.9940035253329285,1.0,4/17,17.35%,ITGB1;ITGB4;ITGB3;KDM6B
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.24838281740685075,0.6792801835205803,0.9107856191744341,0.9935731416798785,1.0,7/56,11.89%,CIT;SNX18;PDCD6IP;ARL3;SON;IST1;RHOA
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.27246375059763395,-0.6792655532737595,0.8708920187793427,0.9932355143105361,1.0,2/13,7.04%,CD81;SEC16B
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.27806735200961347,0.6791523174622324,0.8356589147286821,0.9932785042210173,1.0,5/26,12.11%,NFE2L2;VNN1;PYCR1;GATA4;REST
prerank,regulation of cellular catabolic process (GO:0031329),0.2464938913111324,0.6788870767073798,0.9093333333333333,0.9931375909948478,1.0,8/62,9.68%,USP13;ABL1;DDIT3;EP300;ATM;SMCR8;USP10;USP33
prerank,Notch signaling involved in heart development (GO:0061314),0.32309810306306674,0.6788064980399627,0.8164335664335665,0.9927789712437654,1.0,4/11,19.33%,NOTCH2;JAG1;GALNT11;HEYL
prerank,glucan biosynthetic process (GO:0009250),0.322943254127021,0.6782259252353565,0.8186440677966101,0.9925605427667402,1.0,2/12,9.73%,PPP1R3C;PER2
prerank,glycogen biosynthetic process (GO:0005978),0.322943254127021,0.6782259252353565,0.8186440677966101,0.9925605427667402,1.0,2/12,9.73%,PPP1R3C;PER2
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.3211443955924514,0.6781471485437731,0.808695652173913,0.992197678603574,1.0,5/13,20.60%,KPNA1;RGPD1;RANBP2;KPNA4;NUP54
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.3121078765423875,0.6775417047117271,0.8421052631578947,0.9924566631225943,1.0,6/16,21.22%,CTCFL;KDM1A;CTR9;SNW1;KMT2A;MYB
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.23767109443001733,0.6775028560677419,0.918075422626788,0.9920647383106078,1.0,7/63,10.17%,ANXA1;CD80;NCK2;CLCF1;TNFRSF4;CD320;CD46
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.2376013987639991,-0.6771260322242416,0.9110512129380054,0.9943857036585831,1.0,4/24,14.33%,JARID2;CREBZF;TRIM27;MTF2
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.2923887018465227,0.676344706262003,0.8394698085419735,0.9929218875962604,1.0,6/21,16.91%,SHPK;DERA;RPIA;GPI;G6PC3;RBKS
prerank,regulation of phosphatase activity (GO:0010921),0.28249474224380317,0.6763025144290099,0.8545176110260337,0.9925206049998118,1.0,6/24,20.38%,RIPK3;PPP6R2;PPP1R36;PPP6R3;CHP1;URI1
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.25510923574410105,0.6760764171441501,0.8822674418604651,0.9923362827883779,1.0,12/41,21.17%,NUP93;EP300;SEC13;NUP188;RANBP2;ZBTB7A;NUP107;AAAS;RAE1;NUP54;NUP98;EIF6
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",-0.2352741273127048,-0.6759963908720702,0.8926553672316384,0.9945236379586504,1.0,6/23,20.27%,CECR2;CASP3;DFFA;FOXL2;SETMAR;H1-0
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.20888976779263202,0.6755505100105029,0.9785407725321889,0.9924816282410855,1.0,72/241,25.72%,DDX5;RBM6;SNRNP48;SYNCRIP;HNRNPH1;ZCCHC8;U2AF1L4;USP49;SNRPB2;DDX42;FUS;CASC3;SRRM2;RSRC1;PRPF3;GCFC2;SRSF5;SRSF6;SF3B2;SF3B1;SRSF12;SRRM1;RBMX;PRPF40B;RBM8A;LSM2;ESS2;SRSF11;GTF2F2;SNRPD3;HNRNPL;SNRNP70;SNW1;DHX9;PRCC;GPKOW;TRA2B;SRRT;POLR2H;RBM4B;CPSF7;PABPC1;CWC22;PHF5A;PRPF6;HNRNPM;TXNL4A;ZCRB1;PPIL1;RNPC3;NUDT21;HNRNPUL1;HNRNPA3;RBM5;CPSF4;SNRNP27;SNRPD2;SNRPD1;SNRNP40;AQR;RBMX2;PNN;U2SURP;ALYREF;RBM4;NCBP2;CSTF2;SNRPE;CSTF1;UPF3B;SRSF7;FIP1L1
prerank,protein insertion into ER membrane (GO:0045048),-0.20862650234386512,-0.6752899999688415,0.9603658536585366,0.9942326664141615,1.0,10/37,25.98%,CYB5A;UBE2J2;MMGT1;APP;SEC61G;TRAM1;EMC3;GET4;EMC8;TRAM1L1
prerank,release of cytochrome c from mitochondria (GO:0001836),-0.25662836842745773,-0.6749253169112684,0.8762886597938144,0.9936613823799415,1.0,7/17,27.53%,BCL2;BCL2L1;BOK;SOD2;DNM1L;BAD;BAK1
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.2899926040224161,0.6745488433787824,0.8539325842696629,0.9931387230082203,1.0,8/20,24.18%,CLU;PSMG2;PSMG1;LONP1;HSPA4;BBS12;TMEM35A;HSPA1A
prerank,response to gamma radiation (GO:0010332),0.27790065369152117,0.6745333203202698,0.8330658105939005,0.9927141262345883,1.0,9/24,23.69%,ATM;KDM1A;XRCC5;PRKAA1;TSPYL5;WRN;TLK2;ATR;TMEM109
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.33219868737564257,0.6743822248485563,0.8170289855072463,0.9924429289668014,1.0,4/10,23.56%,USP7;GNMT;ZNF692;SIRT7
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.3083135874753597,0.6739587284459809,0.8304498269896193,0.9924629888257903,1.0,5/13,25.56%,RHOQ;RAN;ENTPD7;GNAI3;AK3
prerank,regulation of centrosome duplication (GO:0010824),0.27217371544381813,0.6738868585754458,0.8776758409785933,0.9920875169888826,1.0,4/30,8.76%,PDCD6IP;CEP131;STIL;CEP295NL
prerank,regulation of myoblast fusion (GO:1901739),-0.28579365650000177,-0.6737396785833669,0.8397291196388262,0.993817131609981,1.0,4/11,14.75%,RIPOR2;CFLAR;FLOT1;ADGRB1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.2831844130384057,0.6732367195445184,0.8646496815286624,0.9923854002893964,1.0,3/24,7.92%,DDIT3;NFE2L2;CREB3L3
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.279443139024518,-0.6729866219712749,0.8541176470588235,0.9926748752229244,1.0,6/11,38.30%,CCT5;LARP7;CCT2;DKC1;CCT8;CCT7
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.279443139024518,-0.6729866219712749,0.8541176470588235,0.9926748752229244,1.0,6/11,38.30%,CCT5;LARP7;CCT2;DKC1;CCT8;CCT7
prerank,protein-containing complex subunit organization (GO:0043933),0.22204198817820872,0.6729672158782319,0.9532934131736527,0.9922391938390303,1.0,25/109,21.10%,REPS2;PTK2B;MATN1;MAGI1;CREBBP;HES1;TEAD1;MDM4;MNAT1;DMTN;TUBGCP4;PARD3;CAPZA1;SPG7;CAPZA2;SHANK1;PML;MDN1;GPAA1;HFE;LLGL1;DLG4;NUP54;KMT2A;NUP98
prerank,negative regulation of secretion (GO:0051048),-0.29270539793817196,-0.6728537217668761,0.8461538461538461,0.9919059006244032,1.0,7/10,40.22%,NR1H3;CD74;NRG1;VAMP3;ERBB3;PTGER3;VAMP8
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.3084455715604148,0.6720629705752029,0.8330605564648118,0.9928042712874046,1.0,1/15,3.38%,USP46
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.26346033979215494,0.6713906934694751,0.8687415426251691,0.9931207953941981,1.0,18/37,30.04%,CEP131;PCM1;IFT122;TRIP11;IFT88;DYNC2I2;IFT80;TRAF3IP1;IFT81;DYNC2H1;WDR35;TTC21B;DYNC2I1;IFT27;KIF17;CLUAP1;KIF3B;IFT46
prerank,necroptotic process (GO:0070266),0.3034302024015359,0.6712958959624302,0.8484848484848485,0.9927737651525852,1.0,5/16,20.38%,RIPK3;TLR4;TRPM7;TICAM2;LY96
prerank,female gamete generation (GO:0007292),0.26995480075764805,0.6705700345108255,0.8656488549618321,0.9931421958500717,1.0,7/29,19.28%,TOB2;BMP15;IHO1;NANOS2;KMT2D;MCM9;USP9X
prerank,copper ion homeostasis (GO:0055070),-0.25265807166294657,-0.6701742158764434,0.8898071625344353,0.9934098881880581,1.0,5/17,16.90%,ATOX1;MT2A;APP;SLC31A1;ATP7A
prerank,regulation of superoxide anion generation (GO:0032928),0.30928017951225345,0.6695548382671697,0.8412438625204582,0.9937912871967396,1.0,4/14,22.29%,PRKCD;AATF;TGFB1;ITGAM
prerank,regulation of vacuole organization (GO:0044088),0.2849235511586997,0.6694583053757512,0.8733766233766234,0.9934579031092021,1.0,5/20,16.99%,ANXA2;NPRL3;RAB5A;IFT88;ENO4
prerank,regulation of macroautophagy (GO:0016241),0.22426762894055993,0.6694554874499546,0.9535452322738386,0.9930188083238543,1.0,27/105,21.16%,NEDD4;EXOC4;TBC1D25;SMG1;SMCR8;ATP6V0A1;MLST8;MTOR;ATP6V0E1;BNIP3;RB1CC1;ATP6V1H;CLEC16A;ATP6V0D1;PAFAH1B2;SNX32;PRKAA1;PRKACA;RRAGB;MAPK8;CLN3;ULK1;ATP6V1G1;EXOC7;EXOC1;SH3GLB1;VPS26A
prerank,macroautophagy (GO:0016236),0.2189527851444728,0.6688413335694499,0.9623085983510011,0.9932401075567984,1.0,28/118,21.28%,WIPI2;VCP;ZFYVE1;BECN1;ATG3;HDAC10;VPS41;LIX1;CSNK2A2;CSNK2A1;SQSTM1;RB1CC1;ACBD5;TSG101;VIPAS39;AMBRA1;PRKAA1;TBC1D5;VPS37A;CLN3;ATG7;ULK1;HGS;STAM2;CHMP4A;CHMP4B;ATG16L1;LIX1L
prerank,axonal transport (GO:0098930),0.2639662479403255,0.6686709734528454,0.8824383164005806,0.9929693440957769,1.0,4/36,6.61%,AP3B1;PAFAH1B1;KIF1B;FBXW11
prerank,lipoxygenase pathway (GO:0019372),0.30508001543955904,0.667485775520835,0.8406040268456376,0.9937974030177934,1.0,1/14,3.86%,PON3
prerank,regulation of B cell activation (GO:0050864),-0.22947847115053244,-0.66729513566542,0.924791086350975,0.9950691863215033,1.0,5/25,18.58%,AHR;SH3KBP1;SAMSN1;TNFAIP3;TNIP2
prerank,tyrosine metabolic process (GO:0006570),-0.28135593220338984,-0.6666431401431999,0.8708920187793427,0.9947344539293674,1.0,11/11,71.89%,GSTZ1;DCT;IYD;IL4I1;HGD;TH;PAH;TAT;TYR;FAH;THAP4
prerank,microtubule polymerization or depolymerization (GO:0031109),0.2711357518961408,0.6662681172139987,0.8562691131498471,0.994691088504944,1.0,6/25,18.57%,HDGFL3;MAP7D3;FGF13;KIF2C;KIF18A;KIF2A
prerank,postreplication repair (GO:0006301),0.2473153380546513,0.6655745270976122,0.9097222222222222,0.9950049250379147,1.0,9/45,16.77%,UBE2B;VCP;USP10;TRIM25;RPA1;RFC5;REV1;POLD3;UBE2N
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.24452439083847138,-0.6654140669020927,0.8946078431372549,0.9948769475001278,1.0,8/19,27.84%,AQP4;CABYR;CFAP53;SPEF2;NPHP3;ROPN1L;DNAAF2;ODAD4
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.29999845821574367,0.6653227841400884,0.8481848184818482,0.9948171852243887,1.0,6/17,18.12%,NCKAP1;ARFIP1;BRK1;FCHSD2;GMFG;CYFIP1
prerank,defense response to tumor cell (GO:0002357),0.31903256039031463,0.6651932980364909,0.8530465949820788,0.9945118431113532,1.0,2/10,12.77%,KLF4;RBMS3
prerank,glutamate metabolic process (GO:0006536),0.28690563671743624,0.6651062043341451,0.858085808580858,0.9941682784989894,1.0,7/19,24.70%,GCLC;FPGS;GLUL;OAT;GOT1;GLS2;PRODH
prerank,antibacterial humoral response (GO:0019731),0.2960658913375601,0.6647533452689636,0.8555008210180624,0.9940947959259827,1.0,2/16,8.70%,SLPI;RNASE6
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.27939624689950265,0.664623908644423,0.8593996840442338,0.9937861536985347,1.0,10/24,22.88%,SEC24B;IDE;SEC13;ERAP1;SAR1B;SEC24A;SEC23A;HFE;FCER1G;BCAP31
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.3058987364616982,0.6644442993021296,0.8612040133779264,0.9935269540850842,1.0,5/14,22.48%,ETNK1;SELENOI;LPIN2;CEPT1;CHKB
prerank,telomere capping (GO:0016233),0.3021953453382711,0.6637573897832346,0.8664383561643836,0.993784484275328,1.0,5/16,19.95%,STN1;PRKDC;NBN;ACD;MRE11
prerank,pre-replicative complex assembly (GO:0036388),-0.18228045320893418,-0.6636455495947233,0.9585062240663901,0.995438804749149,1.0,21/64,30.71%,RPS27A;UBC;PSMB10;UBB;ORC4;PSME2;ORC6;PSMB3;PSMB4;PSMB8;PSMC5;MCM4;PSME1;PSMA7;PSMD5;PSMA6;PSMD9;MCM3;GMNN;CDC6;PSMA5
prerank,skeletal muscle contraction (GO:0003009),-0.24210524646695186,-0.6636433396231232,0.9152119700748129,0.9945557924400138,1.0,3/19,13.17%,STAC;RCSD1;MYH14
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.282058996105005,0.6634840321800748,0.878740157480315,0.9936434174572957,1.0,4/22,12.15%,IL10;TRPM4;TNFRSF1B;TNFRSF14
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.24080067850352493,-0.6633522554603786,0.9301075268817204,0.9939159396965075,1.0,3/20,14.43%,APOE;ACADL;NR1H4
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.24286533804283525,0.6629665927591262,0.908843537414966,0.9937667472054967,1.0,15/52,22.45%,SHC1;LMNA;DNAJC3;DNAJB11;ADD1;DDX11;ATP6V0D1;ERN2;WFS1;TPP1;TATDN2;DCTN1;VAPB;CUL7;SRPRA
prerank,cellular response to glucose starvation (GO:0042149),0.2556707284544665,0.6629342020502312,0.9008498583569405,0.9933652270105402,1.0,3/41,6.08%,FOXO3;BECN1;SIK2
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.3140254915306949,0.6629310206765117,0.8503401360544217,0.9929315022004706,1.0,4/13,18.44%,PIK3AP1;IRAK4;MYD88;IRAK1
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.27363681971640647,0.6623978221314187,0.8629032258064516,0.9931071430563555,1.0,1/25,1.46%,ANK2
prerank,mitotic chromosome condensation (GO:0007076),0.2750558696716273,0.6623063724623719,0.8667642752562226,0.9927523431414049,1.0,9/26,26.22%,SMC4;RB1;CSNK2A2;CSNK2A1;NCAPH2;CDK1;MCPH1;KMT5A;AKAP8L
prerank,DNA methylation or demethylation (GO:0044728),0.2897754386057018,0.6617756283397628,0.8637137989778535,0.9924519529426366,1.0,5/19,16.54%,BAZ2A;EHMT2;EHMT1;ATRX;DMAP1
prerank,DNA alkylation (GO:0006305),0.2897754386057018,0.6617756283397628,0.8637137989778535,0.9924519529426366,1.0,5/19,16.54%,BAZ2A;EHMT2;EHMT1;ATRX;DMAP1
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.2564738147660438,-0.6616453441757988,0.8705583756345178,0.9944684708991578,1.0,4/15,16.22%,SAMHD1;NLRC5;USP18;METTL3
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.2716117334859167,-0.6611768663238666,0.8833333333333333,0.9939773037098866,1.0,5/12,21.42%,EAPP;NELFCD;NELFA;LARP7;HNRNPU
prerank,miRNA metabolic process (GO:0010586),0.2895899692740031,0.6610001286021991,0.8616352201257862,0.9928184135294292,1.0,4/20,15.49%,DIS3L2;DDX17;RAN;DROSHA
prerank,positive regulation of cellular protein localization (GO:1903829),0.23039059417954633,0.6605057283361003,0.9312101910828026,0.9928820643772065,1.0,9/69,12.41%,LIMK2;GSK3B;DDRGK1;CENPQ;WWTR1;ENTR1;RIC3;EIF2AK3;TRAPPC12
prerank,negative regulation of ATPase activity (GO:0032780),0.2923135927627842,0.6601436790160716,0.8398692810457516,0.9928158247618777,1.0,1/16,5.96%,TNNI3
prerank,regulation of tau-protein kinase activity (GO:1902947),0.3242906418086874,0.6592561901022645,0.8351449275362319,0.9933083084695584,1.0,2/10,11.30%,CLU;RB1
prerank,rRNA transcription (GO:0009303),0.29003987972471734,0.65890557253619,0.8538587848932676,0.9932388300481356,1.0,8/17,32.19%,POLR1G;BRF1;GTF3C2;SIRT7;ANG;TAF1B;SPIN1;GTF3C3
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.30598905065539844,0.658278391027775,0.847571189279732,0.9934669280386007,1.0,4/13,23.90%,MOAP1;BNIP3;RHOT2;RHOT1
prerank,DNA integrity checkpoint signaling (GO:0031570),0.25591221430738226,0.6580478478615003,0.8868194842406877,0.9932527433156352,1.0,10/36,22.95%,ATM;CHEK2;RAD17;CHEK1;CEP63;CLSPN;NBN;ATR;RAD9B;HINFP
prerank,negative regulation of osteoclast differentiation (GO:0045671),-0.24328723561435095,-0.6579438305878453,0.8830845771144279,0.9956867343452439,1.0,9/18,37.14%,TLR3;MAFB;LILRB1;LILRB3;CARTPT;LRRC17;FBN1;IL4;TMEM178A
prerank,cellular response to exogenous dsRNA (GO:0071360),0.3084571865313902,0.6579272116185915,0.8373287671232876,0.9929300490912111,1.0,5/12,26.66%,MAVS;DHX9;MUL1;IFIH1;ZCCHC3
prerank,sno(s)RNA 3'-end processing (GO:0031126),-0.2838617924333469,-0.6578726734297574,0.8815489749430524,0.994874091103275,1.0,5/11,32.70%,TENT4B;LARP7;EXOSC3;EXOSC10;DKC1
prerank,regulation of protein targeting to membrane (GO:0090313),0.265384784668139,0.6577363114056345,0.8808777429467085,0.9926923404219509,1.0,10/28,22.29%,KCNB1;DMTN;C2CD5;ITGB1BP1;TCAF2;CHP1;MIEF1;FIS1;PRNP;ITGAM
prerank,autophagosome maturation (GO:0097352),0.2551380849382121,0.6575015077492995,0.8888888888888888,0.9924987243151216,1.0,5/32,13.64%,WIPI2;VCP;LIX1;TSG101;VIPAS39
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.32297785699353254,0.6570534103218385,0.8310344827586207,0.9925237162729414,1.0,3/10,21.23%,WDR1;CFL2;PDXP
prerank,RNA interference (GO:0016246),0.29536197350884713,0.6567400254308924,0.8538961038961039,0.9924277785161677,1.0,4/17,15.78%,CELF1;NRDE2;DROSHA;DHX9
prerank,positive regulation of telomerase activity (GO:0051973),0.25758108758301845,0.6563634169683191,0.9086892488954345,0.9923545020539143,1.0,8/33,20.77%,KLF4;NEK7;MAPK1;XRCC5;MAPK15;TCP1;ACD;NVL
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.24800247107739581,0.6562860807096005,0.8942028985507247,0.9920118083591236,1.0,12/41,21.17%,NUP93;EP300;SEC13;NUP188;RANBP2;ZBTB7A;NUP107;AAAS;RAE1;NUP54;NUP98;EIF6
prerank,apoptotic DNA fragmentation (GO:0006309),0.29301309332226005,0.656137221131627,0.8610169491525423,0.9917216064236778,1.0,3/16,10.08%,DNASE2B;KPNA1;DFFB
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.247476165361953,-0.6559990804436706,0.9280205655526992,0.9953995934066561,1.0,3/16,13.66%,RIF1;SMCHD1;CGAS
prerank,response to UV-B (GO:0010224),-0.2701647338887373,-0.6549642474982962,0.8888888888888888,0.9953285826394532,1.0,2/12,7.63%,CRIP1;MFAP4
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.280031104609427,0.6545353656353029,0.8575851393188855,0.9929158254881467,1.0,3/21,8.40%,HDGFL3;FGF13;SPEF1
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.27851590630512935,0.6539274177332398,0.8801261829652997,0.9930930312991898,1.0,3/21,7.70%,CRY2;GSK3B;BOD1L1
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),-0.2672874826402699,-0.6538025535839146,0.891156462585034,0.9953449263958054,1.0,1/13,1.23%,APOD
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.2614603242118312,0.653076178583848,0.8959537572254336,0.9935059633654894,1.0,13/34,24.15%,DUSP16;PTPN2;DUSP10;PTPRF;DUSP5;PTPN9;DUSP22;PTPN1;PTPN11;PTPN12;PTPN22;UBASH3B;PTPRQ
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),-0.22390122339112187,-0.6527175490144496,0.9212827988338192,0.9953681444362737,1.0,8/25,25.99%,SORT1;CHMP1A;CHMP4C;LEPROT;CHMP7;CHMP1B;TMEM50A;CHMP2B
prerank,intracellular pH reduction (GO:0051452),0.2575664172388972,0.6516585863055294,0.9066666666666666,0.994440867137192,1.0,7/33,19.26%,ATP6V0A4;ATP6V0A1;ATP6V0E1;ATP6V1H;ATP6V0D1;RAB7A;ATP6V1G1
prerank,RNA modification (GO:0009451),0.2387735831220747,0.6515977175149654,0.9311258278145695,0.9940646184749018,1.0,17/54,23.16%,CTU2;METTL1;ELP5;TYW5;MRM2;JMJD6;QTRT2;NSUN4;NOP2;MEPCE;QTRT1;TRDMT1;TRMT61A;PUS7;AARS1;URM1;FTSJ3
prerank,multivesicular body organization (GO:0036257),0.26179848699329616,0.6515274087913143,0.8895522388059701,0.9936979622082258,1.0,8/31,20.65%,PDCD6IP;IST1;TSG101;VPS37A;HGS;STAM2;CHMP4A;CHMP4B
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.24417500402439118,-0.6513722335243249,0.9248704663212435,0.9955120198521418,1.0,5/18,15.73%,TMEM14A;CHCHD10;BOK;HIP1R;GSK3A
prerank,positive regulation of signaling receptor activity (GO:2000273),0.2566991273128578,0.65033000513102,0.8927038626609443,0.9943960894775029,1.0,5/36,11.08%,ITGB1;ADRB2;IL10;NRP1;TAF1
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.28590074182476133,0.6490369592001223,0.8910256410256411,0.9951711822214587,1.0,2/18,5.50%,ITGB1;GOLPH3
prerank,pyrimidine-containing compound metabolic process (GO:0072527),-0.2812930678476508,-0.6488079024976794,0.8943820224719101,0.9965445769260391,1.0,3/11,15.14%,ENPP3;SLC19A3;SLC25A19
prerank,presynapse assembly (GO:0099054),0.2936628362335633,0.6484912817704768,0.8686868686868687,0.9952433308481454,1.0,1/16,1.71%,BSN
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.2560071268940437,0.648259721507204,0.8903508771929824,0.9950256477974888,1.0,4/30,12.04%,FUT8;UGGT2;ASGR2;DPM1
prerank,interstrand cross-link repair (GO:0036297),0.23799252864716067,0.6474700155937657,0.9425133689839572,0.9953680714384262,1.0,11/53,17.80%,VCP;FAAP24;RNF168;ERCC1;RPA1;RAD51AP1;FANCM;XPA;CENPX;USP1;MCM9
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.2723581573075697,0.6474597247332661,0.8746081504702194,0.9945096341602676,1.0,5/22,18.50%,ZDHHC11;ZDHHC23;ZDHHC15;GOLGA7;ZDHHC7
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.2723581573075697,0.6474597247332661,0.8746081504702194,0.9945096341602676,1.0,5/22,18.50%,ZDHHC11;ZDHHC23;ZDHHC15;GOLGA7;ZDHHC7
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),-0.26745505146050386,-0.6470538281739643,0.892271662763466,0.9969384624593115,1.0,5/12,27.98%,NINL;BICD2;CCDC68;CEP19;CCDC120
prerank,protein autoprocessing (GO:0016540),0.28405003123952827,0.6470088297092239,0.8612040133779264,0.9945023437479041,1.0,3/17,11.64%,TMPRSS2;MYRFL;OMA1
prerank,regulation of osteoclast differentiation (GO:0045670),0.25687910250287727,0.6467713793797767,0.9062027231467473,0.9943008354870747,1.0,9/33,24.01%,TNFSF11;MTOR;TLR4;CEBPB;CAMK4;PRXL2A;CCR1;TCTA;UBASH3B
prerank,megakaryocyte differentiation (GO:0030219),-0.27731445429803114,-0.6466431560527575,0.9069264069264069,0.9963832338236475,1.0,5/11,24.79%,KIT;TAL1;SH2B3;MED1;CDKN2B
prerank,regulation of oxidative phosphorylation (GO:0002082),-0.2521743410241668,-0.6463297858587876,0.9113924050632911,0.9957293253213189,1.0,6/16,23.46%,COX7A2;ATP7A;UQCC2;SLC25A33;NUPR1;SHMT2
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.3034318227868691,0.6461964177026823,0.8469565217391304,0.9943986181647283,1.0,2/13,6.99%,MOV10;CNOT7
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.24326628729961963,-0.6457979845672619,0.9252577319587629,0.9952516676777426,1.0,6/17,32.76%,LPGAT1;PLA2G4E;MBOAT7;PLA2G4C;PLA2G5;PLBD1
prerank,regulation of centriole replication (GO:0046599),0.28248489095414175,0.6455481707743778,0.8697068403908795,0.9945863190480201,1.0,4/18,12.88%,STIL;KAT2A;CEP295NL;KAT2B
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.29322968078407385,0.6453527666522753,0.8789808917197452,0.9943415906621543,1.0,5/18,22.29%,MCM7;GINS3;POLD3;POLA1;MCMDC2
prerank,regulation of programmed necrotic cell death (GO:0062098),0.27746934349956565,0.6444450964045657,0.8841269841269841,0.9947484827623049,1.0,2/20,4.80%,RIPK3;PDCD6IP
prerank,positive regulation of lymphocyte migration (GO:2000403),-0.2622051314013753,-0.6428178556172144,0.9020501138952164,0.9965037562378327,1.0,2/12,11.27%,CXCL12;APP
prerank,cellular response to amino acid stimulus (GO:0071230),0.2559094286585866,0.6426158855784111,0.9001447178002895,0.9960047738304874,1.0,4/33,10.44%,CAPN2;KLHL22;CASTOR2;MTOR
prerank,myelin maintenance (GO:0043217),0.3214318977753678,0.641918688747156,0.8499095840867993,0.9962471144145154,1.0,2/10,9.97%,CLU;CXCR4
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.2201287547962569,0.6418458352662947,0.9523809523809523,0.9958789877173886,1.0,21/86,24.36%,EGLN3;DDIT3;NFE2L2;EP300;CREBBP;HIF3A;CHEK1;PSMC6;PSMD8;INO80;PSMB1;PSMD13;PSMD1;PSMD7;PSMA8;PSMD3;PSMD2;PSMC2;PSMB2;HSPA1A;IMPACT
prerank,regulation of transposition (GO:0010528),0.3070331845132863,0.6416044653545185,0.8519134775374376,0.9956626928568783,1.0,3/13,23.56%,TDRD9;PIWIL4;SIRT7
prerank,dicarboxylic acid catabolic process (GO:0043649),0.29853073293643234,0.6415830021644319,0.875,0.9952566194706719,1.0,2/13,6.89%,QPRT;ACOT8
prerank,mitotic DNA replication (GO:1902969),0.322070145664572,0.6401083738138368,0.856140350877193,0.9961691446690044,1.0,5/10,27.65%,GINS3;POLA1;MCM6;MCMDC2;MCM2
prerank,gene silencing by miRNA (GO:0035195),0.2560671059212988,0.6396646099582318,0.9093525179856116,0.9961235638864985,1.0,8/32,17.88%,TNRC6C;MOV10;CNOT7;ZC3H7A;PUM2;RAN;PUM1;TNRC6A
prerank,positive regulation of translational initiation (GO:0045948),-0.23727246354528547,-0.6385004923800854,0.9212598425196851,0.9987030307260816,1.0,9/18,33.99%,UHMK1;RPS6KB1;EIF2B5;HABP4;POLR2G;BOLL;CDC123;CCL5;POLR2D
prerank,"synaptic transmission, cholinergic (GO:0007271)",-0.22822525195579463,-0.6382468144455845,0.9076517150395779,0.9979954475146497,1.0,3/19,13.39%,APOE;CHRFAM7A;CHRNA7
prerank,DNA-dependent DNA replication (GO:0006261),0.21034195432450134,0.6378982448143408,0.9758897818599311,0.9972814730289894,1.0,33/128,23.72%,REV3L;MCMBP;MCM7;NOC3L;RPA1;BAZ1A;RFC5;GINS3;POLD3;PSMC6;LRWD1;ORC5;PSMD8;POLG2;POLB;WRN;POLA1;PSMB1;PRIM2;PSMD13;PSMD1;PSMD7;WDHD1;PSMA8;PSMD3;RECQL5;MCM6;PSMD2;MCMDC2;PSMC2;RFC1;SIRT7;PSMB2
prerank,negative regulation of viral release from host cell (GO:1902187),0.2981783274319074,0.6378242027256485,0.8773747841105354,0.9969156016622868,1.0,5/13,26.96%,TRIM26;PML;TRIM35;MID2;TRIM28
prerank,positive regulation of double-strand break repair (GO:2000781),0.24480546493500666,0.6377035016651934,0.9114799446749654,0.9965906654190181,1.0,8/39,16.35%,FUS;SHLD1;MRNIP;RAD51AP1;KDM4D;DDX11;FOXM1;PRKDC
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.2233867182421633,-0.6374010220531849,0.9381720430107527,0.9977321698112008,1.0,2/23,8.27%,CALM1;NMT2
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.2773492008463592,0.6366026111517622,0.9040697674418605,0.9971334847809408,1.0,3/24,5.43%,PID1;NR4A3;COQ10B
prerank,tRNA processing (GO:0008033),0.2280444791547067,0.6365561903200864,0.953519256308101,0.996755495789231,1.0,27/61,31.48%,CTU2;METTL1;ELP5;TYW5;DDX1;TSEN54;QTRT2;TRMT10B;QTRT1;TRDMT1;TRMT61A;CPSF4;AARS1;URM1;POP1;CSTF2;RTCB;ELAC2;FARS2;KARS1;THG1L;TRPT1;ADAT1;PUS3;PTCD1;TRMT6;TSEN2
prerank,maturation of 5.8S rRNA (GO:0000460),0.28438191271978347,0.6357677787935828,0.8922829581993569,0.9970447805269615,1.0,8/17,23.16%,RPF1;RRP15;C1D;PRKDC;WDR12;EIF6;EXOSC4;FTSJ3
prerank,negative regulation of DNA recombination at telomere (GO:0048239),-0.23646999489835313,-0.6347288521882981,0.9329758713136729,0.9977970032753058,1.0,5/19,22.65%,POLR2K;TERF2IP;POLR2C;POLR2G;POLR2L
prerank,regulation of DNA recombination at telomere (GO:0072695),-0.23646999489835313,-0.6347288521882981,0.9329758713136729,0.9977970032753058,1.0,5/19,22.65%,POLR2K;TERF2IP;POLR2C;POLR2G;POLR2L
prerank,regulation of neurogenesis (GO:0050767),-0.1820858280853981,-0.6344193033832908,0.9786324786324786,0.9971506914402567,1.0,14/55,22.59%,TGM2;B2M;NOTCH1;HEY2;FAIM;CX3CR1;APPL2;NUMBL;BHLHE41;HEY1;HES6;DLL1;TRIM32;YAP1
prerank,mitochondrial gene expression (GO:0140053),0.24535670525141634,0.6342669640244835,0.9205479452054794,0.997926790000242,1.0,11/42,25.95%,FOXO3;GFM2;MRPL57;MRPS28;MRPL47;NDUFA7;MRPS24;MRPS18B;MRPS7;PTCD3;MRPS34
prerank,cellular response to virus (GO:0098586),0.2562416452831276,0.6336630104087452,0.9213973799126638,0.9980235585753365,1.0,11/30,27.66%,VWCE;CHUK;LGALS8;GBF1;FMR1;IFIH1;MAPK14;IRF3;IL6;ZC3H12A;ARF1
prerank,protein deneddylation (GO:0000338),0.30359718640278777,0.6336582976809455,0.8701298701298701,0.9975974820633802,1.0,2/10,14.03%,COPS7B;COPS5
prerank,nucleus organization (GO:0006997),0.23336563195627416,0.6336059048773166,0.9206128133704735,0.997215317256354,1.0,13/47,23.62%,NUP93;SUN3;PDCD6IP;PITPNB;TMEM170A;LEMD3;SYNE1;NUP54;CHMP4A;CHMP4B;NUP98;SUN2;USP36
prerank,modulation by host of viral genome replication (GO:0044827),0.29730244775933323,0.6334553881951606,0.8873720136518771,0.9969192276350743,1.0,4/13,22.40%,EIF2AK4;VAPA;TBC1D20;FMR1
prerank,neuron apoptotic process (GO:0051402),0.2754846404754562,0.633287281959818,0.8704,0.9966225226793394,1.0,4/19,12.81%,CIT;DIABLO;BNIP3;TRPC5
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.24200694528003078,-0.6326583528079605,0.9361111111111111,0.9975087337798233,1.0,6/17,26.87%,APOE;FGF1;ABCG1;ERLIN2;ABCA2;LPCAT3
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.25213355844602325,0.6323014974037826,0.913767019667171,0.9970679872283269,1.0,11/33,25.54%,TELO2;STN1;RPA1;PPP6R3;ANKRD28;ACD;PINX1;MRE11;PPP6C;RFC1;TERT
prerank,regulation of receptor recycling (GO:0001919),0.2825987807577915,0.6314735825143925,0.8573770491803279,0.9973835286517534,1.0,2/16,8.34%,ANXA2;NSF
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.2557545487753513,0.6311260839595034,0.9069069069069069,0.9972555971459757,1.0,8/29,15.55%,MNAT1;ERCC3;RPA1;XPA;CHD1L;CUL4A;RAD23B;XPC
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.23973204110617796,-0.6310381508518169,0.9445843828715366,0.9976796482080671,1.0,1/17,0.63%,LYN
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.3102739901393342,0.6308689911578246,0.8669064748201439,0.997056546271065,1.0,3/10,15.16%,TSKU;PLS1;IFT88
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.2603949145661997,0.6308022197120461,0.9053254437869822,0.9966918254721955,1.0,7/27,18.32%,ETNK1;SELENOI;ABHD4;NAAA;LPIN2;PLA2G15;CEPT1
prerank,macrophage migration (GO:1905517),-0.2567137808268304,-0.6307982949506421,0.9035294117647059,0.9969798190734667,1.0,6/13,34.82%,EDNRB;P2RY12;TAFA4;CCL2;CCL5;CXCL17
prerank,positive regulation of exocytosis (GO:0045921),0.24748803663922458,0.6302051728972927,0.9283625730994152,0.9967496530754169,1.0,10/35,20.26%,PDCD6IP;EXPH5;SYTL4;RAB27B;SDC4;TSG101;RAB5A;SDC1;RAB7A;HGS
prerank,peptidyl-asparagine modification (GO:0018196),0.24794957846727145,0.6298900033507969,0.9127906976744186,0.9965914156559813,1.0,4/31,12.04%,FUT8;UGGT2;ASGR2;DPM1
prerank,oogenesis (GO:0048477),0.28254306074492197,0.6297924029261683,0.8719611021069692,0.99625511261935,1.0,3/15,14.18%,IHO1;NANOS2;KMT2D
prerank,snRNA processing (GO:0016180),0.2841605631022991,0.6297601046175991,0.8809135399673735,0.9958558223561302,1.0,7/16,31.08%,INTS3;INTS8;INTS9;TOE1;INTS1;INTS2;INTS12
prerank,negative regulation of interleukin-2 production (GO:0032703),0.2741692775043125,0.6296742259902066,0.8985507246376812,0.9954971626192789,1.0,2/18,9.16%,EZR;KAT5
prerank,serine family amino acid catabolic process (GO:0009071),-0.2779627432684213,-0.6292129512036354,0.9111617312072893,0.9971721495856457,1.0,5/10,34.50%,SHMT2;GLDC;SHMT1;CBS;DAO
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.2450298322432053,0.6291156970696159,0.9278642149929278,0.9955497487310566,1.0,5/39,7.95%,TTC7A;IP6K2;SOCS2;SMG1;IP6K3
prerank,regulation of protein acetylation (GO:1901983),0.29429690407656045,0.6288675410770279,0.8769771528998243,0.9953369604701768,1.0,2/12,9.16%,GSK3B;KAT5
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.29895060799208073,0.6287952997993598,0.8581314878892734,0.9949720607286032,1.0,4/12,23.81%,FDX1;AKR1B1;STARD3NL;TSPOAP1
prerank,chromatin disassembly (GO:0031498),-0.2510861167500904,-0.6287394385855897,0.9114832535885168,0.9957311896888341,1.0,8/14,35.85%,SET;SMARCD1;SMARCE1;SMARCD3;SMARCB1;GRWD1;NFE2;HMGA1
prerank,nucleosome disassembly (GO:0006337),-0.2510861167500904,-0.6287394385855897,0.9114832535885168,0.9957311896888341,1.0,8/14,35.85%,SET;SMARCD1;SMARCE1;SMARCD3;SMARCB1;GRWD1;NFE2;HMGA1
prerank,mitochondrial fusion (GO:0008053),0.27717073761971367,0.6285569045620375,0.8951747088186356,0.9947523496380116,1.0,4/18,19.48%,SPG7;STOML2;MIEF1;FIS1
prerank,cellular response to ionizing radiation (GO:0071479),0.23514276330959508,0.6282130468970063,0.9431345353675451,0.9946132309194659,1.0,16/47,26.21%,TANK;ATM;KDM1A;RAD51AP1;KDM4D;XRCC5;TSPYL5;WRN;TLK2;INO80;ATR;RAD9B;TMEM109;CDKN1A;MAPK14;LIG4
prerank,positive regulation of macroautophagy (GO:0016239),0.23126076088415876,0.6279446081414888,0.9410187667560321,0.9944081201812299,1.0,14/48,25.00%,ADRB2;RAB3GAP2;LRSAM1;SMCR8;BNIP3;VPS13D;PAFAH1B2;FYCO1;SPTLC1;SH3GLB1;LARP1;WAC;SPTLC2;GNAI3
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.2836380117617263,0.6274675431519784,0.8873720136518771,0.9943971135990937,1.0,2/16,7.77%,WDTC1;ERLIN1
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.28936185335964854,0.6274506545610391,0.8693379790940766,0.9939915165238432,1.0,4/13,15.78%,TRIM44;MAVS;TAF9;DHX9
prerank,protein import into peroxisome matrix (GO:0016558),-0.2633238891260017,-0.6266517231104797,0.9158878504672897,0.9962200282069816,1.0,2/12,8.79%,PEX5L;PEX6
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.25485400325671803,0.6263147912638641,0.8990683229813664,0.9945386839044619,1.0,12/27,30.64%,ZC3H12D;RNASE6;LACTB2;NYNRIN;RNASEH1;POP1;TOE1;ZC3H12A;PARN;NUDT16;PCF11;XRN1
prerank,mitotic sister chromatid segregation (GO:0000070),0.21636842665865866,0.6261086341900804,0.9753390875462392,0.9942877994487923,1.0,19/98,20.65%,SMC4;PDCD6IP;KLHL22;BECN1;DIS3L2;KIF2C;RB1;CSNK2A2;CSNK2A1;PIBF1;SMC1A;RAN;NCAPH2;INO80;KIF18A;PINX1;TEX14;CHMP4A;CHMP4B
prerank,positive regulation of protein depolymerization (GO:1901881),-0.26238188522564976,-0.625942041425326,0.9150485436893204,0.9957744169334277,1.0,2/11,8.53%,NES;PLEK
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.27720376565991856,-0.6256813610503761,0.8941684665226782,0.9950849515604241,1.0,4/10,22.11%,MFSD2A;MTMR9;MTMR2;MTMR1
prerank,DNA replication checkpoint signaling (GO:0000076),0.28401883830455255,0.6252788147022871,0.8714285714285714,0.9945933463031652,1.0,16/16,71.63%,RAD17;CLSPN;RAD9B;DNA2;ORC1;TIPIN;TIMELESS;CDC45;RAD9A;CDT1;NAE1;TOPBP1;HUS1;TICRR;CDC6;HUS1B
prerank,synaptic vesicle localization (GO:0097479),-0.25259894489615276,-0.6247143877828634,0.9292682926829269,0.9948389924521979,1.0,5/13,25.16%,KIF5C;RAB27A;NLGN1;SNAPIN;CDK5
prerank,histone monoubiquitination (GO:0010390),0.2594343874187418,0.6245681418538549,0.9214175654853621,0.9947503712758052,1.0,9/24,26.06%,RNF2;CTR9;RNF168;PAF1;PCGF1;LEO1;WAC;RING1;CUL4B
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.30890540033066005,0.6241673602072855,0.8664259927797834,0.9946535160549842,1.0,2/10,13.73%,KAT5;FOXM1
prerank,mitochondrion distribution (GO:0048311),-0.25822205890934824,-0.6236418216964055,0.9092920353982301,0.9946297931923542,1.0,7/12,29.86%,LRRK2;MAPT;TRAK2;DNM1L;HAP1;CLUH;MTM1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.17060145791884412,-0.6234089844326416,1.0,0.9939194630869699,1.0,18/70,24.08%,B2M;CYBA;CALR;TAP2;PSMB10;PDIA3;MFSD6;PSME2;PSMB3;LNPEP;NCF2;PSMB4;PSMB8;FCGR1A;PSMC5;PSME1;PSMA7;PSMD5
prerank,membrane fusion (GO:0061025),0.2507690997192101,0.6228108816544683,0.9351032448377581,0.9953508164298399,1.0,9/33,19.08%,STX11;RABEP1;NSF;VAPA;SNAP23;RABIF;HUWE1;USO1;CHP1
prerank,purine nucleotide biosynthetic process (GO:0006164),-0.2548210291090211,-0.6227094015882304,0.9088729016786571,0.9935030651993509,1.0,3/12,17.97%,PRPSAP2;PRPS1L1;PRPS1
prerank,positive regulation of osteoclast differentiation (GO:0045672),-0.24673595434913226,-0.6223272723042531,0.9116279069767442,0.9928800546520131,1.0,2/14,10.90%,CSF1;ATP6AP1
prerank,RNA stabilization (GO:0043489),0.24463682073295787,0.6219888781520152,0.920863309352518,0.9955792022088156,1.0,10/33,22.77%,GDNF;FUS;TENT5D;VIP;TAF15;TENT5C;PABPC1;TRDMT1;EIF4ENIF1;LARP1
prerank,defense response to fungus (GO:0050832),0.2781709150283047,0.6219619193706419,0.8719211822660099,0.9951783552026361,1.0,4/17,19.82%,BCL10;FAM3A;CLEC6A;RNASE7
prerank,positive regulation of ATPase activity (GO:0032781),0.23555289229694426,0.6217799999983131,0.926829268292683,0.9949021411103849,1.0,3/41,5.80%,ATP1B1;TOR1AIP1;PLSCR1
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.30198286944471575,0.6210590596005209,0.8942652329749103,0.9950728206867149,1.0,2/11,13.73%,KAT5;FOXM1
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.2621787018233007,0.6204412094509377,0.9145569620253164,0.9951492486405593,1.0,7/22,24.10%,TCERG1;SCAF8;THOC5;CDK12;CCNT1;LEO1;ALYREF
prerank,phagosome-lysosome fusion (GO:0090385),-0.26826598293616377,-0.6200179949441325,0.9137168141592921,0.9934479782584117,1.0,2/10,8.88%,SYT7;ARL8B
prerank,chromosome condensation (GO:0030261),0.2440733322830602,0.6197781437458426,0.9206798866855525,0.995258685294479,1.0,14/36,28.59%,SMC4;DFFB;RB1;CSNK2A2;CSNK2A1;ERN2;NCAPH2;CDK1;MCPH1;AIFM1;KMT5A;AKAP8L;NCAPD3;ACIN1
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.28751625412791004,0.6182770905940604,0.8867924528301887,0.9960099002807855,1.0,3/13,21.30%,PVR;CYRIB;FADD
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.2968928446595819,0.6182208093514745,0.9001814882032668,0.9956253411698786,1.0,2/11,12.11%,GATA4;REST
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.2609393654513605,-0.6177448667872635,0.9232456140350878,0.993934995489784,1.0,7/11,41.35%,IL6ST;STAT1;CANX;IL27RA;IL12A;JAK1;EBI3
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.2481899009505833,-0.6175621081730459,0.9249394673123487,0.9932022570430338,1.0,10/15,41.18%,IQGAP2;TRIM27;ARPC3;ARPC5L;ARPC1A;ACTR2;ARPC4;JMY;ARPC5;MAGEL2
prerank,cell cycle checkpoint signaling (GO:0000075),0.2898487036223242,0.616581584876503,0.903448275862069,0.9965138950502483,1.0,12/12,71.04%,PRCC;CHFR;ZWILCH;WEE1;NABP1;ZW10;ZWINT;NABP2;WEE2;PLK2;BUB1;BUB1B
prerank,defense response to Gram-positive bacterium (GO:0050830),-0.1886581089582652,-0.6164914726499459,0.9739776951672863,0.9929864829631995,1.0,8/40,17.92%,GBP7;DEFA6;GBP4;PGLYRP1;RPL39;GBP2;TIRAP;GSDMD
prerank,midbody abscission (GO:0061952),-0.23106331519072554,-0.6158948845603531,0.93048128342246,0.9924807195480925,1.0,8/17,30.46%,CHMP1A;CHMP4C;CHMP7;CEP55;CHMP1B;CHMP2B;KIF20A;VPS4A
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.21563121926569565,0.6152646001003222,0.970360824742268,0.9971071103041652,1.0,13/72,14.44%,DXO;IHO1;RNASE6;ERCC3;ERCC1;RPA1;XPA;RFC5;CHD1L;CUL4A;EXD2;POLD3;DDX1
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.25593145079497437,0.6151150957865591,0.9184339314845025,0.996807869976938,1.0,9/24,22.29%,KCNB1;C2CD5;ITGB1BP1;TCAF2;CHP1;MIEF1;FIS1;PRNP;ITGAM
prerank,negative regulation of hormone secretion (GO:0046888),0.3024651684031273,0.6150630709977915,0.9079189686924494,0.9964240529740842,1.0,1/10,6.93%,RAB11FIP3
prerank,protein prenylation (GO:0018342),-0.27090761717839473,-0.6146766276535944,0.9206349206349206,0.9923246273169258,1.0,1/10,5.82%,PTAR1
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.29646634482243206,0.614312649523569,0.9032258064516129,0.9965775919177985,1.0,3/11,22.29%,MAVS;CAMK4;ITGAM
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.2624556227681555,0.6141806561497092,0.919672131147541,0.9962459942254074,1.0,9/22,29.85%,HNF1A;MED14;PSMC6;MED17;PSMC2;MED12;ESR1;PSMC4;MED13
prerank,histone H3-K4 methylation (GO:0051568),0.2556627186591644,0.6129615811088462,0.912781954887218,0.9967426477708885,1.0,6/26,20.94%,CTR9;KMT2C;KMT2D;ASH2L;SETD1B;KMT2A
prerank,negative regulation of activated T cell proliferation (GO:0046007),-0.26854213098689794,-0.612582359334898,0.930648769574944,0.992680668985826,1.0,1/10,8.99%,PRKAR1A
prerank,regulation of neuroblast proliferation (GO:1902692),-0.23821045423001244,-0.6120692696389144,0.9427860696517413,0.9921413109939101,1.0,6/15,24.17%,LRRK2;CX3CR1;TAFA1;VEGFA;PTN;SMARCD3
prerank,heme biosynthetic process (GO:0006783),0.2629111487174415,0.6120665878596734,0.9248,0.9970092004526769,1.0,1/22,2.82%,ABCG2
prerank,positive regulation of sodium ion transport (GO:0010765),-0.25311130900896006,-0.6108547917228284,0.8881431767337807,0.991975037540927,1.0,5/12,26.18%,ANK3;NOS1;SCN3B;SCN4B;SCN1B
prerank,regulation of store-operated calcium entry (GO:2001256),0.2983933509711482,0.6107904540232891,0.8830715532286213,0.9975842043213958,1.0,4/10,18.49%,HOMER2;SLC8B1;HOMER1;GRAMD2A
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.25304613192935305,0.608729946394115,0.9122257053291536,0.998683079629308,1.0,5/25,11.30%,GATA1;PER2;GATA3;NIBAN2;RB1
prerank,regulation of receptor internalization (GO:0002090),0.23124905297915951,0.6086200289133945,0.9279661016949152,0.9983431766744933,1.0,11/35,22.40%,LRPAP1;MKLN1;RIN3;TBC1D5;ANKRD13D;ATXN2;ANGPT1;DLG4;SFRP4;EGF;FMR1
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.24621065137621567,0.6084373226741825,0.926829268292683,0.9980586422886077,1.0,12/30,26.46%,KIF13A;GOLPH3;NSF;GGA2;GOLGA7;ARFRP1;SYS1;VAMP4;GOLGA4;BBS2;RAB10;SEC16A
prerank,positive regulation of interleukin-1 production (GO:0032732),0.22511670279356139,0.6083239520220549,0.9635627530364372,0.9977261188084163,1.0,8/51,14.20%,ISL1;RIPK2;TLR6;TLR4;IL16;CD36;STAT3;TRIM16
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.252303593567118,0.6078054152910981,0.916256157635468,0.9976809965538623,1.0,9/25,23.20%,PRPF3;SF3B1;SRRM1;SCAF11;TRA2B;GEMIN2;PRPF6;TXNL4A;SNRNP40
prerank,RNA methylation (GO:0001510),0.21585132064494553,0.6071878631194828,0.9640564826700898,0.9977203490692964,1.0,16/60,23.67%,TRMT13;METTL6;METTL1;MRM2;MTO1;GTPBP3;NSUN4;ZCCHC4;NOP2;MEPCE;TRDMT1;ALKBH8;TRMT61A;TRMT12;FTSJ3;PCIF1
prerank,mitotic cytokinetic process (GO:1902410),-0.218108607025929,-0.6068271100227091,0.9539295392953929,0.9934434893171546,1.0,9/20,30.46%,KLHDC8B;CHMP1A;CHMP4C;CHMP7;CEP55;CHMP1B;CHMP2B;KIF20A;VPS4A
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.24871368583873557,0.6058156410187815,0.9328467153284672,0.9982976189189953,1.0,9/27,25.71%,CTPS2;RRM2;AK9;NUDT13;CMPK1;GSR;AK5;AK6;DTYMK
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.23517078038176484,0.6048129094846566,0.9433139534883721,0.9986234360490118,1.0,8/37,14.34%,ERCC3;ERCC1;RPA1;XPA;RFC5;CHD1L;CUL4A;POLD3
prerank,P-body assembly (GO:0033962),0.28802812480381695,0.6043627587482331,0.8875219683655536,0.9985362727508476,1.0,12/12,71.22%,EDC3;ATXN2;EIF4ENIF1;DYNC1H1;LSM4;LSM14A;RC3H1;LIMD1;LSM3;DDX6;PATL1;PATL2
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.2604000547284551,0.6025451741532468,0.9286775631500743,0.9994249555387875,1.0,6/23,24.25%,SAMM50;MOAP1;HSPA4;TIMM10B;AGK;TIMM29
prerank,rRNA 3'-end processing (GO:0031125),0.2935736077816642,0.6024480324654434,0.8952879581151832,0.9990664525295978,1.0,2/10,9.85%,ERI3;EXOSC7
prerank,microtubule anchoring (GO:0034453),-0.25289218717829753,-0.6023430008037183,0.9198113207547169,0.994970380047798,1.0,8/12,44.50%,CLASP2;BICD2;PEX14;DAG1;SAXO2;BCCIP;BICD1;SAXO1
prerank,amyloid precursor protein catabolic process (GO:0042987),-0.24077340055024213,-0.6022393398237779,0.9336870026525199,0.994180655838132,1.0,7/14,33.72%,ABCG1;APH1B;PSENEN;ADAM19;APH1A;NCSTN;ABCA7
prerank,nucleotide-sugar biosynthetic process (GO:0009226),-0.2200454918393235,-0.6016935497084969,0.9516129032258065,0.9936423181387202,1.0,2/19,5.56%,UGDH;SLC35D1
prerank,chromatin remodeling at centromere (GO:0031055),-0.19593996481160286,-0.6011159715680258,0.9701986754966887,0.9931148906203334,1.0,16/31,39.47%,RUVBL1;CENPP;KNL1;MIS18BP1;HELLS;CENPI;CENPV;CENPA;NPM1;MIS18A;CENPL;ITGB3BP;CENPN;CENPM;RSF1;CENPS
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.2594450353261848,0.6010380628550752,0.9046052631578947,0.9996223747004629,1.0,3/18,13.66%,COA8;COX16;SCO2
prerank,ncRNA catabolic process (GO:0034661),0.24405390041218802,0.6009376498233577,0.9218289085545722,0.9992628146105675,1.0,12/28,31.14%,ZCCHC8;EXOSC7;DIS3L2;ERN2;EXOSC5;EXOSC4;POP1;NUDT16L1;PARN;NUDT16;XRN1;DEDD2
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.25608881796034466,-0.5998897746528604,0.9227373068432672,0.9929195159640696,1.0,1/10,8.02%,MALT1
prerank,striated muscle cell differentiation (GO:0051146),0.26876068343126386,0.5992412656380555,0.918918918918919,1.0,1.0,5/16,18.13%,AKAP13;SKI;KDM6B;MYEF2;SDC1
prerank,secondary alcohol biosynthetic process (GO:1902653),0.24012672613883548,0.5992094135069465,0.9431988041853513,0.9996275063260751,1.0,8/30,20.81%,MVD;FDPS;LBR;EBP;FDFT1;HMGCR;ARV1;DHCR7
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.23694395883494898,0.5986143850093549,0.9318840579710145,0.9996076980408766,1.0,5/34,12.15%,IL10;CLCF1;TNFRSF4;GPI;TNFRSF14
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.2871895963841871,0.598140788887271,0.8973913043478261,0.9994953700311913,1.0,5/11,24.49%,PAF1;ZFP36L1;LEO1;NCBP2;AHCYL1
prerank,mRNA splice site selection (GO:0006376),0.24205255768187034,0.5973415137586247,0.9414483821263482,0.9996109857020339,1.0,9/30,21.32%,LUC7L2;CELF1;SRSF5;SRSF6;SRSF12;SFSWAP;NOL3;LUC7L;PSIP1
prerank,tRNA aminoacylation (GO:0043039),0.23407711903320838,0.5958796141746231,0.9429763560500696,1.0,1.0,2/37,7.64%,WARS2;YARS1
prerank,proteasome assembly (GO:0043248),0.2923524155473368,0.5956645042102768,0.8840336134453781,0.999940705316317,1.0,3/11,19.48%,PSMG2;PSMG1;PSMD13
prerank,negative regulation of protein transport (GO:0051224),0.24627294050340287,0.5955314426765845,0.9354354354354354,0.9996144236747577,1.0,4/25,12.65%,WWP2;DRD3;CSK;SNX12
prerank,regulation of cell aging (GO:0090342),-0.2509672144182552,-0.5952371081660005,0.923963133640553,0.9943672024039998,1.0,5/11,22.31%,NUAK1;VASH1;MIF;ING2;NEK4
prerank,presynaptic endocytosis (GO:0140238),0.24807125034172609,0.5940254710772059,0.9095238095238095,1.0,1.0,2/24,4.30%,STON1;SYT8
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.28465927745775355,0.5938769188683056,0.9130434782608695,0.9998874123706427,1.0,2/12,6.10%,NR4A3;IRS1
prerank,protein lipidation (GO:0006497),0.21417679746802687,0.5938437876423218,0.9624161073825503,0.9994951148820033,1.0,14/59,19.16%,WIPI2;PIGB;PIGL;PIGU;PIGN;ZDHHC23;DPM1;ZDHHC5;ZDHHC15;GLUL;PIGH;PGAP2;ZDHHC7;ATG7
prerank,replication fork processing (GO:0031297),0.23091471047650822,0.5929612220783984,0.9410029498525073,0.999642121374947,1.0,10/38,21.73%,BOD1L1;BRCA2;FANCM;EXD2;DDX11;CENPX;ATRX;WRN;MRE11;ATR
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.23658052734283785,-0.5927659080338775,0.9308755760368663,0.9947342657214449,1.0,1/12,4.92%,APOBEC1
prerank,positive regulation of secretion (GO:0051047),0.28639281348615253,0.5926550468032704,0.9182608695652174,0.9994337849360994,1.0,1/11,5.14%,ACSL3
prerank,positive regulation of viral transcription (GO:0050434),0.24892039128182425,0.5924429818678381,0.9385826771653544,0.9991469997250293,1.0,5/25,18.62%,MDFIC;GTF2F2;DHX9;NELFE;POLR2H
prerank,alpha-amino acid metabolic process (GO:1901605),0.22190028776343826,0.5909342790480259,0.9561042524005487,0.9997038190496393,1.0,14/45,25.87%,HNF4A;PYCR1;GADL1;KYAT1;GNMT;GLUL;MTHFR;SLC25A12;OAT;GOT1;FOLH1;GLS2;MTRR;DPEP1
prerank,mitochondrial genome maintenance (GO:0000002),0.2860840085256405,0.588296768191187,0.912739965095986,1.0,1.0,5/11,21.86%,MEF2A;TOP3A;LONP1;SLC25A36;MPV17
prerank,protein targeting (GO:0006605),0.19059574441067118,0.5876788677517673,0.9905771495877503,1.0,1.0,26/118,19.91%,ZDHHC11;GIPC1;LTBP2;AP4E1;HACL1;ATG3;SEC63;HPS4;AP4B1;PARD3;ZDHHC23;DNAJC19;PITRM1;ZDHHC15;TIMM17B;GOLGA7;CHM;VPS37A;AP4M1;ZDHHC7;PEX12;TIMM10B;FIS1;PEX16;RABGEF1;LONP2
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.24989308105149405,0.586029017331563,0.9487577639751553,1.0,1.0,4/23,18.17%,PLA2G4F;ABHD4;PLA2G4A;MBOAT1
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),-0.23682851574407618,-0.5857642870683337,0.9473684210526315,0.9972369432295016,1.0,2/13,6.29%,NR1H3;AQP11
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),-0.2110626089092903,-0.5842100695223482,0.9621621621621622,0.9970752210997903,1.0,6/20,24.58%,AGO1;AGO4;TARBP2;SPOUT1;MRPL44;ZC3H7B
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.25771706830013935,0.5831057038228319,0.9106858054226475,1.0,1.0,8/18,29.63%,WDR43;EIF2AK3;WDR75;FLNA;SIRT7;HEATR1;ERBB2;UTP15
prerank,mitotic recombination (GO:0006312),0.2632460255580078,0.5817885469652866,0.910472972972973,1.0,1.0,4/15,18.20%,RAD52;ERCC1;NSMCE2;SMC5
prerank,establishment of spindle localization (GO:0051293),0.2714486226943937,0.5806255925480813,0.9324324324324325,1.0,1.0,1/14,4.42%,TLE6
prerank,phagolysosome assembly (GO:0001845),-0.24203881146322342,-0.5806182637084311,0.9417249417249417,0.9977870356805443,1.0,6/12,32.29%,SYT7;ARL8B;RAB14;RAB20;PLA2G5;RAB39A
prerank,regulation of ATP metabolic process (GO:1903578),0.20998818894981647,0.579535376784912,0.9823609226594301,1.0,1.0,14/54,21.17%,NUP93;EP300;SEC13;NUP188;RANBP2;COX7A1;ZBTB7A;NUP107;AAAS;FIS1;RAE1;NUP54;NUP98;EIF6
prerank,mitotic metaphase plate congression (GO:0007080),0.21635607575111676,0.5791632091195026,0.9675675675675676,1.0,1.0,16/51,29.13%,PDCD6IP;BECN1;RMDN1;KIF2C;PIBF1;KIF18A;PINX1;CHMP4A;CHMP4B;CENPC;SPDL1;CHAMP1;CHMP5;KIF14;NUDC;CUL3
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.24759644326343438,-0.5786912025964412,0.9391100702576113,0.9977981361969446,1.0,3/11,25.56%,NOS1AP;TREM2;AKAP6
prerank,RNA transport (GO:0050658),0.2052616093174484,0.5781695706004237,0.9856770833333334,1.0,1.0,26/71,27.50%,TGFBR2;U2AF1L4;CASC3;SRSF5;NUP188;SRSF6;NXF1;SRRM1;THOC2;RBM8A;SRSF11;THOC5;ZFP36L1;ATXN2;ZC3H11A;CHTOP;RAE1;FMR1;SIDT2;ALYREF;NCBP2;UPF3B;SRSF7;XPO5;NUP153;PNPT1
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.2219083461103742,0.5774504416657952,0.9670014347202296,1.0,1.0,8/40,17.80%,BOD1L1;FANCM;EXD2;DDX11;CENPX;ATRX;WRN;MCM9
prerank,nucleic acid-templated transcription (GO:0097659),0.21621311090078996,0.5748220096417058,0.972027972027972,1.0,1.0,9/42,20.19%,MEF2A;NR4A2;BAZ2A;PPP5C;THAP1;EPC1;CREBL2;POLR2H;HOXD3
prerank,positive regulation of interleukin-10 production (GO:0032733),0.23320938304845745,0.5745217691989873,0.9459041731066461,1.0,1.0,4/30,12.58%,CD46;TLR4;STAT3;PIBF1
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.21634698916933537,0.573822377238371,0.9641379310344828,1.0,1.0,8/45,16.70%,ISL1;RIPK2;TLR6;TLR4;CD36;STAT3;TRIM16;MYD88
prerank,spliceosomal snRNP assembly (GO:0000387),0.22157076312184587,0.5737187906773282,0.9622641509433962,1.0,1.0,14/38,28.52%,PRPF3;SRSF12;LSM2;SNRPD3;USP4;GEMIN8;GEMIN2;PRPF6;SNRPD2;SNRPD1;SNRPE;COIL;SART1;PRPF31
prerank,stress granule assembly (GO:0034063),0.24870157449789712,0.5729430165496687,0.9420289855072463,1.0,1.0,8/20,28.55%,PRRC2C;YTHDF3;ATXN2;YTHDF2;CSDE1;YTHDF1;CIRBP;DYNC1H1
prerank,steroid catabolic process (GO:0006706),0.2809341820915786,0.5728866297375961,0.9113475177304965,1.0,1.0,2/10,10.46%,CYP27B1;CYP19A1
prerank,regulation of interleukin-6 production (GO:0032675),0.19255592583348088,0.5723525407401484,0.9878787878787879,1.0,1.0,11/96,12.38%,LBP;ISL1;IL10;MAVS;TLR6;IL17RA;BCL10;RAB7B;TLR4;IL16;STAT3
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.2693361914326652,0.5723397799214773,0.9232081911262798,1.0,1.0,3/12,17.86%,CHEK2;RAD17;CLSPN
prerank,protein targeting to mitochondrion (GO:0006626),0.2112964223636739,0.5716294060709957,0.9812583668005355,1.0,1.0,17/52,26.83%,SAMM50;PMPCB;DNAJC19;IMMP1L;PITRM1;TIMM17B;HSPA4;TIMM10B;FIS1;AGK;BCAP31;AIFM1;TIMM29;TOMM34;TIMM23;TOMM20;GRPEL2
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.2703526263535144,0.5711121248934744,0.92573402417962,1.0,1.0,4/12,27.84%,PLK3;PRKDC;WAC;RFWD3
prerank,isotype switching (GO:0045190),0.27613538881009264,0.5710596865340577,0.9132007233273056,1.0,1.0,1/10,9.20%,RNF168
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.26671561292368307,0.5689113331902502,0.9189655172413793,1.0,1.0,4/13,20.31%,ALG13;ALG14;ALG9;ALG3
prerank,2-oxoglutarate metabolic process (GO:0006103),0.2623288379088489,0.5687115259736999,0.9142857142857143,1.0,1.0,3/13,19.90%,D2HGDH;OGDH;GOT1
prerank,regulation of microtubule depolymerization (GO:0031114),0.2383883853567525,0.5682186168635432,0.968798751950078,1.0,1.0,4/25,12.94%,HDGFL3;FGF13;SPEF1;MAP1B
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.22478329070502212,0.5670566225387008,0.9629101283880172,1.0,1.0,4/30,12.58%,PRKCD;PTPN2;DMTN;PIBF1
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.23040845975994223,0.5664744887631653,0.9525316455696202,1.0,1.0,5/26,14.76%,ANAPC5;CDC16;RB1;NSMCE2;RIOK2
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.2378061497215374,0.5663269002874167,0.9517884914463453,1.0,1.0,1/24,2.82%,ABCG2
prerank,protein destabilization (GO:0031648),0.22496106630192853,0.5663195253686379,0.9676945668135095,1.0,1.0,4/32,7.81%,GSN;EP300;FBXW11;CREBBP
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.21400360017090708,-0.5645606407193317,0.9725,1.0,1.0,4/17,24.95%,MMGT1;EMC3;GET4;EMC8
prerank,positive regulation of cellular respiration (GO:1901857),0.27106010726319046,0.5645288737449162,0.9206349206349206,1.0,1.0,1/11,4.82%,VCP
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.2569674418648826,0.56246138553236,0.945,1.0,1.0,7/16,29.57%,SRSF12;SFSWAP;PSIP1;NCBP2;SART1;SNRNP200;WBP4
prerank,covalent chromatin modification (GO:0016569),-0.22563236738752288,-0.562070376328667,0.9694117647058823,1.0,1.0,3/14,19.50%,MBD2;PARK7;HELLS
prerank,transferrin transport (GO:0033572),0.22195603521269727,0.5617964646238879,0.9722627737226277,1.0,1.0,8/33,20.05%,ATP6V0A4;ATP6V0A1;ATP6V0E1;ATP6V1H;ATP6V0D1;MCOLN1;ATP6V1G1;HFE
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.26034640223269445,0.5617740762390108,0.9281045751633987,1.0,1.0,4/14,23.16%,ZNHIT3;WDR12;DDX18;FTSJ3
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.22881934424655226,0.5607340982957998,0.9657228017883756,1.0,1.0,2/29,6.99%,P3H4;IHO1
prerank,sensory perception of pain (GO:0019233),-0.20092472256960503,-0.5603549921478104,0.983957219251337,1.0,1.0,1/21,1.34%,RETREG1
prerank,regulation of primary metabolic process (GO:0080090),0.18471455544873344,0.5596712873159299,0.9977011494252873,1.0,1.0,34/126,24.53%,TNFAIP8L3;CHD9;HNF4A;TBL1X;SCD;CREBBP;MVD;FDPS;NFYA;RXRA;PLPP1;FDFT1;CARM1;PSMC6;IRS2;PSMD8;HMGCR;ADIPOR1;AZIN1;LACTB;PSMB1;PSMD13;LDLR;PSMD1;PSMD7;PSMA8;DHCR7;PSMD3;PSMD2;PSMC2;PPARG;PSMB2;HMGCS1;NCOR1
prerank,protein localization to kinetochore (GO:0034501),-0.2214478558422804,-0.5589875372151943,0.972568578553616,1.0,1.0,14/14,77.88%,KNL1;TTK;IK;AURKB;MIS12;MTBP;ZW10;RCC2;CENPT;BUB3;CHAMP1;ZWILCH;SPDL1;CDK1
prerank,regulation of protein metabolic process (GO:0051246),0.2096118458740227,0.5589204831017859,0.9832167832167832,1.0,1.0,12/44,21.60%,KLF4;CHEK2;LTBP4;PARL;MAP2K5;SPOP;FAF1;MAPK8;WFS1;LDLR;HGS;TRAF3
prerank,mucosal immune response (GO:0002385),-0.21405815891682722,-0.557621227239206,0.9693396226415094,1.0,1.0,2/15,10.80%,DEFA6;RPL39
prerank,primary miRNA processing (GO:0031053),0.2689481243907292,0.5572147969642447,0.9163822525597269,1.0,1.0,4/10,22.94%,PUS10;DROSHA;SRRT;SMAD2
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.2641915005789533,0.5571206855677082,0.9222797927461139,1.0,1.0,1/11,8.83%,CBFB
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.2326223784514045,0.5566813188823043,0.9537037037037037,1.0,1.0,5/23,19.40%,PLK3;CHEK1;INTS3;PRCC;CHFR
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.26433335234100575,0.5552534966197465,0.9279279279279279,1.0,1.0,4/12,25.11%,RMDN1;KIF2C;CENPC;CHAMP1
prerank,regulation of DNA damage checkpoint (GO:2000001),0.279406727959583,0.5547145842664162,0.918625678119349,1.0,1.0,4/10,27.84%,THOC5;FEM1B;WDR76;RFWD3
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.2633417429585722,0.5542925238325097,0.935042735042735,1.0,1.0,2/13,7.71%,PLXNA2;NRP1
prerank,regulation of endocytic recycling (GO:2001135),0.2624694474524245,0.5525495706184933,0.926056338028169,1.0,1.0,4/11,22.63%,EHD1;ATP9A;EHD2;ARHGAP1
prerank,negative regulation of defense response to virus (GO:0050687),0.265022631650485,0.5522093884852288,0.9278350515463918,1.0,1.0,6/10,32.33%,TRAF3IP1;RNF26;MUL1;ILRUN;PPM1B;ITCH
prerank,cellular response to interferon-beta (GO:0035458),0.25332437603160507,0.551823708664058,0.941747572815534,1.0,1.0,2/14,11.24%,ACOD1;IRF1
prerank,regulation of response to interferon-gamma (GO:0060330),0.2529670835594929,0.5510504746366529,0.9448160535117057,1.0,1.0,5/14,24.91%,PTPN2;PIAS1;SUMO1;IFNGR2;IFNGR1
prerank,cellular response to dsRNA (GO:0071359),0.2491237361203071,0.5492107823175296,0.9366666666666666,1.0,1.0,5/15,26.66%,MAVS;DHX9;MUL1;IFIH1;ZCCHC3
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.22416384161446978,0.5490746443277771,0.9548762736535662,1.0,1.0,5/29,17.46%,ABL1;DCUN1D4;UBE2N;FEM1B;FEM1A
prerank,synaptonemal complex organization (GO:0070193),0.2517341108838566,0.5485937609465966,0.9263322884012539,1.0,1.0,1/15,5.74%,P3H4
prerank,synaptonemal complex assembly (GO:0007130),0.2517341108838566,0.5485937609465966,0.9263322884012539,1.0,1.0,1/15,5.74%,P3H4
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.1868435813831794,-0.546484837706414,0.9783783783783784,1.0,1.0,8/24,27.56%,RPS27A;UBC;UBB;POLD1;RFC2;LIG1;RPA3;POLD2
prerank,resolution of meiotic recombination intermediates (GO:0000712),-0.2080945139412569,-0.5459767761212684,0.9639423076923077,1.0,1.0,1/16,2.87%,TOP2B
prerank,cellular senescence (GO:0090398),0.22641054260929647,0.545029755336457,0.9675425038639877,1.0,1.0,5/27,18.20%,PRKCD;ECRG4;NSMCE2;PML;SMC5
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.23782281063520577,0.544964312331977,0.9521452145214522,1.0,1.0,3/15,14.76%,CDC16;TACC3;RIOK2
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.199495052274935,0.5449109635422804,0.9778085991678225,1.0,1.0,12/48,21.17%,NUP93;EP300;SEC13;NUP188;RANBP2;ZBTB7A;NUP107;AAAS;RAE1;NUP54;NUP98;EIF6
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.21474269176382466,-0.5446709376225484,0.9708029197080292,1.0,1.0,4/15,25.80%,ERN1;RTRAF;TSEN15;TSEN34
prerank,pigment granule transport (GO:0051904),0.23806922615874415,0.5427123430939094,0.9463414634146341,1.0,1.0,3/18,15.41%,MLPH;RAB27B;RAB17
prerank,melanosome transport (GO:0032402),0.23806922615874415,0.5427123430939094,0.9463414634146341,1.0,1.0,3/18,15.41%,MLPH;RAB27B;RAB17
prerank,negative regulation of intracellular protein transport (GO:0090317),-0.18900027305588218,-0.5426356410104155,0.9826302729528535,1.0,1.0,5/22,21.53%,APOD;LRRK2;SP100;PARK7;INPP5K
prerank,nuclear membrane organization (GO:0071763),0.2380871798479484,0.5424816297663756,0.9615975422427036,1.0,1.0,8/19,29.47%,TOR1AIP1;DCTN1;CHMP4B;TOR1B;AKAP8L;TARDBP;NSFL1C;TMEM43
prerank,regulation of mitotic spindle assembly (GO:1901673),0.23412909428093626,0.5411300524332453,0.9575163398692811,1.0,1.0,6/19,27.02%,PDCD6IP;CEP97;CHMP4B;HSPA1A;CCSAP;CHMP5
prerank,snRNA 3'-end processing (GO:0034472),0.23566441211271014,0.5408400299186472,0.9579288025889967,1.0,1.0,7/19,28.61%,EXOSC7;INTS8;EXOSC5;EXOSC4;TOE1;INTS1;INTS2
prerank,synaptic vesicle transport (GO:0048489),-0.22693064879788666,-0.5391676310434417,0.9654377880184332,1.0,1.0,4/11,25.16%,KIF5C;RAB27A;SNAPIN;CDK5
prerank,regulation of T cell activation (GO:0050863),0.20490452737897474,0.5380534707297988,0.9765840220385675,1.0,1.0,4/42,8.32%,ABL1;TNFSF11;KAT2A;TNFRSF1B
prerank,negative regulation of viral genome replication (GO:0045071),0.20563450800568833,0.5378610743827703,0.9831223628691983,1.0,1.0,10/40,24.13%,SLPI;PLSCR1;MAVS;SRPK1;RESF1;TNIP1;MPHOSPH8;N4BP1;TASOR;IFIH1
prerank,RNA biosynthetic process (GO:0032774),-0.17420136893855837,-0.5375296303539951,0.9969040247678018,1.0,1.0,6/31,20.93%,SETX;TBPL1;POLA2;TAF10;TAF6;TCEA2
prerank,regulation of spindle assembly (GO:0090169),0.2212820887692127,0.5371590606284896,0.9629057187017002,1.0,1.0,11/25,31.78%,PDCD6IP;CEP97;CHMP4B;GPSM2;HSPA1A;CCSAP;CHMP5;DYNC1H1;RNF4;EML3;NUMA1
prerank,rRNA modification (GO:0000154),-0.1978119536834119,-0.5370812317318154,0.974293059125964,1.0,1.0,12/21,39.97%,TSR3;THUMPD1;DIMT1;MTERF4;NOP10;TFB1M;TFB2M;DKC1;NHP2;NAT10;FBLL1;TRMT112
prerank,cholesterol biosynthetic process (GO:0006695),0.21257500613799157,0.5351838251082676,0.9749262536873157,1.0,1.0,8/31,20.81%,MVD;FDPS;LBR;EBP;FDFT1;HMGCR;ARV1;DHCR7
prerank,regulation of cytoplasmic translation (GO:2000765),0.24986477720982986,0.5350228514469453,0.9454545454545454,1.0,1.0,1/14,3.71%,YBX3
prerank,protein localization to condensed chromosome (GO:1903083),-0.22142005147843558,-0.5348338868675397,0.960880195599022,1.0,1.0,12/12,77.88%,KNL1;TTK;IK;AURKB;MIS12;MTBP;ZW10;BUB3;CHAMP1;ZWILCH;SPDL1;CDK1
prerank,telomere maintenance via recombination (GO:0000722),0.25640359332114404,0.5343033081810826,0.9412780656303973,1.0,1.0,3/11,18.20%,ERCC1;NSMCE2;SMC5
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.1767206183679672,-0.5325772809802969,0.9881305637982196,1.0,1.0,7/29,20.26%,CNOT8;EXOSC8;LSM1;DCP1B;DCP2;EXOSC3;HBS1L
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.22060509924570226,-0.5316194962256301,0.9707207207207207,1.0,1.0,1/12,6.99%,PRKCQ
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.213509489520413,0.5307623168619517,0.958204334365325,1.0,1.0,10/29,25.54%,TELO2;RPA1;PPP6R3;ANKRD28;ACD;PINX1;MRE11;PPP6C;RFC1;TERT
prerank,DNA replication initiation (GO:0006270),0.21029572924773865,0.5302962270990748,0.9899569583931134,1.0,1.0,8/37,21.94%,MCM7;NOC3L;RPA1;LRWD1;ORC5;POLA1;PRIM2;MCM6
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.18292829544416717,0.5293357497990978,0.9987819732034104,1.0,1.0,14/83,16.33%,INHBA;PLK3;RRM2;CDKN1B;MNAT1;E2F3;PIM2;RB1;ACVR1;CUL4A;CDKN2D;CDK18;CDKN3;GSPT1
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.2508480288033525,0.5282357682797745,0.9344827586206896,1.0,1.0,7/12,31.13%,TGFB1;PPARG;NCOR1;TERT;ESR1;ZC3H12A;NCOR2
prerank,telomere organization (GO:0032200),0.19882355266819224,0.5242250577257125,0.9831223628691983,1.0,1.0,12/43,22.38%,ATM;STN1;RPA1;XRCC5;POLD3;PRKDC;WRN;NBN;ACD;MRE11;ATR;APEX1
prerank,endosome organization (GO:0007032),0.19873051891440463,0.5238866598944724,0.9817158931082982,1.0,1.0,11/41,24.96%,EEA1;WASHC5;SQSTM1;HOOK2;RAB22A;TMCC1;RNF26;RILP;CORO1C;ANXA8;ANXA8L1
prerank,regulation of mitotic spindle organization (GO:0060236),0.20259759722782184,0.5209334883672736,0.9725829725829725,1.0,1.0,11/35,28.55%,PDCD6IP;TACC3;CEP97;RAE1;DCTN1;CHMP4B;GPSM2;HSPA1A;CCSAP;CHMP5;DYNC1H1
prerank,indolalkylamine catabolic process (GO:0046218),0.25634886533493995,0.5202772231949793,0.9607142857142857,1.0,1.0,1/10,9.92%,KYAT1
prerank,regulation of TOR signaling (GO:0032006),0.18448393565935847,0.5200780879853517,0.995,1.0,1.0,11/67,16.13%,GOLPH3;SMCR8;DYRK3;SEC13;TELO2;MLST8;NPRL3;GPAT3;PRKAA1;MIOS;RRAGB
prerank,regulation of viral release from host cell (GO:1902186),0.22099409937699044,0.5198317492967282,0.9716088328075709,1.0,1.0,4/21,15.85%,TRIM26;TRIM25;TSG101;PML
prerank,telomere maintenance (GO:0000723),0.19310000286735868,0.5189465594174257,0.991701244813278,1.0,1.0,14/50,22.38%,ATM;STN1;RPA1;XRCC5;NSMCE2;POLD3;PRKDC;WRN;NBN;SMC5;ACD;MRE11;ATR;APEX1
prerank,positive regulation of chromatin organization (GO:1905269),0.2484209314894082,0.5180193991877506,0.956140350877193,1.0,1.0,3/12,18.45%,ATRX;UBE2N;ACD
prerank,icosanoid biosynthetic process (GO:0046456),-0.2240790843525067,-0.5177953175908141,0.9689578713968958,1.0,1.0,5/10,31.50%,MGST3;PLA2G5;ALOX5AP;ALOX5;LTA4H
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.2466797487256057,0.517279078374407,0.9474576271186441,1.0,1.0,1/12,5.11%,TRPM4
prerank,phosphate ion transmembrane transport (GO:0035435),0.24295689242809151,0.5170683280775481,0.9632224168126094,1.0,1.0,2/12,14.30%,SLC25A14;SLC20A1
prerank,steroid metabolic process (GO:0008202),0.18201427924887692,0.5163349452673819,0.9948849104859335,1.0,1.0,9/72,16.53%,CYP1B1;SULT1A1;FDX1;CYP27B1;CYP19A1;FDFT1;NPC1;CYP39A1;SULT2B1
prerank,pinocytosis (GO:0006907),0.2607494821417364,0.5161580085309034,0.9531835205992509,1.0,1.0,10/10,73.94%,MAPKAPK2;SNX33;CARMIL1;RAB34;MAPKAPK3;PPT1;PYCARD;SNX5;AHSG;DOCK2
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.19025848810100826,0.5155108464139337,0.9902642559109874,1.0,1.0,7/50,16.57%,CCNA2;CDKN1B;MNAT1;GTPBP4;CDKN2D;CDKN3;CCND3
prerank,positive regulation of tissue remodeling (GO:0034105),-0.22188077503940112,-0.5151033563019018,0.9734513274336283,1.0,1.0,1/10,9.17%,IL18
prerank,transcription by RNA polymerase III (GO:0006383),0.20720342426660873,0.5123856240509382,0.9861111111111112,1.0,1.0,11/27,28.45%,CRCP;POLR3GL;SNAPC5;SNAPC4;BRF1;ICE2;GTF3C2;SNAPC2;POLR3K;POLR3G;SNAPC1
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.24650469469061514,0.5121089711648162,0.9642184557438794,1.0,1.0,1/11,8.41%,PKD2L1
prerank,T cell activation involved in immune response (GO:0002286),-0.20788538961248948,-0.5110230609827623,0.9753914988814317,1.0,1.0,4/12,27.95%,MDK;CD74;LCP1;LILRB1
prerank,negative regulation of T cell activation (GO:0050868),0.19670186734044354,0.5091869766448317,0.9796215429403202,1.0,1.0,5/35,16.15%,IL10;CD80;SDC4;CEBPB;LAX1
prerank,GTP metabolic process (GO:0046039),0.22774852210939522,0.5081404041973605,0.9519725557461407,1.0,1.0,5/15,25.56%,RHOQ;RAN;ENTPD7;GNAI3;AK3
prerank,negative regulation of RNA metabolic process (GO:0051253),-0.19230359842214767,-0.5072039856841357,0.9899749373433584,1.0,1.0,3/18,12.57%,RPS13;TMBIM6;PTBP2
prerank,modulation by host of symbiont process (GO:0051851),0.20062305934976254,0.5059416948736658,0.9861751152073732,1.0,1.0,6/31,16.77%,EP300;JUN;SMARCA4;REST;SNW1;SAP30
prerank,aromatic amino acid family metabolic process (GO:0009072),0.24757189928046447,0.5057685043380737,0.9521276595744681,1.0,1.0,2/10,14.85%,KYAT1;PCBD1
prerank,protein localization to lysosome (GO:0061462),0.20533139398702366,0.5051056138087652,0.982274741506647,1.0,1.0,1/28,1.90%,NEDD4
prerank,regulation of cellular amino acid metabolic process (GO:0006521),-0.1445115810674723,-0.5050965347575921,1.0,1.0,1.0,53/53,85.60%,PPM1K;PSMB10;PSME2;OAZ1;PSMB3;PSMB4;PSMB8;PSMC5;PSME1;PSMA7;PSMD5;PSMA6;PSMD9;PSMA5;PSMF1;OAZ3;PSMA2;ODC1;PSMB9;PSMA4;PSMD10;PSMA1;NQO1;PSMB5;PSMB11;BCKDK;PSMD4;PSMB6;PSMA3;PSMC1;PSMC3;BHMT;PSMD6;OAZ2;PSMB7;PSMD12;PSME3;PSME4;PSMD11;PSMC4;PSMD14;PSMB2;PSMC2;PSMD2;PSMD3;PSMA8;PSMD7;PSMD1;PSMD13;PSMB1;AZIN1;PSMD8;PSMC6
prerank,aminoglycan metabolic process (GO:0006022),0.25030222595931384,0.503965371929595,0.95,1.0,1.0,4/10,24.85%,B4GALT7;B3GALT6;XYLT1;CHST9
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.22955318131112604,0.5024765737211553,0.9559322033898305,1.0,1.0,7/14,30.02%,YBX3;MYD88;MAPKAPK2;ANGEL2;MAPK14;TARDBP;ZFP36
prerank,lipoprotein transport (GO:0042953),0.24380398783473783,0.5011654919484149,0.9488536155202821,1.0,1.0,2/10,13.93%,CD36;LRP1
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.1972100131662412,0.5004708036489595,0.9802731411229135,1.0,1.0,8/31,22.32%,CNOT7;EXOSC7;DIS3L2;LSM2;EDC3;EXOSC5;EXOSC4;DCP1A
prerank,homocysteine metabolic process (GO:0050667),0.23440050219711228,0.49850644271618516,0.9601386481802426,1.0,1.0,11/11,76.58%,MTHFR;MTRR;DPEP1;CTH;MPST;BLMH;CPS1;MMUT;TST;CBS;NOX4
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.14448429928890566,-0.4944057374981459,1.0,1.0,1.0,50/50,85.60%,PSMB10;PSME2;OAZ1;PSMB3;PSMB4;PSMB8;PSMC5;PSME1;PSMA7;PSMD5;PSMA6;PSMD9;PSMA5;PSMF1;OAZ3;PSMA2;ODC1;PSMB9;PSMA4;PSMD10;PSMA1;NQO1;PSMB5;PSMB11;PSMD4;PSMB6;PSMA3;PSMC1;PSMC3;PSMD6;OAZ2;PSMB7;PSMD12;PSME3;PSME4;PSMD11;PSMC4;PSMD14;PSMB2;PSMC2;PSMD2;PSMD3;PSMA8;PSMD7;PSMD1;PSMD13;PSMB1;AZIN1;PSMD8;PSMC6
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.23111847162833826,0.49190115549527347,0.9491803278688524,1.0,1.0,2/13,9.13%,HES1;PIGU
prerank,tRNA 5'-end processing (GO:0099116),-0.1942109387464569,-0.4907886974354684,0.9896907216494846,1.0,1.0,6/15,28.49%,POP5;PRORP;HSD17B10;RPP25L;POP7;RPP21
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.1952837041273586,-0.49005044276920695,0.980349344978166,1.0,1.0,3/13,21.11%,HSP90AB1;STX3;TYROBP
prerank,glycine metabolic process (GO:0006544),0.23466633184757366,0.4894242302819793,0.9774696707105719,1.0,1.0,12/12,76.55%,GCAT;DLD;GCSH;AMT;SDSL;SDS;BAAT;RIDA;GLYAT;SHMT1;GLDC;SHMT2
prerank,folic acid metabolic process (GO:0046655),0.20988799065185376,0.48941792293997594,0.9847198641765704,1.0,1.0,6/18,25.04%,FPGS;MTHFD2;MTHFR;MTHFD2L;SLC19A1;MTRR
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.2416528814390719,0.4890970249411013,0.958974358974359,1.0,1.0,3/11,24.25%,TIMM10B;AGK;TIMM29
prerank,folic acid-containing compound metabolic process (GO:0006760),0.2100782053812558,0.489090853739883,0.9689655172413794,1.0,1.0,6/19,25.04%,FPGS;MTHFD2;MTHFR;MTHFD2L;SLC19A1;MTRR
prerank,regulation of lymphocyte proliferation (GO:0050670),-0.19336822444532265,-0.4890795243424865,0.9879518072289156,1.0,1.0,1/16,3.62%,AHR
prerank,lipoprotein localization (GO:0044872),0.23277375203264922,0.4859501066670942,0.9616055846422339,1.0,1.0,2/11,13.93%,CD36;LRP1
prerank,tryptophan catabolic process (GO:0006569),0.23565599497802875,0.48558075959579594,0.9750445632798574,1.0,1.0,11/11,76.45%,KYAT1;HAAO;IL4I1;KMO;ACMSD;IDO1;TDO2;IDO2;AADAT;KYNU;AFMID
prerank,aromatic amino acid family catabolic process (GO:0009074),-0.1931159711887348,-0.4855050357492247,0.9878345498783455,1.0,1.0,3/15,23.66%,QDPR;GSTZ1;KYNU
prerank,protein-DNA complex assembly (GO:0065004),0.16300468262612003,0.4845445699205316,1.0,1.0,1.0,35/116,26.36%,CHAF1B;KAT6B;NAP1L2;MCM7;MNAT1;ERCC3;RPA1;XPA;CHD1L;CUL4A;RAD23B;PSMC6;ORC5;XPC;ATRX;PSMD8;PSMB1;PSMD13;PSMD1;PSMD7;PSMA8;PSMD3;MCM6;PSMD2;PSMC2;ERCC2;PSMB2;ERCC5;HMGB2;BRD2;DMC1;PSMD14;ORC2;CUL4B;SMARCA5
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.16017646522737,-0.4832607687879202,0.9937304075235109,1.0,1.0,14/29,39.47%,RUVBL1;CENPP;KNL1;MIS18BP1;CENPI;CENPA;NPM1;MIS18A;CENPL;ITGB3BP;CENPN;CENPM;RSF1;CENPS
prerank,CENP-A containing chromatin organization (GO:0061641),-0.16017646522737,-0.4832607687879202,0.9937304075235109,1.0,1.0,14/29,39.47%,RUVBL1;CENPP;KNL1;MIS18BP1;CENPI;CENPA;NPM1;MIS18A;CENPL;ITGB3BP;CENPN;CENPM;RSF1;CENPS
prerank,DNA biosynthetic process (GO:0071897),0.21701981014517147,0.48250688695041133,0.9749582637729549,1.0,1.0,4/16,17.81%,POLD3;CDKN2D;WRN;POLA1
prerank,male meiosis I (GO:0007141),0.22141363592948177,0.48021300447800747,0.964110929853181,1.0,1.0,1/16,6.23%,TDRD9
prerank,regulation of lipid catabolic process (GO:0050994),-0.1726771427798578,-0.4800100261829603,0.9948586118251928,1.0,1.0,2/19,13.96%,ADRA2A;PDE3B
prerank,microtubule anchoring at centrosome (GO:0034454),0.24195970551634227,0.47975715838765753,0.9685314685314685,1.0,1.0,3/10,20.02%,PCM1;NIN;DCTN1
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.19227436301638762,0.47725703714603396,0.9925373134328358,1.0,1.0,1/29,2.80%,ANO6
prerank,B cell mediated immunity (GO:0019724),-0.2085870315736614,-0.47701287465464526,0.9888143176733781,1.0,1.0,10/10,79.16%,CD74;FCGR2B;CARD9;SLA2;CD19;MSH2;CD70;CD27;TLR8;FCER1G
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.16931922348157644,0.4761958496656019,1.0,1.0,1.0,17/67,23.72%,ITGAV;CHUK;ITGB5;SEC22B;SNAP23;CD36;PSMC6;PSMD8;PSMB1;PSMD13;PSMD1;PSMD7;PSMA8;PSMD3;PSMD2;PSMC2;PSMB2
prerank,histone exchange (GO:0043486),0.18594106878638988,0.47611119475275365,0.9914893617021276,1.0,1.0,10/37,23.44%,CENPQ;SRCAP;CENPX;VPS72;DMAP1;RBBP4;ZNHIT1;OIP5;CENPU;CENPC
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.2032028567888907,0.4751924144567346,0.9799691833590138,1.0,1.0,7/22,26.28%,ERI3;EXOSC7;WDR12;FTSJ3;ERI2;UTP20;KRI1
prerank,tRNA 5'-leader removal (GO:0001682),0.2202881012090178,0.47325050760421083,0.9796610169491525,1.0,1.0,1/13,5.54%,RPP38
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.1885475404618521,-0.4727853334552551,0.9895561357702349,1.0,1.0,4/14,24.90%,FASTKD2;UQCC2;COA3;RCC1L
prerank,lysine catabolic process (GO:0006554),0.22080864255026006,0.4706663693571117,0.9765886287625418,1.0,1.0,4/12,20.92%,OGDH;HYKK;DLD;PIPOX
prerank,lysine metabolic process (GO:0006553),0.22080864255026006,0.4706663693571117,0.9765886287625418,1.0,1.0,4/12,20.92%,OGDH;HYKK;DLD;PIPOX
prerank,tetrahydrofolate metabolic process (GO:0046653),0.22333256991659353,0.47047734086768167,0.9704797047970479,1.0,1.0,3/10,19.14%,MTHFD2;MTHFR;MTHFD2L
prerank,regulation of alcohol biosynthetic process (GO:1902930),-0.19454450454058736,-0.4694656226208802,0.9974619289340102,1.0,1.0,1/12,5.06%,CLCN2
prerank,vitamin D metabolic process (GO:0042359),0.21584630838774482,0.46220761211220607,0.9865771812080537,1.0,1.0,13/13,78.43%,CYP27B1;LRP2;VDR;PIAS4;UGT1A4;CYP11A1;FGF23;CYP24A1;CYP2R1;GC;CYP1A1;LGMN;CUBN
prerank,intracellular protein transmembrane transport (GO:0065002),0.17460696227878772,0.4590178811070614,0.9972527472527473,1.0,1.0,17/42,31.32%,SEC63;PEX2;DNAJC19;C2CD5;TIMM17B;PEX12;PEX16;PEX7;SEC61A2;AIFM1;TIMM23;TOMM20;GRPEL2;SEC61A1;DNAJC15;PEX5;HSPA5
prerank,purine-containing compound salvage (GO:0043101),-0.1916002260028878,-0.45449522772110973,1.0,1.0,1.0,12/12,80.86%,GMPR;APRT;AMPD1;PNP;DCK;GMPR2;ADK;DGUOK;AMPD2;HPRT1;ADA;AMPD3
prerank,snRNA transcription (GO:0009301),-0.12492301639105384,-0.45211271047387774,1.0,1.0,1.0,14/70,22.65%,RPRD2;RPAP2;POLR2K;PHAX;ELL;TAF6;ZC3H8;CCNK;ELL2;POLR2C;INTS4;POLR2G;SNAPC3;POLR2L
prerank,phosphate ion transport (GO:0006817),0.2048786900991247,0.45199431662737627,0.978441127694859,1.0,1.0,2/16,14.30%,SLC25A14;SLC20A1
prerank,regulation of mitochondrial translation (GO:0070129),-0.1585247656807261,-0.45136643864912745,0.9971671388101983,1.0,1.0,5/21,24.90%,FASTKD2;UQCC2;COA3;SHMT2;RCC1L
prerank,snRNA transcription by RNA polymerase II (GO:0042795),-0.12547775089574337,-0.4504832009233439,1.0,0.9995572173855877,1.0,14/69,22.65%,RPRD2;RPAP2;POLR2K;PHAX;ELL;TAF6;ZC3H8;CCNK;ELL2;POLR2C;INTS4;POLR2G;SNAPC3;POLR2L
prerank,defense response to Gram-negative bacterium (GO:0050829),0.16942605293240784,0.44808492373534614,0.9971509971509972,1.0,1.0,4/42,12.15%,LBP;RNASE6;TLR4;TNFRSF14
prerank,DNA catabolic process (GO:0006308),0.2179377531482703,0.4476048323056605,0.978984238178634,1.0,1.0,2/11,18.41%,DFFB;REXO4
prerank,anterograde synaptic vesicle transport (GO:0048490),0.2053904081409896,0.44505419821551195,0.9931740614334471,1.0,1.0,1/15,5.62%,AP3B1
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.2053904081409896,0.44505419821551195,0.9931740614334471,1.0,1.0,1/15,5.62%,AP3B1
prerank,negative regulation of interferon-beta production (GO:0032688),-0.19312057661909476,-0.4449720325472935,0.9932885906040269,0.9992339550744727,1.0,1/10,7.45%,SIRPA
prerank,meiosis I (GO:0007127),0.18739791431084324,0.4430345562591398,0.9954058192955589,1.0,1.0,23/23,81.29%,TDRD9;FOXJ2;MEIOB;FOXJ3;ZSCAN21;BCL2L11;SGO1;ZCWPW1;SYCP3;PTTG1;BTBD18;MEIOC;MEI1;DNMT3L;CCNA1;BRDT;MEIKIN;MOV10L1;SLC25A31;MYBL1;DDX4;HSF2BP;ING2
prerank,protein import into mitochondrial matrix (GO:0030150),-0.16111837459542916,-0.44236455309331224,0.9889196675900277,0.9986615920866876,1.0,6/18,31.79%,TIMM44;GRPEL1;TOMM40L;TOMM40;DNLZ;TIMM17A
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.17237762134220583,-0.44198582031868183,0.995260663507109,0.9978768321476192,1.0,5/16,26.78%,RAD21;BOD1;PDS5B;REC8;DSCC1
prerank,mRNA polyadenylation (GO:0006378),0.18140185003995102,0.4381369469285025,0.9955290611028316,1.0,1.0,9/26,27.50%,SCAF8;PAF1;PABPC1;GRSF1;MTPAP;LEO1;AHCYL1;FIP1L1;PNPT1
prerank,RNA polyadenylation (GO:0043631),0.18140185003995102,0.4381369469285025,0.9955290611028316,1.0,1.0,9/26,27.50%,SCAF8;PAF1;PABPC1;GRSF1;MTPAP;LEO1;AHCYL1;FIP1L1;PNPT1
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.21097231812190098,0.43310476793410996,0.9856373429084381,1.0,1.0,10/10,78.92%,CDC42;APC;SIRT2;RCC2;KNSTRN;ECT2;NEK2;CCNB1;RACGAP1;SPAG5
prerank,B cell activation involved in immune response (GO:0002312),0.19907701796503333,0.43282792178176416,0.9894366197183099,1.0,1.0,1/13,9.20%,RNF168
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.18865602935200304,0.4321673531831158,0.99185667752443,1.0,1.0,4/19,20.56%,MTOR;ZNF76;AR;ICE2
prerank,regulation of spindle organization (GO:0090224),0.1909310605560227,0.430945654308331,0.9951923076923077,1.0,1.0,8/18,33.07%,TACC3;RAE1;DCTN1;GPSM2;DYNC1H1;RNF4;NUMA1;GNAI1
prerank,regulation of lymphocyte activation (GO:0051249),0.20290546818127592,0.4285010056099151,0.9914089347079038,1.0,1.0,2/12,18.39%,KAT2A;IKZF3
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.20557403803904345,0.42780592004055457,0.9946524064171123,1.0,1.0,10/10,79.46%,PSMC6;PSMC2;ESR1;PSMC4;HMGB1;PSMC3;ATF7IP;TP53;THRA;PSMC5
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.18196512154073757,0.4275550410054121,0.9921507064364207,1.0,1.0,1/22,4.43%,NFE2L2
prerank,rRNA catabolic process (GO:0016075),0.1910999441004671,0.42540223984323666,0.9918433931484503,1.0,1.0,4/16,21.90%,EXOSC7;ERN2;EXOSC5;EXOSC4
prerank,cellular response to radiation (GO:0071478),-0.1313122023018917,-0.423239130767415,1.0,0.9984941320071792,1.0,15/40,34.35%,NET1;RHOB;GRB2;NSMCE3;BLM;GPR88;RAD51;TP53;RRH;FIGNL1;HUS1;RHNO1;EEF1D;RAD1;INTS7
prerank,C21-steroid hormone metabolic process (GO:0008207),0.18087972389892598,0.4172324895193898,0.9919614147909968,1.0,1.0,4/20,23.81%,FDX1;AKR1B1;STARD3NL;TSPOAP1
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.1671424758458311,0.41649148037667344,0.997134670487106,1.0,1.0,10/31,26.83%,PEX2;DNAJC19;TIMM17B;PEX12;PEX16;PEX7;AIFM1;TIMM23;TOMM20;GRPEL2
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.16817670341547464,0.41383984329914414,0.9954954954954955,1.0,1.0,6/28,23.56%,SHLD1;MRNIP;KDM4D;PRKDC;SHLD2;SIRT7
prerank,rRNA pseudouridine synthesis (GO:0031118),0.2009733286372697,0.41208201806473904,0.9839285714285714,1.0,1.0,1/10,8.44%,RPUSD1
prerank,glutathione metabolic process (GO:0006749),0.159269284485887,0.411205138734308,1.0,1.0,1.0,7/38,22.63%,GCLC;MMACHC;GSTM4;MGST2;GSTM5;GSS;GSR
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.18592755780125664,0.4098288860828093,0.9919224555735057,1.0,1.0,5/16,27.02%,TMEM50B;CHMP4A;CHMP4B;SNF8;CHMP5
prerank,negative regulation of double-strand break repair (GO:2000780),0.16376789629293428,0.4093284028607417,0.994277539341917,1.0,1.0,6/30,20.85%,TRIP12;SHLD1;UBR5;OTUB1;RMI2;SHLD2
prerank,double-strand break repair via break-induced replication (GO:0000727),0.19518257019565757,0.4068034046182892,0.9897959183673469,1.0,1.0,3/12,22.29%,MCM7;MCM6;MCMDC2
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.1764225599799018,0.40661111810267647,0.9932659932659933,0.9999485153804952,1.0,19/19,82.38%,POLD3;AMPD3;ADA;TERT;HPRT1;AMPD2;DGUOK;ADK;TYMS;GMPR2;DCK;PNP;AMPD1;APRT;POLL;POLD2;POLD1;CDA;GMPR
prerank,tryptophan metabolic process (GO:0006568),0.19379941509833282,0.4033267311185111,0.9911032028469751,0.999803572747905,1.0,1/11,9.92%,KYAT1
prerank,regulation of exit from mitosis (GO:0007096),0.15360500981860248,0.3984776507557249,1.0,0.999797258007489,1.0,6/38,18.61%,ANAPC5;ANAPC16;CDC16;UBE2S;MAD2L1BP;CDC14A
prerank,production of siRNA involved in RNA interference (GO:0030422),-0.17182346813781718,-0.3982647258425284,0.9977924944812362,0.9989374692230394,1.0,2/10,22.46%,TARBP2;MRPL44
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.15853193456777936,0.39262224652895095,1.0,0.999813692201643,1.0,7/26,26.71%,ACOD1;TRAFD1;CARD16;TRAF3IP1;RNF26;MUL1;ILRUN
prerank,pseudouridine synthesis (GO:0001522),0.178616273229533,0.3822350851718194,0.9928057553956835,1.0,1.0,13/13,82.15%,PUS10;TRUB2;PUS7;PUS3;GAR1;PUSL1;PUS1;NHP2;DKC1;NOP10;RPUSD2;TRUB1;PUS7L
prerank,steroid hormone biosynthetic process (GO:0120178),0.1531731819514781,0.3779173352312562,0.998567335243553,0.9998816074833112,1.0,8/29,28.09%,FDX1;CYP19A1;AKR1B1;STARD3NL;DHCR7;TSPOAP1;SRD5A3;HSD17B2
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.18428463764721176,0.377846778395631,0.9965217391304347,0.999491473259858,1.0,2/12,18.02%,METTL4;NBN
prerank,rRNA methylation (GO:0031167),0.16015668515346865,0.37657369644976635,0.9923664122137404,0.9991598110908377,1.0,7/22,26.08%,MRM2;MRM1;NSUN4;ZCCHC4;NOP2;FTSJ3;METTL15
prerank,cilium-dependent cell motility (GO:0060285),0.15965222063420612,0.37529221845607613,0.998422712933754,0.9988252243287777,1.0,6/22,24.55%,DNAH8;TEKT2;DNAH2;RSPH9;GAS8;CCDC65
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.16528751706256772,0.36648544962319574,0.9983606557377049,0.9988093603147971,1.0,6/17,27.73%,RB1;CDK1;SPDL1;ZWILCH;CHAMP1;CTCF
